data_1k0v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k0v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -147.2 75.35 1.37 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.579 1.151 . . . . 10.0 108.204 170.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -92.2 175.52 6.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.308 1.051 . . . . 10.0 109.341 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -150.86 137.85 19.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.87 101.7 14.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.774 -2.306 . . . . 10.0 104.774 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.05 147.27 51.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.28 131.53 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.203 1.401 . . . . 10.0 112.587 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -78.6 -59.66 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.332 2.653 . . . . 10.0 110.862 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.05 -36.15 0.05 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.757 -0.469 . . . . 10.0 112.778 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 166.48 2.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.129 0.966 . . . . 10.0 111.957 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 m -156.17 42.94 0.4 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t -112.61 96.15 5.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.552 -1.648 . . . . 10.0 106.552 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -55.96 -25.12 42.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.353 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -74.95 -41.34 59.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.76 0.824 . . . . 10.0 109.322 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.66 -71.41 0.08 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.832 0.853 . . . . 10.0 109.43 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -48.57 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 O-C-N 121.677 -0.639 . . . . 10.0 112.663 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -28.15 64.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.24 78.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -84.39 -41.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 118.61 -0.71 . . . . 10.0 110.519 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -39.4 -52.94 2.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.293 1.037 . . . . 10.0 110.503 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -48.84 75.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.612 -0.722 . . . . 10.0 110.907 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 m -59.34 -49.79 76.48 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.166 0.586 . . . . 10.0 111.227 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -55.27 -33.67 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.529 -0.732 . . . . 10.0 110.985 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.42 -18.37 14.77 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.922 0.772 . . . . 10.0 113.105 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.08 -34.38 75.04 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 118.626 1.213 . . . . 10.0 110.369 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 95.37 0.56 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.372 -0.83 . . . . 10.0 110.593 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -21.03 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.615 2.766 . . . . 10.0 114.347 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -44.66 -53.93 6.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.28 0.943 . . . . 10.0 113.865 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -52.63 111.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.452 1.101 . . . . 10.0 109.721 -173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -37.92 58.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.118 -0.947 . . . . 10.0 108.727 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.86 156.97 9.63 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.42 113.27 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.211 1.405 . . . . 10.0 107.231 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -116.66 78.18 1.18 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.089 0.956 . . . . 10.0 108.684 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.02 115.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.185 0.994 . . . . 10.0 109.847 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -144.92 48.78 1.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.139 0.975 . . . . 10.0 110.09 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -49.84 -45.81 50.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 10.0 112.205 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.42 -42.71 82.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.515 1.126 . . . . 10.0 111.11 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.06 58.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.036 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.29 -70.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.474 1.035 . . . . 10.0 111.064 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.36 177.88 5.82 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.681 1.593 . . . . 10.0 109.418 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 m -93.71 109.85 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 108.094 -1.076 . . . . 10.0 108.094 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -93.51 118.8 31.8 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.1 t -132.35 137.49 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 122.227 1.013 . . . . 10.0 109.958 -168.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.1 m -105.12 66.36 0.75 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 -172.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.41 138.77 56.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.158 -1.383 . . . . 10.0 108.643 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -83.44 89.74 7.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.503 -0.479 . . . . 10.0 111.473 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.86 -19.59 1.81 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.77 -14.3 45.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.447 1.021 . . . . 10.0 110.62 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -117.34 -52.95 2.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.272 1.029 . . . . 10.0 109.252 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.84 139.37 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.175 0.99 . . . . 10.0 110.31 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -93.04 145.18 24.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.541 -0.724 . . . . 10.0 109.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -34.83 -46.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 128.956 2.902 . . . . 10.0 110.405 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -32.3 -51.26 0.25 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.523 1.129 . . . . 10.0 112.221 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -52.37 -72.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.954 1.302 . . . . 10.0 110.59 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -57.96 -49.17 82.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 125.366 1.466 . . . . 10.0 112.161 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.81 -59.13 2.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.495 1.918 . . . . 10.0 109.916 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.11 -43.72 82.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.395 0.617 . . . . 10.0 109.827 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.83 61.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.607 0.763 . . . . 10.0 111.045 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -32.74 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 120.799 -1.188 . . . . 10.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -53.26 40.97 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.535 -0.728 . . . . 10.0 109.572 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -39.3 -64.66 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.888 1.275 . . . . 10.0 114.067 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -139.9 30.77 2.03 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.99 -54.09 0.32 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.0 -0.889 . . . . 10.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 64.66 110.65 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.795 2.038 . . . . 10.0 110.77 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 163.47 -32.25 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.78 1.232 . . . . 10.0 109.644 -168.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 69.3 t -72.4 87.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.394 -0.816 . . . . 10.0 111.073 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.47 -55.75 12.35 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.296 -1.002 . . . . 10.0 108.296 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -174.59 156.9 2.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.099 -1.445 . . . . 10.0 107.099 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.765 0 C-N-CA 124.506 1.122 . . . . 10.0 110.4 168.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.5 102.82 4.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.089 1.756 . . . . 10.0 107.847 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -117.83 168.74 10.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.503 1.145 . . . . 10.0 109.694 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.55 126.13 49.57 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.608 -2.367 . . . . 10.0 104.608 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.92 105.79 17.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 103.582 -2.747 . . . . 10.0 103.582 167.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -68.29 151.71 46.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.381 -0.97 . . . . 10.0 108.381 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.29 131.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.188 1.395 . . . . 10.0 113.604 -169.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -73.81 -62.3 1.54 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 128.547 2.739 . . . . 10.0 109.319 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.53 -26.79 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.834 -1.174 . . . . 10.0 114.163 -169.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -179.35 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.125 1.463 . . . . 10.0 110.656 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 t -163.7 65.23 0.17 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' C ' ' H ' ' A' ' 15' ' ' HIS . 48.8 t -144.82 91.86 2.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -55.86 -3.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.206 1.187 . . . . 10.0 114.206 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 13' ' ' CYS . 1.6 t-80 -94.84 -42.52 8.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 10.0 109.771 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.46 -66.29 0.41 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.648 0.779 . . . . 10.0 109.184 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -40.56 -47.83 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.49 0.716 . . . . 10.0 111.769 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -58.62 -31.48 68.14 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.8 -31.32 58.86 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.548 0.613 . . . . 10.0 110.133 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -95.03 -35.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.879 1.272 . . . . 10.0 111.073 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -36.45 -57.3 0.76 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.018 1.727 . . . . 10.0 110.724 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 p -51.98 -59.89 3.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.677 1.191 . . . . 10.0 111.204 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -56.28 -49.4 74.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.042 0.937 . . . . 10.0 110.929 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.33 -43.9 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 122.02 -0.425 . . . . 10.0 110.269 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.71 -30.87 14.9 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 123.474 0.559 . . . . 10.0 112.968 171.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.73 -36.36 80.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.169 0.985 . . . . 10.0 110.569 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 95.14 0.54 Allowed 'General case' 0 C--O 1.22 -0.473 0 O-C-N 121.352 -0.842 . . . . 10.0 109.409 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -19.02 -50.53 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.979 2.911 . . . . 10.0 114.756 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.01 -18.98 20.93 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.676 1.132 . . . . 10.0 115.138 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.63 108.25 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 119.392 -2.24 . . . . 10.0 105.699 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -36.14 78.16 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.023 -0.99 . . . . 10.0 109.912 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.13 154.76 9.15 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.974 -0.751 . . . . 10.0 108.974 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.34 142.21 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.496 1.518 . . . . 10.0 109.334 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 88.83 1.51 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 122.33 1.062 . . . . 10.0 108.94 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.56 124.46 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 124.834 1.253 . . . . 10.0 108.903 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -145.48 48.97 1.25 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.015 0.526 . . . . 10.0 110.83 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -49.2 24.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.511 0.724 . . . . 10.0 110.333 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.79 -23.52 61.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.261 1.024 . . . . 10.0 111.869 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.22 -29.79 21.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.588 0.232 . . . . 10.0 110.423 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.24 -57.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.935 0.778 . . . . 10.0 111.777 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 174.32 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.061 1.344 . . . . 10.0 111.586 -170.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.1 132.84 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.36 112.05 18.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.437 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 42.9 t -127.7 146.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.753 1.221 . . . . 10.0 109.001 -168.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -99.04 81.67 2.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 104.469 -2.419 . . . . 10.0 104.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 15.1 m-85 -85.88 127.91 34.7 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.079 -1.082 . . . . 10.0 108.079 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -86.08 82.17 8.19 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.38 -1.341 . . . . 10.0 107.38 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 -14.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.961 1.704 . . . . 10.0 113.528 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.15 -26.74 60.48 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.017 2.127 . . . . 10.0 108.775 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -121.19 -56.18 1.92 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.388 1.075 . . . . 10.0 108.496 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.12 138.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 124.131 0.972 . . . . 10.0 108.935 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 t -89.12 158.5 17.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.488 1.137 . . . . 10.0 110.202 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.1 m -47.45 -37.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 128.062 2.545 . . . . 10.0 107.744 165.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -56.06 -25.76 46.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 119.793 1.179 . . . . 10.0 112.853 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.45 -60.99 2.37 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.71 1.595 . . . . 10.0 109.104 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.28 -53.16 43.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 124.785 1.234 . . . . 10.0 112.599 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.91 -56.37 4.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.681 1.992 . . . . 10.0 110.163 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -59.76 -44.82 93.68 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.419 1.488 . . . . 10.0 108.87 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.27 -46.74 72.76 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.57 -0.706 . . . . 10.0 112.004 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -34.82 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 O-C-N 120.824 -1.172 . . . . 10.0 110.335 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -53.52 -42.34 67.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.776 -1.203 . . . . 10.0 110.394 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -53.6 -65.73 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.261 1.025 . . . . 10.0 112.72 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -136.42 34.48 2.74 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.188 -0.945 . . . . 10.0 113.543 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.05 -57.26 0.26 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.686 0.676 . . . . 10.0 112.484 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 62.64 102.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.445 1.898 . . . . 10.0 111.775 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t0 172.57 -40.07 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.752 2.021 . . . . 10.0 107.655 -168.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.06 98.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 120.526 -1.359 . . . . 10.0 112.657 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.99 -55.08 5.21 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.89 -0.782 . . . . 10.0 108.89 167.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -170.47 146.28 2.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.346 1.459 . . . . 10.0 107.125 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 123.886 0.875 . . . . 10.0 109.594 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 122.458 1.123 . . . . 10.0 109.337 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 pm0 -72.99 72.26 1.12 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.081 1.352 . . . . 10.0 110.337 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 160.65 30.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.745 1.259 . . . . 10.0 108.289 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -120.75 115.5 23.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.3 92.24 8.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.912 -2.255 . . . . 10.0 104.912 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -67.09 142.73 57.02 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.72 130.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.599 1.56 . . . . 10.0 112.784 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -81.72 -53.73 5.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.47 2.708 . . . . 10.0 110.479 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.79 -40.13 0.09 OUTLIER Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.237 -0.506 . . . . 10.0 112.428 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 156.92 21.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.55 0.675 . . . . 10.0 110.994 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.17 11.57 3.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.901 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.6 t -85.25 94.25 8.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.817 0.817 . . . . 10.0 109.101 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -57.63 -4.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.325 1.05 . . . . 10.0 113.651 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -92.9 -32.06 14.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.778 1.172 . . . . 10.0 111.15 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.4 m -63.35 -74.45 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -46.62 -49.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 112.944 0.72 . . . . 10.0 112.944 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.27 -33.45 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.209 0.818 . . . . 10.0 113.209 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.95 67.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.938 0.495 . . . . 10.0 109.911 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.39 -49.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 118.287 -0.863 . . . . 10.0 109.88 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -38.71 -49.29 1.57 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.977 1.711 . . . . 10.0 110.883 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.69 -51.33 50.57 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 10.0 111.152 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.94 -42.24 63.64 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.871 0.868 . . . . 10.0 111.568 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.59 -41.19 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.097 -1.002 . . . . 10.0 109.898 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.03 -26.33 19.31 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.702 1.144 . . . . 10.0 113.866 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.63 -29.83 67.4 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.845 1.323 . . . . 10.0 110.685 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 111.98 5.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.109 0.868 . . . . 10.0 109.407 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -42.62 -41.1 2.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.566 1.947 . . . . 10.0 112.693 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.54 -26.99 57.95 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.262 0.934 . . . . 10.0 113.904 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.96 112.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 120.203 -1.763 . . . . 10.0 106.616 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -79.39 -37.77 36.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 10.0 109.758 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.82 161.29 17.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.659 -1.237 . . . . 10.0 107.659 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.73 134.16 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.012 1.325 . . . . 10.0 108.25 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -143.36 89.57 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.49 1.116 . . . . 10.0 110.072 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.8 134.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.218 1.007 . . . . 10.0 110.286 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -156.79 49.45 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.871 0.468 . . . . 10.0 110.933 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -54.39 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 10.0 111.943 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.65 -38.11 86.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.566 0.746 . . . . 10.0 111.208 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -34.77 65.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.919 -174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.33 -73.35 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.61 -1.396 . . . . 10.0 109.61 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 -172.35 1.6 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.094 1.758 . . . . 10.0 107.666 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.06 117.8 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -100.88 130.1 46.84 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 44.5 t -136.55 149.54 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.87 -1.53 . . . . 10.0 106.87 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -111.04 85.77 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 104.915 -2.254 . . . . 10.0 104.915 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 39.9 m-85 -92.11 141.61 28.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.673 1.589 . . . . 10.0 108.276 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -89.89 93.3 9.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.617 0.767 . . . . 10.0 109.969 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.6 -14.67 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.714 -0.66 . . . . 10.0 112.296 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.3 -0.25 57.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.801 0.728 . . . . 10.0 109.685 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -130.52 -53.25 1.09 Allowed 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.675 -0.641 . . . . 10.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.89 164.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 118.701 0.682 . . . . 10.0 110.72 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.5 m -111.17 147.96 33.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -42.26 -34.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 C-N-CA 127.068 2.147 . . . . 10.0 110.148 167.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -48.29 -28.41 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.014 0.825 . . . . 10.0 112.324 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -68.9 -70.79 0.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.78 0.832 . . . . 10.0 109.008 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -59.33 -53.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.239 1.416 . . . . 10.0 113.787 -172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.11 -56.92 3.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.124 1.77 . . . . 10.0 109.953 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -58.91 -46.25 88.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.906 0.882 . . . . 10.0 109.459 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.5 67.62 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.767 -0.583 . . . . 10.0 111.207 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.07 -38.6 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.09 -1.006 . . . . 10.0 110.037 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -54.5 -41.18 69.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.523 -1.361 . . . . 10.0 110.293 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -53.95 -65.53 0.55 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.424 1.09 . . . . 10.0 112.925 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.28 50.39 1.8 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.655 -0.653 . . . . 10.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.79 -55.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 64.0 112.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.255 2.222 . . . . 10.0 110.432 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 168.34 -41.85 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.461 0 O-C-N 121.543 -0.723 . . . . 10.0 109.337 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -75.09 84.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.028 0.442 . . . . 10.0 110.885 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.28 -50.38 60.58 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -163.79 153.0 14.22 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 172.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.01 0 C-N-CA 124.904 1.282 . . . . 10.0 108.28 168.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -141.04 113.42 8.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -120.54 -178.63 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.973 0.909 . . . . 10.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -137.87 116.6 12.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.128 -1.805 . . . . 10.0 106.128 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -86.28 94.19 9.27 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 104.58 -2.378 . . . . 10.0 104.58 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -59.32 148.02 33.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.1 128.16 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.205 1.402 . . . . 10.0 110.797 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.9 -56.52 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.808 2.043 . . . . 10.0 108.016 170.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.82 -37.03 0.05 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.513 -1.327 . . . . 10.0 113.909 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 161.26 30.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.062 0.931 . . . . 10.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -143.31 21.28 1.89 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.246 0.618 . . . . 10.0 109.955 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.5 t -97.39 101.37 12.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -66.8 2.36 1.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -45.52 6.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.969 1.308 . . . . 10.0 110.641 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.0 m -49.43 -68.88 0.14 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.377 1.471 . . . . 10.0 109.526 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -39.85 -45.65 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 C-N-CA 123.972 0.909 . . . . 10.0 112.297 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 6.0 tttp -56.17 -31.17 63.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.158 1.17 . . . . 10.0 114.158 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -31.8 52.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.199 0.454 . . . . 10.0 110.524 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.75 -33.58 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.855 1.662 . . . . 10.0 110.602 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 25.4 tt0 -43.3 -47.82 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.994 1.318 . . . . 10.0 110.592 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -46.39 -61.37 1.83 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.987 0.915 . . . . 10.0 110.996 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -57.56 -50.35 73.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.385 1.074 . . . . 10.0 110.877 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.53 -47.29 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.757 0.823 . . . . 10.0 109.57 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.16 -38.92 88.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.716 0.674 . . . . 10.0 112.204 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -42.57 99.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.359 1.063 . . . . 10.0 110.724 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 112.58 1.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.796 -0.565 . . . . 10.0 111.216 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -35.85 -56.09 0.71 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.852 2.461 . . . . 10.0 112.303 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.94 -19.84 51.62 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.251 0.46 . . . . 10.0 114.251 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.45 109.17 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 119.17 -2.371 . . . . 10.0 107.498 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -74.84 -31.12 61.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.806 -1.088 . . . . 10.0 109.415 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 158.07 8.91 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.22 138.61 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.358 1.063 . . . . 10.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -158.48 101.14 1.68 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.9 123.03 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 C-N-CA 125.339 1.456 . . . . 10.0 107.732 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -137.19 53.1 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.46 0.573 . . . . 10.0 110.871 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mp -44.99 -47.67 11.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.465 1.106 . . . . 10.0 112.136 -175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.32 -33.39 73.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.491 0.716 . . . . 10.0 111.902 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.0 58.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.34 -64.04 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.82 -170.23 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.941 1.296 . . . . 10.0 110.822 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -94.98 128.29 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.778 1.231 . . . . 10.0 108.824 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.96 71.39 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.744 1.618 . . . . 10.0 109.04 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 12.4 t -84.78 152.31 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.836 1.254 . . . . 10.0 109.393 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 t -110.15 71.32 0.75 Allowed 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.257 -1.757 . . . . 10.0 106.257 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 12.4 m-85 -72.03 130.11 40.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.355 -1.293 . . . . 10.0 109.107 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -80.93 85.4 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.281 -0.887 . . . . 10.0 109.838 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.35 -21.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.902 1.281 . . . . 10.0 113.845 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.78 -19.91 51.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.296 0.953 . . . . 10.0 109.706 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -116.65 -53.96 2.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.889 1.275 . . . . 10.0 110.466 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -138.2 159.71 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.077 0.551 . . . . 10.0 109.938 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.5 p -108.37 161.51 14.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 m -31.86 -42.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.238 2.215 . . . . 10.0 111.656 168.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -29.6 -54.47 0.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.65 1.58 . . . . 10.0 111.303 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.11 -59.42 5.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.376 1.084 . . . . 10.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.61 -58.67 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.623 1.569 . . . . 10.0 111.955 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.46 -55.31 2.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 128.003 2.521 . . . . 10.0 110.007 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -56.86 -48.69 77.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.891 0.853 . . . . 10.0 110.557 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.6 79.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.454 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -35.84 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 120.558 -1.339 . . . . 10.0 109.967 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.26 -39.77 73.14 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.169 1.349 . . . . 10.0 111.755 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -49.43 -63.23 1.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.168 0.587 . . . . 10.0 112.341 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -134.81 13.34 3.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.532 0.938 . . . . 10.0 113.532 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -55.21 0.55 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.062 -0.854 . . . . 10.0 113.241 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 64.33 108.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.973 2.109 . . . . 10.0 111.256 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.75 -36.58 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.187 0.995 . . . . 10.0 109.951 -167.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.03 87.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.409 -0.807 . . . . 10.0 111.773 -169.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.79 10.36 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.288 -0.882 . . . . 10.0 110.136 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -174.13 152.85 1.93 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.579 -1.638 . . . . 10.0 106.579 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.041 0 C-N-CA 123.815 0.846 . . . . 10.0 110.038 178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 114.39 19.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.688 2.395 . . . . 10.0 105.379 170.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -123.01 168.05 12.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.946 -1.501 . . . . 10.0 106.946 168.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.64 122.24 32.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.45 97.43 11.07 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 172.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.86 153.28 42.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.604 0.761 . . . . 10.0 109.379 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.27 131.63 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -70.0 -56.91 5.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 130.491 3.516 . . . . 10.0 109.824 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.32 -30.21 0.18 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.451 -0.638 . . . . 10.0 112.423 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 169.58 10.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.133 0.967 . . . . 10.0 111.557 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.3 m -156.07 40.73 0.37 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.42 89.56 3.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -52.93 -16.28 1.0 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.132 0.973 . . . . 10.0 113.43 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -82.6 -39.64 21.92 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.196 -0.94 . . . . 10.0 109.835 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -57.53 -71.24 0.11 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.772 1.295 . . . . 10.0 108.31 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -46.46 -51.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.219 0.452 . . . . 10.0 112.219 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -28.93 68.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.366 0.984 . . . . 10.0 113.01 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.77 61.75 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 121.719 -0.613 . . . . 10.0 110.923 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.0 -44.59 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 118.156 -0.926 . . . . 10.0 110.633 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -44.95 -46.91 11.3 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.927 1.291 . . . . 10.0 110.302 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -50.14 -60.26 3.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.016 0.526 . . . . 10.0 111.553 174.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -58.7 -43.85 90.18 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.476 0.71 . . . . 10.0 111.767 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 t -53.45 -39.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.221 1.008 . . . . 10.0 110.21 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -45.92 -27.28 2.32 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.317 0.96 . . . . 10.0 114.423 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.23 -26.3 61.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.15 1.475 . . . . 10.0 112.149 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.77 113.56 2.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.179 0.9 . . . . 10.0 110.542 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -39.78 -45.9 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.194 2.198 . . . . 10.0 111.735 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -17.9 75.32 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.785 0.674 . . . . 10.0 114.785 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.91 107.54 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 118.683 -2.657 . . . . 10.0 107.245 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 t -79.35 -29.3 42.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.3 157.64 13.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.43 135.53 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.158 0.983 . . . . 10.0 109.103 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -149.21 87.22 1.52 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 t -73.19 117.4 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 123.726 0.81 . . . . 10.0 110.275 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.42 49.07 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.555 0.742 . . . . 10.0 111.437 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -52.42 -39.86 61.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.472 0.653 . . . . 10.0 112.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.91 -39.55 90.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.463 1.505 . . . . 10.0 110.69 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.2 -33.65 24.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.189 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.18 -67.65 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 179.01 5.16 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.355 1.862 . . . . 10.0 110.842 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -92.56 127.81 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 124.944 1.298 . . . . 10.0 107.941 173.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.83 94.02 4.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.33 1.052 . . . . 10.0 109.494 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 31.4 t -104.86 146.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.957 1.703 . . . . 10.0 107.738 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -103.8 68.89 0.94 Allowed 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.156 -2.165 . . . . 10.0 105.156 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 m-85 -66.78 128.43 36.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.915 -1.493 . . . . 10.0 108.662 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -79.95 85.4 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.83 -23.36 0.42 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.189 1.396 . . . . 10.0 113.385 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.04 -15.15 52.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.361 1.064 . . . . 10.0 110.603 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -121.48 -56.13 1.9 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.769 1.228 . . . . 10.0 109.42 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.41 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.227 1.411 . . . . 10.0 108.409 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -156.51 167.23 31.08 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.537 -1.283 . . . . 10.0 107.537 168.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -34.24 -42.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 128.116 2.566 . . . . 10.0 112.237 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -35.05 -41.48 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.017 1.327 . . . . 10.0 113.224 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.92 -67.38 0.51 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.869 0.843 . . . . 10.0 110.627 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.92 -55.81 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.846 1.259 . . . . 10.0 112.97 -173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.61 -56.9 4.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.813 2.045 . . . . 10.0 109.731 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.92 -49.62 65.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.55 0.691 . . . . 10.0 110.131 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.96 78.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.793 -0.639 . . . . 10.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -36.86 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 120.656 -1.278 . . . . 10.0 110.096 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.32 -40.87 71.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.499 -1.376 . . . . 10.0 111.645 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -51.5 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.154 0.888 . . . . 10.0 112.54 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.0 46.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.24 0.459 . . . . 10.0 112.24 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.57 -59.65 0.11 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.02 110.64 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.41 2.284 . . . . 10.0 110.919 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 t0 169.78 -38.55 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.93 1.692 . . . . 10.0 109.224 -167.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.93 90.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 120.484 -1.385 . . . . 10.0 112.382 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.9 -56.84 4.62 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.467 -0.77 . . . . 10.0 110.708 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -163.63 143.74 8.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.848 -1.538 . . . . 10.0 106.848 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.437 -1.078 0 C-N-CA 124.7 1.2 . . . . 10.0 108.311 172.767 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.346 0.593 . . . . 10.0 109.978 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.92 107.81 5.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.252 2.221 . . . . 10.0 106.369 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 161.34 15.71 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.24 -1.393 . . . . 10.0 107.24 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.38 115.55 26.77 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.99 96.98 7.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.948 -1.871 . . . . 10.0 105.948 168.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -65.0 155.71 33.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 10.0 109.662 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.12 129.61 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.302 1.441 . . . . 10.0 110.447 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 66' ' ' ASP . 28.1 tt0 -75.14 -43.63 51.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.962 1.705 . . . . 10.0 107.408 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.37 12.19 0.96 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.533 -1.148 . . . . 10.0 113.371 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -177.04 1.96 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.714 1.757 . . . . 10.0 109.722 169.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 p -155.53 15.16 0.37 Allowed 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.034 -0.416 . . . . 10.0 111.362 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -99.35 95.29 6.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -64.2 2.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.468 0.914 . . . . 10.0 113.468 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -94.0 -48.36 6.28 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.781 1.173 . . . . 10.0 110.046 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.3 m -48.21 -70.16 0.1 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.536 1.134 . . . . 10.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 m -38.45 -48.46 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.35 1.06 . . . . 10.0 111.89 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -38.14 89.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.359 1.064 . . . . 10.0 112.535 -174.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.4 69.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.5 t -73.46 -38.14 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.68 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -46.2 -49.81 16.57 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.922 1.289 . . . . 10.0 110.358 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -50.57 72.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.901 0.381 . . . . 10.0 111.264 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -70.79 -10.49 59.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.947 0.721 . . . . 10.0 112.947 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 -43.0 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.624 1.17 . . . . 10.0 108.312 169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.54 -30.35 19.64 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.886 1.231 . . . . 10.0 114.2 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.21 -31.24 72.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.145 0.973 . . . . 10.0 111.462 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.3 105.19 1.37 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -31.8 -42.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.054 2.142 . . . . 10.0 113.836 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.83 -20.43 47.97 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.426 1.012 . . . . 10.0 114.808 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.32 107.93 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 119.542 -2.152 . . . . 10.0 106.833 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -77.05 -29.4 55.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.185 -0.916 . . . . 10.0 109.378 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.08 13.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.182 -1.784 . . . . 10.0 106.182 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.84 119.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -136.31 97.87 3.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.282 1.033 . . . . 10.0 108.951 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.47 114.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.513 -0.921 . . . . 10.0 108.513 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -127.05 47.61 2.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.322 0.51 . . . . 10.0 111.963 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -49.53 -48.57 48.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 10.0 112.291 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -35.41 74.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.588 0.755 . . . . 10.0 110.99 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.08 -30.64 31.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.894 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.21 -69.72 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 123.98 0.8 . . . . 10.0 111.218 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -170.44 174.31 5.23 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.941 1.696 . . . . 10.0 112.627 -169.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.2 t -88.77 103.57 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 124.787 1.235 . . . . 10.0 107.971 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.2 116.36 30.26 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.461 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 57.0 t -136.3 135.13 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 -171.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.4 t -94.71 73.58 3.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.307 -1.368 . . . . 10.0 107.307 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 43.1 m-85 -68.67 136.41 52.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.519 -1.218 . . . . 10.0 109.281 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.71 87.03 7.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.545 0.688 . . . . 10.0 110.15 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.13 -20.1 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.08 -1.418 . . . . 10.0 113.623 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.67 -18.84 32.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 119.12 0.873 . . . . 10.0 110.215 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -117.45 -44.93 2.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.364 0.666 . . . . 10.0 109.745 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.53 -172.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.044 0.938 . . . . 10.0 109.425 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -142.62 159.18 42.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.737 0.779 . . . . 10.0 109.403 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -44.83 -36.44 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 128.274 2.63 . . . . 10.0 110.294 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -41.92 -50.3 4.51 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.434 1.016 . . . . 10.0 110.736 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.24 -49.84 74.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.587 1.185 . . . . 10.0 111.46 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -71.52 -58.46 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.256 1.822 . . . . 10.0 111.674 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.99 -59.21 1.51 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.348 2.259 . . . . 10.0 109.57 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -49.25 -51.99 30.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.442 1.497 . . . . 10.0 109.888 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.56 80.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -68.77 -58.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -37.42 -47.51 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.224 1.01 . . . . 10.0 113.007 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -42.92 -60.08 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.019 0.927 . . . . 10.0 113.407 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -136.63 -30.45 0.9 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.086 1.143 . . . . 10.0 114.086 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.8 94.43 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.51 172.18 0.19 Allowed 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.826 1.65 . . . . 10.0 110.112 -174.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.404 ' HA ' ' CB ' ' A' ' 9' ' ' GLU 0.336 7.5 t70 81.55 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.904 1.281 . . . . 10.0 112.431 177.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.38 93.95 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.223 1.409 . . . . 10.0 109.623 169.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.0 4.1 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.03 159.62 1.35 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.84 1.256 . . . . 10.0 107.791 -175.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 108.28 -1.008 . . . . 10.0 108.28 166.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -122.99 121.16 35.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.629 -2.73 . . . . 10.0 103.629 167.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -117.82 178.25 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.52 121.71 12.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 -177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.02 90.34 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 103.631 -2.729 . . . . 10.0 103.631 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.46 141.77 58.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -67.71 126.54 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.849 1.659 . . . . 10.0 112.45 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -75.03 -55.26 5.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.992 2.117 . . . . 10.0 109.319 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.02 -35.75 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.13 -1.034 . . . . 10.0 113.313 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.86 158.87 26.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.929 0.865 . . . . 10.0 109.24 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.71 20.93 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.918 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.2 113.14 25.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.64 -1.615 . . . . 10.0 106.64 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.02 -16.8 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.744 -0.383 . . . . 10.0 111.511 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -83.92 -44.17 14.52 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.709 0.686 . . . . 10.0 110.332 -169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -43.91 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.978 1.711 . . . . 10.0 109.195 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.55 -47.85 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 112.689 0.626 . . . . 10.0 112.689 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -44.25 -41.97 6.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.123 1.157 . . . . 10.0 114.123 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.86 -34.91 42.87 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.716 0.406 . . . . 10.0 110.379 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.4 -31.84 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.319 1.447 . . . . 10.0 111.123 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -43.6 -47.49 7.49 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.259 1.423 . . . . 10.0 109.323 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -55.04 -58.69 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.651 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -56.73 -49.66 74.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.947 1.299 . . . . 10.0 110.271 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 t -60.23 -49.96 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.568 0.747 . . . . 10.0 109.981 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.6 -32.14 38.57 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.007 0.813 . . . . 10.0 112.598 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.7 -32.35 73.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.385 1.074 . . . . 10.0 110.498 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 109.37 3.81 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 121.214 -0.929 . . . . 10.0 109.325 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -42.29 -40.42 2.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.755 1.622 . . . . 10.0 112.899 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.07 -18.39 54.6 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.094 1.33 . . . . 10.0 114.898 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.46 113.34 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 169.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -77.28 -32.96 55.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.331 -0.849 . . . . 10.0 110.69 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -171.5 158.97 5.38 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.894 -1.521 . . . . 10.0 106.894 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.58 136.88 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 105.995 -1.854 . . . . 10.0 105.995 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.89 84.15 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.575 1.178 . . . . 10.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.18 118.77 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.313 1.445 . . . . 10.0 110.302 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -144.69 50.12 1.28 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.942 0.497 . . . . 10.0 111.43 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mp -48.2 -58.03 5.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.37 1.068 . . . . 10.0 112.359 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.77 -43.21 94.0 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.94 0.876 . . . . 10.0 110.553 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.34 -29.34 68.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.733 -1.122 . . . . 10.0 111.019 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.27 -72.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.462 1.03 . . . . 10.0 111.098 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.37 -178.05 3.87 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.324 1.45 . . . . 10.0 110.25 -173.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -87.6 106.8 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -82.33 140.6 33.46 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.329 -1.359 . . . . 10.0 107.329 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -160.27 140.78 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 118.669 0.668 . . . . 10.0 109.45 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -116.91 82.91 1.88 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 -169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD2' HG11 ' A' ' 53' ' ' VAL . 44.0 m-85 -70.06 172.89 7.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.467 -0.788 . . . . 10.0 108.967 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -127.95 101.51 6.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 10.0 108.942 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -18.45 24.88 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.174 0.59 . . . . 10.0 111.881 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.03 -11.89 59.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.697 0.68 . . . . 10.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -121.29 -56.25 1.91 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.487 1.115 . . . . 10.0 109.246 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.1 159.49 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.454 1.102 . . . . 10.0 111.237 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 p -107.49 148.48 29.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.287 0.565 . . . . 10.0 109.991 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG11 ' CD2' ' A' ' 46' ' ' PHE . 21.4 m -37.62 -45.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 C-N-CA 129.063 2.945 . . . . 10.0 110.677 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -35.67 -49.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.773 0.829 . . . . 10.0 112.016 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -54.25 -63.93 0.99 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.885 0.874 . . . . 10.0 110.429 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -65.89 -50.73 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.184 0.994 . . . . 10.0 112.776 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.95 -62.84 0.58 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.924 2.09 . . . . 10.0 109.192 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.07 -45.06 79.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.605 0.717 . . . . 10.0 110.268 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.73 69.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.487 0.715 . . . . 10.0 110.872 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -34.87 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 120.969 -1.082 . . . . 10.0 110.117 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -57.62 -33.56 68.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.871 1.214 . . . . 10.0 111.738 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -56.9 -68.4 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.19 0.904 . . . . 10.0 111.862 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -135.49 33.6 3.01 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.84 -57.81 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.22 -0.767 . . . . 10.0 112.216 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.49 107.17 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.733 2.013 . . . . 10.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t70 171.49 -35.52 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 124.813 1.245 . . . . 10.0 110.171 -168.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.9 85.81 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.546 -0.721 . . . . 10.0 111.063 -172.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.84 -49.78 55.51 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -167.14 148.51 5.8 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.585 -1.635 . . . . 10.0 106.585 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 169.903 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -144.71 108.73 4.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -115.22 164.49 14.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.752 1.263 . . . . 10.0 108.809 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -122.23 114.59 21.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 127.004 2.122 . . . . 10.0 106.709 -167.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.79 85.79 6.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -59.96 149.75 30.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.04 0.936 . . . . 10.0 109.836 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.84 129.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.636 1.574 . . . . 10.0 111.86 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.59 -64.33 0.9 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 130.024 3.33 . . . . 10.0 108.799 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.08 -31.39 0.19 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.248 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 169.03 5.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.621 1.211 . . . . 10.0 110.048 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.7 t -158.86 39.32 0.22 Allowed 'General case' 0 C--N 1.334 -0.074 0 O-C-N 121.568 -0.708 . . . . 10.0 109.228 -169.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.09 97.55 6.14 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.87 -14.37 2.38 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.526 0.936 . . . . 10.0 113.526 174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -86.54 -47.97 8.77 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.509 1.05 . . . . 10.0 109.38 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.4 m -45.96 -65.45 0.55 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.676 1.19 . . . . 10.0 110.198 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 m -48.71 -48.18 15.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.23 0.468 . . . . 10.0 110.894 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -54.71 -34.62 62.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.23 57.62 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.78 -33.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.509 1.124 . . . . 10.0 111.085 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -41.15 -55.9 2.5 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 10.0 109.727 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.93 96.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.627 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m -56.88 -58.54 7.7 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.202 0.601 . . . . 10.0 109.989 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -49.99 -32.92 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.107 1.363 . . . . 10.0 112.446 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -22.8 4.05 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 114.637 0.615 . . . . 10.0 114.637 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.66 -32.28 73.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.422 1.489 . . . . 10.0 111.429 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.7 104.04 0.62 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.06 -37.07 14.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.965 1.306 . . . . 10.0 111.832 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.42 70.46 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.443 1.02 . . . . 10.0 113.977 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.75 106.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 120.192 -1.769 . . . . 10.0 107.501 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 m -73.37 -40.12 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.8 -1.091 . . . . 10.0 110.196 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.79 156.79 23.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.376 -1.342 . . . . 10.0 107.376 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.89 127.7 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.36 98.98 5.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 107.216 -1.402 . . . . 10.0 107.216 170.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.73 112.59 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.96 1.304 . . . . 10.0 108.441 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.99 48.3 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.632 0.604 . . . . 10.0 112.632 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.4 -46.54 62.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.618 -0.676 . . . . 10.0 112.304 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.1 -31.71 71.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.137 0.975 . . . . 10.0 111.017 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.01 18.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.861 0.362 . . . . 10.0 111.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.3 -78.49 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -1.379 . . . . 10.0 109.652 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 178.56 5.4 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.365 1.866 . . . . 10.0 109.256 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.19 105.44 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -102.0 125.88 48.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 10.0 108.119 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.4 t -136.54 142.35 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.979 0.895 . . . . 10.0 108.746 -168.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -101.69 77.5 1.74 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 105.849 -1.908 . . . . 10.0 105.849 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.44 138.04 46.84 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.048 -1.887 . . . . 10.0 107.509 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -90.49 95.78 10.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.035 -0.357 . . . . 10.0 110.035 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -19.94 14.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.881 0.872 . . . . 10.0 112.818 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.75 -15.86 59.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 119.23 0.923 . . . . 10.0 109.878 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -119.99 -54.39 2.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.752 0.821 . . . . 10.0 110.346 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.0 161.72 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.417 0.687 . . . . 10.0 110.782 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.9 t -110.3 156.38 20.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.485 1.136 . . . . 10.0 110.444 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 36.0 m -45.14 -39.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.098 2.559 . . . . 10.0 109.304 166.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -43.39 -39.27 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.445 1.02 . . . . 10.0 111.844 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.4 -58.9 3.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.425 0.557 . . . . 10.0 111.034 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.18 -50.09 71.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 120.84 -1.163 . . . . 10.0 112.163 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.97 -54.85 4.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.161 1.785 . . . . 10.0 109.352 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.37 -49.15 77.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.815 0.817 . . . . 10.0 109.879 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.69 67.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.63 0.772 . . . . 10.0 111.356 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.11 -42.94 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 O-C-N 120.962 -1.087 . . . . 10.0 110.878 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.287 0.1 OUTLIER -66.5 -26.7 67.29 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.723 1.601 . . . . 10.0 112.13 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -45.63 -66.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.059 0.944 . . . . 10.0 112.859 171.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.76 15.09 2.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.099 0.777 . . . . 10.0 113.099 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.2 -56.16 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.528 1.061 . . . . 10.0 111.461 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.31 113.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 10.0 112.292 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 163.13 -39.25 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 126.647 1.979 . . . . 10.0 108.487 -169.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.22 93.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 121.649 -0.657 . . . . 10.0 111.312 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.25 -56.97 5.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -170.61 162.86 8.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.728 -1.582 . . . . 10.0 106.728 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.894 0 C-N-CA 125.628 1.571 . . . . 10.0 110.474 170.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 121.949 0.881 . . . . 10.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.76 82.27 7.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.038 0.935 . . . . 10.0 110.473 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -75.96 150.31 37.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.4 132.11 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 103.809 -2.663 . . . . 10.0 103.809 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.4 92.89 4.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.007 -2.22 . . . . 10.0 105.007 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -61.71 146.65 48.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.708 -1.587 . . . . 10.0 108.534 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.72 134.4 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.961 1.304 . . . . 10.0 113.42 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -78.09 -68.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.686 1.995 . . . . 10.0 109.063 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.0 -38.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.018 -0.61 . . . . 10.0 113.252 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.04 160.43 6.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 117.961 0.88 . . . . 10.0 111.858 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 m -149.22 48.65 0.97 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -126.4 91.43 3.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.332 1.053 . . . . 10.0 108.402 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.5 -5.33 0.52 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.03 -37.69 14.96 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 120.87 -1.144 . . . . 10.0 110.291 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -58.72 -71.94 0.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 171.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -43.6 -52.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -56.84 -31.18 64.5 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.967 0.728 . . . . 10.0 112.967 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.36 68.19 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.05 -40.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 123.939 0.895 . . . . 10.0 109.749 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -41.62 -48.5 4.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.889 0.876 . . . . 10.0 110.533 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -53.16 61.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.959 0.409 . . . . 10.0 111.123 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -62.52 -16.86 58.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.106 1.762 . . . . 10.0 113.043 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -89.22 -42.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.477 1.111 . . . . 10.0 109.91 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.96 -26.18 47.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.748 1.166 . . . . 10.0 112.878 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -69.31 -28.26 66.11 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.948 0.874 . . . . 10.0 111.719 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.9 110.46 2.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.948 -0.701 . . . . 10.0 110.036 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -35.64 -44.16 0.31 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.404 2.282 . . . . 10.0 111.403 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 8.64 5.89 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.185 1.234 . . . . 10.0 116.185 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.21 111.49 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -74.45 -31.18 62.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.59 161.31 9.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.24 145.51 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.298 1.039 . . . . 10.0 109.757 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.35 82.89 0.84 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.988 0.899 . . . . 10.0 109.304 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.31 140.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.784 0.834 . . . . 10.0 109.597 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -161.17 44.44 0.17 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-O 121.172 0.51 . . . . 10.0 111.787 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.83 -46.64 64.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.507 0.723 . . . . 10.0 112.819 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -70.39 -24.78 63.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.965 1.306 . . . . 10.0 110.783 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.37 -27.27 19.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.136 0.574 . . . . 10.0 111.182 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.64 -69.7 0.09 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.524 1.059 . . . . 10.0 111.036 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.76 173.9 8.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.292 1.837 . . . . 10.0 108.701 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.9 138.6 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 169.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -122.52 110.46 15.61 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.103 1.761 . . . . 10.0 107.435 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 34.7 t -124.09 146.55 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.004 1.322 . . . . 10.0 107.576 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 t -103.28 78.59 1.63 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.308 -1.738 . . . . 10.0 106.308 -170.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 69.1 m-85 -83.78 138.1 33.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.936 -1.029 . . . . 10.0 109.905 -172.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -88.08 84.36 6.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.167 -0.924 . . . . 10.0 108.707 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.44 -21.19 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.138 1.375 . . . . 10.0 113.056 168.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -25.8 59.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.914 2.086 . . . . 10.0 109.976 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -117.7 -49.64 2.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.253 1.021 . . . . 10.0 109.261 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.98 -175.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.303 1.041 . . . . 10.0 109.612 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.9 p -133.81 158.82 42.41 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.72 -0.844 . . . . 10.0 108.72 170.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -44.02 -34.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.35 1.86 . . . . 10.0 111.133 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -47.39 -30.34 3.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.592 0.633 . . . . 10.0 112.129 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.4 -65.5 0.69 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 118.574 0.625 . . . . 10.0 109.623 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.58 -53.93 33.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.909 1.283 . . . . 10.0 112.909 -170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.0 -56.3 4.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.187 1.395 . . . . 10.0 109.764 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.6 -45.2 85.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.815 0.446 . . . . 10.0 110.271 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.37 -48.6 62.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.882 0.473 . . . . 10.0 110.601 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.56 -38.7 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.086 -1.009 . . . . 10.0 110.49 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.26 -34.84 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.32 -1.488 . . . . 10.0 111.564 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.02 -66.86 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.448 0.567 . . . . 10.0 112.262 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -134.69 40.86 2.93 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.212 0.605 . . . . 10.0 112.593 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.67 -59.04 0.08 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.825 -0.986 . . . . 10.0 111.305 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 64.92 108.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.215 2.206 . . . . 10.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.0 -37.6 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.888 0.875 . . . . 10.0 109.869 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -74.19 89.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.248 -0.908 . . . . 10.0 110.914 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.82 -52.3 31.46 Favored 'General case' 0 C--O 1.227 -0.103 0 O-C-N 121.508 -0.745 . . . . 10.0 109.016 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -170.13 153.12 4.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.028 0 C-N-CA 124.175 0.99 . . . . 10.0 110.686 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.03 126.09 24.45 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.229 1.411 . . . . 10.0 107.319 168.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.72 159.84 19.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.142 0.977 . . . . 10.0 109.879 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.16 122.25 46.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 mt -91.89 80.7 5.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.682 -1.97 . . . . 10.0 105.682 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -57.15 149.04 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 110.212 -0.292 . . . . 10.0 110.212 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.68 131.1 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.389 1.075 . . . . 10.0 113.212 -169.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.0 -58.65 3.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.245 2.618 . . . . 10.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.43 -34.33 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.134 -0.485 . . . . 10.0 112.551 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.93 165.79 10.26 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.781 0.791 . . . . 10.0 111.27 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 p -135.54 -34.81 0.83 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.368 1.067 . . . . 10.0 112.405 -168.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 t -48.37 88.49 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.14 1.776 . . . . 10.0 112.813 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.85 -7.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.498 -0.751 . . . . 10.0 112.904 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -86.61 -36.02 19.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.077 0.951 . . . . 10.0 110.031 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.7 m -59.6 -66.67 0.48 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -47.24 -50.88 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 112.213 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.261 0.7 OUTLIER -58.8 -32.25 69.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.403 -0.519 . . . . 10.0 112.297 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.37 -49.01 68.08 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.421 -0.799 . . . . 10.0 109.464 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.43 -44.25 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.814 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -39.8 -48.48 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.202 1.401 . . . . 10.0 110.844 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.3 p -50.51 -50.03 54.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.17 0.441 . . . . 10.0 111.574 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 m -71.26 -51.34 25.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.964 0.906 . . . . 10.0 110.552 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -53.78 -41.8 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.946 0.403 . . . . 10.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.96 -5.35 5.42 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.017 -1.435 . . . . 10.0 114.812 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -98.9 -18.58 17.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.672 1.736 . . . . 10.0 112.909 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 123.41 18.08 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 120.717 1.599 . . . . 10.0 109.941 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -41.26 -43.34 2.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.325 1.85 . . . . 10.0 112.58 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.85 -8.97 86.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.896 0.76 . . . . 10.0 114.897 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 102.56 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.728 -2.323 . . . . 10.0 104.728 169.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -70.54 -33.47 71.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.961 -1.018 . . . . 10.0 109.273 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.92 157.85 14.29 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.91 135.98 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.793 1.237 . . . . 10.0 108.794 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 91.75 2.5 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.276 1.03 . . . . 10.0 108.379 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -82.86 115.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.345 1.058 . . . . 10.0 109.48 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -143.96 49.55 1.37 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.35 -45.27 62.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.039 0.755 . . . . 10.0 113.039 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.11 -30.01 67.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.221 1.008 . . . . 10.0 111.646 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.89 18.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.759 0.314 . . . . 10.0 110.782 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.97 -69.89 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.34 -177.41 3.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.818 1.247 . . . . 10.0 110.975 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -92.46 110.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.523 -1.658 . . . . 10.0 106.523 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.57 126.3 51.53 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 76.8 t -138.54 143.43 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 t -100.12 78.01 2.04 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 53.5 m-85 -82.94 137.27 34.26 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.498 -1.228 . . . . 10.0 110.79 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.61 89.2 7.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.137 1.375 . . . . 10.0 109.728 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.93 -15.92 1.6 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.77 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -30.76 71.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.219 2.207 . . . . 10.0 108.96 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -120.7 -54.07 2.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.138 0.975 . . . . 10.0 109.615 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.77 160.52 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 123.75 0.82 . . . . 10.0 110.356 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 m -110.38 152.92 25.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.137 -1.06 . . . . 10.0 108.137 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -37.76 -39.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 127.902 2.481 . . . . 10.0 110.796 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -43.07 -31.32 0.53 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 10.0 113.599 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.01 -64.18 0.91 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.694 0.759 . . . . 10.0 110.605 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -62.75 -54.66 30.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 C-N-CA 125.792 1.637 . . . . 10.0 112.628 -174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.46 -65.1 0.33 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.798 2.039 . . . . 10.0 109.026 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -51.65 -47.64 63.68 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 10.0 110.868 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -46.57 70.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.203 0.601 . . . . 10.0 111.813 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -39.53 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.792 -1.192 . . . . 10.0 110.015 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.55 -30.88 65.57 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.868 -1.145 . . . . 10.0 111.154 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -59.45 -69.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.674 0.67 . . . . 10.0 112.17 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -133.03 33.11 3.69 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.845 0.858 . . . . 10.0 112.362 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.12 -61.07 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.798 0.713 . . . . 10.0 111.884 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 67.63 113.06 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.065 2.146 . . . . 10.0 112.297 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 166.64 -39.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 126.053 1.741 . . . . 10.0 109.267 -169.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.2 91.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.577 -0.702 . . . . 10.0 110.844 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.28 -53.78 18.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 121.692 -0.63 . . . . 10.0 109.586 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 147.96 5.81 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.641 -1.615 . . . . 10.0 106.641 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 107.903 -1.147 . . . . 10.0 107.903 176.195 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -146.83 69.7 1.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.769 2.028 . . . . 10.0 109.02 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -77.64 158.05 29.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.681 0.753 . . . . 10.0 109.66 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.44 125.61 51.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 -175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.13 88.41 5.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 169.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -61.41 148.33 42.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.41 0.684 . . . . 10.0 109.48 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.23 132.38 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.765 1.024 . . . . 10.0 113.765 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -71.73 -54.73 9.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.679 2.792 . . . . 10.0 108.596 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.36 -23.68 0.13 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.308 -0.86 . . . . 10.0 113.738 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 169.74 4.23 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.589 1.195 . . . . 10.0 111.987 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 28.83 0.73 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.37 93.39 4.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.087 -1.079 . . . . 10.0 108.087 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -58.75 -13.06 5.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -80.02 -45.59 18.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.6 m -52.07 -63.4 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.814 0.846 . . . . 10.0 109.609 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.69 -50.25 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.903 -0.57 . . . . 10.0 111.109 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -61.86 -32.97 73.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.44 1.018 . . . . 10.0 112.936 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.56 -40.83 69.13 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.585 -0.697 . . . . 10.0 109.484 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.13 -42.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 118.166 -0.921 . . . . 10.0 111.385 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -35.92 -57.9 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.145 1.778 . . . . 10.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -42.78 76.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 10.0 111.281 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -64.93 -50.64 65.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.234 1.014 . . . . 10.0 109.676 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.18 -39.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.461 0.704 . . . . 10.0 110.41 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.5 -27.87 9.13 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.755 1.169 . . . . 10.0 113.766 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -71.54 -25.96 62.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.984 1.392 . . . . 10.0 111.533 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 104.48 1.28 Allowed 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.356 -0.84 . . . . 10.0 109.315 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -46.08 -37.24 6.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.271 1.828 . . . . 10.0 112.729 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -8.99 55.54 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.844 -0.535 . . . . 10.0 114.166 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.84 109.85 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.97 1.885 . . . . 10.0 106.303 168.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -73.71 -30.07 62.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.731 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -172.25 168.35 5.66 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.89 135.26 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.863 1.265 . . . . 10.0 108.756 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 90.02 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.198 0.999 . . . . 10.0 109.602 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.56 106.77 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.527 1.131 . . . . 10.0 109.455 -176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -134.76 49.55 2.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.202 0.601 . . . . 10.0 112.241 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.6 -47.18 70.42 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.383 0.512 . . . . 10.0 112.383 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -63.91 -36.41 83.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.845 0.858 . . . . 10.0 111.074 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.22 22.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.859 -172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.62 -69.41 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 10.0 110.572 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.29 178.67 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.167 2.187 . . . . 10.0 110.822 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.55 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.45 121.19 39.07 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.7 t -132.27 144.4 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 t -101.73 69.49 1.21 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -69.01 137.87 54.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.973 -1.467 . . . . 10.0 108.733 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -94.24 87.12 5.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.047 168.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 -16.58 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.349 1.06 . . . . 10.0 113.376 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.82 -12.72 59.39 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.293 0.951 . . . . 10.0 110.033 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -131.12 -54.42 1.04 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.473 1.109 . . . . 10.0 110.391 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.62 135.74 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.817 1.247 . . . . 10.0 109.435 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 150.72 20.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -36.38 -41.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 128.72 2.808 . . . . 10.0 111.242 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -34.39 -49.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.302 0.955 . . . . 10.0 111.768 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.63 -67.22 0.3 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.42 1.105 . . . . 10.0 110.716 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.68 -57.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.374 . . . . 10.0 112.496 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.15 -59.34 0.87 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.656 2.382 . . . . 10.0 109.971 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.48 -51.11 68.07 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.87 0.468 . . . . 10.0 110.56 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.08 73.31 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.653 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -41.09 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.182 -0.949 . . . . 10.0 110.094 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.51 -36.75 69.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.974 1.261 . . . . 10.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.37 -59.57 4.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.085 0.554 . . . . 10.0 112.457 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -139.08 -18.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.382 1.252 . . . . 10.0 114.382 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.97 -47.13 40.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.847 0.749 . . . . 10.0 111.29 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 56.61 110.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.109 2.164 . . . . 10.0 112.525 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 167.24 -39.84 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.239 1.415 . . . . 10.0 109.285 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.84 92.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 O-C-N 121.496 -0.753 . . . . 10.0 111.209 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.86 4.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.711 0.767 . . . . 10.0 109.084 169.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.88 146.54 7.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.18 -1.415 . . . . 10.0 107.18 -171.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.438 -1.03 0 C-N-CA 124.782 1.233 . . . . 10.0 107.778 175.435 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 121.963 0.887 . . . . 10.0 108.826 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -140.98 112.91 7.74 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.788 2.435 . . . . 10.0 105.389 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 172.92 7.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.951 -1.87 . . . . 10.0 105.951 169.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.49 126.35 38.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.313 -2.476 . . . . 10.0 104.313 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -95.95 95.62 8.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -68.91 148.1 50.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.832 -0.803 . . . . 10.0 108.832 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.04 130.45 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 125.268 1.427 . . . . 10.0 112.958 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -71.64 -61.23 1.85 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.033 2.933 . . . . 10.0 108.196 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.0 -39.21 0.13 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.172 -0.771 . . . . 10.0 111.172 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.64 157.98 13.46 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.588 0.694 . . . . 10.0 110.518 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.9 51.84 0.39 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 -172.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.97 94.01 4.1 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.824 1.25 . . . . 10.0 107.785 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -59.99 0.57 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.19 1.182 . . . . 10.0 114.19 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -43.15 10.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.504 1.047 . . . . 10.0 109.464 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 m -57.96 -67.69 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.609 0.764 . . . . 10.0 109.13 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -43.11 -46.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 C-N-CA 123.331 0.652 . . . . 10.0 112.086 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -54.87 -33.07 61.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.776 1.028 . . . . 10.0 113.776 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.31 -29.15 57.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.473 0.309 . . . . 10.0 110.737 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.66 -33.57 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.564 1.546 . . . . 10.0 110.989 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -41.19 -49.47 3.56 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.706 1.203 . . . . 10.0 110.289 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.5 p -46.15 -68.65 0.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.517 1.527 . . . . 10.0 111.231 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -57.19 -39.37 75.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.873 1.269 . . . . 10.0 111.85 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.02 -42.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.875 -0.417 . . . . 10.0 109.875 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.83 48.38 1.97 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.274 1.416 . . . . 10.0 112.136 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.27 -42.86 0.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 127.86 2.464 . . . . 10.0 109.1 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -50.64 127.28 17.65 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.411 1.459 . . . . 10.0 110.794 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -46.46 -42.86 16.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.357 1.463 . . . . 10.0 111.966 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 -13.27 83.11 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.404 0.522 . . . . 10.0 114.404 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.55 109.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 119.708 -2.054 . . . . 10.0 106.094 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.04 -32.54 50.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.448 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.58 151.05 9.11 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.1 146.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.5 100.92 1.05 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 -173.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.88 109.92 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -135.33 46.61 2.38 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 111.762 0.282 . . . . 10.0 111.762 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -52.5 -48.68 65.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.835 0.854 . . . . 10.0 111.746 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -67.47 -26.83 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.991 0.916 . . . . 10.0 110.488 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 -30.89 16.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.572 0.349 . . . . 10.0 111.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -67.38 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.06 0.838 . . . . 10.0 112.074 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -171.11 176.11 4.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.862 1.665 . . . . 10.0 111.674 -169.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.52 129.51 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.296 0.638 . . . . 10.0 109.732 171.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -120.27 74.12 1.03 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.31 2.244 . . . . 10.0 108.852 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -94.05 149.97 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.205 1.402 . . . . 10.0 109.195 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -107.04 76.23 1.08 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -73.26 139.26 46.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.283 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.49 95.7 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.597 0.759 . . . . 10.0 109.78 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.87 -21.9 12.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.499 0.719 . . . . 10.0 112.784 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -87.62 -8.24 56.46 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.907 0.776 . . . . 10.0 110.68 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -119.72 -54.82 2.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.14 -170.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.433 1.493 . . . . 10.0 108.878 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.2 t -147.35 158.19 43.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.765 -0.828 . . . . 10.0 108.765 168.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -38.71 -46.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 C-N-CA 128.37 2.668 . . . . 10.0 109.598 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -44.15 2.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.54 1.064 . . . . 10.0 112.284 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.32 -61.54 2.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.566 0.698 . . . . 10.0 110.844 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -61.43 -53.6 46.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 124.542 1.137 . . . . 10.0 111.514 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.69 -62.52 0.53 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.923 2.089 . . . . 10.0 109.41 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.47 -43.87 75.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.366 0.603 . . . . 10.0 110.741 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.43 75.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.694 0.798 . . . . 10.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.51 -36.21 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 120.76 -1.212 . . . . 10.0 109.23 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.82 -42.19 75.32 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.609 -1.307 . . . . 10.0 111.273 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -52.25 -62.92 1.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.885 0.874 . . . . 10.0 112.546 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -144.22 66.89 1.27 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.088 0.555 . . . . 10.0 110.666 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.97 -59.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.012 -0.882 . . . . 10.0 111.467 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 68.84 113.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.253 2.221 . . . . 10.0 111.35 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 166.43 -32.45 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.284 1.434 . . . . 10.0 109.737 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.94 85.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 121.0 -1.063 . . . . 10.0 112.257 -168.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.1 -52.68 25.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.315 -0.866 . . . . 10.0 109.596 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -166.5 142.39 4.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.905 -1.517 . . . . 10.0 106.905 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.125 0 C-N-CA 125.483 1.513 . . . . 10.0 107.671 174.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.68 86.14 1.38 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.304 -0.999 . . . . 10.0 108.304 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -103.32 163.8 12.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.956 0.884 . . . . 10.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.68 109.62 16.86 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.613 -2.366 . . . . 10.0 104.613 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mp -83.07 87.72 6.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -54.73 152.17 7.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.115 0.966 . . . . 10.0 110.01 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.56 131.78 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 124.265 1.026 . . . . 10.0 110.65 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -69.61 -54.23 15.0 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 124.015 0.822 . . . . 10.0 109.312 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.37 -9.34 2.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.749 -0.473 . . . . 10.0 113.357 -170.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -58.29 176.31 0.18 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.969 0.884 . . . . 10.0 111.478 170.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t -152.44 31.76 0.52 Allowed 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.601 -0.687 . . . . 10.0 110.36 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.5 t -118.86 89.56 3.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.14 0.495 . . . . 10.0 110.8 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.71 -11.98 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.353 1.242 . . . . 10.0 114.353 170.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -91.69 -25.86 18.91 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.07 0.85 . . . . 10.0 111.395 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.28 -67.16 0.44 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -42.56 -55.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.519 0.728 . . . . 10.0 111.906 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -21.44 65.04 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.948 0.722 . . . . 10.0 112.948 -175.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.91 99.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.404 1.002 . . . . 10.0 109.232 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -82.51 -37.55 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.02 0.528 . . . . 10.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -41.34 -47.04 3.44 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.545 1.138 . . . . 10.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -51.3 64.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.078 0.466 . . . . 10.0 110.871 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -63.16 -47.63 81.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.447 1.099 . . . . 10.0 110.72 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 t -56.0 -40.93 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 10.0 110.013 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.11 -27.95 16.5 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.776 1.179 . . . . 10.0 113.767 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.15 -29.8 69.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.134 1.467 . . . . 10.0 110.744 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.61 80.67 1.09 Allowed 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.616 -0.678 . . . . 10.0 110.927 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD2' ' NZ ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -5.74 -57.52 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.948 3.299 . . . . 10.0 115.651 168.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.32 -56.65 1.48 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.868 1.223 . . . . 10.0 113.913 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.54 111.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.48 1.512 . . . . 10.0 109.853 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.31 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.88 -1.055 . . . . 10.0 109.982 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.95 12.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -136.27 94.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.912 1.285 . . . . 10.0 109.463 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -107.54 91.07 3.5 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.31 109.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 172.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -128.32 47.86 2.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.457 0.539 . . . . 10.0 112.457 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -51.33 -46.76 62.72 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.525 0.602 . . . . 10.0 112.113 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -70.12 -34.83 73.57 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.579 0.752 . . . . 10.0 110.955 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.09 -32.53 30.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.593 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.35 -73.02 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.26 -172.12 1.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.965 1.306 . . . . 10.0 112.598 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.06 100.73 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 108.466 -0.939 . . . . 10.0 108.466 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -98.0 108.99 21.83 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 42.7 t -128.14 131.5 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 -169.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 m -83.56 69.74 10.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 57.6 m-85 -64.73 141.41 58.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.321 0.648 . . . . 10.0 109.771 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -86.68 86.95 7.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.08 -18.26 0.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.844 1.054 . . . . 10.0 113.844 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.49 -18.65 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.599 1.091 . . . . 10.0 110.401 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -117.17 -55.78 2.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -175.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.07 129.88 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 124.402 1.081 . . . . 10.0 110.531 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.2 m -88.82 152.7 21.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.629 -0.669 . . . . 10.0 110.198 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.4 m -41.1 -38.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 128.269 2.628 . . . . 10.0 110.659 167.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -49.84 -37.42 30.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.429 -0.794 . . . . 10.0 112.342 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.44 -58.36 4.08 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.263 1.03 . . . . 10.0 109.399 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -56.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -168.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.21 -52.32 4.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.377 1.471 . . . . 10.0 109.861 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.97 -49.09 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.437 0.695 . . . . 10.0 110.54 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.7 68.15 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.765 0.826 . . . . 10.0 111.172 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -58.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 108.76 -0.83 . . . . 10.0 108.76 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -40.01 -40.63 1.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.512 1.051 . . . . 10.0 113.79 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -40.83 -50.88 3.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.605 0.965 . . . . 10.0 113.605 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -151.32 -41.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.533 1.133 . . . . 10.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-O 118.793 -1.004 . . . . 10.0 111.295 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 58.29 175.29 0.06 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.203 1.801 . . . . 10.0 112.545 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 93.9 28.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.437 2.295 . . . . 10.0 112.771 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.66 91.36 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.866 1.267 . . . . 10.0 109.484 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.61 -55.52 7.6 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 168.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -172.34 162.13 5.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.014 1.325 . . . . 10.0 107.429 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.915 0 C-N-CA 125.09 1.356 . . . . 10.0 110.241 170.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -141.84 87.63 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.037 -1.098 . . . . 10.0 108.037 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -98.03 162.65 13.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.956 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 122.77 46.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 104.65 -2.352 . . . . 10.0 104.65 -177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.53 95.99 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 103.512 -2.773 . . . . 10.0 103.512 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.04 150.65 46.39 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 10.0 108.189 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.95 134.54 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -168.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -69.22 -64.96 0.77 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.04 -34.37 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.348 -0.93 . . . . 10.0 114.881 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.0 172.37 2.37 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.305 1.053 . . . . 10.0 112.022 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -157.41 52.69 0.48 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.6 t -130.98 94.88 3.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.414 1.086 . . . . 10.0 108.143 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.61 -21.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.87 1.668 . . . . 10.0 111.418 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -82.74 -41.7 18.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.044 -0.725 . . . . 10.0 109.044 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.9 m -52.47 -66.27 0.41 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -51.41 -50.93 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 122.006 -0.434 . . . . 10.0 111.563 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU 0.26 0.0 OUTLIER -60.35 -26.42 66.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.995 0.739 . . . . 10.0 112.995 -178.174 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.22 84.08 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.06 -1.025 . . . . 10.0 109.035 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -75.64 -40.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.343 0.657 . . . . 10.0 111.364 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 3.4 tm-20 -34.78 -49.28 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.114 1.766 . . . . 10.0 111.019 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -54.72 -60.11 3.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.631 0.253 . . . . 10.0 111.522 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -55.09 -48.54 73.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.01 0.924 . . . . 10.0 110.502 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 t -56.85 -44.26 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.141 0.576 . . . . 10.0 110.367 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.7 -31.2 57.61 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.185 0.898 . . . . 10.0 113.146 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.28 -29.16 66.99 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.167 0.984 . . . . 10.0 110.773 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 108.31 4.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.077 -1.015 . . . . 10.0 109.624 176.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -37.35 -37.1 0.17 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 10.0 112.61 169.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.69 -2.07 1.59 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.225 1.393 . . . . 10.0 116.036 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.29 120.29 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.539 1.936 . . . . 10.0 106.32 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -29.2 25.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.269 0.628 . . . . 10.0 109.894 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.09 160.51 9.9 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.34 133.82 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.351 1.061 . . . . 10.0 110.58 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -143.21 81.4 1.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.909 1.284 . . . . 10.0 108.855 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.64 135.74 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.319 1.048 . . . . 10.0 108.85 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -163.55 48.07 0.13 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.517 0.675 . . . . 10.0 110.796 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -61.05 -41.97 97.6 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.86 -0.525 . . . . 10.0 111.373 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.98 -39.91 93.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.499 0.72 . . . . 10.0 110.25 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.0 -31.8 27.29 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.507 0.723 . . . . 10.0 110.932 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.61 -59.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.397 -0.668 . . . . 10.0 113.154 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 173.33 4.96 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.859 2.064 . . . . 10.0 109.78 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.05 119.88 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 172.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.26 120.21 40.32 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.457 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 48.1 t -133.01 143.83 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.881 -1.526 . . . . 10.0 106.881 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.0 m -96.59 71.54 2.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.457 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 49.3 m-85 -73.39 134.56 44.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.871 0.843 . . . . 10.0 109.108 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.57 77.8 9.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.699 0.762 . . . . 10.0 109.069 172.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.96 -17.68 0.42 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.886 1.675 . . . . 10.0 113.917 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.11 -6.28 59.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.424 1.89 . . . . 10.0 111.072 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -57.52 1.13 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.736 1.614 . . . . 10.0 108.726 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.7 143.96 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 126.222 1.809 . . . . 10.0 107.572 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 m -98.22 147.65 24.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -31.82 -44.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 128.346 2.658 . . . . 10.0 110.96 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -28.36 -53.23 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.967 1.307 . . . . 10.0 111.892 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.04 -69.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.358 1.063 . . . . 10.0 111.473 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -60.38 -53.53 47.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 125.207 1.403 . . . . 10.0 111.683 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.35 -58.61 1.49 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.924 2.089 . . . . 10.0 110.398 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.4 -45.26 91.99 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.891 0.377 . . . . 10.0 110.219 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.77 -45.18 67.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 10.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.08 -53.02 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 O-C-N 121.272 -0.892 . . . . 10.0 108.713 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.23 -21.4 47.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.956 1.707 . . . . 10.0 114.288 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.29 -58.67 5.94 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.897 0.771 . . . . 10.0 111.474 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -143.56 -19.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.534 1.679 . . . . 10.0 115.534 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.68 -51.68 24.11 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.686 1.136 . . . . 10.0 112.045 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 66.42 97.61 0.05 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.412 1.885 . . . . 10.0 111.759 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 174.28 31.09 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.362 1.865 . . . . 10.0 112.987 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -141.7 80.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 O-C-N 119.617 -1.927 . . . . 10.0 110.331 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.7 76.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 171.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -167.55 143.8 4.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 125.091 1.357 . . . . 10.0 107.415 169.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.473 -0.565 . . . . 10.0 109.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -140.2 78.87 1.68 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.804 1.242 . . . . 10.0 107.695 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -89.73 165.54 14.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.279 -0.873 . . . . 10.0 108.91 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.83 133.3 44.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 102.796 -3.038 . . . . 10.0 102.796 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.02 96.6 6.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 104.371 -2.455 . . . . 10.0 104.371 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -62.23 148.74 43.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.069 -0.968 . . . . 10.0 108.624 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.61 132.34 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 125.07 1.348 . . . . 10.0 112.807 -172.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.89 -64.22 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.046 2.538 . . . . 10.0 109.453 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.0 -40.53 0.04 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.656 -0.578 . . . . 10.0 111.656 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 170.05 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.437 0.903 . . . . 10.0 113.437 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 p -145.99 12.77 1.27 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.742 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.84 86.47 6.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -55.58 -12.18 1.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.422 ' CD2' ' HZ2' ' A' ' 18' ' ' LYS . 15.4 t60 -83.43 -35.89 24.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.408 -0.807 . . . . 10.0 109.375 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -62.12 -68.21 0.35 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.85 -52.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.689 0.795 . . . . 10.0 113.117 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HZ2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -57.47 -29.79 64.53 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.671 -0.643 . . . . 10.0 112.595 -177.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.16 -43.86 64.32 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.61 -41.97 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.218 -0.896 . . . . 10.0 110.838 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.04 -38.51 11.11 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.311 0.96 . . . . 10.0 110.509 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.4 p -51.1 -65.03 0.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.933 0.788 . . . . 10.0 111.533 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -55.8 -51.0 68.97 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.994 1.318 . . . . 10.0 110.079 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.06 -42.76 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.693 0.797 . . . . 10.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.22 -27.71 11.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.561 1.077 . . . . 10.0 113.816 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.25 -19.81 35.69 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.768 1.284 . . . . 10.0 112.279 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.73 118.89 7.73 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.851 1.205 . . . . 10.0 109.985 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -39.9 -44.26 1.64 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.156 1.783 . . . . 10.0 112.515 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.49 -16.23 80.1 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.113 0.387 . . . . 10.0 113.884 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.84 111.59 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 O-C-N 119.454 -2.204 . . . . 10.0 106.628 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -30.74 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.804 . . . . 10.0 109.618 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.74 157.54 24.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.88 145.01 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.976 1.311 . . . . 10.0 108.192 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -161.86 82.86 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -64.77 138.72 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.191 0.596 . . . . 10.0 110.543 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.04 46.41 0.24 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.065 0.46 . . . . 10.0 111.061 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.51 -49.65 67.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.268 0.47 . . . . 10.0 112.268 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.08 -31.13 70.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.036 0.934 . . . . 10.0 110.707 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.76 -29.52 32.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.94 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.23 -62.17 0.12 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.169 0.89 . . . . 10.0 112.119 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.24 171.59 7.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.498 1.919 . . . . 10.0 109.833 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.53 132.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 169.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.18 111.04 16.91 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.0 142.25 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.384 1.074 . . . . 10.0 108.218 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.7 m -102.07 73.57 1.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -66.85 131.81 46.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.701 -1.591 . . . . 10.0 109.089 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.89 86.1 7.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.526 -0.916 . . . . 10.0 108.526 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.01 -10.96 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.994 1.109 . . . . 10.0 113.994 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -85.89 -13.21 48.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.411 1.005 . . . . 10.0 110.141 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -131.31 -54.36 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.7 p -103.09 -174.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 125.184 1.394 . . . . 10.0 109.239 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.4 p -148.81 151.91 35.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.182 -0.949 . . . . 10.0 108.523 167.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.75 -40.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.85 2.06 . . . . 10.0 110.132 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.47 -25.89 27.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.879 0.763 . . . . 10.0 112.813 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -70.67 -64.03 0.98 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.15 0.886 . . . . 10.0 109.637 168.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -63.65 -51.41 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.097 0.959 . . . . 10.0 112.563 -172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.24 -56.8 3.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.293 1.837 . . . . 10.0 109.622 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.01 -44.58 91.72 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.578 0.751 . . . . 10.0 110.329 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.48 70.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.212 0.605 . . . . 10.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.72 -35.92 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 121.095 -1.003 . . . . 10.0 109.447 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.32 -41.84 85.46 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.628 -1.295 . . . . 10.0 110.533 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -54.5 -67.7 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.016 0.926 . . . . 10.0 112.14 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -133.41 57.25 1.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.161 0.584 . . . . 10.0 111.704 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.01 -58.85 0.01 OUTLIER Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.213 -0.771 . . . . 10.0 111.369 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 67.46 106.9 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.153 2.181 . . . . 10.0 110.623 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 168.16 -35.17 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.241 1.416 . . . . 10.0 109.595 -168.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.73 93.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.181 -0.949 . . . . 10.0 111.285 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.21 -56.49 4.6 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.456 0.646 . . . . 10.0 109.907 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -164.4 143.13 7.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 10.0 109.057 175.042 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.965 0.888 . . . . 10.0 110.418 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.14 68.25 1.13 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.613 2.365 . . . . 10.0 106.998 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -75.68 160.27 30.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -131.15 132.85 45.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.978 -1.489 . . . . 10.0 106.978 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.79 108.32 19.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -75.96 148.28 38.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.683 -0.636 . . . . 10.0 109.306 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.05 130.33 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.584 1.554 . . . . 10.0 113.617 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -74.84 -58.74 3.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.143 2.577 . . . . 10.0 109.475 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.84 -32.24 0.06 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-O 119.185 -0.786 . . . . 10.0 113.464 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.03 169.5 5.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.594 1.197 . . . . 10.0 111.44 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 m -160.66 54.38 0.31 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 15' ' ' HIS . 53.0 t -128.75 93.04 3.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -51.74 2.52 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.05 1.87 . . . . 10.0 116.05 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -97.82 -50.81 4.3 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.841 1.655 . . . . 10.0 109.784 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.17 -62.14 1.8 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.083 0.953 . . . . 10.0 110.176 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.01 -47.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.764 0.316 . . . . 10.0 110.783 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -56.61 -35.54 68.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.307 1.225 . . . . 10.0 114.307 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -38.27 56.74 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 t -84.49 -37.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.142 0.977 . . . . 10.0 110.984 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -38.6 -56.09 1.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.697 1.599 . . . . 10.0 110.62 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -58.0 -48.7 79.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -56.98 -54.5 45.96 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.639 1.175 . . . . 10.0 109.57 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.64 -40.85 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 121.926 -0.484 . . . . 10.0 110.288 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.1 -31.86 6.17 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.059 0.837 . . . . 10.0 113.494 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -74.01 -26.38 60.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.865 1.332 . . . . 10.0 111.589 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.71 96.76 1.27 Allowed 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.138 -0.976 . . . . 10.0 110.157 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -20.56 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.58 2.752 . . . . 10.0 113.286 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.39 1.16 5.53 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.273 1.269 . . . . 10.0 116.273 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.87 110.93 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 104.602 -2.369 . . . . 10.0 104.602 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -30.05 48.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.658 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.96 158.15 10.35 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.95 125.01 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.983 1.313 . . . . 10.0 108.383 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -128.4 80.54 1.97 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.763 1.225 . . . . 10.0 108.498 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 t -74.42 108.5 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 126.273 1.829 . . . . 10.0 109.884 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -142.07 52.28 1.48 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.176 1.39 . . . . 10.0 110.173 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.55 -46.72 88.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.711 0.291 . . . . 10.0 111.458 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -68.11 -40.86 82.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.111 1.364 . . . . 10.0 109.922 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.56 -35.27 67.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.397 -0.819 . . . . 10.0 111.518 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.56 -64.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.434 0.54 . . . . 10.0 112.764 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 165.14 12.02 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 125.594 1.557 . . . . 10.0 109.259 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 m -88.14 115.12 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -102.6 121.25 42.01 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.12 131.96 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -94.54 78.55 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.239 -1.393 . . . . 10.0 107.239 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -75.59 135.82 40.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.54 -1.209 . . . . 10.0 109.489 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -90.08 89.08 7.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.011 1.324 . . . . 10.0 107.805 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.45 -16.18 8.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.249 0.833 . . . . 10.0 113.249 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.24 -18.33 62.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.828 1.651 . . . . 10.0 109.722 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -124.73 -55.86 1.6 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.757 1.223 . . . . 10.0 110.152 -169.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -137.33 148.44 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.092 0.957 . . . . 10.0 109.989 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -101.08 152.37 20.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -39.87 -40.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 C-N-CA 127.608 2.363 . . . . 10.0 110.961 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.87 -34.12 0.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.69 -65.38 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.855 0.752 . . . . 10.0 110.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.4 mp -64.79 -48.98 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.53 1.132 . . . . 10.0 112.543 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.77 -57.01 2.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.549 1.94 . . . . 10.0 110.423 170.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.5 -46.8 85.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.77 0.795 . . . . 10.0 109.662 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.54 -48.91 68.64 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.573 0.749 . . . . 10.0 111.332 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -73.03 -39.33 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.15 -0.969 . . . . 10.0 111.022 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.5 -34.55 78.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.588 1.54 . . . . 10.0 110.767 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -47.8 -66.25 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.594 1.157 . . . . 10.0 112.731 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -126.59 3.73 6.83 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.239 1.2 . . . . 10.0 114.239 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.07 -53.5 0.89 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.643 1.116 . . . . 10.0 112.489 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 68.0 111.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.5 2.32 . . . . 10.0 111.258 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 164.41 -34.88 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 110.574 -168.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.99 89.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 121.096 -1.003 . . . . 10.0 112.066 -168.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.39 -54.4 7.68 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 121.145 0.497 . . . . 10.0 110.042 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -169.04 143.58 3.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 -169.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 125.414 1.486 . . . . 10.0 110.015 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.718 -0.104 . . . . 10.0 110.718 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -128.72 90.7 3.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.755 2.422 . . . . 10.0 107.44 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -94.53 179.48 5.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.294 1.045 . . . . 10.0 109.957 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 t -146.14 134.96 22.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.931 -1.507 . . . . 10.0 106.931 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.61 95.73 10.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.522 -2.399 . . . . 10.0 104.522 170.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.59 144.1 57.28 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 128.12 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 124.644 1.178 . . . . 10.0 113.794 -169.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -69.55 -58.49 3.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 129.526 3.131 . . . . 10.0 110.254 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.73 -28.01 0.19 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.42 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.35 164.05 12.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.871 0.836 . . . . 10.0 110.35 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -147.52 12.05 1.02 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.784 0.434 . . . . 10.0 111.075 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -95.4 94.35 7.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -50.91 -18.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -35.83 36.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.87 0.759 . . . . 10.0 109.829 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -63.04 -67.27 0.44 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -49.97 -49.24 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.032 -0.417 . . . . 10.0 112.075 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -27.94 65.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.08 0.77 . . . . 10.0 113.08 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -36.4 74.43 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.42 -43.83 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 123.792 0.837 . . . . 10.0 110.163 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -39.25 -45.98 1.46 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.891 1.676 . . . . 10.0 111.339 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -48.99 68.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.544 0.688 . . . . 10.0 111.654 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.8 t -68.37 -54.18 19.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.654 1.182 . . . . 10.0 109.118 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 t -53.78 -38.96 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.197 0.599 . . . . 10.0 111.321 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.24 71.34 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.98 1.276 . . . . 10.0 113.385 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.25 -37.55 37.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.679 1.239 . . . . 10.0 110.39 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.92 122.67 10.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.798 0.726 . . . . 10.0 110.551 -175.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -48.24 -41.7 28.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.047 1.739 . . . . 10.0 112.532 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.55 -6.15 88.14 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.275 0.464 . . . . 10.0 113.928 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.96 115.32 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.363 -2.088 . . . . 10.0 105.363 168.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -77.85 -32.61 52.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.377 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.11 160.39 11.81 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.23 147.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.64 1.576 . . . . 10.0 107.975 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.51 89.98 1.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.713 0.768 . . . . 10.0 109.256 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.27 118.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 123.449 0.699 . . . . 10.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.95 44.65 1.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.568 0.747 . . . . 10.0 109.123 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -59.65 -51.33 70.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.502 -0.749 . . . . 10.0 112.19 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.89 -36.83 80.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.966 0.906 . . . . 10.0 110.034 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.33 62.53 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.479 -0.782 . . . . 10.0 111.286 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.97 -77.77 0.07 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.223 0.916 . . . . 10.0 111.498 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 171.26 11.66 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 126.586 1.954 . . . . 10.0 107.977 -173.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.6 t -90.83 105.55 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -82.45 136.99 34.8 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.62 139.55 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-O 122.161 0.981 . . . . 10.0 109.875 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 m -111.64 77.03 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.639 -0.71 . . . . 10.0 109.454 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.34 140.64 46.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -96.51 94.09 7.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.428 0.691 . . . . 10.0 109.439 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.66 -22.03 1.22 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.965 1.306 . . . . 10.0 113.738 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.34 -6.99 58.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.275 0.943 . . . . 10.0 110.048 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -126.54 -55.83 1.41 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.15 0.98 . . . . 10.0 109.891 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.28 164.05 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 119.535 1.062 . . . . 10.0 111.018 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.2 m -118.14 168.4 10.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.56 0.744 . . . . 10.0 109.344 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -44.43 -29.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.69 2.796 . . . . 10.0 112.462 170.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -36.29 6.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.667 0.667 . . . . 10.0 111.397 172.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.89 -60.14 2.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.637 1.208 . . . . 10.0 110.385 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -70.01 -57.0 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 114.535 1.309 . . . . 10.0 114.535 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.67 8.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.897 0.879 . . . . 10.0 108.871 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.74 -51.38 56.59 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.789 0.435 . . . . 10.0 110.72 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.641 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -48.61 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.137 -0.977 . . . . 10.0 110.272 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.66 -25.6 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.308 -0.87 . . . . 10.0 112.178 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.96 -44.56 40.92 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.626 0.77 . . . . 10.0 112.378 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -166.1 -28.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.21 -55.14 16.8 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.798 -1.001 . . . . 10.0 112.103 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 60.32 120.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.768 2.027 . . . . 10.0 111.963 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 163.66 -34.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 126.03 1.732 . . . . 10.0 109.805 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.5 88.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 121.006 -1.059 . . . . 10.0 111.424 -174.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.39 -52.93 27.56 Favored 'General case' 0 CA--C 1.523 -0.066 0 O-C-N 121.587 -0.696 . . . . 10.0 109.135 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -169.6 159.39 8.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 126.033 1.733 . . . . 10.0 108.367 -179.345 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.483 0.659 . . . . 10.0 111.715 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.46 112.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.516 1.527 . . . . 10.0 107.892 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.66 172.48 6.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.359 1.464 . . . . 10.0 108.071 172.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 124.77 42.28 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.29 97.67 10.76 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -62.32 153.89 29.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.249 -0.648 . . . . 10.0 109.249 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -65.65 128.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.672 1.589 . . . . 10.0 111.968 -173.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -73.28 -61.56 1.78 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.868 2.867 . . . . 10.0 109.135 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.38 -34.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.437 -0.887 . . . . 10.0 112.347 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.29 170.59 5.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.041 0.921 . . . . 10.0 110.928 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -159.15 30.89 0.21 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.848 -0.614 . . . . 10.0 109.412 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.43 102.68 12.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -56.11 -20.1 15.93 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -76.91 -42.23 40.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.984 0.811 . . . . 10.0 109.127 -172.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -55.49 -68.13 0.22 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.459 1.104 . . . . 10.0 109.874 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.5 -50.07 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -54.35 -33.69 59.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.943 0.792 . . . . 10.0 113.128 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.23 -34.23 66.13 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.361 0.6 . . . . 10.0 110.224 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 37.8 t -85.56 -45.07 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.783 0.833 . . . . 10.0 109.919 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -46.39 -42.1 14.57 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.571 1.148 . . . . 10.0 110.591 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -54.92 -45.69 74.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.43 0.559 . . . . 10.0 112.309 174.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -72.37 -42.37 65.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.607 0.763 . . . . 10.0 111.893 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.22 -43.22 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.516 0.726 . . . . 10.0 109.744 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.37 2.7 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.882 1.229 . . . . 10.0 111.877 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.39 -47.03 0.19 Allowed 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 127.382 2.273 . . . . 10.0 108.212 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 126.28 15.36 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.394 0.997 . . . . 10.0 110.488 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.73 -39.39 58.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.744 1.218 . . . . 10.0 112.156 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.33 -8.4 59.16 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.79 0.71 . . . . 10.0 114.14 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.76 106.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 O-C-N 119.271 -2.311 . . . . 10.0 105.441 168.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 t -74.37 -28.28 61.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.51 156.65 11.93 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.6 148.13 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.218 1.007 . . . . 10.0 108.604 176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -165.73 87.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.48 118.96 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.243 1.817 . . . . 10.0 109.915 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.11 48.74 1.87 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.745 0.418 . . . . 10.0 111.385 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -52.61 -44.55 66.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 10.0 111.963 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.63 -26.75 66.39 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.942 0.897 . . . . 10.0 111.286 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.12 13.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.678 0.391 . . . . 10.0 111.155 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.0 -65.63 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.8 179.29 3.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.026 2.13 . . . . 10.0 110.741 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -93.67 130.46 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 125.512 1.525 . . . . 10.0 107.609 172.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.63 70.7 0.95 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.863 0.839 . . . . 10.0 110.374 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.436 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 11.3 t -83.79 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.828 1.251 . . . . 10.0 108.783 -171.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.87 77.17 1.31 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.436 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 8.8 m-85 -79.82 134.05 36.32 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.472 1.509 . . . . 10.0 108.84 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.41 88.22 6.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.334 -0.853 . . . . 10.0 109.221 170.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.31 -16.09 0.16 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.15 0.98 . . . . 10.0 113.292 168.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.95 -20.67 28.61 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.362 2.265 . . . . 10.0 110.461 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -129.26 -58.14 1.13 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 10.0 109.786 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.0 t -129.87 120.26 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 125.02 1.328 . . . . 10.0 108.002 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 p -87.76 158.19 18.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -38.03 -40.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 126.885 2.074 . . . . 10.0 110.618 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.95 -47.06 0.51 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.275 0.943 . . . . 10.0 111.551 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -64.06 -57.74 8.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.562 1.172 . . . . 10.0 111.096 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.72 -57.11 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.836 1.654 . . . . 10.0 112.001 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.19 -61.58 0.87 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.166 2.186 . . . . 10.0 109.52 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.56 -49.97 54.74 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.157 0.583 . . . . 10.0 110.666 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.41 77.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.745 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.44 -39.53 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 120.98 -1.075 . . . . 10.0 110.415 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.33 -29.14 69.71 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.261 -0.899 . . . . 10.0 111.628 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.45 -64.27 0.87 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.976 0.807 . . . . 10.0 111.614 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.98 -7.33 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.265 1.58 . . . . 10.0 115.265 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.74 -51.8 10.77 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.714 -0.954 . . . . 10.0 110.714 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 58.25 109.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.75 2.42 . . . . 10.0 111.539 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t0 175.59 -41.31 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 125.363 1.465 . . . . 10.0 107.991 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.95 95.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 120.806 -1.184 . . . . 10.0 112.298 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.86 -57.46 3.86 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.773 0.829 . . . . 10.0 109.731 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -164.94 142.94 6.33 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.888 -1.523 . . . . 10.0 106.888 -171.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.439 -0.99 0 C-N-CA 124.163 0.985 . . . . 10.0 108.552 172.552 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.25 98.22 10.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -175.79 4.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.569 -1.641 . . . . 10.0 106.569 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -139.17 137.13 35.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.754 -1.943 . . . . 10.0 105.754 169.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 99.89 12.08 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 105.141 -2.17 . . . . 10.0 105.141 171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.03 146.57 42.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.152 -0.684 . . . . 10.0 109.152 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.19 130.3 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 125.13 1.372 . . . . 10.0 113.128 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -78.86 -57.56 3.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.375 2.27 . . . . 10.0 110.618 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.65 -46.46 0.1 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 117.637 -2.22 . . . . 10.0 112.792 -169.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.91 158.99 4.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 117.3 0.55 . . . . 10.0 110.928 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.1 m -144.83 37.57 1.18 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.084 -0.962 . . . . 10.0 108.875 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.3 t -110.12 94.96 5.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.66 -9.85 0.6 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -90.35 -29.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.182 0.901 . . . . 10.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -65.33 -73.79 0.12 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.931 -1.137 . . . . 10.0 107.931 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -33.83 -54.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 125.542 1.537 . . . . 10.0 113.858 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -56.01 -33.16 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.969 0.729 . . . . 10.0 112.969 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.94 -32.8 61.69 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.599 0.76 . . . . 10.0 110.582 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.28 -47.68 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 117.829 -1.081 . . . . 10.0 110.39 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -41.85 -49.48 4.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.077 1.351 . . . . 10.0 110.752 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.5 p -46.17 -62.32 1.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.349 1.06 . . . . 10.0 111.247 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -57.76 -48.06 80.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.598 1.159 . . . . 10.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -55.08 -40.64 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.76 0.824 . . . . 10.0 110.155 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.63 6.4 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.54 1.066 . . . . 10.0 113.744 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.87 -26.62 60.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.92 1.36 . . . . 10.0 111.621 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.15 107.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 119.128 0.877 . . . . 10.0 109.373 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -36.7 -43.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.165 2.186 . . . . 10.0 113.17 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.05 -28.5 63.9 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.688 0.661 . . . . 10.0 114.119 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.51 109.56 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 119.566 -2.137 . . . . 10.0 107.399 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -81.82 -31.73 31.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.903 -1.044 . . . . 10.0 109.712 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.19 158.22 18.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.509 1.123 . . . . 10.0 108.303 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -162.55 106.4 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.69 117.55 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 C-N-CA 124.124 0.97 . . . . 10.0 109.237 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -132.22 48.58 2.4 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.505 0.322 . . . . 10.0 111.349 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -42.96 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.087 0.955 . . . . 10.0 112.89 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.49 -37.92 88.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.82 0.848 . . . . 10.0 111.032 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -35.9 20.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.564 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.38 -67.8 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.926 -0.87 . . . . 10.0 110.926 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -174.74 2.51 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.055 1.342 . . . . 10.0 110.673 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.28 125.79 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 175.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -110.77 92.69 4.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.524 2.33 . . . . 10.0 108.343 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 25.4 t -110.89 151.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.647 1.579 . . . . 10.0 107.88 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -109.73 77.2 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.556 -1.646 . . . . 10.0 106.556 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.402 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 5.6 m-85 -78.01 127.67 32.69 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.317 -1.31 . . . . 10.0 107.721 -176.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.93 85.0 6.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.642 -0.662 . . . . 10.0 110.292 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.75 -23.17 0.96 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.985 0.914 . . . . 10.0 113.389 174.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.27 -5.38 56.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.436 0.562 . . . . 10.0 109.943 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -133.35 -54.15 0.9 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.492 1.117 . . . . 10.0 110.511 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.18 141.04 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 125.051 1.341 . . . . 10.0 109.435 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -97.26 143.57 27.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.0 m -31.76 -49.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 129.369 3.068 . . . . 10.0 110.003 168.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -31.93 -51.61 0.23 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.807 1.243 . . . . 10.0 112.089 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -55.69 -60.54 3.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.396 1.079 . . . . 10.0 110.949 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -66.05 -54.53 26.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 125.17 1.388 . . . . 10.0 110.948 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.15 -62.28 0.66 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.917 2.087 . . . . 10.0 110.389 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -53.85 -50.25 66.65 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.731 0.813 . . . . 10.0 110.097 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.27 -47.69 55.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.035 0.534 . . . . 10.0 111.453 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -35.9 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.974 -1.079 . . . . 10.0 111.067 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.65 -30.59 65.53 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.871 -1.143 . . . . 10.0 111.579 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.87 -62.08 2.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.234 0.925 . . . . 10.0 111.964 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -142.86 56.07 1.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.89 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.22 -0.766 . . . . 10.0 111.288 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 65.08 107.15 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.124 1.77 . . . . 10.0 112.248 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 161.28 -24.87 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 128.413 2.685 . . . . 10.0 110.987 -170.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.5 t -67.88 90.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 120.985 -1.072 . . . . 10.0 111.486 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.67 -52.07 11.35 Favored 'General case' 0 C--N 1.338 0.094 0 O-C-N 121.774 -0.579 . . . . 10.0 109.463 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -170.24 144.12 2.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.52 1.128 . . . . 10.0 108.409 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 124.433 1.093 . . . . 10.0 108.489 169.626 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 122.372 1.082 . . . . 10.0 109.147 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.62 126.56 35.01 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.566 -2.753 . . . . 10.0 103.566 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -124.86 176.07 6.86 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.87 126.81 38.88 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.7 97.86 11.05 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 104.69 -2.337 . . . . 10.0 104.69 172.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.88 150.7 44.35 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.01 127.68 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.658 1.183 . . . . 10.0 113.019 -169.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -62.35 1.42 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.602 1.961 . . . . 10.0 108.57 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.34 -31.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.508 -169.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 178.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.461 1.124 . . . . 10.0 112.582 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p -150.31 -43.57 0.13 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.533 -1.212 . . . . 10.0 110.913 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -37.44 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.855 1.262 . . . . 10.0 111.678 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -3.27 23.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.337 -0.363 . . . . 10.0 111.687 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -46.64 8.71 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.603 0.638 . . . . 10.0 109.448 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 m -46.93 -68.68 0.17 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.703 0.801 . . . . 10.0 110.157 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -46.63 -51.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 O-C-N 122.304 -0.247 . . . . 10.0 111.483 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -60.61 -33.75 73.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.17 50.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.981 0.512 . . . . 10.0 110.144 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.94 -41.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.232 -0.889 . . . . 10.0 110.726 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -39.89 -51.49 2.45 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.345 1.458 . . . . 10.0 111.297 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -51.0 -55.69 16.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.03 0.932 . . . . 10.0 110.552 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.82 -49.73 74.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.705 1.202 . . . . 10.0 110.534 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.7 t -53.85 -41.5 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.248 1.019 . . . . 10.0 110.111 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.0 -32.55 6.3 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.72 1.152 . . . . 10.0 114.052 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.09 -26.21 60.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.924 1.362 . . . . 10.0 111.944 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.4 109.67 2.81 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.435 -0.79 . . . . 10.0 110.251 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.3 -38.44 2.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.097 2.159 . . . . 10.0 113.175 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.33 -20.89 71.85 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.503 -0.748 . . . . 10.0 114.215 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.02 105.31 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 120.036 -1.861 . . . . 10.0 107.211 171.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -29.86 62.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.351 -1.295 . . . . 10.0 110.097 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.49 157.05 14.48 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.25 130.51 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.074 0.95 . . . . 10.0 109.913 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -148.07 94.3 2.31 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.931 0.892 . . . . 10.0 108.714 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 t -86.66 114.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 10.0 108.371 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.95 48.62 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.835 0.454 . . . . 10.0 111.497 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.95 -44.17 60.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.673 0.789 . . . . 10.0 112.414 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.1 -29.84 70.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.727 1.211 . . . . 10.0 111.096 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 -36.86 14.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.63 0.372 . . . . 10.0 110.755 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.07 -65.07 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.218 0.913 . . . . 10.0 111.045 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.12 178.78 4.87 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.399 1.48 . . . . 10.0 111.025 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -94.2 127.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 125.145 1.378 . . . . 10.0 108.228 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -117.59 89.13 3.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.622 1.169 . . . . 10.0 108.629 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 17.1 t -98.2 149.76 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.668 1.587 . . . . 10.0 107.637 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 t -104.29 79.89 1.64 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 9.7 m-85 -73.93 130.35 39.71 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.912 -1.494 . . . . 10.0 108.204 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -84.33 87.1 7.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -11.82 1.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.162 0.801 . . . . 10.0 113.162 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.46 -15.37 52.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.608 1.094 . . . . 10.0 109.759 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -127.08 -61.44 1.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.451 1.1 . . . . 10.0 109.152 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.9 126.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.825 1.25 . . . . 10.0 109.223 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 m -96.4 163.84 12.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.308 -0.86 . . . . 10.0 108.828 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -38.43 -39.57 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 127.478 2.311 . . . . 10.0 111.353 168.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -37.33 1.47 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.594 0.633 . . . . 10.0 112.543 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.61 -63.87 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.071 0.938 . . . . 10.0 111.061 172.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mm -60.29 -54.03 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.713 1.205 . . . . 10.0 112.483 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.47 -53.05 15.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.904 2.082 . . . . 10.0 109.593 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.57 -47.78 78.77 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.133 0.573 . . . . 10.0 110.204 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -51.0 68.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -34.74 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.118 -0.989 . . . . 10.0 109.948 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -57.04 -43.36 81.89 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.603 -1.311 . . . . 10.0 111.503 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.69 -62.24 1.75 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.469 0.577 . . . . 10.0 111.969 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -141.18 44.67 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.04 -57.78 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.944 0.783 . . . . 10.0 112.102 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 66.3 107.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.129 2.172 . . . . 10.0 111.087 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 t0 170.39 -38.47 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.668 1.587 . . . . 10.0 108.253 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.24 89.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 120.746 -1.221 . . . . 10.0 112.031 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.72 2.62 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.284 -0.885 . . . . 10.0 109.689 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -165.3 155.91 13.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.166 -1.791 . . . . 10.0 106.166 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.119 0 C-N-CA 124.607 1.163 . . . . 10.0 110.143 174.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 106.937 -1.505 . . . . 10.0 106.937 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -139.72 110.16 6.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.868 -1.901 . . . . 10.0 105.868 168.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.83 176.39 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.514 1.926 . . . . 10.0 106.717 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -148.81 128.8 13.5 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.064 -1.828 . . . . 10.0 106.064 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.68 104.26 15.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 172.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -68.43 149.71 49.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.51 132.78 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -170.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -74.41 -60.51 2.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.916 2.486 . . . . 10.0 108.174 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.31 -31.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.862 -0.966 . . . . 10.0 115.137 -171.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.8 178.45 4.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.606 1.703 . . . . 10.0 110.241 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -158.81 26.96 0.22 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.693 0.797 . . . . 10.0 109.249 170.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.8 t -90.09 100.04 12.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.098 -1.815 . . . . 10.0 106.098 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -52.57 -26.73 14.14 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 174.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -72.55 -46.08 56.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.939 -0.763 . . . . 10.0 108.939 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.9 m -50.31 -65.88 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.848 1.659 . . . . 10.0 110.415 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.77 -45.09 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 120.484 -0.487 . . . . 10.0 111.08 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 17.7 tttm -52.44 -33.76 45.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.624 1.342 . . . . 10.0 114.624 176.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.06 65.39 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.065 0.848 . . . . 10.0 110.038 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -87.05 -37.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 117.339 -1.315 . . . . 10.0 110.575 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.512 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 1.4 tt0 -36.63 -56.03 0.84 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.556 1.542 . . . . 10.0 110.549 174.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -58.94 -45.38 90.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.686 0.395 . . . . 10.0 111.381 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m -65.55 -57.03 9.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.43 0.692 . . . . 10.0 109.8 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.71 -37.48 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.992 0.917 . . . . 10.0 110.796 177.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.63 -27.32 54.69 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.024 0.821 . . . . 10.0 112.193 177.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.37 -27.35 59.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 118.319 1.059 . . . . 10.0 110.416 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.51 103.65 2.54 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 120.94 -1.1 . . . . 10.0 108.859 178.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -41.01 -32.37 0.23 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.668 1.987 . . . . 10.0 113.043 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.72 3.76 4.76 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.15 0.881 . . . . 10.0 115.288 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.17 119.61 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 169.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -36.99 29.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.61 157.24 14.41 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 176.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.986 2.114 . . . . 10.0 107.281 171.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -133.46 96.33 3.69 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 126.327 1.851 . . . . 10.0 107.742 172.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.8 119.12 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.044 0.937 . . . . 10.0 108.933 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -146.38 51.59 1.13 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.073 0.549 . . . . 10.0 111.213 -172.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.52 -48.99 56.93 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.279 0.632 . . . . 10.0 112.078 178.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.83 -37.01 83.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.176 0.591 . . . . 10.0 110.718 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.92 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.133 -173.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.43 -79.33 0.05 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.598 -1.001 . . . . 10.0 110.598 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -168.8 179.8 4.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.549 2.739 . . . . 10.0 106.873 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -94.31 118.58 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 107.68 -1.229 . . . . 10.0 107.68 -174.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.15 127.68 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 176.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.1 t -139.58 137.19 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.408 1.099 . . . . 10.0 108.757 -171.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -110.08 76.0 0.97 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 -169.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.407 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 28.1 m-85 -82.12 137.19 35.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.7 1.6 . . . . 10.0 109.797 -173.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -84.64 84.25 7.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.95 0.881 . . . . 10.0 108.83 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.31 -20.25 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.648 1.579 . . . . 10.0 112.409 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.04 -12.87 58.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.815 1.646 . . . . 10.0 110.12 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -120.59 -53.67 2.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.131 0.972 . . . . 10.0 109.248 -174.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 m -125.92 -168.65 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.879 1.672 . . . . 10.0 108.971 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 m -144.28 147.68 33.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.022 -1.049 . . . . 10.0 108.744 169.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -31.46 -48.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 130.037 3.335 . . . . 10.0 110.731 175.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -28.93 -52.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.312 1.445 . . . . 10.0 112.352 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.53 -59.77 4.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.18 0.592 . . . . 10.0 111.739 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.64 -51.03 55.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 125.325 1.45 . . . . 10.0 110.737 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.26 -63.89 0.46 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.87 2.068 . . . . 10.0 109.399 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -56.46 -47.87 78.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.403 0.681 . . . . 10.0 110.126 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.29 -46.79 62.62 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.978 0.911 . . . . 10.0 111.546 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -72.53 -42.19 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.616 -0.677 . . . . 10.0 110.586 176.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.19 -34.89 66.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.984 1.266 . . . . 10.0 112.159 178.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -48.49 -63.02 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.697 0.681 . . . . 10.0 112.533 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -134.59 -17.89 1.96 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.37 1.068 . . . . 10.0 113.387 -171.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.23 -49.26 12.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.879 -0.888 . . . . 10.0 110.879 -177.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 58.67 108.48 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.689 2.395 . . . . 10.0 111.586 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.29 -42.0 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 121.807 0.813 . . . . 10.0 109.189 -167.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.32 94.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.601 -0.687 . . . . 10.0 111.245 -172.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.64 -51.65 11.14 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.399 0.618 . . . . 10.0 109.396 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -171.4 143.13 1.77 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 -170.133 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.442 -0.866 0 C-N-CA 124.864 1.266 . . . . 10.0 109.779 176.914 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 106.04 -1.837 . . . . 10.0 106.04 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -147.55 75.48 1.36 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.022 1.392 . . . . 10.0 110.806 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.0 m -130.36 124.5 32.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.788 -2.301 . . . . 10.0 104.788 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -83.31 110.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.372 -2.455 . . . . 10.0 104.372 169.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -65.99 155.71 35.79 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.9 126.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.895 0.878 . . . . 10.0 110.028 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.32 -47.54 60.66 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.975 1.31 . . . . 10.0 109.203 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -19.75 0.67 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.442 -176.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 167.14 3.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.831 0.815 . . . . 10.0 111.5 174.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 19.83 1.35 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.34 -177.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -101.74 96.73 7.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.25 -14.47 7.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.802 0.667 . . . . 10.0 112.802 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -85.76 -35.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.997 0.817 . . . . 10.0 109.976 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.5 m -58.09 -67.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.883 1.273 . . . . 10.0 109.262 172.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -45.55 -51.43 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -177.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -20.79 63.03 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.623 0.972 . . . . 10.0 113.623 -177.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.78 90.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 175.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.44 -42.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.88 -0.581 . . . . 10.0 110.301 177.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -38.65 -48.91 1.51 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.429 1.492 . . . . 10.0 111.393 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -47.93 76.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.233 0.539 . . . . 10.0 111.328 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -65.14 -50.04 67.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.015 0.926 . . . . 10.0 110.203 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -52.73 -44.05 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.812 0.845 . . . . 10.0 109.914 176.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.48 -30.26 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.953 1.263 . . . . 10.0 113.765 173.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.77 -27.69 64.11 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.914 1.357 . . . . 10.0 110.91 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.43 105.58 2.65 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 174.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -36.04 -39.05 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.631 1.972 . . . . 10.0 113.543 170.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -13.39 21.42 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.849 1.214 . . . . 10.0 115.524 176.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 108.56 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 O-C-N 120.164 -1.786 . . . . 10.0 106.336 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -80.15 -29.89 38.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.91 158.97 15.37 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 177.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -139.35 122.12 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.328 1.451 . . . . 10.0 108.417 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -132.79 77.27 1.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.794 2.038 . . . . 10.0 107.546 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.13 123.81 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 125.026 1.33 . . . . 10.0 109.173 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -147.94 53.19 1.03 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.044 0.937 . . . . 10.0 110.09 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.63 -46.27 87.43 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.631 -0.668 . . . . 10.0 112.123 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.06 -35.14 77.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.09 0.956 . . . . 10.0 110.811 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.5 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.34 -175.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.05 -88.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.906 1.241 . . . . 10.0 110.945 -173.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -166.49 164.09 17.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.393 2.677 . . . . 10.0 106.411 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -86.85 118.63 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 118.824 0.738 . . . . 10.0 110.575 -168.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.88 124.72 37.07 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.717 1.207 . . . . 10.0 108.402 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.5 136.73 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 -177.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -99.96 70.98 1.62 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.26 -1.385 . . . . 10.0 107.26 -174.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -72.46 135.46 45.74 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.023 -176.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.65 86.84 7.27 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.287 1.435 . . . . 10.0 108.264 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -18.61 1.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.905 1.282 . . . . 10.0 112.537 168.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.68 -16.05 56.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.561 1.544 . . . . 10.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.99 -56.1 2.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.324 1.05 . . . . 10.0 109.289 -177.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.12 155.92 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 123.91 0.884 . . . . 10.0 109.305 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -99.37 147.03 25.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.493 -0.928 . . . . 10.0 108.493 176.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.7 m -30.71 -43.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 129.228 3.011 . . . . 10.0 111.202 168.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -28.87 -55.41 0.13 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.747 1.219 . . . . 10.0 111.549 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -48.21 -71.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.275 1.43 . . . . 10.0 111.05 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -60.41 -55.34 25.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.511 1.525 . . . . 10.0 112.238 -176.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.6 -58.41 1.3 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.263 2.225 . . . . 10.0 110.908 172.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.47 -45.93 92.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.558 0.743 . . . . 10.0 109.752 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.67 -44.11 65.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.443 0.697 . . . . 10.0 111.535 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.42 -58.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 117.824 -1.084 . . . . 10.0 108.805 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER -46.74 -37.81 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.772 1.169 . . . . 10.0 112.849 -174.655 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -41.17 -61.14 1.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.041 1.336 . . . . 10.0 112.882 172.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -132.82 -40.52 0.95 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.62 98.69 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.29 -1.124 . . . . 10.0 110.29 -176.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 173.67 0.17 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.131 1.372 . . . . 10.0 110.5 -176.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 86.67 37.98 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.451 1.5 . . . . 10.0 111.621 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.96 89.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.91 1.284 . . . . 10.0 110.09 172.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.64 -58.86 3.42 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.419 -0.585 . . . . 10.0 109.419 169.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -176.13 158.44 1.96 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.691 -1.596 . . . . 10.0 106.691 -174.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.932 0 C-N-CA 123.715 0.806 . . . . 10.0 111.474 171.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.472 0.653 . . . . 10.0 111.692 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.98 94.94 8.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.264 1.425 . . . . 10.0 108.235 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 161.13 14.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 173.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.85 107.53 14.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.613 1.565 . . . . 10.0 107.381 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 mt -78.8 92.41 4.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 169.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -69.17 144.87 53.68 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.86 126.93 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.045 2.138 . . . . 10.0 113.281 -174.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -70.15 -66.19 0.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.653 2.381 . . . . 10.0 109.782 176.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.01 -25.86 0.05 OUTLIER Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.688 -1.062 . . . . 10.0 115.465 -168.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 177.17 2.36 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.837 1.819 . . . . 10.0 109.765 174.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.6 m -165.17 56.77 0.12 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 -178.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.73 108.05 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.046 -1.835 . . . . 10.0 106.046 173.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.17 -24.49 64.8 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.489 0.185 . . . . 10.0 110.576 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -45.21 38.28 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.1 m -47.1 -71.11 0.08 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.039 1.335 . . . . 10.0 110.437 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.17 -49.1 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.249 0.219 . . . . 10.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -55.62 -34.7 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.84 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.531 -0.731 . . . . 10.0 109.352 174.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -82.38 -40.08 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 117.684 -1.15 . . . . 10.0 111.209 176.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -35.09 -60.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.994 1.718 . . . . 10.0 110.669 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -40.59 88.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.851 -1.068 . . . . 10.0 111.227 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -63.6 -56.13 18.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.077 0.951 . . . . 10.0 110.285 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.35 -33.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 124.185 0.994 . . . . 10.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -41.45 -27.93 0.31 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.951 -0.916 . . . . 10.0 114.981 170.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.16 70.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.568 1.684 . . . . 10.0 112.262 177.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.16 93.15 0.28 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 174.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.21 -39.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.887 1.675 . . . . 10.0 112.97 172.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.56 -9.02 42.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.121 0.867 . . . . 10.0 115.022 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.74 105.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.875 -2.268 . . . . 10.0 104.875 168.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -73.51 -33.21 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.564 179.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.92 159.05 13.07 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.747 -1.205 . . . . 10.0 107.747 177.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.49 128.2 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.637 1.175 . . . . 10.0 108.486 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 91.54 2.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.338 -0.986 . . . . 10.0 108.338 175.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 t -86.46 108.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.772 1.229 . . . . 10.0 109.073 -171.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -142.99 52.45 1.38 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.563 0.745 . . . . 10.0 111.665 -173.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.62 51.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.249 0.62 . . . . 10.0 111.136 -178.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.27 -46.72 76.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.573 1.149 . . . . 10.0 110.172 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.49 69.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.339 -0.846 . . . . 10.0 110.089 -176.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.9 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 122.92 0.295 . . . . 10.0 112.432 170.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 171.67 7.91 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.93 0.892 . . . . 10.0 112.049 -169.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.71 102.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 173.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -93.19 113.67 25.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 45.5 t -125.78 143.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.355 -1.35 . . . . 10.0 107.355 -171.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -105.97 82.7 1.81 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.329 -2.1 . . . . 10.0 105.329 -174.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 13.7 m-85 -88.24 132.31 34.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.259 1.424 . . . . 10.0 108.948 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -90.77 88.28 7.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.209 1.003 . . . . 10.0 108.356 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.85 -18.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.677 1.591 . . . . 10.0 112.819 167.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -19.15 58.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.614 1.966 . . . . 10.0 110.465 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -127.68 -48.61 1.39 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.199 1.0 . . . . 10.0 110.756 -169.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 m -134.09 165.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 123.986 0.914 . . . . 10.0 109.565 176.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 p -109.81 143.36 39.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.282 0.492 . . . . 10.0 109.921 175.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -40.34 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 128.23 2.612 . . . . 10.0 108.841 169.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -35.16 -49.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.448 1.022 . . . . 10.0 112.194 175.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.45 -53.81 54.16 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.519 0.676 . . . . 10.0 111.077 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.89 -51.75 41.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.475 1.51 . . . . 10.0 111.289 -177.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.03 -59.96 1.13 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.971 2.108 . . . . 10.0 109.923 169.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.75 -48.34 75.42 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.082 0.953 . . . . 10.0 109.989 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.71 71.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.93 0.892 . . . . 10.0 111.511 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.08 -34.09 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 O-C-N 120.729 -1.232 . . . . 10.0 109.271 177.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.21 -40.98 92.02 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.7 -1.25 . . . . 10.0 110.837 175.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -45.85 -66.62 0.38 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.356 1.063 . . . . 10.0 112.41 178.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -139.93 23.79 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.45 -49.4 0.6 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.46 1.029 . . . . 10.0 112.219 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 64.31 101.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.407 1.883 . . . . 10.0 111.558 173.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 173.36 -32.88 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 125.473 1.509 . . . . 10.0 109.799 -168.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.5 86.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 121.359 -0.838 . . . . 10.0 112.104 -171.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.41 -58.79 3.35 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 169.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -164.29 150.41 10.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.452 -0.349 0 C-N-CA 124.973 1.309 . . . . 10.0 110.429 179.09 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 104.919 -2.252 . . . . 10.0 104.919 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.21 124.76 23.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.646 -1.983 . . . . 10.0 105.646 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -127.76 158.95 36.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.868 1.318 . . . . 10.0 108.617 167.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -119.5 98.14 5.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.982 2.913 . . . . 10.0 104.933 -168.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.65 86.63 4.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.793 -2.299 . . . . 10.0 104.793 170.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.96 152.79 9.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.111 0.964 . . . . 10.0 109.267 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.63 127.12 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.698 1.199 . . . . 10.0 109.234 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -75.23 -68.61 0.54 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 172.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.59 -32.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.518 -1.325 . . . . 10.0 115.806 -168.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -175.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.233 1.016 . . . . 10.0 108.721 173.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -168.47 39.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.133 1.373 . . . . 10.0 108.03 172.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -99.29 98.23 9.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.07 -17.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.39 1.876 . . . . 10.0 114.6 176.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -96.84 -37.28 10.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.797 1.239 . . . . 10.0 110.251 -176.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 m -56.62 -62.64 1.59 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 177.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -49.65 -47.13 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.947 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 7.2 tttp -56.26 -34.82 66.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.269 1.211 . . . . 10.0 114.269 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -39.34 61.16 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.55 -0.537 . . . . 10.0 109.55 172.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.65 -37.26 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 117.903 -1.046 . . . . 10.0 111.199 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 26.8 tt0 -40.47 -57.0 1.92 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.733 1.613 . . . . 10.0 110.255 -178.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -46.61 89.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.369 -0.832 . . . . 10.0 111.012 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 t -56.46 -53.77 53.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.207 1.003 . . . . 10.0 109.687 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.86 -39.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 O-C-N 121.655 -0.653 . . . . 10.0 110.055 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.13 -26.94 3.39 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.05 -0.861 . . . . 10.0 113.92 172.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.47 -27.94 64.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.125 1.462 . . . . 10.0 111.579 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.44 108.49 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.945 0.793 . . . . 10.0 110.8 178.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -39.65 -45.52 1.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.551 1.54 . . . . 10.0 111.922 170.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.37 17.43 1.92 Allowed Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.378 0.911 . . . . 10.0 115.378 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.48 109.39 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 104.213 -2.514 . . . . 10.0 104.213 167.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -74.38 -32.6 62.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.1 151.83 6.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.932 -1.506 . . . . 10.0 106.932 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.05 136.31 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 177.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.07 92.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 t -93.47 108.58 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 126.601 1.96 . . . . 10.0 107.38 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 72.11 1.35 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 10.0 109.721 -171.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -49.79 43.18 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -172.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.155 1.782 . . . . 10.0 110.029 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -35.25 44.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.628 -176.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.49 -75.25 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 177.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -177.92 4.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.671 1.988 . . . . 10.0 111.631 -178.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.61 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 -176.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -95.14 99.27 11.28 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.5 t -116.74 148.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -170.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -112.32 90.25 3.29 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 -174.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.71 144.17 26.2 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 126.972 2.109 . . . . 10.0 108.803 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -97.57 94.52 7.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 167.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.8 7.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 10.0 111.973 170.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.6 t70 -71.59 -25.25 62.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.002 2.121 . . . . 10.0 110.346 173.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -121.8 -56.51 1.85 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.239 1.016 . . . . 10.0 109.668 -168.092 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.85 144.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 125.691 1.596 . . . . 10.0 109.63 -175.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 p -97.67 142.82 28.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.432 0.634 . . . . 10.0 110.146 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -43.31 -43.28 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 127.978 2.511 . . . . 10.0 108.615 168.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -44.73 -44.3 9.11 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.652 -1.165 . . . . 10.0 111.269 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.47 -63.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.614 0.643 . . . . 10.0 110.25 177.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mp -62.27 -51.58 70.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.366 1.066 . . . . 10.0 111.817 -176.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.72 -56.56 2.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.594 1.958 . . . . 10.0 109.763 171.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.96 -46.57 88.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.052 0.453 . . . . 10.0 110.314 175.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.99 77.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 10.0 111.154 -175.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.7 -49.8 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -49.56 -36.13 22.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.714 1.143 . . . . 10.0 112.939 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.91 -61.34 2.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.554 1.142 . . . . 10.0 112.545 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -138.86 -17.41 1.08 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.55 -46.29 48.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 119.147 0.885 . . . . 10.0 110.915 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 58.17 93.45 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.932 2.093 . . . . 10.0 111.102 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.28 46.17 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.1 2.56 . . . . 10.0 112.869 173.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.08 86.17 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.107 -0.996 . . . . 10.0 109.071 173.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 174.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.32 155.92 0.52 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.239 1.816 . . . . 10.0 106.38 176.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.123 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 169.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 122.201 1.0 . . . . 10.0 112.134 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -71.93 71.67 0.8 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.461 1.505 . . . . 10.0 111.479 175.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -72.39 151.43 42.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 123.445 1.593 . . . . 10.0 108.883 168.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.87 111.12 21.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.144 -2.539 . . . . 10.0 104.144 -176.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.49 87.91 6.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.55 -2.019 . . . . 10.0 105.55 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -60.9 146.3 47.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.296 -1.32 . . . . 10.0 109.355 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.64 129.74 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.259 1.824 . . . . 10.0 113.547 -169.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -77.0 -51.42 11.12 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 127.623 2.369 . . . . 10.0 109.465 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.66 -0.67 1.7 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.467 -0.873 . . . . 10.0 114.181 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.26 171.06 4.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.873 1.337 . . . . 10.0 107.542 168.045 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -153.15 56.26 0.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.374 -1.343 . . . . 10.0 107.374 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.56 96.7 3.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.359 -1.349 . . . . 10.0 107.359 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -52.25 -21.73 3.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.304 0.483 . . . . 10.0 112.304 170.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.35 -35.72 35.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.845 -0.535 . . . . 10.0 110.166 -170.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.0 m -55.66 -74.13 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.366 1.067 . . . . 10.0 108.167 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -44.58 -52.02 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 113.523 0.934 . . . . 10.0 113.523 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -55.38 -31.18 61.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.205 0.911 . . . . 10.0 113.284 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.82 65.43 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 122.724 0.41 . . . . 10.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.45 -44.11 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 118.061 -0.971 . . . . 10.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -45.3 -45.1 11.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.525 1.057 . . . . 10.0 110.529 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -52.8 -48.92 66.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.497 0.665 . . . . 10.0 111.792 175.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 t -71.14 -38.47 72.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.931 1.292 . . . . 10.0 111.218 -178.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.25 -37.38 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.698 -0.626 . . . . 10.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.29 0.83 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.605 1.097 . . . . 10.0 113.025 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.7 -43.53 2.37 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.825 2.85 . . . . 10.0 109.364 175.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.72 123.56 13.68 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.22 0.918 . . . . 10.0 109.727 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -50.23 -41.57 50.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.246 1.018 . . . . 10.0 112.068 -174.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.78 69.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 116.233 -0.44 . . . . 10.0 113.588 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -74.62 108.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 119.643 -2.092 . . . . 10.0 106.197 172.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -37.97 73.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.166 173.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.88 155.2 11.93 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.128 -1.434 . . . . 10.0 107.128 -176.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.13 137.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -149.8 91.72 1.83 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.266 -1.012 . . . . 10.0 108.266 176.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.08 110.44 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 124.327 1.051 . . . . 10.0 110.218 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.43 49.81 2.15 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.699 0.8 . . . . 10.0 112.114 -178.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -50.2 30.85 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.025 0.93 . . . . 10.0 111.429 -175.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.47 -36.2 73.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.565 0.746 . . . . 10.0 110.858 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.96 62.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.458 -177.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.73 -65.33 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.7 178.92 5.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.342 1.057 . . . . 10.0 112.631 -169.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.57 105.97 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.075 -1.454 . . . . 10.0 107.075 176.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.14 117.86 35.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 72.3 t -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -168.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.2 t -110.91 87.76 2.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.879 -1.896 . . . . 10.0 105.879 -169.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 58.6 m-85 -95.36 129.12 42.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.435 1.494 . . . . 10.0 109.959 -173.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -81.46 88.98 6.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 172.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.36 -11.16 1.11 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -89.89 -2.9 58.28 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.571 1.078 . . . . 10.0 110.615 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -134.69 -54.52 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.889 0.876 . . . . 10.0 110.335 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.22 141.86 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 124.662 1.185 . . . . 10.0 109.911 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.7 p -107.77 153.6 22.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.679 0.752 . . . . 10.0 109.664 178.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -43.56 -37.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 127.483 2.313 . . . . 10.0 111.056 169.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -47.97 -32.59 6.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.475 0.58 . . . . 10.0 111.77 176.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -59.64 2.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.097 0.862 . . . . 10.0 111.108 171.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.8 -52.53 34.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 124.18 0.992 . . . . 10.0 112.775 -170.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.98 -54.35 13.19 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.54 1.536 . . . . 10.0 109.486 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -51.14 -50.73 58.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 10.0 109.71 172.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.96 76.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.04 0.536 . . . . 10.0 112.107 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.46 -37.03 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 O-C-N 120.61 -1.306 . . . . 10.0 111.258 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -51.3 -45.84 62.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.841 -1.162 . . . . 10.0 110.932 168.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -47.82 -62.2 1.57 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -147.15 55.65 1.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.838 0.455 . . . . 10.0 112.04 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.78 -54.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.84 -0.978 . . . . 10.0 111.039 176.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 64.69 107.0 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.323 1.849 . . . . 10.0 111.563 173.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 164.19 -25.73 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 125.368 1.467 . . . . 10.0 110.453 -169.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.7 t -86.13 88.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 121.027 -1.046 . . . . 10.0 109.087 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.98 69.5 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -169.41 153.45 5.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.116 -1.809 . . . . 10.0 106.116 177.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.885 0 C-N-CA 123.572 0.749 . . . . 10.0 109.312 173.501 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -147.35 82.55 1.54 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.015 0.926 . . . . 10.0 109.292 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.48 165.39 14.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.557 1.143 . . . . 10.0 108.966 173.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -120.46 111.28 17.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.314 1.846 . . . . 10.0 108.141 -168.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 83.32 7.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.08 147.41 50.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.127 -0.942 . . . . 10.0 110.288 -176.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.51 119.37 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.983 2.113 . . . . 10.0 113.138 -169.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -66.04 -50.11 65.33 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.887 1.275 . . . . 10.0 110.094 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.3 -22.48 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.048 -0.524 . . . . 10.0 112.242 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.97 170.36 0.86 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.539 1.162 . . . . 10.0 111.852 174.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -151.94 23.91 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.594 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.7 t -103.88 92.69 4.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -52.77 -20.14 2.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.046 0.758 . . . . 10.0 113.046 171.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.08 -39.42 29.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.336 -0.852 . . . . 10.0 109.21 -175.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 m -56.68 -67.03 0.34 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 175.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -46.99 -50.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 119.281 -0.39 . . . . 10.0 111.887 -177.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -58.78 -31.09 68.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.761 0.71 . . . . 10.0 112.808 -175.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.24 68.33 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 110.29 -0.263 . . . . 10.0 110.29 176.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.0 t -87.28 -39.24 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 118.437 -0.792 . . . . 10.0 110.951 176.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -41.64 -43.28 2.74 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.183 1.393 . . . . 10.0 110.964 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.8 -57.35 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.977 0.353 . . . . 10.0 110.88 174.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -58.64 -54.57 45.57 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.841 1.256 . . . . 10.0 109.968 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -52.76 -42.89 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.201 1.001 . . . . 10.0 110.1 176.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.92 -38.19 83.06 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.748 1.166 . . . . 10.0 112.733 173.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.0 -27.55 65.79 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.36 1.08 . . . . 10.0 111.502 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.91 104.24 0.53 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 119.572 -0.851 . . . . 10.0 109.196 171.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -26.3 -49.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.116 2.566 . . . . 10.0 114.11 169.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.99 -13.43 59.58 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.597 0.599 . . . . 10.0 114.597 -176.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.64 110.12 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 119.871 1.836 . . . . 10.0 106.469 171.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -82.21 -28.8 31.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.22 -176.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.04 159.17 17.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 176.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.62 128.95 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 78.5 1.83 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.66 116.91 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 124.744 1.218 . . . . 10.0 108.504 176.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -149.36 46.96 0.97 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.328 0.651 . . . . 10.0 110.622 -175.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -54.09 -43.4 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.079 0.551 . . . . 10.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.03 -40.45 75.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.862 1.265 . . . . 10.0 110.533 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.92 -30.26 50.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.653 -0.703 . . . . 10.0 111.51 -178.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 -61.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.539 0.59 . . . . 10.0 112.457 -179.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -170.06 176.05 4.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.484 1.514 . . . . 10.0 112.087 -171.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 96.1 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 106.109 -1.811 . . . . 10.0 106.109 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.71 118.85 31.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 40.6 t -129.22 146.21 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -169.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 t -106.93 71.03 0.82 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.38 -1.711 . . . . 10.0 106.38 -173.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.454 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 22.0 m-85 -67.34 142.34 56.83 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.64 -1.618 . . . . 10.0 107.435 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -100.83 94.71 6.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.018 0.527 . . . . 10.0 109.954 169.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.54 -15.42 2.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.105 0.962 . . . . 10.0 113.443 174.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.71 -9.52 58.78 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.079 0.854 . . . . 10.0 110.009 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -126.25 -54.61 1.47 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.367 1.067 . . . . 10.0 108.49 -175.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.97 144.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.817 1.247 . . . . 10.0 110.482 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 m -101.58 139.24 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 m -34.24 -50.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 129.9 3.28 . . . . 10.0 110.877 176.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -29.71 -53.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.06 1.344 . . . . 10.0 112.491 172.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.05 -63.14 1.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.089 0.956 . . . . 10.0 110.679 177.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.51 -54.49 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 C-N-CA 125.97 1.708 . . . . 10.0 111.779 -176.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.49 -60.56 0.79 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.016 2.126 . . . . 10.0 110.403 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.54 -46.21 89.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.006 0.522 . . . . 10.0 110.569 176.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.19 71.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.023 0.929 . . . . 10.0 111.489 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -59.27 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 174.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.8 -45.13 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.647 0.779 . . . . 10.0 112.249 -176.371 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -32.8 -50.91 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.493 1.517 . . . . 10.0 114.675 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -152.22 -37.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.096 0.959 . . . . 10.0 113.003 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -53.51 -44.24 67.4 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.424 -0.671 . . . . 10.0 111.424 178.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.44 169.6 0.23 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.266 1.426 . . . . 10.0 110.5 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.1 t70 104.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.588 1.955 . . . . 10.0 112.4 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.53 77.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.943 1.697 . . . . 10.0 108.697 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.31 -52.16 43.81 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.663 1.221 . . . . 10.0 108.446 176.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.51 127.92 2.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 104.829 -2.285 . . . . 10.0 104.829 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.4 HD13 ' CE1' ' A' ' 46' ' ' PHE . 3.6 tp . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 106.029 -1.841 . . . . 10.0 106.029 168.103 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 106.11 -1.811 . . . . 10.0 106.11 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -135.51 133.2 38.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.93 2.092 . . . . 10.0 106.616 169.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -178.07 4.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.64 -2.726 . . . . 10.0 103.64 168.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 124.1 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.185 -2.524 . . . . 10.0 104.185 -177.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mt -88.26 89.25 7.91 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 105.102 -2.184 . . . . 10.0 105.102 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -53.44 143.33 19.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.423 0.556 . . . . 10.0 110.314 -174.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.31 132.63 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.179 0.992 . . . . 10.0 112.745 -168.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -86.13 -47.26 9.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.811 2.444 . . . . 10.0 111.249 -176.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -37.27 0.16 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.653 -0.526 . . . . 10.0 113.149 -174.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 155.97 38.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.054 0.927 . . . . 10.0 109.567 175.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -140.47 16.45 2.38 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.593 0.757 . . . . 10.0 110.535 175.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -88.99 103.76 16.35 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.58 -1.64 0.87 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.171 -0.919 . . . . 10.0 113.398 174.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.7 -45.37 7.04 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.158 1.345 . . . . 10.0 110.572 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -47.13 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.574 1.95 . . . . 10.0 109.844 175.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -36.47 -46.43 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.238 1.415 . . . . 10.0 112.767 173.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -55.27 -31.7 61.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.176 1.176 . . . . 10.0 114.176 -178.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.31 -34.95 62.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.751 0.25 . . . . 10.0 110.548 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.07 -34.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.031 1.333 . . . . 10.0 110.942 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -42.62 -47.37 5.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.553 1.141 . . . . 10.0 109.947 178.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -56.49 18.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.952 0.406 . . . . 10.0 111.112 177.144 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 m -62.92 -53.51 53.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.924 1.289 . . . . 10.0 110.963 -175.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.74 -43.87 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.923 0.889 . . . . 10.0 109.738 178.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.92 -42.01 69.05 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.595 0.617 . . . . 10.0 111.969 171.15 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -34.82 78.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.398 1.079 . . . . 10.0 111.038 178.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 105.21 1.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.222 -0.924 . . . . 10.0 110.025 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -32.96 -35.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.093 2.557 . . . . 10.0 114.173 170.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.19 5.4 2.83 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 116.115 1.206 . . . . 10.0 116.115 175.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.33 124.95 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.074 1.75 . . . . 10.0 107.24 169.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -92.32 -27.66 17.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.787 0.835 . . . . 10.0 111.028 175.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 151.47 10.14 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -136.64 128.76 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.779 1.232 . . . . 10.0 109.825 -177.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -151.49 100.17 2.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.295 1.038 . . . . 10.0 109.289 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.35 108.66 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 126.024 1.73 . . . . 10.0 109.329 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -128.1 53.44 1.8 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.097 0.559 . . . . 10.0 111.604 -176.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -41.93 -52.34 4.14 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.281 1.432 . . . . 10.0 112.259 -178.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.13 -36.47 83.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.668 0.787 . . . . 10.0 111.619 -177.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.16 -37.6 28.51 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.872 0.367 . . . . 10.0 110.448 -171.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.89 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.649 -1.381 . . . . 10.0 109.649 177.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -171.88 1.91 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.513 1.525 . . . . 10.0 109.342 178.191 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.81 133.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.016 0.927 . . . . 10.0 108.873 168.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.4 96.21 5.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.858 1.263 . . . . 10.0 108.265 175.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 17.7 t -105.44 149.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.835 1.654 . . . . 10.0 107.684 -178.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -106.71 77.21 1.17 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.912 -1.884 . . . . 10.0 105.912 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 6.9 m-85 -74.45 131.84 41.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.29 -1.323 . . . . 10.0 108.469 -176.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.62 83.58 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.471 0.708 . . . . 10.0 109.091 171.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.59 -18.42 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 170.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.64 -12.11 60.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.687 1.995 . . . . 10.0 110.033 178.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -131.42 -58.48 0.99 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.76 1.624 . . . . 10.0 109.219 -172.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -131.39 141.09 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.966 1.706 . . . . 10.0 109.553 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -90.18 149.0 22.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.511 -0.743 . . . . 10.0 109.837 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 m -37.3 -46.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 C-N-CA 128.047 2.539 . . . . 10.0 109.431 167.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -42.22 -41.27 2.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.619 -0.705 . . . . 10.0 112.145 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.76 -66.48 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.479 0.581 . . . . 10.0 110.52 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.52 -56.99 12.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.306 1.442 . . . . 10.0 112.145 -175.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.93 -64.04 0.43 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.666 2.386 . . . . 10.0 110.137 172.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.46 -38.75 91.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.33 0.586 . . . . 10.0 110.185 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.27 76.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.542 -0.723 . . . . 10.0 111.41 175.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -37.69 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 120.677 -1.265 . . . . 10.0 109.302 174.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.22 -42.34 73.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.035 1.288 . . . . 10.0 111.112 173.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -46.96 -66.98 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.681 0.792 . . . . 10.0 112.755 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.6 52.22 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.956 0.502 . . . . 10.0 111.453 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.94 -69.3 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 t80 69.25 130.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.08 1.752 . . . . 10.0 107.943 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 158.88 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.325 1.45 . . . . 10.0 109.965 -167.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.79 87.85 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.6 0.76 . . . . 10.0 111.602 -169.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.44 -53.72 17.89 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.685 -0.634 . . . . 10.0 109.671 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -168.1 167.77 12.25 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 178.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.951 0 C-N-CA 126.685 1.994 . . . . 10.0 110.536 173.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.155 0.502 . . . . 10.0 111.256 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -66.55 81.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.479 0.711 . . . . 10.0 110.498 169.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -85.86 157.94 20.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.147 0.975 . . . . 10.0 109.028 168.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.25 101.25 8.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.458 -2.053 . . . . 10.0 105.458 -171.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.18 101.39 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.058 -2.201 . . . . 10.0 105.058 167.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -77.34 147.77 35.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.71 128.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 125.941 1.697 . . . . 10.0 112.901 -170.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -69.41 -61.55 1.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.308 2.243 . . . . 10.0 108.964 177.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.51 -35.2 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.358 -0.69 . . . . 10.0 113.3 -169.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.91 178.24 2.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.593 1.197 . . . . 10.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 p -141.42 -50.98 0.43 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.453 -169.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -32.46 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.987 1.715 . . . . 10.0 113.202 -175.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -54.73 -9.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -88.46 -43.14 11.67 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.407 1.003 . . . . 10.0 110.166 -177.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.4 m -50.58 -68.18 0.19 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.746 0.818 . . . . 10.0 109.375 175.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.61 -46.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.672 -0.24 . . . . 10.0 111.338 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.84 -36.4 64.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.138 1.162 . . . . 10.0 114.138 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.68 54.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.517 0.675 . . . . 10.0 110.02 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.14 -38.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 117.832 -1.08 . . . . 10.0 110.893 175.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 4.5 tt0 -36.89 -52.73 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.922 1.689 . . . . 10.0 111.015 176.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 p -58.07 -49.43 76.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.101 0.56 . . . . 10.0 111.399 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.3 m -62.93 -48.23 79.83 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.326 0.65 . . . . 10.0 110.402 -177.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.45 -42.72 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.863 0.865 . . . . 10.0 109.69 176.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.21 -43.35 56.82 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 123.579 0.609 . . . . 10.0 112.09 170.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.96 -30.32 70.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.585 0.692 . . . . 10.0 111.984 177.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 110.38 2.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.608 1.094 . . . . 10.0 110.431 177.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -35.31 -43.7 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.184 2.194 . . . . 10.0 113.081 173.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 20.22 1.92 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.223 0.849 . . . . 10.0 115.223 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.13 113.46 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 169.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.8 t -72.72 -33.79 66.66 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.457 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.24 159.75 9.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 -177.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.01 137.04 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.506 1.522 . . . . 10.0 107.695 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -136.31 82.47 1.94 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 125.599 1.56 . . . . 10.0 107.185 168.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.19 130.05 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.96 -1.018 . . . . 10.0 108.892 174.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.86 44.75 0.16 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.06 0.457 . . . . 10.0 111.11 -173.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -57.68 -47.03 83.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.385 0.674 . . . . 10.0 112.114 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.766 1.226 . . . . 10.0 110.106 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.99 38.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.516 -178.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.43 -60.56 0.15 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.303 0.954 . . . . 10.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -170.65 166.33 8.09 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.09 1.356 . . . . 10.0 110.592 -171.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.72 118.15 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 172.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.08 120.05 40.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 56.1 t -131.48 138.9 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -170.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -92.51 67.28 4.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.738 -2.319 . . . . 10.0 104.738 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 45.6 m-85 -69.32 139.7 54.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.911 -1.515 . . . . 10.0 106.911 -177.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.59 88.6 5.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 -176.116 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.65 -24.01 45.46 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.443 0.534 . . . . 10.0 112.443 -178.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.76 -17.97 56.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.749 1.62 . . . . 10.0 110.253 -177.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -107.62 -55.09 2.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.222 1.009 . . . . 10.0 108.401 -173.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.33 178.49 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.656 1.182 . . . . 10.0 108.931 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 p -112.75 152.22 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -32.17 -44.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 129.74 3.216 . . . . 10.0 110.656 168.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -30.05 -53.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.42 1.088 . . . . 10.0 111.578 171.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.96 -59.1 5.08 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.592 0.757 . . . . 10.0 111.366 178.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -68.31 -53.68 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 125.096 1.358 . . . . 10.0 111.727 -176.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.59 -55.7 2.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 126.235 1.814 . . . . 10.0 110.226 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.79 -45.93 88.72 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.728 -0.607 . . . . 10.0 110.695 174.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.13 65.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.675 0.39 . . . . 10.0 111.183 178.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.25 -35.98 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.245 -0.909 . . . . 10.0 110.306 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.13 -37.99 72.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.702 1.137 . . . . 10.0 111.624 173.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -55.72 -66.9 0.34 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.455 0.57 . . . . 10.0 111.533 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.9 39.32 2.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -174.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.75 -58.28 0.09 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.92 -0.933 . . . . 10.0 112.348 -178.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 66.76 109.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.038 2.135 . . . . 10.0 110.938 178.081 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 166.92 -29.89 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 10.0 110.664 -168.198 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.14 85.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 121.077 -1.014 . . . . 10.0 112.229 -171.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.75 -57.23 4.13 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 121.808 0.813 . . . . 10.0 108.811 170.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -175.93 146.26 0.7 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 -171.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 124.524 1.129 . . . . 10.0 109.18 168.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -71.26 63.47 0.36 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 10.0 110.569 172.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -69.8 172.48 7.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.315 1.055 . . . . 10.0 108.206 168.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.13 104.89 15.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 177.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -62.55 150.09 41.35 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.705 0.802 . . . . 10.0 108.912 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.22 123.8 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 125.51 1.524 . . . . 10.0 111.063 -172.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.44 -45.48 75.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.594 1.558 . . . . 10.0 109.505 174.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.34 -8.41 0.39 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.855 -0.97 . . . . 10.0 114.094 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.93 179.45 1.47 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 119.425 1.612 . . . . 10.0 110.843 175.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -160.04 41.09 0.19 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -122.9 93.79 4.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.378 0.671 . . . . 10.0 109.672 176.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -55.92 -10.13 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.042 1.497 . . . . 10.0 115.042 172.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.94 -50.3 6.52 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 120.097 1.317 . . . . 10.0 109.609 -176.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -46.53 -62.62 1.29 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.196 0.998 . . . . 10.0 109.959 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -45.73 -52.58 2.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 122.41 0.284 . . . . 10.0 111.553 176.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -56.88 -37.49 71.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.811 0.844 . . . . 10.0 112.68 -178.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.31 -41.75 51.51 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.341 -0.615 . . . . 10.0 109.341 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.93 -36.69 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-O 117.229 -1.367 . . . . 10.0 111.592 173.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -43.54 -51.15 6.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.888 1.677 . . . . 10.0 110.001 -177.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.46 -47.98 83.4 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.278 0.561 . . . . 10.0 111.387 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -60.31 -40.73 91.6 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.471 1.108 . . . . 10.0 110.752 -177.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.5 -39.11 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.933 0.893 . . . . 10.0 109.846 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.76 -23.93 46.53 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.416 1.008 . . . . 10.0 112.281 178.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.33 -32.33 68.45 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.318 1.047 . . . . 10.0 110.655 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.43 111.97 2.9 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.179 -0.951 . . . . 10.0 110.688 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -37.54 -37.88 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.683 2.793 . . . . 10.0 112.973 174.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.47 4.55 81.27 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.448 0.939 . . . . 10.0 115.448 -177.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.13 107.65 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 104.289 -2.485 . . . . 10.0 104.289 167.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 -28.72 55.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.26 157.29 15.22 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.69 140.61 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.609 1.564 . . . . 10.0 109.013 -177.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -155.72 80.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.544 1.537 . . . . 10.0 109.078 173.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.33 115.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 121.688 -0.633 . . . . 10.0 109.885 169.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -143.86 48.52 1.41 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.901 0.881 . . . . 10.0 110.71 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -55.74 25.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.392 0.677 . . . . 10.0 111.261 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.64 -22.47 64.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.815 -0.553 . . . . 10.0 110.324 -172.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.4 -35.45 21.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.948 0.899 . . . . 10.0 111.287 177.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.09 -72.1 0.06 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.125 0.869 . . . . 10.0 112.49 -171.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 176.77 5.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.283 2.233 . . . . 10.0 110.933 -175.088 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.3 t -96.35 102.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.186 0.994 . . . . 10.0 108.486 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -84.14 132.13 34.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.05 0.94 . . . . 10.0 108.583 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.88 129.52 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 O-C-N 121.528 -0.732 . . . . 10.0 110.001 -172.027 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.5 m -96.49 80.99 3.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.147 -1.427 . . . . 10.0 107.147 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -81.63 130.64 35.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.429 -0.805 . . . . 10.0 110.234 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -91.69 87.23 6.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.422 1.889 . . . . 10.0 108.653 174.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -20.51 2.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.593 1.157 . . . . 10.0 113.293 171.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.657 1.583 . . . . 10.0 109.237 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -59.0 1.96 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 125.959 1.704 . . . . 10.0 109.155 -170.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 m -140.05 154.21 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 123.826 0.851 . . . . 10.0 110.742 178.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 t -100.01 160.09 14.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.13 0.966 . . . . 10.0 111.016 177.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.22 -35.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 C-N-CA 128.187 2.595 . . . . 10.0 109.418 166.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -52.53 -28.2 19.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.193 0.906 . . . . 10.0 112.392 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.09 -62.98 1.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.346 0.976 . . . . 10.0 109.358 169.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -65.66 -51.39 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 O-C-N 121.512 -0.743 . . . . 10.0 112.491 -169.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.05 -53.51 6.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.013 1.725 . . . . 10.0 109.872 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.84 -49.11 78.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.818 0.847 . . . . 10.0 110.05 175.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.13 -42.46 66.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.569 1.147 . . . . 10.0 111.595 -179.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -56.39 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 118.215 -0.897 . . . . 10.0 108.832 174.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -34.5 59.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.883 1.219 . . . . 10.0 112.105 -171.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -38.19 -54.82 1.36 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.935 1.694 . . . . 10.0 113.527 172.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -144.86 -38.39 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.89 85.56 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.32 171.38 0.24 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.025 1.33 . . . . 10.0 109.958 -176.012 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.269 0.1 OUTLIER 102.13 3.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 127.425 2.29 . . . . 10.0 113.203 174.752 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -88.65 88.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 124.806 1.242 . . . . 10.0 110.173 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.56 -58.44 4.29 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -175.36 152.88 1.44 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -175.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.865 0 C-N-CA 123.81 0.844 . . . . 10.0 111.811 173.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.235 0.54 . . . . 10.0 111.808 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -84.6 99.19 10.61 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.662 1.185 . . . . 10.0 110.276 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.65 164.84 12.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 167.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.82 113.78 21.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.072 -1.825 . . . . 10.0 106.072 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.88 83.19 6.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 174.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.82 147.02 20.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 -176.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.28 130.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.938 0.718 . . . . 10.0 112.938 -169.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -66.39 -48.6 69.59 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.847 1.659 . . . . 10.0 107.468 172.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.33 11.76 0.12 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.4 -1.222 . . . . 10.0 114.624 175.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -175.27 2.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 120.382 2.091 . . . . 10.0 108.52 173.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -170.17 58.45 0.04 OUTLIER 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.649 -1.241 . . . . 10.0 107.649 173.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.8 t -132.16 108.94 9.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 174.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -66.04 -10.56 41.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.11 0.964 . . . . 10.0 111.41 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -93.05 -48.27 6.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.538 0.735 . . . . 10.0 110.156 -171.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 m -43.64 -70.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.008 1.723 . . . . 10.0 110.197 171.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -39.56 -48.66 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 C-N-CA 123.962 0.905 . . . . 10.0 111.789 173.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.07 -34.86 61.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -31.34 45.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.36 0.527 . . . . 10.0 110.542 174.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.01 -32.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.498 1.519 . . . . 10.0 111.232 177.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 27.8 tt0 -43.37 -47.58 6.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.154 1.382 . . . . 10.0 110.087 -179.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -44.62 -70.04 0.12 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.802 1.641 . . . . 10.0 111.836 169.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.5 t -58.59 -47.21 85.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.116 1.367 . . . . 10.0 110.57 -172.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.37 -42.99 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.023 0.529 . . . . 10.0 109.8 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.31 -45.35 74.97 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.419 0.533 . . . . 10.0 111.769 170.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -61.52 -36.42 80.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 10.0 111.632 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 95.65 0.21 Allowed 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.276 -0.89 . . . . 10.0 109.972 177.131 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -28.03 -41.94 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.942 2.497 . . . . 10.0 114.902 173.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.83 5.15 0.56 Allowed Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.885 1.231 . . . . 10.0 115.74 174.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.74 111.31 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 104.474 -2.417 . . . . 10.0 104.474 169.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -74.08 -30.59 62.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.32 156.78 10.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.874 -1.528 . . . . 10.0 106.874 178.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.58 145.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 O-C-N 123.927 0.767 . . . . 10.0 109.677 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.29 96.67 1.2 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 173.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 t -87.3 120.34 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 178.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.08 49.8 2.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.424 0.556 . . . . 10.0 110.023 -174.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -42.46 -53.96 4.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.655 1.582 . . . . 10.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -35.68 74.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.508 0.723 . . . . 10.0 111.706 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -32.65 41.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.978 -171.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.95 -73.59 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.413 -1.475 . . . . 10.0 109.413 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -171.87 1.93 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 127.129 2.171 . . . . 10.0 108.582 177.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.44 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 172.255 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -120.98 100.78 7.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.564 -1.273 . . . . 10.0 107.564 176.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 t -110.83 148.58 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.649 1.58 . . . . 10.0 106.97 -175.422 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 t -101.25 72.19 1.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.034 -1.839 . . . . 10.0 106.034 -175.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 27.6 m-85 -75.82 134.68 40.32 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.112 -172.07 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -83.03 81.17 8.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.492 -0.755 . . . . 10.0 109.81 177.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.42 -25.97 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.865 1.266 . . . . 10.0 113.252 169.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.0 -22.54 33.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 126.325 1.85 . . . . 10.0 110.294 -173.255 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -117.67 -48.74 2.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.378 0.671 . . . . 10.0 109.448 -169.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.15 -170.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 125.445 1.498 . . . . 10.0 108.836 177.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.9 m -143.64 144.48 31.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 169.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 m -32.35 -42.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 130.524 3.529 . . . . 10.0 111.596 174.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -29.67 -55.88 0.16 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.192 0.997 . . . . 10.0 111.522 170.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -51.75 -67.45 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.721 1.208 . . . . 10.0 110.75 175.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -60.32 -55.49 23.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 124.296 1.038 . . . . 10.0 111.869 -175.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.83 -59.94 1.53 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.886 2.074 . . . . 10.0 110.572 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.88 -46.86 78.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.763 0.792 . . . . 10.0 110.39 176.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.78 -42.84 80.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.102 0.961 . . . . 10.0 111.45 -178.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -43.85 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.045 -1.034 . . . . 10.0 108.765 175.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.18 -36.99 32.79 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.119 1.327 . . . . 10.0 112.27 176.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.54 -67.72 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.697 0.68 . . . . 10.0 112.584 176.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -129.48 14.87 6.05 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.97 -53.59 0.18 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.212 0.911 . . . . 10.0 112.904 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 63.4 169.97 0.15 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.241 2.216 . . . . 10.0 110.97 -172.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.288 1.3 p30 108.43 -8.24 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 129.395 3.078 . . . . 10.0 113.166 -176.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.2 81.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 124.302 1.041 . . . . 10.0 111.664 -178.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.33 -56.64 5.15 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 168.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -179.07 145.07 0.25 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.486 1.114 . . . . 10.0 108.433 -171.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.327 1.051 . . . . 10.0 110.061 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.697 -0.668 . . . . 10.0 109.416 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.54 -175.59 4.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.076 1.35 . . . . 10.0 109.161 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -147.2 75.35 1.37 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.579 1.151 . . . . 10.0 108.204 170.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -92.2 175.52 6.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.308 1.051 . . . . 10.0 109.341 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -150.86 137.85 19.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.87 101.7 14.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.774 -2.306 . . . . 10.0 104.774 177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.05 147.27 51.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.28 131.53 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.203 1.401 . . . . 10.0 112.587 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -78.6 -59.66 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.332 2.653 . . . . 10.0 110.862 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.05 -36.15 0.05 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.757 -0.469 . . . . 10.0 112.778 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 166.48 2.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.129 0.966 . . . . 10.0 111.957 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 m -156.17 42.94 0.4 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t -112.61 96.15 5.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.552 -1.648 . . . . 10.0 106.552 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -55.96 -25.12 42.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.353 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -74.95 -41.34 59.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.76 0.824 . . . . 10.0 109.322 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.66 -71.41 0.08 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.832 0.853 . . . . 10.0 109.43 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -48.57 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 O-C-N 121.677 -0.639 . . . . 10.0 112.663 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -28.15 64.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.24 78.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -84.39 -41.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 118.61 -0.71 . . . . 10.0 110.519 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -39.4 -52.94 2.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.293 1.037 . . . . 10.0 110.503 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -48.84 75.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.612 -0.722 . . . . 10.0 110.907 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 m -59.34 -49.79 76.48 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.166 0.586 . . . . 10.0 111.227 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -55.27 -33.67 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.529 -0.732 . . . . 10.0 110.985 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.42 -18.37 14.77 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.922 0.772 . . . . 10.0 113.105 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.08 -34.38 75.04 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 118.626 1.213 . . . . 10.0 110.369 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 95.37 0.56 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.372 -0.83 . . . . 10.0 110.593 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -21.03 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.615 2.766 . . . . 10.0 114.347 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -44.66 -53.93 6.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.28 0.943 . . . . 10.0 113.865 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -52.63 111.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.452 1.101 . . . . 10.0 109.721 -173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -37.92 58.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.118 -0.947 . . . . 10.0 108.727 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.86 156.97 9.63 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.42 113.27 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.211 1.405 . . . . 10.0 107.231 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -116.66 78.18 1.18 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.089 0.956 . . . . 10.0 108.684 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.02 115.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.185 0.994 . . . . 10.0 109.847 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -144.92 48.78 1.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.139 0.975 . . . . 10.0 110.09 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -49.84 -45.81 50.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 10.0 112.205 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.42 -42.71 82.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.515 1.126 . . . . 10.0 111.11 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.06 58.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.036 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.29 -70.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.474 1.035 . . . . 10.0 111.064 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.36 177.88 5.82 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.681 1.593 . . . . 10.0 109.418 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 m -93.71 109.85 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 108.094 -1.076 . . . . 10.0 108.094 175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -93.51 118.8 31.8 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.1 t -132.35 137.49 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 122.227 1.013 . . . . 10.0 109.958 -168.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.1 m -105.12 66.36 0.75 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 -172.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.41 138.77 56.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.158 -1.383 . . . . 10.0 108.643 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -83.44 89.74 7.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.503 -0.479 . . . . 10.0 111.473 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.86 -19.59 1.81 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.77 -14.3 45.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.447 1.021 . . . . 10.0 110.62 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -117.34 -52.95 2.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.272 1.029 . . . . 10.0 109.252 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.84 139.37 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.175 0.99 . . . . 10.0 110.31 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -93.04 145.18 24.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.541 -0.724 . . . . 10.0 109.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -34.83 -46.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 128.956 2.902 . . . . 10.0 110.405 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -32.3 -51.26 0.25 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.523 1.129 . . . . 10.0 112.221 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -52.37 -72.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.954 1.302 . . . . 10.0 110.59 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -57.96 -49.17 82.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 125.366 1.466 . . . . 10.0 112.161 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.81 -59.13 2.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.495 1.918 . . . . 10.0 109.916 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.11 -43.72 82.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.395 0.617 . . . . 10.0 109.827 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.83 61.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.607 0.763 . . . . 10.0 111.045 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.16 -32.74 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 120.799 -1.188 . . . . 10.0 109.813 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -53.26 40.97 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.535 -0.728 . . . . 10.0 109.572 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -39.3 -64.66 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.888 1.275 . . . . 10.0 114.067 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -139.9 30.77 2.03 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.99 -54.09 0.32 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.0 -0.889 . . . . 10.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 64.66 110.65 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.795 2.038 . . . . 10.0 110.77 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 163.47 -32.25 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.78 1.232 . . . . 10.0 109.644 -168.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 69.3 t -72.4 87.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.394 -0.816 . . . . 10.0 111.073 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.47 -55.75 12.35 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.296 -1.002 . . . . 10.0 108.296 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -174.59 156.9 2.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.099 -1.445 . . . . 10.0 107.099 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.1 137.08 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 124.506 1.122 . . . . 10.0 110.4 168.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -110.14 -112.0 0.32 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 168.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.34 -95.67 0.06 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.117 1.341 . . . . 10.0 113.765 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.234 0 CA-C-O 116.922 -1.513 . . . . 10.0 107.8 -173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 106.313 -1.736 . . . . 10.0 106.313 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.86 170.4 12.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.5 102.82 4.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.089 1.756 . . . . 10.0 107.847 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -117.83 168.74 10.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.503 1.145 . . . . 10.0 109.694 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.55 126.13 49.57 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.608 -2.367 . . . . 10.0 104.608 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.92 105.79 17.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 103.582 -2.747 . . . . 10.0 103.582 167.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -68.29 151.71 46.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.381 -0.97 . . . . 10.0 108.381 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.29 131.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.188 1.395 . . . . 10.0 113.604 -169.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -73.81 -62.3 1.54 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 128.547 2.739 . . . . 10.0 109.319 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.53 -26.79 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.834 -1.174 . . . . 10.0 114.163 -169.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -179.35 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.125 1.463 . . . . 10.0 110.656 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 t -163.7 65.23 0.17 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' C ' ' H ' ' A' ' 15' ' ' HIS . 48.8 t -144.82 91.86 2.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 175.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -55.86 -3.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.206 1.187 . . . . 10.0 114.206 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.417 ' H ' ' C ' ' A' ' 13' ' ' CYS . 1.6 t-80 -94.84 -42.52 8.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 10.0 109.771 178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.46 -66.29 0.41 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.648 0.779 . . . . 10.0 109.184 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -40.56 -47.83 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.49 0.716 . . . . 10.0 111.769 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -58.62 -31.48 68.14 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.8 -31.32 58.86 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.548 0.613 . . . . 10.0 110.133 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -95.03 -35.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.879 1.272 . . . . 10.0 111.073 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -36.45 -57.3 0.76 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.018 1.727 . . . . 10.0 110.724 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 p -51.98 -59.89 3.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.677 1.191 . . . . 10.0 111.204 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -56.28 -49.4 74.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.042 0.937 . . . . 10.0 110.929 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.2 t -59.33 -43.9 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 122.02 -0.425 . . . . 10.0 110.269 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.71 -30.87 14.9 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 123.474 0.559 . . . . 10.0 112.968 171.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.73 -36.36 80.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.169 0.985 . . . . 10.0 110.569 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 95.14 0.54 Allowed 'General case' 0 C--O 1.22 -0.473 0 O-C-N 121.352 -0.842 . . . . 10.0 109.409 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -19.02 -50.53 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.979 2.911 . . . . 10.0 114.756 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.01 -18.98 20.93 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.676 1.132 . . . . 10.0 115.138 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.63 108.25 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 119.392 -2.24 . . . . 10.0 105.699 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -36.14 78.16 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.023 -0.99 . . . . 10.0 109.912 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.13 154.76 9.15 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.974 -0.751 . . . . 10.0 108.974 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.34 142.21 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.496 1.518 . . . . 10.0 109.334 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 88.83 1.51 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 122.33 1.062 . . . . 10.0 108.94 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.56 124.46 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 124.834 1.253 . . . . 10.0 108.903 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -145.48 48.97 1.25 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.015 0.526 . . . . 10.0 110.83 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -49.2 24.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.511 0.724 . . . . 10.0 110.333 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.79 -23.52 61.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.261 1.024 . . . . 10.0 111.869 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.22 -29.79 21.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.588 0.232 . . . . 10.0 110.423 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.24 -57.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.935 0.778 . . . . 10.0 111.777 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 174.32 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.061 1.344 . . . . 10.0 111.586 -170.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.1 132.84 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 169.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.36 112.05 18.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.437 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 42.9 t -127.7 146.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.753 1.221 . . . . 10.0 109.001 -168.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -99.04 81.67 2.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 104.469 -2.419 . . . . 10.0 104.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.437 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 15.1 m-85 -85.88 127.91 34.7 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.079 -1.082 . . . . 10.0 108.079 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -86.08 82.17 8.19 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.38 -1.341 . . . . 10.0 107.38 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 -14.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.961 1.704 . . . . 10.0 113.528 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.15 -26.74 60.48 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.017 2.127 . . . . 10.0 108.775 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -121.19 -56.18 1.92 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.388 1.075 . . . . 10.0 108.496 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.12 138.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 124.131 0.972 . . . . 10.0 108.935 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 t -89.12 158.5 17.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.488 1.137 . . . . 10.0 110.202 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.1 m -47.45 -37.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 128.062 2.545 . . . . 10.0 107.744 165.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -56.06 -25.76 46.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 119.793 1.179 . . . . 10.0 112.853 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.45 -60.99 2.37 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.71 1.595 . . . . 10.0 109.104 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.28 -53.16 43.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 124.785 1.234 . . . . 10.0 112.599 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.91 -56.37 4.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.681 1.992 . . . . 10.0 110.163 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -59.76 -44.82 93.68 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.419 1.488 . . . . 10.0 108.87 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.27 -46.74 72.76 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.57 -0.706 . . . . 10.0 112.004 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.51 -34.82 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 O-C-N 120.824 -1.172 . . . . 10.0 110.335 178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -53.52 -42.34 67.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.776 -1.203 . . . . 10.0 110.394 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -53.6 -65.73 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.261 1.025 . . . . 10.0 112.72 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -136.42 34.48 2.74 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.188 -0.945 . . . . 10.0 113.543 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.05 -57.26 0.26 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.686 0.676 . . . . 10.0 112.484 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 62.64 102.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.445 1.898 . . . . 10.0 111.775 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t0 172.57 -40.07 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.752 2.021 . . . . 10.0 107.655 -168.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.4 t -69.06 98.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 120.526 -1.359 . . . . 10.0 112.657 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.99 -55.08 5.21 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.89 -0.782 . . . . 10.0 108.89 167.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -170.47 146.28 2.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.346 1.459 . . . . 10.0 107.125 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.55 151.03 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 123.886 0.875 . . . . 10.0 109.594 171.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -150.83 142.71 23.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.25 -120.57 1.06 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 -169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.401 HH11 ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 CA-C-N 117.857 0.828 . . . . 10.0 111.161 178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 117.662 -1.161 . . . . 10.0 107.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.85 126.37 44.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.086 1.354 . . . . 10.0 109.337 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 pm0 -72.99 72.26 1.12 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.081 1.352 . . . . 10.0 110.337 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 160.65 30.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.745 1.259 . . . . 10.0 108.289 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -120.75 115.5 23.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.0 mt -86.3 92.24 8.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.912 -2.255 . . . . 10.0 104.912 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -67.09 142.73 57.02 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.72 130.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.599 1.56 . . . . 10.0 112.784 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -81.72 -53.73 5.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.47 2.708 . . . . 10.0 110.479 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.79 -40.13 0.09 OUTLIER Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.237 -0.506 . . . . 10.0 112.428 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 156.92 21.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.55 0.675 . . . . 10.0 110.994 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.17 11.57 3.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.901 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.6 t -85.25 94.25 8.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.817 0.817 . . . . 10.0 109.101 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -57.63 -4.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.325 1.05 . . . . 10.0 113.651 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -92.9 -32.06 14.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.778 1.172 . . . . 10.0 111.15 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.4 m -63.35 -74.45 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -46.62 -49.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 112.944 0.72 . . . . 10.0 112.944 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.27 -33.45 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.209 0.818 . . . . 10.0 113.209 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.95 67.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.938 0.495 . . . . 10.0 109.911 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.39 -49.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 118.287 -0.863 . . . . 10.0 109.88 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -38.71 -49.29 1.57 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.977 1.711 . . . . 10.0 110.883 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.69 -51.33 50.57 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 10.0 111.152 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.94 -42.24 63.64 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.871 0.868 . . . . 10.0 111.568 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.59 -41.19 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.097 -1.002 . . . . 10.0 109.898 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.03 -26.33 19.31 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.702 1.144 . . . . 10.0 113.866 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.63 -29.83 67.4 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.845 1.323 . . . . 10.0 110.685 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 111.98 5.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.109 0.868 . . . . 10.0 109.407 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -42.62 -41.1 2.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.566 1.947 . . . . 10.0 112.693 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.54 -26.99 57.95 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.262 0.934 . . . . 10.0 113.904 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.96 112.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 120.203 -1.763 . . . . 10.0 106.616 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -79.39 -37.77 36.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 10.0 109.758 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.82 161.29 17.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.659 -1.237 . . . . 10.0 107.659 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.73 134.16 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.012 1.325 . . . . 10.0 108.25 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -143.36 89.57 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.49 1.116 . . . . 10.0 110.072 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.8 134.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.218 1.007 . . . . 10.0 110.286 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -156.79 49.45 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.871 0.468 . . . . 10.0 110.933 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -54.39 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 10.0 111.943 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.65 -38.11 86.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.566 0.746 . . . . 10.0 111.208 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.51 -34.77 65.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.919 -174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.33 -73.35 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.61 -1.396 . . . . 10.0 109.61 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 -172.35 1.6 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.094 1.758 . . . . 10.0 107.666 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.9 t -99.06 117.8 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -100.88 130.1 46.84 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 44.5 t -136.55 149.54 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.87 -1.53 . . . . 10.0 106.87 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -111.04 85.77 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 104.915 -2.254 . . . . 10.0 104.915 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 39.9 m-85 -92.11 141.61 28.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.673 1.589 . . . . 10.0 108.276 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -89.89 93.3 9.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.617 0.767 . . . . 10.0 109.969 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.6 -14.67 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.714 -0.66 . . . . 10.0 112.296 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.3 -0.25 57.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.801 0.728 . . . . 10.0 109.685 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -130.52 -53.25 1.09 Allowed 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.675 -0.641 . . . . 10.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.89 164.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 118.701 0.682 . . . . 10.0 110.72 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.5 m -111.17 147.96 33.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.4 m -42.26 -34.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 C-N-CA 127.068 2.147 . . . . 10.0 110.148 167.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -48.29 -28.41 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.014 0.825 . . . . 10.0 112.324 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -68.9 -70.79 0.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.78 0.832 . . . . 10.0 109.008 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -59.33 -53.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.239 1.416 . . . . 10.0 113.787 -172.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.11 -56.92 3.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.124 1.77 . . . . 10.0 109.953 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -58.91 -46.25 88.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.906 0.882 . . . . 10.0 109.459 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.5 67.62 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.767 -0.583 . . . . 10.0 111.207 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.07 -38.6 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.09 -1.006 . . . . 10.0 110.037 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -54.5 -41.18 69.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.523 -1.361 . . . . 10.0 110.293 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -53.95 -65.53 0.55 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.424 1.09 . . . . 10.0 112.925 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.28 50.39 1.8 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.655 -0.653 . . . . 10.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.79 -55.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 64.0 112.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.255 2.222 . . . . 10.0 110.432 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 168.34 -41.85 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.461 0 O-C-N 121.543 -0.723 . . . . 10.0 109.337 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -75.09 84.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.028 0.442 . . . . 10.0 110.885 -168.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.28 -50.38 60.58 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -163.79 153.0 14.22 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 172.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.14 147.21 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 124.904 1.282 . . . . 10.0 108.28 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -81.62 -82.49 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.157 -0.312 . . . . 10.0 110.157 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.73 -71.54 0.6 Allowed Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.02 1.168 . . . . 10.0 116.02 -169.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 . . . . . 0 C--O 1.251 1.145 0 N-CA-C 105.658 -1.978 . . . . 10.0 105.658 -179.012 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -130.24 170.0 14.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.738 1.215 . . . . 10.0 108.564 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -141.04 113.42 8.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -120.54 -178.63 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.973 0.909 . . . . 10.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -137.87 116.6 12.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.128 -1.805 . . . . 10.0 106.128 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -86.28 94.19 9.27 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 104.58 -2.378 . . . . 10.0 104.58 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -59.32 148.02 33.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.1 128.16 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.205 1.402 . . . . 10.0 110.797 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.9 -56.52 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.808 2.043 . . . . 10.0 108.016 170.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.82 -37.03 0.05 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.513 -1.327 . . . . 10.0 113.909 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 161.26 30.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.062 0.931 . . . . 10.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -143.31 21.28 1.89 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.246 0.618 . . . . 10.0 109.955 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.5 t -97.39 101.37 12.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -66.8 2.36 1.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -45.52 6.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.969 1.308 . . . . 10.0 110.641 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.0 m -49.43 -68.88 0.14 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.377 1.471 . . . . 10.0 109.526 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -39.85 -45.65 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 C-N-CA 123.972 0.909 . . . . 10.0 112.297 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 6.0 tttp -56.17 -31.17 63.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.158 1.17 . . . . 10.0 114.158 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -31.8 52.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.199 0.454 . . . . 10.0 110.524 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.75 -33.58 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.855 1.662 . . . . 10.0 110.602 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 25.4 tt0 -43.3 -47.82 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.994 1.318 . . . . 10.0 110.592 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -46.39 -61.37 1.83 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.987 0.915 . . . . 10.0 110.996 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -57.56 -50.35 73.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.385 1.074 . . . . 10.0 110.877 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.2 t -55.53 -47.29 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.757 0.823 . . . . 10.0 109.57 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.16 -38.92 88.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.716 0.674 . . . . 10.0 112.204 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -42.57 99.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.359 1.063 . . . . 10.0 110.724 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 112.58 1.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.796 -0.565 . . . . 10.0 111.216 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -35.85 -56.09 0.71 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.852 2.461 . . . . 10.0 112.303 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.94 -19.84 51.62 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.251 0.46 . . . . 10.0 114.251 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.45 109.17 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 119.17 -2.371 . . . . 10.0 107.498 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -74.84 -31.12 61.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.806 -1.088 . . . . 10.0 109.415 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 158.07 8.91 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.22 138.61 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.358 1.063 . . . . 10.0 109.403 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -158.48 101.14 1.68 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.9 123.03 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 C-N-CA 125.339 1.456 . . . . 10.0 107.732 176.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -137.19 53.1 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.46 0.573 . . . . 10.0 110.871 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mp -44.99 -47.67 11.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.465 1.106 . . . . 10.0 112.136 -175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.32 -33.39 73.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.491 0.716 . . . . 10.0 111.902 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.0 58.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.34 -64.04 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.82 -170.23 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.941 1.296 . . . . 10.0 110.822 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -94.98 128.29 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.778 1.231 . . . . 10.0 108.824 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.96 71.39 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.744 1.618 . . . . 10.0 109.04 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 12.4 t -84.78 152.31 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.836 1.254 . . . . 10.0 109.393 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 t -110.15 71.32 0.75 Allowed 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.257 -1.757 . . . . 10.0 106.257 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 12.4 m-85 -72.03 130.11 40.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.355 -1.293 . . . . 10.0 109.107 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -80.93 85.4 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.281 -0.887 . . . . 10.0 109.838 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.35 -21.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.902 1.281 . . . . 10.0 113.845 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.78 -19.91 51.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.296 0.953 . . . . 10.0 109.706 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -116.65 -53.96 2.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.889 1.275 . . . . 10.0 110.466 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -138.2 159.71 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.077 0.551 . . . . 10.0 109.938 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.5 p -108.37 161.51 14.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 m -31.86 -42.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.238 2.215 . . . . 10.0 111.656 168.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -29.6 -54.47 0.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.65 1.58 . . . . 10.0 111.303 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.11 -59.42 5.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.376 1.084 . . . . 10.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 mm -62.61 -58.67 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.623 1.569 . . . . 10.0 111.955 -175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.46 -55.31 2.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 128.003 2.521 . . . . 10.0 110.007 172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -56.86 -48.69 77.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.891 0.853 . . . . 10.0 110.557 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.23 -45.6 79.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.454 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -35.84 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 120.558 -1.339 . . . . 10.0 109.967 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.26 -39.77 73.14 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.169 1.349 . . . . 10.0 111.755 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -49.43 -63.23 1.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.168 0.587 . . . . 10.0 112.341 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -134.81 13.34 3.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.532 0.938 . . . . 10.0 113.532 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -55.21 0.55 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.062 -0.854 . . . . 10.0 113.241 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 64.33 108.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.973 2.109 . . . . 10.0 111.256 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.75 -36.58 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.187 0.995 . . . . 10.0 109.951 -167.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.03 87.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.409 -0.807 . . . . 10.0 111.773 -169.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.79 10.36 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.288 -0.882 . . . . 10.0 110.136 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -174.13 152.85 1.93 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.579 -1.638 . . . . 10.0 106.579 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.38 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.815 0.846 . . . . 10.0 110.038 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -106.39 -103.47 0.34 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 169.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.04 -116.48 8.84 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.975 1.261 . . . . 10.0 113.168 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.792 1.637 . . . . 10.0 107.296 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 114.865 1.431 . . . . 10.0 114.865 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.53 173.49 10.2 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 126.106 2.128 . . . . 10.0 108.341 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 114.39 19.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.688 2.395 . . . . 10.0 105.379 170.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -123.01 168.05 12.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.946 -1.501 . . . . 10.0 106.946 168.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.64 122.24 32.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.45 97.43 11.07 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 172.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.86 153.28 42.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.604 0.761 . . . . 10.0 109.379 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.27 131.63 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -70.0 -56.91 5.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 130.491 3.516 . . . . 10.0 109.824 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.32 -30.21 0.18 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.451 -0.638 . . . . 10.0 112.423 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 169.58 10.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.133 0.967 . . . . 10.0 111.557 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.3 m -156.07 40.73 0.37 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.42 89.56 3.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -52.93 -16.28 1.0 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.132 0.973 . . . . 10.0 113.43 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -82.6 -39.64 21.92 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.196 -0.94 . . . . 10.0 109.835 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -57.53 -71.24 0.11 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.772 1.295 . . . . 10.0 108.31 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -46.46 -51.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.219 0.452 . . . . 10.0 112.219 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -28.93 68.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.366 0.984 . . . . 10.0 113.01 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.77 61.75 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 121.719 -0.613 . . . . 10.0 110.923 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.0 -44.59 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 118.156 -0.926 . . . . 10.0 110.633 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -44.95 -46.91 11.3 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.927 1.291 . . . . 10.0 110.302 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -50.14 -60.26 3.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.016 0.526 . . . . 10.0 111.553 174.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -58.7 -43.85 90.18 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.476 0.71 . . . . 10.0 111.767 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.3 t -53.45 -39.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.221 1.008 . . . . 10.0 110.21 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -45.92 -27.28 2.32 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.317 0.96 . . . . 10.0 114.423 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.23 -26.3 61.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.15 1.475 . . . . 10.0 112.149 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.77 113.56 2.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.179 0.9 . . . . 10.0 110.542 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -39.78 -45.9 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.194 2.198 . . . . 10.0 111.735 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -17.9 75.32 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.785 0.674 . . . . 10.0 114.785 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.91 107.54 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 118.683 -2.657 . . . . 10.0 107.245 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 t -79.35 -29.3 42.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.3 157.64 13.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -134.43 135.53 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.158 0.983 . . . . 10.0 109.103 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -149.21 87.22 1.52 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 t -73.19 117.4 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 123.726 0.81 . . . . 10.0 110.275 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.42 49.07 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.555 0.742 . . . . 10.0 111.437 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -52.42 -39.86 61.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.472 0.653 . . . . 10.0 112.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.91 -39.55 90.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.463 1.505 . . . . 10.0 110.69 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.2 -33.65 24.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.189 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.18 -67.65 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 179.01 5.16 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.355 1.862 . . . . 10.0 110.842 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -92.56 127.81 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 124.944 1.298 . . . . 10.0 107.941 173.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.83 94.02 4.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.33 1.052 . . . . 10.0 109.494 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.422 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 31.4 t -104.86 146.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.957 1.703 . . . . 10.0 107.738 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -103.8 68.89 0.94 Allowed 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.156 -2.165 . . . . 10.0 105.156 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.422 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 m-85 -66.78 128.43 36.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.915 -1.493 . . . . 10.0 108.662 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -79.95 85.4 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.83 -23.36 0.42 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.189 1.396 . . . . 10.0 113.385 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.04 -15.15 52.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.361 1.064 . . . . 10.0 110.603 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -121.48 -56.13 1.9 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.769 1.228 . . . . 10.0 109.42 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.41 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.227 1.411 . . . . 10.0 108.409 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -156.51 167.23 31.08 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.537 -1.283 . . . . 10.0 107.537 168.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -34.24 -42.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 128.116 2.566 . . . . 10.0 112.237 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -35.05 -41.48 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.017 1.327 . . . . 10.0 113.224 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.92 -67.38 0.51 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.869 0.843 . . . . 10.0 110.627 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 mm -55.92 -55.81 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.846 1.259 . . . . 10.0 112.97 -173.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.61 -56.9 4.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.813 2.045 . . . . 10.0 109.731 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.92 -49.62 65.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.55 0.691 . . . . 10.0 110.131 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.96 78.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.793 -0.639 . . . . 10.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.52 -36.86 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 120.656 -1.278 . . . . 10.0 110.096 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.32 -40.87 71.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.499 -1.376 . . . . 10.0 111.645 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -51.5 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.154 0.888 . . . . 10.0 112.54 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.0 46.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.24 0.459 . . . . 10.0 112.24 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.57 -59.65 0.11 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.02 110.64 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.41 2.284 . . . . 10.0 110.919 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 t0 169.78 -38.55 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.93 1.692 . . . . 10.0 109.224 -167.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 73.4 t -74.93 90.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 120.484 -1.385 . . . . 10.0 112.382 -172.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.9 -56.84 4.62 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.467 -0.77 . . . . 10.0 110.708 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -163.63 143.74 8.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.848 -1.538 . . . . 10.0 106.848 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp -83.52 135.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 C-N-CA 124.7 1.2 . . . . 10.0 108.311 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.86 135.91 47.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.144 -1.799 . . . . 10.0 106.144 170.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -120.44 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 107.393 -2.283 . . . . 10.0 107.393 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.365 -1.302 . . . . 10.0 109.045 169.519 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttp . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.93 -174.55 4.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.905 0.775 . . . . 10.0 109.978 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.92 107.81 5.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.252 2.221 . . . . 10.0 106.369 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 161.34 15.71 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.24 -1.393 . . . . 10.0 107.24 168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.38 115.55 26.77 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.9 mt -81.99 96.98 7.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.948 -1.871 . . . . 10.0 105.948 168.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -65.0 155.71 33.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 10.0 109.662 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.12 129.61 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.302 1.441 . . . . 10.0 110.447 -176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' CB ' ' HA ' ' A' ' 66' ' ' ASP . 28.1 tt0 -75.14 -43.63 51.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.962 1.705 . . . . 10.0 107.408 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.37 12.19 0.96 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.533 -1.148 . . . . 10.0 113.371 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -177.04 1.96 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.714 1.757 . . . . 10.0 109.722 169.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 p -155.53 15.16 0.37 Allowed 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.034 -0.416 . . . . 10.0 111.362 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -99.35 95.29 6.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -64.2 2.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.468 0.914 . . . . 10.0 113.468 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -94.0 -48.36 6.28 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.781 1.173 . . . . 10.0 110.046 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.3 m -48.21 -70.16 0.1 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.536 1.134 . . . . 10.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 m -38.45 -48.46 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.35 1.06 . . . . 10.0 111.89 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -38.14 89.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.359 1.064 . . . . 10.0 112.535 -174.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.4 69.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.5 t -73.46 -38.14 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.68 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -46.2 -49.81 16.57 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.922 1.289 . . . . 10.0 110.358 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -50.57 72.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.901 0.381 . . . . 10.0 111.264 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -70.79 -10.49 59.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.947 0.721 . . . . 10.0 112.947 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 -43.0 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.624 1.17 . . . . 10.0 108.312 169.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.54 -30.35 19.64 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.886 1.231 . . . . 10.0 114.2 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.21 -31.24 72.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.145 0.973 . . . . 10.0 111.462 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.3 105.19 1.37 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -31.8 -42.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.054 2.142 . . . . 10.0 113.836 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.83 -20.43 47.97 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.426 1.012 . . . . 10.0 114.808 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.32 107.93 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 119.542 -2.152 . . . . 10.0 106.833 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -77.05 -29.4 55.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.185 -0.916 . . . . 10.0 109.378 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.08 13.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.182 -1.784 . . . . 10.0 106.182 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.84 119.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -136.31 97.87 3.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.282 1.033 . . . . 10.0 108.951 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.47 114.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.513 -0.921 . . . . 10.0 108.513 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -127.05 47.61 2.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.322 0.51 . . . . 10.0 111.963 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -49.53 -48.57 48.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 10.0 112.291 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -35.41 74.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.588 0.755 . . . . 10.0 110.99 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.08 -30.64 31.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.894 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.21 -69.72 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 123.98 0.8 . . . . 10.0 111.218 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -170.44 174.31 5.23 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.941 1.696 . . . . 10.0 112.627 -169.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.2 t -88.77 103.57 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 124.787 1.235 . . . . 10.0 107.971 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.2 116.36 30.26 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.461 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 57.0 t -136.3 135.13 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 -171.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.4 t -94.71 73.58 3.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.307 -1.368 . . . . 10.0 107.307 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 43.1 m-85 -68.67 136.41 52.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.519 -1.218 . . . . 10.0 109.281 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.71 87.03 7.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.545 0.688 . . . . 10.0 110.15 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.13 -20.1 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.08 -1.418 . . . . 10.0 113.623 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.67 -18.84 32.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 119.12 0.873 . . . . 10.0 110.215 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -117.45 -44.93 2.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.364 0.666 . . . . 10.0 109.745 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.53 -172.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.044 0.938 . . . . 10.0 109.425 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -142.62 159.18 42.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.737 0.779 . . . . 10.0 109.403 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.6 m -44.83 -36.44 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 128.274 2.63 . . . . 10.0 110.294 170.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -41.92 -50.3 4.51 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.434 1.016 . . . . 10.0 110.736 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.24 -49.84 74.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.587 1.185 . . . . 10.0 111.46 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -71.52 -58.46 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.256 1.822 . . . . 10.0 111.674 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.99 -59.21 1.51 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.348 2.259 . . . . 10.0 109.57 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -49.25 -51.99 30.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.442 1.497 . . . . 10.0 109.888 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.56 80.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -68.77 -58.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -37.42 -47.51 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.224 1.01 . . . . 10.0 113.007 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -42.92 -60.08 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.019 0.927 . . . . 10.0 113.407 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -136.63 -30.45 0.9 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.086 1.143 . . . . 10.0 114.086 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.8 94.43 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.51 172.18 0.19 Allowed 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.826 1.65 . . . . 10.0 110.112 -174.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.404 ' HA ' ' CB ' ' A' ' 9' ' ' GLU 0.336 7.5 t70 81.55 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.904 1.281 . . . . 10.0 112.431 177.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 t -120.38 93.95 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.223 1.409 . . . . 10.0 109.623 169.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.0 4.1 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.03 159.62 1.35 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.84 1.256 . . . . 10.0 107.791 -175.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.34 139.96 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 108.28 -1.008 . . . . 10.0 108.28 166.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -89.9 -44.75 9.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.7 2.0 . . . . 10.0 109.796 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.84 -88.49 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.674 1.131 . . . . 10.0 113.851 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.909 0 CA-C-O 115.671 -2.109 . . . . 10.0 107.463 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.297 -0.382 . . . . 10.0 110.104 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -140.89 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.89 2.076 . . . . 10.0 106.726 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -122.99 121.16 35.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.629 -2.73 . . . . 10.0 103.629 167.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -117.82 178.25 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.52 121.71 12.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 -177.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.02 90.34 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 103.631 -2.729 . . . . 10.0 103.631 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.46 141.77 58.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -67.71 126.54 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.849 1.659 . . . . 10.0 112.45 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -75.03 -55.26 5.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.992 2.117 . . . . 10.0 109.319 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.02 -35.75 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.13 -1.034 . . . . 10.0 113.313 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.86 158.87 26.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.929 0.865 . . . . 10.0 109.24 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.71 20.93 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.918 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.2 113.14 25.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.64 -1.615 . . . . 10.0 106.64 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.02 -16.8 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.744 -0.383 . . . . 10.0 111.511 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -83.92 -44.17 14.52 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.709 0.686 . . . . 10.0 110.332 -169.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -43.91 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.978 1.711 . . . . 10.0 109.195 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -43.55 -47.85 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 112.689 0.626 . . . . 10.0 112.689 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -44.25 -41.97 6.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.123 1.157 . . . . 10.0 114.123 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.86 -34.91 42.87 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.716 0.406 . . . . 10.0 110.379 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.4 -31.84 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.319 1.447 . . . . 10.0 111.123 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -43.6 -47.49 7.49 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.259 1.423 . . . . 10.0 109.323 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -55.04 -58.69 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.651 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -56.73 -49.66 74.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.947 1.299 . . . . 10.0 110.271 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 t -60.23 -49.96 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.568 0.747 . . . . 10.0 109.981 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.6 -32.14 38.57 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.007 0.813 . . . . 10.0 112.598 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.7 -32.35 73.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.385 1.074 . . . . 10.0 110.498 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 109.37 3.81 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 121.214 -0.929 . . . . 10.0 109.325 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -42.29 -40.42 2.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.755 1.622 . . . . 10.0 112.899 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.07 -18.39 54.6 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.094 1.33 . . . . 10.0 114.898 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.46 113.34 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 169.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -77.28 -32.96 55.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.331 -0.849 . . . . 10.0 110.69 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -171.5 158.97 5.38 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.894 -1.521 . . . . 10.0 106.894 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.58 136.88 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 105.995 -1.854 . . . . 10.0 105.995 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.89 84.15 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.575 1.178 . . . . 10.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.18 118.77 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.313 1.445 . . . . 10.0 110.302 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -144.69 50.12 1.28 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.942 0.497 . . . . 10.0 111.43 -177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mp -48.2 -58.03 5.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.37 1.068 . . . . 10.0 112.359 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.77 -43.21 94.0 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.94 0.876 . . . . 10.0 110.553 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.34 -29.34 68.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.733 -1.122 . . . . 10.0 111.019 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.27 -72.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.462 1.03 . . . . 10.0 111.098 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.37 -178.05 3.87 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.324 1.45 . . . . 10.0 110.25 -173.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -87.6 106.8 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -82.33 140.6 33.46 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.329 -1.359 . . . . 10.0 107.329 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -160.27 140.78 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 118.669 0.668 . . . . 10.0 109.45 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -116.91 82.91 1.88 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 -169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD2' HG11 ' A' ' 53' ' ' VAL . 44.0 m-85 -70.06 172.89 7.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.467 -0.788 . . . . 10.0 108.967 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -127.95 101.51 6.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 10.0 108.942 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -18.45 24.88 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.174 0.59 . . . . 10.0 111.881 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.03 -11.89 59.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.697 0.68 . . . . 10.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -121.29 -56.25 1.91 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.487 1.115 . . . . 10.0 109.246 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.1 159.49 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.454 1.102 . . . . 10.0 111.237 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 p -107.49 148.48 29.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.287 0.565 . . . . 10.0 109.991 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG11 ' CD2' ' A' ' 46' ' ' PHE . 21.4 m -37.62 -45.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 C-N-CA 129.063 2.945 . . . . 10.0 110.677 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -35.67 -49.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.773 0.829 . . . . 10.0 112.016 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -54.25 -63.93 0.99 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.885 0.874 . . . . 10.0 110.429 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -65.89 -50.73 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.184 0.994 . . . . 10.0 112.776 -174.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.95 -62.84 0.58 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.924 2.09 . . . . 10.0 109.192 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.07 -45.06 79.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.605 0.717 . . . . 10.0 110.268 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.73 69.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.487 0.715 . . . . 10.0 110.872 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.69 -34.87 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 120.969 -1.082 . . . . 10.0 110.117 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -57.62 -33.56 68.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.871 1.214 . . . . 10.0 111.738 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -56.9 -68.4 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.19 0.904 . . . . 10.0 111.862 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -135.49 33.6 3.01 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.84 -57.81 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.22 -0.767 . . . . 10.0 112.216 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.49 107.17 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.733 2.013 . . . . 10.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t70 171.49 -35.52 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 124.813 1.245 . . . . 10.0 110.171 -168.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.9 85.81 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.546 -0.721 . . . . 10.0 111.063 -172.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.84 -49.78 55.51 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -167.14 148.51 5.8 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.585 -1.635 . . . . 10.0 106.585 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -85.17 136.34 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 169.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.92 140.37 32.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.48 -91.8 0.1 OUTLIER Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.583 0.611 . . . . 10.0 111.885 167.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 116.427 -1.749 . . . . 10.0 107.621 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 118.9 -0.572 . . . . 10.0 110.146 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.98 -176.25 2.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.597 1.559 . . . . 10.0 108.399 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -144.71 108.73 4.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -115.22 164.49 14.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.752 1.263 . . . . 10.0 108.809 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -122.23 114.59 21.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 127.004 2.122 . . . . 10.0 106.709 -167.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.79 85.79 6.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -59.96 149.75 30.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.04 0.936 . . . . 10.0 109.836 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.84 129.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.636 1.574 . . . . 10.0 111.86 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.59 -64.33 0.9 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 130.024 3.33 . . . . 10.0 108.799 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.08 -31.39 0.19 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.248 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 169.03 5.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.621 1.211 . . . . 10.0 110.048 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.7 t -158.86 39.32 0.22 Allowed 'General case' 0 C--N 1.334 -0.074 0 O-C-N 121.568 -0.708 . . . . 10.0 109.228 -169.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.09 97.55 6.14 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.87 -14.37 2.38 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.526 0.936 . . . . 10.0 113.526 174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -86.54 -47.97 8.77 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.509 1.05 . . . . 10.0 109.38 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.4 m -45.96 -65.45 0.55 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.676 1.19 . . . . 10.0 110.198 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 m -48.71 -48.18 15.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.23 0.468 . . . . 10.0 110.894 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -54.71 -34.62 62.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.23 57.62 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.78 -33.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.509 1.124 . . . . 10.0 111.085 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -41.15 -55.9 2.5 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 10.0 109.727 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.93 96.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.627 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m -56.88 -58.54 7.7 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.202 0.601 . . . . 10.0 109.989 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -49.99 -32.92 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.107 1.363 . . . . 10.0 112.446 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -22.8 4.05 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 114.637 0.615 . . . . 10.0 114.637 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.66 -32.28 73.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.422 1.489 . . . . 10.0 111.429 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.7 104.04 0.62 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.06 -37.07 14.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.965 1.306 . . . . 10.0 111.832 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.42 70.46 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.443 1.02 . . . . 10.0 113.977 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.75 106.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 120.192 -1.769 . . . . 10.0 107.501 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 m -73.37 -40.12 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.8 -1.091 . . . . 10.0 110.196 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.79 156.79 23.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.376 -1.342 . . . . 10.0 107.376 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.89 127.7 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.36 98.98 5.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 107.216 -1.402 . . . . 10.0 107.216 170.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.73 112.59 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.96 1.304 . . . . 10.0 108.441 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.99 48.3 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.632 0.604 . . . . 10.0 112.632 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.4 -46.54 62.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.618 -0.676 . . . . 10.0 112.304 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.1 -31.71 71.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.137 0.975 . . . . 10.0 111.017 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.01 18.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.861 0.362 . . . . 10.0 111.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.3 -78.49 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -1.379 . . . . 10.0 109.652 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 178.56 5.4 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.365 1.866 . . . . 10.0 109.256 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.19 105.44 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -102.0 125.88 48.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 10.0 108.119 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.4 t -136.54 142.35 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.979 0.895 . . . . 10.0 108.746 -168.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -101.69 77.5 1.74 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 105.849 -1.908 . . . . 10.0 105.849 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -72.44 138.04 46.84 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.048 -1.887 . . . . 10.0 107.509 173.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -90.49 95.78 10.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.035 -0.357 . . . . 10.0 110.035 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -19.94 14.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.881 0.872 . . . . 10.0 112.818 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.75 -15.86 59.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 119.23 0.923 . . . . 10.0 109.878 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -119.99 -54.39 2.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.752 0.821 . . . . 10.0 110.346 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.0 161.72 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.417 0.687 . . . . 10.0 110.782 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.9 t -110.3 156.38 20.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.485 1.136 . . . . 10.0 110.444 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 36.0 m -45.14 -39.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.098 2.559 . . . . 10.0 109.304 166.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -43.39 -39.27 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.445 1.02 . . . . 10.0 111.844 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.4 -58.9 3.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.425 0.557 . . . . 10.0 111.034 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.18 -50.09 71.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 120.84 -1.163 . . . . 10.0 112.163 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.97 -54.85 4.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.161 1.785 . . . . 10.0 109.352 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.37 -49.15 77.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.815 0.817 . . . . 10.0 109.879 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.69 67.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.63 0.772 . . . . 10.0 111.356 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -72.11 -42.94 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 O-C-N 120.962 -1.087 . . . . 10.0 110.878 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.287 0.1 OUTLIER -66.5 -26.7 67.29 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.723 1.601 . . . . 10.0 112.13 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -45.63 -66.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.059 0.944 . . . . 10.0 112.859 171.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.76 15.09 2.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.099 0.777 . . . . 10.0 113.099 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.2 -56.16 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.528 1.061 . . . . 10.0 111.461 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.31 113.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 10.0 112.292 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 163.13 -39.25 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 126.647 1.979 . . . . 10.0 108.487 -169.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.22 93.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 121.649 -0.657 . . . . 10.0 111.312 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.25 -56.97 5.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -170.61 162.86 8.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.728 -1.582 . . . . 10.0 106.728 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.25 144.42 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.628 1.571 . . . . 10.0 110.474 170.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -138.73 149.71 45.35 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 106.43 -1.693 . . . . 10.0 106.43 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.74 -129.99 3.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 107.191 -2.364 . . . . 10.0 107.191 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? . . . . . 0 C--O 1.251 1.142 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 167.283 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttp . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.47 142.14 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.949 0.881 . . . . 10.0 112.453 -167.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.76 82.27 7.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.038 0.935 . . . . 10.0 110.473 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -75.96 150.31 37.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.4 132.11 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 103.809 -2.663 . . . . 10.0 103.809 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.4 92.89 4.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.007 -2.22 . . . . 10.0 105.007 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -61.71 146.65 48.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.708 -1.587 . . . . 10.0 108.534 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.72 134.4 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.961 1.304 . . . . 10.0 113.42 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -78.09 -68.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.686 1.995 . . . . 10.0 109.063 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.0 -38.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.018 -0.61 . . . . 10.0 113.252 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.04 160.43 6.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 117.961 0.88 . . . . 10.0 111.858 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 m -149.22 48.65 0.97 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -126.4 91.43 3.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.332 1.053 . . . . 10.0 108.402 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.5 -5.33 0.52 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.03 -37.69 14.96 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 120.87 -1.144 . . . . 10.0 110.291 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -58.72 -71.94 0.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 171.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -43.6 -52.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -56.84 -31.18 64.5 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.967 0.728 . . . . 10.0 112.967 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.36 68.19 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.1 t -88.05 -40.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 123.939 0.895 . . . . 10.0 109.749 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -41.62 -48.5 4.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.889 0.876 . . . . 10.0 110.533 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -53.16 61.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.959 0.409 . . . . 10.0 111.123 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -62.52 -16.86 58.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.106 1.762 . . . . 10.0 113.043 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -89.22 -42.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.477 1.111 . . . . 10.0 109.91 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.96 -26.18 47.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.748 1.166 . . . . 10.0 112.878 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -69.31 -28.26 66.11 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.948 0.874 . . . . 10.0 111.719 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.9 110.46 2.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.948 -0.701 . . . . 10.0 110.036 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -35.64 -44.16 0.31 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.404 2.282 . . . . 10.0 111.403 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 8.64 5.89 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.185 1.234 . . . . 10.0 116.185 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.21 111.49 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -74.45 -31.18 62.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.59 161.31 9.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.24 145.51 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.298 1.039 . . . . 10.0 109.757 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.35 82.89 0.84 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.988 0.899 . . . . 10.0 109.304 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.31 140.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.784 0.834 . . . . 10.0 109.597 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -161.17 44.44 0.17 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-O 121.172 0.51 . . . . 10.0 111.787 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.83 -46.64 64.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.507 0.723 . . . . 10.0 112.819 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -70.39 -24.78 63.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.965 1.306 . . . . 10.0 110.783 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.37 -27.27 19.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.136 0.574 . . . . 10.0 111.182 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.64 -69.7 0.09 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.524 1.059 . . . . 10.0 111.036 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.76 173.9 8.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.292 1.837 . . . . 10.0 108.701 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.9 138.6 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 169.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -122.52 110.46 15.61 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.103 1.761 . . . . 10.0 107.435 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 34.7 t -124.09 146.55 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.004 1.322 . . . . 10.0 107.576 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 t -103.28 78.59 1.63 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.308 -1.738 . . . . 10.0 106.308 -170.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 69.1 m-85 -83.78 138.1 33.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.936 -1.029 . . . . 10.0 109.905 -172.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -88.08 84.36 6.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.167 -0.924 . . . . 10.0 108.707 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.44 -21.19 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.138 1.375 . . . . 10.0 113.056 168.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -25.8 59.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.914 2.086 . . . . 10.0 109.976 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -117.7 -49.64 2.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.253 1.021 . . . . 10.0 109.261 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.98 -175.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.303 1.041 . . . . 10.0 109.612 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.9 p -133.81 158.82 42.41 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.72 -0.844 . . . . 10.0 108.72 170.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -44.02 -34.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.35 1.86 . . . . 10.0 111.133 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -47.39 -30.34 3.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.592 0.633 . . . . 10.0 112.129 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.4 -65.5 0.69 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 118.574 0.625 . . . . 10.0 109.623 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.58 -53.93 33.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.909 1.283 . . . . 10.0 112.909 -170.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.0 -56.3 4.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.187 1.395 . . . . 10.0 109.764 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.6 -45.2 85.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.815 0.446 . . . . 10.0 110.271 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.37 -48.6 62.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.882 0.473 . . . . 10.0 110.601 176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.56 -38.7 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.086 -1.009 . . . . 10.0 110.49 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.26 -34.84 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.32 -1.488 . . . . 10.0 111.564 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.02 -66.86 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.448 0.567 . . . . 10.0 112.262 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -134.69 40.86 2.93 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.212 0.605 . . . . 10.0 112.593 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.67 -59.04 0.08 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.825 -0.986 . . . . 10.0 111.305 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 64.92 108.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.215 2.206 . . . . 10.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.0 -37.6 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.888 0.875 . . . . 10.0 109.869 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.4 t -74.19 89.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.248 -0.908 . . . . 10.0 110.914 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.82 -52.3 31.46 Favored 'General case' 0 C--O 1.227 -0.103 0 O-C-N 121.508 -0.745 . . . . 10.0 109.016 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -170.13 153.12 4.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.87 159.14 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.175 0.99 . . . . 10.0 110.686 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.62 -69.34 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.679 -0.692 . . . . 10.0 109.234 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.95 -80.29 0.48 Allowed Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.363 0.505 . . . . 10.0 114.363 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.229 -0.891 . . . . 10.0 110.842 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 40.4 ttm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 117.679 -1.153 . . . . 10.0 107.921 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -144.08 -173.11 3.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.522 1.129 . . . . 10.0 108.053 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.03 126.09 24.45 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.229 1.411 . . . . 10.0 107.319 168.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.72 159.84 19.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.142 0.977 . . . . 10.0 109.879 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.16 122.25 46.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 mt -91.89 80.7 5.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.682 -1.97 . . . . 10.0 105.682 173.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -57.15 149.04 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 110.212 -0.292 . . . . 10.0 110.212 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.68 131.1 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.389 1.075 . . . . 10.0 113.212 -169.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.0 -58.65 3.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.245 2.618 . . . . 10.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.43 -34.33 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.134 -0.485 . . . . 10.0 112.551 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.93 165.79 10.26 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.781 0.791 . . . . 10.0 111.27 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 p -135.54 -34.81 0.83 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.368 1.067 . . . . 10.0 112.405 -168.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 t -48.37 88.49 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.14 1.776 . . . . 10.0 112.813 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.85 -7.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.498 -0.751 . . . . 10.0 112.904 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -86.61 -36.02 19.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.077 0.951 . . . . 10.0 110.031 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.7 m -59.6 -66.67 0.48 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -47.24 -50.88 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 112.213 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.261 0.7 OUTLIER -58.8 -32.25 69.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.403 -0.519 . . . . 10.0 112.297 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.37 -49.01 68.08 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.421 -0.799 . . . . 10.0 109.464 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.43 -44.25 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.814 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -39.8 -48.48 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.202 1.401 . . . . 10.0 110.844 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.3 p -50.51 -50.03 54.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.17 0.441 . . . . 10.0 111.574 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 m -71.26 -51.34 25.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.964 0.906 . . . . 10.0 110.552 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -53.78 -41.8 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.946 0.403 . . . . 10.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.96 -5.35 5.42 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.017 -1.435 . . . . 10.0 114.812 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -98.9 -18.58 17.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.672 1.736 . . . . 10.0 112.909 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 123.41 18.08 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 120.717 1.599 . . . . 10.0 109.941 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -41.26 -43.34 2.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.325 1.85 . . . . 10.0 112.58 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.85 -8.97 86.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.896 0.76 . . . . 10.0 114.897 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 102.56 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.728 -2.323 . . . . 10.0 104.728 169.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -70.54 -33.47 71.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.961 -1.018 . . . . 10.0 109.273 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.92 157.85 14.29 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.91 135.98 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.793 1.237 . . . . 10.0 108.794 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 91.75 2.5 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.276 1.03 . . . . 10.0 108.379 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -82.86 115.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.345 1.058 . . . . 10.0 109.48 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -143.96 49.55 1.37 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.35 -45.27 62.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.039 0.755 . . . . 10.0 113.039 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.11 -30.01 67.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.221 1.008 . . . . 10.0 111.646 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.77 -34.89 18.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.759 0.314 . . . . 10.0 110.782 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.97 -69.89 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.34 -177.41 3.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.818 1.247 . . . . 10.0 110.975 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -92.46 110.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.523 -1.658 . . . . 10.0 106.523 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.57 126.3 51.53 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.431 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 76.8 t -138.54 143.43 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 t -100.12 78.01 2.04 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 53.5 m-85 -82.94 137.27 34.26 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.498 -1.228 . . . . 10.0 110.79 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.61 89.2 7.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.137 1.375 . . . . 10.0 109.728 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.93 -15.92 1.6 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.77 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -66.67 -30.76 71.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.219 2.207 . . . . 10.0 108.96 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -120.7 -54.07 2.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.138 0.975 . . . . 10.0 109.615 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.77 160.52 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 123.75 0.82 . . . . 10.0 110.356 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 m -110.38 152.92 25.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.137 -1.06 . . . . 10.0 108.137 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 m -37.76 -39.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 127.902 2.481 . . . . 10.0 110.796 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -43.07 -31.32 0.53 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 10.0 113.599 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.01 -64.18 0.91 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.694 0.759 . . . . 10.0 110.605 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -62.75 -54.66 30.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 C-N-CA 125.792 1.637 . . . . 10.0 112.628 -174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.46 -65.1 0.33 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.798 2.039 . . . . 10.0 109.026 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -51.65 -47.64 63.68 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 10.0 110.868 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -46.57 70.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.203 0.601 . . . . 10.0 111.813 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.13 -39.53 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.792 -1.192 . . . . 10.0 110.015 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.55 -30.88 65.57 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.868 -1.145 . . . . 10.0 111.154 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -59.45 -69.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.674 0.67 . . . . 10.0 112.17 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -133.03 33.11 3.69 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.845 0.858 . . . . 10.0 112.362 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.12 -61.07 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.798 0.713 . . . . 10.0 111.884 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 67.63 113.06 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.065 2.146 . . . . 10.0 112.297 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 166.64 -39.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 126.053 1.741 . . . . 10.0 109.267 -169.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.0 t -72.2 91.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.577 -0.702 . . . . 10.0 110.844 -171.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.28 -53.78 18.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 121.692 -0.63 . . . . 10.0 109.586 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 147.96 5.81 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.641 -1.615 . . . . 10.0 106.641 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -84.87 132.42 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.903 -1.147 . . . . 10.0 107.903 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.19 124.54 51.76 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.86 -1.533 . . . . 10.0 106.86 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.08 -131.81 4.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 116.801 -1.571 . . . . 10.0 110.158 -177.806 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttp . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 118.187 -0.911 . . . . 10.0 108.907 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.97 -173.09 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -146.83 69.7 1.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.769 2.028 . . . . 10.0 109.02 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -77.64 158.05 29.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.681 0.753 . . . . 10.0 109.66 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.44 125.61 51.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 -175.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 74.3 mt -95.13 88.41 5.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 169.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -61.41 148.33 42.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.41 0.684 . . . . 10.0 109.48 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.23 132.38 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.765 1.024 . . . . 10.0 113.765 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -71.73 -54.73 9.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.679 2.792 . . . . 10.0 108.596 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.36 -23.68 0.13 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.308 -0.86 . . . . 10.0 113.738 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 169.74 4.23 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.589 1.195 . . . . 10.0 111.987 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 28.83 0.73 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.37 93.39 4.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.087 -1.079 . . . . 10.0 108.087 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -58.75 -13.06 5.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -80.02 -45.59 18.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.6 m -52.07 -63.4 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.814 0.846 . . . . 10.0 109.609 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.69 -50.25 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.903 -0.57 . . . . 10.0 111.109 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -61.86 -32.97 73.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.44 1.018 . . . . 10.0 112.936 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.56 -40.83 69.13 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.585 -0.697 . . . . 10.0 109.484 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.13 -42.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 118.166 -0.921 . . . . 10.0 111.385 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -35.92 -57.9 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.145 1.778 . . . . 10.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -42.78 76.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 10.0 111.281 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -64.93 -50.64 65.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.234 1.014 . . . . 10.0 109.676 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 t -54.18 -39.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.461 0.704 . . . . 10.0 110.41 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.5 -27.87 9.13 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.755 1.169 . . . . 10.0 113.766 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -71.54 -25.96 62.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.984 1.392 . . . . 10.0 111.533 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 104.48 1.28 Allowed 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.356 -0.84 . . . . 10.0 109.315 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -46.08 -37.24 6.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.271 1.828 . . . . 10.0 112.729 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -8.99 55.54 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.844 -0.535 . . . . 10.0 114.166 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.84 109.85 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.97 1.885 . . . . 10.0 106.303 168.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -73.71 -30.07 62.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.731 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -172.25 168.35 5.66 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.89 135.26 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.863 1.265 . . . . 10.0 108.756 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 90.02 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.198 0.999 . . . . 10.0 109.602 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.56 106.77 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.527 1.131 . . . . 10.0 109.455 -176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -134.76 49.55 2.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.202 0.601 . . . . 10.0 112.241 -177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.6 -47.18 70.42 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.383 0.512 . . . . 10.0 112.383 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -63.91 -36.41 83.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.845 0.858 . . . . 10.0 111.074 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.74 -34.22 22.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.859 -172.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.62 -69.41 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 10.0 110.572 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.29 178.67 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.167 2.187 . . . . 10.0 110.822 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.55 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.45 121.19 39.07 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.7 t -132.27 144.4 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 -169.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 t -101.73 69.49 1.21 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -69.01 137.87 54.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.973 -1.467 . . . . 10.0 108.733 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -94.24 87.12 5.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.047 168.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 -16.58 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.349 1.06 . . . . 10.0 113.376 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.82 -12.72 59.39 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.293 0.951 . . . . 10.0 110.033 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -131.12 -54.42 1.04 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.473 1.109 . . . . 10.0 110.391 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.62 135.74 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.817 1.247 . . . . 10.0 109.435 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 150.72 20.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -36.38 -41.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 128.72 2.808 . . . . 10.0 111.242 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -34.39 -49.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.302 0.955 . . . . 10.0 111.768 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.63 -67.22 0.3 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.42 1.105 . . . . 10.0 110.716 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mm -60.68 -57.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.374 . . . . 10.0 112.496 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.15 -59.34 0.87 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.656 2.382 . . . . 10.0 109.971 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.48 -51.11 68.07 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.87 0.468 . . . . 10.0 110.56 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.08 73.31 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.653 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.76 -41.09 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.182 -0.949 . . . . 10.0 110.094 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.51 -36.75 69.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.974 1.261 . . . . 10.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.37 -59.57 4.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.085 0.554 . . . . 10.0 112.457 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -139.08 -18.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.382 1.252 . . . . 10.0 114.382 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.97 -47.13 40.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.847 0.749 . . . . 10.0 111.29 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 56.61 110.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.109 2.164 . . . . 10.0 112.525 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 167.24 -39.84 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.239 1.415 . . . . 10.0 109.285 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.9 t -69.84 92.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 O-C-N 121.496 -0.753 . . . . 10.0 111.209 -173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.86 4.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.711 0.767 . . . . 10.0 109.084 169.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.88 146.54 7.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.18 -1.415 . . . . 10.0 107.18 -171.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -84.21 131.73 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.782 1.233 . . . . 10.0 107.778 175.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.14 121.21 36.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.48 -154.98 25.97 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 107.228 -2.349 . . . . 10.0 107.228 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.754 1.222 . . . . 10.0 109.03 169.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.514 -0.43 0 N-CA-C 106.912 -1.514 . . . . 10.0 106.912 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -175.95 2.88 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.998 1.436 . . . . 10.0 108.826 -169.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -140.98 112.91 7.74 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.788 2.435 . . . . 10.0 105.389 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 172.92 7.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.951 -1.87 . . . . 10.0 105.951 169.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.49 126.35 38.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.313 -2.476 . . . . 10.0 104.313 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -95.95 95.62 8.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -68.91 148.1 50.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.832 -0.803 . . . . 10.0 108.832 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.04 130.45 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 125.268 1.427 . . . . 10.0 112.958 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -71.64 -61.23 1.85 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.033 2.933 . . . . 10.0 108.196 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.0 -39.21 0.13 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.172 -0.771 . . . . 10.0 111.172 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.64 157.98 13.46 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.588 0.694 . . . . 10.0 110.518 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.9 51.84 0.39 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 -172.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.97 94.01 4.1 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.824 1.25 . . . . 10.0 107.785 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -59.99 0.57 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.19 1.182 . . . . 10.0 114.19 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -43.15 10.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.504 1.047 . . . . 10.0 109.464 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 m -57.96 -67.69 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.609 0.764 . . . . 10.0 109.13 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -43.11 -46.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 C-N-CA 123.331 0.652 . . . . 10.0 112.086 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -54.87 -33.07 61.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.776 1.028 . . . . 10.0 113.776 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.31 -29.15 57.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.473 0.309 . . . . 10.0 110.737 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.66 -33.57 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.564 1.546 . . . . 10.0 110.989 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -41.19 -49.47 3.56 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.706 1.203 . . . . 10.0 110.289 177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.5 p -46.15 -68.65 0.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.517 1.527 . . . . 10.0 111.231 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -57.19 -39.37 75.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.873 1.269 . . . . 10.0 111.85 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.02 -42.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.875 -0.417 . . . . 10.0 109.875 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.83 48.38 1.97 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.274 1.416 . . . . 10.0 112.136 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.27 -42.86 0.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 127.86 2.464 . . . . 10.0 109.1 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -50.64 127.28 17.65 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.411 1.459 . . . . 10.0 110.794 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -46.46 -42.86 16.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.357 1.463 . . . . 10.0 111.966 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 -13.27 83.11 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.404 0.522 . . . . 10.0 114.404 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.55 109.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 119.708 -2.054 . . . . 10.0 106.094 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.04 -32.54 50.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.448 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.58 151.05 9.11 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -123.1 146.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.5 100.92 1.05 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 -173.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.88 109.92 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 -171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -135.33 46.61 2.38 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 111.762 0.282 . . . . 10.0 111.762 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -52.5 -48.68 65.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.835 0.854 . . . . 10.0 111.746 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -67.47 -26.83 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.991 0.916 . . . . 10.0 110.488 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 -30.89 16.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.572 0.349 . . . . 10.0 111.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -67.38 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.06 0.838 . . . . 10.0 112.074 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -171.11 176.11 4.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.862 1.665 . . . . 10.0 111.674 -169.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.52 129.51 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.296 0.638 . . . . 10.0 109.732 171.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -120.27 74.12 1.03 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.31 2.244 . . . . 10.0 108.852 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -94.05 149.97 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.205 1.402 . . . . 10.0 109.195 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -107.04 76.23 1.08 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -73.26 139.26 46.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.283 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.49 95.7 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.597 0.759 . . . . 10.0 109.78 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.87 -21.9 12.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.499 0.719 . . . . 10.0 112.784 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -87.62 -8.24 56.46 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.907 0.776 . . . . 10.0 110.68 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -119.72 -54.82 2.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.14 -170.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.433 1.493 . . . . 10.0 108.878 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.2 t -147.35 158.19 43.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.765 -0.828 . . . . 10.0 108.765 168.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -38.71 -46.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 C-N-CA 128.37 2.668 . . . . 10.0 109.598 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -44.15 2.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.54 1.064 . . . . 10.0 112.284 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.32 -61.54 2.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.566 0.698 . . . . 10.0 110.844 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -61.43 -53.6 46.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 124.542 1.137 . . . . 10.0 111.514 -176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.69 -62.52 0.53 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.923 2.089 . . . . 10.0 109.41 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.47 -43.87 75.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.366 0.603 . . . . 10.0 110.741 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.43 75.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.694 0.798 . . . . 10.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.51 -36.21 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 120.76 -1.212 . . . . 10.0 109.23 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.82 -42.19 75.32 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.609 -1.307 . . . . 10.0 111.273 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -52.25 -62.92 1.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.885 0.874 . . . . 10.0 112.546 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -144.22 66.89 1.27 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.088 0.555 . . . . 10.0 110.666 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.97 -59.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.012 -0.882 . . . . 10.0 111.467 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 68.84 113.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.253 2.221 . . . . 10.0 111.35 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 166.43 -32.45 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.284 1.434 . . . . 10.0 109.737 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.94 85.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 121.0 -1.063 . . . . 10.0 112.257 -168.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.1 -52.68 25.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.315 -0.866 . . . . 10.0 109.596 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -166.5 142.39 4.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.905 -1.517 . . . . 10.0 106.905 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.98 138.45 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 125.483 1.513 . . . . 10.0 107.671 174.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -50.7 -44.21 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.67 0.788 . . . . 10.0 109.645 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.26 43.28 93.68 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.687 -0.965 . . . . 10.0 110.687 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 107.852 -1.166 . . . . 10.0 107.852 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 118.705 -0.664 . . . . 10.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -102.67 -174.19 2.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.451 1.9 . . . . 10.0 108.766 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.68 86.14 1.38 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.304 -0.999 . . . . 10.0 108.304 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -103.32 163.8 12.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.956 0.884 . . . . 10.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.68 109.62 16.86 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.613 -2.366 . . . . 10.0 104.613 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mp -83.07 87.72 6.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -54.73 152.17 7.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.115 0.966 . . . . 10.0 110.01 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.56 131.78 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 124.265 1.026 . . . . 10.0 110.65 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -69.61 -54.23 15.0 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 124.015 0.822 . . . . 10.0 109.312 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.37 -9.34 2.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.749 -0.473 . . . . 10.0 113.357 -170.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -58.29 176.31 0.18 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.969 0.884 . . . . 10.0 111.478 170.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t -152.44 31.76 0.52 Allowed 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.601 -0.687 . . . . 10.0 110.36 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.5 t -118.86 89.56 3.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.14 0.495 . . . . 10.0 110.8 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.71 -11.98 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.353 1.242 . . . . 10.0 114.353 170.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -91.69 -25.86 18.91 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.07 0.85 . . . . 10.0 111.395 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.28 -67.16 0.44 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -42.56 -55.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.519 0.728 . . . . 10.0 111.906 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -21.44 65.04 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.948 0.722 . . . . 10.0 112.948 -175.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.91 99.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.404 1.002 . . . . 10.0 109.232 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -82.51 -37.55 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.02 0.528 . . . . 10.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -41.34 -47.04 3.44 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.545 1.138 . . . . 10.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -51.3 64.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.078 0.466 . . . . 10.0 110.871 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -63.16 -47.63 81.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.447 1.099 . . . . 10.0 110.72 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 t -56.0 -40.93 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 10.0 110.013 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.11 -27.95 16.5 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.776 1.179 . . . . 10.0 113.767 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.15 -29.8 69.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.134 1.467 . . . . 10.0 110.744 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.61 80.67 1.09 Allowed 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.616 -0.678 . . . . 10.0 110.927 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' OD2' ' NZ ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -5.74 -57.52 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.948 3.299 . . . . 10.0 115.651 168.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.32 -56.65 1.48 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.868 1.223 . . . . 10.0 113.913 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.54 111.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.48 1.512 . . . . 10.0 109.853 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.31 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.88 -1.055 . . . . 10.0 109.982 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.95 12.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -136.27 94.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.912 1.285 . . . . 10.0 109.463 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -107.54 91.07 3.5 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.31 109.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 172.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -128.32 47.86 2.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.457 0.539 . . . . 10.0 112.457 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -51.33 -46.76 62.72 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.525 0.602 . . . . 10.0 112.113 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -70.12 -34.83 73.57 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.579 0.752 . . . . 10.0 110.955 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.09 -32.53 30.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.593 -174.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.35 -73.02 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.26 -172.12 1.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.965 1.306 . . . . 10.0 112.598 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.06 100.73 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 108.466 -0.939 . . . . 10.0 108.466 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -98.0 108.99 21.83 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.437 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 42.7 t -128.14 131.5 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 -169.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 m -83.56 69.74 10.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.437 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 57.6 m-85 -64.73 141.41 58.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.321 0.648 . . . . 10.0 109.771 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -86.68 86.95 7.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.08 -18.26 0.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.844 1.054 . . . . 10.0 113.844 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.49 -18.65 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.599 1.091 . . . . 10.0 110.401 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -117.17 -55.78 2.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -175.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.07 129.88 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 124.402 1.081 . . . . 10.0 110.531 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.2 m -88.82 152.7 21.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.629 -0.669 . . . . 10.0 110.198 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.4 m -41.1 -38.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 128.269 2.628 . . . . 10.0 110.659 167.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -49.84 -37.42 30.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.429 -0.794 . . . . 10.0 112.342 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.44 -58.36 4.08 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.263 1.03 . . . . 10.0 109.399 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -56.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -168.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.21 -52.32 4.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.377 1.471 . . . . 10.0 109.861 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.97 -49.09 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.437 0.695 . . . . 10.0 110.54 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.7 68.15 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.765 0.826 . . . . 10.0 111.172 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -58.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 108.76 -0.83 . . . . 10.0 108.76 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -40.01 -40.63 1.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.512 1.051 . . . . 10.0 113.79 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -40.83 -50.88 3.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.605 0.965 . . . . 10.0 113.605 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -151.32 -41.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.533 1.133 . . . . 10.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-O 118.793 -1.004 . . . . 10.0 111.295 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 58.29 175.29 0.06 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.203 1.801 . . . . 10.0 112.545 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 93.9 28.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.437 2.295 . . . . 10.0 112.771 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.66 91.36 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.866 1.267 . . . . 10.0 109.484 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.61 -55.52 7.6 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 168.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -172.34 162.13 5.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.014 1.325 . . . . 10.0 107.429 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.69 142.57 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 125.09 1.356 . . . . 10.0 110.241 170.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.24 147.78 51.11 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.637 -2.357 . . . . 10.0 104.637 165.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.47 -131.34 5.15 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.774 -2.13 . . . . 10.0 107.774 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.224 0 N-CA-C 108.377 -0.972 . . . . 10.0 108.377 168.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.715 -0.476 . . . . 10.0 109.715 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -153.19 175.69 12.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -141.84 87.63 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.037 -1.098 . . . . 10.0 108.037 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -98.03 162.65 13.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.956 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 122.77 46.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 104.65 -2.352 . . . . 10.0 104.65 -177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mp -93.53 95.99 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 103.512 -2.773 . . . . 10.0 103.512 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.04 150.65 46.39 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 10.0 108.189 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.95 134.54 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -168.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -69.22 -64.96 0.77 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.04 -34.37 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.348 -0.93 . . . . 10.0 114.881 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.0 172.37 2.37 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.305 1.053 . . . . 10.0 112.022 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -157.41 52.69 0.48 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.6 t -130.98 94.88 3.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.414 1.086 . . . . 10.0 108.143 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.61 -21.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.87 1.668 . . . . 10.0 111.418 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -82.74 -41.7 18.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.044 -0.725 . . . . 10.0 109.044 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.9 m -52.47 -66.27 0.41 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -51.41 -50.93 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 122.006 -0.434 . . . . 10.0 111.563 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU 0.26 0.0 OUTLIER -60.35 -26.42 66.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.995 0.739 . . . . 10.0 112.995 -178.174 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.22 84.08 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.06 -1.025 . . . . 10.0 109.035 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -75.64 -40.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.343 0.657 . . . . 10.0 111.364 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 3.4 tm-20 -34.78 -49.28 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.114 1.766 . . . . 10.0 111.019 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -54.72 -60.11 3.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.631 0.253 . . . . 10.0 111.522 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -55.09 -48.54 73.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.01 0.924 . . . . 10.0 110.502 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 t -56.85 -44.26 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.141 0.576 . . . . 10.0 110.367 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.7 -31.2 57.61 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.185 0.898 . . . . 10.0 113.146 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.28 -29.16 66.99 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.167 0.984 . . . . 10.0 110.773 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 108.31 4.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.077 -1.015 . . . . 10.0 109.624 176.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -37.35 -37.1 0.17 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 10.0 112.61 169.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.69 -2.07 1.59 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.225 1.393 . . . . 10.0 116.036 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.29 120.29 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.539 1.936 . . . . 10.0 106.32 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -29.2 25.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.269 0.628 . . . . 10.0 109.894 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.09 160.51 9.9 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.34 133.82 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.351 1.061 . . . . 10.0 110.58 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -143.21 81.4 1.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.909 1.284 . . . . 10.0 108.855 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.64 135.74 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.319 1.048 . . . . 10.0 108.85 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -163.55 48.07 0.13 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.517 0.675 . . . . 10.0 110.796 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -61.05 -41.97 97.6 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.86 -0.525 . . . . 10.0 111.373 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.98 -39.91 93.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.499 0.72 . . . . 10.0 110.25 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.0 -31.8 27.29 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.507 0.723 . . . . 10.0 110.932 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.61 -59.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.397 -0.668 . . . . 10.0 113.154 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 173.33 4.96 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.859 2.064 . . . . 10.0 109.78 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.05 119.88 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 172.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.26 120.21 40.32 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.457 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 48.1 t -133.01 143.83 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.881 -1.526 . . . . 10.0 106.881 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.0 m -96.59 71.54 2.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.457 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 49.3 m-85 -73.39 134.56 44.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.871 0.843 . . . . 10.0 109.108 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.57 77.8 9.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.699 0.762 . . . . 10.0 109.069 172.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.96 -17.68 0.42 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.886 1.675 . . . . 10.0 113.917 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.11 -6.28 59.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.424 1.89 . . . . 10.0 111.072 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -57.52 1.13 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.736 1.614 . . . . 10.0 108.726 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.7 143.96 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 126.222 1.809 . . . . 10.0 107.572 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 m -98.22 147.65 24.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -31.82 -44.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 128.346 2.658 . . . . 10.0 110.96 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -28.36 -53.23 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.967 1.307 . . . . 10.0 111.892 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.04 -69.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.358 1.063 . . . . 10.0 111.473 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mp -60.38 -53.53 47.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 125.207 1.403 . . . . 10.0 111.683 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.35 -58.61 1.49 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.924 2.089 . . . . 10.0 110.398 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.4 -45.26 91.99 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.891 0.377 . . . . 10.0 110.219 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.77 -45.18 67.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 10.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.08 -53.02 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 O-C-N 121.272 -0.892 . . . . 10.0 108.713 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.23 -21.4 47.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.956 1.707 . . . . 10.0 114.288 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.29 -58.67 5.94 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.897 0.771 . . . . 10.0 111.474 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -143.56 -19.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.534 1.679 . . . . 10.0 115.534 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.68 -51.68 24.11 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.686 1.136 . . . . 10.0 112.045 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 66.42 97.61 0.05 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.412 1.885 . . . . 10.0 111.759 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 174.28 31.09 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.362 1.865 . . . . 10.0 112.987 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.8 t -141.7 80.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 O-C-N 119.617 -1.927 . . . . 10.0 110.331 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.7 76.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 171.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -167.55 143.8 4.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp -83.71 131.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 125.091 1.357 . . . . 10.0 107.415 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.75 125.58 46.89 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.15 -2.167 . . . . 10.0 105.15 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.31 -153.48 24.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.728 -1.749 . . . . 10.0 108.728 -170.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? . . . . . 0 C--O 1.258 1.523 0 CA-C-O 117.503 -1.237 . . . . 10.0 113.469 -170.78 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -111.39 175.24 5.5 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.999 0.92 . . . . 10.0 109.473 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -140.2 78.87 1.68 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.804 1.242 . . . . 10.0 107.695 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -89.73 165.54 14.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.279 -0.873 . . . . 10.0 108.91 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.83 133.3 44.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 102.796 -3.038 . . . . 10.0 102.796 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.02 96.6 6.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 104.371 -2.455 . . . . 10.0 104.371 176.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -62.23 148.74 43.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.069 -0.968 . . . . 10.0 108.624 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.61 132.34 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 125.07 1.348 . . . . 10.0 112.807 -172.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.89 -64.22 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.046 2.538 . . . . 10.0 109.453 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.0 -40.53 0.04 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.656 -0.578 . . . . 10.0 111.656 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 170.05 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.437 0.903 . . . . 10.0 113.437 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 p -145.99 12.77 1.27 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.742 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.84 86.47 6.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -55.58 -12.18 1.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.422 ' CD2' ' HZ2' ' A' ' 18' ' ' LYS . 15.4 t60 -83.43 -35.89 24.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.408 -0.807 . . . . 10.0 109.375 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -62.12 -68.21 0.35 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.85 -52.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.689 0.795 . . . . 10.0 113.117 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HZ2' ' CD2' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -57.47 -29.79 64.53 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.671 -0.643 . . . . 10.0 112.595 -177.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.16 -43.86 64.32 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.61 -41.97 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.218 -0.896 . . . . 10.0 110.838 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.04 -38.51 11.11 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.311 0.96 . . . . 10.0 110.509 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.4 p -51.1 -65.03 0.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.933 0.788 . . . . 10.0 111.533 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -55.8 -51.0 68.97 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.994 1.318 . . . . 10.0 110.079 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.06 -42.76 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.693 0.797 . . . . 10.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.22 -27.71 11.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.561 1.077 . . . . 10.0 113.816 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.25 -19.81 35.69 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.768 1.284 . . . . 10.0 112.279 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.73 118.89 7.73 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.851 1.205 . . . . 10.0 109.985 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -39.9 -44.26 1.64 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.156 1.783 . . . . 10.0 112.515 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.49 -16.23 80.1 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.113 0.387 . . . . 10.0 113.884 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.84 111.59 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 O-C-N 119.454 -2.204 . . . . 10.0 106.628 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -30.74 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.804 . . . . 10.0 109.618 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.74 157.54 24.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.88 145.01 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.976 1.311 . . . . 10.0 108.192 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -161.86 82.86 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -64.77 138.72 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.191 0.596 . . . . 10.0 110.543 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.04 46.41 0.24 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.065 0.46 . . . . 10.0 111.061 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.51 -49.65 67.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.268 0.47 . . . . 10.0 112.268 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.08 -31.13 70.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.036 0.934 . . . . 10.0 110.707 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.76 -29.52 32.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.94 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.23 -62.17 0.12 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.169 0.89 . . . . 10.0 112.119 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.24 171.59 7.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.498 1.919 . . . . 10.0 109.833 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.53 132.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 169.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.18 111.04 16.91 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.5 t -130.0 142.25 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.384 1.074 . . . . 10.0 108.218 -168.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.7 m -102.07 73.57 1.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -66.85 131.81 46.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.701 -1.591 . . . . 10.0 109.089 176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.89 86.1 7.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.526 -0.916 . . . . 10.0 108.526 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.01 -10.96 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.994 1.109 . . . . 10.0 113.994 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -85.89 -13.21 48.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.411 1.005 . . . . 10.0 110.141 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -131.31 -54.36 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.7 p -103.09 -174.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 125.184 1.394 . . . . 10.0 109.239 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.4 p -148.81 151.91 35.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.182 -0.949 . . . . 10.0 108.523 167.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.75 -40.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.85 2.06 . . . . 10.0 110.132 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.47 -25.89 27.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.879 0.763 . . . . 10.0 112.813 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -70.67 -64.03 0.98 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.15 0.886 . . . . 10.0 109.637 168.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -63.65 -51.41 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.097 0.959 . . . . 10.0 112.563 -172.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.24 -56.8 3.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.293 1.837 . . . . 10.0 109.622 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.01 -44.58 91.72 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.578 0.751 . . . . 10.0 110.329 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.48 70.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.212 0.605 . . . . 10.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.72 -35.92 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 121.095 -1.003 . . . . 10.0 109.447 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.32 -41.84 85.46 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.628 -1.295 . . . . 10.0 110.533 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -54.5 -67.7 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.016 0.926 . . . . 10.0 112.14 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -133.41 57.25 1.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.161 0.584 . . . . 10.0 111.704 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.01 -58.85 0.01 OUTLIER Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.213 -0.771 . . . . 10.0 111.369 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 67.46 106.9 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.153 2.181 . . . . 10.0 110.623 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 168.16 -35.17 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.241 1.416 . . . . 10.0 109.595 -168.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.73 93.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.181 -0.949 . . . . 10.0 111.285 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.21 -56.49 4.6 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.456 0.646 . . . . 10.0 109.907 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -164.4 143.13 7.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.12 147.35 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 10.0 109.057 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -67.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.191 0.52 . . . . 10.0 109.678 176.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.15 55.62 2.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.013 -1.235 . . . . 10.0 110.013 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 . . . . . 0 C--O 1.255 1.369 0 CA-C-O 115.777 -2.059 . . . . 10.0 107.422 -169.737 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -138.86 -175.31 4.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.965 0.888 . . . . 10.0 110.418 -168.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.14 68.25 1.13 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.613 2.365 . . . . 10.0 106.998 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -75.68 160.27 30.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -131.15 132.85 45.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.978 -1.489 . . . . 10.0 106.978 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.79 108.32 19.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -75.96 148.28 38.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.683 -0.636 . . . . 10.0 109.306 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.05 130.33 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.584 1.554 . . . . 10.0 113.617 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -74.84 -58.74 3.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.143 2.577 . . . . 10.0 109.475 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.84 -32.24 0.06 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-O 119.185 -0.786 . . . . 10.0 113.464 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.03 169.5 5.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.594 1.197 . . . . 10.0 111.44 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 m -160.66 54.38 0.31 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 15' ' ' HIS . 53.0 t -128.75 93.04 3.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -51.74 2.52 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.05 1.87 . . . . 10.0 116.05 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.402 ' H ' ' C ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -97.82 -50.81 4.3 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.841 1.655 . . . . 10.0 109.784 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.17 -62.14 1.8 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.083 0.953 . . . . 10.0 110.176 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.01 -47.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.764 0.316 . . . . 10.0 110.783 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -56.61 -35.54 68.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.307 1.225 . . . . 10.0 114.307 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -38.27 56.74 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 t -84.49 -37.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.142 0.977 . . . . 10.0 110.984 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -38.6 -56.09 1.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.697 1.599 . . . . 10.0 110.62 -179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -58.0 -48.7 79.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -56.98 -54.5 45.96 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.639 1.175 . . . . 10.0 109.57 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.64 -40.85 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 121.926 -0.484 . . . . 10.0 110.288 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.1 -31.86 6.17 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.059 0.837 . . . . 10.0 113.494 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -74.01 -26.38 60.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.865 1.332 . . . . 10.0 111.589 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.71 96.76 1.27 Allowed 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.138 -0.976 . . . . 10.0 110.157 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -20.56 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.58 2.752 . . . . 10.0 113.286 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.39 1.16 5.53 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.273 1.269 . . . . 10.0 116.273 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -94.87 110.93 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 104.602 -2.369 . . . . 10.0 104.602 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -30.05 48.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.658 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.96 158.15 10.35 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.95 125.01 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.983 1.313 . . . . 10.0 108.383 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -128.4 80.54 1.97 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.763 1.225 . . . . 10.0 108.498 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 t -74.42 108.5 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 126.273 1.829 . . . . 10.0 109.884 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -142.07 52.28 1.48 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.176 1.39 . . . . 10.0 110.173 -172.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.55 -46.72 88.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.711 0.291 . . . . 10.0 111.458 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -68.11 -40.86 82.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.111 1.364 . . . . 10.0 109.922 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.56 -35.27 67.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.397 -0.819 . . . . 10.0 111.518 -177.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.56 -64.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.434 0.54 . . . . 10.0 112.764 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 165.14 12.02 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 125.594 1.557 . . . . 10.0 109.259 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 m -88.14 115.12 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -102.6 121.25 42.01 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.12 131.96 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -94.54 78.55 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.239 -1.393 . . . . 10.0 107.239 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -75.59 135.82 40.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.54 -1.209 . . . . 10.0 109.489 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -90.08 89.08 7.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.011 1.324 . . . . 10.0 107.805 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.45 -16.18 8.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.249 0.833 . . . . 10.0 113.249 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.24 -18.33 62.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.828 1.651 . . . . 10.0 109.722 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -124.73 -55.86 1.6 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.757 1.223 . . . . 10.0 110.152 -169.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -137.33 148.44 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.092 0.957 . . . . 10.0 109.989 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -101.08 152.37 20.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -39.87 -40.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 C-N-CA 127.608 2.363 . . . . 10.0 110.961 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.87 -34.12 0.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.69 -65.38 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.855 0.752 . . . . 10.0 110.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.4 mp -64.79 -48.98 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.53 1.132 . . . . 10.0 112.543 -172.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.77 -57.01 2.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.549 1.94 . . . . 10.0 110.423 170.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.5 -46.8 85.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.77 0.795 . . . . 10.0 109.662 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.54 -48.91 68.64 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.573 0.749 . . . . 10.0 111.332 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -73.03 -39.33 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.15 -0.969 . . . . 10.0 111.022 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.5 -34.55 78.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.588 1.54 . . . . 10.0 110.767 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -47.8 -66.25 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.594 1.157 . . . . 10.0 112.731 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -126.59 3.73 6.83 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.239 1.2 . . . . 10.0 114.239 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.07 -53.5 0.89 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.643 1.116 . . . . 10.0 112.489 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 68.0 111.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.5 2.32 . . . . 10.0 111.258 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 164.41 -34.88 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 110.574 -168.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -72.99 89.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 121.096 -1.003 . . . . 10.0 112.066 -168.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.39 -54.4 7.68 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 121.145 0.497 . . . . 10.0 110.042 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -169.04 143.58 3.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 -169.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.52 129.4 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.414 1.486 . . . . 10.0 110.015 177.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -127.09 135.8 51.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.95 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 C--O 1.256 1.399 0 N-CA-C 104.482 -2.414 . . . . 10.0 104.482 175.46 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ttt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.79 -179.84 5.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.964 0.505 . . . . 10.0 110.718 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -128.72 90.7 3.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.755 2.422 . . . . 10.0 107.44 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -94.53 179.48 5.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.294 1.045 . . . . 10.0 109.957 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 t -146.14 134.96 22.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.931 -1.507 . . . . 10.0 106.931 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.61 95.73 10.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.522 -2.399 . . . . 10.0 104.522 170.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.59 144.1 57.28 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 128.12 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 124.644 1.178 . . . . 10.0 113.794 -169.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -69.55 -58.49 3.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 129.526 3.131 . . . . 10.0 110.254 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.73 -28.01 0.19 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.42 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.35 164.05 12.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.871 0.836 . . . . 10.0 110.35 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -147.52 12.05 1.02 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.784 0.434 . . . . 10.0 111.075 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -95.4 94.35 7.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -50.91 -18.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -35.83 36.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.87 0.759 . . . . 10.0 109.829 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -63.04 -67.27 0.44 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -49.97 -49.24 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.032 -0.417 . . . . 10.0 112.075 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -27.94 65.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.08 0.77 . . . . 10.0 113.08 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -36.4 74.43 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.42 -43.83 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 123.792 0.837 . . . . 10.0 110.163 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -39.25 -45.98 1.46 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.891 1.676 . . . . 10.0 111.339 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -48.99 68.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.544 0.688 . . . . 10.0 111.654 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.8 t -68.37 -54.18 19.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.654 1.182 . . . . 10.0 109.118 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 t -53.78 -38.96 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.197 0.599 . . . . 10.0 111.321 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.24 71.34 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.98 1.276 . . . . 10.0 113.385 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.25 -37.55 37.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.679 1.239 . . . . 10.0 110.39 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.92 122.67 10.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.798 0.726 . . . . 10.0 110.551 -175.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -48.24 -41.7 28.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.047 1.739 . . . . 10.0 112.532 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.55 -6.15 88.14 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.275 0.464 . . . . 10.0 113.928 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.96 115.32 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.363 -2.088 . . . . 10.0 105.363 168.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -77.85 -32.61 52.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.377 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.11 160.39 11.81 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.23 147.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.64 1.576 . . . . 10.0 107.975 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.51 89.98 1.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.713 0.768 . . . . 10.0 109.256 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.27 118.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 123.449 0.699 . . . . 10.0 109.392 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.95 44.65 1.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.568 0.747 . . . . 10.0 109.123 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -59.65 -51.33 70.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.502 -0.749 . . . . 10.0 112.19 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.89 -36.83 80.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.966 0.906 . . . . 10.0 110.034 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.33 62.53 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.479 -0.782 . . . . 10.0 111.286 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.97 -77.77 0.07 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.223 0.916 . . . . 10.0 111.498 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 171.26 11.66 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 126.586 1.954 . . . . 10.0 107.977 -173.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.6 t -90.83 105.55 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -82.45 136.99 34.8 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.62 139.55 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-O 122.161 0.981 . . . . 10.0 109.875 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 m -111.64 77.03 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.639 -0.71 . . . . 10.0 109.454 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.34 140.64 46.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -96.51 94.09 7.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.428 0.691 . . . . 10.0 109.439 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.66 -22.03 1.22 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.965 1.306 . . . . 10.0 113.738 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.34 -6.99 58.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.275 0.943 . . . . 10.0 110.048 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -126.54 -55.83 1.41 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.15 0.98 . . . . 10.0 109.891 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.28 164.05 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 119.535 1.062 . . . . 10.0 111.018 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.2 m -118.14 168.4 10.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.56 0.744 . . . . 10.0 109.344 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -44.43 -29.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.69 2.796 . . . . 10.0 112.462 170.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -36.29 6.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.667 0.667 . . . . 10.0 111.397 172.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.89 -60.14 2.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.637 1.208 . . . . 10.0 110.385 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.2 mm -70.01 -57.0 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 114.535 1.309 . . . . 10.0 114.535 -168.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.67 8.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.897 0.879 . . . . 10.0 108.871 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.74 -51.38 56.59 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.789 0.435 . . . . 10.0 110.72 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.641 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.6 -48.61 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.137 -0.977 . . . . 10.0 110.272 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.66 -25.6 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.308 -0.87 . . . . 10.0 112.178 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.96 -44.56 40.92 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.626 0.77 . . . . 10.0 112.378 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -166.1 -28.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.21 -55.14 16.8 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.798 -1.001 . . . . 10.0 112.103 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 60.32 120.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.768 2.027 . . . . 10.0 111.963 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 163.66 -34.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 126.03 1.732 . . . . 10.0 109.805 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 92.3 t -71.5 88.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 121.006 -1.059 . . . . 10.0 111.424 -174.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.39 -52.93 27.56 Favored 'General case' 0 CA--C 1.523 -0.066 0 O-C-N 121.587 -0.696 . . . . 10.0 109.135 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -169.6 159.39 8.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 pp -102.62 121.98 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 126.033 1.733 . . . . 10.0 108.367 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -109.59 117.57 34.31 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.42 -91.21 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.742 1.163 . . . . 10.0 110.497 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.668 -1.158 . . . . 10.0 112.078 -173.216 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 38.3 ttp . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 119.04 -0.505 . . . . 10.0 111.34 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -156.27 129.85 8.3 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.8 0.727 . . . . 10.0 111.715 168.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.46 112.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.516 1.527 . . . . 10.0 107.892 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.66 172.48 6.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.359 1.464 . . . . 10.0 108.071 172.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 124.77 42.28 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.29 97.67 10.76 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -62.32 153.89 29.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.249 -0.648 . . . . 10.0 109.249 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -65.65 128.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.672 1.589 . . . . 10.0 111.968 -173.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -73.28 -61.56 1.78 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.868 2.867 . . . . 10.0 109.135 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.38 -34.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.437 -0.887 . . . . 10.0 112.347 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.29 170.59 5.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.041 0.921 . . . . 10.0 110.928 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -159.15 30.89 0.21 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.848 -0.614 . . . . 10.0 109.412 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.43 102.68 12.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -56.11 -20.1 15.93 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -76.91 -42.23 40.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.984 0.811 . . . . 10.0 109.127 -172.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -55.49 -68.13 0.22 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.459 1.104 . . . . 10.0 109.874 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.5 -50.07 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -54.35 -33.69 59.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.943 0.792 . . . . 10.0 113.128 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.23 -34.23 66.13 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.361 0.6 . . . . 10.0 110.224 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 37.8 t -85.56 -45.07 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.783 0.833 . . . . 10.0 109.919 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -46.39 -42.1 14.57 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.571 1.148 . . . . 10.0 110.591 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -54.92 -45.69 74.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.43 0.559 . . . . 10.0 112.309 174.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -72.37 -42.37 65.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.607 0.763 . . . . 10.0 111.893 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.22 -43.22 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.516 0.726 . . . . 10.0 109.744 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.37 2.7 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.882 1.229 . . . . 10.0 111.877 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.39 -47.03 0.19 Allowed 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 127.382 2.273 . . . . 10.0 108.212 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 126.28 15.36 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.394 0.997 . . . . 10.0 110.488 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.73 -39.39 58.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.744 1.218 . . . . 10.0 112.156 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.33 -8.4 59.16 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.79 0.71 . . . . 10.0 114.14 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.76 106.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 O-C-N 119.271 -2.311 . . . . 10.0 105.441 168.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 t -74.37 -28.28 61.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.51 156.65 11.93 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.6 148.13 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.218 1.007 . . . . 10.0 108.604 176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -165.73 87.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.48 118.96 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.243 1.817 . . . . 10.0 109.915 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.11 48.74 1.87 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.745 0.418 . . . . 10.0 111.385 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -52.61 -44.55 66.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 10.0 111.963 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.63 -26.75 66.39 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.942 0.897 . . . . 10.0 111.286 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.12 13.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.678 0.391 . . . . 10.0 111.155 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.0 -65.63 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.8 179.29 3.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.026 2.13 . . . . 10.0 110.741 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -93.67 130.46 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 125.512 1.525 . . . . 10.0 107.609 172.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.63 70.7 0.95 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.863 0.839 . . . . 10.0 110.374 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.436 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 11.3 t -83.79 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.828 1.251 . . . . 10.0 108.783 -171.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.87 77.17 1.31 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.436 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 8.8 m-85 -79.82 134.05 36.32 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.472 1.509 . . . . 10.0 108.84 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.41 88.22 6.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.334 -0.853 . . . . 10.0 109.221 170.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.31 -16.09 0.16 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.15 0.98 . . . . 10.0 113.292 168.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 1' ' ' MET . 5.6 m-20 -85.95 -20.67 28.61 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.362 2.265 . . . . 10.0 110.461 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -129.26 -58.14 1.13 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 10.0 109.786 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.0 t -129.87 120.26 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 125.02 1.328 . . . . 10.0 108.002 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 p -87.76 158.19 18.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -38.03 -40.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 126.885 2.074 . . . . 10.0 110.618 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.95 -47.06 0.51 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.275 0.943 . . . . 10.0 111.551 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -64.06 -57.74 8.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.562 1.172 . . . . 10.0 111.096 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.9 mm -65.72 -57.11 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.836 1.654 . . . . 10.0 112.001 -173.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.19 -61.58 0.87 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.166 2.186 . . . . 10.0 109.52 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.56 -49.97 54.74 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.157 0.583 . . . . 10.0 110.666 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.41 77.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.745 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.44 -39.53 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 120.98 -1.075 . . . . 10.0 110.415 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.33 -29.14 69.71 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.261 -0.899 . . . . 10.0 111.628 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.45 -64.27 0.87 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.976 0.807 . . . . 10.0 111.614 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.98 -7.33 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.265 1.58 . . . . 10.0 115.265 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.74 -51.8 10.77 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.714 -0.954 . . . . 10.0 110.714 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 58.25 109.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.75 2.42 . . . . 10.0 111.539 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t0 175.59 -41.31 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 125.363 1.465 . . . . 10.0 107.991 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.0 t -69.95 95.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 120.806 -1.184 . . . . 10.0 112.298 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.86 -57.46 3.86 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.773 0.829 . . . . 10.0 109.731 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 71' ' ' GLU . 6.4 ptmm? -164.94 142.94 6.33 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.888 -1.523 . . . . 10.0 106.888 -171.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp -80.97 141.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 124.163 0.985 . . . . 10.0 108.552 172.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 69' ' ' LYS . 3.5 tt0 -131.06 130.96 43.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 138.18 -103.91 0.43 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.759 1.647 . . . . 10.0 109.803 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.154 0.982 . . . . 10.0 109.264 -173.497 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -129.33 127.18 40.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.975 1.422 . . . . 10.0 107.91 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.25 98.22 10.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -175.79 4.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.569 -1.641 . . . . 10.0 106.569 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -139.17 137.13 35.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.754 -1.943 . . . . 10.0 105.754 169.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 99.89 12.08 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 105.141 -2.17 . . . . 10.0 105.141 171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.03 146.57 42.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.152 -0.684 . . . . 10.0 109.152 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.19 130.3 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 125.13 1.372 . . . . 10.0 113.128 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -78.86 -57.56 3.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.375 2.27 . . . . 10.0 110.618 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.65 -46.46 0.1 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 117.637 -2.22 . . . . 10.0 112.792 -169.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.91 158.99 4.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 117.3 0.55 . . . . 10.0 110.928 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.1 m -144.83 37.57 1.18 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.084 -0.962 . . . . 10.0 108.875 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.3 t -110.12 94.96 5.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.66 -9.85 0.6 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -90.35 -29.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.182 0.901 . . . . 10.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -65.33 -73.79 0.12 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.931 -1.137 . . . . 10.0 107.931 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -33.83 -54.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 125.542 1.537 . . . . 10.0 113.858 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -56.01 -33.16 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.969 0.729 . . . . 10.0 112.969 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.94 -32.8 61.69 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.599 0.76 . . . . 10.0 110.582 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.28 -47.68 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 117.829 -1.081 . . . . 10.0 110.39 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -41.85 -49.48 4.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.077 1.351 . . . . 10.0 110.752 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.5 p -46.17 -62.32 1.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.349 1.06 . . . . 10.0 111.247 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -57.76 -48.06 80.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.598 1.159 . . . . 10.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -55.08 -40.64 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.76 0.824 . . . . 10.0 110.155 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.63 6.4 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.54 1.066 . . . . 10.0 113.744 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.87 -26.62 60.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.92 1.36 . . . . 10.0 111.621 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.15 107.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 119.128 0.877 . . . . 10.0 109.373 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -36.7 -43.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.165 2.186 . . . . 10.0 113.17 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.05 -28.5 63.9 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.688 0.661 . . . . 10.0 114.119 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.51 109.56 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 119.566 -2.137 . . . . 10.0 107.399 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -81.82 -31.73 31.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.903 -1.044 . . . . 10.0 109.712 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.19 158.22 18.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.509 1.123 . . . . 10.0 108.303 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -162.55 106.4 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.7 t -95.69 117.55 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 C-N-CA 124.124 0.97 . . . . 10.0 109.237 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -132.22 48.58 2.4 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.505 0.322 . . . . 10.0 111.349 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -42.96 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.087 0.955 . . . . 10.0 112.89 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.49 -37.92 88.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.82 0.848 . . . . 10.0 111.032 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -35.9 20.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.564 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.38 -67.8 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.926 -0.87 . . . . 10.0 110.926 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -174.74 2.51 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.055 1.342 . . . . 10.0 110.673 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.28 125.79 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 175.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -110.77 92.69 4.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.524 2.33 . . . . 10.0 108.343 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 25.4 t -110.89 151.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.647 1.579 . . . . 10.0 107.88 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -109.73 77.2 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.556 -1.646 . . . . 10.0 106.556 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.402 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 5.6 m-85 -78.01 127.67 32.69 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.317 -1.31 . . . . 10.0 107.721 -176.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.93 85.0 6.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.642 -0.662 . . . . 10.0 110.292 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.75 -23.17 0.96 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.985 0.914 . . . . 10.0 113.389 174.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.27 -5.38 56.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.436 0.562 . . . . 10.0 109.943 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -133.35 -54.15 0.9 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.492 1.117 . . . . 10.0 110.511 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.18 141.04 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 125.051 1.341 . . . . 10.0 109.435 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -97.26 143.57 27.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.0 m -31.76 -49.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 129.369 3.068 . . . . 10.0 110.003 168.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -31.93 -51.61 0.23 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.807 1.243 . . . . 10.0 112.089 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -55.69 -60.54 3.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.396 1.079 . . . . 10.0 110.949 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -66.05 -54.53 26.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 125.17 1.388 . . . . 10.0 110.948 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.15 -62.28 0.66 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.917 2.087 . . . . 10.0 110.389 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -53.85 -50.25 66.65 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.731 0.813 . . . . 10.0 110.097 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.27 -47.69 55.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.035 0.534 . . . . 10.0 111.453 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -35.9 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.974 -1.079 . . . . 10.0 111.067 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.65 -30.59 65.53 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.871 -1.143 . . . . 10.0 111.579 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.87 -62.08 2.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.234 0.925 . . . . 10.0 111.964 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -142.86 56.07 1.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.89 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.22 -0.766 . . . . 10.0 111.288 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 65.08 107.15 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.124 1.77 . . . . 10.0 112.248 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 161.28 -24.87 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 128.413 2.685 . . . . 10.0 110.987 -170.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.5 t -67.88 90.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 120.985 -1.072 . . . . 10.0 111.486 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.67 -52.07 11.35 Favored 'General case' 0 C--N 1.338 0.094 0 O-C-N 121.774 -0.579 . . . . 10.0 109.463 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -170.24 144.12 2.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.52 1.128 . . . . 10.0 108.409 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp -73.21 140.86 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 124.433 1.093 . . . . 10.0 108.489 169.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.68 132.19 48.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.452 -1.314 . . . . 10.0 107.452 168.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.33 -148.25 19.29 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.485 -1.846 . . . . 10.0 108.485 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 168.089 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -132.76 177.15 7.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 122.372 1.082 . . . . 10.0 109.147 -169.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.62 126.56 35.01 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.566 -2.753 . . . . 10.0 103.566 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' HZ1' ' C ' ' A' ' 73' ' ' ARG . 23.7 mttm -124.86 176.07 6.86 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 168.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.87 126.81 38.88 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.7 97.86 11.05 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 104.69 -2.337 . . . . 10.0 104.69 172.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.88 150.7 44.35 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.01 127.68 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.658 1.183 . . . . 10.0 113.019 -169.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -62.35 1.42 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.602 1.961 . . . . 10.0 108.57 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.34 -31.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.508 -169.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 178.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.461 1.124 . . . . 10.0 112.582 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p -150.31 -43.57 0.13 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.533 -1.212 . . . . 10.0 110.913 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -37.44 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.855 1.262 . . . . 10.0 111.678 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -3.27 23.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.337 -0.363 . . . . 10.0 111.687 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -46.64 8.71 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.603 0.638 . . . . 10.0 109.448 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 m -46.93 -68.68 0.17 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.703 0.801 . . . . 10.0 110.157 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -46.63 -51.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 O-C-N 122.304 -0.247 . . . . 10.0 111.483 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -60.61 -33.75 73.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.17 50.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.981 0.512 . . . . 10.0 110.144 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.94 -41.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.232 -0.889 . . . . 10.0 110.726 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -39.89 -51.49 2.45 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.345 1.458 . . . . 10.0 111.297 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -51.0 -55.69 16.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.03 0.932 . . . . 10.0 110.552 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.82 -49.73 74.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.705 1.202 . . . . 10.0 110.534 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.7 t -53.85 -41.5 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.248 1.019 . . . . 10.0 110.111 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.0 -32.55 6.3 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.72 1.152 . . . . 10.0 114.052 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.09 -26.21 60.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.924 1.362 . . . . 10.0 111.944 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.4 109.67 2.81 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.435 -0.79 . . . . 10.0 110.251 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.3 -38.44 2.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.097 2.159 . . . . 10.0 113.175 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.33 -20.89 71.85 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.503 -0.748 . . . . 10.0 114.215 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.02 105.31 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 120.036 -1.861 . . . . 10.0 107.211 171.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -29.86 62.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.351 -1.295 . . . . 10.0 110.097 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.49 157.05 14.48 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.25 130.51 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.074 0.95 . . . . 10.0 109.913 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -148.07 94.3 2.31 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.931 0.892 . . . . 10.0 108.714 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 t -86.66 114.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 10.0 108.371 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.95 48.62 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.835 0.454 . . . . 10.0 111.497 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.95 -44.17 60.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.673 0.789 . . . . 10.0 112.414 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.1 -29.84 70.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.727 1.211 . . . . 10.0 111.096 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 -36.86 14.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.63 0.372 . . . . 10.0 110.755 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.07 -65.07 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.218 0.913 . . . . 10.0 111.045 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.12 178.78 4.87 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.399 1.48 . . . . 10.0 111.025 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -94.2 127.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 125.145 1.378 . . . . 10.0 108.228 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -117.59 89.13 3.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.622 1.169 . . . . 10.0 108.629 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 17.1 t -98.2 149.76 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.668 1.587 . . . . 10.0 107.637 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 t -104.29 79.89 1.64 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 9.7 m-85 -73.93 130.35 39.71 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.912 -1.494 . . . . 10.0 108.204 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -84.33 87.1 7.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -11.82 1.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.162 0.801 . . . . 10.0 113.162 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.46 -15.37 52.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.608 1.094 . . . . 10.0 109.759 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -127.08 -61.44 1.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.451 1.1 . . . . 10.0 109.152 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.9 126.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.825 1.25 . . . . 10.0 109.223 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 m -96.4 163.84 12.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.308 -0.86 . . . . 10.0 108.828 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -38.43 -39.57 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 127.478 2.311 . . . . 10.0 111.353 168.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -37.33 1.47 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.594 0.633 . . . . 10.0 112.543 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.61 -63.87 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.071 0.938 . . . . 10.0 111.061 172.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mm -60.29 -54.03 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.713 1.205 . . . . 10.0 112.483 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.47 -53.05 15.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.904 2.082 . . . . 10.0 109.593 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.57 -47.78 78.77 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.133 0.573 . . . . 10.0 110.204 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -51.0 68.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.14 -34.74 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.118 -0.989 . . . . 10.0 109.948 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -57.04 -43.36 81.89 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.603 -1.311 . . . . 10.0 111.503 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.69 -62.24 1.75 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.469 0.577 . . . . 10.0 111.969 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -141.18 44.67 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.04 -57.78 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.944 0.783 . . . . 10.0 112.102 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 66.3 107.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.129 2.172 . . . . 10.0 111.087 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 t0 170.39 -38.47 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.668 1.587 . . . . 10.0 108.253 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.7 t -69.24 89.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 120.746 -1.221 . . . . 10.0 112.031 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.72 2.62 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.284 -0.885 . . . . 10.0 109.689 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -165.3 155.91 13.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.166 -1.791 . . . . 10.0 106.166 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.72 145.07 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 124.607 1.163 . . . . 10.0 110.143 174.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.03 147.27 41.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.218 -1.771 . . . . 10.0 106.218 169.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.56 -128.72 3.32 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.028 1.299 . . . . 10.0 111.264 -172.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' C ' ' HZ1' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.989 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 168.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.08 -173.54 3.14 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.134 1.522 . . . . 10.0 106.937 167.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -139.72 110.16 6.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.868 -1.901 . . . . 10.0 105.868 168.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.83 176.39 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.514 1.926 . . . . 10.0 106.717 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -148.81 128.8 13.5 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.064 -1.828 . . . . 10.0 106.064 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.68 104.26 15.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 172.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -68.43 149.71 49.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.51 132.78 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -170.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -74.41 -60.51 2.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.916 2.486 . . . . 10.0 108.174 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.31 -31.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.862 -0.966 . . . . 10.0 115.137 -171.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.8 178.45 4.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.606 1.703 . . . . 10.0 110.241 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -158.81 26.96 0.22 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.693 0.797 . . . . 10.0 109.249 170.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.8 t -90.09 100.04 12.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.098 -1.815 . . . . 10.0 106.098 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -52.57 -26.73 14.14 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 174.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -72.55 -46.08 56.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.939 -0.763 . . . . 10.0 108.939 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.9 m -50.31 -65.88 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.848 1.659 . . . . 10.0 110.415 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.77 -45.09 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 120.484 -0.487 . . . . 10.0 111.08 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 17.7 tttm -52.44 -33.76 45.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.624 1.342 . . . . 10.0 114.624 176.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.06 65.39 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.065 0.848 . . . . 10.0 110.038 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -87.05 -37.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 117.339 -1.315 . . . . 10.0 110.575 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.512 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 1.4 tt0 -36.63 -56.03 0.84 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.556 1.542 . . . . 10.0 110.549 174.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -58.94 -45.38 90.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.686 0.395 . . . . 10.0 111.381 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m -65.55 -57.03 9.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.43 0.692 . . . . 10.0 109.8 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.71 -37.48 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.992 0.917 . . . . 10.0 110.796 177.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.63 -27.32 54.69 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.024 0.821 . . . . 10.0 112.193 177.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.37 -27.35 59.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 118.319 1.059 . . . . 10.0 110.416 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.51 103.65 2.54 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 120.94 -1.1 . . . . 10.0 108.859 178.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -41.01 -32.37 0.23 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.668 1.987 . . . . 10.0 113.043 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.72 3.76 4.76 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.15 0.881 . . . . 10.0 115.288 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.17 119.61 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 169.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -36.99 29.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.61 157.24 14.41 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 176.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.986 2.114 . . . . 10.0 107.281 171.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -133.46 96.33 3.69 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 126.327 1.851 . . . . 10.0 107.742 172.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.8 119.12 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.044 0.937 . . . . 10.0 108.933 -174.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -146.38 51.59 1.13 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.073 0.549 . . . . 10.0 111.213 -172.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.52 -48.99 56.93 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.279 0.632 . . . . 10.0 112.078 178.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.83 -37.01 83.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.176 0.591 . . . . 10.0 110.718 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.92 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.133 -173.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.43 -79.33 0.05 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.598 -1.001 . . . . 10.0 110.598 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -168.8 179.8 4.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.549 2.739 . . . . 10.0 106.873 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -94.31 118.58 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 107.68 -1.229 . . . . 10.0 107.68 -174.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.15 127.68 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 176.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.407 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.1 t -139.58 137.19 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.408 1.099 . . . . 10.0 108.757 -171.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -110.08 76.0 0.97 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 -169.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.407 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 28.1 m-85 -82.12 137.19 35.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.7 1.6 . . . . 10.0 109.797 -173.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -84.64 84.25 7.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.95 0.881 . . . . 10.0 108.83 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.31 -20.25 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.648 1.579 . . . . 10.0 112.409 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.04 -12.87 58.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.815 1.646 . . . . 10.0 110.12 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -120.59 -53.67 2.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.131 0.972 . . . . 10.0 109.248 -174.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 m -125.92 -168.65 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.879 1.672 . . . . 10.0 108.971 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 m -144.28 147.68 33.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.022 -1.049 . . . . 10.0 108.744 169.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -31.46 -48.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 130.037 3.335 . . . . 10.0 110.731 175.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -28.93 -52.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.312 1.445 . . . . 10.0 112.352 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.53 -59.77 4.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.18 0.592 . . . . 10.0 111.739 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.64 -51.03 55.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 125.325 1.45 . . . . 10.0 110.737 -175.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.26 -63.89 0.46 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.87 2.068 . . . . 10.0 109.399 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -56.46 -47.87 78.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.403 0.681 . . . . 10.0 110.126 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.29 -46.79 62.62 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.978 0.911 . . . . 10.0 111.546 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -72.53 -42.19 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.616 -0.677 . . . . 10.0 110.586 176.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.19 -34.89 66.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.984 1.266 . . . . 10.0 112.159 178.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -48.49 -63.02 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.697 0.681 . . . . 10.0 112.533 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -134.59 -17.89 1.96 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.37 1.068 . . . . 10.0 113.387 -171.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.23 -49.26 12.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.879 -0.888 . . . . 10.0 110.879 -177.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 58.67 108.48 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.689 2.395 . . . . 10.0 111.586 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.29 -42.0 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 121.807 0.813 . . . . 10.0 109.189 -167.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 55.1 t -71.32 94.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.601 -0.687 . . . . 10.0 111.245 -172.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.64 -51.65 11.14 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.399 0.618 . . . . 10.0 109.396 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -171.4 143.13 1.77 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 -170.133 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.4 pp -89.1 127.94 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.864 1.266 . . . . 10.0 109.779 176.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -75.2 80.79 2.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.852 -1.166 . . . . 10.0 107.852 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.26 87.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.604 . . . . 10.0 113.927 -169.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 116.01 -1.948 . . . . 10.0 111.899 173.819 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 111.804 0.298 . . . . 10.0 111.804 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -172.46 2.22 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.04 -1.837 . . . . 10.0 106.04 168.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -147.55 75.48 1.36 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.022 1.392 . . . . 10.0 110.806 169.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.0 m -130.36 124.5 32.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.788 -2.301 . . . . 10.0 104.788 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -83.31 110.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.372 -2.455 . . . . 10.0 104.372 169.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -65.99 155.71 35.79 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.9 126.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.895 0.878 . . . . 10.0 110.028 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.32 -47.54 60.66 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.975 1.31 . . . . 10.0 109.203 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -19.75 0.67 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.442 -176.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 167.14 3.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.831 0.815 . . . . 10.0 111.5 174.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 19.83 1.35 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.34 -177.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -101.74 96.73 7.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.25 -14.47 7.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.802 0.667 . . . . 10.0 112.802 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -85.76 -35.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.997 0.817 . . . . 10.0 109.976 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.5 m -58.09 -67.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.883 1.273 . . . . 10.0 109.262 172.053 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -45.55 -51.43 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -177.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -20.79 63.03 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.623 0.972 . . . . 10.0 113.623 -177.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.78 90.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 175.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.44 -42.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.88 -0.581 . . . . 10.0 110.301 177.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -38.65 -48.91 1.51 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.429 1.492 . . . . 10.0 111.393 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -47.93 76.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.233 0.539 . . . . 10.0 111.328 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -65.14 -50.04 67.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.015 0.926 . . . . 10.0 110.203 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -52.73 -44.05 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.812 0.845 . . . . 10.0 109.914 176.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.48 -30.26 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.953 1.263 . . . . 10.0 113.765 173.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.77 -27.69 64.11 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.914 1.357 . . . . 10.0 110.91 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.43 105.58 2.65 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 174.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -36.04 -39.05 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.631 1.972 . . . . 10.0 113.543 170.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -13.39 21.42 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.849 1.214 . . . . 10.0 115.524 176.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 108.56 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 O-C-N 120.164 -1.786 . . . . 10.0 106.336 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -80.15 -29.89 38.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.91 158.97 15.37 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 177.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -139.35 122.12 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.328 1.451 . . . . 10.0 108.417 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -132.79 77.27 1.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.794 2.038 . . . . 10.0 107.546 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.13 123.81 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 125.026 1.33 . . . . 10.0 109.173 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -147.94 53.19 1.03 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.044 0.937 . . . . 10.0 110.09 -177.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.63 -46.27 87.43 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.631 -0.668 . . . . 10.0 112.123 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.06 -35.14 77.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.09 0.956 . . . . 10.0 110.811 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.67 -32.5 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.34 -175.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.05 -88.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.906 1.241 . . . . 10.0 110.945 -173.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -166.49 164.09 17.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.393 2.677 . . . . 10.0 106.411 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -86.85 118.63 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 118.824 0.738 . . . . 10.0 110.575 -168.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.88 124.72 37.07 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.717 1.207 . . . . 10.0 108.402 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.5 136.73 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 -177.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -99.96 70.98 1.62 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.26 -1.385 . . . . 10.0 107.26 -174.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -72.46 135.46 45.74 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.023 -176.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.65 86.84 7.27 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.287 1.435 . . . . 10.0 108.264 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -18.61 1.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.905 1.282 . . . . 10.0 112.537 168.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.68 -16.05 56.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.561 1.544 . . . . 10.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.99 -56.1 2.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.324 1.05 . . . . 10.0 109.289 -177.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.12 155.92 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 123.91 0.884 . . . . 10.0 109.305 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -99.37 147.03 25.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.493 -0.928 . . . . 10.0 108.493 176.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.7 m -30.71 -43.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 129.228 3.011 . . . . 10.0 111.202 168.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -28.87 -55.41 0.13 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.747 1.219 . . . . 10.0 111.549 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -48.21 -71.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.275 1.43 . . . . 10.0 111.05 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.1 mp -60.41 -55.34 25.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.511 1.525 . . . . 10.0 112.238 -176.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.6 -58.41 1.3 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.263 2.225 . . . . 10.0 110.908 172.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.47 -45.93 92.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.558 0.743 . . . . 10.0 109.752 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.67 -44.11 65.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.443 0.697 . . . . 10.0 111.535 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -70.42 -58.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 117.824 -1.084 . . . . 10.0 108.805 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER -46.74 -37.81 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.772 1.169 . . . . 10.0 112.849 -174.655 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -41.17 -61.14 1.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.041 1.336 . . . . 10.0 112.882 172.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -132.82 -40.52 0.95 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.62 98.69 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.29 -1.124 . . . . 10.0 110.29 -176.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 173.67 0.17 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.131 1.372 . . . . 10.0 110.5 -176.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 86.67 37.98 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.451 1.5 . . . . 10.0 111.621 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.96 89.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.91 1.284 . . . . 10.0 110.09 172.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.64 -58.86 3.42 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.419 -0.585 . . . . 10.0 109.419 169.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -176.13 158.44 1.96 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.691 -1.596 . . . . 10.0 106.691 -174.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.09 143.74 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 123.715 0.806 . . . . 10.0 111.474 171.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -106.65 115.05 29.53 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 168.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.61 -111.46 0.51 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.856 -1.069 . . . . 10.0 110.069 -177.975 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.32 152.27 38.86 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.472 0.653 . . . . 10.0 111.692 -169.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.98 94.94 8.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.264 1.425 . . . . 10.0 108.235 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.97 161.13 14.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 173.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.85 107.53 14.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.613 1.565 . . . . 10.0 107.381 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 mt -78.8 92.41 4.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 169.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -69.17 144.87 53.68 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.86 126.93 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.045 2.138 . . . . 10.0 113.281 -174.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -70.15 -66.19 0.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.653 2.381 . . . . 10.0 109.782 176.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.01 -25.86 0.05 OUTLIER Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.688 -1.062 . . . . 10.0 115.465 -168.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 177.17 2.36 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.837 1.819 . . . . 10.0 109.765 174.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.6 m -165.17 56.77 0.12 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 -178.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.73 108.05 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.046 -1.835 . . . . 10.0 106.046 173.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.17 -24.49 64.8 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.489 0.185 . . . . 10.0 110.576 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -45.21 38.28 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.1 m -47.1 -71.11 0.08 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.039 1.335 . . . . 10.0 110.437 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.17 -49.1 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.249 0.219 . . . . 10.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -55.62 -34.7 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.84 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.531 -0.731 . . . . 10.0 109.352 174.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -82.38 -40.08 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 117.684 -1.15 . . . . 10.0 111.209 176.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -35.09 -60.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.994 1.718 . . . . 10.0 110.669 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -40.59 88.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.851 -1.068 . . . . 10.0 111.227 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -63.6 -56.13 18.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.077 0.951 . . . . 10.0 110.285 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.35 -33.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 124.185 0.994 . . . . 10.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -41.45 -27.93 0.31 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.951 -0.916 . . . . 10.0 114.981 170.082 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.16 70.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.568 1.684 . . . . 10.0 112.262 177.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.16 93.15 0.28 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 174.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.21 -39.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.887 1.675 . . . . 10.0 112.97 172.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.56 -9.02 42.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.121 0.867 . . . . 10.0 115.022 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.74 105.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.875 -2.268 . . . . 10.0 104.875 168.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -73.51 -33.21 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.564 179.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.92 159.05 13.07 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.747 -1.205 . . . . 10.0 107.747 177.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.49 128.2 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.637 1.175 . . . . 10.0 108.486 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 91.54 2.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.338 -0.986 . . . . 10.0 108.338 175.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 t -86.46 108.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.772 1.229 . . . . 10.0 109.073 -171.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -142.99 52.45 1.38 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.563 0.745 . . . . 10.0 111.665 -173.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.62 51.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.249 0.62 . . . . 10.0 111.136 -178.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.27 -46.72 76.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.573 1.149 . . . . 10.0 110.172 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.49 69.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.339 -0.846 . . . . 10.0 110.089 -176.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.9 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 122.92 0.295 . . . . 10.0 112.432 170.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 171.67 7.91 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.93 0.892 . . . . 10.0 112.049 -169.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.71 102.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 173.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -93.19 113.67 25.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 45.5 t -125.78 143.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.355 -1.35 . . . . 10.0 107.355 -171.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -105.97 82.7 1.81 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.329 -2.1 . . . . 10.0 105.329 -174.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 13.7 m-85 -88.24 132.31 34.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.259 1.424 . . . . 10.0 108.948 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -90.77 88.28 7.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.209 1.003 . . . . 10.0 108.356 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.85 -18.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.677 1.591 . . . . 10.0 112.819 167.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -19.15 58.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.614 1.966 . . . . 10.0 110.465 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -127.68 -48.61 1.39 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.199 1.0 . . . . 10.0 110.756 -169.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 m -134.09 165.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 123.986 0.914 . . . . 10.0 109.565 176.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 p -109.81 143.36 39.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.282 0.492 . . . . 10.0 109.921 175.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.6 m -40.34 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 128.23 2.612 . . . . 10.0 108.841 169.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -35.16 -49.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.448 1.022 . . . . 10.0 112.194 175.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.45 -53.81 54.16 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.519 0.676 . . . . 10.0 111.077 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.89 -51.75 41.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.475 1.51 . . . . 10.0 111.289 -177.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.03 -59.96 1.13 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.971 2.108 . . . . 10.0 109.923 169.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.75 -48.34 75.42 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.082 0.953 . . . . 10.0 109.989 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.71 71.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.93 0.892 . . . . 10.0 111.511 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.08 -34.09 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 O-C-N 120.729 -1.232 . . . . 10.0 109.271 177.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.21 -40.98 92.02 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.7 -1.25 . . . . 10.0 110.837 175.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -45.85 -66.62 0.38 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.356 1.063 . . . . 10.0 112.41 178.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -139.93 23.79 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.45 -49.4 0.6 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.46 1.029 . . . . 10.0 112.219 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 64.31 101.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.407 1.883 . . . . 10.0 111.558 173.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 173.36 -32.88 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 125.473 1.509 . . . . 10.0 109.799 -168.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.3 t -67.5 86.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 121.359 -0.838 . . . . 10.0 112.104 -171.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.41 -58.79 3.35 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 169.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -164.29 150.41 10.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 tp -120.2 98.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.973 1.309 . . . . 10.0 110.429 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -118.8 -100.49 0.44 Allowed 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 174.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.43 -66.87 0.98 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.488 -1.045 . . . . 10.0 110.488 -171.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 170.48 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -106.22 -172.42 2.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.919 -2.252 . . . . 10.0 104.919 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.21 124.76 23.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.646 -1.983 . . . . 10.0 105.646 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.553 ' HZ3' ' C ' ' A' ' 73' ' ' ARG . 1.9 mttt -127.76 158.95 36.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.868 1.318 . . . . 10.0 108.617 167.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -119.5 98.14 5.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.982 2.913 . . . . 10.0 104.933 -168.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.65 86.63 4.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.793 -2.299 . . . . 10.0 104.793 170.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.96 152.79 9.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.111 0.964 . . . . 10.0 109.267 178.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.2 t -63.63 127.12 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.698 1.199 . . . . 10.0 109.234 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -75.23 -68.61 0.54 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 172.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.59 -32.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.518 -1.325 . . . . 10.0 115.806 -168.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -175.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.233 1.016 . . . . 10.0 108.721 173.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -168.47 39.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.133 1.373 . . . . 10.0 108.03 172.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -99.29 98.23 9.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.07 -17.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.39 1.876 . . . . 10.0 114.6 176.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -96.84 -37.28 10.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.797 1.239 . . . . 10.0 110.251 -176.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 m -56.62 -62.64 1.59 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 177.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -49.65 -47.13 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.947 179.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 7.2 tttp -56.26 -34.82 66.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.269 1.211 . . . . 10.0 114.269 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -39.34 61.16 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.55 -0.537 . . . . 10.0 109.55 172.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.65 -37.26 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 117.903 -1.046 . . . . 10.0 111.199 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 26.8 tt0 -40.47 -57.0 1.92 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.733 1.613 . . . . 10.0 110.255 -178.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -46.61 89.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.369 -0.832 . . . . 10.0 111.012 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 t -56.46 -53.77 53.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.207 1.003 . . . . 10.0 109.687 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.86 -39.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 O-C-N 121.655 -0.653 . . . . 10.0 110.055 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.13 -26.94 3.39 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.05 -0.861 . . . . 10.0 113.92 172.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.47 -27.94 64.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.125 1.462 . . . . 10.0 111.579 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.44 108.49 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.945 0.793 . . . . 10.0 110.8 178.452 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -39.65 -45.52 1.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.551 1.54 . . . . 10.0 111.922 170.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.37 17.43 1.92 Allowed Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.378 0.911 . . . . 10.0 115.378 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.48 109.39 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 104.213 -2.514 . . . . 10.0 104.213 167.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -74.38 -32.6 62.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.1 151.83 6.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.932 -1.506 . . . . 10.0 106.932 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.05 136.31 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 177.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.07 92.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 t -93.47 108.58 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 126.601 1.96 . . . . 10.0 107.38 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 72.11 1.35 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 10.0 109.721 -171.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.72 -49.79 43.18 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -172.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.155 1.782 . . . . 10.0 110.029 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -35.25 44.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.628 -176.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.49 -75.25 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 177.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.16 -177.92 4.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.671 1.988 . . . . 10.0 111.631 -178.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.61 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 -176.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -95.14 99.27 11.28 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.5 t -116.74 148.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -170.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -112.32 90.25 3.29 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 -174.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.71 144.17 26.2 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 126.972 2.109 . . . . 10.0 108.803 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -97.57 94.52 7.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 167.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.8 7.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 10.0 111.973 170.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.6 t70 -71.59 -25.25 62.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.002 2.121 . . . . 10.0 110.346 173.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -121.8 -56.51 1.85 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.239 1.016 . . . . 10.0 109.668 -168.092 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.85 144.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 125.691 1.596 . . . . 10.0 109.63 -175.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 p -97.67 142.82 28.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.432 0.634 . . . . 10.0 110.146 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -43.31 -43.28 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 127.978 2.511 . . . . 10.0 108.615 168.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -44.73 -44.3 9.11 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.652 -1.165 . . . . 10.0 111.269 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.47 -63.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.614 0.643 . . . . 10.0 110.25 177.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mp -62.27 -51.58 70.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.366 1.066 . . . . 10.0 111.817 -176.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.72 -56.56 2.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.594 1.958 . . . . 10.0 109.763 171.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.96 -46.57 88.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.052 0.453 . . . . 10.0 110.314 175.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.99 77.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 10.0 111.154 -175.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.7 -49.8 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -49.56 -36.13 22.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.714 1.143 . . . . 10.0 112.939 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.91 -61.34 2.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.554 1.142 . . . . 10.0 112.545 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -138.86 -17.41 1.08 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.55 -46.29 48.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 119.147 0.885 . . . . 10.0 110.915 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 58.17 93.45 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.932 2.093 . . . . 10.0 111.102 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.28 46.17 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.1 2.56 . . . . 10.0 112.869 173.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.08 86.17 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.107 -0.996 . . . . 10.0 109.071 173.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 174.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.32 155.92 0.52 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.239 1.816 . . . . 10.0 106.38 176.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.19 130.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 169.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -121.78 133.51 54.91 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.721 -1.585 . . . . 10.0 106.721 172.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.59 -134.68 2.86 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 108.471 -1.851 . . . . 10.0 108.471 177.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.553 ' C ' ' HZ3' ' A' ' 4' ' ' LYS . 25.9 ttt-85 . . . . . 0 C--O 1.252 1.185 0 N-CA-C 103.559 -2.756 . . . . 10.0 103.559 168.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -110.2 116.45 31.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 124.756 1.285 . . . . 10.0 112.134 -165.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -71.93 71.67 0.8 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.461 1.505 . . . . 10.0 111.479 175.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -72.39 151.43 42.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 123.445 1.593 . . . . 10.0 108.883 168.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.87 111.12 21.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.144 -2.539 . . . . 10.0 104.144 -176.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.49 87.91 6.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.55 -2.019 . . . . 10.0 105.55 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -60.9 146.3 47.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.296 -1.32 . . . . 10.0 109.355 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.0 p -67.64 129.74 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.259 1.824 . . . . 10.0 113.547 -169.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -77.0 -51.42 11.12 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 127.623 2.369 . . . . 10.0 109.465 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.66 -0.67 1.7 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.467 -0.873 . . . . 10.0 114.181 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.26 171.06 4.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.873 1.337 . . . . 10.0 107.542 168.045 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -153.15 56.26 0.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.374 -1.343 . . . . 10.0 107.374 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.56 96.7 3.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.359 -1.349 . . . . 10.0 107.359 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -52.25 -21.73 3.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.304 0.483 . . . . 10.0 112.304 170.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.35 -35.72 35.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.845 -0.535 . . . . 10.0 110.166 -170.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.0 m -55.66 -74.13 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.366 1.067 . . . . 10.0 108.167 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -44.58 -52.02 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 113.523 0.934 . . . . 10.0 113.523 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -55.38 -31.18 61.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.205 0.911 . . . . 10.0 113.284 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.82 65.43 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 122.724 0.41 . . . . 10.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.45 -44.11 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 118.061 -0.971 . . . . 10.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -45.3 -45.1 11.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.525 1.057 . . . . 10.0 110.529 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -52.8 -48.92 66.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.497 0.665 . . . . 10.0 111.792 175.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 t -71.14 -38.47 72.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.931 1.292 . . . . 10.0 111.218 -178.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.25 -37.38 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.698 -0.626 . . . . 10.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.29 0.83 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.605 1.097 . . . . 10.0 113.025 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.7 -43.53 2.37 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.825 2.85 . . . . 10.0 109.364 175.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.72 123.56 13.68 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.22 0.918 . . . . 10.0 109.727 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -50.23 -41.57 50.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.246 1.018 . . . . 10.0 112.068 -174.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.78 69.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 116.233 -0.44 . . . . 10.0 113.588 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -74.62 108.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 119.643 -2.092 . . . . 10.0 106.197 172.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -37.97 73.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.166 173.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.88 155.2 11.93 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.128 -1.434 . . . . 10.0 107.128 -176.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.13 137.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -149.8 91.72 1.83 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.266 -1.012 . . . . 10.0 108.266 176.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.08 110.44 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 124.327 1.051 . . . . 10.0 110.218 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.43 49.81 2.15 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.699 0.8 . . . . 10.0 112.114 -178.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -50.2 30.85 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.025 0.93 . . . . 10.0 111.429 -175.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.47 -36.2 73.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.565 0.746 . . . . 10.0 110.858 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.96 62.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.458 -177.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.73 -65.33 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.7 178.92 5.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.342 1.057 . . . . 10.0 112.631 -169.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.57 105.97 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.075 -1.454 . . . . 10.0 107.075 176.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.14 117.86 35.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 72.3 t -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -168.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.2 t -110.91 87.76 2.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.879 -1.896 . . . . 10.0 105.879 -169.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 58.6 m-85 -95.36 129.12 42.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.435 1.494 . . . . 10.0 109.959 -173.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -81.46 88.98 6.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 172.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.36 -11.16 1.11 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -89.89 -2.9 58.28 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.571 1.078 . . . . 10.0 110.615 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -134.69 -54.52 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.889 0.876 . . . . 10.0 110.335 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.22 141.86 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 124.662 1.185 . . . . 10.0 109.911 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.7 p -107.77 153.6 22.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.679 0.752 . . . . 10.0 109.664 178.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -43.56 -37.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 127.483 2.313 . . . . 10.0 111.056 169.046 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -47.97 -32.59 6.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.475 0.58 . . . . 10.0 111.77 176.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -59.64 2.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.097 0.862 . . . . 10.0 111.108 171.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.8 -52.53 34.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 124.18 0.992 . . . . 10.0 112.775 -170.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.98 -54.35 13.19 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.54 1.536 . . . . 10.0 109.486 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -51.14 -50.73 58.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 10.0 109.71 172.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.96 76.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.04 0.536 . . . . 10.0 112.107 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -72.46 -37.03 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 O-C-N 120.61 -1.306 . . . . 10.0 111.258 178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -51.3 -45.84 62.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.841 -1.162 . . . . 10.0 110.932 168.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -47.82 -62.2 1.57 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -147.15 55.65 1.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.838 0.455 . . . . 10.0 112.04 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.78 -54.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.84 -0.978 . . . . 10.0 111.039 176.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 64.69 107.0 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.323 1.849 . . . . 10.0 111.563 173.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 164.19 -25.73 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 125.368 1.467 . . . . 10.0 110.453 -169.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.7 t -86.13 88.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 121.027 -1.046 . . . . 10.0 109.087 -174.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.98 69.5 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -169.41 153.45 5.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.116 -1.809 . . . . 10.0 106.116 177.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.83 142.44 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 123.572 0.749 . . . . 10.0 109.312 173.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.88 84.82 4.62 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 169.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.86 -107.13 0.32 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.736 -0.48 . . . . 10.0 112.23 169.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 114.996 -2.43 . . . . 10.0 105.522 -169.511 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 106.503 -1.666 . . . . 10.0 106.503 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -125.2 177.3 6.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.992 1.317 . . . . 10.0 109.399 -174.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -147.35 82.55 1.54 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.015 0.926 . . . . 10.0 109.292 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' NZ ' ' OXT' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -89.48 165.39 14.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.557 1.143 . . . . 10.0 108.966 173.736 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -120.46 111.28 17.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.314 1.846 . . . . 10.0 108.141 -168.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.99 83.32 7.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 178.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.08 147.41 50.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.127 -0.942 . . . . 10.0 110.288 -176.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.51 119.37 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.983 2.113 . . . . 10.0 113.138 -169.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -66.04 -50.11 65.33 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.887 1.275 . . . . 10.0 110.094 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.3 -22.48 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.048 -0.524 . . . . 10.0 112.242 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.97 170.36 0.86 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.539 1.162 . . . . 10.0 111.852 174.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -151.94 23.91 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.594 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.7 t -103.88 92.69 4.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -52.77 -20.14 2.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.046 0.758 . . . . 10.0 113.046 171.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.08 -39.42 29.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.336 -0.852 . . . . 10.0 109.21 -175.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 m -56.68 -67.03 0.34 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 175.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -46.99 -50.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 119.281 -0.39 . . . . 10.0 111.887 -177.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -58.78 -31.09 68.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.761 0.71 . . . . 10.0 112.808 -175.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.24 68.33 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 110.29 -0.263 . . . . 10.0 110.29 176.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.0 t -87.28 -39.24 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 118.437 -0.792 . . . . 10.0 110.951 176.185 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -41.64 -43.28 2.74 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.183 1.393 . . . . 10.0 110.964 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.8 -57.35 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.977 0.353 . . . . 10.0 110.88 174.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -58.64 -54.57 45.57 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.841 1.256 . . . . 10.0 109.968 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.0 t -52.76 -42.89 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.201 1.001 . . . . 10.0 110.1 176.471 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.92 -38.19 83.06 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.748 1.166 . . . . 10.0 112.733 173.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.0 -27.55 65.79 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.36 1.08 . . . . 10.0 111.502 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.91 104.24 0.53 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 119.572 -0.851 . . . . 10.0 109.196 171.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -26.3 -49.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.116 2.566 . . . . 10.0 114.11 169.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.99 -13.43 59.58 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.597 0.599 . . . . 10.0 114.597 -176.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.64 110.12 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 119.871 1.836 . . . . 10.0 106.469 171.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -82.21 -28.8 31.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.22 -176.415 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.04 159.17 17.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 176.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.62 128.95 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 78.5 1.83 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.66 116.91 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 124.744 1.218 . . . . 10.0 108.504 176.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -149.36 46.96 0.97 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.328 0.651 . . . . 10.0 110.622 -175.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -54.09 -43.4 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.079 0.551 . . . . 10.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.03 -40.45 75.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.862 1.265 . . . . 10.0 110.533 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.92 -30.26 50.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.653 -0.703 . . . . 10.0 111.51 -178.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 -61.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.539 0.59 . . . . 10.0 112.457 -179.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -170.06 176.05 4.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.484 1.514 . . . . 10.0 112.087 -171.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 96.1 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 106.109 -1.811 . . . . 10.0 106.109 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.71 118.85 31.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.454 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 40.6 t -129.22 146.21 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -169.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 t -106.93 71.03 0.82 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.38 -1.711 . . . . 10.0 106.38 -173.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.454 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 22.0 m-85 -67.34 142.34 56.83 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.64 -1.618 . . . . 10.0 107.435 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -100.83 94.71 6.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.018 0.527 . . . . 10.0 109.954 169.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.54 -15.42 2.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.105 0.962 . . . . 10.0 113.443 174.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.71 -9.52 58.78 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.079 0.854 . . . . 10.0 110.009 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -126.25 -54.61 1.47 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.367 1.067 . . . . 10.0 108.49 -175.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.97 144.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.817 1.247 . . . . 10.0 110.482 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 m -101.58 139.24 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 m -34.24 -50.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 129.9 3.28 . . . . 10.0 110.877 176.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -29.71 -53.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.06 1.344 . . . . 10.0 112.491 172.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.05 -63.14 1.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.089 0.956 . . . . 10.0 110.679 177.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.51 -54.49 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 C-N-CA 125.97 1.708 . . . . 10.0 111.779 -176.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.49 -60.56 0.79 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.016 2.126 . . . . 10.0 110.403 171.165 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.54 -46.21 89.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.006 0.522 . . . . 10.0 110.569 176.819 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.19 71.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.023 0.929 . . . . 10.0 111.489 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.71 -59.27 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 174.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.8 -45.13 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.647 0.779 . . . . 10.0 112.249 -176.371 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -32.8 -50.91 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.493 1.517 . . . . 10.0 114.675 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -152.22 -37.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.096 0.959 . . . . 10.0 113.003 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -53.51 -44.24 67.4 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.424 -0.671 . . . . 10.0 111.424 178.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.44 169.6 0.23 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.266 1.426 . . . . 10.0 110.5 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.1 t70 104.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.588 1.955 . . . . 10.0 112.4 171.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.53 77.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.943 1.697 . . . . 10.0 108.697 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.31 -52.16 43.81 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.663 1.221 . . . . 10.0 108.446 176.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.51 127.92 2.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 104.829 -2.285 . . . . 10.0 104.829 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.4 HD13 ' CE1' ' A' ' 46' ' ' PHE . 3.6 tp -89.71 124.93 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.029 -1.841 . . . . 10.0 106.029 168.103 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.45 176.32 0.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.496 0.665 . . . . 10.0 109.802 174.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.96 75.18 0.18 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 19.7 ttm180 . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 167.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttp . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.107 -0.473 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -149.12 179.46 7.87 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 106.11 -1.811 . . . . 10.0 106.11 169.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -135.51 133.2 38.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.93 2.092 . . . . 10.0 106.616 169.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.01 -178.07 4.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.64 -2.726 . . . . 10.0 103.64 168.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 124.1 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.185 -2.524 . . . . 10.0 104.185 -177.007 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mt -88.26 89.25 7.91 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 105.102 -2.184 . . . . 10.0 105.102 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -53.44 143.33 19.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.423 0.556 . . . . 10.0 110.314 -174.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.31 132.63 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.179 0.992 . . . . 10.0 112.745 -168.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -86.13 -47.26 9.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.811 2.444 . . . . 10.0 111.249 -176.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -37.27 0.16 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.653 -0.526 . . . . 10.0 113.149 -174.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 155.97 38.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.054 0.927 . . . . 10.0 109.567 175.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -140.47 16.45 2.38 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.593 0.757 . . . . 10.0 110.535 175.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -88.99 103.76 16.35 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.58 -1.64 0.87 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.171 -0.919 . . . . 10.0 113.398 174.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.7 -45.37 7.04 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.158 1.345 . . . . 10.0 110.572 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -47.13 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.574 1.95 . . . . 10.0 109.844 175.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 m -36.47 -46.43 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.238 1.415 . . . . 10.0 112.767 173.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -55.27 -31.7 61.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.176 1.176 . . . . 10.0 114.176 -178.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.31 -34.95 62.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.751 0.25 . . . . 10.0 110.548 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.07 -34.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.031 1.333 . . . . 10.0 110.942 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -42.62 -47.37 5.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.553 1.141 . . . . 10.0 109.947 178.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -56.49 18.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.952 0.406 . . . . 10.0 111.112 177.144 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 m -62.92 -53.51 53.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.924 1.289 . . . . 10.0 110.963 -175.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.74 -43.87 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.923 0.889 . . . . 10.0 109.738 178.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.92 -42.01 69.05 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.595 0.617 . . . . 10.0 111.969 171.15 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -34.82 78.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.398 1.079 . . . . 10.0 111.038 178.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 105.21 1.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.222 -0.924 . . . . 10.0 110.025 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -32.96 -35.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.093 2.557 . . . . 10.0 114.173 170.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.19 5.4 2.83 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 116.115 1.206 . . . . 10.0 116.115 175.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.33 124.95 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.074 1.75 . . . . 10.0 107.24 169.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -92.32 -27.66 17.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.787 0.835 . . . . 10.0 111.028 175.378 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 151.47 10.14 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -136.64 128.76 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.779 1.232 . . . . 10.0 109.825 -177.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -151.49 100.17 2.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.295 1.038 . . . . 10.0 109.289 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.1 t -93.35 108.66 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 126.024 1.73 . . . . 10.0 109.329 -175.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -128.1 53.44 1.8 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.097 0.559 . . . . 10.0 111.604 -176.049 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -41.93 -52.34 4.14 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.281 1.432 . . . . 10.0 112.259 -178.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.13 -36.47 83.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.668 0.787 . . . . 10.0 111.619 -177.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.16 -37.6 28.51 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.872 0.367 . . . . 10.0 110.448 -171.24 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.89 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.649 -1.381 . . . . 10.0 109.649 177.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -171.88 1.91 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.513 1.525 . . . . 10.0 109.342 178.191 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.81 133.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.016 0.927 . . . . 10.0 108.873 168.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.4 96.21 5.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.858 1.263 . . . . 10.0 108.265 175.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 17.7 t -105.44 149.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.835 1.654 . . . . 10.0 107.684 -178.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -106.71 77.21 1.17 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.912 -1.884 . . . . 10.0 105.912 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.444 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 6.9 m-85 -74.45 131.84 41.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.29 -1.323 . . . . 10.0 108.469 -176.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.62 83.58 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.471 0.708 . . . . 10.0 109.091 171.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.59 -18.42 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 170.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.64 -12.11 60.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.687 1.995 . . . . 10.0 110.033 178.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -131.42 -58.48 0.99 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.76 1.624 . . . . 10.0 109.219 -172.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -131.39 141.09 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.966 1.706 . . . . 10.0 109.553 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -90.18 149.0 22.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.511 -0.743 . . . . 10.0 109.837 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.4 m -37.3 -46.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 C-N-CA 128.047 2.539 . . . . 10.0 109.431 167.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -42.22 -41.27 2.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.619 -0.705 . . . . 10.0 112.145 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.76 -66.48 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.479 0.581 . . . . 10.0 110.52 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -58.52 -56.99 12.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.306 1.442 . . . . 10.0 112.145 -175.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.93 -64.04 0.43 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.666 2.386 . . . . 10.0 110.137 172.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.46 -38.75 91.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.33 0.586 . . . . 10.0 110.185 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.27 76.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.542 -0.723 . . . . 10.0 111.41 175.181 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -70.46 -37.69 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 120.677 -1.265 . . . . 10.0 109.302 174.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.22 -42.34 73.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.035 1.288 . . . . 10.0 111.112 173.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -46.96 -66.98 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.681 0.792 . . . . 10.0 112.755 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.6 52.22 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.956 0.502 . . . . 10.0 111.453 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.94 -69.3 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 t80 69.25 130.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.08 1.752 . . . . 10.0 107.943 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 158.88 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.325 1.45 . . . . 10.0 109.965 -167.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.79 87.85 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.6 0.76 . . . . 10.0 111.602 -169.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.44 -53.72 17.89 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.685 -0.634 . . . . 10.0 109.671 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -168.1 167.77 12.25 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 178.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.73 148.44 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 126.685 1.994 . . . . 10.0 110.536 173.013 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -95.79 -63.53 1.15 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.685 0.794 . . . . 10.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.81 -61.05 7.81 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 -169.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.262 0 N-CA-C 105.408 -2.071 . . . . 10.0 105.408 164.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mmt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 106.821 -1.548 . . . . 10.0 106.821 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -96.16 118.59 33.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.981 0.801 . . . . 10.0 111.256 -167.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -66.55 81.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.479 0.711 . . . . 10.0 110.498 169.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -85.86 157.94 20.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.147 0.975 . . . . 10.0 109.028 168.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.25 101.25 8.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.458 -2.053 . . . . 10.0 105.458 -171.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.18 101.39 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.058 -2.201 . . . . 10.0 105.058 167.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -77.34 147.77 35.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.71 128.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 125.941 1.697 . . . . 10.0 112.901 -170.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -69.41 -61.55 1.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.308 2.243 . . . . 10.0 108.964 177.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.51 -35.2 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.358 -0.69 . . . . 10.0 113.3 -169.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.91 178.24 2.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.593 1.197 . . . . 10.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 p -141.42 -50.98 0.43 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.453 -169.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -32.46 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.987 1.715 . . . . 10.0 113.202 -175.87 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -54.73 -9.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -88.46 -43.14 11.67 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.407 1.003 . . . . 10.0 110.166 -177.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.4 m -50.58 -68.18 0.19 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.746 0.818 . . . . 10.0 109.375 175.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -46.61 -46.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.672 -0.24 . . . . 10.0 111.338 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.84 -36.4 64.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.138 1.162 . . . . 10.0 114.138 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.68 54.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.517 0.675 . . . . 10.0 110.02 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.14 -38.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 117.832 -1.08 . . . . 10.0 110.893 175.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 4.5 tt0 -36.89 -52.73 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.922 1.689 . . . . 10.0 111.015 176.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 p -58.07 -49.43 76.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.101 0.56 . . . . 10.0 111.399 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.3 m -62.93 -48.23 79.83 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.326 0.65 . . . . 10.0 110.402 -177.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.0 t -59.45 -42.72 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.863 0.865 . . . . 10.0 109.69 176.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.21 -43.35 56.82 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 123.579 0.609 . . . . 10.0 112.09 170.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.96 -30.32 70.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.585 0.692 . . . . 10.0 111.984 177.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 110.38 2.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.608 1.094 . . . . 10.0 110.431 177.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -35.31 -43.7 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.184 2.194 . . . . 10.0 113.081 173.804 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 20.22 1.92 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.223 0.849 . . . . 10.0 115.223 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.13 113.46 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 169.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.8 t -72.72 -33.79 66.66 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.457 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.24 159.75 9.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 -177.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.01 137.04 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.506 1.522 . . . . 10.0 107.695 179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -136.31 82.47 1.94 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 125.599 1.56 . . . . 10.0 107.185 168.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.19 130.05 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.96 -1.018 . . . . 10.0 108.892 174.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.86 44.75 0.16 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.06 0.457 . . . . 10.0 111.11 -173.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -57.68 -47.03 83.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.385 0.674 . . . . 10.0 112.114 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.766 1.226 . . . . 10.0 110.106 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.99 38.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.516 -178.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.43 -60.56 0.15 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.303 0.954 . . . . 10.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -170.65 166.33 8.09 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.09 1.356 . . . . 10.0 110.592 -171.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.72 118.15 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 172.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.08 120.05 40.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 56.1 t -131.48 138.9 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -170.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -92.51 67.28 4.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.738 -2.319 . . . . 10.0 104.738 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 45.6 m-85 -69.32 139.7 54.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.911 -1.515 . . . . 10.0 106.911 -177.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.59 88.6 5.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 -176.116 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.65 -24.01 45.46 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.443 0.534 . . . . 10.0 112.443 -178.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.76 -17.97 56.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.749 1.62 . . . . 10.0 110.253 -177.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -107.62 -55.09 2.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.222 1.009 . . . . 10.0 108.401 -173.103 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.33 178.49 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.656 1.182 . . . . 10.0 108.931 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 p -112.75 152.22 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -32.17 -44.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 129.74 3.216 . . . . 10.0 110.656 168.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -30.05 -53.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.42 1.088 . . . . 10.0 111.578 171.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.96 -59.1 5.08 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.592 0.757 . . . . 10.0 111.366 178.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -68.31 -53.68 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 125.096 1.358 . . . . 10.0 111.727 -176.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.59 -55.7 2.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 126.235 1.814 . . . . 10.0 110.226 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.79 -45.93 88.72 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.728 -0.607 . . . . 10.0 110.695 174.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.13 65.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.675 0.39 . . . . 10.0 111.183 178.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -71.25 -35.98 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.245 -0.909 . . . . 10.0 110.306 178.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.13 -37.99 72.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.702 1.137 . . . . 10.0 111.624 173.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -55.72 -66.9 0.34 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.455 0.57 . . . . 10.0 111.533 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.9 39.32 2.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -174.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.75 -58.28 0.09 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.92 -0.933 . . . . 10.0 112.348 -178.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 66.76 109.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.038 2.135 . . . . 10.0 110.938 178.081 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 166.92 -29.89 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 10.0 110.664 -168.198 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.14 85.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 121.077 -1.014 . . . . 10.0 112.229 -171.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.75 -57.23 4.13 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 121.808 0.813 . . . . 10.0 108.811 170.714 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -175.93 146.26 0.7 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 -171.526 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.76 133.26 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 124.524 1.129 . . . . 10.0 109.18 168.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -113.87 134.8 54.58 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.816 -1.92 . . . . 10.0 105.816 168.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.7 -121.57 1.68 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.984 -1.246 . . . . 10.0 109.984 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.415 -1.278 . . . . 10.0 111.301 -176.228 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 106.496 -1.668 . . . . 10.0 106.496 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.0 155.37 13.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.848 -0.741 . . . . 10.0 112.586 -165.169 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -71.26 63.47 0.36 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 10.0 110.569 172.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' NZ ' ' OXT' ' A' ' 73' ' ' ARG . 24.9 mttm -69.8 172.48 7.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.315 1.055 . . . . 10.0 108.206 168.316 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.13 104.89 15.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 177.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -62.55 150.09 41.35 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.705 0.802 . . . . 10.0 108.912 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.22 123.8 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 125.51 1.524 . . . . 10.0 111.063 -172.676 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.44 -45.48 75.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.594 1.558 . . . . 10.0 109.505 174.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.34 -8.41 0.39 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.855 -0.97 . . . . 10.0 114.094 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.93 179.45 1.47 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 119.425 1.612 . . . . 10.0 110.843 175.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -160.04 41.09 0.19 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -122.9 93.79 4.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.378 0.671 . . . . 10.0 109.672 176.372 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -55.92 -10.13 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.042 1.497 . . . . 10.0 115.042 172.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.94 -50.3 6.52 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 120.097 1.317 . . . . 10.0 109.609 -176.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -46.53 -62.62 1.29 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.196 0.998 . . . . 10.0 109.959 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -45.73 -52.58 2.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 122.41 0.284 . . . . 10.0 111.553 176.414 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -56.88 -37.49 71.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.811 0.844 . . . . 10.0 112.68 -178.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.31 -41.75 51.51 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.341 -0.615 . . . . 10.0 109.341 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.93 -36.69 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-O 117.229 -1.367 . . . . 10.0 111.592 173.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -43.54 -51.15 6.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.888 1.677 . . . . 10.0 110.001 -177.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.46 -47.98 83.4 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.278 0.561 . . . . 10.0 111.387 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -60.31 -40.73 91.6 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.471 1.108 . . . . 10.0 110.752 -177.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.5 -39.11 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.933 0.893 . . . . 10.0 109.846 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.76 -23.93 46.53 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.416 1.008 . . . . 10.0 112.281 178.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.33 -32.33 68.45 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.318 1.047 . . . . 10.0 110.655 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.43 111.97 2.9 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.179 -0.951 . . . . 10.0 110.688 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -37.54 -37.88 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.683 2.793 . . . . 10.0 112.973 174.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.47 4.55 81.27 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.448 0.939 . . . . 10.0 115.448 -177.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.13 107.65 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 104.289 -2.485 . . . . 10.0 104.289 167.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 -28.72 55.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.26 157.29 15.22 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 178.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.69 140.61 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.609 1.564 . . . . 10.0 109.013 -177.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -155.72 80.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.544 1.537 . . . . 10.0 109.078 173.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.33 115.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 121.688 -0.633 . . . . 10.0 109.885 169.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -143.86 48.52 1.41 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.901 0.881 . . . . 10.0 110.71 -179.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -55.74 25.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.392 0.677 . . . . 10.0 111.261 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.64 -22.47 64.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.815 -0.553 . . . . 10.0 110.324 -172.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.4 -35.45 21.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.948 0.899 . . . . 10.0 111.287 177.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.09 -72.1 0.06 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.125 0.869 . . . . 10.0 112.49 -171.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 176.77 5.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.283 2.233 . . . . 10.0 110.933 -175.088 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.3 t -96.35 102.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.186 0.994 . . . . 10.0 108.486 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -84.14 132.13 34.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.05 0.94 . . . . 10.0 108.583 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.88 129.52 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 O-C-N 121.528 -0.732 . . . . 10.0 110.001 -172.027 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.5 m -96.49 80.99 3.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.147 -1.427 . . . . 10.0 107.147 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -81.63 130.64 35.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.429 -0.805 . . . . 10.0 110.234 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -91.69 87.23 6.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.422 1.889 . . . . 10.0 108.653 174.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -20.51 2.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.593 1.157 . . . . 10.0 113.293 171.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.657 1.583 . . . . 10.0 109.237 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -59.0 1.96 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 125.959 1.704 . . . . 10.0 109.155 -170.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 m -140.05 154.21 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 123.826 0.851 . . . . 10.0 110.742 178.678 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 t -100.01 160.09 14.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.13 0.966 . . . . 10.0 111.016 177.227 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.22 -35.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 C-N-CA 128.187 2.595 . . . . 10.0 109.418 166.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -52.53 -28.2 19.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.193 0.906 . . . . 10.0 112.392 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.09 -62.98 1.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.346 0.976 . . . . 10.0 109.358 169.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -65.66 -51.39 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 O-C-N 121.512 -0.743 . . . . 10.0 112.491 -169.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.05 -53.51 6.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.013 1.725 . . . . 10.0 109.872 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.84 -49.11 78.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.818 0.847 . . . . 10.0 110.05 175.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.13 -42.46 66.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.569 1.147 . . . . 10.0 111.595 -179.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -56.39 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 118.215 -0.897 . . . . 10.0 108.832 174.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -34.5 59.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.883 1.219 . . . . 10.0 112.105 -171.264 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -38.19 -54.82 1.36 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.935 1.694 . . . . 10.0 113.527 172.172 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -144.86 -38.39 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.89 85.56 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.32 171.38 0.24 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.025 1.33 . . . . 10.0 109.958 -176.012 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.269 0.1 OUTLIER 102.13 3.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 127.425 2.29 . . . . 10.0 113.203 174.752 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.6 t -88.65 88.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 124.806 1.242 . . . . 10.0 110.173 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.56 -58.44 4.29 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -175.36 152.88 1.44 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -175.688 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.25 147.1 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 123.81 0.844 . . . . 10.0 111.811 173.682 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -111.06 -123.07 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 167.294 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.27 -67.8 0.15 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.491 1.52 . . . . 10.0 112.541 -170.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 N-CA-C 107.856 -1.165 . . . . 10.0 107.856 -174.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 29.6 ttp . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.14 137.51 49.07 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 123.795 0.684 . . . . 10.0 111.808 -168.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -84.6 99.19 10.61 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.662 1.185 . . . . 10.0 110.276 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.65 164.84 12.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 167.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.82 113.78 21.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.072 -1.825 . . . . 10.0 106.072 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.88 83.19 6.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 174.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.82 147.02 20.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 -176.3 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.28 130.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.938 0.718 . . . . 10.0 112.938 -169.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -66.39 -48.6 69.59 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.847 1.659 . . . . 10.0 107.468 172.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.33 11.76 0.12 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.4 -1.222 . . . . 10.0 114.624 175.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -175.27 2.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 120.382 2.091 . . . . 10.0 108.52 173.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -170.17 58.45 0.04 OUTLIER 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.649 -1.241 . . . . 10.0 107.649 173.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.8 t -132.16 108.94 9.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 174.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -66.04 -10.56 41.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.11 0.964 . . . . 10.0 111.41 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -93.05 -48.27 6.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.538 0.735 . . . . 10.0 110.156 -171.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 m -43.64 -70.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.008 1.723 . . . . 10.0 110.197 171.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -39.56 -48.66 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 C-N-CA 123.962 0.905 . . . . 10.0 111.789 173.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.07 -34.86 61.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -31.34 45.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.36 0.527 . . . . 10.0 110.542 174.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.01 -32.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.498 1.519 . . . . 10.0 111.232 177.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 27.8 tt0 -43.37 -47.58 6.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.154 1.382 . . . . 10.0 110.087 -179.323 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -44.62 -70.04 0.12 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.802 1.641 . . . . 10.0 111.836 169.711 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.5 t -58.59 -47.21 85.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.116 1.367 . . . . 10.0 110.57 -172.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.37 -42.99 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.023 0.529 . . . . 10.0 109.8 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.31 -45.35 74.97 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.419 0.533 . . . . 10.0 111.769 170.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -61.52 -36.42 80.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 10.0 111.632 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 95.65 0.21 Allowed 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.276 -0.89 . . . . 10.0 109.972 177.131 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -28.03 -41.94 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.942 2.497 . . . . 10.0 114.902 173.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.83 5.15 0.56 Allowed Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.885 1.231 . . . . 10.0 115.74 174.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.74 111.31 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 104.474 -2.417 . . . . 10.0 104.474 169.083 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -74.08 -30.59 62.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.32 156.78 10.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.874 -1.528 . . . . 10.0 106.874 178.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.58 145.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 O-C-N 123.927 0.767 . . . . 10.0 109.677 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.29 96.67 1.2 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 173.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.7 t -87.3 120.34 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 178.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.08 49.8 2.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.424 0.556 . . . . 10.0 110.023 -174.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -42.46 -53.96 4.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.655 1.582 . . . . 10.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -35.68 74.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.508 0.723 . . . . 10.0 111.706 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -32.65 41.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.978 -171.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.95 -73.59 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.413 -1.475 . . . . 10.0 109.413 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -171.87 1.93 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 127.129 2.171 . . . . 10.0 108.582 177.195 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.44 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 172.255 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -120.98 100.78 7.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.564 -1.273 . . . . 10.0 107.564 176.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 25.7 t -110.83 148.58 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.649 1.58 . . . . 10.0 106.97 -175.422 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 t -101.25 72.19 1.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.034 -1.839 . . . . 10.0 106.034 -175.393 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 27.6 m-85 -75.82 134.68 40.32 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.112 -172.07 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -83.03 81.17 8.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.492 -0.755 . . . . 10.0 109.81 177.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.42 -25.97 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.865 1.266 . . . . 10.0 113.252 169.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 1' ' ' MET . 21.9 m-20 -83.0 -22.54 33.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 126.325 1.85 . . . . 10.0 110.294 -173.255 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -117.67 -48.74 2.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.378 0.671 . . . . 10.0 109.448 -169.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.15 -170.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 125.445 1.498 . . . . 10.0 108.836 177.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.9 m -143.64 144.48 31.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 169.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 m -32.35 -42.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 130.524 3.529 . . . . 10.0 111.596 174.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -29.67 -55.88 0.16 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.192 0.997 . . . . 10.0 111.522 170.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -51.75 -67.45 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.721 1.208 . . . . 10.0 110.75 175.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mp -60.32 -55.49 23.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 124.296 1.038 . . . . 10.0 111.869 -175.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.83 -59.94 1.53 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.886 2.074 . . . . 10.0 110.572 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.88 -46.86 78.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.763 0.792 . . . . 10.0 110.39 176.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.78 -42.84 80.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.102 0.961 . . . . 10.0 111.45 -178.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -43.85 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.045 -1.034 . . . . 10.0 108.765 175.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.18 -36.99 32.79 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.119 1.327 . . . . 10.0 112.27 176.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.54 -67.72 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.697 0.68 . . . . 10.0 112.584 176.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -129.48 14.87 6.05 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.97 -53.59 0.18 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.212 0.911 . . . . 10.0 112.904 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 63.4 169.97 0.15 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.241 2.216 . . . . 10.0 110.97 -172.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.288 1.3 p30 108.43 -8.24 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 129.395 3.078 . . . . 10.0 113.166 -176.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.4 t -74.2 81.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 124.302 1.041 . . . . 10.0 111.664 -178.023 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.33 -56.64 5.15 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 168.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -179.07 145.07 0.25 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.486 1.114 . . . . 10.0 108.433 -171.045 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.34 137.22 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.327 1.051 . . . . 10.0 110.061 169.549 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.76 -58.24 7.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.5 0.591 . . . . 10.0 111.326 174.742 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.32 104.22 2.93 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.672 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.479 0 N-CA-C 101.263 -3.606 . . . . 10.0 101.263 163.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -147.2 75.35 1.37 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.579 1.151 . . . . 10.0 108.204 170.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -92.2 175.52 6.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.308 1.051 . . . . 10.0 109.341 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -150.86 137.85 19.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -92.87 101.7 14.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.774 -2.306 . . . . 10.0 104.774 177.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.05 147.27 51.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.28 131.53 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.203 1.401 . . . . 10.0 112.587 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -78.6 -59.66 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.332 2.653 . . . . 10.0 110.862 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.05 -36.15 0.05 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.757 -0.469 . . . . 10.0 112.778 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 166.48 2.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.129 0.966 . . . . 10.0 111.957 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 m -156.17 42.94 0.4 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t -112.61 96.15 5.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.552 -1.648 . . . . 10.0 106.552 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -55.96 -25.12 42.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.353 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -74.95 -41.34 59.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.76 0.824 . . . . 10.0 109.322 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.66 -71.41 0.08 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.832 0.853 . . . . 10.0 109.43 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -48.57 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 O-C-N 121.677 -0.639 . . . . 10.0 112.663 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -28.15 64.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.24 78.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -84.39 -41.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 118.61 -0.71 . . . . 10.0 110.519 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -39.4 -52.94 2.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.293 1.037 . . . . 10.0 110.503 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -48.84 75.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.612 -0.722 . . . . 10.0 110.907 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 m -59.34 -49.79 76.48 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.166 0.586 . . . . 10.0 111.227 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -55.27 -33.67 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.529 -0.732 . . . . 10.0 110.985 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.42 -18.37 14.77 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.922 0.772 . . . . 10.0 113.105 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.08 -34.38 75.04 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 118.626 1.213 . . . . 10.0 110.369 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 95.37 0.56 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.372 -0.83 . . . . 10.0 110.593 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -21.03 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.615 2.766 . . . . 10.0 114.347 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -44.66 -53.93 6.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.28 0.943 . . . . 10.0 113.865 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -52.63 111.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.452 1.101 . . . . 10.0 109.721 -173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -37.92 58.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.118 -0.947 . . . . 10.0 108.727 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.86 156.97 9.63 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.42 113.27 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.211 1.405 . . . . 10.0 107.231 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -116.66 78.18 1.18 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.089 0.956 . . . . 10.0 108.684 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.02 115.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.185 0.994 . . . . 10.0 109.847 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 41.0 m-80 -144.92 48.78 1.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.139 0.975 . . . . 10.0 110.09 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -49.84 -45.81 50.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 10.0 112.205 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.42 -42.71 82.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.515 1.126 . . . . 10.0 111.11 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -76.47 -32.06 58.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.036 -175.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.29 -70.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.474 1.035 . . . . 10.0 111.064 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.36 177.88 5.82 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.681 1.593 . . . . 10.0 109.418 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.422 HG23 HD12 ' A' ' 6' ' ' LEU . 17.2 m -93.71 109.85 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 108.094 -1.076 . . . . 10.0 108.094 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -93.51 118.8 31.8 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.1 t -132.35 137.49 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 122.227 1.013 . . . . 10.0 109.958 -168.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.1 m -105.12 66.36 0.75 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 -172.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.41 138.77 56.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.158 -1.383 . . . . 10.0 108.643 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -83.44 89.74 7.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.503 -0.479 . . . . 10.0 111.473 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.86 -19.59 1.81 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.77 -14.3 45.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.447 1.021 . . . . 10.0 110.62 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -117.34 -52.95 2.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.272 1.029 . . . . 10.0 109.252 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.84 139.37 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.175 0.99 . . . . 10.0 110.31 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -93.04 145.18 24.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.541 -0.724 . . . . 10.0 109.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -34.83 -46.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 128.956 2.902 . . . . 10.0 110.405 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -32.3 -51.26 0.25 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.523 1.129 . . . . 10.0 112.221 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -52.37 -72.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.954 1.302 . . . . 10.0 110.59 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -57.96 -49.17 82.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 125.366 1.466 . . . . 10.0 112.161 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.81 -59.13 2.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.495 1.918 . . . . 10.0 109.916 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.11 -43.72 82.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.395 0.617 . . . . 10.0 109.827 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.83 61.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.607 0.763 . . . . 10.0 111.045 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.495 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.16 -32.74 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 120.799 -1.188 . . . . 10.0 109.813 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -53.26 40.97 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.535 -0.728 . . . . 10.0 109.572 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -39.3 -64.66 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.888 1.275 . . . . 10.0 114.067 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -139.9 30.77 2.03 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.99 -54.09 0.32 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.0 -0.889 . . . . 10.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 64.66 110.65 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.795 2.038 . . . . 10.0 110.77 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 163.47 -32.25 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.78 1.232 . . . . 10.0 109.644 -168.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' CG2' ' A' ' 60' ' ' ILE . 69.3 t -72.4 87.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.394 -0.816 . . . . 10.0 111.073 -173.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.47 -55.75 12.35 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.296 -1.002 . . . . 10.0 108.296 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -174.59 156.9 2.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.099 -1.445 . . . . 10.0 107.099 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.765 0 C-N-CA 124.506 1.122 . . . . 10.0 110.4 168.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.5 102.82 4.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.089 1.756 . . . . 10.0 107.847 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -117.83 168.74 10.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.503 1.145 . . . . 10.0 109.694 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.55 126.13 49.57 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.608 -2.367 . . . . 10.0 104.608 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -93.92 105.79 17.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 103.582 -2.747 . . . . 10.0 103.582 167.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -68.29 151.71 46.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.381 -0.97 . . . . 10.0 108.381 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.29 131.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.188 1.395 . . . . 10.0 113.604 -169.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -73.81 -62.3 1.54 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 128.547 2.739 . . . . 10.0 109.319 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.53 -26.79 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.834 -1.174 . . . . 10.0 114.163 -169.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -179.35 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.125 1.463 . . . . 10.0 110.656 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 t -163.7 65.23 0.17 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -144.82 91.86 2.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -55.86 -3.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.206 1.187 . . . . 10.0 114.206 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -94.84 -42.52 8.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 10.0 109.771 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.46 -66.29 0.41 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.648 0.779 . . . . 10.0 109.184 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -40.56 -47.83 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.49 0.716 . . . . 10.0 111.769 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.2 tttm -58.62 -31.48 68.14 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.8 -31.32 58.86 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.548 0.613 . . . . 10.0 110.133 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -95.03 -35.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.879 1.272 . . . . 10.0 111.073 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 19.2 tt0 -36.45 -57.3 0.76 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.018 1.727 . . . . 10.0 110.724 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 p -51.98 -59.89 3.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.677 1.191 . . . . 10.0 111.204 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -56.28 -49.4 74.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.042 0.937 . . . . 10.0 110.929 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 30' ' ' VAL . 24.2 t -59.33 -43.9 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 122.02 -0.425 . . . . 10.0 110.269 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.71 -30.87 14.9 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 123.474 0.559 . . . . 10.0 112.968 171.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.73 -36.36 80.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.169 0.985 . . . . 10.0 110.569 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 95.14 0.54 Allowed 'General case' 0 C--O 1.22 -0.473 0 O-C-N 121.352 -0.842 . . . . 10.0 109.409 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -19.02 -50.53 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.979 2.911 . . . . 10.0 114.756 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.01 -18.98 20.93 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.676 1.132 . . . . 10.0 115.138 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 24' ' ' VAL . 2.1 t -81.63 108.25 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 119.392 -2.24 . . . . 10.0 105.699 170.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -36.14 78.16 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.023 -0.99 . . . . 10.0 109.912 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.13 154.76 9.15 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.974 -0.751 . . . . 10.0 108.974 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.34 142.21 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.496 1.518 . . . . 10.0 109.334 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 88.83 1.51 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 122.33 1.062 . . . . 10.0 108.94 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.56 124.46 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 124.834 1.253 . . . . 10.0 108.903 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 59.8 m-80 -145.48 48.97 1.25 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.015 0.526 . . . . 10.0 110.83 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -49.2 24.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.511 0.724 . . . . 10.0 110.333 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.79 -23.52 61.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.261 1.024 . . . . 10.0 111.869 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.22 -29.79 21.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.588 0.232 . . . . 10.0 110.423 174.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.24 -57.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.935 0.778 . . . . 10.0 111.777 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 174.32 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.061 1.344 . . . . 10.0 111.586 -170.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -91.1 132.84 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 169.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.36 112.05 18.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 42' ' ' VAL . 42.9 t -127.7 146.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.753 1.221 . . . . 10.0 109.001 -168.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -99.04 81.67 2.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 104.469 -2.419 . . . . 10.0 104.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 15.1 m-85 -85.88 127.91 34.7 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.079 -1.082 . . . . 10.0 108.079 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -86.08 82.17 8.19 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.38 -1.341 . . . . 10.0 107.38 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 -14.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.961 1.704 . . . . 10.0 113.528 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.15 -26.74 60.48 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.017 2.127 . . . . 10.0 108.775 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -121.19 -56.18 1.92 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.388 1.075 . . . . 10.0 108.496 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.12 138.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 124.131 0.972 . . . . 10.0 108.935 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 t -89.12 158.5 17.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.488 1.137 . . . . 10.0 110.202 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 70' ' ' ILE . 18.1 m -47.45 -37.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 128.062 2.545 . . . . 10.0 107.744 165.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -56.06 -25.76 46.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 119.793 1.179 . . . . 10.0 112.853 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.45 -60.99 2.37 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.71 1.595 . . . . 10.0 109.104 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -65.28 -53.16 43.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 124.785 1.234 . . . . 10.0 112.599 -171.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.91 -56.37 4.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.681 1.992 . . . . 10.0 110.163 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -59.76 -44.82 93.68 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.419 1.488 . . . . 10.0 108.87 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.27 -46.74 72.76 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.57 -0.706 . . . . 10.0 112.004 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.553 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.51 -34.82 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 O-C-N 120.824 -1.172 . . . . 10.0 110.335 178.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -53.52 -42.34 67.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.776 -1.203 . . . . 10.0 110.394 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -53.6 -65.73 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.261 1.025 . . . . 10.0 112.72 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -136.42 34.48 2.74 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.188 -0.945 . . . . 10.0 113.543 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.05 -57.26 0.26 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.686 0.676 . . . . 10.0 112.484 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 62.64 102.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.445 1.898 . . . . 10.0 111.775 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t0 172.57 -40.07 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.752 2.021 . . . . 10.0 107.655 -168.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.553 HG23 HG21 ' A' ' 60' ' ' ILE . 51.4 t -69.06 98.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 120.526 -1.359 . . . . 10.0 112.657 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.99 -55.08 5.21 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.89 -0.782 . . . . 10.0 108.89 167.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -170.47 146.28 2.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.346 1.459 . . . . 10.0 107.125 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.73 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 123.886 0.875 . . . . 10.0 109.594 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 122.458 1.123 . . . . 10.0 109.337 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 pm0 -72.99 72.26 1.12 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.081 1.352 . . . . 10.0 110.337 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 160.65 30.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.745 1.259 . . . . 10.0 108.289 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -120.75 115.5 23.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 67' ' ' VAL . 74.0 mt -86.3 92.24 8.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.912 -2.255 . . . . 10.0 104.912 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -67.09 142.73 57.02 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.72 130.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.599 1.56 . . . . 10.0 112.784 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -81.72 -53.73 5.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.47 2.708 . . . . 10.0 110.479 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.79 -40.13 0.09 OUTLIER Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.237 -0.506 . . . . 10.0 112.428 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 156.92 21.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.55 0.675 . . . . 10.0 110.994 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.17 11.57 3.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.901 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.6 t -85.25 94.25 8.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.817 0.817 . . . . 10.0 109.101 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -57.63 -4.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.325 1.05 . . . . 10.0 113.651 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -92.9 -32.06 14.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.778 1.172 . . . . 10.0 111.15 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.4 m -63.35 -74.45 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -46.62 -49.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 112.944 0.72 . . . . 10.0 112.944 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.27 -33.45 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.209 0.818 . . . . 10.0 113.209 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.95 67.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.938 0.495 . . . . 10.0 109.911 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.39 -49.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 118.287 -0.863 . . . . 10.0 109.88 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -38.71 -49.29 1.57 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.977 1.711 . . . . 10.0 110.883 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.69 -51.33 50.57 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 10.0 111.152 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.94 -42.24 63.64 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.871 0.868 . . . . 10.0 111.568 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.59 -41.19 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.097 -1.002 . . . . 10.0 109.898 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.03 -26.33 19.31 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.702 1.144 . . . . 10.0 113.866 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.63 -29.83 67.4 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.845 1.323 . . . . 10.0 110.685 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 111.98 5.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.109 0.868 . . . . 10.0 109.407 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -42.62 -41.1 2.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.566 1.947 . . . . 10.0 112.693 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.54 -26.99 57.95 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.262 0.934 . . . . 10.0 113.904 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.96 112.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 120.203 -1.763 . . . . 10.0 106.616 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -79.39 -37.77 36.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 10.0 109.758 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.82 161.29 17.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.659 -1.237 . . . . 10.0 107.659 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.73 134.16 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.012 1.325 . . . . 10.0 108.25 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -143.36 89.57 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.49 1.116 . . . . 10.0 110.072 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 t -66.8 134.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.218 1.007 . . . . 10.0 110.286 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.8 m-20 -156.79 49.45 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.871 0.468 . . . . 10.0 110.933 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -54.39 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 10.0 111.943 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.65 -38.11 86.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.566 0.746 . . . . 10.0 111.208 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -73.51 -34.77 65.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.919 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.33 -73.35 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.61 -1.396 . . . . 10.0 109.61 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 -172.35 1.6 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.094 1.758 . . . . 10.0 107.666 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 35' ' ' VAL . 41.9 t -99.06 117.8 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -100.88 130.1 46.84 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 44.5 t -136.55 149.54 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.87 -1.53 . . . . 10.0 106.87 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -111.04 85.77 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 104.915 -2.254 . . . . 10.0 104.915 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 39.9 m-85 -92.11 141.61 28.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.673 1.589 . . . . 10.0 108.276 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -89.89 93.3 9.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.617 0.767 . . . . 10.0 109.969 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.6 -14.67 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.714 -0.66 . . . . 10.0 112.296 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.3 -0.25 57.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.801 0.728 . . . . 10.0 109.685 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -130.52 -53.25 1.09 Allowed 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.675 -0.641 . . . . 10.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.89 164.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 118.701 0.682 . . . . 10.0 110.72 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.5 m -111.17 147.96 33.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 46' ' ' PHE . 15.4 m -42.26 -34.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 C-N-CA 127.068 2.147 . . . . 10.0 110.148 167.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -48.29 -28.41 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.014 0.825 . . . . 10.0 112.324 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -68.9 -70.79 0.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.78 0.832 . . . . 10.0 109.008 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -59.33 -53.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.239 1.416 . . . . 10.0 113.787 -172.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.11 -56.92 3.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.124 1.77 . . . . 10.0 109.953 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -58.91 -46.25 88.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.906 0.882 . . . . 10.0 109.459 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.5 67.62 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.767 -0.583 . . . . 10.0 111.207 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -71.07 -38.6 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.09 -1.006 . . . . 10.0 110.037 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -54.5 -41.18 69.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.523 -1.361 . . . . 10.0 110.293 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -53.95 -65.53 0.55 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.424 1.09 . . . . 10.0 112.925 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.28 50.39 1.8 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.655 -0.653 . . . . 10.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.79 -55.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 64.0 112.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.255 2.222 . . . . 10.0 110.432 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 168.34 -41.85 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.461 0 O-C-N 121.543 -0.723 . . . . 10.0 109.337 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 60' ' ' ILE . 88.1 t -75.09 84.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.028 0.442 . . . . 10.0 110.885 -168.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.28 -50.38 60.58 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -163.79 153.0 14.22 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 172.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.01 0 C-N-CA 124.904 1.282 . . . . 10.0 108.28 168.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -141.04 113.42 8.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -120.54 -178.63 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.973 0.909 . . . . 10.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -137.87 116.6 12.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.128 -1.805 . . . . 10.0 106.128 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 HG22 ' A' ' 70' ' ' ILE . 1.2 mt -86.28 94.19 9.27 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 104.58 -2.378 . . . . 10.0 104.58 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -59.32 148.02 33.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.1 128.16 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.205 1.402 . . . . 10.0 110.797 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.9 -56.52 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.808 2.043 . . . . 10.0 108.016 170.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.82 -37.03 0.05 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.513 -1.327 . . . . 10.0 113.909 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 161.26 30.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.062 0.931 . . . . 10.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -143.31 21.28 1.89 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.246 0.618 . . . . 10.0 109.955 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.5 t -97.39 101.37 12.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -66.8 2.36 1.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -45.52 6.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.969 1.308 . . . . 10.0 110.641 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.0 m -49.43 -68.88 0.14 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.377 1.471 . . . . 10.0 109.526 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.784 HG21 HG11 ' A' ' 35' ' ' VAL . 2.0 m -39.85 -45.65 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 C-N-CA 123.972 0.909 . . . . 10.0 112.297 172.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 6.0 tttp -56.17 -31.17 63.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.158 1.17 . . . . 10.0 114.158 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -31.8 52.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.199 0.454 . . . . 10.0 110.524 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' C ' ' A' ' 59' ' ' ALA . 2.5 t -97.75 -33.58 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.855 1.662 . . . . 10.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 25.4 tt0 -43.3 -47.82 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.994 1.318 . . . . 10.0 110.592 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -46.39 -61.37 1.83 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.987 0.915 . . . . 10.0 110.996 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -57.56 -50.35 73.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.385 1.074 . . . . 10.0 110.877 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 20' ' ' VAL . 97.2 t -55.53 -47.29 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.757 0.823 . . . . 10.0 109.57 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.16 -38.92 88.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.716 0.674 . . . . 10.0 112.204 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -42.57 99.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.359 1.063 . . . . 10.0 110.724 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 112.58 1.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.796 -0.565 . . . . 10.0 111.216 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -35.85 -56.09 0.71 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.852 2.461 . . . . 10.0 112.303 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.94 -19.84 51.62 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.251 0.46 . . . . 10.0 114.251 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.45 109.17 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 119.17 -2.371 . . . . 10.0 107.498 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -74.84 -31.12 61.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.806 -1.088 . . . . 10.0 109.415 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 158.07 8.91 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.2 m -133.22 138.61 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.358 1.063 . . . . 10.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -158.48 101.14 1.68 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.784 HG11 HG21 ' A' ' 17' ' ' VAL . 36.9 t -89.9 123.03 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 C-N-CA 125.339 1.456 . . . . 10.0 107.732 176.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -137.19 53.1 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.46 0.573 . . . . 10.0 110.871 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 37' ' ' LEU . 1.2 mp -44.99 -47.67 11.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.465 1.106 . . . . 10.0 112.136 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.32 -33.39 73.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.491 0.716 . . . . 10.0 111.902 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.0 58.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.34 -64.04 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.82 -170.23 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.941 1.296 . . . . 10.0 110.822 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.98 128.29 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.778 1.231 . . . . 10.0 108.824 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.96 71.39 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.744 1.618 . . . . 10.0 109.04 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.634 HG23 ' CG2' ' A' ' 42' ' ' VAL . 12.4 t -84.78 152.31 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.836 1.254 . . . . 10.0 109.393 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 t -110.15 71.32 0.75 Allowed 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.257 -1.757 . . . . 10.0 106.257 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 12.4 m-85 -72.03 130.11 40.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.355 -1.293 . . . . 10.0 109.107 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -80.93 85.4 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.281 -0.887 . . . . 10.0 109.838 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.35 -21.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.902 1.281 . . . . 10.0 113.845 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.78 -19.91 51.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.296 0.953 . . . . 10.0 109.706 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -116.65 -53.96 2.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.889 1.275 . . . . 10.0 110.466 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -138.2 159.71 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.077 0.551 . . . . 10.0 109.938 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.5 p -108.37 161.51 14.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 m -31.86 -42.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.238 2.215 . . . . 10.0 111.656 168.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -29.6 -54.47 0.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.65 1.58 . . . . 10.0 111.303 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.11 -59.42 5.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.376 1.084 . . . . 10.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.41 HG23 ' CG1' ' A' ' 24' ' ' VAL . 3.6 mm -62.61 -58.67 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.623 1.569 . . . . 10.0 111.955 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' A' ' 67' ' ' VAL . . . -41.46 -55.31 2.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 128.003 2.521 . . . . 10.0 110.007 172.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -56.86 -48.69 77.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.891 0.853 . . . . 10.0 110.557 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -56.23 -45.6 79.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.454 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.66 -35.84 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 120.558 -1.339 . . . . 10.0 109.967 178.05 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.26 -39.77 73.14 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.169 1.349 . . . . 10.0 111.755 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -49.43 -63.23 1.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.168 0.587 . . . . 10.0 112.341 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -134.81 13.34 3.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.532 0.938 . . . . 10.0 113.532 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -55.21 0.55 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.062 -0.854 . . . . 10.0 113.241 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 64.33 108.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.973 2.109 . . . . 10.0 111.256 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.75 -36.58 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.187 0.995 . . . . 10.0 109.951 -167.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 57' ' ' ALA . 66.2 t -73.03 87.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.409 -0.807 . . . . 10.0 111.773 -169.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.79 10.36 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.288 -0.882 . . . . 10.0 110.136 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -174.13 152.85 1.93 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.579 -1.638 . . . . 10.0 106.579 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.676 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.041 0 C-N-CA 123.815 0.846 . . . . 10.0 110.038 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 114.39 19.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.688 2.395 . . . . 10.0 105.379 170.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -123.01 168.05 12.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.946 -1.501 . . . . 10.0 106.946 168.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.64 122.24 32.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -91.45 97.43 11.07 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 172.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.86 153.28 42.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.604 0.761 . . . . 10.0 109.379 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.27 131.63 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -70.0 -56.91 5.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 130.491 3.516 . . . . 10.0 109.824 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.32 -30.21 0.18 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.451 -0.638 . . . . 10.0 112.423 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 169.58 10.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.133 0.967 . . . . 10.0 111.557 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.3 m -156.07 40.73 0.37 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.42 89.56 3.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -52.93 -16.28 1.0 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.132 0.973 . . . . 10.0 113.43 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -82.6 -39.64 21.92 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.196 -0.94 . . . . 10.0 109.835 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -57.53 -71.24 0.11 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.772 1.295 . . . . 10.0 108.31 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -46.46 -51.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.219 0.452 . . . . 10.0 112.219 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -28.93 68.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.366 0.984 . . . . 10.0 113.01 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.77 61.75 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 121.719 -0.613 . . . . 10.0 110.923 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.0 -44.59 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 118.156 -0.926 . . . . 10.0 110.633 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -44.95 -46.91 11.3 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.927 1.291 . . . . 10.0 110.302 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -50.14 -60.26 3.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.016 0.526 . . . . 10.0 111.553 174.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -58.7 -43.85 90.18 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.476 0.71 . . . . 10.0 111.767 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 56' ' ' ILE . 6.3 t -53.45 -39.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.221 1.008 . . . . 10.0 110.21 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -45.92 -27.28 2.32 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.317 0.96 . . . . 10.0 114.423 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.23 -26.3 61.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.15 1.475 . . . . 10.0 112.149 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.77 113.56 2.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.179 0.9 . . . . 10.0 110.542 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -39.78 -45.9 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.194 2.198 . . . . 10.0 111.735 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -17.9 75.32 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.785 0.674 . . . . 10.0 114.785 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.91 107.54 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 118.683 -2.657 . . . . 10.0 107.245 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 t -79.35 -29.3 42.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.3 157.64 13.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 44' ' ' VAL . 5.9 m -134.43 135.53 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.158 0.983 . . . . 10.0 109.103 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -149.21 87.22 1.52 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 t -73.19 117.4 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 123.726 0.81 . . . . 10.0 110.275 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.42 49.07 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.555 0.742 . . . . 10.0 111.437 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -52.42 -39.86 61.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.472 0.653 . . . . 10.0 112.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.91 -39.55 90.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.463 1.505 . . . . 10.0 110.69 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.2 -33.65 24.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.189 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.18 -67.65 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 179.01 5.16 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.355 1.862 . . . . 10.0 110.842 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.539 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -92.56 127.81 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 124.944 1.298 . . . . 10.0 107.941 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.83 94.02 4.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.33 1.052 . . . . 10.0 109.494 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' CG2' ' A' ' 42' ' ' VAL . 31.4 t -104.86 146.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.957 1.703 . . . . 10.0 107.738 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -103.8 68.89 0.94 Allowed 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.156 -2.165 . . . . 10.0 105.156 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 m-85 -66.78 128.43 36.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.915 -1.493 . . . . 10.0 108.662 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -79.95 85.4 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.83 -23.36 0.42 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.189 1.396 . . . . 10.0 113.385 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.04 -15.15 52.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.361 1.064 . . . . 10.0 110.603 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -121.48 -56.13 1.9 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.769 1.228 . . . . 10.0 109.42 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.41 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.227 1.411 . . . . 10.0 108.409 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -156.51 167.23 31.08 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.537 -1.283 . . . . 10.0 107.537 168.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -34.24 -42.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 128.116 2.566 . . . . 10.0 112.237 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -35.05 -41.48 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.017 1.327 . . . . 10.0 113.224 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.92 -67.38 0.51 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.869 0.843 . . . . 10.0 110.627 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 24' ' ' VAL . 3.6 mm -55.92 -55.81 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.846 1.259 . . . . 10.0 112.97 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.61 -56.9 4.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.813 2.045 . . . . 10.0 109.731 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.92 -49.62 65.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.55 0.691 . . . . 10.0 110.131 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.96 78.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.793 -0.639 . . . . 10.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -69.52 -36.86 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 120.656 -1.278 . . . . 10.0 110.096 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.32 -40.87 71.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.499 -1.376 . . . . 10.0 111.645 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -51.5 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.154 0.888 . . . . 10.0 112.54 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.0 46.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.24 0.459 . . . . 10.0 112.24 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.57 -59.65 0.11 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.02 110.64 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.41 2.284 . . . . 10.0 110.919 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 t0 169.78 -38.55 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.93 1.692 . . . . 10.0 109.224 -167.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 60' ' ' ILE . 73.4 t -74.93 90.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 120.484 -1.385 . . . . 10.0 112.382 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.9 -56.84 4.62 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.467 -0.77 . . . . 10.0 110.708 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -163.63 143.74 8.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.848 -1.538 . . . . 10.0 106.848 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.666 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.437 -1.078 0 C-N-CA 124.7 1.2 . . . . 10.0 108.311 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.346 0.593 . . . . 10.0 109.978 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.92 107.81 5.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.252 2.221 . . . . 10.0 106.369 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -110.29 161.34 15.71 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.24 -1.393 . . . . 10.0 107.24 168.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.38 115.55 26.77 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 6' ' ' LEU . 20.9 mt -81.99 96.98 7.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.948 -1.871 . . . . 10.0 105.948 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -65.0 155.71 33.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 10.0 109.662 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' A' ' 66' ' ' ASP . 2.1 t -63.12 129.61 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.302 1.441 . . . . 10.0 110.447 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ASP . 28.1 tt0 -75.14 -43.63 51.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.962 1.705 . . . . 10.0 107.408 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.37 12.19 0.96 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.533 -1.148 . . . . 10.0 113.371 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -177.04 1.96 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.714 1.757 . . . . 10.0 109.722 169.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 p -155.53 15.16 0.37 Allowed 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.034 -0.416 . . . . 10.0 111.362 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -99.35 95.29 6.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -64.2 2.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.468 0.914 . . . . 10.0 113.468 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -94.0 -48.36 6.28 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.781 1.173 . . . . 10.0 110.046 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.3 m -48.21 -70.16 0.1 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.536 1.134 . . . . 10.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 m -38.45 -48.46 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.35 1.06 . . . . 10.0 111.89 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.85 -38.14 89.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.359 1.064 . . . . 10.0 112.535 -174.145 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.4 69.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.5 t -73.46 -38.14 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.68 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 28.8 tt0 -46.2 -49.81 16.57 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.922 1.289 . . . . 10.0 110.358 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -50.57 72.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.901 0.381 . . . . 10.0 111.264 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -70.79 -10.49 59.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.947 0.721 . . . . 10.0 112.947 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 -43.0 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.624 1.17 . . . . 10.0 108.312 169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.54 -30.35 19.64 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.886 1.231 . . . . 10.0 114.2 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.21 -31.24 72.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.145 0.973 . . . . 10.0 111.462 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.3 105.19 1.37 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -31.8 -42.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.054 2.142 . . . . 10.0 113.836 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.83 -20.43 47.97 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.426 1.012 . . . . 10.0 114.808 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.32 107.93 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 119.542 -2.152 . . . . 10.0 106.833 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -77.05 -29.4 55.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.185 -0.916 . . . . 10.0 109.378 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.08 13.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.182 -1.784 . . . . 10.0 106.182 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.84 119.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -136.31 97.87 3.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.282 1.033 . . . . 10.0 108.951 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.47 114.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.513 -0.921 . . . . 10.0 108.513 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -127.05 47.61 2.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.322 0.51 . . . . 10.0 111.963 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -49.53 -48.57 48.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 10.0 112.291 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -35.41 74.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.588 0.755 . . . . 10.0 110.99 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.08 -30.64 31.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.894 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.21 -69.72 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 123.98 0.8 . . . . 10.0 111.218 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -170.44 174.31 5.23 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.941 1.696 . . . . 10.0 112.627 -169.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.2 t -88.77 103.57 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 124.787 1.235 . . . . 10.0 107.971 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.2 116.36 30.26 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 57.0 t -136.3 135.13 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 -171.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.4 t -94.71 73.58 3.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.307 -1.368 . . . . 10.0 107.307 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.487 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 43.1 m-85 -68.67 136.41 52.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.519 -1.218 . . . . 10.0 109.281 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.71 87.03 7.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.545 0.688 . . . . 10.0 110.15 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.13 -20.1 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.08 -1.418 . . . . 10.0 113.623 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.67 -18.84 32.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 119.12 0.873 . . . . 10.0 110.215 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -117.45 -44.93 2.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.364 0.666 . . . . 10.0 109.745 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.53 -172.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.044 0.938 . . . . 10.0 109.425 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -142.62 159.18 42.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.737 0.779 . . . . 10.0 109.403 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 70' ' ' ILE . 34.6 m -44.83 -36.44 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 128.274 2.63 . . . . 10.0 110.294 170.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -41.92 -50.3 4.51 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.434 1.016 . . . . 10.0 110.736 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.24 -49.84 74.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.587 1.185 . . . . 10.0 111.46 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -71.52 -58.46 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.256 1.822 . . . . 10.0 111.674 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.99 -59.21 1.51 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.348 2.259 . . . . 10.0 109.57 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -49.25 -51.99 30.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.442 1.497 . . . . 10.0 109.888 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.56 80.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.5 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -68.77 -58.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -37.42 -47.51 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.224 1.01 . . . . 10.0 113.007 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -42.92 -60.08 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.019 0.927 . . . . 10.0 113.407 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -136.63 -30.45 0.9 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.086 1.143 . . . . 10.0 114.086 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.8 94.43 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.51 172.18 0.19 Allowed 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.826 1.65 . . . . 10.0 110.112 -174.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' A' ' 8' ' ' VAL 0.336 7.5 t70 81.55 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.904 1.281 . . . . 10.0 112.431 177.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG23 HG21 ' A' ' 60' ' ' ILE . 3.4 t -120.38 93.95 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.223 1.409 . . . . 10.0 109.623 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.0 4.1 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.03 159.62 1.35 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.84 1.256 . . . . 10.0 107.791 -175.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 108.28 -1.008 . . . . 10.0 108.28 166.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -122.99 121.16 35.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.629 -2.73 . . . . 10.0 103.629 167.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -117.82 178.25 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.52 121.71 12.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 -177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.02 90.34 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 103.631 -2.729 . . . . 10.0 103.631 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.46 141.77 58.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -67.71 126.54 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.849 1.659 . . . . 10.0 112.45 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -75.03 -55.26 5.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.992 2.117 . . . . 10.0 109.319 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.02 -35.75 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.13 -1.034 . . . . 10.0 113.313 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.86 158.87 26.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.929 0.865 . . . . 10.0 109.24 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.71 20.93 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.918 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.2 113.14 25.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.64 -1.615 . . . . 10.0 106.64 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.02 -16.8 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.744 -0.383 . . . . 10.0 111.511 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -83.92 -44.17 14.52 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.709 0.686 . . . . 10.0 110.332 -169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -43.91 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.978 1.711 . . . . 10.0 109.195 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 35' ' ' VAL . 6.2 m -43.55 -47.85 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 112.689 0.626 . . . . 10.0 112.689 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 9.7 tptt -44.25 -41.97 6.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.123 1.157 . . . . 10.0 114.123 174.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.86 -34.91 42.87 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.716 0.406 . . . . 10.0 110.379 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.4 -31.84 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.319 1.447 . . . . 10.0 111.123 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 35.2 tt0 -43.6 -47.49 7.49 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.259 1.423 . . . . 10.0 109.323 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -55.04 -58.69 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.651 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -56.73 -49.66 74.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.947 1.299 . . . . 10.0 110.271 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 56' ' ' ILE . 35.7 t -60.23 -49.96 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.568 0.747 . . . . 10.0 109.981 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.6 -32.14 38.57 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.007 0.813 . . . . 10.0 112.598 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.7 -32.35 73.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.385 1.074 . . . . 10.0 110.498 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 109.37 3.81 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 121.214 -0.929 . . . . 10.0 109.325 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -42.29 -40.42 2.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.755 1.622 . . . . 10.0 112.899 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.07 -18.39 54.6 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.094 1.33 . . . . 10.0 114.898 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.46 113.34 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 169.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -77.28 -32.96 55.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.331 -0.849 . . . . 10.0 110.69 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -171.5 158.97 5.38 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.894 -1.521 . . . . 10.0 106.894 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.58 136.88 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 105.995 -1.854 . . . . 10.0 105.995 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.89 84.15 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.575 1.178 . . . . 10.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 17' ' ' VAL . 48.1 t -64.18 118.77 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.313 1.445 . . . . 10.0 110.302 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 42.6 m-80 -144.69 50.12 1.28 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.942 0.497 . . . . 10.0 111.43 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mp -48.2 -58.03 5.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.37 1.068 . . . . 10.0 112.359 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.77 -43.21 94.0 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.94 0.876 . . . . 10.0 110.553 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.34 -29.34 68.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.733 -1.122 . . . . 10.0 111.019 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.27 -72.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.462 1.03 . . . . 10.0 111.098 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.37 -178.05 3.87 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.324 1.45 . . . . 10.0 110.25 -173.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -87.6 106.8 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -82.33 140.6 33.46 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.329 -1.359 . . . . 10.0 107.329 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -160.27 140.78 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 118.669 0.668 . . . . 10.0 109.45 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -116.91 82.91 1.88 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 -169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.676 ' CD2' HG12 ' A' ' 53' ' ' VAL . 44.0 m-85 -70.06 172.89 7.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.467 -0.788 . . . . 10.0 108.967 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -127.95 101.51 6.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 10.0 108.942 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -18.45 24.88 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.174 0.59 . . . . 10.0 111.881 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.03 -11.89 59.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.697 0.68 . . . . 10.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -121.29 -56.25 1.91 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.487 1.115 . . . . 10.0 109.246 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.1 159.49 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.454 1.102 . . . . 10.0 111.237 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 p -107.49 148.48 29.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.287 0.565 . . . . 10.0 109.991 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 46' ' ' PHE . 21.4 m -37.62 -45.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 C-N-CA 129.063 2.945 . . . . 10.0 110.677 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -35.67 -49.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.773 0.829 . . . . 10.0 112.016 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -54.25 -63.93 0.99 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.885 0.874 . . . . 10.0 110.429 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.491 HG21 ' HE1' ' A' ' 46' ' ' PHE . 4.5 mp -65.89 -50.73 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.184 0.994 . . . . 10.0 112.776 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.95 -62.84 0.58 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.924 2.09 . . . . 10.0 109.192 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.07 -45.06 79.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.605 0.717 . . . . 10.0 110.268 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.73 69.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.487 0.715 . . . . 10.0 110.872 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.639 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.69 -34.87 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 120.969 -1.082 . . . . 10.0 110.117 178.383 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -57.62 -33.56 68.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.871 1.214 . . . . 10.0 111.738 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -56.9 -68.4 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.19 0.904 . . . . 10.0 111.862 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -135.49 33.6 3.01 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.84 -57.81 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.22 -0.767 . . . . 10.0 112.216 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.49 107.17 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.733 2.013 . . . . 10.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t70 171.49 -35.52 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 124.813 1.245 . . . . 10.0 110.171 -168.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.639 HG23 ' CG2' ' A' ' 60' ' ' ILE . 65.1 t -69.9 85.81 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.546 -0.721 . . . . 10.0 111.063 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.84 -49.78 55.51 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -167.14 148.51 5.8 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.585 -1.635 . . . . 10.0 106.585 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.8 pp . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -144.71 108.73 4.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -115.22 164.49 14.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.752 1.263 . . . . 10.0 108.809 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -122.23 114.59 21.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 127.004 2.122 . . . . 10.0 106.709 -167.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' ILE . 88.5 mt -89.79 85.79 6.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -59.96 149.75 30.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.04 0.936 . . . . 10.0 109.836 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.84 129.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.636 1.574 . . . . 10.0 111.86 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.59 -64.33 0.9 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 130.024 3.33 . . . . 10.0 108.799 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.08 -31.39 0.19 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.248 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 169.03 5.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.621 1.211 . . . . 10.0 110.048 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.7 t -158.86 39.32 0.22 Allowed 'General case' 0 C--N 1.334 -0.074 0 O-C-N 121.568 -0.708 . . . . 10.0 109.228 -169.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.09 97.55 6.14 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.87 -14.37 2.38 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.526 0.936 . . . . 10.0 113.526 174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -86.54 -47.97 8.77 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.509 1.05 . . . . 10.0 109.38 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.4 m -45.96 -65.45 0.55 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.676 1.19 . . . . 10.0 110.198 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 m -48.71 -48.18 15.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.23 0.468 . . . . 10.0 110.894 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.3 tttm -54.71 -34.62 62.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.23 57.62 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.78 -33.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.509 1.124 . . . . 10.0 111.085 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.1 tt0 -41.15 -55.9 2.5 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 10.0 109.727 176.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.93 96.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.627 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m -56.88 -58.54 7.7 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.202 0.601 . . . . 10.0 109.989 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -49.99 -32.92 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.107 1.363 . . . . 10.0 112.446 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -22.8 4.05 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 114.637 0.615 . . . . 10.0 114.637 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.66 -32.28 73.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.422 1.489 . . . . 10.0 111.429 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.7 104.04 0.62 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.06 -37.07 14.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.965 1.306 . . . . 10.0 111.832 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.42 70.46 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.443 1.02 . . . . 10.0 113.977 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.75 106.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 120.192 -1.769 . . . . 10.0 107.501 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 m -73.37 -40.12 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.8 -1.091 . . . . 10.0 110.196 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.79 156.79 23.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.376 -1.342 . . . . 10.0 107.376 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.89 127.7 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.36 98.98 5.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 107.216 -1.402 . . . . 10.0 107.216 170.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.73 112.59 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.96 1.304 . . . . 10.0 108.441 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.99 48.3 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.632 0.604 . . . . 10.0 112.632 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.4 -46.54 62.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.618 -0.676 . . . . 10.0 112.304 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.1 -31.71 71.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.137 0.975 . . . . 10.0 111.017 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.01 18.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.861 0.362 . . . . 10.0 111.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.3 -78.49 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -1.379 . . . . 10.0 109.652 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 178.56 5.4 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.365 1.866 . . . . 10.0 109.256 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.19 105.44 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -102.0 125.88 48.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 10.0 108.119 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 74.4 t -136.54 142.35 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.979 0.895 . . . . 10.0 108.746 -168.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -101.69 77.5 1.74 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 105.849 -1.908 . . . . 10.0 105.849 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG12 ' A' ' 53' ' ' VAL . 28.1 m-85 -72.44 138.04 46.84 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.048 -1.887 . . . . 10.0 107.509 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -90.49 95.78 10.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.035 -0.357 . . . . 10.0 110.035 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -19.94 14.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.881 0.872 . . . . 10.0 112.818 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.75 -15.86 59.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 119.23 0.923 . . . . 10.0 109.878 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -119.99 -54.39 2.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.752 0.821 . . . . 10.0 110.346 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.0 161.72 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.417 0.687 . . . . 10.0 110.782 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.9 t -110.3 156.38 20.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.485 1.136 . . . . 10.0 110.444 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 70' ' ' ILE . 36.0 m -45.14 -39.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.098 2.559 . . . . 10.0 109.304 166.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -43.39 -39.27 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.445 1.02 . . . . 10.0 111.844 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.4 -58.9 3.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.425 0.557 . . . . 10.0 111.034 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.18 -50.09 71.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 120.84 -1.163 . . . . 10.0 112.163 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.97 -54.85 4.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.161 1.785 . . . . 10.0 109.352 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.37 -49.15 77.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.815 0.817 . . . . 10.0 109.879 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.69 67.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.63 0.772 . . . . 10.0 111.356 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -72.11 -42.94 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 O-C-N 120.962 -1.087 . . . . 10.0 110.878 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.287 0.1 OUTLIER -66.5 -26.7 67.29 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.723 1.601 . . . . 10.0 112.13 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -45.63 -66.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.059 0.944 . . . . 10.0 112.859 171.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.76 15.09 2.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.099 0.777 . . . . 10.0 113.099 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.2 -56.16 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.528 1.061 . . . . 10.0 111.461 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.31 113.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 10.0 112.292 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 163.13 -39.25 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 126.647 1.979 . . . . 10.0 108.487 -169.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 HG21 ' A' ' 60' ' ' ILE . 40.3 t -65.22 93.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 121.649 -0.657 . . . . 10.0 111.312 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.25 -56.97 5.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -170.61 162.86 8.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.728 -1.582 . . . . 10.0 106.728 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.894 0 C-N-CA 125.628 1.571 . . . . 10.0 110.474 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 121.949 0.881 . . . . 10.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.76 82.27 7.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.038 0.935 . . . . 10.0 110.473 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -75.96 150.31 37.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.4 132.11 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 103.809 -2.663 . . . . 10.0 103.809 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -108.4 92.89 4.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.007 -2.22 . . . . 10.0 105.007 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -61.71 146.65 48.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.708 -1.587 . . . . 10.0 108.534 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.72 134.4 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.961 1.304 . . . . 10.0 113.42 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -78.09 -68.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.686 1.995 . . . . 10.0 109.063 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.0 -38.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.018 -0.61 . . . . 10.0 113.252 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.04 160.43 6.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 117.961 0.88 . . . . 10.0 111.858 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 m -149.22 48.65 0.97 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -126.4 91.43 3.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.332 1.053 . . . . 10.0 108.402 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.5 -5.33 0.52 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.03 -37.69 14.96 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 120.87 -1.144 . . . . 10.0 110.291 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -58.72 -71.94 0.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 171.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -43.6 -52.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -56.84 -31.18 64.5 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.967 0.728 . . . . 10.0 112.967 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.36 68.19 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG11 ' C ' ' A' ' 59' ' ' ALA . 59.1 t -88.05 -40.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 123.939 0.895 . . . . 10.0 109.749 176.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -41.62 -48.5 4.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.889 0.876 . . . . 10.0 110.533 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -53.16 61.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.959 0.409 . . . . 10.0 111.123 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -62.52 -16.86 58.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.106 1.762 . . . . 10.0 113.043 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -89.22 -42.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.477 1.111 . . . . 10.0 109.91 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.96 -26.18 47.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.748 1.166 . . . . 10.0 112.878 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -69.31 -28.26 66.11 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.948 0.874 . . . . 10.0 111.719 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.9 110.46 2.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.948 -0.701 . . . . 10.0 110.036 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -35.64 -44.16 0.31 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.404 2.282 . . . . 10.0 111.403 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 8.64 5.89 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.185 1.234 . . . . 10.0 116.185 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.21 111.49 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -74.45 -31.18 62.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.59 161.31 9.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.24 145.51 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.298 1.039 . . . . 10.0 109.757 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.35 82.89 0.84 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.988 0.899 . . . . 10.0 109.304 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.31 140.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.784 0.834 . . . . 10.0 109.597 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -161.17 44.44 0.17 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-O 121.172 0.51 . . . . 10.0 111.787 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.83 -46.64 64.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.507 0.723 . . . . 10.0 112.819 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -70.39 -24.78 63.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.965 1.306 . . . . 10.0 110.783 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.37 -27.27 19.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.136 0.574 . . . . 10.0 111.182 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.64 -69.7 0.09 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.524 1.059 . . . . 10.0 111.036 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.76 173.9 8.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.292 1.837 . . . . 10.0 108.701 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.598 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -83.9 138.6 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 169.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -122.52 110.46 15.61 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.103 1.761 . . . . 10.0 107.435 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.598 HG23 ' CG2' ' A' ' 42' ' ' VAL . 34.7 t -124.09 146.55 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.004 1.322 . . . . 10.0 107.576 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 t -103.28 78.59 1.63 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.308 -1.738 . . . . 10.0 106.308 -170.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 6' ' ' LEU . 69.1 m-85 -83.78 138.1 33.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.936 -1.029 . . . . 10.0 109.905 -172.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -88.08 84.36 6.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.167 -0.924 . . . . 10.0 108.707 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.44 -21.19 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.138 1.375 . . . . 10.0 113.056 168.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -25.8 59.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.914 2.086 . . . . 10.0 109.976 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -117.7 -49.64 2.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.253 1.021 . . . . 10.0 109.261 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.98 -175.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.303 1.041 . . . . 10.0 109.612 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.9 p -133.81 158.82 42.41 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.72 -0.844 . . . . 10.0 108.72 170.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -44.02 -34.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.35 1.86 . . . . 10.0 111.133 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -47.39 -30.34 3.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.592 0.633 . . . . 10.0 112.129 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.4 -65.5 0.69 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 118.574 0.625 . . . . 10.0 109.623 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.2 mp -65.58 -53.93 33.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.909 1.283 . . . . 10.0 112.909 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -44.0 -56.3 4.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.187 1.395 . . . . 10.0 109.764 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.6 -45.2 85.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.815 0.446 . . . . 10.0 110.271 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -51.37 -48.6 62.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.882 0.473 . . . . 10.0 110.601 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.544 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.56 -38.7 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.086 -1.009 . . . . 10.0 110.49 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.26 -34.84 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.32 -1.488 . . . . 10.0 111.564 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.02 -66.86 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.448 0.567 . . . . 10.0 112.262 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -134.69 40.86 2.93 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.212 0.605 . . . . 10.0 112.593 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.67 -59.04 0.08 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.825 -0.986 . . . . 10.0 111.305 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 64.92 108.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.215 2.206 . . . . 10.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.0 -37.6 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.888 0.875 . . . . 10.0 109.869 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.544 HG23 HG21 ' A' ' 60' ' ' ILE . 54.4 t -74.19 89.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.248 -0.908 . . . . 10.0 110.914 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.82 -52.3 31.46 Favored 'General case' 0 C--O 1.227 -0.103 0 O-C-N 121.508 -0.745 . . . . 10.0 109.016 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -170.13 153.12 4.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.028 0 C-N-CA 124.175 0.99 . . . . 10.0 110.686 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.03 126.09 24.45 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.229 1.411 . . . . 10.0 107.319 168.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.72 159.84 19.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.142 0.977 . . . . 10.0 109.879 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.16 122.25 46.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.588 HD23 HG22 ' A' ' 70' ' ' ILE . 45.2 mt -91.89 80.7 5.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.682 -1.97 . . . . 10.0 105.682 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -57.15 149.04 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 110.212 -0.292 . . . . 10.0 110.212 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.68 131.1 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.389 1.075 . . . . 10.0 113.212 -169.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.0 -58.65 3.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.245 2.618 . . . . 10.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.43 -34.33 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.134 -0.485 . . . . 10.0 112.551 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.93 165.79 10.26 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.781 0.791 . . . . 10.0 111.27 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 p -135.54 -34.81 0.83 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.368 1.067 . . . . 10.0 112.405 -168.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 t -48.37 88.49 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.14 1.776 . . . . 10.0 112.813 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.85 -7.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.498 -0.751 . . . . 10.0 112.904 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -86.61 -36.02 19.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.077 0.951 . . . . 10.0 110.031 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.7 m -59.6 -66.67 0.48 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -47.24 -50.88 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 112.213 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.261 0.7 OUTLIER -58.8 -32.25 69.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.403 -0.519 . . . . 10.0 112.297 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.37 -49.01 68.08 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.421 -0.799 . . . . 10.0 109.464 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.43 -44.25 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.814 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -39.8 -48.48 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.202 1.401 . . . . 10.0 110.844 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.3 p -50.51 -50.03 54.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.17 0.441 . . . . 10.0 111.574 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 m -71.26 -51.34 25.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.964 0.906 . . . . 10.0 110.552 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -53.78 -41.8 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.946 0.403 . . . . 10.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.96 -5.35 5.42 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.017 -1.435 . . . . 10.0 114.812 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -98.9 -18.58 17.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.672 1.736 . . . . 10.0 112.909 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 123.41 18.08 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 120.717 1.599 . . . . 10.0 109.941 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -41.26 -43.34 2.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.325 1.85 . . . . 10.0 112.58 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.85 -8.97 86.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.896 0.76 . . . . 10.0 114.897 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 102.56 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.728 -2.323 . . . . 10.0 104.728 169.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -70.54 -33.47 71.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.961 -1.018 . . . . 10.0 109.273 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.92 157.85 14.29 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.91 135.98 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.793 1.237 . . . . 10.0 108.794 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 91.75 2.5 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.276 1.03 . . . . 10.0 108.379 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -82.86 115.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.345 1.058 . . . . 10.0 109.48 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -143.96 49.55 1.37 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.35 -45.27 62.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.039 0.755 . . . . 10.0 113.039 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.11 -30.01 67.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.221 1.008 . . . . 10.0 111.646 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.77 -34.89 18.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.759 0.314 . . . . 10.0 110.782 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.97 -69.89 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.34 -177.41 3.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.818 1.247 . . . . 10.0 110.975 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -92.46 110.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.523 -1.658 . . . . 10.0 106.523 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.57 126.3 51.53 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 76.8 t -138.54 143.43 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 t -100.12 78.01 2.04 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 53.5 m-85 -82.94 137.27 34.26 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.498 -1.228 . . . . 10.0 110.79 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.61 89.2 7.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.137 1.375 . . . . 10.0 109.728 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.93 -15.92 1.6 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.77 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -30.76 71.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.219 2.207 . . . . 10.0 108.96 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -120.7 -54.07 2.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.138 0.975 . . . . 10.0 109.615 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.77 160.52 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 123.75 0.82 . . . . 10.0 110.356 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 m -110.38 152.92 25.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.137 -1.06 . . . . 10.0 108.137 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 70' ' ' ILE . 21.9 m -37.76 -39.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 127.902 2.481 . . . . 10.0 110.796 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -43.07 -31.32 0.53 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 10.0 113.599 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.01 -64.18 0.91 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.694 0.759 . . . . 10.0 110.605 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -62.75 -54.66 30.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 C-N-CA 125.792 1.637 . . . . 10.0 112.628 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.46 -65.1 0.33 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.798 2.039 . . . . 10.0 109.026 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -51.65 -47.64 63.68 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 10.0 110.868 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -46.57 70.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.203 0.601 . . . . 10.0 111.813 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.13 -39.53 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.792 -1.192 . . . . 10.0 110.015 177.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.55 -30.88 65.57 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.868 -1.145 . . . . 10.0 111.154 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -59.45 -69.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.674 0.67 . . . . 10.0 112.17 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -133.03 33.11 3.69 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.845 0.858 . . . . 10.0 112.362 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.12 -61.07 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.798 0.713 . . . . 10.0 111.884 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 67.63 113.06 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.065 2.146 . . . . 10.0 112.297 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 166.64 -39.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 126.053 1.741 . . . . 10.0 109.267 -169.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 HG21 ' A' ' 60' ' ' ILE . 88.0 t -72.2 91.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.577 -0.702 . . . . 10.0 110.844 -171.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.28 -53.78 18.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 121.692 -0.63 . . . . 10.0 109.586 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 147.96 5.81 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.641 -1.615 . . . . 10.0 106.641 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.588 HG22 HD23 ' A' ' 6' ' ' LEU . 1.3 pp . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 107.903 -1.147 . . . . 10.0 107.903 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -146.83 69.7 1.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.769 2.028 . . . . 10.0 109.02 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -77.64 158.05 29.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.681 0.753 . . . . 10.0 109.66 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.44 125.61 51.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 -175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' CD2' HG22 ' A' ' 70' ' ' ILE . 74.3 mt -95.13 88.41 5.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 169.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -61.41 148.33 42.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.41 0.684 . . . . 10.0 109.48 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.23 132.38 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.765 1.024 . . . . 10.0 113.765 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -71.73 -54.73 9.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.679 2.792 . . . . 10.0 108.596 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.36 -23.68 0.13 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.308 -0.86 . . . . 10.0 113.738 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 169.74 4.23 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.589 1.195 . . . . 10.0 111.987 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 28.83 0.73 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.37 93.39 4.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.087 -1.079 . . . . 10.0 108.087 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -58.75 -13.06 5.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -80.02 -45.59 18.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.6 m -52.07 -63.4 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.814 0.846 . . . . 10.0 109.609 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.69 -50.25 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.903 -0.57 . . . . 10.0 111.109 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -61.86 -32.97 73.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.44 1.018 . . . . 10.0 112.936 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.56 -40.83 69.13 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.585 -0.697 . . . . 10.0 109.484 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.13 -42.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 118.166 -0.921 . . . . 10.0 111.385 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -35.92 -57.9 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.145 1.778 . . . . 10.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -42.78 76.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 10.0 111.281 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -64.93 -50.64 65.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.234 1.014 . . . . 10.0 109.676 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 56' ' ' ILE . 12.9 t -54.18 -39.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.461 0.704 . . . . 10.0 110.41 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.5 -27.87 9.13 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.755 1.169 . . . . 10.0 113.766 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -71.54 -25.96 62.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.984 1.392 . . . . 10.0 111.533 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 104.48 1.28 Allowed 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.356 -0.84 . . . . 10.0 109.315 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -46.08 -37.24 6.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.271 1.828 . . . . 10.0 112.729 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -8.99 55.54 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.844 -0.535 . . . . 10.0 114.166 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.84 109.85 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.97 1.885 . . . . 10.0 106.303 168.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -73.71 -30.07 62.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.731 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -172.25 168.35 5.66 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.89 135.26 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.863 1.265 . . . . 10.0 108.756 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 90.02 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.198 0.999 . . . . 10.0 109.602 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.56 106.77 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.527 1.131 . . . . 10.0 109.455 -176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.2 m120 -134.76 49.55 2.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.202 0.601 . . . . 10.0 112.241 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.6 -47.18 70.42 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.383 0.512 . . . . 10.0 112.383 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -63.91 -36.41 83.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.845 0.858 . . . . 10.0 111.074 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -84.74 -34.22 22.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.859 -172.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.62 -69.41 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 10.0 110.572 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.29 178.67 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.167 2.187 . . . . 10.0 110.822 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.55 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.45 121.19 39.07 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 53.7 t -132.27 144.4 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 t -101.73 69.49 1.21 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 33.3 m-85 -69.01 137.87 54.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.973 -1.467 . . . . 10.0 108.733 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -94.24 87.12 5.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.047 168.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 -16.58 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.349 1.06 . . . . 10.0 113.376 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.82 -12.72 59.39 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.293 0.951 . . . . 10.0 110.033 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -131.12 -54.42 1.04 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.473 1.109 . . . . 10.0 110.391 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.62 135.74 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.817 1.247 . . . . 10.0 109.435 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 150.72 20.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -36.38 -41.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 128.72 2.808 . . . . 10.0 111.242 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -34.39 -49.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.302 0.955 . . . . 10.0 111.768 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.63 -67.22 0.3 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.42 1.105 . . . . 10.0 110.716 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 24' ' ' VAL . 4.0 mm -60.68 -57.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.374 . . . . 10.0 112.496 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.15 -59.34 0.87 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.656 2.382 . . . . 10.0 109.971 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.48 -51.11 68.07 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.87 0.468 . . . . 10.0 110.56 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.08 73.31 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.653 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.561 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.76 -41.09 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.182 -0.949 . . . . 10.0 110.094 175.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.51 -36.75 69.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.974 1.261 . . . . 10.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.37 -59.57 4.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.085 0.554 . . . . 10.0 112.457 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -139.08 -18.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.382 1.252 . . . . 10.0 114.382 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.97 -47.13 40.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.847 0.749 . . . . 10.0 111.29 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 56.61 110.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.109 2.164 . . . . 10.0 112.525 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 167.24 -39.84 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.239 1.415 . . . . 10.0 109.285 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 60' ' ' ILE . 62.9 t -69.84 92.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 O-C-N 121.496 -0.753 . . . . 10.0 111.209 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.86 4.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.711 0.767 . . . . 10.0 109.084 169.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.88 146.54 7.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.18 -1.415 . . . . 10.0 107.18 -171.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 pp . . . . . 0 N--CA 1.438 -1.03 0 C-N-CA 124.782 1.233 . . . . 10.0 107.778 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 121.963 0.887 . . . . 10.0 108.826 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -140.98 112.91 7.74 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.788 2.435 . . . . 10.0 105.389 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 172.92 7.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.951 -1.87 . . . . 10.0 105.951 169.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.49 126.35 38.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.313 -2.476 . . . . 10.0 104.313 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -95.95 95.62 8.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -68.91 148.1 50.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.832 -0.803 . . . . 10.0 108.832 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.04 130.45 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 125.268 1.427 . . . . 10.0 112.958 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -71.64 -61.23 1.85 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.033 2.933 . . . . 10.0 108.196 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.0 -39.21 0.13 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.172 -0.771 . . . . 10.0 111.172 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.64 157.98 13.46 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.588 0.694 . . . . 10.0 110.518 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.9 51.84 0.39 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 -172.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.97 94.01 4.1 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.824 1.25 . . . . 10.0 107.785 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -59.99 0.57 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.19 1.182 . . . . 10.0 114.19 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -43.15 10.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.504 1.047 . . . . 10.0 109.464 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 m -57.96 -67.69 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.609 0.764 . . . . 10.0 109.13 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -43.11 -46.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 C-N-CA 123.331 0.652 . . . . 10.0 112.086 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 14.5 tttt -54.87 -33.07 61.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.776 1.028 . . . . 10.0 113.776 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.31 -29.15 57.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.473 0.309 . . . . 10.0 110.737 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.66 -33.57 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.564 1.546 . . . . 10.0 110.989 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 12.6 tt0 -41.19 -49.47 3.56 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.706 1.203 . . . . 10.0 110.289 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.5 p -46.15 -68.65 0.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.517 1.527 . . . . 10.0 111.231 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -57.19 -39.37 75.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.873 1.269 . . . . 10.0 111.85 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.02 -42.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.875 -0.417 . . . . 10.0 109.875 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.83 48.38 1.97 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.274 1.416 . . . . 10.0 112.136 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.27 -42.86 0.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 127.86 2.464 . . . . 10.0 109.1 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -50.64 127.28 17.65 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.411 1.459 . . . . 10.0 110.794 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -46.46 -42.86 16.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.357 1.463 . . . . 10.0 111.966 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 -13.27 83.11 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.404 0.522 . . . . 10.0 114.404 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.55 109.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 119.708 -2.054 . . . . 10.0 106.094 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.04 -32.54 50.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.448 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.58 151.05 9.11 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.551 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.5 m -123.1 146.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.5 100.92 1.05 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 -173.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -107.88 109.92 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -135.33 46.61 2.38 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 111.762 0.282 . . . . 10.0 111.762 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -52.5 -48.68 65.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.835 0.854 . . . . 10.0 111.746 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -67.47 -26.83 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.991 0.916 . . . . 10.0 110.488 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 -30.89 16.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.572 0.349 . . . . 10.0 111.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -67.38 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.06 0.838 . . . . 10.0 112.074 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -171.11 176.11 4.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.862 1.665 . . . . 10.0 111.674 -169.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -93.52 129.51 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.296 0.638 . . . . 10.0 109.732 171.117 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -120.27 74.12 1.03 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.31 2.244 . . . . 10.0 108.852 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 42' ' ' VAL . 24.1 t -94.05 149.97 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.205 1.402 . . . . 10.0 109.195 -176.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -107.04 76.23 1.08 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -73.26 139.26 46.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.283 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.49 95.7 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.597 0.759 . . . . 10.0 109.78 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.87 -21.9 12.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.499 0.719 . . . . 10.0 112.784 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -87.62 -8.24 56.46 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.907 0.776 . . . . 10.0 110.68 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -119.72 -54.82 2.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.14 -170.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.433 1.493 . . . . 10.0 108.878 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.2 t -147.35 158.19 43.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.765 -0.828 . . . . 10.0 108.765 168.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -38.71 -46.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 C-N-CA 128.37 2.668 . . . . 10.0 109.598 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -44.15 2.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.54 1.064 . . . . 10.0 112.284 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.32 -61.54 2.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.566 0.698 . . . . 10.0 110.844 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -61.43 -53.6 46.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 124.542 1.137 . . . . 10.0 111.514 -176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.69 -62.52 0.53 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.923 2.089 . . . . 10.0 109.41 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.47 -43.87 75.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.366 0.603 . . . . 10.0 110.741 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.43 75.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.694 0.798 . . . . 10.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.431 HG22 HG23 ' A' ' 67' ' ' VAL . 1.6 mp -70.51 -36.21 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 120.76 -1.212 . . . . 10.0 109.23 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.82 -42.19 75.32 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.609 -1.307 . . . . 10.0 111.273 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -52.25 -62.92 1.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.885 0.874 . . . . 10.0 112.546 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -144.22 66.89 1.27 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.088 0.555 . . . . 10.0 110.666 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.97 -59.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.012 -0.882 . . . . 10.0 111.467 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 68.84 113.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.253 2.221 . . . . 10.0 111.35 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 166.43 -32.45 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.284 1.434 . . . . 10.0 109.737 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' ILE . 6.7 t -71.94 85.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 121.0 -1.063 . . . . 10.0 112.257 -168.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.1 -52.68 25.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.315 -0.866 . . . . 10.0 109.596 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -166.5 142.39 4.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.905 -1.517 . . . . 10.0 106.905 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.125 0 C-N-CA 125.483 1.513 . . . . 10.0 107.671 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.68 86.14 1.38 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.304 -0.999 . . . . 10.0 108.304 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -103.32 163.8 12.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.956 0.884 . . . . 10.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.68 109.62 16.86 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.613 -2.366 . . . . 10.0 104.613 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' CD1' HG22 ' A' ' 70' ' ' ILE . 3.6 mp -83.07 87.72 6.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 171.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -54.73 152.17 7.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.115 0.966 . . . . 10.0 110.01 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.56 131.78 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 124.265 1.026 . . . . 10.0 110.65 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -69.61 -54.23 15.0 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 124.015 0.822 . . . . 10.0 109.312 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.37 -9.34 2.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.749 -0.473 . . . . 10.0 113.357 -170.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.562 ' SD ' HD13 ' A' ' 37' ' ' LEU . 3.5 ppp? -58.29 176.31 0.18 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.969 0.884 . . . . 10.0 111.478 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t -152.44 31.76 0.52 Allowed 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.601 -0.687 . . . . 10.0 110.36 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.5 t -118.86 89.56 3.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.14 0.495 . . . . 10.0 110.8 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -53.71 -11.98 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.353 1.242 . . . . 10.0 114.353 170.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -91.69 -25.86 18.91 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.07 0.85 . . . . 10.0 111.395 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.28 -67.16 0.44 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -42.56 -55.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.519 0.728 . . . . 10.0 111.906 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -21.44 65.04 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.948 0.722 . . . . 10.0 112.948 -175.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.91 99.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.404 1.002 . . . . 10.0 109.232 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -82.51 -37.55 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.02 0.528 . . . . 10.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -41.34 -47.04 3.44 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.545 1.138 . . . . 10.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -51.3 64.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.078 0.466 . . . . 10.0 110.871 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -63.16 -47.63 81.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.447 1.099 . . . . 10.0 110.72 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 t -56.0 -40.93 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 10.0 110.013 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.11 -27.95 16.5 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.776 1.179 . . . . 10.0 113.767 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.15 -29.8 69.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.134 1.467 . . . . 10.0 110.744 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.61 80.67 1.09 Allowed 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.616 -0.678 . . . . 10.0 110.927 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -5.74 -57.52 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.948 3.299 . . . . 10.0 115.651 168.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.32 -56.65 1.48 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.868 1.223 . . . . 10.0 113.913 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.54 111.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.48 1.512 . . . . 10.0 109.853 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.31 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.88 -1.055 . . . . 10.0 109.982 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.95 12.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 33' ' ' VAL . 10.6 m -136.27 94.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.912 1.285 . . . . 10.0 109.463 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -107.54 91.07 3.5 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.31 109.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 172.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -128.32 47.86 2.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.457 0.539 . . . . 10.0 112.457 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD13 ' SD ' ' A' ' 11' ' ' MET . 1.6 pt? -51.33 -46.76 62.72 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.525 0.602 . . . . 10.0 112.113 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -70.12 -34.83 73.57 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.579 0.752 . . . . 10.0 110.955 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.09 -32.53 30.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.593 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.35 -73.02 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.26 -172.12 1.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.965 1.306 . . . . 10.0 112.598 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.06 100.73 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 108.466 -0.939 . . . . 10.0 108.466 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -98.0 108.99 21.83 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 42.7 t -128.14 131.5 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 -169.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 m -83.56 69.74 10.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' A' ' 6' ' ' LEU . 57.6 m-85 -64.73 141.41 58.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.321 0.648 . . . . 10.0 109.771 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -86.68 86.95 7.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.08 -18.26 0.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.844 1.054 . . . . 10.0 113.844 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.49 -18.65 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.599 1.091 . . . . 10.0 110.401 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.17 -55.78 2.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.07 129.88 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 124.402 1.081 . . . . 10.0 110.531 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.2 m -88.82 152.7 21.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.629 -0.669 . . . . 10.0 110.198 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.4 m -41.1 -38.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 128.269 2.628 . . . . 10.0 110.659 167.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -49.84 -37.42 30.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.429 -0.794 . . . . 10.0 112.342 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.44 -58.36 4.08 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.263 1.03 . . . . 10.0 109.399 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -56.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -168.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.21 -52.32 4.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.377 1.471 . . . . 10.0 109.861 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.97 -49.09 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.437 0.695 . . . . 10.0 110.54 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.7 68.15 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.765 0.826 . . . . 10.0 111.172 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -58.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 108.76 -0.83 . . . . 10.0 108.76 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -40.01 -40.63 1.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.512 1.051 . . . . 10.0 113.79 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -40.83 -50.88 3.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.605 0.965 . . . . 10.0 113.605 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -151.32 -41.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.533 1.133 . . . . 10.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-O 118.793 -1.004 . . . . 10.0 111.295 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 58.29 175.29 0.06 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.203 1.801 . . . . 10.0 112.545 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 93.9 28.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.437 2.295 . . . . 10.0 112.771 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.66 91.36 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.866 1.267 . . . . 10.0 109.484 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.61 -55.52 7.6 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 168.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -172.34 162.13 5.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.014 1.325 . . . . 10.0 107.429 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.485 HG22 ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.915 0 C-N-CA 125.09 1.356 . . . . 10.0 110.241 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -141.84 87.63 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.037 -1.098 . . . . 10.0 108.037 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -98.03 162.65 13.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.956 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 122.77 46.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 104.65 -2.352 . . . . 10.0 104.65 -177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.702 ' HB2' HG13 ' A' ' 42' ' ' VAL . 6.0 mp -93.53 95.99 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 103.512 -2.773 . . . . 10.0 103.512 170.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.04 150.65 46.39 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 10.0 108.189 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.95 134.54 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -168.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -69.22 -64.96 0.77 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.04 -34.37 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.348 -0.93 . . . . 10.0 114.881 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.0 172.37 2.37 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.305 1.053 . . . . 10.0 112.022 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -157.41 52.69 0.48 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.6 t -130.98 94.88 3.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.414 1.086 . . . . 10.0 108.143 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.61 -21.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.87 1.668 . . . . 10.0 111.418 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -82.74 -41.7 18.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.044 -0.725 . . . . 10.0 109.044 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.9 m -52.47 -66.27 0.41 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -51.41 -50.93 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 122.006 -0.434 . . . . 10.0 111.563 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU 0.26 0.0 OUTLIER -60.35 -26.42 66.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.995 0.739 . . . . 10.0 112.995 -178.174 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.22 84.08 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.06 -1.025 . . . . 10.0 109.035 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -75.64 -40.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.343 0.657 . . . . 10.0 111.364 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 3.4 tm-20 -34.78 -49.28 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.114 1.766 . . . . 10.0 111.019 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -54.72 -60.11 3.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.631 0.253 . . . . 10.0 111.522 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -55.09 -48.54 73.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.01 0.924 . . . . 10.0 110.502 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 t -56.85 -44.26 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.141 0.576 . . . . 10.0 110.367 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.7 -31.2 57.61 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.185 0.898 . . . . 10.0 113.146 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.28 -29.16 66.99 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.167 0.984 . . . . 10.0 110.773 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 108.31 4.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.077 -1.015 . . . . 10.0 109.624 176.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -37.35 -37.1 0.17 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 10.0 112.61 169.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.69 -2.07 1.59 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.225 1.393 . . . . 10.0 116.036 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.29 120.29 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.539 1.936 . . . . 10.0 106.32 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -29.2 25.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.269 0.628 . . . . 10.0 109.894 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.09 160.51 9.9 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.34 133.82 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.351 1.061 . . . . 10.0 110.58 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -143.21 81.4 1.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.909 1.284 . . . . 10.0 108.855 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.64 135.74 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.319 1.048 . . . . 10.0 108.85 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -163.55 48.07 0.13 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.517 0.675 . . . . 10.0 110.796 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -61.05 -41.97 97.6 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.86 -0.525 . . . . 10.0 111.373 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.98 -39.91 93.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.499 0.72 . . . . 10.0 110.25 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.0 -31.8 27.29 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.507 0.723 . . . . 10.0 110.932 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.61 -59.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.397 -0.668 . . . . 10.0 113.154 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 173.33 4.96 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.859 2.064 . . . . 10.0 109.78 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -91.05 119.88 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 172.248 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.26 120.21 40.32 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 48.1 t -133.01 143.83 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.881 -1.526 . . . . 10.0 106.881 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.0 m -96.59 71.54 2.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 49.3 m-85 -73.39 134.56 44.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.871 0.843 . . . . 10.0 109.108 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.57 77.8 9.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.699 0.762 . . . . 10.0 109.069 172.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.96 -17.68 0.42 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.886 1.675 . . . . 10.0 113.917 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.11 -6.28 59.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.424 1.89 . . . . 10.0 111.072 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -57.52 1.13 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.736 1.614 . . . . 10.0 108.726 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.7 143.96 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 126.222 1.809 . . . . 10.0 107.572 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 m -98.22 147.65 24.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -31.82 -44.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 128.346 2.658 . . . . 10.0 110.96 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -28.36 -53.23 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.967 1.307 . . . . 10.0 111.892 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.04 -69.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.358 1.063 . . . . 10.0 111.473 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.5 mp -60.38 -53.53 47.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 125.207 1.403 . . . . 10.0 111.683 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.35 -58.61 1.49 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.924 2.089 . . . . 10.0 110.398 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.4 -45.26 91.99 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.891 0.377 . . . . 10.0 110.219 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.77 -45.18 67.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 10.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.08 -53.02 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 O-C-N 121.272 -0.892 . . . . 10.0 108.713 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.23 -21.4 47.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.956 1.707 . . . . 10.0 114.288 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.29 -58.67 5.94 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.897 0.771 . . . . 10.0 111.474 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -143.56 -19.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.534 1.679 . . . . 10.0 115.534 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.68 -51.68 24.11 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.686 1.136 . . . . 10.0 112.045 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 66.42 97.61 0.05 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.412 1.885 . . . . 10.0 111.759 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 174.28 31.09 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.362 1.865 . . . . 10.0 112.987 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.486 HG13 ' HG ' ' A' ' 6' ' ' LEU . 5.8 t -141.7 80.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 O-C-N 119.617 -1.927 . . . . 10.0 110.331 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.7 76.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 171.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -167.55 143.8 4.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 6' ' ' LEU . 2.2 pp . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 125.091 1.357 . . . . 10.0 107.415 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 23.8 mt-10 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.473 -0.565 . . . . 10.0 109.473 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -140.2 78.87 1.68 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.804 1.242 . . . . 10.0 107.695 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' NZ ' ' OE1' ' A' ' 2' ' ' GLU . 1.8 mttt -89.73 165.54 14.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.279 -0.873 . . . . 10.0 108.91 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.83 133.3 44.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 102.796 -3.038 . . . . 10.0 102.796 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.751 HD11 ' HZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -104.02 96.6 6.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 104.371 -2.455 . . . . 10.0 104.371 176.482 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -62.23 148.74 43.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.069 -0.968 . . . . 10.0 108.624 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.61 132.34 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 125.07 1.348 . . . . 10.0 112.807 -172.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.89 -64.22 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.046 2.538 . . . . 10.0 109.453 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.0 -40.53 0.04 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.656 -0.578 . . . . 10.0 111.656 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 170.05 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.437 0.903 . . . . 10.0 113.437 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 p -145.99 12.77 1.27 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.742 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.84 86.47 6.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -55.58 -12.18 1.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -83.43 -35.89 24.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.408 -0.807 . . . . 10.0 109.375 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -62.12 -68.21 0.35 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.85 -52.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.689 0.795 . . . . 10.0 113.117 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -29.79 64.53 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.671 -0.643 . . . . 10.0 112.595 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.16 -43.86 64.32 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.61 -41.97 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.218 -0.896 . . . . 10.0 110.838 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.04 -38.51 11.11 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.311 0.96 . . . . 10.0 110.509 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.4 p -51.1 -65.03 0.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.933 0.788 . . . . 10.0 111.533 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -55.8 -51.0 68.97 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.994 1.318 . . . . 10.0 110.079 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.06 -42.76 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.693 0.797 . . . . 10.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.22 -27.71 11.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.561 1.077 . . . . 10.0 113.816 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.25 -19.81 35.69 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.768 1.284 . . . . 10.0 112.279 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.73 118.89 7.73 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.851 1.205 . . . . 10.0 109.985 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -39.9 -44.26 1.64 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.156 1.783 . . . . 10.0 112.515 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.49 -16.23 80.1 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.113 0.387 . . . . 10.0 113.884 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.84 111.59 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 O-C-N 119.454 -2.204 . . . . 10.0 106.628 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -30.74 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.804 . . . . 10.0 109.618 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.74 157.54 24.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.88 145.01 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.976 1.311 . . . . 10.0 108.192 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -161.86 82.86 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -64.77 138.72 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.191 0.596 . . . . 10.0 110.543 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.04 46.41 0.24 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.065 0.46 . . . . 10.0 111.061 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.51 -49.65 67.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.268 0.47 . . . . 10.0 112.268 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.08 -31.13 70.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.036 0.934 . . . . 10.0 110.707 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.76 -29.52 32.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.94 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.23 -62.17 0.12 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.169 0.89 . . . . 10.0 112.119 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.24 171.59 7.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.498 1.919 . . . . 10.0 109.833 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -87.53 132.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 169.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.18 111.04 16.91 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 42' ' ' VAL . 47.5 t -130.0 142.25 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.384 1.074 . . . . 10.0 108.218 -168.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.7 m -102.07 73.57 1.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.751 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 39.9 m-85 -66.85 131.81 46.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.701 -1.591 . . . . 10.0 109.089 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.89 86.1 7.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.526 -0.916 . . . . 10.0 108.526 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.01 -10.96 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.994 1.109 . . . . 10.0 113.994 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -85.89 -13.21 48.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.411 1.005 . . . . 10.0 110.141 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -131.31 -54.36 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 52' ' ' SER . 9.7 p -103.09 -174.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 125.184 1.394 . . . . 10.0 109.239 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.498 ' H ' HG22 ' A' ' 51' ' ' VAL . 63.4 p -148.81 151.91 35.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.182 -0.949 . . . . 10.0 108.523 167.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.75 -40.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.85 2.06 . . . . 10.0 110.132 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.47 -25.89 27.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.879 0.763 . . . . 10.0 112.813 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -70.67 -64.03 0.98 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.15 0.886 . . . . 10.0 109.637 168.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.2 mp -63.65 -51.41 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.097 0.959 . . . . 10.0 112.563 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.24 -56.8 3.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.293 1.837 . . . . 10.0 109.622 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.01 -44.58 91.72 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.578 0.751 . . . . 10.0 110.329 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.48 70.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.212 0.605 . . . . 10.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.72 -35.92 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 121.095 -1.003 . . . . 10.0 109.447 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.32 -41.84 85.46 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.628 -1.295 . . . . 10.0 110.533 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -54.5 -67.7 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.016 0.926 . . . . 10.0 112.14 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -133.41 57.25 1.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.161 0.584 . . . . 10.0 111.704 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.01 -58.85 0.01 OUTLIER Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.213 -0.771 . . . . 10.0 111.369 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 67.46 106.9 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.153 2.181 . . . . 10.0 110.623 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 168.16 -35.17 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.241 1.416 . . . . 10.0 109.595 -168.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.73 93.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.181 -0.949 . . . . 10.0 111.285 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.21 -56.49 4.6 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.456 0.646 . . . . 10.0 109.907 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -164.4 143.13 7.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 10.0 109.057 175.042 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.965 0.888 . . . . 10.0 110.418 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.14 68.25 1.13 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.613 2.365 . . . . 10.0 106.998 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -75.68 160.27 30.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -131.15 132.85 45.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.978 -1.489 . . . . 10.0 106.978 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD12 HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -88.79 108.32 19.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 173.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -75.96 148.28 38.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.683 -0.636 . . . . 10.0 109.306 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.05 130.33 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.584 1.554 . . . . 10.0 113.617 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -74.84 -58.74 3.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.143 2.577 . . . . 10.0 109.475 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.84 -32.24 0.06 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-O 119.185 -0.786 . . . . 10.0 113.464 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.03 169.5 5.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.594 1.197 . . . . 10.0 111.44 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 m -160.66 54.38 0.31 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 t -128.75 93.04 3.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -51.74 2.52 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.05 1.87 . . . . 10.0 116.05 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -50.81 4.3 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.841 1.655 . . . . 10.0 109.784 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.17 -62.14 1.8 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.083 0.953 . . . . 10.0 110.176 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.01 -47.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.764 0.316 . . . . 10.0 110.783 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 15.9 tttt -56.61 -35.54 68.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.307 1.225 . . . . 10.0 114.307 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -38.27 56.74 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 t -84.49 -37.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.142 0.977 . . . . 10.0 110.984 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 21.1 tt0 -38.6 -56.09 1.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.697 1.599 . . . . 10.0 110.62 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -58.0 -48.7 79.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -56.98 -54.5 45.96 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.639 1.175 . . . . 10.0 109.57 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.441 ' CG1' HG21 ' A' ' 30' ' ' VAL . 42.0 t -57.64 -40.85 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 121.926 -0.484 . . . . 10.0 110.288 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.1 -31.86 6.17 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.059 0.837 . . . . 10.0 113.494 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -74.01 -26.38 60.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.865 1.332 . . . . 10.0 111.589 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.71 96.76 1.27 Allowed 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.138 -0.976 . . . . 10.0 110.157 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -20.56 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.58 2.752 . . . . 10.0 113.286 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.39 1.16 5.53 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.273 1.269 . . . . 10.0 116.273 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG21 ' CG1' ' A' ' 24' ' ' VAL . 1.3 t -94.87 110.93 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 104.602 -2.369 . . . . 10.0 104.602 168.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -30.05 48.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.658 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.96 158.15 10.35 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.95 125.01 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.983 1.313 . . . . 10.0 108.383 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -128.4 80.54 1.97 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.763 1.225 . . . . 10.0 108.498 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.683 ' HA ' HG12 ' A' ' 42' ' ' VAL . 7.2 t -74.42 108.5 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 126.273 1.829 . . . . 10.0 109.884 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 53.0 m-80 -142.07 52.28 1.48 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.176 1.39 . . . . 10.0 110.173 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.55 -46.72 88.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.711 0.291 . . . . 10.0 111.458 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -68.11 -40.86 82.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.111 1.364 . . . . 10.0 109.922 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -72.56 -35.27 67.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.397 -0.819 . . . . 10.0 111.518 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.56 -64.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.434 0.54 . . . . 10.0 112.764 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 165.14 12.02 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 125.594 1.557 . . . . 10.0 109.259 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 35' ' ' VAL . 17.2 m -88.14 115.12 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -102.6 121.25 42.01 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.12 131.96 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -94.54 78.55 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.239 -1.393 . . . . 10.0 107.239 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -75.59 135.82 40.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.54 -1.209 . . . . 10.0 109.489 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -90.08 89.08 7.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.011 1.324 . . . . 10.0 107.805 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.45 -16.18 8.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.249 0.833 . . . . 10.0 113.249 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.24 -18.33 62.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.828 1.651 . . . . 10.0 109.722 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -124.73 -55.86 1.6 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.757 1.223 . . . . 10.0 110.152 -169.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -137.33 148.44 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.092 0.957 . . . . 10.0 109.989 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -101.08 152.37 20.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -39.87 -40.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 C-N-CA 127.608 2.363 . . . . 10.0 110.961 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.87 -34.12 0.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.69 -65.38 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.855 0.752 . . . . 10.0 110.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.4 mp -64.79 -48.98 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.53 1.132 . . . . 10.0 112.543 -172.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.77 -57.01 2.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.549 1.94 . . . . 10.0 110.423 170.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.5 -46.8 85.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.77 0.795 . . . . 10.0 109.662 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.54 -48.91 68.64 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.573 0.749 . . . . 10.0 111.332 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.437 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -73.03 -39.33 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.15 -0.969 . . . . 10.0 111.022 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.5 -34.55 78.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.588 1.54 . . . . 10.0 110.767 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -47.8 -66.25 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.594 1.157 . . . . 10.0 112.731 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -126.59 3.73 6.83 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.239 1.2 . . . . 10.0 114.239 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.07 -53.5 0.89 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.643 1.116 . . . . 10.0 112.489 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 68.0 111.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.5 2.32 . . . . 10.0 111.258 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 164.41 -34.88 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 110.574 -168.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG23 ' CG2' ' A' ' 60' ' ' ILE . 74.0 t -72.99 89.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 121.096 -1.003 . . . . 10.0 112.066 -168.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.39 -54.4 7.68 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 121.145 0.497 . . . . 10.0 110.042 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -169.04 143.58 3.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 -169.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 125.414 1.486 . . . . 10.0 110.015 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.718 -0.104 . . . . 10.0 110.718 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -128.72 90.7 3.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.755 2.422 . . . . 10.0 107.44 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -94.53 179.48 5.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.294 1.045 . . . . 10.0 109.957 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 t -146.14 134.96 22.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.931 -1.507 . . . . 10.0 106.931 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 70' ' ' ILE . 21.0 mt -88.61 95.73 10.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.522 -2.399 . . . . 10.0 104.522 170.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.59 144.1 57.28 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 128.12 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 124.644 1.178 . . . . 10.0 113.794 -169.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -69.55 -58.49 3.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 129.526 3.131 . . . . 10.0 110.254 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.73 -28.01 0.19 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.42 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.35 164.05 12.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.871 0.836 . . . . 10.0 110.35 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -147.52 12.05 1.02 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.784 0.434 . . . . 10.0 111.075 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -95.4 94.35 7.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -50.91 -18.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -35.83 36.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.87 0.759 . . . . 10.0 109.829 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -63.04 -67.27 0.44 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -49.97 -49.24 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.032 -0.417 . . . . 10.0 112.075 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -27.94 65.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.08 0.77 . . . . 10.0 113.08 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -36.4 74.43 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.42 -43.83 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 123.792 0.837 . . . . 10.0 110.163 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -39.25 -45.98 1.46 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.891 1.676 . . . . 10.0 111.339 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -48.99 68.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.544 0.688 . . . . 10.0 111.654 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.8 t -68.37 -54.18 19.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.654 1.182 . . . . 10.0 109.118 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 t -53.78 -38.96 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.197 0.599 . . . . 10.0 111.321 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.24 71.34 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.98 1.276 . . . . 10.0 113.385 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.25 -37.55 37.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.679 1.239 . . . . 10.0 110.39 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.92 122.67 10.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.798 0.726 . . . . 10.0 110.551 -175.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -48.24 -41.7 28.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.047 1.739 . . . . 10.0 112.532 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.55 -6.15 88.14 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.275 0.464 . . . . 10.0 113.928 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.96 115.32 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.363 -2.088 . . . . 10.0 105.363 168.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -77.85 -32.61 52.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.377 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.11 160.39 11.81 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.23 147.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.64 1.576 . . . . 10.0 107.975 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.51 89.98 1.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.713 0.768 . . . . 10.0 109.256 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.6 t -75.27 118.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 123.449 0.699 . . . . 10.0 109.392 -177.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.95 44.65 1.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.568 0.747 . . . . 10.0 109.123 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -59.65 -51.33 70.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.502 -0.749 . . . . 10.0 112.19 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.89 -36.83 80.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.966 0.906 . . . . 10.0 110.034 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.33 62.53 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.479 -0.782 . . . . 10.0 111.286 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.97 -77.77 0.07 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.223 0.916 . . . . 10.0 111.498 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 171.26 11.66 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 126.586 1.954 . . . . 10.0 107.977 -173.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 35' ' ' VAL . 44.6 t -90.83 105.55 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -82.45 136.99 34.8 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.62 139.55 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-O 122.161 0.981 . . . . 10.0 109.875 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 m -111.64 77.03 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.639 -0.71 . . . . 10.0 109.454 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.663 ' HE1' HG21 ' A' ' 56' ' ' ILE . 21.5 m-85 -73.34 140.64 46.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -96.51 94.09 7.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.428 0.691 . . . . 10.0 109.439 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.66 -22.03 1.22 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.965 1.306 . . . . 10.0 113.738 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.34 -6.99 58.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.275 0.943 . . . . 10.0 110.048 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -126.54 -55.83 1.41 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.15 0.98 . . . . 10.0 109.891 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.28 164.05 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 119.535 1.062 . . . . 10.0 111.018 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.2 m -118.14 168.4 10.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.56 0.744 . . . . 10.0 109.344 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -44.43 -29.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.69 2.796 . . . . 10.0 112.462 170.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -36.29 6.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.667 0.667 . . . . 10.0 111.397 172.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.89 -60.14 2.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.637 1.208 . . . . 10.0 110.385 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.663 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.2 mm -70.01 -57.0 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 114.535 1.309 . . . . 10.0 114.535 -168.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.67 8.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.897 0.879 . . . . 10.0 108.871 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.74 -51.38 56.59 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.789 0.435 . . . . 10.0 110.72 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.641 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.664 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.6 -48.61 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.137 -0.977 . . . . 10.0 110.272 177.432 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.66 -25.6 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.308 -0.87 . . . . 10.0 112.178 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.96 -44.56 40.92 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.626 0.77 . . . . 10.0 112.378 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -166.1 -28.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.21 -55.14 16.8 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.798 -1.001 . . . . 10.0 112.103 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 60.32 120.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.768 2.027 . . . . 10.0 111.963 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 163.66 -34.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 126.03 1.732 . . . . 10.0 109.805 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.664 HG23 HG21 ' A' ' 60' ' ' ILE . 92.3 t -71.5 88.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 121.006 -1.059 . . . . 10.0 111.424 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.39 -52.93 27.56 Favored 'General case' 0 CA--C 1.523 -0.066 0 O-C-N 121.587 -0.696 . . . . 10.0 109.135 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -169.6 159.39 8.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.604 HG22 HD23 ' A' ' 6' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 126.033 1.733 . . . . 10.0 108.367 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.483 0.659 . . . . 10.0 111.715 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.46 112.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.516 1.527 . . . . 10.0 107.892 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.66 172.48 6.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.359 1.464 . . . . 10.0 108.071 172.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 124.77 42.28 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.775 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -93.29 97.67 10.76 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -62.32 153.89 29.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.249 -0.648 . . . . 10.0 109.249 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -65.65 128.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.672 1.589 . . . . 10.0 111.968 -173.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -73.28 -61.56 1.78 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.868 2.867 . . . . 10.0 109.135 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.38 -34.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.437 -0.887 . . . . 10.0 112.347 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.29 170.59 5.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.041 0.921 . . . . 10.0 110.928 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -159.15 30.89 0.21 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.848 -0.614 . . . . 10.0 109.412 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.43 102.68 12.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -56.11 -20.1 15.93 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -76.91 -42.23 40.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.984 0.811 . . . . 10.0 109.127 -172.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -55.49 -68.13 0.22 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.459 1.104 . . . . 10.0 109.874 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.5 -50.07 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -54.35 -33.69 59.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.943 0.792 . . . . 10.0 113.128 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.23 -34.23 66.13 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.361 0.6 . . . . 10.0 110.224 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 37.8 t -85.56 -45.07 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.783 0.833 . . . . 10.0 109.919 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -46.39 -42.1 14.57 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.571 1.148 . . . . 10.0 110.591 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -54.92 -45.69 74.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.43 0.559 . . . . 10.0 112.309 174.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -72.37 -42.37 65.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.607 0.763 . . . . 10.0 111.893 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 56' ' ' ILE . 15.0 t -66.22 -43.22 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.516 0.726 . . . . 10.0 109.744 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.37 2.7 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.882 1.229 . . . . 10.0 111.877 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.39 -47.03 0.19 Allowed 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 127.382 2.273 . . . . 10.0 108.212 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 126.28 15.36 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.394 0.997 . . . . 10.0 110.488 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.73 -39.39 58.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.744 1.218 . . . . 10.0 112.156 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.33 -8.4 59.16 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.79 0.71 . . . . 10.0 114.14 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.76 106.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 O-C-N 119.271 -2.311 . . . . 10.0 105.441 168.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 t -74.37 -28.28 61.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.51 156.65 11.93 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.0 m -130.6 148.13 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.218 1.007 . . . . 10.0 108.604 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -165.73 87.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.48 118.96 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.243 1.817 . . . . 10.0 109.915 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.11 48.74 1.87 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.745 0.418 . . . . 10.0 111.385 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -52.61 -44.55 66.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 10.0 111.963 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.63 -26.75 66.39 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.942 0.897 . . . . 10.0 111.286 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.12 13.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.678 0.391 . . . . 10.0 111.155 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.0 -65.63 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.8 179.29 3.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.026 2.13 . . . . 10.0 110.741 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.597 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -93.67 130.46 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 125.512 1.525 . . . . 10.0 107.609 172.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.63 70.7 0.95 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.863 0.839 . . . . 10.0 110.374 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 42' ' ' VAL . 11.3 t -83.79 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.828 1.251 . . . . 10.0 108.783 -171.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.87 77.17 1.31 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 8.8 m-85 -79.82 134.05 36.32 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.472 1.509 . . . . 10.0 108.84 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.41 88.22 6.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.334 -0.853 . . . . 10.0 109.221 170.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.31 -16.09 0.16 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.15 0.98 . . . . 10.0 113.292 168.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.95 -20.67 28.61 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.362 2.265 . . . . 10.0 110.461 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -129.26 -58.14 1.13 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 10.0 109.786 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.0 t -129.87 120.26 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 125.02 1.328 . . . . 10.0 108.002 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 p -87.76 158.19 18.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -38.03 -40.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 126.885 2.074 . . . . 10.0 110.618 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.95 -47.06 0.51 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.275 0.943 . . . . 10.0 111.551 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -64.06 -57.74 8.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.562 1.172 . . . . 10.0 111.096 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' CG1' ' A' ' 24' ' ' VAL . 5.9 mm -65.72 -57.11 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.836 1.654 . . . . 10.0 112.001 -173.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.19 -61.58 0.87 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.166 2.186 . . . . 10.0 109.52 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.56 -49.97 54.74 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.157 0.583 . . . . 10.0 110.666 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.41 77.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.745 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -71.44 -39.53 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 120.98 -1.075 . . . . 10.0 110.415 177.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.33 -29.14 69.71 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.261 -0.899 . . . . 10.0 111.628 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.45 -64.27 0.87 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.976 0.807 . . . . 10.0 111.614 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.98 -7.33 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.265 1.58 . . . . 10.0 115.265 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.74 -51.8 10.77 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.714 -0.954 . . . . 10.0 110.714 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 58.25 109.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.75 2.42 . . . . 10.0 111.539 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t0 175.59 -41.31 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 125.363 1.465 . . . . 10.0 107.991 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 60' ' ' ILE . 72.0 t -69.95 95.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 120.806 -1.184 . . . . 10.0 112.298 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.86 -57.46 3.86 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.773 0.829 . . . . 10.0 109.731 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -164.94 142.94 6.33 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.888 -1.523 . . . . 10.0 106.888 -171.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.775 HG22 HD23 ' A' ' 6' ' ' LEU . 2.2 pp . . . . . 0 N--CA 1.439 -0.99 0 C-N-CA 124.163 0.985 . . . . 10.0 108.552 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.25 98.22 10.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -175.79 4.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.569 -1.641 . . . . 10.0 106.569 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -139.17 137.13 35.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.754 -1.943 . . . . 10.0 105.754 169.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -94.15 99.89 12.08 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 105.141 -2.17 . . . . 10.0 105.141 171.036 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.03 146.57 42.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.152 -0.684 . . . . 10.0 109.152 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.19 130.3 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 125.13 1.372 . . . . 10.0 113.128 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -78.86 -57.56 3.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.375 2.27 . . . . 10.0 110.618 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.65 -46.46 0.1 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 117.637 -2.22 . . . . 10.0 112.792 -169.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.91 158.99 4.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 117.3 0.55 . . . . 10.0 110.928 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.1 m -144.83 37.57 1.18 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.084 -0.962 . . . . 10.0 108.875 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.3 t -110.12 94.96 5.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.66 -9.85 0.6 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -90.35 -29.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.182 0.901 . . . . 10.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -65.33 -73.79 0.12 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.931 -1.137 . . . . 10.0 107.931 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 35' ' ' VAL . 4.5 m -33.83 -54.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 125.542 1.537 . . . . 10.0 113.858 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -56.01 -33.16 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.969 0.729 . . . . 10.0 112.969 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.94 -32.8 61.69 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.599 0.76 . . . . 10.0 110.582 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.28 -47.68 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 117.829 -1.081 . . . . 10.0 110.39 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -41.85 -49.48 4.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.077 1.351 . . . . 10.0 110.752 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.5 p -46.17 -62.32 1.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.349 1.06 . . . . 10.0 111.247 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -57.76 -48.06 80.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.598 1.159 . . . . 10.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -55.08 -40.64 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.76 0.824 . . . . 10.0 110.155 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.63 6.4 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.54 1.066 . . . . 10.0 113.744 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.87 -26.62 60.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.92 1.36 . . . . 10.0 111.621 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.15 107.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 119.128 0.877 . . . . 10.0 109.373 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -36.7 -43.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.165 2.186 . . . . 10.0 113.17 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.05 -28.5 63.9 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.688 0.661 . . . . 10.0 114.119 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.51 109.56 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 119.566 -2.137 . . . . 10.0 107.399 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -81.82 -31.73 31.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.903 -1.044 . . . . 10.0 109.712 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.19 158.22 18.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' HG22 ' A' ' 44' ' ' VAL . 10.4 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.509 1.123 . . . . 10.0 108.303 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -162.55 106.4 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 17' ' ' VAL . 43.7 t -95.69 117.55 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 C-N-CA 124.124 0.97 . . . . 10.0 109.237 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -132.22 48.58 2.4 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.505 0.322 . . . . 10.0 111.349 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -47.52 -42.96 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.087 0.955 . . . . 10.0 112.89 177.166 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.49 -37.92 88.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.82 0.848 . . . . 10.0 111.032 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -35.9 20.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.564 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.38 -67.8 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.926 -0.87 . . . . 10.0 110.926 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -174.74 2.51 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.055 1.342 . . . . 10.0 110.673 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.565 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -97.28 125.79 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 175.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -110.77 92.69 4.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.524 2.33 . . . . 10.0 108.343 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.4 t -110.89 151.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.647 1.579 . . . . 10.0 107.88 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -109.73 77.2 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.556 -1.646 . . . . 10.0 106.556 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 5.6 m-85 -78.01 127.67 32.69 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.317 -1.31 . . . . 10.0 107.721 -176.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.93 85.0 6.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.642 -0.662 . . . . 10.0 110.292 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.75 -23.17 0.96 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.985 0.914 . . . . 10.0 113.389 174.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.27 -5.38 56.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.436 0.562 . . . . 10.0 109.943 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -133.35 -54.15 0.9 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.492 1.117 . . . . 10.0 110.511 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.18 141.04 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 125.051 1.341 . . . . 10.0 109.435 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -97.26 143.57 27.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.0 m -31.76 -49.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 129.369 3.068 . . . . 10.0 110.003 168.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -31.93 -51.61 0.23 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.807 1.243 . . . . 10.0 112.089 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -55.69 -60.54 3.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.396 1.079 . . . . 10.0 110.949 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -66.05 -54.53 26.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 125.17 1.388 . . . . 10.0 110.948 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.15 -62.28 0.66 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.917 2.087 . . . . 10.0 110.389 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -53.85 -50.25 66.65 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.731 0.813 . . . . 10.0 110.097 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.27 -47.69 55.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.035 0.534 . . . . 10.0 111.453 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 HG21 HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -71.55 -35.9 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.974 -1.079 . . . . 10.0 111.067 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.65 -30.59 65.53 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.871 -1.143 . . . . 10.0 111.579 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.87 -62.08 2.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.234 0.925 . . . . 10.0 111.964 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -142.86 56.07 1.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.89 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.22 -0.766 . . . . 10.0 111.288 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 65.08 107.15 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.124 1.77 . . . . 10.0 112.248 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' HD23 ' A' ' 37' ' ' LEU . 12.0 p-10 161.28 -24.87 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 128.413 2.685 . . . . 10.0 110.987 -170.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 HG21 ' A' ' 60' ' ' ILE . 63.5 t -67.88 90.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 120.985 -1.072 . . . . 10.0 111.486 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.67 -52.07 11.35 Favored 'General case' 0 C--N 1.338 0.094 0 O-C-N 121.774 -0.579 . . . . 10.0 109.463 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -170.24 144.12 2.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.52 1.128 . . . . 10.0 108.409 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.732 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 124.433 1.093 . . . . 10.0 108.489 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 122.372 1.082 . . . . 10.0 109.147 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.62 126.56 35.01 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.566 -2.753 . . . . 10.0 103.566 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -124.86 176.07 6.86 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.87 126.81 38.88 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -92.7 97.86 11.05 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 104.69 -2.337 . . . . 10.0 104.69 172.167 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.88 150.7 44.35 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.01 127.68 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.658 1.183 . . . . 10.0 113.019 -169.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -62.35 1.42 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.602 1.961 . . . . 10.0 108.57 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.34 -31.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.508 -169.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 178.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.461 1.124 . . . . 10.0 112.582 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p -150.31 -43.57 0.13 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.533 -1.212 . . . . 10.0 110.913 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -37.44 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.855 1.262 . . . . 10.0 111.678 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -3.27 23.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.337 -0.363 . . . . 10.0 111.687 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -46.64 8.71 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.603 0.638 . . . . 10.0 109.448 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 m -46.93 -68.68 0.17 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.703 0.801 . . . . 10.0 110.157 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -46.63 -51.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 O-C-N 122.304 -0.247 . . . . 10.0 111.483 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 10.4 tttt -60.61 -33.75 73.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.17 50.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.981 0.512 . . . . 10.0 110.144 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.94 -41.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.232 -0.889 . . . . 10.0 110.726 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 tt0 -39.89 -51.49 2.45 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.345 1.458 . . . . 10.0 111.297 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -51.0 -55.69 16.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.03 0.932 . . . . 10.0 110.552 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.82 -49.73 74.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.705 1.202 . . . . 10.0 110.534 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 HD12 ' A' ' 56' ' ' ILE . 49.7 t -53.85 -41.5 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.248 1.019 . . . . 10.0 110.111 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.0 -32.55 6.3 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.72 1.152 . . . . 10.0 114.052 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.09 -26.21 60.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.924 1.362 . . . . 10.0 111.944 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.4 109.67 2.81 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.435 -0.79 . . . . 10.0 110.251 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.3 -38.44 2.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.097 2.159 . . . . 10.0 113.175 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.33 -20.89 71.85 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.503 -0.748 . . . . 10.0 114.215 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.02 105.31 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 120.036 -1.861 . . . . 10.0 107.211 171.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -29.86 62.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.351 -1.295 . . . . 10.0 110.097 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.49 157.05 14.48 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.532 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.8 m -136.25 130.51 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.074 0.95 . . . . 10.0 109.913 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -148.07 94.3 2.31 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.931 0.892 . . . . 10.0 108.714 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 t -86.66 114.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 10.0 108.371 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.95 48.62 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.835 0.454 . . . . 10.0 111.497 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.95 -44.17 60.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.673 0.789 . . . . 10.0 112.414 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.1 -29.84 70.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.727 1.211 . . . . 10.0 111.096 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 -36.86 14.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.63 0.372 . . . . 10.0 110.755 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.07 -65.07 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.218 0.913 . . . . 10.0 111.045 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.12 178.78 4.87 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.399 1.48 . . . . 10.0 111.025 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.2 127.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 125.145 1.378 . . . . 10.0 108.228 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -117.59 89.13 3.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.622 1.169 . . . . 10.0 108.629 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 42' ' ' VAL . 17.1 t -98.2 149.76 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.668 1.587 . . . . 10.0 107.637 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 t -104.29 79.89 1.64 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 9.7 m-85 -73.93 130.35 39.71 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.912 -1.494 . . . . 10.0 108.204 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -84.33 87.1 7.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -11.82 1.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.162 0.801 . . . . 10.0 113.162 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.46 -15.37 52.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.608 1.094 . . . . 10.0 109.759 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -127.08 -61.44 1.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.451 1.1 . . . . 10.0 109.152 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.9 126.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.825 1.25 . . . . 10.0 109.223 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 m -96.4 163.84 12.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.308 -0.86 . . . . 10.0 108.828 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -38.43 -39.57 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 127.478 2.311 . . . . 10.0 111.353 168.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -37.33 1.47 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.594 0.633 . . . . 10.0 112.543 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.61 -63.87 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.071 0.938 . . . . 10.0 111.061 172.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 24' ' ' VAL . 3.8 mm -60.29 -54.03 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.713 1.205 . . . . 10.0 112.483 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.47 -53.05 15.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.904 2.082 . . . . 10.0 109.593 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.57 -47.78 78.77 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.133 0.573 . . . . 10.0 110.204 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -51.0 68.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.14 -34.74 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.118 -0.989 . . . . 10.0 109.948 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -57.04 -43.36 81.89 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.603 -1.311 . . . . 10.0 111.503 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.69 -62.24 1.75 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.469 0.577 . . . . 10.0 111.969 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -141.18 44.67 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.04 -57.78 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.944 0.783 . . . . 10.0 112.102 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 66.3 107.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.129 2.172 . . . . 10.0 111.087 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 t0 170.39 -38.47 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.668 1.587 . . . . 10.0 108.253 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 ' CG2' ' A' ' 60' ' ' ILE . 54.7 t -69.24 89.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 120.746 -1.221 . . . . 10.0 112.031 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.72 2.62 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.284 -0.885 . . . . 10.0 109.689 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -165.3 155.91 13.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.166 -1.791 . . . . 10.0 106.166 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.522 ' CG2' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.119 0 C-N-CA 124.607 1.163 . . . . 10.0 110.143 174.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 106.937 -1.505 . . . . 10.0 106.937 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -139.72 110.16 6.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.868 -1.901 . . . . 10.0 105.868 168.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.83 176.39 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.514 1.926 . . . . 10.0 106.717 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -148.81 128.8 13.5 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.064 -1.828 . . . . 10.0 106.064 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.68 104.26 15.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 172.518 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -68.43 149.71 49.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.51 132.78 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -170.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -74.41 -60.51 2.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.916 2.486 . . . . 10.0 108.174 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.31 -31.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.862 -0.966 . . . . 10.0 115.137 -171.28 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.8 178.45 4.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.606 1.703 . . . . 10.0 110.241 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -158.81 26.96 0.22 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.693 0.797 . . . . 10.0 109.249 170.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.8 t -90.09 100.04 12.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.098 -1.815 . . . . 10.0 106.098 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -52.57 -26.73 14.14 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 174.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -72.55 -46.08 56.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.939 -0.763 . . . . 10.0 108.939 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.9 m -50.31 -65.88 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.848 1.659 . . . . 10.0 110.415 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.77 -45.09 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 120.484 -0.487 . . . . 10.0 111.08 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 17.7 tttm -52.44 -33.76 45.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.624 1.342 . . . . 10.0 114.624 176.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.06 65.39 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.065 0.848 . . . . 10.0 110.038 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -87.05 -37.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 117.339 -1.315 . . . . 10.0 110.575 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 1.4 tt0 -36.63 -56.03 0.84 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.556 1.542 . . . . 10.0 110.549 174.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -58.94 -45.38 90.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.686 0.395 . . . . 10.0 111.381 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m -65.55 -57.03 9.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.43 0.692 . . . . 10.0 109.8 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.71 -37.48 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.992 0.917 . . . . 10.0 110.796 177.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.63 -27.32 54.69 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.024 0.821 . . . . 10.0 112.193 177.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.37 -27.35 59.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 118.319 1.059 . . . . 10.0 110.416 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.51 103.65 2.54 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 120.94 -1.1 . . . . 10.0 108.859 178.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -41.01 -32.37 0.23 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.668 1.987 . . . . 10.0 113.043 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.72 3.76 4.76 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.15 0.881 . . . . 10.0 115.288 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.17 119.61 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 169.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -36.99 29.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.61 157.24 14.41 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 176.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.986 2.114 . . . . 10.0 107.281 171.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -133.46 96.33 3.69 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 126.327 1.851 . . . . 10.0 107.742 172.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 42' ' ' VAL . 2.2 t -87.8 119.12 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.044 0.937 . . . . 10.0 108.933 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 15.3 m120 -146.38 51.59 1.13 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.073 0.549 . . . . 10.0 111.213 -172.085 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.52 -48.99 56.93 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.279 0.632 . . . . 10.0 112.078 178.077 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.83 -37.01 83.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.176 0.591 . . . . 10.0 110.718 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -83.4 -31.92 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.133 -173.229 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.43 -79.33 0.05 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.598 -1.001 . . . . 10.0 110.598 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -168.8 179.8 4.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.549 2.739 . . . . 10.0 106.873 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 6' ' ' LEU . 31.0 m -94.31 118.58 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 107.68 -1.229 . . . . 10.0 107.68 -174.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.15 127.68 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 176.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.1 t -139.58 137.19 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.408 1.099 . . . . 10.0 108.757 -171.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -110.08 76.0 0.97 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 -169.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 28.1 m-85 -82.12 137.19 35.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.7 1.6 . . . . 10.0 109.797 -173.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -84.64 84.25 7.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.95 0.881 . . . . 10.0 108.83 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.31 -20.25 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.648 1.579 . . . . 10.0 112.409 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.04 -12.87 58.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.815 1.646 . . . . 10.0 110.12 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -120.59 -53.67 2.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.131 0.972 . . . . 10.0 109.248 -174.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 m -125.92 -168.65 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.879 1.672 . . . . 10.0 108.971 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 m -144.28 147.68 33.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.022 -1.049 . . . . 10.0 108.744 169.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -31.46 -48.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 130.037 3.335 . . . . 10.0 110.731 175.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -28.93 -52.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.312 1.445 . . . . 10.0 112.352 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.53 -59.77 4.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.18 0.592 . . . . 10.0 111.739 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.2 mp -67.64 -51.03 55.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 125.325 1.45 . . . . 10.0 110.737 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.26 -63.89 0.46 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.87 2.068 . . . . 10.0 109.399 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -56.46 -47.87 78.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.403 0.681 . . . . 10.0 110.126 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.29 -46.79 62.62 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.978 0.911 . . . . 10.0 111.546 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -72.53 -42.19 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.616 -0.677 . . . . 10.0 110.586 176.361 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.19 -34.89 66.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.984 1.266 . . . . 10.0 112.159 178.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -48.49 -63.02 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.697 0.681 . . . . 10.0 112.533 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -134.59 -17.89 1.96 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.37 1.068 . . . . 10.0 113.387 -171.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.23 -49.26 12.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.879 -0.888 . . . . 10.0 110.879 -177.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 58.67 108.48 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.689 2.395 . . . . 10.0 111.586 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.29 -42.0 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 121.807 0.813 . . . . 10.0 109.189 -167.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' A' ' 60' ' ' ILE . 55.1 t -71.32 94.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.601 -0.687 . . . . 10.0 111.245 -172.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.64 -51.65 11.14 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.399 0.618 . . . . 10.0 109.396 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -171.4 143.13 1.77 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 -170.133 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 6' ' ' LEU . 2.4 pp . . . . . 0 N--CA 1.442 -0.866 0 C-N-CA 124.864 1.266 . . . . 10.0 109.779 176.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 106.04 -1.837 . . . . 10.0 106.04 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -147.55 75.48 1.36 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HD2' HG11 ' A' ' 53' ' ' VAL . 6.5 mtmt -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.022 1.392 . . . . 10.0 110.806 169.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.0 m -130.36 124.5 32.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.788 -2.301 . . . . 10.0 104.788 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 HG22 ' A' ' 70' ' ' ILE . 1.1 mt -83.31 110.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.372 -2.455 . . . . 10.0 104.372 169.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -65.99 155.71 35.79 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.9 126.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.895 0.878 . . . . 10.0 110.028 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.32 -47.54 60.66 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.975 1.31 . . . . 10.0 109.203 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -19.75 0.67 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.442 -176.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 167.14 3.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.831 0.815 . . . . 10.0 111.5 174.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 19.83 1.35 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.34 -177.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -101.74 96.73 7.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.25 -14.47 7.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.802 0.667 . . . . 10.0 112.802 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -85.76 -35.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.997 0.817 . . . . 10.0 109.976 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.5 m -58.09 -67.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.883 1.273 . . . . 10.0 109.262 172.053 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -45.55 -51.43 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -177.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -20.79 63.03 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.623 0.972 . . . . 10.0 113.623 -177.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.78 90.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 175.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.44 -42.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.88 -0.581 . . . . 10.0 110.301 177.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -38.65 -48.91 1.51 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.429 1.492 . . . . 10.0 111.393 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -47.93 76.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.233 0.539 . . . . 10.0 111.328 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -65.14 -50.04 67.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.015 0.926 . . . . 10.0 110.203 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -52.73 -44.05 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.812 0.845 . . . . 10.0 109.914 176.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.48 -30.26 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.953 1.263 . . . . 10.0 113.765 173.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.77 -27.69 64.11 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.914 1.357 . . . . 10.0 110.91 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.43 105.58 2.65 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 174.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -36.04 -39.05 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.631 1.972 . . . . 10.0 113.543 170.152 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -13.39 21.42 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.849 1.214 . . . . 10.0 115.524 176.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 108.56 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 O-C-N 120.164 -1.786 . . . . 10.0 106.336 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -80.15 -29.89 38.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.91 158.97 15.37 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 177.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -139.35 122.12 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.328 1.451 . . . . 10.0 108.417 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -132.79 77.27 1.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.794 2.038 . . . . 10.0 107.546 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.13 123.81 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 125.026 1.33 . . . . 10.0 109.173 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 36.5 m-80 -147.94 53.19 1.03 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.044 0.937 . . . . 10.0 110.09 -177.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.63 -46.27 87.43 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.631 -0.668 . . . . 10.0 112.123 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.06 -35.14 77.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.09 0.956 . . . . 10.0 110.811 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.67 -32.5 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.34 -175.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.05 -88.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.906 1.241 . . . . 10.0 110.945 -173.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -166.49 164.09 17.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.393 2.677 . . . . 10.0 106.411 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -86.85 118.63 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 118.824 0.738 . . . . 10.0 110.575 -168.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.88 124.72 37.07 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.717 1.207 . . . . 10.0 108.402 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.414 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.2 t -134.5 136.73 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -99.96 70.98 1.62 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.26 -1.385 . . . . 10.0 107.26 -174.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 20.4 m-85 -72.46 135.46 45.74 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.023 -176.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.65 86.84 7.27 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.287 1.435 . . . . 10.0 108.264 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -18.61 1.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.905 1.282 . . . . 10.0 112.537 168.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.68 -16.05 56.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.561 1.544 . . . . 10.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.99 -56.1 2.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.324 1.05 . . . . 10.0 109.289 -177.021 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.12 155.92 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 123.91 0.884 . . . . 10.0 109.305 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -99.37 147.03 25.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.493 -0.928 . . . . 10.0 108.493 176.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 53' ' ' VAL . 18.7 m -30.71 -43.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 129.228 3.011 . . . . 10.0 111.202 168.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -28.87 -55.41 0.13 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.747 1.219 . . . . 10.0 111.549 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -48.21 -71.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.275 1.43 . . . . 10.0 111.05 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -60.41 -55.34 25.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.511 1.525 . . . . 10.0 112.238 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.6 -58.41 1.3 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.263 2.225 . . . . 10.0 110.908 172.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.47 -45.93 92.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.558 0.743 . . . . 10.0 109.752 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.67 -44.11 65.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.443 0.697 . . . . 10.0 111.535 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.41 HG21 HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.42 -58.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 117.824 -1.084 . . . . 10.0 108.805 176.555 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER -46.74 -37.81 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.772 1.169 . . . . 10.0 112.849 -174.655 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -41.17 -61.14 1.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.041 1.336 . . . . 10.0 112.882 172.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -132.82 -40.52 0.95 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.62 98.69 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.29 -1.124 . . . . 10.0 110.29 -176.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 173.67 0.17 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.131 1.372 . . . . 10.0 110.5 -176.017 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 86.67 37.98 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.451 1.5 . . . . 10.0 111.621 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 60' ' ' ILE . 40.0 t -117.96 89.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.91 1.284 . . . . 10.0 110.09 172.113 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.64 -58.86 3.42 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.419 -0.585 . . . . 10.0 109.419 169.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -176.13 158.44 1.96 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.691 -1.596 . . . . 10.0 106.691 -174.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.407 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.932 0 C-N-CA 123.715 0.806 . . . . 10.0 111.474 171.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.472 0.653 . . . . 10.0 111.692 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.98 94.94 8.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.264 1.425 . . . . 10.0 108.235 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HB3' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -95.97 161.13 14.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 173.412 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.85 107.53 14.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.613 1.565 . . . . 10.0 107.381 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.67 HD22 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -78.8 92.41 4.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 169.266 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -69.17 144.87 53.68 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.86 126.93 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.045 2.138 . . . . 10.0 113.281 -174.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -70.15 -66.19 0.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.653 2.381 . . . . 10.0 109.782 176.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.01 -25.86 0.05 OUTLIER Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.688 -1.062 . . . . 10.0 115.465 -168.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 177.17 2.36 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.837 1.819 . . . . 10.0 109.765 174.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.738 ' HA ' HD21 ' A' ' 37' ' ' LEU . 31.6 m -165.17 56.77 0.12 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 -178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.73 108.05 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.046 -1.835 . . . . 10.0 106.046 173.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.17 -24.49 64.8 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.489 0.185 . . . . 10.0 110.576 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -45.21 38.28 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.1 m -47.1 -71.11 0.08 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.039 1.335 . . . . 10.0 110.437 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.17 -49.1 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.249 0.219 . . . . 10.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 28.7 tttt -55.62 -34.7 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.84 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.531 -0.731 . . . . 10.0 109.352 174.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -82.38 -40.08 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 117.684 -1.15 . . . . 10.0 111.209 176.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -35.09 -60.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.994 1.718 . . . . 10.0 110.669 178.969 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -40.59 88.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.851 -1.068 . . . . 10.0 111.227 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -63.6 -56.13 18.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.077 0.951 . . . . 10.0 110.285 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.35 -33.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 124.185 0.994 . . . . 10.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -41.45 -27.93 0.31 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.951 -0.916 . . . . 10.0 114.981 170.082 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.16 70.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.568 1.684 . . . . 10.0 112.262 177.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.16 93.15 0.28 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 174.377 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.21 -39.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.887 1.675 . . . . 10.0 112.97 172.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.56 -9.02 42.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.121 0.867 . . . . 10.0 115.022 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.74 105.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.875 -2.268 . . . . 10.0 104.875 168.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -73.51 -33.21 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.564 179.076 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.92 159.05 13.07 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.747 -1.205 . . . . 10.0 107.747 177.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.49 128.2 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.637 1.175 . . . . 10.0 108.486 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 91.54 2.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.338 -0.986 . . . . 10.0 108.338 175.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 t -86.46 108.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.772 1.229 . . . . 10.0 109.073 -171.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.2 m120 -142.99 52.45 1.38 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.563 0.745 . . . . 10.0 111.665 -173.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.94 -48.62 51.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.249 0.62 . . . . 10.0 111.136 -178.915 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD22 ' A' ' 37' ' ' LEU . 38.0 mt-10 -66.27 -46.72 76.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.573 1.149 . . . . 10.0 110.172 -175.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.67 -30.49 69.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.339 -0.846 . . . . 10.0 110.089 -176.614 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.9 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 122.92 0.295 . . . . 10.0 112.432 170.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 171.67 7.91 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.93 0.892 . . . . 10.0 112.049 -169.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG12 HG23 ' A' ' 44' ' ' VAL . 40.2 t -93.71 102.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 173.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -93.19 113.67 25.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 45.5 t -125.78 143.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.355 -1.35 . . . . 10.0 107.355 -171.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -105.97 82.7 1.81 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.329 -2.1 . . . . 10.0 105.329 -174.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 53' ' ' VAL . 13.7 m-85 -88.24 132.31 34.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.259 1.424 . . . . 10.0 108.948 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -90.77 88.28 7.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.209 1.003 . . . . 10.0 108.356 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.85 -18.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.677 1.591 . . . . 10.0 112.819 167.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -19.15 58.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.614 1.966 . . . . 10.0 110.465 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -127.68 -48.61 1.39 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.199 1.0 . . . . 10.0 110.756 -169.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 m -134.09 165.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 123.986 0.914 . . . . 10.0 109.565 176.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 p -109.81 143.36 39.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.282 0.492 . . . . 10.0 109.921 175.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 46' ' ' PHE . 23.6 m -40.34 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 128.23 2.612 . . . . 10.0 108.841 169.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -35.16 -49.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.448 1.022 . . . . 10.0 112.194 175.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.45 -53.81 54.16 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.519 0.676 . . . . 10.0 111.077 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.89 -51.75 41.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.475 1.51 . . . . 10.0 111.289 -177.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -40.03 -59.96 1.13 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.971 2.108 . . . . 10.0 109.923 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.75 -48.34 75.42 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.082 0.953 . . . . 10.0 109.989 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.71 71.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.93 0.892 . . . . 10.0 111.511 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 HG23 ' A' ' 67' ' ' VAL . 1.3 mp -71.08 -34.09 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 O-C-N 120.729 -1.232 . . . . 10.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.21 -40.98 92.02 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.7 -1.25 . . . . 10.0 110.837 175.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -45.85 -66.62 0.38 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.356 1.063 . . . . 10.0 112.41 178.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -139.93 23.79 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.45 -49.4 0.6 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.46 1.029 . . . . 10.0 112.219 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 64.31 101.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.407 1.883 . . . . 10.0 111.558 173.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 173.36 -32.88 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 125.473 1.509 . . . . 10.0 109.799 -168.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.691 HG23 HG22 ' A' ' 60' ' ' ILE . 64.3 t -67.5 86.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 121.359 -0.838 . . . . 10.0 112.104 -171.429 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.41 -58.79 3.35 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 169.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -164.29 150.41 10.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 4' ' ' LYS . 5.2 tp . . . . . 0 N--CA 1.452 -0.349 0 C-N-CA 124.973 1.309 . . . . 10.0 110.429 179.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 104.919 -2.252 . . . . 10.0 104.919 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.21 124.76 23.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.646 -1.983 . . . . 10.0 105.646 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -127.76 158.95 36.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.868 1.318 . . . . 10.0 108.617 167.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 41' ' ' LYS . 1.8 m -119.5 98.14 5.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.982 2.913 . . . . 10.0 104.933 -168.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.65 86.63 4.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.793 -2.299 . . . . 10.0 104.793 170.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 53.9 tt0 -55.96 152.79 9.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.111 0.964 . . . . 10.0 109.267 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 2.2 t -63.63 127.12 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.698 1.199 . . . . 10.0 109.234 -178.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -75.23 -68.61 0.54 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 172.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.59 -32.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.518 -1.325 . . . . 10.0 115.806 -168.562 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -175.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.233 1.016 . . . . 10.0 108.721 173.503 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -168.47 39.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.133 1.373 . . . . 10.0 108.03 172.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -99.29 98.23 9.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.07 -17.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.39 1.876 . . . . 10.0 114.6 176.352 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -96.84 -37.28 10.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.797 1.239 . . . . 10.0 110.251 -176.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 m -56.62 -62.64 1.59 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 177.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 37' ' ' LEU . 9.2 m -49.65 -47.13 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.947 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 7.2 tttp -56.26 -34.82 66.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.269 1.211 . . . . 10.0 114.269 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -39.34 61.16 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.55 -0.537 . . . . 10.0 109.55 172.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.65 -37.26 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 117.903 -1.046 . . . . 10.0 111.199 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 26.8 tt0 -40.47 -57.0 1.92 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.733 1.613 . . . . 10.0 110.255 -178.199 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -46.61 89.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.369 -0.832 . . . . 10.0 111.012 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 t -56.46 -53.77 53.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.207 1.003 . . . . 10.0 109.687 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.86 -39.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 O-C-N 121.655 -0.653 . . . . 10.0 110.055 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.13 -26.94 3.39 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.05 -0.861 . . . . 10.0 113.92 172.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.47 -27.94 64.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.125 1.462 . . . . 10.0 111.579 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.44 108.49 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.945 0.793 . . . . 10.0 110.8 178.452 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -39.65 -45.52 1.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.551 1.54 . . . . 10.0 111.922 170.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.37 17.43 1.92 Allowed Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.378 0.911 . . . . 10.0 115.378 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.48 109.39 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 104.213 -2.514 . . . . 10.0 104.213 167.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -74.38 -32.6 62.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.1 151.83 6.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.932 -1.506 . . . . 10.0 106.932 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.05 136.31 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 177.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.07 92.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 t -93.47 108.58 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 126.601 1.96 . . . . 10.0 107.38 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 72.11 1.35 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 10.0 109.721 -171.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.79 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -70.72 -49.79 43.18 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -172.264 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.155 1.782 . . . . 10.0 110.029 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -35.25 44.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.628 -176.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.49 -75.25 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 177.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -166.16 -177.92 4.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.671 1.988 . . . . 10.0 111.631 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 HG23 ' A' ' 44' ' ' VAL . 61.9 t -89.61 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 -176.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -95.14 99.27 11.28 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 42' ' ' VAL . 52.5 t -116.74 148.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -170.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -112.32 90.25 3.29 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 -174.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.71 144.17 26.2 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 126.972 2.109 . . . . 10.0 108.803 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -97.57 94.52 7.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 167.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.8 7.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 10.0 111.973 170.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.6 t70 -71.59 -25.25 62.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.002 2.121 . . . . 10.0 110.346 173.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -121.8 -56.51 1.85 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.239 1.016 . . . . 10.0 109.668 -168.092 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.85 144.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 125.691 1.596 . . . . 10.0 109.63 -175.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 p -97.67 142.82 28.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.432 0.634 . . . . 10.0 110.146 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -43.31 -43.28 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 127.978 2.511 . . . . 10.0 108.615 168.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -44.73 -44.3 9.11 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.652 -1.165 . . . . 10.0 111.269 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.47 -63.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.614 0.643 . . . . 10.0 110.25 177.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.3 mp -62.27 -51.58 70.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.366 1.066 . . . . 10.0 111.817 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.72 -56.56 2.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.594 1.958 . . . . 10.0 109.763 171.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.96 -46.57 88.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.052 0.453 . . . . 10.0 110.314 175.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.99 77.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 10.0 111.154 -175.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.7 -49.8 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -49.56 -36.13 22.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.714 1.143 . . . . 10.0 112.939 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.91 -61.34 2.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.554 1.142 . . . . 10.0 112.545 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -138.86 -17.41 1.08 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.55 -46.29 48.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 119.147 0.885 . . . . 10.0 110.915 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 58.17 93.45 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.932 2.093 . . . . 10.0 111.102 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.28 46.17 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.1 2.56 . . . . 10.0 112.869 173.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.08 86.17 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.107 -0.996 . . . . 10.0 109.071 173.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 8' ' ' VAL . . . -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 174.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.32 155.92 0.52 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.239 1.816 . . . . 10.0 106.38 176.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.123 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 169.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 122.201 1.0 . . . . 10.0 112.134 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -71.93 71.67 0.8 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.461 1.505 . . . . 10.0 111.479 175.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -72.39 151.43 42.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 123.445 1.593 . . . . 10.0 108.883 168.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.87 111.12 21.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.144 -2.539 . . . . 10.0 104.144 -176.408 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' A' ' 70' ' ' ILE . 9.0 mp -90.49 87.91 6.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.55 -2.019 . . . . 10.0 105.55 173.048 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -60.9 146.3 47.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.296 -1.32 . . . . 10.0 109.355 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASP . 5.0 p -67.64 129.74 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.259 1.824 . . . . 10.0 113.547 -169.294 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -77.0 -51.42 11.12 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 127.623 2.369 . . . . 10.0 109.465 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.66 -0.67 1.7 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.467 -0.873 . . . . 10.0 114.181 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.26 171.06 4.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.873 1.337 . . . . 10.0 107.542 168.045 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -153.15 56.26 0.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.374 -1.343 . . . . 10.0 107.374 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.56 96.7 3.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.359 -1.349 . . . . 10.0 107.359 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -52.25 -21.73 3.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.304 0.483 . . . . 10.0 112.304 170.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.35 -35.72 35.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.845 -0.535 . . . . 10.0 110.166 -170.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.0 m -55.66 -74.13 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.366 1.067 . . . . 10.0 108.167 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -44.58 -52.02 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 113.523 0.934 . . . . 10.0 113.523 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -55.38 -31.18 61.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.205 0.911 . . . . 10.0 113.284 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.82 65.43 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 122.724 0.41 . . . . 10.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.45 -44.11 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 118.061 -0.971 . . . . 10.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -45.3 -45.1 11.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.525 1.057 . . . . 10.0 110.529 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -52.8 -48.92 66.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.497 0.665 . . . . 10.0 111.792 175.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 t -71.14 -38.47 72.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.931 1.292 . . . . 10.0 111.218 -178.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.25 -37.38 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.698 -0.626 . . . . 10.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.29 0.83 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.605 1.097 . . . . 10.0 113.025 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.7 -43.53 2.37 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.825 2.85 . . . . 10.0 109.364 175.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.72 123.56 13.68 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.22 0.918 . . . . 10.0 109.727 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -50.23 -41.57 50.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.246 1.018 . . . . 10.0 112.068 -174.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.78 69.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 116.233 -0.44 . . . . 10.0 113.588 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -74.62 108.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 119.643 -2.092 . . . . 10.0 106.197 172.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -37.97 73.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.166 173.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.88 155.2 11.93 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.128 -1.434 . . . . 10.0 107.128 -176.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.13 137.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -149.8 91.72 1.83 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.266 -1.012 . . . . 10.0 108.266 176.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.08 110.44 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 124.327 1.051 . . . . 10.0 110.218 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.43 49.81 2.15 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.699 0.8 . . . . 10.0 112.114 -178.469 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -50.2 30.85 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.025 0.93 . . . . 10.0 111.429 -175.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.47 -36.2 73.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.565 0.746 . . . . 10.0 110.858 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.96 62.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.458 -177.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.73 -65.33 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.7 178.92 5.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.342 1.057 . . . . 10.0 112.631 -169.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.57 105.97 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.075 -1.454 . . . . 10.0 107.075 176.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.14 117.86 35.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 72.3 t -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -168.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.2 t -110.91 87.76 2.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.879 -1.896 . . . . 10.0 105.879 -169.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 58.6 m-85 -95.36 129.12 42.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.435 1.494 . . . . 10.0 109.959 -173.08 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -81.46 88.98 6.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 172.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.36 -11.16 1.11 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -89.89 -2.9 58.28 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.571 1.078 . . . . 10.0 110.615 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -134.69 -54.52 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.889 0.876 . . . . 10.0 110.335 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.22 141.86 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 124.662 1.185 . . . . 10.0 109.911 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.7 p -107.77 153.6 22.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.679 0.752 . . . . 10.0 109.664 178.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -43.56 -37.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 127.483 2.313 . . . . 10.0 111.056 169.046 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -47.97 -32.59 6.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.475 0.58 . . . . 10.0 111.77 176.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -59.64 2.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.097 0.862 . . . . 10.0 111.108 171.038 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.8 -52.53 34.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 124.18 0.992 . . . . 10.0 112.775 -170.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.98 -54.35 13.19 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.54 1.536 . . . . 10.0 109.486 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -51.14 -50.73 58.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 10.0 109.71 172.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.96 76.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.04 0.536 . . . . 10.0 112.107 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.46 -37.03 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 O-C-N 120.61 -1.306 . . . . 10.0 111.258 178.879 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -51.3 -45.84 62.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.841 -1.162 . . . . 10.0 110.932 168.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -47.82 -62.2 1.57 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -147.15 55.65 1.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.838 0.455 . . . . 10.0 112.04 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.78 -54.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.84 -0.978 . . . . 10.0 111.039 176.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 64.69 107.0 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.323 1.849 . . . . 10.0 111.563 173.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 m-20 164.19 -25.73 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 125.368 1.467 . . . . 10.0 110.453 -169.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 60' ' ' ILE . 61.7 t -86.13 88.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 121.027 -1.046 . . . . 10.0 109.087 -174.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.98 69.5 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -169.41 153.45 5.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.116 -1.809 . . . . 10.0 106.116 177.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.885 0 C-N-CA 123.572 0.749 . . . . 10.0 109.312 173.501 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -147.35 82.55 1.54 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.015 0.926 . . . . 10.0 109.292 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.48 165.39 14.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.557 1.143 . . . . 10.0 108.966 173.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -120.46 111.28 17.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.314 1.846 . . . . 10.0 108.141 -168.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.586 HD21 HG22 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -87.99 83.32 7.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 178.646 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.08 147.41 50.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.127 -0.942 . . . . 10.0 110.288 -176.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' OD1' ' A' ' 66' ' ' ASP . 10.4 p -65.51 119.37 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.983 2.113 . . . . 10.0 113.138 -169.732 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -66.04 -50.11 65.33 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.887 1.275 . . . . 10.0 110.094 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.3 -22.48 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.048 -0.524 . . . . 10.0 112.242 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.97 170.36 0.86 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.539 1.162 . . . . 10.0 111.852 174.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -151.94 23.91 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.594 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.7 t -103.88 92.69 4.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -52.77 -20.14 2.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.046 0.758 . . . . 10.0 113.046 171.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.08 -39.42 29.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.336 -0.852 . . . . 10.0 109.21 -175.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 m -56.68 -67.03 0.34 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 175.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -46.99 -50.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 119.281 -0.39 . . . . 10.0 111.887 -177.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -58.78 -31.09 68.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.761 0.71 . . . . 10.0 112.808 -175.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.24 68.33 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 110.29 -0.263 . . . . 10.0 110.29 176.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.0 t -87.28 -39.24 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 118.437 -0.792 . . . . 10.0 110.951 176.185 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -41.64 -43.28 2.74 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.183 1.393 . . . . 10.0 110.964 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.8 -57.35 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.977 0.353 . . . . 10.0 110.88 174.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -58.64 -54.57 45.57 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.841 1.256 . . . . 10.0 109.968 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 HG12 ' A' ' 56' ' ' ILE . 14.0 t -52.76 -42.89 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.201 1.001 . . . . 10.0 110.1 176.471 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.92 -38.19 83.06 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.748 1.166 . . . . 10.0 112.733 173.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.0 -27.55 65.79 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.36 1.08 . . . . 10.0 111.502 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.91 104.24 0.53 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 119.572 -0.851 . . . . 10.0 109.196 171.688 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -26.3 -49.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.116 2.566 . . . . 10.0 114.11 169.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.99 -13.43 59.58 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.597 0.599 . . . . 10.0 114.597 -176.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.64 110.12 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 119.871 1.836 . . . . 10.0 106.469 171.183 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -82.21 -28.8 31.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.22 -176.415 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.04 159.17 17.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 176.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.62 128.95 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 78.5 1.83 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.467 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.66 116.91 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 124.744 1.218 . . . . 10.0 108.504 176.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -149.36 46.96 0.97 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.328 0.651 . . . . 10.0 110.622 -175.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -54.09 -43.4 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.079 0.551 . . . . 10.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.03 -40.45 75.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.862 1.265 . . . . 10.0 110.533 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.92 -30.26 50.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.653 -0.703 . . . . 10.0 111.51 -178.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 -61.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.539 0.59 . . . . 10.0 112.457 -179.194 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -170.06 176.05 4.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.484 1.514 . . . . 10.0 112.087 -171.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 96.1 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 106.109 -1.811 . . . . 10.0 106.109 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.71 118.85 31.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 40.6 t -129.22 146.21 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -169.095 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 t -106.93 71.03 0.82 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.38 -1.711 . . . . 10.0 106.38 -173.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 22.0 m-85 -67.34 142.34 56.83 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.64 -1.618 . . . . 10.0 107.435 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -100.83 94.71 6.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.018 0.527 . . . . 10.0 109.954 169.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.54 -15.42 2.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.105 0.962 . . . . 10.0 113.443 174.445 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.71 -9.52 58.78 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.079 0.854 . . . . 10.0 110.009 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -126.25 -54.61 1.47 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.367 1.067 . . . . 10.0 108.49 -175.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.97 144.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.817 1.247 . . . . 10.0 110.482 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 m -101.58 139.24 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.407 HG13 ' H ' ' A' ' 53' ' ' VAL . 9.4 m -34.24 -50.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 129.9 3.28 . . . . 10.0 110.877 176.409 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -29.71 -53.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.06 1.344 . . . . 10.0 112.491 172.311 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.05 -63.14 1.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.089 0.956 . . . . 10.0 110.679 177.051 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.415 HG12 HG13 ' A' ' 24' ' ' VAL . 2.7 mp -64.51 -54.49 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 C-N-CA 125.97 1.708 . . . . 10.0 111.779 -176.49 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 70' ' ' ILE . . . -38.49 -60.56 0.79 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.016 2.126 . . . . 10.0 110.403 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.54 -46.21 89.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.006 0.522 . . . . 10.0 110.569 176.819 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.19 71.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.023 0.929 . . . . 10.0 111.489 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -67.71 -59.27 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 174.858 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.8 -45.13 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.647 0.779 . . . . 10.0 112.249 -176.371 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -32.8 -50.91 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.493 1.517 . . . . 10.0 114.675 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -152.22 -37.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.096 0.959 . . . . 10.0 113.003 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -53.51 -44.24 67.4 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.424 -0.671 . . . . 10.0 111.424 178.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.44 169.6 0.23 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.266 1.426 . . . . 10.0 110.5 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 8' ' ' VAL . 12.1 t70 104.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.588 1.955 . . . . 10.0 112.4 171.579 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG22 HD21 ' A' ' 6' ' ' LEU . 21.3 t -102.53 77.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.943 1.697 . . . . 10.0 108.697 -177.176 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.31 -52.16 43.81 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.663 1.221 . . . . 10.0 108.446 176.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.51 127.92 2.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 104.829 -2.285 . . . . 10.0 104.829 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.405 HG21 ' HB2' ' A' ' 57' ' ' ALA . 3.6 tp . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 106.029 -1.841 . . . . 10.0 106.029 168.103 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 106.11 -1.811 . . . . 10.0 106.11 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -135.51 133.2 38.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.93 2.092 . . . . 10.0 106.616 169.433 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.01 -178.07 4.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.64 -2.726 . . . . 10.0 103.64 168.943 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 124.1 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.185 -2.524 . . . . 10.0 104.185 -177.007 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.654 HD12 HG11 ' A' ' 42' ' ' VAL . 4.0 mt -88.26 89.25 7.91 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 105.102 -2.184 . . . . 10.0 105.102 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -53.44 143.33 19.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.423 0.556 . . . . 10.0 110.314 -174.252 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.31 132.63 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.179 0.992 . . . . 10.0 112.745 -168.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -86.13 -47.26 9.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.811 2.444 . . . . 10.0 111.249 -176.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -37.27 0.16 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.653 -0.526 . . . . 10.0 113.149 -174.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 155.97 38.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.054 0.927 . . . . 10.0 109.567 175.986 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -140.47 16.45 2.38 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.593 0.757 . . . . 10.0 110.535 175.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -88.99 103.76 16.35 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.58 -1.64 0.87 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.171 -0.919 . . . . 10.0 113.398 174.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.7 -45.37 7.04 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.158 1.345 . . . . 10.0 110.572 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -47.13 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.574 1.95 . . . . 10.0 109.844 175.101 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.585 HG21 HG11 ' A' ' 35' ' ' VAL . 5.8 m -36.47 -46.43 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.238 1.415 . . . . 10.0 112.767 173.011 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 2.5 tttm -55.27 -31.7 61.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.176 1.176 . . . . 10.0 114.176 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.31 -34.95 62.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.751 0.25 . . . . 10.0 110.548 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.07 -34.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.031 1.333 . . . . 10.0 110.942 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 30.9 tt0 -42.62 -47.37 5.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.553 1.141 . . . . 10.0 109.947 178.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -56.49 18.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.952 0.406 . . . . 10.0 111.112 177.144 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 m -62.92 -53.51 53.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.924 1.289 . . . . 10.0 110.963 -175.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.74 -43.87 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.923 0.889 . . . . 10.0 109.738 178.315 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.92 -42.01 69.05 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.595 0.617 . . . . 10.0 111.969 171.15 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -34.82 78.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.398 1.079 . . . . 10.0 111.038 178.024 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 105.21 1.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.222 -0.924 . . . . 10.0 110.025 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -32.96 -35.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.093 2.557 . . . . 10.0 114.173 170.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.19 5.4 2.83 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 116.115 1.206 . . . . 10.0 116.115 175.143 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.33 124.95 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.074 1.75 . . . . 10.0 107.24 169.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -92.32 -27.66 17.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.787 0.835 . . . . 10.0 111.028 175.378 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 151.47 10.14 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 44' ' ' VAL . 14.2 m -136.64 128.76 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.779 1.232 . . . . 10.0 109.825 -177.091 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -151.49 100.17 2.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.295 1.038 . . . . 10.0 109.289 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 17' ' ' VAL . 37.1 t -93.35 108.66 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 126.024 1.73 . . . . 10.0 109.329 -175.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 32.1 m-80 -128.1 53.44 1.8 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.097 0.559 . . . . 10.0 111.604 -176.049 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -41.93 -52.34 4.14 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.281 1.432 . . . . 10.0 112.259 -178.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.13 -36.47 83.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.668 0.787 . . . . 10.0 111.619 -177.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -81.16 -37.6 28.51 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.872 0.367 . . . . 10.0 110.448 -171.24 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.89 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.649 -1.381 . . . . 10.0 109.649 177.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -171.88 1.91 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.513 1.525 . . . . 10.0 109.342 178.191 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG11 HD12 ' A' ' 6' ' ' LEU . 2.8 p -84.81 133.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.016 0.927 . . . . 10.0 108.873 168.655 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.4 96.21 5.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.858 1.263 . . . . 10.0 108.265 175.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 33' ' ' VAL . 17.7 t -105.44 149.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.835 1.654 . . . . 10.0 107.684 -178.864 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -106.71 77.21 1.17 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.912 -1.884 . . . . 10.0 105.912 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CZ ' HD21 ' A' ' 6' ' ' LEU . 6.9 m-85 -74.45 131.84 41.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.29 -1.323 . . . . 10.0 108.469 -176.187 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.62 83.58 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.471 0.708 . . . . 10.0 109.091 171.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.59 -18.42 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 170.221 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.64 -12.11 60.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.687 1.995 . . . . 10.0 110.033 178.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -131.42 -58.48 0.99 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.76 1.624 . . . . 10.0 109.219 -172.704 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -131.39 141.09 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.966 1.706 . . . . 10.0 109.553 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -90.18 149.0 22.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.511 -0.743 . . . . 10.0 109.837 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 4' ' ' LYS . 11.4 m -37.3 -46.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 C-N-CA 128.047 2.539 . . . . 10.0 109.431 167.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -42.22 -41.27 2.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.619 -0.705 . . . . 10.0 112.145 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.76 -66.48 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.479 0.581 . . . . 10.0 110.52 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.7 mp -58.52 -56.99 12.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.306 1.442 . . . . 10.0 112.145 -175.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -37.93 -64.04 0.43 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.666 2.386 . . . . 10.0 110.137 172.551 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.46 -38.75 91.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.33 0.586 . . . . 10.0 110.185 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.27 76.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.542 -0.723 . . . . 10.0 111.41 175.181 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.46 -37.69 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 120.677 -1.265 . . . . 10.0 109.302 174.666 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.22 -42.34 73.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.035 1.288 . . . . 10.0 111.112 173.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -46.96 -66.98 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.681 0.792 . . . . 10.0 112.755 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.6 52.22 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.956 0.502 . . . . 10.0 111.453 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.94 -69.3 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 t80 69.25 130.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.08 1.752 . . . . 10.0 107.943 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 158.88 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.325 1.45 . . . . 10.0 109.965 -167.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.452 HG23 ' CG2' ' A' ' 60' ' ' ILE . 94.3 t -82.79 87.85 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.6 0.76 . . . . 10.0 111.602 -169.335 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.44 -53.72 17.89 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.685 -0.634 . . . . 10.0 109.671 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -168.1 167.77 12.25 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 178.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.65 HG22 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.951 0 C-N-CA 126.685 1.994 . . . . 10.0 110.536 173.013 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.155 0.502 . . . . 10.0 111.256 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -66.55 81.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.479 0.711 . . . . 10.0 110.498 169.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -85.86 157.94 20.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.147 0.975 . . . . 10.0 109.028 168.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.25 101.25 8.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.458 -2.053 . . . . 10.0 105.458 -171.108 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.467 ' CB ' HG13 ' A' ' 42' ' ' VAL . 8.1 mt -72.18 101.39 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.058 -2.201 . . . . 10.0 105.058 167.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -77.34 147.77 35.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.71 128.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 125.941 1.697 . . . . 10.0 112.901 -170.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -69.41 -61.55 1.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.308 2.243 . . . . 10.0 108.964 177.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.51 -35.2 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.358 -0.69 . . . . 10.0 113.3 -169.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.91 178.24 2.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.593 1.197 . . . . 10.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 p -141.42 -50.98 0.43 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.453 -169.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -32.46 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.987 1.715 . . . . 10.0 113.202 -175.87 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -54.73 -9.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -88.46 -43.14 11.67 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.407 1.003 . . . . 10.0 110.166 -177.212 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.4 m -50.58 -68.18 0.19 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.746 0.818 . . . . 10.0 109.375 175.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 37' ' ' LEU . 2.6 m -46.61 -46.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.672 -0.24 . . . . 10.0 111.338 178.37 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.84 -36.4 64.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.138 1.162 . . . . 10.0 114.138 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.68 54.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.517 0.675 . . . . 10.0 110.02 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.14 -38.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 117.832 -1.08 . . . . 10.0 110.893 175.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 4.5 tt0 -36.89 -52.73 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.922 1.689 . . . . 10.0 111.015 176.511 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 p -58.07 -49.43 76.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.101 0.56 . . . . 10.0 111.399 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.3 m -62.93 -48.23 79.83 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.326 0.65 . . . . 10.0 110.402 -177.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 30' ' ' VAL . 54.0 t -59.45 -42.72 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.863 0.865 . . . . 10.0 109.69 176.375 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.21 -43.35 56.82 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 123.579 0.609 . . . . 10.0 112.09 170.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.96 -30.32 70.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.585 0.692 . . . . 10.0 111.984 177.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 110.38 2.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.608 1.094 . . . . 10.0 110.431 177.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -35.31 -43.7 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.184 2.194 . . . . 10.0 113.081 173.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 20.22 1.92 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.223 0.849 . . . . 10.0 115.223 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 24' ' ' VAL . 1.4 t -125.13 113.46 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 169.258 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.8 t -72.72 -33.79 66.66 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.457 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.24 159.75 9.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 -177.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 44' ' ' VAL . 39.8 t -134.01 137.04 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.506 1.522 . . . . 10.0 107.695 179.138 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -136.31 82.47 1.94 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 125.599 1.56 . . . . 10.0 107.185 168.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.19 130.05 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.96 -1.018 . . . . 10.0 108.892 174.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.86 44.75 0.16 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.06 0.457 . . . . 10.0 111.11 -173.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 17' ' ' VAL . 1.6 pt? -57.68 -47.03 83.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.385 0.674 . . . . 10.0 112.114 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.766 1.226 . . . . 10.0 110.106 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.99 38.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.516 -178.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.43 -60.56 0.15 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.303 0.954 . . . . 10.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -170.65 166.33 8.09 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.09 1.356 . . . . 10.0 110.592 -171.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.467 HG13 ' CB ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.72 118.15 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 172.488 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.08 120.05 40.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 56.1 t -131.48 138.9 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -170.805 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -92.51 67.28 4.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.738 -2.319 . . . . 10.0 104.738 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 45.6 m-85 -69.32 139.7 54.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.911 -1.515 . . . . 10.0 106.911 -177.787 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.59 88.6 5.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 -176.116 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.65 -24.01 45.46 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.443 0.534 . . . . 10.0 112.443 -178.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.76 -17.97 56.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.749 1.62 . . . . 10.0 110.253 -177.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -107.62 -55.09 2.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.222 1.009 . . . . 10.0 108.401 -173.103 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.33 178.49 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.656 1.182 . . . . 10.0 108.931 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 p -112.75 152.22 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -32.17 -44.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 129.74 3.216 . . . . 10.0 110.656 168.378 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -30.05 -53.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.42 1.088 . . . . 10.0 111.578 171.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.96 -59.1 5.08 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.592 0.757 . . . . 10.0 111.366 178.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -68.31 -53.68 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 125.096 1.358 . . . . 10.0 111.727 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.59 -55.7 2.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 126.235 1.814 . . . . 10.0 110.226 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.79 -45.93 88.72 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.728 -0.607 . . . . 10.0 110.695 174.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.13 65.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.675 0.39 . . . . 10.0 111.183 178.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.531 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -71.25 -35.98 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.245 -0.909 . . . . 10.0 110.306 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.13 -37.99 72.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.702 1.137 . . . . 10.0 111.624 173.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -55.72 -66.9 0.34 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.455 0.57 . . . . 10.0 111.533 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.9 39.32 2.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -174.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.75 -58.28 0.09 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.92 -0.933 . . . . 10.0 112.348 -178.392 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 66.76 109.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.038 2.135 . . . . 10.0 110.938 178.081 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 166.92 -29.89 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 10.0 110.664 -168.198 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' CG2' ' A' ' 60' ' ' ILE . 40.6 t -68.14 85.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 121.077 -1.014 . . . . 10.0 112.229 -171.132 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.75 -57.23 4.13 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 121.808 0.813 . . . . 10.0 108.811 170.714 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -175.93 146.26 0.7 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 -171.526 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 124.524 1.129 . . . . 10.0 109.18 168.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -71.26 63.47 0.36 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 10.0 110.569 172.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -69.8 172.48 7.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.315 1.055 . . . . 10.0 108.206 168.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.13 104.89 15.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 177.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -62.55 150.09 41.35 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.705 0.802 . . . . 10.0 108.912 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.22 123.8 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 125.51 1.524 . . . . 10.0 111.063 -172.676 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.44 -45.48 75.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.594 1.558 . . . . 10.0 109.505 174.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.34 -8.41 0.39 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.855 -0.97 . . . . 10.0 114.094 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.93 179.45 1.47 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 119.425 1.612 . . . . 10.0 110.843 175.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -160.04 41.09 0.19 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -122.9 93.79 4.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.378 0.671 . . . . 10.0 109.672 176.372 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -55.92 -10.13 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.042 1.497 . . . . 10.0 115.042 172.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.94 -50.3 6.52 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 120.097 1.317 . . . . 10.0 109.609 -176.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -46.53 -62.62 1.29 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.196 0.998 . . . . 10.0 109.959 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -45.73 -52.58 2.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 122.41 0.284 . . . . 10.0 111.553 176.414 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 4.2 tmtp? -56.88 -37.49 71.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.811 0.844 . . . . 10.0 112.68 -178.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.31 -41.75 51.51 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.341 -0.615 . . . . 10.0 109.341 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.93 -36.69 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-O 117.229 -1.367 . . . . 10.0 111.592 173.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.5 tp10 -43.54 -51.15 6.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.888 1.677 . . . . 10.0 110.001 -177.229 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.46 -47.98 83.4 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.278 0.561 . . . . 10.0 111.387 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -60.31 -40.73 91.6 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.471 1.108 . . . . 10.0 110.752 -177.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.5 -39.11 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.933 0.893 . . . . 10.0 109.846 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.76 -23.93 46.53 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.416 1.008 . . . . 10.0 112.281 178.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.33 -32.33 68.45 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.318 1.047 . . . . 10.0 110.655 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.43 111.97 2.9 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.179 -0.951 . . . . 10.0 110.688 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -37.54 -37.88 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.683 2.793 . . . . 10.0 112.973 174.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.47 4.55 81.27 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.448 0.939 . . . . 10.0 115.448 -177.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.13 107.65 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 104.289 -2.485 . . . . 10.0 104.289 167.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 -28.72 55.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.26 157.29 15.22 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.69 140.61 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.609 1.564 . . . . 10.0 109.013 -177.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -155.72 80.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.544 1.537 . . . . 10.0 109.078 173.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.33 115.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 121.688 -0.633 . . . . 10.0 109.885 169.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.6 m120 -143.86 48.52 1.41 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.901 0.881 . . . . 10.0 110.71 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -55.74 25.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.392 0.677 . . . . 10.0 111.261 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.64 -22.47 64.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.815 -0.553 . . . . 10.0 110.324 -172.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -85.4 -35.45 21.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.948 0.899 . . . . 10.0 111.287 177.57 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.09 -72.1 0.06 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.125 0.869 . . . . 10.0 112.49 -171.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 176.77 5.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.283 2.233 . . . . 10.0 110.933 -175.088 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.3 t -96.35 102.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.186 0.994 . . . . 10.0 108.486 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -84.14 132.13 34.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.05 0.94 . . . . 10.0 108.583 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.88 129.52 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 O-C-N 121.528 -0.732 . . . . 10.0 110.001 -172.027 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.5 m -96.49 80.99 3.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.147 -1.427 . . . . 10.0 107.147 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CE2' HG12 ' A' ' 53' ' ' VAL . 42.2 m-85 -81.63 130.64 35.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.429 -0.805 . . . . 10.0 110.234 -178.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -91.69 87.23 6.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.422 1.889 . . . . 10.0 108.653 174.022 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -20.51 2.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.593 1.157 . . . . 10.0 113.293 171.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.657 1.583 . . . . 10.0 109.237 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -59.0 1.96 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 125.959 1.704 . . . . 10.0 109.155 -170.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 m -140.05 154.21 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 123.826 0.851 . . . . 10.0 110.742 178.678 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 t -100.01 160.09 14.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.13 0.966 . . . . 10.0 111.016 177.227 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' CE2' ' A' ' 46' ' ' PHE . 31.1 m -48.22 -35.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 C-N-CA 128.187 2.595 . . . . 10.0 109.418 166.641 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -52.53 -28.2 19.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.193 0.906 . . . . 10.0 112.392 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.09 -62.98 1.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.346 0.976 . . . . 10.0 109.358 169.003 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -65.66 -51.39 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 O-C-N 121.512 -0.743 . . . . 10.0 112.491 -169.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.05 -53.51 6.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.013 1.725 . . . . 10.0 109.872 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.84 -49.11 78.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.818 0.847 . . . . 10.0 110.05 175.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.13 -42.46 66.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.569 1.147 . . . . 10.0 111.595 -179.268 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.38 -56.39 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 118.215 -0.897 . . . . 10.0 108.832 174.488 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -34.5 59.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.883 1.219 . . . . 10.0 112.105 -171.264 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -38.19 -54.82 1.36 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.935 1.694 . . . . 10.0 113.527 172.172 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -144.86 -38.39 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.89 85.56 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.32 171.38 0.24 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.025 1.33 . . . . 10.0 109.958 -176.012 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.269 0.1 OUTLIER 102.13 3.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 127.425 2.29 . . . . 10.0 113.203 174.752 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 60' ' ' ILE . 38.6 t -88.65 88.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 124.806 1.242 . . . . 10.0 110.173 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.56 -58.44 4.29 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -175.36 152.88 1.44 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -175.688 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.865 0 C-N-CA 123.81 0.844 . . . . 10.0 111.811 173.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.235 0.54 . . . . 10.0 111.808 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -84.6 99.19 10.61 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.662 1.185 . . . . 10.0 110.276 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.65 164.84 12.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 167.129 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.82 113.78 21.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.072 -1.825 . . . . 10.0 106.072 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 42' ' ' VAL . 5.7 mt -80.88 83.19 6.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 174.262 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.82 147.02 20.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 -176.3 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.28 130.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.938 0.718 . . . . 10.0 112.938 -169.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -66.39 -48.6 69.59 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.847 1.659 . . . . 10.0 107.468 172.172 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.33 11.76 0.12 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.4 -1.222 . . . . 10.0 114.624 175.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -175.27 2.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 120.382 2.091 . . . . 10.0 108.52 173.182 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -170.17 58.45 0.04 OUTLIER 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.649 -1.241 . . . . 10.0 107.649 173.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.8 t -132.16 108.94 9.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 174.233 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -66.04 -10.56 41.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.11 0.964 . . . . 10.0 111.41 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -93.05 -48.27 6.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.538 0.735 . . . . 10.0 110.156 -171.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 m -43.64 -70.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.008 1.723 . . . . 10.0 110.197 171.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.591 HG21 HG11 ' A' ' 35' ' ' VAL . 4.1 m -39.56 -48.66 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 C-N-CA 123.962 0.905 . . . . 10.0 111.789 173.459 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.07 -34.86 61.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -31.34 45.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.36 0.527 . . . . 10.0 110.542 174.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.01 -32.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.498 1.519 . . . . 10.0 111.232 177.722 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 27.8 tt0 -43.37 -47.58 6.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.154 1.382 . . . . 10.0 110.087 -179.323 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -44.62 -70.04 0.12 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.802 1.641 . . . . 10.0 111.836 169.711 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.5 t -58.59 -47.21 85.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.116 1.367 . . . . 10.0 110.57 -172.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.37 -42.99 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.023 0.529 . . . . 10.0 109.8 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.31 -45.35 74.97 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.419 0.533 . . . . 10.0 111.769 170.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -61.52 -36.42 80.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 10.0 111.632 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 95.65 0.21 Allowed 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.276 -0.89 . . . . 10.0 109.972 177.131 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -28.03 -41.94 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.942 2.497 . . . . 10.0 114.902 173.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.83 5.15 0.56 Allowed Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.885 1.231 . . . . 10.0 115.74 174.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.74 111.31 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 104.474 -2.417 . . . . 10.0 104.474 169.083 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -74.08 -30.59 62.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.32 156.78 10.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.874 -1.528 . . . . 10.0 106.874 178.75 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.58 145.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 O-C-N 123.927 0.767 . . . . 10.0 109.677 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.29 96.67 1.2 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 173.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 17' ' ' VAL . 25.7 t -87.3 120.34 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.08 49.8 2.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.424 0.556 . . . . 10.0 110.023 -174.118 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -42.46 -53.96 4.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.655 1.582 . . . . 10.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -35.68 74.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.508 0.723 . . . . 10.0 111.706 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -32.65 41.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.978 -171.138 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.95 -73.59 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.413 -1.475 . . . . 10.0 109.413 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -171.87 1.93 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 127.129 2.171 . . . . 10.0 108.582 177.195 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -85.76 128.44 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 172.255 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -120.98 100.78 7.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.564 -1.273 . . . . 10.0 107.564 176.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.48 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.7 t -110.83 148.58 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.649 1.58 . . . . 10.0 106.97 -175.422 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 t -101.25 72.19 1.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.034 -1.839 . . . . 10.0 106.034 -175.393 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 27.6 m-85 -75.82 134.68 40.32 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.112 -172.07 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -83.03 81.17 8.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.492 -0.755 . . . . 10.0 109.81 177.242 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.42 -25.97 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.865 1.266 . . . . 10.0 113.252 169.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.0 -22.54 33.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 126.325 1.85 . . . . 10.0 110.294 -173.255 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -117.67 -48.74 2.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.378 0.671 . . . . 10.0 109.448 -169.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.15 -170.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 125.445 1.498 . . . . 10.0 108.836 177.381 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.9 m -143.64 144.48 31.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 169.072 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 m -32.35 -42.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 130.524 3.529 . . . . 10.0 111.596 174.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -29.67 -55.88 0.16 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.192 0.997 . . . . 10.0 111.522 170.204 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -51.75 -67.45 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.721 1.208 . . . . 10.0 110.75 175.695 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -60.32 -55.49 23.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 124.296 1.038 . . . . 10.0 111.869 -175.048 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.83 -59.94 1.53 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.886 2.074 . . . . 10.0 110.572 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.88 -46.86 78.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.763 0.792 . . . . 10.0 110.39 176.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.78 -42.84 80.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.102 0.961 . . . . 10.0 111.45 -178.537 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.465 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -70.13 -43.85 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.045 -1.034 . . . . 10.0 108.765 175.105 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.18 -36.99 32.79 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.119 1.327 . . . . 10.0 112.27 176.027 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.54 -67.72 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.697 0.68 . . . . 10.0 112.584 176.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -129.48 14.87 6.05 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.97 -53.59 0.18 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.212 0.911 . . . . 10.0 112.904 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 63.4 169.97 0.15 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.241 2.216 . . . . 10.0 110.97 -172.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.288 1.3 p30 108.43 -8.24 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 129.395 3.078 . . . . 10.0 113.166 -176.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 60' ' ' ILE . 53.4 t -74.2 81.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 124.302 1.041 . . . . 10.0 111.664 -178.023 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.33 -56.64 5.15 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 168.254 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -179.07 145.07 0.25 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.486 1.114 . . . . 10.0 108.433 -171.045 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.327 1.051 . . . . 10.0 110.061 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.697 -0.668 . . . . 10.0 109.416 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.54 -175.59 4.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.076 1.35 . . . . 10.0 109.161 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -147.2 75.35 1.37 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.579 1.151 . . . . 10.0 108.204 170.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -92.2 175.52 6.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.308 1.051 . . . . 10.0 109.341 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -150.86 137.85 19.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -92.87 101.7 14.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.774 -2.306 . . . . 10.0 104.774 177.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.05 147.27 51.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.28 131.53 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.203 1.401 . . . . 10.0 112.587 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -78.6 -59.66 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.332 2.653 . . . . 10.0 110.862 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.05 -36.15 0.05 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.757 -0.469 . . . . 10.0 112.778 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 166.48 2.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.129 0.966 . . . . 10.0 111.957 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 m -156.17 42.94 0.4 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t -112.61 96.15 5.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.552 -1.648 . . . . 10.0 106.552 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -55.96 -25.12 42.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.353 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -74.95 -41.34 59.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.76 0.824 . . . . 10.0 109.322 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.66 -71.41 0.08 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.832 0.853 . . . . 10.0 109.43 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -48.57 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 O-C-N 121.677 -0.639 . . . . 10.0 112.663 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -28.15 64.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.24 78.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -84.39 -41.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 118.61 -0.71 . . . . 10.0 110.519 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -39.4 -52.94 2.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.293 1.037 . . . . 10.0 110.503 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -48.84 75.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.612 -0.722 . . . . 10.0 110.907 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 m -59.34 -49.79 76.48 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.166 0.586 . . . . 10.0 111.227 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -55.27 -33.67 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.529 -0.732 . . . . 10.0 110.985 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.42 -18.37 14.77 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.922 0.772 . . . . 10.0 113.105 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.08 -34.38 75.04 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 118.626 1.213 . . . . 10.0 110.369 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 95.37 0.56 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.372 -0.83 . . . . 10.0 110.593 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -21.03 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.615 2.766 . . . . 10.0 114.347 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -44.66 -53.93 6.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.28 0.943 . . . . 10.0 113.865 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -52.63 111.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.452 1.101 . . . . 10.0 109.721 -173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -37.92 58.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.118 -0.947 . . . . 10.0 108.727 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.86 156.97 9.63 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.42 113.27 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.211 1.405 . . . . 10.0 107.231 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -116.66 78.18 1.18 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.089 0.956 . . . . 10.0 108.684 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.02 115.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.185 0.994 . . . . 10.0 109.847 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 41.0 m-80 -144.92 48.78 1.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.139 0.975 . . . . 10.0 110.09 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -49.84 -45.81 50.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 10.0 112.205 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.42 -42.71 82.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.515 1.126 . . . . 10.0 111.11 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -76.47 -32.06 58.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.036 -175.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.29 -70.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.474 1.035 . . . . 10.0 111.064 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.36 177.88 5.82 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.681 1.593 . . . . 10.0 109.418 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.422 HG23 HD12 ' A' ' 6' ' ' LEU . 17.2 m -93.71 109.85 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 108.094 -1.076 . . . . 10.0 108.094 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -93.51 118.8 31.8 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.1 t -132.35 137.49 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 122.227 1.013 . . . . 10.0 109.958 -168.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.1 m -105.12 66.36 0.75 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 -172.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.41 138.77 56.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.158 -1.383 . . . . 10.0 108.643 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -83.44 89.74 7.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.503 -0.479 . . . . 10.0 111.473 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.86 -19.59 1.81 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.77 -14.3 45.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.447 1.021 . . . . 10.0 110.62 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -117.34 -52.95 2.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.272 1.029 . . . . 10.0 109.252 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.84 139.37 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.175 0.99 . . . . 10.0 110.31 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -93.04 145.18 24.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.541 -0.724 . . . . 10.0 109.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -34.83 -46.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 128.956 2.902 . . . . 10.0 110.405 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -32.3 -51.26 0.25 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.523 1.129 . . . . 10.0 112.221 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -52.37 -72.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.954 1.302 . . . . 10.0 110.59 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -57.96 -49.17 82.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 125.366 1.466 . . . . 10.0 112.161 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.81 -59.13 2.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.495 1.918 . . . . 10.0 109.916 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.11 -43.72 82.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.395 0.617 . . . . 10.0 109.827 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.83 61.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.607 0.763 . . . . 10.0 111.045 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.495 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.16 -32.74 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 120.799 -1.188 . . . . 10.0 109.813 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -53.26 40.97 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.535 -0.728 . . . . 10.0 109.572 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -39.3 -64.66 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.888 1.275 . . . . 10.0 114.067 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -139.9 30.77 2.03 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.99 -54.09 0.32 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.0 -0.889 . . . . 10.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 64.66 110.65 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.795 2.038 . . . . 10.0 110.77 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 163.47 -32.25 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.78 1.232 . . . . 10.0 109.644 -168.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' CG2' ' A' ' 60' ' ' ILE . 69.3 t -72.4 87.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.394 -0.816 . . . . 10.0 111.073 -173.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.47 -55.75 12.35 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.296 -1.002 . . . . 10.0 108.296 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -174.59 156.9 2.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.099 -1.445 . . . . 10.0 107.099 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -74.1 137.08 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 124.506 1.122 . . . . 10.0 110.4 168.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -110.14 -112.0 0.32 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 168.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.34 -95.67 0.06 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.117 1.341 . . . . 10.0 113.765 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.234 0 CA-C-O 116.922 -1.513 . . . . 10.0 107.8 -173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 106.313 -1.736 . . . . 10.0 106.313 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.86 170.4 12.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.5 102.82 4.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.089 1.756 . . . . 10.0 107.847 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -117.83 168.74 10.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.503 1.145 . . . . 10.0 109.694 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.55 126.13 49.57 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.608 -2.367 . . . . 10.0 104.608 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -93.92 105.79 17.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 103.582 -2.747 . . . . 10.0 103.582 167.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -68.29 151.71 46.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.381 -0.97 . . . . 10.0 108.381 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.29 131.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.188 1.395 . . . . 10.0 113.604 -169.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -73.81 -62.3 1.54 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 128.547 2.739 . . . . 10.0 109.319 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.53 -26.79 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.834 -1.174 . . . . 10.0 114.163 -169.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -179.35 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.125 1.463 . . . . 10.0 110.656 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 t -163.7 65.23 0.17 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -144.82 91.86 2.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -55.86 -3.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.206 1.187 . . . . 10.0 114.206 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -94.84 -42.52 8.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 10.0 109.771 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.46 -66.29 0.41 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.648 0.779 . . . . 10.0 109.184 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -40.56 -47.83 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.49 0.716 . . . . 10.0 111.769 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.2 tttm -58.62 -31.48 68.14 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.8 -31.32 58.86 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.548 0.613 . . . . 10.0 110.133 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -95.03 -35.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.879 1.272 . . . . 10.0 111.073 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 19.2 tt0 -36.45 -57.3 0.76 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.018 1.727 . . . . 10.0 110.724 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 p -51.98 -59.89 3.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.677 1.191 . . . . 10.0 111.204 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -56.28 -49.4 74.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.042 0.937 . . . . 10.0 110.929 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 30' ' ' VAL . 24.2 t -59.33 -43.9 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 122.02 -0.425 . . . . 10.0 110.269 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.71 -30.87 14.9 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 123.474 0.559 . . . . 10.0 112.968 171.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.73 -36.36 80.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.169 0.985 . . . . 10.0 110.569 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 95.14 0.54 Allowed 'General case' 0 C--O 1.22 -0.473 0 O-C-N 121.352 -0.842 . . . . 10.0 109.409 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -19.02 -50.53 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.979 2.911 . . . . 10.0 114.756 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.01 -18.98 20.93 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.676 1.132 . . . . 10.0 115.138 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 24' ' ' VAL . 2.1 t -81.63 108.25 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 119.392 -2.24 . . . . 10.0 105.699 170.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -36.14 78.16 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.023 -0.99 . . . . 10.0 109.912 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.13 154.76 9.15 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.974 -0.751 . . . . 10.0 108.974 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.34 142.21 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.496 1.518 . . . . 10.0 109.334 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 88.83 1.51 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 122.33 1.062 . . . . 10.0 108.94 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.56 124.46 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 124.834 1.253 . . . . 10.0 108.903 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 59.8 m-80 -145.48 48.97 1.25 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.015 0.526 . . . . 10.0 110.83 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -49.2 24.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.511 0.724 . . . . 10.0 110.333 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.79 -23.52 61.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.261 1.024 . . . . 10.0 111.869 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.22 -29.79 21.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.588 0.232 . . . . 10.0 110.423 174.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.24 -57.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.935 0.778 . . . . 10.0 111.777 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 174.32 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.061 1.344 . . . . 10.0 111.586 -170.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -91.1 132.84 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 169.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.36 112.05 18.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 42' ' ' VAL . 42.9 t -127.7 146.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.753 1.221 . . . . 10.0 109.001 -168.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -99.04 81.67 2.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 104.469 -2.419 . . . . 10.0 104.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 15.1 m-85 -85.88 127.91 34.7 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.079 -1.082 . . . . 10.0 108.079 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -86.08 82.17 8.19 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.38 -1.341 . . . . 10.0 107.38 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 -14.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.961 1.704 . . . . 10.0 113.528 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.15 -26.74 60.48 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.017 2.127 . . . . 10.0 108.775 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -121.19 -56.18 1.92 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.388 1.075 . . . . 10.0 108.496 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.12 138.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 124.131 0.972 . . . . 10.0 108.935 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 t -89.12 158.5 17.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.488 1.137 . . . . 10.0 110.202 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 70' ' ' ILE . 18.1 m -47.45 -37.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 128.062 2.545 . . . . 10.0 107.744 165.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -56.06 -25.76 46.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 119.793 1.179 . . . . 10.0 112.853 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.45 -60.99 2.37 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.71 1.595 . . . . 10.0 109.104 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -65.28 -53.16 43.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 124.785 1.234 . . . . 10.0 112.599 -171.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.91 -56.37 4.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.681 1.992 . . . . 10.0 110.163 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -59.76 -44.82 93.68 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.419 1.488 . . . . 10.0 108.87 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.27 -46.74 72.76 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.57 -0.706 . . . . 10.0 112.004 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.51 -34.82 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 O-C-N 120.824 -1.172 . . . . 10.0 110.335 178.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -53.52 -42.34 67.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.776 -1.203 . . . . 10.0 110.394 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -53.6 -65.73 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.261 1.025 . . . . 10.0 112.72 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -136.42 34.48 2.74 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.188 -0.945 . . . . 10.0 113.543 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.05 -57.26 0.26 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.686 0.676 . . . . 10.0 112.484 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 62.64 102.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.445 1.898 . . . . 10.0 111.775 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t0 172.57 -40.07 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.752 2.021 . . . . 10.0 107.655 -168.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.553 HG23 HG21 ' A' ' 60' ' ' ILE . 51.4 t -69.06 98.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 120.526 -1.359 . . . . 10.0 112.657 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.99 -55.08 5.21 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.89 -0.782 . . . . 10.0 108.89 167.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -170.47 146.28 2.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.346 1.459 . . . . 10.0 107.125 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.73 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -73.55 151.03 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 123.886 0.875 . . . . 10.0 109.594 171.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -150.83 142.71 23.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.25 -120.57 1.06 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 -169.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 CA-C-N 117.857 0.828 . . . . 10.0 111.161 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 117.662 -1.161 . . . . 10.0 107.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.85 126.37 44.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.086 1.354 . . . . 10.0 109.337 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 pm0 -72.99 72.26 1.12 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.081 1.352 . . . . 10.0 110.337 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 160.65 30.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.745 1.259 . . . . 10.0 108.289 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -120.75 115.5 23.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 67' ' ' VAL . 74.0 mt -86.3 92.24 8.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.912 -2.255 . . . . 10.0 104.912 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -67.09 142.73 57.02 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.72 130.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.599 1.56 . . . . 10.0 112.784 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -81.72 -53.73 5.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.47 2.708 . . . . 10.0 110.479 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.79 -40.13 0.09 OUTLIER Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.237 -0.506 . . . . 10.0 112.428 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 156.92 21.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.55 0.675 . . . . 10.0 110.994 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.17 11.57 3.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.901 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.6 t -85.25 94.25 8.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.817 0.817 . . . . 10.0 109.101 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -57.63 -4.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.325 1.05 . . . . 10.0 113.651 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -92.9 -32.06 14.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.778 1.172 . . . . 10.0 111.15 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.4 m -63.35 -74.45 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -46.62 -49.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 112.944 0.72 . . . . 10.0 112.944 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.27 -33.45 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.209 0.818 . . . . 10.0 113.209 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.95 67.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.938 0.495 . . . . 10.0 109.911 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.39 -49.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 118.287 -0.863 . . . . 10.0 109.88 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -38.71 -49.29 1.57 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.977 1.711 . . . . 10.0 110.883 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.69 -51.33 50.57 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 10.0 111.152 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.94 -42.24 63.64 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.871 0.868 . . . . 10.0 111.568 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.59 -41.19 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.097 -1.002 . . . . 10.0 109.898 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.03 -26.33 19.31 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.702 1.144 . . . . 10.0 113.866 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.63 -29.83 67.4 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.845 1.323 . . . . 10.0 110.685 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 111.98 5.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.109 0.868 . . . . 10.0 109.407 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -42.62 -41.1 2.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.566 1.947 . . . . 10.0 112.693 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.54 -26.99 57.95 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.262 0.934 . . . . 10.0 113.904 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.96 112.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 120.203 -1.763 . . . . 10.0 106.616 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -79.39 -37.77 36.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 10.0 109.758 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.82 161.29 17.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.659 -1.237 . . . . 10.0 107.659 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.73 134.16 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.012 1.325 . . . . 10.0 108.25 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -143.36 89.57 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.49 1.116 . . . . 10.0 110.072 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 t -66.8 134.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.218 1.007 . . . . 10.0 110.286 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.8 m-20 -156.79 49.45 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.871 0.468 . . . . 10.0 110.933 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -54.39 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 10.0 111.943 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.65 -38.11 86.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.566 0.746 . . . . 10.0 111.208 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -73.51 -34.77 65.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.919 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.33 -73.35 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.61 -1.396 . . . . 10.0 109.61 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 -172.35 1.6 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.094 1.758 . . . . 10.0 107.666 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 35' ' ' VAL . 41.9 t -99.06 117.8 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -100.88 130.1 46.84 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 44.5 t -136.55 149.54 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.87 -1.53 . . . . 10.0 106.87 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -111.04 85.77 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 104.915 -2.254 . . . . 10.0 104.915 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 39.9 m-85 -92.11 141.61 28.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.673 1.589 . . . . 10.0 108.276 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -89.89 93.3 9.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.617 0.767 . . . . 10.0 109.969 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.6 -14.67 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.714 -0.66 . . . . 10.0 112.296 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.3 -0.25 57.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.801 0.728 . . . . 10.0 109.685 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -130.52 -53.25 1.09 Allowed 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.675 -0.641 . . . . 10.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.89 164.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 118.701 0.682 . . . . 10.0 110.72 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.5 m -111.17 147.96 33.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 46' ' ' PHE . 15.4 m -42.26 -34.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 C-N-CA 127.068 2.147 . . . . 10.0 110.148 167.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -48.29 -28.41 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.014 0.825 . . . . 10.0 112.324 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -68.9 -70.79 0.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.78 0.832 . . . . 10.0 109.008 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -59.33 -53.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.239 1.416 . . . . 10.0 113.787 -172.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.11 -56.92 3.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.124 1.77 . . . . 10.0 109.953 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -58.91 -46.25 88.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.906 0.882 . . . . 10.0 109.459 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.5 67.62 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.767 -0.583 . . . . 10.0 111.207 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -71.07 -38.6 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.09 -1.006 . . . . 10.0 110.037 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -54.5 -41.18 69.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.523 -1.361 . . . . 10.0 110.293 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -53.95 -65.53 0.55 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.424 1.09 . . . . 10.0 112.925 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.28 50.39 1.8 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.655 -0.653 . . . . 10.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.79 -55.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 64.0 112.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.255 2.222 . . . . 10.0 110.432 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 168.34 -41.85 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.461 0 O-C-N 121.543 -0.723 . . . . 10.0 109.337 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 60' ' ' ILE . 88.1 t -75.09 84.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.028 0.442 . . . . 10.0 110.885 -168.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.28 -50.38 60.58 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 174.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -163.79 153.0 14.22 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 172.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.14 147.21 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 124.904 1.282 . . . . 10.0 108.28 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -81.62 -82.49 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.157 -0.312 . . . . 10.0 110.157 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.73 -71.54 0.6 Allowed Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.02 1.168 . . . . 10.0 116.02 -169.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 . . . . . 0 C--O 1.251 1.145 0 N-CA-C 105.658 -1.978 . . . . 10.0 105.658 -179.012 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -130.24 170.0 14.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.738 1.215 . . . . 10.0 108.564 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -141.04 113.42 8.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -120.54 -178.63 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.973 0.909 . . . . 10.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -137.87 116.6 12.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.128 -1.805 . . . . 10.0 106.128 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 HG22 ' A' ' 70' ' ' ILE . 1.2 mt -86.28 94.19 9.27 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 104.58 -2.378 . . . . 10.0 104.58 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -59.32 148.02 33.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.1 128.16 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.205 1.402 . . . . 10.0 110.797 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.9 -56.52 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.808 2.043 . . . . 10.0 108.016 170.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.82 -37.03 0.05 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.513 -1.327 . . . . 10.0 113.909 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 161.26 30.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.062 0.931 . . . . 10.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -143.31 21.28 1.89 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.246 0.618 . . . . 10.0 109.955 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.5 t -97.39 101.37 12.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -66.8 2.36 1.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -45.52 6.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.969 1.308 . . . . 10.0 110.641 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.0 m -49.43 -68.88 0.14 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.377 1.471 . . . . 10.0 109.526 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.784 HG21 HG11 ' A' ' 35' ' ' VAL . 2.0 m -39.85 -45.65 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 C-N-CA 123.972 0.909 . . . . 10.0 112.297 172.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 6.0 tttp -56.17 -31.17 63.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.158 1.17 . . . . 10.0 114.158 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -31.8 52.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.199 0.454 . . . . 10.0 110.524 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' C ' ' A' ' 59' ' ' ALA . 2.5 t -97.75 -33.58 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.855 1.662 . . . . 10.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 25.4 tt0 -43.3 -47.82 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.994 1.318 . . . . 10.0 110.592 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -46.39 -61.37 1.83 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.987 0.915 . . . . 10.0 110.996 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -57.56 -50.35 73.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.385 1.074 . . . . 10.0 110.877 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 20' ' ' VAL . 97.2 t -55.53 -47.29 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.757 0.823 . . . . 10.0 109.57 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.16 -38.92 88.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.716 0.674 . . . . 10.0 112.204 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -42.57 99.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.359 1.063 . . . . 10.0 110.724 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 112.58 1.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.796 -0.565 . . . . 10.0 111.216 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -35.85 -56.09 0.71 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.852 2.461 . . . . 10.0 112.303 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.94 -19.84 51.62 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.251 0.46 . . . . 10.0 114.251 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.45 109.17 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 119.17 -2.371 . . . . 10.0 107.498 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -74.84 -31.12 61.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.806 -1.088 . . . . 10.0 109.415 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 158.07 8.91 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.2 m -133.22 138.61 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.358 1.063 . . . . 10.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -158.48 101.14 1.68 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.784 HG11 HG21 ' A' ' 17' ' ' VAL . 36.9 t -89.9 123.03 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 C-N-CA 125.339 1.456 . . . . 10.0 107.732 176.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -137.19 53.1 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.46 0.573 . . . . 10.0 110.871 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 37' ' ' LEU . 1.2 mp -44.99 -47.67 11.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.465 1.106 . . . . 10.0 112.136 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.32 -33.39 73.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.491 0.716 . . . . 10.0 111.902 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.0 58.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.34 -64.04 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.82 -170.23 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.941 1.296 . . . . 10.0 110.822 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.98 128.29 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.778 1.231 . . . . 10.0 108.824 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.96 71.39 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.744 1.618 . . . . 10.0 109.04 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.634 HG23 ' CG2' ' A' ' 42' ' ' VAL . 12.4 t -84.78 152.31 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.836 1.254 . . . . 10.0 109.393 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 t -110.15 71.32 0.75 Allowed 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.257 -1.757 . . . . 10.0 106.257 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 12.4 m-85 -72.03 130.11 40.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.355 -1.293 . . . . 10.0 109.107 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -80.93 85.4 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.281 -0.887 . . . . 10.0 109.838 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.35 -21.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.902 1.281 . . . . 10.0 113.845 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.78 -19.91 51.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.296 0.953 . . . . 10.0 109.706 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -116.65 -53.96 2.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.889 1.275 . . . . 10.0 110.466 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -138.2 159.71 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.077 0.551 . . . . 10.0 109.938 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.5 p -108.37 161.51 14.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 m -31.86 -42.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.238 2.215 . . . . 10.0 111.656 168.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -29.6 -54.47 0.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.65 1.58 . . . . 10.0 111.303 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.11 -59.42 5.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.376 1.084 . . . . 10.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.41 HG23 ' CG1' ' A' ' 24' ' ' VAL . 3.6 mm -62.61 -58.67 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.623 1.569 . . . . 10.0 111.955 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' A' ' 67' ' ' VAL . . . -41.46 -55.31 2.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 128.003 2.521 . . . . 10.0 110.007 172.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -56.86 -48.69 77.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.891 0.853 . . . . 10.0 110.557 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -56.23 -45.6 79.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.454 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.66 -35.84 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 120.558 -1.339 . . . . 10.0 109.967 178.05 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.26 -39.77 73.14 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.169 1.349 . . . . 10.0 111.755 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -49.43 -63.23 1.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.168 0.587 . . . . 10.0 112.341 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -134.81 13.34 3.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.532 0.938 . . . . 10.0 113.532 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -55.21 0.55 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.062 -0.854 . . . . 10.0 113.241 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 64.33 108.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.973 2.109 . . . . 10.0 111.256 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.75 -36.58 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.187 0.995 . . . . 10.0 109.951 -167.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 57' ' ' ALA . 66.2 t -73.03 87.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.409 -0.807 . . . . 10.0 111.773 -169.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.79 10.36 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.288 -0.882 . . . . 10.0 110.136 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -174.13 152.85 1.93 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.579 -1.638 . . . . 10.0 106.579 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.676 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -93.38 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.815 0.846 . . . . 10.0 110.038 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -106.39 -103.47 0.34 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 169.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.04 -116.48 8.84 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.975 1.261 . . . . 10.0 113.168 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.792 1.637 . . . . 10.0 107.296 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 114.865 1.431 . . . . 10.0 114.865 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.53 173.49 10.2 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 126.106 2.128 . . . . 10.0 108.341 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 114.39 19.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.688 2.395 . . . . 10.0 105.379 170.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -123.01 168.05 12.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.946 -1.501 . . . . 10.0 106.946 168.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.64 122.24 32.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -91.45 97.43 11.07 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 172.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.86 153.28 42.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.604 0.761 . . . . 10.0 109.379 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.27 131.63 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -70.0 -56.91 5.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 130.491 3.516 . . . . 10.0 109.824 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.32 -30.21 0.18 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.451 -0.638 . . . . 10.0 112.423 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 169.58 10.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.133 0.967 . . . . 10.0 111.557 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.3 m -156.07 40.73 0.37 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.42 89.56 3.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -52.93 -16.28 1.0 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.132 0.973 . . . . 10.0 113.43 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -82.6 -39.64 21.92 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.196 -0.94 . . . . 10.0 109.835 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -57.53 -71.24 0.11 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.772 1.295 . . . . 10.0 108.31 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -46.46 -51.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.219 0.452 . . . . 10.0 112.219 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -28.93 68.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.366 0.984 . . . . 10.0 113.01 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.77 61.75 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 121.719 -0.613 . . . . 10.0 110.923 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.0 -44.59 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 118.156 -0.926 . . . . 10.0 110.633 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -44.95 -46.91 11.3 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.927 1.291 . . . . 10.0 110.302 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -50.14 -60.26 3.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.016 0.526 . . . . 10.0 111.553 174.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -58.7 -43.85 90.18 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.476 0.71 . . . . 10.0 111.767 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 56' ' ' ILE . 6.3 t -53.45 -39.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.221 1.008 . . . . 10.0 110.21 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -45.92 -27.28 2.32 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.317 0.96 . . . . 10.0 114.423 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.23 -26.3 61.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.15 1.475 . . . . 10.0 112.149 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.77 113.56 2.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.179 0.9 . . . . 10.0 110.542 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -39.78 -45.9 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.194 2.198 . . . . 10.0 111.735 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -17.9 75.32 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.785 0.674 . . . . 10.0 114.785 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.91 107.54 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 118.683 -2.657 . . . . 10.0 107.245 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 t -79.35 -29.3 42.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.3 157.64 13.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 44' ' ' VAL . 5.9 m -134.43 135.53 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.158 0.983 . . . . 10.0 109.103 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -149.21 87.22 1.52 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 t -73.19 117.4 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 123.726 0.81 . . . . 10.0 110.275 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.42 49.07 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.555 0.742 . . . . 10.0 111.437 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -52.42 -39.86 61.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.472 0.653 . . . . 10.0 112.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.91 -39.55 90.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.463 1.505 . . . . 10.0 110.69 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.2 -33.65 24.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.189 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.18 -67.65 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 179.01 5.16 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.355 1.862 . . . . 10.0 110.842 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -92.56 127.81 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 124.944 1.298 . . . . 10.0 107.941 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.83 94.02 4.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.33 1.052 . . . . 10.0 109.494 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' CG2' ' A' ' 42' ' ' VAL . 31.4 t -104.86 146.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.957 1.703 . . . . 10.0 107.738 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -103.8 68.89 0.94 Allowed 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.156 -2.165 . . . . 10.0 105.156 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 m-85 -66.78 128.43 36.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.915 -1.493 . . . . 10.0 108.662 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 29.5 t0 -79.95 85.4 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.83 -23.36 0.42 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.189 1.396 . . . . 10.0 113.385 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.04 -15.15 52.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.361 1.064 . . . . 10.0 110.603 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -121.48 -56.13 1.9 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.769 1.228 . . . . 10.0 109.42 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.41 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.227 1.411 . . . . 10.0 108.409 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -156.51 167.23 31.08 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.537 -1.283 . . . . 10.0 107.537 168.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -34.24 -42.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 128.116 2.566 . . . . 10.0 112.237 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -35.05 -41.48 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.017 1.327 . . . . 10.0 113.224 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.92 -67.38 0.51 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.869 0.843 . . . . 10.0 110.627 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 24' ' ' VAL . 3.6 mm -55.92 -55.81 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.846 1.259 . . . . 10.0 112.97 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.61 -56.9 4.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.813 2.045 . . . . 10.0 109.731 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.92 -49.62 65.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.55 0.691 . . . . 10.0 110.131 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.96 78.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.793 -0.639 . . . . 10.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -69.52 -36.86 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 120.656 -1.278 . . . . 10.0 110.096 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.32 -40.87 71.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.499 -1.376 . . . . 10.0 111.645 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -51.5 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.154 0.888 . . . . 10.0 112.54 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.0 46.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.24 0.459 . . . . 10.0 112.24 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.57 -59.65 0.11 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.02 110.64 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.41 2.284 . . . . 10.0 110.919 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 t0 169.78 -38.55 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.93 1.692 . . . . 10.0 109.224 -167.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 60' ' ' ILE . 73.4 t -74.93 90.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 120.484 -1.385 . . . . 10.0 112.382 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.9 -56.84 4.62 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.467 -0.77 . . . . 10.0 110.708 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -163.63 143.74 8.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.848 -1.538 . . . . 10.0 106.848 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.666 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp -83.52 135.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 C-N-CA 124.7 1.2 . . . . 10.0 108.311 172.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.86 135.91 47.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.144 -1.799 . . . . 10.0 106.144 170.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -120.44 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 107.393 -2.283 . . . . 10.0 107.393 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.365 -1.302 . . . . 10.0 109.045 169.519 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttp . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.93 -174.55 4.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.905 0.775 . . . . 10.0 109.978 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.92 107.81 5.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.252 2.221 . . . . 10.0 106.369 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -110.29 161.34 15.71 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.24 -1.393 . . . . 10.0 107.24 168.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.38 115.55 26.77 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 6' ' ' LEU . 20.9 mt -81.99 96.98 7.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.948 -1.871 . . . . 10.0 105.948 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -65.0 155.71 33.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 10.0 109.662 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' A' ' 66' ' ' ASP . 2.1 t -63.12 129.61 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.302 1.441 . . . . 10.0 110.447 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ASP . 28.1 tt0 -75.14 -43.63 51.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.962 1.705 . . . . 10.0 107.408 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.37 12.19 0.96 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.533 -1.148 . . . . 10.0 113.371 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -177.04 1.96 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.714 1.757 . . . . 10.0 109.722 169.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 p -155.53 15.16 0.37 Allowed 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.034 -0.416 . . . . 10.0 111.362 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -99.35 95.29 6.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -64.2 2.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.468 0.914 . . . . 10.0 113.468 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -94.0 -48.36 6.28 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.781 1.173 . . . . 10.0 110.046 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.3 m -48.21 -70.16 0.1 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.536 1.134 . . . . 10.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 m -38.45 -48.46 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.35 1.06 . . . . 10.0 111.89 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.85 -38.14 89.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.359 1.064 . . . . 10.0 112.535 -174.145 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.4 69.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.5 t -73.46 -38.14 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.68 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 28.8 tt0 -46.2 -49.81 16.57 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.922 1.289 . . . . 10.0 110.358 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -50.57 72.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.901 0.381 . . . . 10.0 111.264 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -70.79 -10.49 59.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.947 0.721 . . . . 10.0 112.947 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 -43.0 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.624 1.17 . . . . 10.0 108.312 169.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.54 -30.35 19.64 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.886 1.231 . . . . 10.0 114.2 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.21 -31.24 72.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.145 0.973 . . . . 10.0 111.462 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.3 105.19 1.37 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -31.8 -42.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.054 2.142 . . . . 10.0 113.836 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.83 -20.43 47.97 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.426 1.012 . . . . 10.0 114.808 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.32 107.93 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 119.542 -2.152 . . . . 10.0 106.833 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -77.05 -29.4 55.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.185 -0.916 . . . . 10.0 109.378 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.08 13.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.182 -1.784 . . . . 10.0 106.182 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.84 119.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -136.31 97.87 3.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.282 1.033 . . . . 10.0 108.951 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.47 114.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.513 -0.921 . . . . 10.0 108.513 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -127.05 47.61 2.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.322 0.51 . . . . 10.0 111.963 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -49.53 -48.57 48.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 10.0 112.291 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -35.41 74.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.588 0.755 . . . . 10.0 110.99 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.08 -30.64 31.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.894 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.21 -69.72 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 123.98 0.8 . . . . 10.0 111.218 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -170.44 174.31 5.23 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.941 1.696 . . . . 10.0 112.627 -169.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.2 t -88.77 103.57 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 124.787 1.235 . . . . 10.0 107.971 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.2 116.36 30.26 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 57.0 t -136.3 135.13 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 -171.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.4 t -94.71 73.58 3.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.307 -1.368 . . . . 10.0 107.307 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.487 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 43.1 m-85 -68.67 136.41 52.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.519 -1.218 . . . . 10.0 109.281 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.71 87.03 7.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.545 0.688 . . . . 10.0 110.15 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.13 -20.1 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.08 -1.418 . . . . 10.0 113.623 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.67 -18.84 32.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 119.12 0.873 . . . . 10.0 110.215 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -117.45 -44.93 2.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.364 0.666 . . . . 10.0 109.745 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.53 -172.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.044 0.938 . . . . 10.0 109.425 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -142.62 159.18 42.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.737 0.779 . . . . 10.0 109.403 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 70' ' ' ILE . 34.6 m -44.83 -36.44 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 128.274 2.63 . . . . 10.0 110.294 170.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -41.92 -50.3 4.51 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.434 1.016 . . . . 10.0 110.736 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.24 -49.84 74.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.587 1.185 . . . . 10.0 111.46 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -71.52 -58.46 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.256 1.822 . . . . 10.0 111.674 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.99 -59.21 1.51 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.348 2.259 . . . . 10.0 109.57 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -49.25 -51.99 30.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.442 1.497 . . . . 10.0 109.888 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.56 80.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.5 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -68.77 -58.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -37.42 -47.51 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.224 1.01 . . . . 10.0 113.007 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -42.92 -60.08 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.019 0.927 . . . . 10.0 113.407 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -136.63 -30.45 0.9 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.086 1.143 . . . . 10.0 114.086 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.8 94.43 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.51 172.18 0.19 Allowed 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.826 1.65 . . . . 10.0 110.112 -174.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' A' ' 8' ' ' VAL 0.336 7.5 t70 81.55 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.904 1.281 . . . . 10.0 112.431 177.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG23 HG21 ' A' ' 60' ' ' ILE . 3.4 t -120.38 93.95 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.223 1.409 . . . . 10.0 109.623 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.0 4.1 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.03 159.62 1.35 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.84 1.256 . . . . 10.0 107.791 -175.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -71.34 139.96 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 108.28 -1.008 . . . . 10.0 108.28 166.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -89.9 -44.75 9.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.7 2.0 . . . . 10.0 109.796 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.84 -88.49 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.674 1.131 . . . . 10.0 113.851 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.909 0 CA-C-O 115.671 -2.109 . . . . 10.0 107.463 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.297 -0.382 . . . . 10.0 110.104 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -140.89 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.89 2.076 . . . . 10.0 106.726 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -122.99 121.16 35.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.629 -2.73 . . . . 10.0 103.629 167.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -117.82 178.25 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.52 121.71 12.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 -177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.02 90.34 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 103.631 -2.729 . . . . 10.0 103.631 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.46 141.77 58.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -67.71 126.54 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.849 1.659 . . . . 10.0 112.45 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -75.03 -55.26 5.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.992 2.117 . . . . 10.0 109.319 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.02 -35.75 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.13 -1.034 . . . . 10.0 113.313 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.86 158.87 26.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.929 0.865 . . . . 10.0 109.24 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.71 20.93 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.918 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.2 113.14 25.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.64 -1.615 . . . . 10.0 106.64 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.02 -16.8 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.744 -0.383 . . . . 10.0 111.511 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -83.92 -44.17 14.52 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.709 0.686 . . . . 10.0 110.332 -169.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -43.91 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.978 1.711 . . . . 10.0 109.195 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 35' ' ' VAL . 6.2 m -43.55 -47.85 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 112.689 0.626 . . . . 10.0 112.689 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 9.7 tptt -44.25 -41.97 6.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.123 1.157 . . . . 10.0 114.123 174.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.86 -34.91 42.87 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.716 0.406 . . . . 10.0 110.379 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.4 -31.84 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.319 1.447 . . . . 10.0 111.123 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 35.2 tt0 -43.6 -47.49 7.49 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.259 1.423 . . . . 10.0 109.323 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -55.04 -58.69 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.651 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -56.73 -49.66 74.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.947 1.299 . . . . 10.0 110.271 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 56' ' ' ILE . 35.7 t -60.23 -49.96 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.568 0.747 . . . . 10.0 109.981 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.6 -32.14 38.57 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.007 0.813 . . . . 10.0 112.598 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.7 -32.35 73.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.385 1.074 . . . . 10.0 110.498 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 109.37 3.81 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 121.214 -0.929 . . . . 10.0 109.325 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -42.29 -40.42 2.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.755 1.622 . . . . 10.0 112.899 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.07 -18.39 54.6 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.094 1.33 . . . . 10.0 114.898 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.46 113.34 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 169.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -77.28 -32.96 55.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.331 -0.849 . . . . 10.0 110.69 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -171.5 158.97 5.38 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.894 -1.521 . . . . 10.0 106.894 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.58 136.88 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 105.995 -1.854 . . . . 10.0 105.995 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.89 84.15 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.575 1.178 . . . . 10.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 17' ' ' VAL . 48.1 t -64.18 118.77 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.313 1.445 . . . . 10.0 110.302 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 42.6 m-80 -144.69 50.12 1.28 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.942 0.497 . . . . 10.0 111.43 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mp -48.2 -58.03 5.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.37 1.068 . . . . 10.0 112.359 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.77 -43.21 94.0 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.94 0.876 . . . . 10.0 110.553 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.34 -29.34 68.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.733 -1.122 . . . . 10.0 111.019 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.27 -72.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.462 1.03 . . . . 10.0 111.098 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.37 -178.05 3.87 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.324 1.45 . . . . 10.0 110.25 -173.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -87.6 106.8 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -82.33 140.6 33.46 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.329 -1.359 . . . . 10.0 107.329 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -160.27 140.78 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 118.669 0.668 . . . . 10.0 109.45 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -116.91 82.91 1.88 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 -169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.676 ' CD2' HG12 ' A' ' 53' ' ' VAL . 44.0 m-85 -70.06 172.89 7.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.467 -0.788 . . . . 10.0 108.967 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -127.95 101.51 6.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 10.0 108.942 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -18.45 24.88 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.174 0.59 . . . . 10.0 111.881 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.03 -11.89 59.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.697 0.68 . . . . 10.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -121.29 -56.25 1.91 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.487 1.115 . . . . 10.0 109.246 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.1 159.49 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.454 1.102 . . . . 10.0 111.237 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 p -107.49 148.48 29.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.287 0.565 . . . . 10.0 109.991 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 46' ' ' PHE . 21.4 m -37.62 -45.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 C-N-CA 129.063 2.945 . . . . 10.0 110.677 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -35.67 -49.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.773 0.829 . . . . 10.0 112.016 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -54.25 -63.93 0.99 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.885 0.874 . . . . 10.0 110.429 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.491 HG21 ' HE1' ' A' ' 46' ' ' PHE . 4.5 mp -65.89 -50.73 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.184 0.994 . . . . 10.0 112.776 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.95 -62.84 0.58 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.924 2.09 . . . . 10.0 109.192 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.07 -45.06 79.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.605 0.717 . . . . 10.0 110.268 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.73 69.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.487 0.715 . . . . 10.0 110.872 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.639 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.69 -34.87 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 120.969 -1.082 . . . . 10.0 110.117 178.383 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -57.62 -33.56 68.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.871 1.214 . . . . 10.0 111.738 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -56.9 -68.4 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.19 0.904 . . . . 10.0 111.862 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -135.49 33.6 3.01 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.84 -57.81 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.22 -0.767 . . . . 10.0 112.216 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.49 107.17 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.733 2.013 . . . . 10.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t70 171.49 -35.52 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 124.813 1.245 . . . . 10.0 110.171 -168.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.639 HG23 ' CG2' ' A' ' 60' ' ' ILE . 65.1 t -69.9 85.81 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.546 -0.721 . . . . 10.0 111.063 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.84 -49.78 55.51 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -167.14 148.51 5.8 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.585 -1.635 . . . . 10.0 106.585 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.8 pp -85.17 136.34 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 169.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.92 140.37 32.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.48 -91.8 0.1 OUTLIER Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.583 0.611 . . . . 10.0 111.885 167.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 116.427 -1.749 . . . . 10.0 107.621 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 118.9 -0.572 . . . . 10.0 110.146 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.98 -176.25 2.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.597 1.559 . . . . 10.0 108.399 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -144.71 108.73 4.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -115.22 164.49 14.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.752 1.263 . . . . 10.0 108.809 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -122.23 114.59 21.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 127.004 2.122 . . . . 10.0 106.709 -167.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' ILE . 88.5 mt -89.79 85.79 6.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -59.96 149.75 30.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.04 0.936 . . . . 10.0 109.836 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.84 129.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.636 1.574 . . . . 10.0 111.86 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.59 -64.33 0.9 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 130.024 3.33 . . . . 10.0 108.799 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.08 -31.39 0.19 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.248 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 169.03 5.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.621 1.211 . . . . 10.0 110.048 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.7 t -158.86 39.32 0.22 Allowed 'General case' 0 C--N 1.334 -0.074 0 O-C-N 121.568 -0.708 . . . . 10.0 109.228 -169.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.09 97.55 6.14 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.87 -14.37 2.38 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.526 0.936 . . . . 10.0 113.526 174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -86.54 -47.97 8.77 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.509 1.05 . . . . 10.0 109.38 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.4 m -45.96 -65.45 0.55 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.676 1.19 . . . . 10.0 110.198 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 m -48.71 -48.18 15.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.23 0.468 . . . . 10.0 110.894 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.3 tttm -54.71 -34.62 62.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.23 57.62 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.78 -33.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.509 1.124 . . . . 10.0 111.085 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.1 tt0 -41.15 -55.9 2.5 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 10.0 109.727 176.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.93 96.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.627 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m -56.88 -58.54 7.7 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.202 0.601 . . . . 10.0 109.989 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -49.99 -32.92 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.107 1.363 . . . . 10.0 112.446 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -22.8 4.05 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 114.637 0.615 . . . . 10.0 114.637 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.66 -32.28 73.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.422 1.489 . . . . 10.0 111.429 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.7 104.04 0.62 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.06 -37.07 14.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.965 1.306 . . . . 10.0 111.832 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.42 70.46 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.443 1.02 . . . . 10.0 113.977 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.75 106.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 120.192 -1.769 . . . . 10.0 107.501 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 m -73.37 -40.12 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.8 -1.091 . . . . 10.0 110.196 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.79 156.79 23.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.376 -1.342 . . . . 10.0 107.376 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.89 127.7 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.36 98.98 5.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 107.216 -1.402 . . . . 10.0 107.216 170.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.73 112.59 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.96 1.304 . . . . 10.0 108.441 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.99 48.3 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.632 0.604 . . . . 10.0 112.632 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.4 -46.54 62.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.618 -0.676 . . . . 10.0 112.304 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.1 -31.71 71.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.137 0.975 . . . . 10.0 111.017 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.01 18.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.861 0.362 . . . . 10.0 111.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.3 -78.49 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -1.379 . . . . 10.0 109.652 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 178.56 5.4 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.365 1.866 . . . . 10.0 109.256 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.19 105.44 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -102.0 125.88 48.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 10.0 108.119 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 74.4 t -136.54 142.35 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.979 0.895 . . . . 10.0 108.746 -168.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -101.69 77.5 1.74 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 105.849 -1.908 . . . . 10.0 105.849 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG12 ' A' ' 53' ' ' VAL . 28.1 m-85 -72.44 138.04 46.84 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.048 -1.887 . . . . 10.0 107.509 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -90.49 95.78 10.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.035 -0.357 . . . . 10.0 110.035 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -19.94 14.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.881 0.872 . . . . 10.0 112.818 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.75 -15.86 59.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 119.23 0.923 . . . . 10.0 109.878 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -119.99 -54.39 2.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.752 0.821 . . . . 10.0 110.346 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.0 161.72 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.417 0.687 . . . . 10.0 110.782 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.9 t -110.3 156.38 20.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.485 1.136 . . . . 10.0 110.444 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 70' ' ' ILE . 36.0 m -45.14 -39.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.098 2.559 . . . . 10.0 109.304 166.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -43.39 -39.27 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.445 1.02 . . . . 10.0 111.844 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.4 -58.9 3.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.425 0.557 . . . . 10.0 111.034 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.18 -50.09 71.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 120.84 -1.163 . . . . 10.0 112.163 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.97 -54.85 4.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.161 1.785 . . . . 10.0 109.352 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.37 -49.15 77.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.815 0.817 . . . . 10.0 109.879 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.69 67.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.63 0.772 . . . . 10.0 111.356 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -72.11 -42.94 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 O-C-N 120.962 -1.087 . . . . 10.0 110.878 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.287 0.1 OUTLIER -66.5 -26.7 67.29 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.723 1.601 . . . . 10.0 112.13 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -45.63 -66.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.059 0.944 . . . . 10.0 112.859 171.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.76 15.09 2.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.099 0.777 . . . . 10.0 113.099 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.2 -56.16 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.528 1.061 . . . . 10.0 111.461 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.31 113.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 10.0 112.292 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 163.13 -39.25 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 126.647 1.979 . . . . 10.0 108.487 -169.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 HG21 ' A' ' 60' ' ' ILE . 40.3 t -65.22 93.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 121.649 -0.657 . . . . 10.0 111.312 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.25 -56.97 5.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -170.61 162.86 8.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.728 -1.582 . . . . 10.0 106.728 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -83.25 144.42 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.628 1.571 . . . . 10.0 110.474 170.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -138.73 149.71 45.35 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 106.43 -1.693 . . . . 10.0 106.43 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.74 -129.99 3.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 107.191 -2.364 . . . . 10.0 107.191 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? . . . . . 0 C--O 1.251 1.142 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 167.283 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttp . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.47 142.14 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.949 0.881 . . . . 10.0 112.453 -167.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.76 82.27 7.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.038 0.935 . . . . 10.0 110.473 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -75.96 150.31 37.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.4 132.11 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 103.809 -2.663 . . . . 10.0 103.809 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -108.4 92.89 4.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.007 -2.22 . . . . 10.0 105.007 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -61.71 146.65 48.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.708 -1.587 . . . . 10.0 108.534 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.72 134.4 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.961 1.304 . . . . 10.0 113.42 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -78.09 -68.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.686 1.995 . . . . 10.0 109.063 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.0 -38.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.018 -0.61 . . . . 10.0 113.252 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.04 160.43 6.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 117.961 0.88 . . . . 10.0 111.858 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 m -149.22 48.65 0.97 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -126.4 91.43 3.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.332 1.053 . . . . 10.0 108.402 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.5 -5.33 0.52 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.03 -37.69 14.96 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 120.87 -1.144 . . . . 10.0 110.291 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -58.72 -71.94 0.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 171.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -43.6 -52.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -56.84 -31.18 64.5 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.967 0.728 . . . . 10.0 112.967 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.36 68.19 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG11 ' C ' ' A' ' 59' ' ' ALA . 59.1 t -88.05 -40.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 123.939 0.895 . . . . 10.0 109.749 176.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -41.62 -48.5 4.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.889 0.876 . . . . 10.0 110.533 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -53.16 61.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.959 0.409 . . . . 10.0 111.123 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -62.52 -16.86 58.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.106 1.762 . . . . 10.0 113.043 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -89.22 -42.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.477 1.111 . . . . 10.0 109.91 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.96 -26.18 47.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.748 1.166 . . . . 10.0 112.878 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -69.31 -28.26 66.11 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.948 0.874 . . . . 10.0 111.719 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.9 110.46 2.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.948 -0.701 . . . . 10.0 110.036 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -35.64 -44.16 0.31 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.404 2.282 . . . . 10.0 111.403 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 8.64 5.89 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.185 1.234 . . . . 10.0 116.185 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.21 111.49 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -74.45 -31.18 62.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.59 161.31 9.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.24 145.51 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.298 1.039 . . . . 10.0 109.757 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.35 82.89 0.84 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.988 0.899 . . . . 10.0 109.304 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.31 140.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.784 0.834 . . . . 10.0 109.597 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -161.17 44.44 0.17 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-O 121.172 0.51 . . . . 10.0 111.787 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.83 -46.64 64.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.507 0.723 . . . . 10.0 112.819 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -70.39 -24.78 63.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.965 1.306 . . . . 10.0 110.783 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.37 -27.27 19.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.136 0.574 . . . . 10.0 111.182 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.64 -69.7 0.09 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.524 1.059 . . . . 10.0 111.036 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.76 173.9 8.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.292 1.837 . . . . 10.0 108.701 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.598 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -83.9 138.6 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 169.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -122.52 110.46 15.61 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.103 1.761 . . . . 10.0 107.435 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.598 HG23 ' CG2' ' A' ' 42' ' ' VAL . 34.7 t -124.09 146.55 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.004 1.322 . . . . 10.0 107.576 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 t -103.28 78.59 1.63 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.308 -1.738 . . . . 10.0 106.308 -170.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 6' ' ' LEU . 69.1 m-85 -83.78 138.1 33.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.936 -1.029 . . . . 10.0 109.905 -172.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -88.08 84.36 6.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.167 -0.924 . . . . 10.0 108.707 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.44 -21.19 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.138 1.375 . . . . 10.0 113.056 168.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -25.8 59.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.914 2.086 . . . . 10.0 109.976 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -117.7 -49.64 2.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.253 1.021 . . . . 10.0 109.261 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.98 -175.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.303 1.041 . . . . 10.0 109.612 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.9 p -133.81 158.82 42.41 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.72 -0.844 . . . . 10.0 108.72 170.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -44.02 -34.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.35 1.86 . . . . 10.0 111.133 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -47.39 -30.34 3.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.592 0.633 . . . . 10.0 112.129 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.4 -65.5 0.69 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 118.574 0.625 . . . . 10.0 109.623 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.2 mp -65.58 -53.93 33.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.909 1.283 . . . . 10.0 112.909 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -44.0 -56.3 4.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.187 1.395 . . . . 10.0 109.764 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.6 -45.2 85.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.815 0.446 . . . . 10.0 110.271 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -51.37 -48.6 62.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.882 0.473 . . . . 10.0 110.601 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.544 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.56 -38.7 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.086 -1.009 . . . . 10.0 110.49 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.26 -34.84 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.32 -1.488 . . . . 10.0 111.564 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.02 -66.86 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.448 0.567 . . . . 10.0 112.262 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -134.69 40.86 2.93 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.212 0.605 . . . . 10.0 112.593 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.67 -59.04 0.08 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.825 -0.986 . . . . 10.0 111.305 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 64.92 108.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.215 2.206 . . . . 10.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.0 -37.6 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.888 0.875 . . . . 10.0 109.869 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.544 HG23 HG21 ' A' ' 60' ' ' ILE . 54.4 t -74.19 89.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.248 -0.908 . . . . 10.0 110.914 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.82 -52.3 31.46 Favored 'General case' 0 C--O 1.227 -0.103 0 O-C-N 121.508 -0.745 . . . . 10.0 109.016 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -170.13 153.12 4.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.87 159.14 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.175 0.99 . . . . 10.0 110.686 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.62 -69.34 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.679 -0.692 . . . . 10.0 109.234 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.95 -80.29 0.48 Allowed Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.363 0.505 . . . . 10.0 114.363 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.229 -0.891 . . . . 10.0 110.842 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 40.4 ttm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 117.679 -1.153 . . . . 10.0 107.921 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -144.08 -173.11 3.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.522 1.129 . . . . 10.0 108.053 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.03 126.09 24.45 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.229 1.411 . . . . 10.0 107.319 168.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.72 159.84 19.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.142 0.977 . . . . 10.0 109.879 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.16 122.25 46.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.588 HD23 HG22 ' A' ' 70' ' ' ILE . 45.2 mt -91.89 80.7 5.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.682 -1.97 . . . . 10.0 105.682 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -57.15 149.04 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 110.212 -0.292 . . . . 10.0 110.212 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.68 131.1 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.389 1.075 . . . . 10.0 113.212 -169.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.0 -58.65 3.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.245 2.618 . . . . 10.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.43 -34.33 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.134 -0.485 . . . . 10.0 112.551 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.93 165.79 10.26 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.781 0.791 . . . . 10.0 111.27 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 p -135.54 -34.81 0.83 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.368 1.067 . . . . 10.0 112.405 -168.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 t -48.37 88.49 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.14 1.776 . . . . 10.0 112.813 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.85 -7.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.498 -0.751 . . . . 10.0 112.904 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -86.61 -36.02 19.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.077 0.951 . . . . 10.0 110.031 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.7 m -59.6 -66.67 0.48 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -47.24 -50.88 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 112.213 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.261 0.7 OUTLIER -58.8 -32.25 69.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.403 -0.519 . . . . 10.0 112.297 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.37 -49.01 68.08 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.421 -0.799 . . . . 10.0 109.464 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.43 -44.25 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.814 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -39.8 -48.48 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.202 1.401 . . . . 10.0 110.844 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.3 p -50.51 -50.03 54.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.17 0.441 . . . . 10.0 111.574 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 m -71.26 -51.34 25.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.964 0.906 . . . . 10.0 110.552 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -53.78 -41.8 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.946 0.403 . . . . 10.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.96 -5.35 5.42 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.017 -1.435 . . . . 10.0 114.812 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -98.9 -18.58 17.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.672 1.736 . . . . 10.0 112.909 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 123.41 18.08 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 120.717 1.599 . . . . 10.0 109.941 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -41.26 -43.34 2.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.325 1.85 . . . . 10.0 112.58 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.85 -8.97 86.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.896 0.76 . . . . 10.0 114.897 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 102.56 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.728 -2.323 . . . . 10.0 104.728 169.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -70.54 -33.47 71.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.961 -1.018 . . . . 10.0 109.273 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.92 157.85 14.29 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.91 135.98 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.793 1.237 . . . . 10.0 108.794 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 91.75 2.5 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.276 1.03 . . . . 10.0 108.379 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -82.86 115.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.345 1.058 . . . . 10.0 109.48 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -143.96 49.55 1.37 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.35 -45.27 62.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.039 0.755 . . . . 10.0 113.039 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.11 -30.01 67.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.221 1.008 . . . . 10.0 111.646 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.77 -34.89 18.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.759 0.314 . . . . 10.0 110.782 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.97 -69.89 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.34 -177.41 3.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.818 1.247 . . . . 10.0 110.975 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -92.46 110.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.523 -1.658 . . . . 10.0 106.523 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.57 126.3 51.53 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 76.8 t -138.54 143.43 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 t -100.12 78.01 2.04 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 53.5 m-85 -82.94 137.27 34.26 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.498 -1.228 . . . . 10.0 110.79 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.61 89.2 7.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.137 1.375 . . . . 10.0 109.728 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.93 -15.92 1.6 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.77 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -66.67 -30.76 71.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.219 2.207 . . . . 10.0 108.96 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -120.7 -54.07 2.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.138 0.975 . . . . 10.0 109.615 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.77 160.52 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 123.75 0.82 . . . . 10.0 110.356 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 m -110.38 152.92 25.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.137 -1.06 . . . . 10.0 108.137 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 70' ' ' ILE . 21.9 m -37.76 -39.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 127.902 2.481 . . . . 10.0 110.796 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -43.07 -31.32 0.53 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 10.0 113.599 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.01 -64.18 0.91 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.694 0.759 . . . . 10.0 110.605 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.8 mp -62.75 -54.66 30.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 C-N-CA 125.792 1.637 . . . . 10.0 112.628 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.46 -65.1 0.33 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.798 2.039 . . . . 10.0 109.026 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -51.65 -47.64 63.68 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 10.0 110.868 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -46.57 70.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.203 0.601 . . . . 10.0 111.813 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.13 -39.53 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.792 -1.192 . . . . 10.0 110.015 177.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.55 -30.88 65.57 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.868 -1.145 . . . . 10.0 111.154 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -59.45 -69.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.674 0.67 . . . . 10.0 112.17 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -133.03 33.11 3.69 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.845 0.858 . . . . 10.0 112.362 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.12 -61.07 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.798 0.713 . . . . 10.0 111.884 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 67.63 113.06 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.065 2.146 . . . . 10.0 112.297 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 166.64 -39.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 126.053 1.741 . . . . 10.0 109.267 -169.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 HG21 ' A' ' 60' ' ' ILE . 88.0 t -72.2 91.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.577 -0.702 . . . . 10.0 110.844 -171.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.28 -53.78 18.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 121.692 -0.63 . . . . 10.0 109.586 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 147.96 5.81 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.641 -1.615 . . . . 10.0 106.641 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.588 HG22 HD23 ' A' ' 6' ' ' LEU . 1.3 pp -84.87 132.42 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.903 -1.147 . . . . 10.0 107.903 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.19 124.54 51.76 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.86 -1.533 . . . . 10.0 106.86 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.08 -131.81 4.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 116.801 -1.571 . . . . 10.0 110.158 -177.806 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttp . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 118.187 -0.911 . . . . 10.0 108.907 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.97 -173.09 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -146.83 69.7 1.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.769 2.028 . . . . 10.0 109.02 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -77.64 158.05 29.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.681 0.753 . . . . 10.0 109.66 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.44 125.61 51.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 -175.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' CD2' HG22 ' A' ' 70' ' ' ILE . 74.3 mt -95.13 88.41 5.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 169.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -61.41 148.33 42.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.41 0.684 . . . . 10.0 109.48 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.23 132.38 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.765 1.024 . . . . 10.0 113.765 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -71.73 -54.73 9.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.679 2.792 . . . . 10.0 108.596 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.36 -23.68 0.13 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.308 -0.86 . . . . 10.0 113.738 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 169.74 4.23 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.589 1.195 . . . . 10.0 111.987 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 28.83 0.73 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.37 93.39 4.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.087 -1.079 . . . . 10.0 108.087 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -58.75 -13.06 5.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -80.02 -45.59 18.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.6 m -52.07 -63.4 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.814 0.846 . . . . 10.0 109.609 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.69 -50.25 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.903 -0.57 . . . . 10.0 111.109 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -61.86 -32.97 73.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.44 1.018 . . . . 10.0 112.936 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.56 -40.83 69.13 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.585 -0.697 . . . . 10.0 109.484 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.13 -42.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 118.166 -0.921 . . . . 10.0 111.385 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -35.92 -57.9 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.145 1.778 . . . . 10.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -42.78 76.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 10.0 111.281 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -64.93 -50.64 65.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.234 1.014 . . . . 10.0 109.676 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 56' ' ' ILE . 12.9 t -54.18 -39.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.461 0.704 . . . . 10.0 110.41 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.5 -27.87 9.13 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.755 1.169 . . . . 10.0 113.766 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -71.54 -25.96 62.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.984 1.392 . . . . 10.0 111.533 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 104.48 1.28 Allowed 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.356 -0.84 . . . . 10.0 109.315 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -46.08 -37.24 6.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.271 1.828 . . . . 10.0 112.729 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -8.99 55.54 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.844 -0.535 . . . . 10.0 114.166 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.84 109.85 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.97 1.885 . . . . 10.0 106.303 168.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -73.71 -30.07 62.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.731 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -172.25 168.35 5.66 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.89 135.26 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.863 1.265 . . . . 10.0 108.756 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 90.02 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.198 0.999 . . . . 10.0 109.602 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.56 106.77 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.527 1.131 . . . . 10.0 109.455 -176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.2 m120 -134.76 49.55 2.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.202 0.601 . . . . 10.0 112.241 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.6 -47.18 70.42 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.383 0.512 . . . . 10.0 112.383 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -63.91 -36.41 83.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.845 0.858 . . . . 10.0 111.074 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -84.74 -34.22 22.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.859 -172.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.62 -69.41 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 10.0 110.572 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.29 178.67 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.167 2.187 . . . . 10.0 110.822 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.55 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.45 121.19 39.07 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 53.7 t -132.27 144.4 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 t -101.73 69.49 1.21 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 33.3 m-85 -69.01 137.87 54.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.973 -1.467 . . . . 10.0 108.733 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -94.24 87.12 5.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.047 168.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 -16.58 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.349 1.06 . . . . 10.0 113.376 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.82 -12.72 59.39 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.293 0.951 . . . . 10.0 110.033 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -131.12 -54.42 1.04 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.473 1.109 . . . . 10.0 110.391 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.62 135.74 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.817 1.247 . . . . 10.0 109.435 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 150.72 20.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -36.38 -41.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 128.72 2.808 . . . . 10.0 111.242 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -34.39 -49.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.302 0.955 . . . . 10.0 111.768 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.63 -67.22 0.3 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.42 1.105 . . . . 10.0 110.716 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 24' ' ' VAL . 4.0 mm -60.68 -57.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.374 . . . . 10.0 112.496 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.15 -59.34 0.87 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.656 2.382 . . . . 10.0 109.971 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.48 -51.11 68.07 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.87 0.468 . . . . 10.0 110.56 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.08 73.31 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.653 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.561 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.76 -41.09 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.182 -0.949 . . . . 10.0 110.094 175.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.51 -36.75 69.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.974 1.261 . . . . 10.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.37 -59.57 4.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.085 0.554 . . . . 10.0 112.457 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -139.08 -18.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.382 1.252 . . . . 10.0 114.382 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.97 -47.13 40.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.847 0.749 . . . . 10.0 111.29 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 56.61 110.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.109 2.164 . . . . 10.0 112.525 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 167.24 -39.84 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.239 1.415 . . . . 10.0 109.285 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 60' ' ' ILE . 62.9 t -69.84 92.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 O-C-N 121.496 -0.753 . . . . 10.0 111.209 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.86 4.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.711 0.767 . . . . 10.0 109.084 169.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.88 146.54 7.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.18 -1.415 . . . . 10.0 107.18 -171.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 pp -84.21 131.73 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.782 1.233 . . . . 10.0 107.778 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.14 121.21 36.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.48 -154.98 25.97 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 107.228 -2.349 . . . . 10.0 107.228 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.754 1.222 . . . . 10.0 109.03 169.834 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.514 -0.43 0 N-CA-C 106.912 -1.514 . . . . 10.0 106.912 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -175.95 2.88 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.998 1.436 . . . . 10.0 108.826 -169.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -140.98 112.91 7.74 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.788 2.435 . . . . 10.0 105.389 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 172.92 7.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.951 -1.87 . . . . 10.0 105.951 169.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.49 126.35 38.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.313 -2.476 . . . . 10.0 104.313 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -95.95 95.62 8.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -68.91 148.1 50.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.832 -0.803 . . . . 10.0 108.832 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.04 130.45 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 125.268 1.427 . . . . 10.0 112.958 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -71.64 -61.23 1.85 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.033 2.933 . . . . 10.0 108.196 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.0 -39.21 0.13 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.172 -0.771 . . . . 10.0 111.172 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.64 157.98 13.46 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.588 0.694 . . . . 10.0 110.518 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.9 51.84 0.39 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 -172.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.97 94.01 4.1 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.824 1.25 . . . . 10.0 107.785 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -59.99 0.57 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.19 1.182 . . . . 10.0 114.19 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -43.15 10.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.504 1.047 . . . . 10.0 109.464 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 m -57.96 -67.69 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.609 0.764 . . . . 10.0 109.13 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -43.11 -46.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 C-N-CA 123.331 0.652 . . . . 10.0 112.086 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 14.5 tttt -54.87 -33.07 61.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.776 1.028 . . . . 10.0 113.776 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.31 -29.15 57.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.473 0.309 . . . . 10.0 110.737 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.66 -33.57 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.564 1.546 . . . . 10.0 110.989 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 12.6 tt0 -41.19 -49.47 3.56 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.706 1.203 . . . . 10.0 110.289 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.5 p -46.15 -68.65 0.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.517 1.527 . . . . 10.0 111.231 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -57.19 -39.37 75.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.873 1.269 . . . . 10.0 111.85 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.02 -42.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.875 -0.417 . . . . 10.0 109.875 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.83 48.38 1.97 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.274 1.416 . . . . 10.0 112.136 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.27 -42.86 0.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 127.86 2.464 . . . . 10.0 109.1 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -50.64 127.28 17.65 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.411 1.459 . . . . 10.0 110.794 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -46.46 -42.86 16.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.357 1.463 . . . . 10.0 111.966 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 -13.27 83.11 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.404 0.522 . . . . 10.0 114.404 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.55 109.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 119.708 -2.054 . . . . 10.0 106.094 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.04 -32.54 50.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.448 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.58 151.05 9.11 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.551 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.5 m -123.1 146.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.5 100.92 1.05 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 -173.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -107.88 109.92 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -135.33 46.61 2.38 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 111.762 0.282 . . . . 10.0 111.762 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -52.5 -48.68 65.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.835 0.854 . . . . 10.0 111.746 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -67.47 -26.83 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.991 0.916 . . . . 10.0 110.488 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 -30.89 16.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.572 0.349 . . . . 10.0 111.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -67.38 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.06 0.838 . . . . 10.0 112.074 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -171.11 176.11 4.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.862 1.665 . . . . 10.0 111.674 -169.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -93.52 129.51 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.296 0.638 . . . . 10.0 109.732 171.117 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -120.27 74.12 1.03 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.31 2.244 . . . . 10.0 108.852 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 42' ' ' VAL . 24.1 t -94.05 149.97 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.205 1.402 . . . . 10.0 109.195 -176.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -107.04 76.23 1.08 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -73.26 139.26 46.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.283 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.49 95.7 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.597 0.759 . . . . 10.0 109.78 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.87 -21.9 12.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.499 0.719 . . . . 10.0 112.784 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -87.62 -8.24 56.46 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.907 0.776 . . . . 10.0 110.68 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -119.72 -54.82 2.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.14 -170.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.433 1.493 . . . . 10.0 108.878 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.2 t -147.35 158.19 43.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.765 -0.828 . . . . 10.0 108.765 168.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -38.71 -46.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 C-N-CA 128.37 2.668 . . . . 10.0 109.598 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -44.15 2.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.54 1.064 . . . . 10.0 112.284 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.32 -61.54 2.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.566 0.698 . . . . 10.0 110.844 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -61.43 -53.6 46.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 124.542 1.137 . . . . 10.0 111.514 -176.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.69 -62.52 0.53 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.923 2.089 . . . . 10.0 109.41 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.47 -43.87 75.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.366 0.603 . . . . 10.0 110.741 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.43 75.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.694 0.798 . . . . 10.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.431 HG22 HG23 ' A' ' 67' ' ' VAL . 1.6 mp -70.51 -36.21 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 120.76 -1.212 . . . . 10.0 109.23 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.82 -42.19 75.32 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.609 -1.307 . . . . 10.0 111.273 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -52.25 -62.92 1.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.885 0.874 . . . . 10.0 112.546 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -144.22 66.89 1.27 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.088 0.555 . . . . 10.0 110.666 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.97 -59.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.012 -0.882 . . . . 10.0 111.467 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 68.84 113.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.253 2.221 . . . . 10.0 111.35 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 166.43 -32.45 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.284 1.434 . . . . 10.0 109.737 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' ILE . 6.7 t -71.94 85.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 121.0 -1.063 . . . . 10.0 112.257 -168.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.1 -52.68 25.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.315 -0.866 . . . . 10.0 109.596 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -166.5 142.39 4.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.905 -1.517 . . . . 10.0 106.905 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -86.98 138.45 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 125.483 1.513 . . . . 10.0 107.671 174.138 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -50.7 -44.21 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.67 0.788 . . . . 10.0 109.645 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.26 43.28 93.68 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.687 -0.965 . . . . 10.0 110.687 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 107.852 -1.166 . . . . 10.0 107.852 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 118.705 -0.664 . . . . 10.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -102.67 -174.19 2.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.451 1.9 . . . . 10.0 108.766 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.68 86.14 1.38 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.304 -0.999 . . . . 10.0 108.304 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -103.32 163.8 12.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.956 0.884 . . . . 10.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -117.68 109.62 16.86 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.613 -2.366 . . . . 10.0 104.613 -170.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' CD1' HG22 ' A' ' 70' ' ' ILE . 3.6 mp -83.07 87.72 6.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 171.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -54.73 152.17 7.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.115 0.966 . . . . 10.0 110.01 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.56 131.78 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 124.265 1.026 . . . . 10.0 110.65 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -69.61 -54.23 15.0 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 124.015 0.822 . . . . 10.0 109.312 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.37 -9.34 2.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.749 -0.473 . . . . 10.0 113.357 -170.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.562 ' SD ' HD13 ' A' ' 37' ' ' LEU . 3.5 ppp? -58.29 176.31 0.18 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.969 0.884 . . . . 10.0 111.478 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t -152.44 31.76 0.52 Allowed 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.601 -0.687 . . . . 10.0 110.36 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.5 t -118.86 89.56 3.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.14 0.495 . . . . 10.0 110.8 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -53.71 -11.98 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.353 1.242 . . . . 10.0 114.353 170.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -91.69 -25.86 18.91 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.07 0.85 . . . . 10.0 111.395 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.28 -67.16 0.44 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -42.56 -55.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.519 0.728 . . . . 10.0 111.906 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -21.44 65.04 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.948 0.722 . . . . 10.0 112.948 -175.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.91 99.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.404 1.002 . . . . 10.0 109.232 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -82.51 -37.55 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.02 0.528 . . . . 10.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -41.34 -47.04 3.44 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.545 1.138 . . . . 10.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -51.3 64.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.078 0.466 . . . . 10.0 110.871 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -63.16 -47.63 81.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.447 1.099 . . . . 10.0 110.72 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 t -56.0 -40.93 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 10.0 110.013 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.11 -27.95 16.5 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.776 1.179 . . . . 10.0 113.767 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.15 -29.8 69.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.134 1.467 . . . . 10.0 110.744 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.61 80.67 1.09 Allowed 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.616 -0.678 . . . . 10.0 110.927 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -5.74 -57.52 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.948 3.299 . . . . 10.0 115.651 168.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.32 -56.65 1.48 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.868 1.223 . . . . 10.0 113.913 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.54 111.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.48 1.512 . . . . 10.0 109.853 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.31 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.88 -1.055 . . . . 10.0 109.982 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.95 12.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' HG23 ' A' ' 33' ' ' VAL . 10.6 m -136.27 94.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.912 1.285 . . . . 10.0 109.463 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -107.54 91.07 3.5 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.31 109.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 172.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -128.32 47.86 2.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.457 0.539 . . . . 10.0 112.457 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD13 ' SD ' ' A' ' 11' ' ' MET . 1.6 pt? -51.33 -46.76 62.72 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.525 0.602 . . . . 10.0 112.113 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -70.12 -34.83 73.57 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.579 0.752 . . . . 10.0 110.955 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.09 -32.53 30.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.593 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.35 -73.02 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.26 -172.12 1.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.965 1.306 . . . . 10.0 112.598 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.06 100.73 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 108.466 -0.939 . . . . 10.0 108.466 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -98.0 108.99 21.83 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 42.7 t -128.14 131.5 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 -169.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 m -83.56 69.74 10.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' A' ' 6' ' ' LEU . 57.6 m-85 -64.73 141.41 58.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.321 0.648 . . . . 10.0 109.771 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -86.68 86.95 7.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.08 -18.26 0.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.844 1.054 . . . . 10.0 113.844 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.49 -18.65 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.599 1.091 . . . . 10.0 110.401 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.17 -55.78 2.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.07 129.88 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 124.402 1.081 . . . . 10.0 110.531 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.2 m -88.82 152.7 21.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.629 -0.669 . . . . 10.0 110.198 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.4 m -41.1 -38.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 128.269 2.628 . . . . 10.0 110.659 167.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -49.84 -37.42 30.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.429 -0.794 . . . . 10.0 112.342 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.44 -58.36 4.08 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.263 1.03 . . . . 10.0 109.399 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -56.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -168.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.21 -52.32 4.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.377 1.471 . . . . 10.0 109.861 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.97 -49.09 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.437 0.695 . . . . 10.0 110.54 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.7 68.15 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.765 0.826 . . . . 10.0 111.172 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -58.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 108.76 -0.83 . . . . 10.0 108.76 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -40.01 -40.63 1.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.512 1.051 . . . . 10.0 113.79 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -40.83 -50.88 3.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.605 0.965 . . . . 10.0 113.605 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -151.32 -41.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.533 1.133 . . . . 10.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-O 118.793 -1.004 . . . . 10.0 111.295 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 58.29 175.29 0.06 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.203 1.801 . . . . 10.0 112.545 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 93.9 28.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.437 2.295 . . . . 10.0 112.771 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.66 91.36 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.866 1.267 . . . . 10.0 109.484 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.61 -55.52 7.6 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 168.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -172.34 162.13 5.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.014 1.325 . . . . 10.0 107.429 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.485 HG22 ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -80.69 142.57 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 125.09 1.356 . . . . 10.0 110.241 170.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.562 ' HB3' HG22 ' A' ' 5' ' ' THR . 7.7 tt0 -129.24 147.78 51.11 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.637 -2.357 . . . . 10.0 104.637 165.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.47 -131.34 5.15 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.774 -2.13 . . . . 10.0 107.774 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.224 0 N-CA-C 108.377 -0.972 . . . . 10.0 108.377 168.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.715 -0.476 . . . . 10.0 109.715 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -153.19 175.69 12.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -141.84 87.63 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.037 -1.098 . . . . 10.0 108.037 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -98.03 162.65 13.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.956 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 122.77 46.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 104.65 -2.352 . . . . 10.0 104.65 -177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.702 ' HB2' HG13 ' A' ' 42' ' ' VAL . 6.0 mp -93.53 95.99 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 103.512 -2.773 . . . . 10.0 103.512 170.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.04 150.65 46.39 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 10.0 108.189 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.95 134.54 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -168.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -69.22 -64.96 0.77 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.04 -34.37 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.348 -0.93 . . . . 10.0 114.881 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.0 172.37 2.37 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.305 1.053 . . . . 10.0 112.022 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -157.41 52.69 0.48 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.6 t -130.98 94.88 3.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.414 1.086 . . . . 10.0 108.143 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.61 -21.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.87 1.668 . . . . 10.0 111.418 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -82.74 -41.7 18.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.044 -0.725 . . . . 10.0 109.044 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.9 m -52.47 -66.27 0.41 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -51.41 -50.93 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 122.006 -0.434 . . . . 10.0 111.563 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU 0.26 0.0 OUTLIER -60.35 -26.42 66.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.995 0.739 . . . . 10.0 112.995 -178.174 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.22 84.08 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.06 -1.025 . . . . 10.0 109.035 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -75.64 -40.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.343 0.657 . . . . 10.0 111.364 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 3.4 tm-20 -34.78 -49.28 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.114 1.766 . . . . 10.0 111.019 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -54.72 -60.11 3.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.631 0.253 . . . . 10.0 111.522 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -55.09 -48.54 73.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.01 0.924 . . . . 10.0 110.502 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 t -56.85 -44.26 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.141 0.576 . . . . 10.0 110.367 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.7 -31.2 57.61 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.185 0.898 . . . . 10.0 113.146 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.28 -29.16 66.99 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.167 0.984 . . . . 10.0 110.773 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 108.31 4.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.077 -1.015 . . . . 10.0 109.624 176.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -37.35 -37.1 0.17 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 10.0 112.61 169.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.69 -2.07 1.59 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.225 1.393 . . . . 10.0 116.036 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.29 120.29 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.539 1.936 . . . . 10.0 106.32 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -29.2 25.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.269 0.628 . . . . 10.0 109.894 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.09 160.51 9.9 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.34 133.82 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.351 1.061 . . . . 10.0 110.58 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -143.21 81.4 1.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.909 1.284 . . . . 10.0 108.855 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.64 135.74 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.319 1.048 . . . . 10.0 108.85 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -163.55 48.07 0.13 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.517 0.675 . . . . 10.0 110.796 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -61.05 -41.97 97.6 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.86 -0.525 . . . . 10.0 111.373 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.98 -39.91 93.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.499 0.72 . . . . 10.0 110.25 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.0 -31.8 27.29 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.507 0.723 . . . . 10.0 110.932 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.61 -59.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.397 -0.668 . . . . 10.0 113.154 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 173.33 4.96 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.859 2.064 . . . . 10.0 109.78 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -91.05 119.88 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 172.248 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.26 120.21 40.32 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 48.1 t -133.01 143.83 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.881 -1.526 . . . . 10.0 106.881 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.0 m -96.59 71.54 2.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 49.3 m-85 -73.39 134.56 44.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.871 0.843 . . . . 10.0 109.108 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.57 77.8 9.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.699 0.762 . . . . 10.0 109.069 172.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.96 -17.68 0.42 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.886 1.675 . . . . 10.0 113.917 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.11 -6.28 59.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.424 1.89 . . . . 10.0 111.072 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -57.52 1.13 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.736 1.614 . . . . 10.0 108.726 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.7 143.96 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 126.222 1.809 . . . . 10.0 107.572 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 m -98.22 147.65 24.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -31.82 -44.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 128.346 2.658 . . . . 10.0 110.96 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -28.36 -53.23 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.967 1.307 . . . . 10.0 111.892 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.04 -69.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.358 1.063 . . . . 10.0 111.473 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.5 mp -60.38 -53.53 47.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 125.207 1.403 . . . . 10.0 111.683 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.35 -58.61 1.49 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.924 2.089 . . . . 10.0 110.398 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.4 -45.26 91.99 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.891 0.377 . . . . 10.0 110.219 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.77 -45.18 67.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 10.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.08 -53.02 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 O-C-N 121.272 -0.892 . . . . 10.0 108.713 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.23 -21.4 47.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.956 1.707 . . . . 10.0 114.288 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.29 -58.67 5.94 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.897 0.771 . . . . 10.0 111.474 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -143.56 -19.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.534 1.679 . . . . 10.0 115.534 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.68 -51.68 24.11 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.686 1.136 . . . . 10.0 112.045 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 66.42 97.61 0.05 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.412 1.885 . . . . 10.0 111.759 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 174.28 31.09 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.362 1.865 . . . . 10.0 112.987 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.486 HG13 ' HG ' ' A' ' 6' ' ' LEU . 5.8 t -141.7 80.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 O-C-N 119.617 -1.927 . . . . 10.0 110.331 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.7 76.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 171.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -167.55 143.8 4.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 6' ' ' LEU . 2.2 pp -83.71 131.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 125.091 1.357 . . . . 10.0 107.415 169.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.75 125.58 46.89 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.15 -2.167 . . . . 10.0 105.15 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.31 -153.48 24.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.728 -1.749 . . . . 10.0 108.728 -170.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? . . . . . 0 C--O 1.258 1.523 0 CA-C-O 117.503 -1.237 . . . . 10.0 113.469 -170.78 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 23.8 mt-10 -111.39 175.24 5.5 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.999 0.92 . . . . 10.0 109.473 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -140.2 78.87 1.68 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.804 1.242 . . . . 10.0 107.695 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' NZ ' ' OE1' ' A' ' 2' ' ' GLU . 1.8 mttt -89.73 165.54 14.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.279 -0.873 . . . . 10.0 108.91 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.83 133.3 44.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 102.796 -3.038 . . . . 10.0 102.796 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.751 HD11 ' HZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -104.02 96.6 6.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 104.371 -2.455 . . . . 10.0 104.371 176.482 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -62.23 148.74 43.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.069 -0.968 . . . . 10.0 108.624 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.61 132.34 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 125.07 1.348 . . . . 10.0 112.807 -172.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.89 -64.22 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.046 2.538 . . . . 10.0 109.453 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.0 -40.53 0.04 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.656 -0.578 . . . . 10.0 111.656 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 170.05 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.437 0.903 . . . . 10.0 113.437 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 p -145.99 12.77 1.27 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.742 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.84 86.47 6.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -55.58 -12.18 1.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -83.43 -35.89 24.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.408 -0.807 . . . . 10.0 109.375 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -62.12 -68.21 0.35 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.85 -52.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.689 0.795 . . . . 10.0 113.117 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -29.79 64.53 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.671 -0.643 . . . . 10.0 112.595 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.16 -43.86 64.32 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.61 -41.97 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.218 -0.896 . . . . 10.0 110.838 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.04 -38.51 11.11 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.311 0.96 . . . . 10.0 110.509 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.4 p -51.1 -65.03 0.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.933 0.788 . . . . 10.0 111.533 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -55.8 -51.0 68.97 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.994 1.318 . . . . 10.0 110.079 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.06 -42.76 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.693 0.797 . . . . 10.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.22 -27.71 11.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.561 1.077 . . . . 10.0 113.816 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.25 -19.81 35.69 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.768 1.284 . . . . 10.0 112.279 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.73 118.89 7.73 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.851 1.205 . . . . 10.0 109.985 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -39.9 -44.26 1.64 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.156 1.783 . . . . 10.0 112.515 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.49 -16.23 80.1 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.113 0.387 . . . . 10.0 113.884 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.84 111.59 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 O-C-N 119.454 -2.204 . . . . 10.0 106.628 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -30.74 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.804 . . . . 10.0 109.618 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.74 157.54 24.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.88 145.01 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.976 1.311 . . . . 10.0 108.192 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -161.86 82.86 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -64.77 138.72 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.191 0.596 . . . . 10.0 110.543 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.04 46.41 0.24 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.065 0.46 . . . . 10.0 111.061 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.51 -49.65 67.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.268 0.47 . . . . 10.0 112.268 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.08 -31.13 70.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.036 0.934 . . . . 10.0 110.707 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.76 -29.52 32.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.94 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.23 -62.17 0.12 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.169 0.89 . . . . 10.0 112.119 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.24 171.59 7.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.498 1.919 . . . . 10.0 109.833 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -87.53 132.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 169.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.18 111.04 16.91 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 42' ' ' VAL . 47.5 t -130.0 142.25 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.384 1.074 . . . . 10.0 108.218 -168.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.7 m -102.07 73.57 1.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.751 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 39.9 m-85 -66.85 131.81 46.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.701 -1.591 . . . . 10.0 109.089 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.89 86.1 7.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.526 -0.916 . . . . 10.0 108.526 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.01 -10.96 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.994 1.109 . . . . 10.0 113.994 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -85.89 -13.21 48.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.411 1.005 . . . . 10.0 110.141 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -131.31 -54.36 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 52' ' ' SER . 9.7 p -103.09 -174.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 125.184 1.394 . . . . 10.0 109.239 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.498 ' H ' HG22 ' A' ' 51' ' ' VAL . 63.4 p -148.81 151.91 35.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.182 -0.949 . . . . 10.0 108.523 167.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.75 -40.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.85 2.06 . . . . 10.0 110.132 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.47 -25.89 27.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.879 0.763 . . . . 10.0 112.813 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -70.67 -64.03 0.98 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.15 0.886 . . . . 10.0 109.637 168.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.2 mp -63.65 -51.41 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.097 0.959 . . . . 10.0 112.563 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.24 -56.8 3.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.293 1.837 . . . . 10.0 109.622 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.01 -44.58 91.72 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.578 0.751 . . . . 10.0 110.329 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.48 70.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.212 0.605 . . . . 10.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.72 -35.92 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 121.095 -1.003 . . . . 10.0 109.447 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.32 -41.84 85.46 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.628 -1.295 . . . . 10.0 110.533 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -54.5 -67.7 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.016 0.926 . . . . 10.0 112.14 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -133.41 57.25 1.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.161 0.584 . . . . 10.0 111.704 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.01 -58.85 0.01 OUTLIER Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.213 -0.771 . . . . 10.0 111.369 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 67.46 106.9 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.153 2.181 . . . . 10.0 110.623 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 168.16 -35.17 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.241 1.416 . . . . 10.0 109.595 -168.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.73 93.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.181 -0.949 . . . . 10.0 111.285 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.21 -56.49 4.6 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.456 0.646 . . . . 10.0 109.907 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -164.4 143.13 7.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.12 147.35 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 10.0 109.057 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -67.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.191 0.52 . . . . 10.0 109.678 176.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.15 55.62 2.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.013 -1.235 . . . . 10.0 110.013 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 . . . . . 0 C--O 1.255 1.369 0 CA-C-O 115.777 -2.059 . . . . 10.0 107.422 -169.737 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -138.86 -175.31 4.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.965 0.888 . . . . 10.0 110.418 -168.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.14 68.25 1.13 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.613 2.365 . . . . 10.0 106.998 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -75.68 160.27 30.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -131.15 132.85 45.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.978 -1.489 . . . . 10.0 106.978 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD12 HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -88.79 108.32 19.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 173.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -75.96 148.28 38.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.683 -0.636 . . . . 10.0 109.306 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.05 130.33 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.584 1.554 . . . . 10.0 113.617 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -74.84 -58.74 3.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.143 2.577 . . . . 10.0 109.475 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.84 -32.24 0.06 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-O 119.185 -0.786 . . . . 10.0 113.464 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.03 169.5 5.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.594 1.197 . . . . 10.0 111.44 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 m -160.66 54.38 0.31 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 t -128.75 93.04 3.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -51.74 2.52 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.05 1.87 . . . . 10.0 116.05 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -50.81 4.3 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.841 1.655 . . . . 10.0 109.784 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.17 -62.14 1.8 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.083 0.953 . . . . 10.0 110.176 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.01 -47.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.764 0.316 . . . . 10.0 110.783 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 15.9 tttt -56.61 -35.54 68.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.307 1.225 . . . . 10.0 114.307 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -38.27 56.74 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 t -84.49 -37.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.142 0.977 . . . . 10.0 110.984 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 21.1 tt0 -38.6 -56.09 1.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.697 1.599 . . . . 10.0 110.62 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -58.0 -48.7 79.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -56.98 -54.5 45.96 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.639 1.175 . . . . 10.0 109.57 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.441 ' CG1' HG21 ' A' ' 30' ' ' VAL . 42.0 t -57.64 -40.85 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 121.926 -0.484 . . . . 10.0 110.288 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.1 -31.86 6.17 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.059 0.837 . . . . 10.0 113.494 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -74.01 -26.38 60.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.865 1.332 . . . . 10.0 111.589 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.71 96.76 1.27 Allowed 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.138 -0.976 . . . . 10.0 110.157 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -20.56 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.58 2.752 . . . . 10.0 113.286 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.39 1.16 5.53 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.273 1.269 . . . . 10.0 116.273 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG21 ' CG1' ' A' ' 24' ' ' VAL . 1.3 t -94.87 110.93 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 104.602 -2.369 . . . . 10.0 104.602 168.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -30.05 48.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.658 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.96 158.15 10.35 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.95 125.01 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.983 1.313 . . . . 10.0 108.383 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -128.4 80.54 1.97 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.763 1.225 . . . . 10.0 108.498 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.683 ' HA ' HG12 ' A' ' 42' ' ' VAL . 7.2 t -74.42 108.5 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 126.273 1.829 . . . . 10.0 109.884 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 53.0 m-80 -142.07 52.28 1.48 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.176 1.39 . . . . 10.0 110.173 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.55 -46.72 88.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.711 0.291 . . . . 10.0 111.458 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -68.11 -40.86 82.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.111 1.364 . . . . 10.0 109.922 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -72.56 -35.27 67.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.397 -0.819 . . . . 10.0 111.518 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.56 -64.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.434 0.54 . . . . 10.0 112.764 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 165.14 12.02 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 125.594 1.557 . . . . 10.0 109.259 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 35' ' ' VAL . 17.2 m -88.14 115.12 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -102.6 121.25 42.01 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.12 131.96 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -94.54 78.55 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.239 -1.393 . . . . 10.0 107.239 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -75.59 135.82 40.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.54 -1.209 . . . . 10.0 109.489 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -90.08 89.08 7.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.011 1.324 . . . . 10.0 107.805 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.45 -16.18 8.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.249 0.833 . . . . 10.0 113.249 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.24 -18.33 62.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.828 1.651 . . . . 10.0 109.722 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -124.73 -55.86 1.6 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.757 1.223 . . . . 10.0 110.152 -169.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -137.33 148.44 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.092 0.957 . . . . 10.0 109.989 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -101.08 152.37 20.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -39.87 -40.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 C-N-CA 127.608 2.363 . . . . 10.0 110.961 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.87 -34.12 0.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.69 -65.38 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.855 0.752 . . . . 10.0 110.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.4 mp -64.79 -48.98 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.53 1.132 . . . . 10.0 112.543 -172.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.77 -57.01 2.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.549 1.94 . . . . 10.0 110.423 170.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.5 -46.8 85.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.77 0.795 . . . . 10.0 109.662 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.54 -48.91 68.64 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.573 0.749 . . . . 10.0 111.332 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.437 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -73.03 -39.33 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.15 -0.969 . . . . 10.0 111.022 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.5 -34.55 78.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.588 1.54 . . . . 10.0 110.767 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -47.8 -66.25 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.594 1.157 . . . . 10.0 112.731 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -126.59 3.73 6.83 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.239 1.2 . . . . 10.0 114.239 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.07 -53.5 0.89 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.643 1.116 . . . . 10.0 112.489 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 68.0 111.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.5 2.32 . . . . 10.0 111.258 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 164.41 -34.88 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 110.574 -168.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG23 ' CG2' ' A' ' 60' ' ' ILE . 74.0 t -72.99 89.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 121.096 -1.003 . . . . 10.0 112.066 -168.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.39 -54.4 7.68 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 121.145 0.497 . . . . 10.0 110.042 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -169.04 143.58 3.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 -169.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.52 129.4 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.414 1.486 . . . . 10.0 110.015 177.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -127.09 135.8 51.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.95 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 C--O 1.256 1.399 0 N-CA-C 104.482 -2.414 . . . . 10.0 104.482 175.46 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ttt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.79 -179.84 5.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.964 0.505 . . . . 10.0 110.718 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -128.72 90.7 3.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.755 2.422 . . . . 10.0 107.44 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -94.53 179.48 5.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.294 1.045 . . . . 10.0 109.957 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 t -146.14 134.96 22.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.931 -1.507 . . . . 10.0 106.931 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 70' ' ' ILE . 21.0 mt -88.61 95.73 10.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.522 -2.399 . . . . 10.0 104.522 170.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.59 144.1 57.28 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 128.12 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 124.644 1.178 . . . . 10.0 113.794 -169.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -69.55 -58.49 3.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 129.526 3.131 . . . . 10.0 110.254 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.73 -28.01 0.19 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.42 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.35 164.05 12.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.871 0.836 . . . . 10.0 110.35 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -147.52 12.05 1.02 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.784 0.434 . . . . 10.0 111.075 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -95.4 94.35 7.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -50.91 -18.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -35.83 36.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.87 0.759 . . . . 10.0 109.829 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -63.04 -67.27 0.44 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -49.97 -49.24 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.032 -0.417 . . . . 10.0 112.075 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -27.94 65.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.08 0.77 . . . . 10.0 113.08 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -36.4 74.43 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.42 -43.83 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 123.792 0.837 . . . . 10.0 110.163 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -39.25 -45.98 1.46 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.891 1.676 . . . . 10.0 111.339 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -48.99 68.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.544 0.688 . . . . 10.0 111.654 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.8 t -68.37 -54.18 19.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.654 1.182 . . . . 10.0 109.118 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 t -53.78 -38.96 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.197 0.599 . . . . 10.0 111.321 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.24 71.34 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.98 1.276 . . . . 10.0 113.385 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.25 -37.55 37.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.679 1.239 . . . . 10.0 110.39 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.92 122.67 10.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.798 0.726 . . . . 10.0 110.551 -175.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -48.24 -41.7 28.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.047 1.739 . . . . 10.0 112.532 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.55 -6.15 88.14 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.275 0.464 . . . . 10.0 113.928 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.96 115.32 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.363 -2.088 . . . . 10.0 105.363 168.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -77.85 -32.61 52.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.377 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.11 160.39 11.81 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.23 147.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.64 1.576 . . . . 10.0 107.975 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.51 89.98 1.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.713 0.768 . . . . 10.0 109.256 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.6 t -75.27 118.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 123.449 0.699 . . . . 10.0 109.392 -177.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.95 44.65 1.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.568 0.747 . . . . 10.0 109.123 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -59.65 -51.33 70.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.502 -0.749 . . . . 10.0 112.19 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.89 -36.83 80.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.966 0.906 . . . . 10.0 110.034 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.33 62.53 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.479 -0.782 . . . . 10.0 111.286 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.97 -77.77 0.07 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.223 0.916 . . . . 10.0 111.498 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 171.26 11.66 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 126.586 1.954 . . . . 10.0 107.977 -173.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 35' ' ' VAL . 44.6 t -90.83 105.55 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -82.45 136.99 34.8 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.62 139.55 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-O 122.161 0.981 . . . . 10.0 109.875 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 m -111.64 77.03 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.639 -0.71 . . . . 10.0 109.454 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.663 ' HE1' HG21 ' A' ' 56' ' ' ILE . 21.5 m-85 -73.34 140.64 46.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -96.51 94.09 7.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.428 0.691 . . . . 10.0 109.439 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.66 -22.03 1.22 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.965 1.306 . . . . 10.0 113.738 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.34 -6.99 58.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.275 0.943 . . . . 10.0 110.048 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -126.54 -55.83 1.41 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.15 0.98 . . . . 10.0 109.891 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.28 164.05 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 119.535 1.062 . . . . 10.0 111.018 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.2 m -118.14 168.4 10.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.56 0.744 . . . . 10.0 109.344 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -44.43 -29.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.69 2.796 . . . . 10.0 112.462 170.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -36.29 6.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.667 0.667 . . . . 10.0 111.397 172.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.89 -60.14 2.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.637 1.208 . . . . 10.0 110.385 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.663 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.2 mm -70.01 -57.0 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 114.535 1.309 . . . . 10.0 114.535 -168.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.67 8.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.897 0.879 . . . . 10.0 108.871 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.74 -51.38 56.59 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.789 0.435 . . . . 10.0 110.72 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.641 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.664 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.6 -48.61 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.137 -0.977 . . . . 10.0 110.272 177.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.66 -25.6 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.308 -0.87 . . . . 10.0 112.178 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.96 -44.56 40.92 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.626 0.77 . . . . 10.0 112.378 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -166.1 -28.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.21 -55.14 16.8 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.798 -1.001 . . . . 10.0 112.103 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 60.32 120.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.768 2.027 . . . . 10.0 111.963 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 163.66 -34.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 126.03 1.732 . . . . 10.0 109.805 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.664 HG23 HG21 ' A' ' 60' ' ' ILE . 92.3 t -71.5 88.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 121.006 -1.059 . . . . 10.0 111.424 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.39 -52.93 27.56 Favored 'General case' 0 CA--C 1.523 -0.066 0 O-C-N 121.587 -0.696 . . . . 10.0 109.135 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -169.6 159.39 8.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.604 HG22 HD23 ' A' ' 6' ' ' LEU . 1.7 pp -102.62 121.98 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 126.033 1.733 . . . . 10.0 108.367 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -109.59 117.57 34.31 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.42 -91.21 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.742 1.163 . . . . 10.0 110.497 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.668 -1.158 . . . . 10.0 112.078 -173.216 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 38.3 ttp . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 119.04 -0.505 . . . . 10.0 111.34 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -156.27 129.85 8.3 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.8 0.727 . . . . 10.0 111.715 168.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.46 112.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.516 1.527 . . . . 10.0 107.892 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.66 172.48 6.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.359 1.464 . . . . 10.0 108.071 172.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 124.77 42.28 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.775 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -93.29 97.67 10.76 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -62.32 153.89 29.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.249 -0.648 . . . . 10.0 109.249 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -65.65 128.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.672 1.589 . . . . 10.0 111.968 -173.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -73.28 -61.56 1.78 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.868 2.867 . . . . 10.0 109.135 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.38 -34.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.437 -0.887 . . . . 10.0 112.347 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.29 170.59 5.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.041 0.921 . . . . 10.0 110.928 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -159.15 30.89 0.21 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.848 -0.614 . . . . 10.0 109.412 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.43 102.68 12.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -56.11 -20.1 15.93 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -76.91 -42.23 40.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.984 0.811 . . . . 10.0 109.127 -172.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -55.49 -68.13 0.22 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.459 1.104 . . . . 10.0 109.874 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.5 -50.07 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -54.35 -33.69 59.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.943 0.792 . . . . 10.0 113.128 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.23 -34.23 66.13 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.361 0.6 . . . . 10.0 110.224 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 37.8 t -85.56 -45.07 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.783 0.833 . . . . 10.0 109.919 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -46.39 -42.1 14.57 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.571 1.148 . . . . 10.0 110.591 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -54.92 -45.69 74.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.43 0.559 . . . . 10.0 112.309 174.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -72.37 -42.37 65.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.607 0.763 . . . . 10.0 111.893 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 56' ' ' ILE . 15.0 t -66.22 -43.22 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.516 0.726 . . . . 10.0 109.744 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.37 2.7 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.882 1.229 . . . . 10.0 111.877 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.39 -47.03 0.19 Allowed 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 127.382 2.273 . . . . 10.0 108.212 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 126.28 15.36 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.394 0.997 . . . . 10.0 110.488 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.73 -39.39 58.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.744 1.218 . . . . 10.0 112.156 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.33 -8.4 59.16 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.79 0.71 . . . . 10.0 114.14 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.76 106.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 O-C-N 119.271 -2.311 . . . . 10.0 105.441 168.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 t -74.37 -28.28 61.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.51 156.65 11.93 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.0 m -130.6 148.13 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.218 1.007 . . . . 10.0 108.604 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -165.73 87.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.48 118.96 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.243 1.817 . . . . 10.0 109.915 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.11 48.74 1.87 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.745 0.418 . . . . 10.0 111.385 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -52.61 -44.55 66.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 10.0 111.963 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.63 -26.75 66.39 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.942 0.897 . . . . 10.0 111.286 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.12 13.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.678 0.391 . . . . 10.0 111.155 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.0 -65.63 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.8 179.29 3.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.026 2.13 . . . . 10.0 110.741 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.597 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -93.67 130.46 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 125.512 1.525 . . . . 10.0 107.609 172.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.63 70.7 0.95 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.863 0.839 . . . . 10.0 110.374 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 42' ' ' VAL . 11.3 t -83.79 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.828 1.251 . . . . 10.0 108.783 -171.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.87 77.17 1.31 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 8.8 m-85 -79.82 134.05 36.32 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.472 1.509 . . . . 10.0 108.84 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.41 88.22 6.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.334 -0.853 . . . . 10.0 109.221 170.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.31 -16.09 0.16 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.15 0.98 . . . . 10.0 113.292 168.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 1' ' ' MET . 5.6 m-20 -85.95 -20.67 28.61 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.362 2.265 . . . . 10.0 110.461 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -129.26 -58.14 1.13 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 10.0 109.786 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.0 t -129.87 120.26 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 125.02 1.328 . . . . 10.0 108.002 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 p -87.76 158.19 18.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -38.03 -40.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 126.885 2.074 . . . . 10.0 110.618 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.95 -47.06 0.51 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.275 0.943 . . . . 10.0 111.551 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -64.06 -57.74 8.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.562 1.172 . . . . 10.0 111.096 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' CG1' ' A' ' 24' ' ' VAL . 5.9 mm -65.72 -57.11 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.836 1.654 . . . . 10.0 112.001 -173.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.19 -61.58 0.87 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.166 2.186 . . . . 10.0 109.52 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.56 -49.97 54.74 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.157 0.583 . . . . 10.0 110.666 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.41 77.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.745 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -71.44 -39.53 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 120.98 -1.075 . . . . 10.0 110.415 177.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.33 -29.14 69.71 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.261 -0.899 . . . . 10.0 111.628 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.45 -64.27 0.87 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.976 0.807 . . . . 10.0 111.614 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.98 -7.33 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.265 1.58 . . . . 10.0 115.265 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.74 -51.8 10.77 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.714 -0.954 . . . . 10.0 110.714 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 58.25 109.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.75 2.42 . . . . 10.0 111.539 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t0 175.59 -41.31 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 125.363 1.465 . . . . 10.0 107.991 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 60' ' ' ILE . 72.0 t -69.95 95.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 120.806 -1.184 . . . . 10.0 112.298 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.86 -57.46 3.86 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.773 0.829 . . . . 10.0 109.731 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 71' ' ' GLU . 6.4 ptmm? -164.94 142.94 6.33 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.888 -1.523 . . . . 10.0 106.888 -171.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.775 HG22 HD23 ' A' ' 6' ' ' LEU . 2.2 pp -80.97 141.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 124.163 0.985 . . . . 10.0 108.552 172.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' OE1' ' NZ ' ' A' ' 69' ' ' LYS . 3.5 tt0 -131.06 130.96 43.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 138.18 -103.91 0.43 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.759 1.647 . . . . 10.0 109.803 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.154 0.982 . . . . 10.0 109.264 -173.497 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -129.33 127.18 40.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.975 1.422 . . . . 10.0 107.91 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.25 98.22 10.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -175.79 4.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.569 -1.641 . . . . 10.0 106.569 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -139.17 137.13 35.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.754 -1.943 . . . . 10.0 105.754 169.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -94.15 99.89 12.08 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 105.141 -2.17 . . . . 10.0 105.141 171.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.03 146.57 42.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.152 -0.684 . . . . 10.0 109.152 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.19 130.3 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 125.13 1.372 . . . . 10.0 113.128 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -78.86 -57.56 3.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.375 2.27 . . . . 10.0 110.618 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.65 -46.46 0.1 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 117.637 -2.22 . . . . 10.0 112.792 -169.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.91 158.99 4.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 117.3 0.55 . . . . 10.0 110.928 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.1 m -144.83 37.57 1.18 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.084 -0.962 . . . . 10.0 108.875 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.3 t -110.12 94.96 5.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.66 -9.85 0.6 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -90.35 -29.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.182 0.901 . . . . 10.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -65.33 -73.79 0.12 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.931 -1.137 . . . . 10.0 107.931 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 35' ' ' VAL . 4.5 m -33.83 -54.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 125.542 1.537 . . . . 10.0 113.858 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -56.01 -33.16 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.969 0.729 . . . . 10.0 112.969 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.94 -32.8 61.69 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.599 0.76 . . . . 10.0 110.582 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.28 -47.68 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 117.829 -1.081 . . . . 10.0 110.39 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -41.85 -49.48 4.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.077 1.351 . . . . 10.0 110.752 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.5 p -46.17 -62.32 1.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.349 1.06 . . . . 10.0 111.247 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -57.76 -48.06 80.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.598 1.159 . . . . 10.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -55.08 -40.64 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.76 0.824 . . . . 10.0 110.155 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.63 6.4 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.54 1.066 . . . . 10.0 113.744 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.87 -26.62 60.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.92 1.36 . . . . 10.0 111.621 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.15 107.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 119.128 0.877 . . . . 10.0 109.373 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -36.7 -43.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.165 2.186 . . . . 10.0 113.17 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.05 -28.5 63.9 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.688 0.661 . . . . 10.0 114.119 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.51 109.56 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 119.566 -2.137 . . . . 10.0 107.399 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -81.82 -31.73 31.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.903 -1.044 . . . . 10.0 109.712 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.19 158.22 18.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' HG22 ' A' ' 44' ' ' VAL . 10.4 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.509 1.123 . . . . 10.0 108.303 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -162.55 106.4 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 17' ' ' VAL . 43.7 t -95.69 117.55 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 C-N-CA 124.124 0.97 . . . . 10.0 109.237 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -132.22 48.58 2.4 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.505 0.322 . . . . 10.0 111.349 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -47.52 -42.96 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.087 0.955 . . . . 10.0 112.89 177.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.49 -37.92 88.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.82 0.848 . . . . 10.0 111.032 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -35.9 20.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.564 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.38 -67.8 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.926 -0.87 . . . . 10.0 110.926 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -174.74 2.51 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.055 1.342 . . . . 10.0 110.673 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.565 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -97.28 125.79 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 175.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -110.77 92.69 4.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.524 2.33 . . . . 10.0 108.343 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.4 t -110.89 151.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.647 1.579 . . . . 10.0 107.88 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -109.73 77.2 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.556 -1.646 . . . . 10.0 106.556 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 5.6 m-85 -78.01 127.67 32.69 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.317 -1.31 . . . . 10.0 107.721 -176.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 50.8 t0 -81.93 85.0 6.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.642 -0.662 . . . . 10.0 110.292 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.75 -23.17 0.96 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.985 0.914 . . . . 10.0 113.389 174.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.27 -5.38 56.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.436 0.562 . . . . 10.0 109.943 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -133.35 -54.15 0.9 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.492 1.117 . . . . 10.0 110.511 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.18 141.04 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 125.051 1.341 . . . . 10.0 109.435 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -97.26 143.57 27.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.0 m -31.76 -49.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 129.369 3.068 . . . . 10.0 110.003 168.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -31.93 -51.61 0.23 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.807 1.243 . . . . 10.0 112.089 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -55.69 -60.54 3.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.396 1.079 . . . . 10.0 110.949 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -66.05 -54.53 26.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 125.17 1.388 . . . . 10.0 110.948 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.15 -62.28 0.66 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.917 2.087 . . . . 10.0 110.389 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -53.85 -50.25 66.65 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.731 0.813 . . . . 10.0 110.097 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.27 -47.69 55.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.035 0.534 . . . . 10.0 111.453 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 HG21 HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -71.55 -35.9 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.974 -1.079 . . . . 10.0 111.067 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.65 -30.59 65.53 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.871 -1.143 . . . . 10.0 111.579 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.87 -62.08 2.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.234 0.925 . . . . 10.0 111.964 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -142.86 56.07 1.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.89 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.22 -0.766 . . . . 10.0 111.288 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 65.08 107.15 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.124 1.77 . . . . 10.0 112.248 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' HD23 ' A' ' 37' ' ' LEU . 12.0 p-10 161.28 -24.87 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 128.413 2.685 . . . . 10.0 110.987 -170.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 HG21 ' A' ' 60' ' ' ILE . 63.5 t -67.88 90.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 120.985 -1.072 . . . . 10.0 111.486 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.67 -52.07 11.35 Favored 'General case' 0 C--N 1.338 0.094 0 O-C-N 121.774 -0.579 . . . . 10.0 109.463 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -170.24 144.12 2.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.52 1.128 . . . . 10.0 108.409 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.732 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp -73.21 140.86 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 124.433 1.093 . . . . 10.0 108.489 169.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.68 132.19 48.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.452 -1.314 . . . . 10.0 107.452 168.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.33 -148.25 19.29 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.485 -1.846 . . . . 10.0 108.485 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 168.089 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -132.76 177.15 7.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 122.372 1.082 . . . . 10.0 109.147 -169.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.62 126.56 35.01 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.566 -2.753 . . . . 10.0 103.566 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -124.86 176.07 6.86 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.87 126.81 38.88 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -92.7 97.86 11.05 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 104.69 -2.337 . . . . 10.0 104.69 172.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.88 150.7 44.35 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.01 127.68 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.658 1.183 . . . . 10.0 113.019 -169.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -62.35 1.42 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.602 1.961 . . . . 10.0 108.57 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.34 -31.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.508 -169.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 178.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.461 1.124 . . . . 10.0 112.582 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p -150.31 -43.57 0.13 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.533 -1.212 . . . . 10.0 110.913 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -37.44 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.855 1.262 . . . . 10.0 111.678 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -3.27 23.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.337 -0.363 . . . . 10.0 111.687 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -46.64 8.71 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.603 0.638 . . . . 10.0 109.448 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 m -46.93 -68.68 0.17 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.703 0.801 . . . . 10.0 110.157 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -46.63 -51.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 O-C-N 122.304 -0.247 . . . . 10.0 111.483 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 10.4 tttt -60.61 -33.75 73.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.17 50.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.981 0.512 . . . . 10.0 110.144 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.94 -41.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.232 -0.889 . . . . 10.0 110.726 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 tt0 -39.89 -51.49 2.45 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.345 1.458 . . . . 10.0 111.297 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -51.0 -55.69 16.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.03 0.932 . . . . 10.0 110.552 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.82 -49.73 74.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.705 1.202 . . . . 10.0 110.534 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 HD12 ' A' ' 56' ' ' ILE . 49.7 t -53.85 -41.5 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.248 1.019 . . . . 10.0 110.111 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.0 -32.55 6.3 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.72 1.152 . . . . 10.0 114.052 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.09 -26.21 60.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.924 1.362 . . . . 10.0 111.944 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.4 109.67 2.81 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.435 -0.79 . . . . 10.0 110.251 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.3 -38.44 2.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.097 2.159 . . . . 10.0 113.175 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.33 -20.89 71.85 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.503 -0.748 . . . . 10.0 114.215 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.02 105.31 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 120.036 -1.861 . . . . 10.0 107.211 171.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -29.86 62.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.351 -1.295 . . . . 10.0 110.097 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.49 157.05 14.48 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.532 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.8 m -136.25 130.51 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.074 0.95 . . . . 10.0 109.913 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -148.07 94.3 2.31 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.931 0.892 . . . . 10.0 108.714 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 t -86.66 114.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 10.0 108.371 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.95 48.62 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.835 0.454 . . . . 10.0 111.497 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.95 -44.17 60.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.673 0.789 . . . . 10.0 112.414 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.1 -29.84 70.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.727 1.211 . . . . 10.0 111.096 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 -36.86 14.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.63 0.372 . . . . 10.0 110.755 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.07 -65.07 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.218 0.913 . . . . 10.0 111.045 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.12 178.78 4.87 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.399 1.48 . . . . 10.0 111.025 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.2 127.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 125.145 1.378 . . . . 10.0 108.228 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -117.59 89.13 3.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.622 1.169 . . . . 10.0 108.629 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 42' ' ' VAL . 17.1 t -98.2 149.76 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.668 1.587 . . . . 10.0 107.637 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 t -104.29 79.89 1.64 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 9.7 m-85 -73.93 130.35 39.71 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.912 -1.494 . . . . 10.0 108.204 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -84.33 87.1 7.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -11.82 1.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.162 0.801 . . . . 10.0 113.162 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.46 -15.37 52.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.608 1.094 . . . . 10.0 109.759 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -127.08 -61.44 1.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.451 1.1 . . . . 10.0 109.152 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.9 126.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.825 1.25 . . . . 10.0 109.223 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 m -96.4 163.84 12.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.308 -0.86 . . . . 10.0 108.828 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -38.43 -39.57 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 127.478 2.311 . . . . 10.0 111.353 168.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -37.33 1.47 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.594 0.633 . . . . 10.0 112.543 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.61 -63.87 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.071 0.938 . . . . 10.0 111.061 172.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 24' ' ' VAL . 3.8 mm -60.29 -54.03 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.713 1.205 . . . . 10.0 112.483 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.47 -53.05 15.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.904 2.082 . . . . 10.0 109.593 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.57 -47.78 78.77 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.133 0.573 . . . . 10.0 110.204 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -51.0 68.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.14 -34.74 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.118 -0.989 . . . . 10.0 109.948 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -57.04 -43.36 81.89 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.603 -1.311 . . . . 10.0 111.503 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.69 -62.24 1.75 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.469 0.577 . . . . 10.0 111.969 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -141.18 44.67 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.04 -57.78 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.944 0.783 . . . . 10.0 112.102 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 66.3 107.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.129 2.172 . . . . 10.0 111.087 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 t0 170.39 -38.47 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.668 1.587 . . . . 10.0 108.253 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 ' CG2' ' A' ' 60' ' ' ILE . 54.7 t -69.24 89.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 120.746 -1.221 . . . . 10.0 112.031 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.72 2.62 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.284 -0.885 . . . . 10.0 109.689 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -165.3 155.91 13.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.166 -1.791 . . . . 10.0 106.166 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.522 ' CG2' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -86.72 145.07 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 124.607 1.163 . . . . 10.0 110.143 174.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.03 147.27 41.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.218 -1.771 . . . . 10.0 106.218 169.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.56 -128.72 3.32 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.028 1.299 . . . . 10.0 111.264 -172.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.989 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 168.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.08 -173.54 3.14 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.134 1.522 . . . . 10.0 106.937 167.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -139.72 110.16 6.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.868 -1.901 . . . . 10.0 105.868 168.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.83 176.39 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.514 1.926 . . . . 10.0 106.717 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -148.81 128.8 13.5 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.064 -1.828 . . . . 10.0 106.064 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.68 104.26 15.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 172.518 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -68.43 149.71 49.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.51 132.78 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -170.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -74.41 -60.51 2.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.916 2.486 . . . . 10.0 108.174 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.31 -31.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.862 -0.966 . . . . 10.0 115.137 -171.28 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.8 178.45 4.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.606 1.703 . . . . 10.0 110.241 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -158.81 26.96 0.22 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.693 0.797 . . . . 10.0 109.249 170.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.8 t -90.09 100.04 12.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.098 -1.815 . . . . 10.0 106.098 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -52.57 -26.73 14.14 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 174.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -72.55 -46.08 56.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.939 -0.763 . . . . 10.0 108.939 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.9 m -50.31 -65.88 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.848 1.659 . . . . 10.0 110.415 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.77 -45.09 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 120.484 -0.487 . . . . 10.0 111.08 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 17.7 tttm -52.44 -33.76 45.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.624 1.342 . . . . 10.0 114.624 176.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.06 65.39 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.065 0.848 . . . . 10.0 110.038 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -87.05 -37.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 117.339 -1.315 . . . . 10.0 110.575 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 1.4 tt0 -36.63 -56.03 0.84 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.556 1.542 . . . . 10.0 110.549 174.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -58.94 -45.38 90.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.686 0.395 . . . . 10.0 111.381 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m -65.55 -57.03 9.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.43 0.692 . . . . 10.0 109.8 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.71 -37.48 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.992 0.917 . . . . 10.0 110.796 177.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.63 -27.32 54.69 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.024 0.821 . . . . 10.0 112.193 177.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.37 -27.35 59.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 118.319 1.059 . . . . 10.0 110.416 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.51 103.65 2.54 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 120.94 -1.1 . . . . 10.0 108.859 178.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -41.01 -32.37 0.23 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.668 1.987 . . . . 10.0 113.043 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.72 3.76 4.76 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.15 0.881 . . . . 10.0 115.288 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.17 119.61 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 169.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -36.99 29.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.61 157.24 14.41 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 176.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.986 2.114 . . . . 10.0 107.281 171.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -133.46 96.33 3.69 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 126.327 1.851 . . . . 10.0 107.742 172.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 42' ' ' VAL . 2.2 t -87.8 119.12 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.044 0.937 . . . . 10.0 108.933 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 15.3 m120 -146.38 51.59 1.13 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.073 0.549 . . . . 10.0 111.213 -172.085 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.52 -48.99 56.93 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.279 0.632 . . . . 10.0 112.078 178.077 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.83 -37.01 83.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.176 0.591 . . . . 10.0 110.718 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -83.4 -31.92 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.133 -173.229 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.43 -79.33 0.05 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.598 -1.001 . . . . 10.0 110.598 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -168.8 179.8 4.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.549 2.739 . . . . 10.0 106.873 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 6' ' ' LEU . 31.0 m -94.31 118.58 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 107.68 -1.229 . . . . 10.0 107.68 -174.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.15 127.68 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 176.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.1 t -139.58 137.19 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.408 1.099 . . . . 10.0 108.757 -171.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -110.08 76.0 0.97 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 -169.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 28.1 m-85 -82.12 137.19 35.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.7 1.6 . . . . 10.0 109.797 -173.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -84.64 84.25 7.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.95 0.881 . . . . 10.0 108.83 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.31 -20.25 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.648 1.579 . . . . 10.0 112.409 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.04 -12.87 58.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.815 1.646 . . . . 10.0 110.12 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -120.59 -53.67 2.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.131 0.972 . . . . 10.0 109.248 -174.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 m -125.92 -168.65 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.879 1.672 . . . . 10.0 108.971 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 m -144.28 147.68 33.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.022 -1.049 . . . . 10.0 108.744 169.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -31.46 -48.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 130.037 3.335 . . . . 10.0 110.731 175.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -28.93 -52.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.312 1.445 . . . . 10.0 112.352 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.53 -59.77 4.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.18 0.592 . . . . 10.0 111.739 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.2 mp -67.64 -51.03 55.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 125.325 1.45 . . . . 10.0 110.737 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.26 -63.89 0.46 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.87 2.068 . . . . 10.0 109.399 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -56.46 -47.87 78.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.403 0.681 . . . . 10.0 110.126 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.29 -46.79 62.62 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.978 0.911 . . . . 10.0 111.546 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -72.53 -42.19 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.616 -0.677 . . . . 10.0 110.586 176.361 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.19 -34.89 66.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.984 1.266 . . . . 10.0 112.159 178.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -48.49 -63.02 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.697 0.681 . . . . 10.0 112.533 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -134.59 -17.89 1.96 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.37 1.068 . . . . 10.0 113.387 -171.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.23 -49.26 12.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.879 -0.888 . . . . 10.0 110.879 -177.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 58.67 108.48 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.689 2.395 . . . . 10.0 111.586 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.29 -42.0 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 121.807 0.813 . . . . 10.0 109.189 -167.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' A' ' 60' ' ' ILE . 55.1 t -71.32 94.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.601 -0.687 . . . . 10.0 111.245 -172.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.64 -51.65 11.14 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.399 0.618 . . . . 10.0 109.396 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -171.4 143.13 1.77 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 -170.133 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 6' ' ' LEU . 2.4 pp -89.1 127.94 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.864 1.266 . . . . 10.0 109.779 176.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -75.2 80.79 2.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.852 -1.166 . . . . 10.0 107.852 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.26 87.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.604 . . . . 10.0 113.927 -169.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 116.01 -1.948 . . . . 10.0 111.899 173.819 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 111.804 0.298 . . . . 10.0 111.804 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -172.46 2.22 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.04 -1.837 . . . . 10.0 106.04 168.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -147.55 75.48 1.36 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HD2' HG11 ' A' ' 53' ' ' VAL . 6.5 mtmt -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.022 1.392 . . . . 10.0 110.806 169.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.0 m -130.36 124.5 32.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.788 -2.301 . . . . 10.0 104.788 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 HG22 ' A' ' 70' ' ' ILE . 1.1 mt -83.31 110.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.372 -2.455 . . . . 10.0 104.372 169.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -65.99 155.71 35.79 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.9 126.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.895 0.878 . . . . 10.0 110.028 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.32 -47.54 60.66 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.975 1.31 . . . . 10.0 109.203 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -19.75 0.67 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.442 -176.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 167.14 3.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.831 0.815 . . . . 10.0 111.5 174.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 19.83 1.35 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.34 -177.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -101.74 96.73 7.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.25 -14.47 7.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.802 0.667 . . . . 10.0 112.802 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -85.76 -35.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.997 0.817 . . . . 10.0 109.976 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.5 m -58.09 -67.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.883 1.273 . . . . 10.0 109.262 172.053 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -45.55 -51.43 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -177.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -20.79 63.03 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.623 0.972 . . . . 10.0 113.623 -177.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.78 90.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 175.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.44 -42.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.88 -0.581 . . . . 10.0 110.301 177.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -38.65 -48.91 1.51 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.429 1.492 . . . . 10.0 111.393 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -47.93 76.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.233 0.539 . . . . 10.0 111.328 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -65.14 -50.04 67.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.015 0.926 . . . . 10.0 110.203 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -52.73 -44.05 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.812 0.845 . . . . 10.0 109.914 176.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.48 -30.26 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.953 1.263 . . . . 10.0 113.765 173.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.77 -27.69 64.11 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.914 1.357 . . . . 10.0 110.91 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.43 105.58 2.65 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 174.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -36.04 -39.05 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.631 1.972 . . . . 10.0 113.543 170.152 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -13.39 21.42 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.849 1.214 . . . . 10.0 115.524 176.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 108.56 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 O-C-N 120.164 -1.786 . . . . 10.0 106.336 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -80.15 -29.89 38.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.91 158.97 15.37 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 177.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -139.35 122.12 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.328 1.451 . . . . 10.0 108.417 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -132.79 77.27 1.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.794 2.038 . . . . 10.0 107.546 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.13 123.81 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 125.026 1.33 . . . . 10.0 109.173 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 36.5 m-80 -147.94 53.19 1.03 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.044 0.937 . . . . 10.0 110.09 -177.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.63 -46.27 87.43 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.631 -0.668 . . . . 10.0 112.123 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.06 -35.14 77.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.09 0.956 . . . . 10.0 110.811 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.67 -32.5 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.34 -175.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.05 -88.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.906 1.241 . . . . 10.0 110.945 -173.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -166.49 164.09 17.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.393 2.677 . . . . 10.0 106.411 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -86.85 118.63 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 118.824 0.738 . . . . 10.0 110.575 -168.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.88 124.72 37.07 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.717 1.207 . . . . 10.0 108.402 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.414 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.2 t -134.5 136.73 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -99.96 70.98 1.62 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.26 -1.385 . . . . 10.0 107.26 -174.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 20.4 m-85 -72.46 135.46 45.74 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.023 -176.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.65 86.84 7.27 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.287 1.435 . . . . 10.0 108.264 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -18.61 1.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.905 1.282 . . . . 10.0 112.537 168.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.68 -16.05 56.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.561 1.544 . . . . 10.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.99 -56.1 2.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.324 1.05 . . . . 10.0 109.289 -177.021 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.12 155.92 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 123.91 0.884 . . . . 10.0 109.305 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -99.37 147.03 25.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.493 -0.928 . . . . 10.0 108.493 176.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 53' ' ' VAL . 18.7 m -30.71 -43.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 129.228 3.011 . . . . 10.0 111.202 168.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -28.87 -55.41 0.13 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.747 1.219 . . . . 10.0 111.549 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -48.21 -71.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.275 1.43 . . . . 10.0 111.05 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.1 mp -60.41 -55.34 25.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.511 1.525 . . . . 10.0 112.238 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.6 -58.41 1.3 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.263 2.225 . . . . 10.0 110.908 172.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.47 -45.93 92.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.558 0.743 . . . . 10.0 109.752 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.67 -44.11 65.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.443 0.697 . . . . 10.0 111.535 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.41 HG21 HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.42 -58.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 117.824 -1.084 . . . . 10.0 108.805 176.555 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER -46.74 -37.81 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.772 1.169 . . . . 10.0 112.849 -174.655 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -41.17 -61.14 1.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.041 1.336 . . . . 10.0 112.882 172.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -132.82 -40.52 0.95 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.62 98.69 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.29 -1.124 . . . . 10.0 110.29 -176.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 173.67 0.17 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.131 1.372 . . . . 10.0 110.5 -176.017 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 86.67 37.98 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.451 1.5 . . . . 10.0 111.621 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 60' ' ' ILE . 40.0 t -117.96 89.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.91 1.284 . . . . 10.0 110.09 172.113 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.64 -58.86 3.42 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.419 -0.585 . . . . 10.0 109.419 169.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -176.13 158.44 1.96 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.691 -1.596 . . . . 10.0 106.691 -174.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.407 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.09 143.74 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 123.715 0.806 . . . . 10.0 111.474 171.865 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -106.65 115.05 29.53 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 168.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.61 -111.46 0.51 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.856 -1.069 . . . . 10.0 110.069 -177.975 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.32 152.27 38.86 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.472 0.653 . . . . 10.0 111.692 -169.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.98 94.94 8.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.264 1.425 . . . . 10.0 108.235 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HB3' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -95.97 161.13 14.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 173.412 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.85 107.53 14.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.613 1.565 . . . . 10.0 107.381 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.67 HD22 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -78.8 92.41 4.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 169.266 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -69.17 144.87 53.68 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.86 126.93 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.045 2.138 . . . . 10.0 113.281 -174.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -70.15 -66.19 0.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.653 2.381 . . . . 10.0 109.782 176.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.01 -25.86 0.05 OUTLIER Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.688 -1.062 . . . . 10.0 115.465 -168.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 177.17 2.36 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.837 1.819 . . . . 10.0 109.765 174.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.738 ' HA ' HD21 ' A' ' 37' ' ' LEU . 31.6 m -165.17 56.77 0.12 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 -178.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.73 108.05 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.046 -1.835 . . . . 10.0 106.046 173.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.17 -24.49 64.8 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.489 0.185 . . . . 10.0 110.576 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -45.21 38.28 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.1 m -47.1 -71.11 0.08 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.039 1.335 . . . . 10.0 110.437 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.17 -49.1 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.249 0.219 . . . . 10.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 28.7 tttt -55.62 -34.7 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.84 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.531 -0.731 . . . . 10.0 109.352 174.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -82.38 -40.08 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 117.684 -1.15 . . . . 10.0 111.209 176.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -35.09 -60.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.994 1.718 . . . . 10.0 110.669 178.969 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -40.59 88.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.851 -1.068 . . . . 10.0 111.227 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -63.6 -56.13 18.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.077 0.951 . . . . 10.0 110.285 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.35 -33.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 124.185 0.994 . . . . 10.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -41.45 -27.93 0.31 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.951 -0.916 . . . . 10.0 114.981 170.082 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.16 70.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.568 1.684 . . . . 10.0 112.262 177.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.16 93.15 0.28 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 174.377 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.21 -39.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.887 1.675 . . . . 10.0 112.97 172.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.56 -9.02 42.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.121 0.867 . . . . 10.0 115.022 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.74 105.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.875 -2.268 . . . . 10.0 104.875 168.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -73.51 -33.21 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.564 179.076 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.92 159.05 13.07 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.747 -1.205 . . . . 10.0 107.747 177.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.49 128.2 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.637 1.175 . . . . 10.0 108.486 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 91.54 2.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.338 -0.986 . . . . 10.0 108.338 175.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 t -86.46 108.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.772 1.229 . . . . 10.0 109.073 -171.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.2 m120 -142.99 52.45 1.38 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.563 0.745 . . . . 10.0 111.665 -173.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.94 -48.62 51.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.249 0.62 . . . . 10.0 111.136 -178.915 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD22 ' A' ' 37' ' ' LEU . 38.0 mt-10 -66.27 -46.72 76.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.573 1.149 . . . . 10.0 110.172 -175.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.67 -30.49 69.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.339 -0.846 . . . . 10.0 110.089 -176.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.9 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 122.92 0.295 . . . . 10.0 112.432 170.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 171.67 7.91 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.93 0.892 . . . . 10.0 112.049 -169.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG12 HG23 ' A' ' 44' ' ' VAL . 40.2 t -93.71 102.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 173.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -93.19 113.67 25.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 45.5 t -125.78 143.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.355 -1.35 . . . . 10.0 107.355 -171.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -105.97 82.7 1.81 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.329 -2.1 . . . . 10.0 105.329 -174.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 53' ' ' VAL . 13.7 m-85 -88.24 132.31 34.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.259 1.424 . . . . 10.0 108.948 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -90.77 88.28 7.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.209 1.003 . . . . 10.0 108.356 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.85 -18.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.677 1.591 . . . . 10.0 112.819 167.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -19.15 58.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.614 1.966 . . . . 10.0 110.465 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -127.68 -48.61 1.39 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.199 1.0 . . . . 10.0 110.756 -169.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 m -134.09 165.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 123.986 0.914 . . . . 10.0 109.565 176.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 p -109.81 143.36 39.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.282 0.492 . . . . 10.0 109.921 175.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 46' ' ' PHE . 23.6 m -40.34 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 128.23 2.612 . . . . 10.0 108.841 169.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -35.16 -49.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.448 1.022 . . . . 10.0 112.194 175.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.45 -53.81 54.16 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.519 0.676 . . . . 10.0 111.077 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.89 -51.75 41.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.475 1.51 . . . . 10.0 111.289 -177.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -40.03 -59.96 1.13 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.971 2.108 . . . . 10.0 109.923 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.75 -48.34 75.42 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.082 0.953 . . . . 10.0 109.989 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.71 71.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.93 0.892 . . . . 10.0 111.511 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 HG23 ' A' ' 67' ' ' VAL . 1.3 mp -71.08 -34.09 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 O-C-N 120.729 -1.232 . . . . 10.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.21 -40.98 92.02 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.7 -1.25 . . . . 10.0 110.837 175.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -45.85 -66.62 0.38 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.356 1.063 . . . . 10.0 112.41 178.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -139.93 23.79 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.45 -49.4 0.6 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.46 1.029 . . . . 10.0 112.219 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 64.31 101.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.407 1.883 . . . . 10.0 111.558 173.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 173.36 -32.88 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 125.473 1.509 . . . . 10.0 109.799 -168.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.691 HG23 HG22 ' A' ' 60' ' ' ILE . 64.3 t -67.5 86.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 121.359 -0.838 . . . . 10.0 112.104 -171.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.41 -58.79 3.35 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 169.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -164.29 150.41 10.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 4' ' ' LYS . 5.2 tp -120.2 98.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.973 1.309 . . . . 10.0 110.429 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -118.8 -100.49 0.44 Allowed 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 174.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.43 -66.87 0.98 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.488 -1.045 . . . . 10.0 110.488 -171.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 170.48 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -106.22 -172.42 2.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.919 -2.252 . . . . 10.0 104.919 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.21 124.76 23.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.646 -1.983 . . . . 10.0 105.646 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HZ3' ' C ' ' A' ' 73' ' ' ARG . 1.9 mttt -127.76 158.95 36.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.868 1.318 . . . . 10.0 108.617 167.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 41' ' ' LYS . 1.8 m -119.5 98.14 5.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.982 2.913 . . . . 10.0 104.933 -168.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.65 86.63 4.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.793 -2.299 . . . . 10.0 104.793 170.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 53.9 tt0 -55.96 152.79 9.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.111 0.964 . . . . 10.0 109.267 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 2.2 t -63.63 127.12 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.698 1.199 . . . . 10.0 109.234 -178.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -75.23 -68.61 0.54 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 172.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.59 -32.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.518 -1.325 . . . . 10.0 115.806 -168.562 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -175.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.233 1.016 . . . . 10.0 108.721 173.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -168.47 39.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.133 1.373 . . . . 10.0 108.03 172.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -99.29 98.23 9.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.07 -17.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.39 1.876 . . . . 10.0 114.6 176.352 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -96.84 -37.28 10.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.797 1.239 . . . . 10.0 110.251 -176.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 m -56.62 -62.64 1.59 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 177.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 37' ' ' LEU . 9.2 m -49.65 -47.13 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.947 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 7.2 tttp -56.26 -34.82 66.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.269 1.211 . . . . 10.0 114.269 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -39.34 61.16 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.55 -0.537 . . . . 10.0 109.55 172.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.65 -37.26 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 117.903 -1.046 . . . . 10.0 111.199 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 26.8 tt0 -40.47 -57.0 1.92 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.733 1.613 . . . . 10.0 110.255 -178.199 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -46.61 89.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.369 -0.832 . . . . 10.0 111.012 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 t -56.46 -53.77 53.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.207 1.003 . . . . 10.0 109.687 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.86 -39.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 O-C-N 121.655 -0.653 . . . . 10.0 110.055 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.13 -26.94 3.39 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.05 -0.861 . . . . 10.0 113.92 172.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.47 -27.94 64.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.125 1.462 . . . . 10.0 111.579 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.44 108.49 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.945 0.793 . . . . 10.0 110.8 178.452 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -39.65 -45.52 1.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.551 1.54 . . . . 10.0 111.922 170.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.37 17.43 1.92 Allowed Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.378 0.911 . . . . 10.0 115.378 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.48 109.39 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 104.213 -2.514 . . . . 10.0 104.213 167.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -74.38 -32.6 62.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.1 151.83 6.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.932 -1.506 . . . . 10.0 106.932 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.05 136.31 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 177.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.07 92.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 t -93.47 108.58 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 126.601 1.96 . . . . 10.0 107.38 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 72.11 1.35 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 10.0 109.721 -171.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.79 HD22 ' H ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -70.72 -49.79 43.18 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -172.264 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.155 1.782 . . . . 10.0 110.029 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -35.25 44.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.628 -176.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.49 -75.25 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 177.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -166.16 -177.92 4.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.671 1.988 . . . . 10.0 111.631 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 HG23 ' A' ' 44' ' ' VAL . 61.9 t -89.61 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 -176.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -95.14 99.27 11.28 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 42' ' ' VAL . 52.5 t -116.74 148.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -170.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -112.32 90.25 3.29 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 -174.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.71 144.17 26.2 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 126.972 2.109 . . . . 10.0 108.803 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -97.57 94.52 7.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 167.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.8 7.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 10.0 111.973 170.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.6 t70 -71.59 -25.25 62.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.002 2.121 . . . . 10.0 110.346 173.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -121.8 -56.51 1.85 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.239 1.016 . . . . 10.0 109.668 -168.092 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.85 144.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 125.691 1.596 . . . . 10.0 109.63 -175.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 p -97.67 142.82 28.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.432 0.634 . . . . 10.0 110.146 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -43.31 -43.28 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 127.978 2.511 . . . . 10.0 108.615 168.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -44.73 -44.3 9.11 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.652 -1.165 . . . . 10.0 111.269 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.47 -63.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.614 0.643 . . . . 10.0 110.25 177.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.499 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.3 mp -62.27 -51.58 70.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.366 1.066 . . . . 10.0 111.817 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.72 -56.56 2.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.594 1.958 . . . . 10.0 109.763 171.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.96 -46.57 88.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.052 0.453 . . . . 10.0 110.314 175.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.99 77.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 10.0 111.154 -175.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.7 -49.8 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -49.56 -36.13 22.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.714 1.143 . . . . 10.0 112.939 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.91 -61.34 2.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.554 1.142 . . . . 10.0 112.545 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -138.86 -17.41 1.08 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.55 -46.29 48.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 119.147 0.885 . . . . 10.0 110.915 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 58.17 93.45 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.932 2.093 . . . . 10.0 111.102 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.28 46.17 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.1 2.56 . . . . 10.0 112.869 173.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.08 86.17 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.107 -0.996 . . . . 10.0 109.071 173.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 8' ' ' VAL . . . -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 174.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.32 155.92 0.52 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.239 1.816 . . . . 10.0 106.38 176.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.19 130.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 169.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -121.78 133.51 54.91 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.721 -1.585 . . . . 10.0 106.721 172.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.59 -134.68 2.86 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 108.471 -1.851 . . . . 10.0 108.471 177.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' C ' ' HZ3' ' A' ' 4' ' ' LYS . 25.9 ttt-85 . . . . . 0 C--O 1.252 1.185 0 N-CA-C 103.559 -2.756 . . . . 10.0 103.559 168.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -110.2 116.45 31.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 124.756 1.285 . . . . 10.0 112.134 -165.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -71.93 71.67 0.8 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.461 1.505 . . . . 10.0 111.479 175.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -72.39 151.43 42.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 123.445 1.593 . . . . 10.0 108.883 168.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.87 111.12 21.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.144 -2.539 . . . . 10.0 104.144 -176.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' A' ' 70' ' ' ILE . 9.0 mp -90.49 87.91 6.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.55 -2.019 . . . . 10.0 105.55 173.048 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -60.9 146.3 47.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.296 -1.32 . . . . 10.0 109.355 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASP . 5.0 p -67.64 129.74 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.259 1.824 . . . . 10.0 113.547 -169.294 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -77.0 -51.42 11.12 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 127.623 2.369 . . . . 10.0 109.465 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.66 -0.67 1.7 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.467 -0.873 . . . . 10.0 114.181 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.26 171.06 4.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.873 1.337 . . . . 10.0 107.542 168.045 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -153.15 56.26 0.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.374 -1.343 . . . . 10.0 107.374 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.56 96.7 3.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.359 -1.349 . . . . 10.0 107.359 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -52.25 -21.73 3.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.304 0.483 . . . . 10.0 112.304 170.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.35 -35.72 35.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.845 -0.535 . . . . 10.0 110.166 -170.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.0 m -55.66 -74.13 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.366 1.067 . . . . 10.0 108.167 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -44.58 -52.02 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 113.523 0.934 . . . . 10.0 113.523 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -55.38 -31.18 61.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.205 0.911 . . . . 10.0 113.284 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.82 65.43 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 122.724 0.41 . . . . 10.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.45 -44.11 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 118.061 -0.971 . . . . 10.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -45.3 -45.1 11.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.525 1.057 . . . . 10.0 110.529 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -52.8 -48.92 66.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.497 0.665 . . . . 10.0 111.792 175.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 t -71.14 -38.47 72.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.931 1.292 . . . . 10.0 111.218 -178.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.25 -37.38 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.698 -0.626 . . . . 10.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.29 0.83 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.605 1.097 . . . . 10.0 113.025 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.7 -43.53 2.37 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.825 2.85 . . . . 10.0 109.364 175.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.72 123.56 13.68 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.22 0.918 . . . . 10.0 109.727 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -50.23 -41.57 50.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.246 1.018 . . . . 10.0 112.068 -174.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.78 69.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 116.233 -0.44 . . . . 10.0 113.588 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -74.62 108.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 119.643 -2.092 . . . . 10.0 106.197 172.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -37.97 73.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.166 173.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.88 155.2 11.93 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.128 -1.434 . . . . 10.0 107.128 -176.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.13 137.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -149.8 91.72 1.83 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.266 -1.012 . . . . 10.0 108.266 176.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.08 110.44 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 124.327 1.051 . . . . 10.0 110.218 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.43 49.81 2.15 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.699 0.8 . . . . 10.0 112.114 -178.469 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -50.2 30.85 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.025 0.93 . . . . 10.0 111.429 -175.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.47 -36.2 73.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.565 0.746 . . . . 10.0 110.858 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.96 62.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.458 -177.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.73 -65.33 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.7 178.92 5.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.342 1.057 . . . . 10.0 112.631 -169.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.57 105.97 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.075 -1.454 . . . . 10.0 107.075 176.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.14 117.86 35.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 72.3 t -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -168.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.2 t -110.91 87.76 2.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.879 -1.896 . . . . 10.0 105.879 -169.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 58.6 m-85 -95.36 129.12 42.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.435 1.494 . . . . 10.0 109.959 -173.08 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -81.46 88.98 6.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 172.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.36 -11.16 1.11 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -89.89 -2.9 58.28 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.571 1.078 . . . . 10.0 110.615 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -134.69 -54.52 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.889 0.876 . . . . 10.0 110.335 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.22 141.86 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 124.662 1.185 . . . . 10.0 109.911 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.7 p -107.77 153.6 22.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.679 0.752 . . . . 10.0 109.664 178.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -43.56 -37.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 127.483 2.313 . . . . 10.0 111.056 169.046 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -47.97 -32.59 6.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.475 0.58 . . . . 10.0 111.77 176.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -59.64 2.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.097 0.862 . . . . 10.0 111.108 171.038 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.8 -52.53 34.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 124.18 0.992 . . . . 10.0 112.775 -170.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.98 -54.35 13.19 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.54 1.536 . . . . 10.0 109.486 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -51.14 -50.73 58.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 10.0 109.71 172.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.96 76.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.04 0.536 . . . . 10.0 112.107 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.46 -37.03 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 O-C-N 120.61 -1.306 . . . . 10.0 111.258 178.879 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -51.3 -45.84 62.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.841 -1.162 . . . . 10.0 110.932 168.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -47.82 -62.2 1.57 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -147.15 55.65 1.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.838 0.455 . . . . 10.0 112.04 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.78 -54.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.84 -0.978 . . . . 10.0 111.039 176.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 64.69 107.0 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.323 1.849 . . . . 10.0 111.563 173.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 m-20 164.19 -25.73 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 125.368 1.467 . . . . 10.0 110.453 -169.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 60' ' ' ILE . 61.7 t -86.13 88.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 121.027 -1.046 . . . . 10.0 109.087 -174.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.98 69.5 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -169.41 153.45 5.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.116 -1.809 . . . . 10.0 106.116 177.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.83 142.44 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 123.572 0.749 . . . . 10.0 109.312 173.501 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.88 84.82 4.62 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 169.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.86 -107.13 0.32 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.736 -0.48 . . . . 10.0 112.23 169.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 114.996 -2.43 . . . . 10.0 105.522 -169.511 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 106.503 -1.666 . . . . 10.0 106.503 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -125.2 177.3 6.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.992 1.317 . . . . 10.0 109.399 -174.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -147.35 82.55 1.54 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.015 0.926 . . . . 10.0 109.292 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' NZ ' ' OXT' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -89.48 165.39 14.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.557 1.143 . . . . 10.0 108.966 173.736 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -120.46 111.28 17.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.314 1.846 . . . . 10.0 108.141 -168.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.586 HD21 HG22 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -87.99 83.32 7.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 178.646 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.08 147.41 50.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.127 -0.942 . . . . 10.0 110.288 -176.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' OD1' ' A' ' 66' ' ' ASP . 10.4 p -65.51 119.37 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.983 2.113 . . . . 10.0 113.138 -169.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -66.04 -50.11 65.33 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.887 1.275 . . . . 10.0 110.094 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.3 -22.48 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.048 -0.524 . . . . 10.0 112.242 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.97 170.36 0.86 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.539 1.162 . . . . 10.0 111.852 174.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -151.94 23.91 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.594 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.7 t -103.88 92.69 4.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -52.77 -20.14 2.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.046 0.758 . . . . 10.0 113.046 171.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.08 -39.42 29.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.336 -0.852 . . . . 10.0 109.21 -175.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 m -56.68 -67.03 0.34 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 175.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -46.99 -50.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 119.281 -0.39 . . . . 10.0 111.887 -177.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -58.78 -31.09 68.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.761 0.71 . . . . 10.0 112.808 -175.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.24 68.33 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 110.29 -0.263 . . . . 10.0 110.29 176.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.0 t -87.28 -39.24 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 118.437 -0.792 . . . . 10.0 110.951 176.185 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -41.64 -43.28 2.74 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.183 1.393 . . . . 10.0 110.964 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.8 -57.35 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.977 0.353 . . . . 10.0 110.88 174.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -58.64 -54.57 45.57 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.841 1.256 . . . . 10.0 109.968 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 HG12 ' A' ' 56' ' ' ILE . 14.0 t -52.76 -42.89 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.201 1.001 . . . . 10.0 110.1 176.471 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.92 -38.19 83.06 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.748 1.166 . . . . 10.0 112.733 173.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.0 -27.55 65.79 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.36 1.08 . . . . 10.0 111.502 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.91 104.24 0.53 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 119.572 -0.851 . . . . 10.0 109.196 171.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -26.3 -49.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.116 2.566 . . . . 10.0 114.11 169.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.99 -13.43 59.58 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.597 0.599 . . . . 10.0 114.597 -176.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.64 110.12 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 119.871 1.836 . . . . 10.0 106.469 171.183 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -82.21 -28.8 31.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.22 -176.415 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.04 159.17 17.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 176.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.62 128.95 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 78.5 1.83 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.66 116.91 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 124.744 1.218 . . . . 10.0 108.504 176.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -149.36 46.96 0.97 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.328 0.651 . . . . 10.0 110.622 -175.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -54.09 -43.4 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.079 0.551 . . . . 10.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.03 -40.45 75.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.862 1.265 . . . . 10.0 110.533 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.92 -30.26 50.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.653 -0.703 . . . . 10.0 111.51 -178.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 -61.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.539 0.59 . . . . 10.0 112.457 -179.194 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -170.06 176.05 4.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.484 1.514 . . . . 10.0 112.087 -171.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 96.1 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 106.109 -1.811 . . . . 10.0 106.109 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.71 118.85 31.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 40.6 t -129.22 146.21 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -169.095 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 t -106.93 71.03 0.82 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.38 -1.711 . . . . 10.0 106.38 -173.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 22.0 m-85 -67.34 142.34 56.83 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.64 -1.618 . . . . 10.0 107.435 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -100.83 94.71 6.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.018 0.527 . . . . 10.0 109.954 169.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.54 -15.42 2.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.105 0.962 . . . . 10.0 113.443 174.445 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.71 -9.52 58.78 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.079 0.854 . . . . 10.0 110.009 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -126.25 -54.61 1.47 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.367 1.067 . . . . 10.0 108.49 -175.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.97 144.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.817 1.247 . . . . 10.0 110.482 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 m -101.58 139.24 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.407 HG13 ' H ' ' A' ' 53' ' ' VAL . 9.4 m -34.24 -50.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 129.9 3.28 . . . . 10.0 110.877 176.409 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -29.71 -53.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.06 1.344 . . . . 10.0 112.491 172.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.05 -63.14 1.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.089 0.956 . . . . 10.0 110.679 177.051 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.415 HG12 HG13 ' A' ' 24' ' ' VAL . 2.7 mp -64.51 -54.49 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 C-N-CA 125.97 1.708 . . . . 10.0 111.779 -176.49 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 70' ' ' ILE . . . -38.49 -60.56 0.79 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.016 2.126 . . . . 10.0 110.403 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.54 -46.21 89.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.006 0.522 . . . . 10.0 110.569 176.819 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.19 71.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.023 0.929 . . . . 10.0 111.489 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -67.71 -59.27 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 174.858 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.8 -45.13 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.647 0.779 . . . . 10.0 112.249 -176.371 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -32.8 -50.91 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.493 1.517 . . . . 10.0 114.675 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -152.22 -37.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.096 0.959 . . . . 10.0 113.003 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -53.51 -44.24 67.4 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.424 -0.671 . . . . 10.0 111.424 178.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.44 169.6 0.23 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.266 1.426 . . . . 10.0 110.5 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 8' ' ' VAL . 12.1 t70 104.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.588 1.955 . . . . 10.0 112.4 171.579 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG22 HD21 ' A' ' 6' ' ' LEU . 21.3 t -102.53 77.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.943 1.697 . . . . 10.0 108.697 -177.176 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.31 -52.16 43.81 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.663 1.221 . . . . 10.0 108.446 176.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.51 127.92 2.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 104.829 -2.285 . . . . 10.0 104.829 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.405 HG21 ' HB2' ' A' ' 57' ' ' ALA . 3.6 tp -89.71 124.93 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.029 -1.841 . . . . 10.0 106.029 168.103 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.45 176.32 0.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.496 0.665 . . . . 10.0 109.802 174.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.96 75.18 0.18 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 19.7 ttm180 . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 167.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttp . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.107 -0.473 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -149.12 179.46 7.87 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 106.11 -1.811 . . . . 10.0 106.11 169.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -135.51 133.2 38.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.93 2.092 . . . . 10.0 106.616 169.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.01 -178.07 4.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.64 -2.726 . . . . 10.0 103.64 168.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 124.1 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.185 -2.524 . . . . 10.0 104.185 -177.007 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.654 HD12 HG11 ' A' ' 42' ' ' VAL . 4.0 mt -88.26 89.25 7.91 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 105.102 -2.184 . . . . 10.0 105.102 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -53.44 143.33 19.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.423 0.556 . . . . 10.0 110.314 -174.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.31 132.63 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.179 0.992 . . . . 10.0 112.745 -168.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -86.13 -47.26 9.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.811 2.444 . . . . 10.0 111.249 -176.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -37.27 0.16 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.653 -0.526 . . . . 10.0 113.149 -174.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 155.97 38.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.054 0.927 . . . . 10.0 109.567 175.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -140.47 16.45 2.38 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.593 0.757 . . . . 10.0 110.535 175.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -88.99 103.76 16.35 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.58 -1.64 0.87 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.171 -0.919 . . . . 10.0 113.398 174.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.7 -45.37 7.04 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.158 1.345 . . . . 10.0 110.572 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -47.13 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.574 1.95 . . . . 10.0 109.844 175.101 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.585 HG21 HG11 ' A' ' 35' ' ' VAL . 5.8 m -36.47 -46.43 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.238 1.415 . . . . 10.0 112.767 173.011 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 2.5 tttm -55.27 -31.7 61.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.176 1.176 . . . . 10.0 114.176 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.31 -34.95 62.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.751 0.25 . . . . 10.0 110.548 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.07 -34.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.031 1.333 . . . . 10.0 110.942 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 30.9 tt0 -42.62 -47.37 5.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.553 1.141 . . . . 10.0 109.947 178.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -56.49 18.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.952 0.406 . . . . 10.0 111.112 177.144 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 m -62.92 -53.51 53.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.924 1.289 . . . . 10.0 110.963 -175.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.74 -43.87 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.923 0.889 . . . . 10.0 109.738 178.315 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.92 -42.01 69.05 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.595 0.617 . . . . 10.0 111.969 171.15 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -34.82 78.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.398 1.079 . . . . 10.0 111.038 178.024 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 105.21 1.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.222 -0.924 . . . . 10.0 110.025 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -32.96 -35.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.093 2.557 . . . . 10.0 114.173 170.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.19 5.4 2.83 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 116.115 1.206 . . . . 10.0 116.115 175.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.33 124.95 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.074 1.75 . . . . 10.0 107.24 169.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -92.32 -27.66 17.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.787 0.835 . . . . 10.0 111.028 175.378 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 151.47 10.14 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 44' ' ' VAL . 14.2 m -136.64 128.76 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.779 1.232 . . . . 10.0 109.825 -177.091 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -151.49 100.17 2.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.295 1.038 . . . . 10.0 109.289 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 17' ' ' VAL . 37.1 t -93.35 108.66 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 126.024 1.73 . . . . 10.0 109.329 -175.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 32.1 m-80 -128.1 53.44 1.8 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.097 0.559 . . . . 10.0 111.604 -176.049 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -41.93 -52.34 4.14 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.281 1.432 . . . . 10.0 112.259 -178.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.13 -36.47 83.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.668 0.787 . . . . 10.0 111.619 -177.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -81.16 -37.6 28.51 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.872 0.367 . . . . 10.0 110.448 -171.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.89 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.649 -1.381 . . . . 10.0 109.649 177.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -171.88 1.91 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.513 1.525 . . . . 10.0 109.342 178.191 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG11 HD12 ' A' ' 6' ' ' LEU . 2.8 p -84.81 133.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.016 0.927 . . . . 10.0 108.873 168.655 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.4 96.21 5.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.858 1.263 . . . . 10.0 108.265 175.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 33' ' ' VAL . 17.7 t -105.44 149.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.835 1.654 . . . . 10.0 107.684 -178.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -106.71 77.21 1.17 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.912 -1.884 . . . . 10.0 105.912 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CZ ' HD21 ' A' ' 6' ' ' LEU . 6.9 m-85 -74.45 131.84 41.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.29 -1.323 . . . . 10.0 108.469 -176.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.62 83.58 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.471 0.708 . . . . 10.0 109.091 171.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.59 -18.42 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 170.221 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.64 -12.11 60.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.687 1.995 . . . . 10.0 110.033 178.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -131.42 -58.48 0.99 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.76 1.624 . . . . 10.0 109.219 -172.704 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -131.39 141.09 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.966 1.706 . . . . 10.0 109.553 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -90.18 149.0 22.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.511 -0.743 . . . . 10.0 109.837 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 4' ' ' LYS . 11.4 m -37.3 -46.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 C-N-CA 128.047 2.539 . . . . 10.0 109.431 167.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -42.22 -41.27 2.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.619 -0.705 . . . . 10.0 112.145 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.76 -66.48 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.479 0.581 . . . . 10.0 110.52 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 56' ' ' ILE . 3.7 mp -58.52 -56.99 12.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.306 1.442 . . . . 10.0 112.145 -175.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -37.93 -64.04 0.43 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.666 2.386 . . . . 10.0 110.137 172.551 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.46 -38.75 91.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.33 0.586 . . . . 10.0 110.185 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.27 76.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.542 -0.723 . . . . 10.0 111.41 175.181 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.452 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.46 -37.69 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 120.677 -1.265 . . . . 10.0 109.302 174.666 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.22 -42.34 73.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.035 1.288 . . . . 10.0 111.112 173.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -46.96 -66.98 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.681 0.792 . . . . 10.0 112.755 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.6 52.22 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.956 0.502 . . . . 10.0 111.453 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.94 -69.3 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 t80 69.25 130.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.08 1.752 . . . . 10.0 107.943 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 158.88 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.325 1.45 . . . . 10.0 109.965 -167.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.452 HG23 ' CG2' ' A' ' 60' ' ' ILE . 94.3 t -82.79 87.85 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.6 0.76 . . . . 10.0 111.602 -169.335 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.44 -53.72 17.89 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.685 -0.634 . . . . 10.0 109.671 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -168.1 167.77 12.25 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 178.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.65 HG22 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -98.73 148.44 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 126.685 1.994 . . . . 10.0 110.536 173.013 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -95.79 -63.53 1.15 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.685 0.794 . . . . 10.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.81 -61.05 7.81 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 -169.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.262 0 N-CA-C 105.408 -2.071 . . . . 10.0 105.408 164.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mmt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 106.821 -1.548 . . . . 10.0 106.821 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -96.16 118.59 33.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.981 0.801 . . . . 10.0 111.256 -167.013 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -66.55 81.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.479 0.711 . . . . 10.0 110.498 169.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -85.86 157.94 20.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.147 0.975 . . . . 10.0 109.028 168.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.25 101.25 8.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.458 -2.053 . . . . 10.0 105.458 -171.108 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.467 ' CB ' HG13 ' A' ' 42' ' ' VAL . 8.1 mt -72.18 101.39 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.058 -2.201 . . . . 10.0 105.058 167.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -77.34 147.77 35.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.71 128.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 125.941 1.697 . . . . 10.0 112.901 -170.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -69.41 -61.55 1.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.308 2.243 . . . . 10.0 108.964 177.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.51 -35.2 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.358 -0.69 . . . . 10.0 113.3 -169.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.91 178.24 2.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.593 1.197 . . . . 10.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 p -141.42 -50.98 0.43 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.453 -169.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -32.46 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.987 1.715 . . . . 10.0 113.202 -175.87 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -54.73 -9.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -88.46 -43.14 11.67 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.407 1.003 . . . . 10.0 110.166 -177.212 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.4 m -50.58 -68.18 0.19 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.746 0.818 . . . . 10.0 109.375 175.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 37' ' ' LEU . 2.6 m -46.61 -46.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.672 -0.24 . . . . 10.0 111.338 178.37 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.84 -36.4 64.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.138 1.162 . . . . 10.0 114.138 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.68 54.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.517 0.675 . . . . 10.0 110.02 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.14 -38.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 117.832 -1.08 . . . . 10.0 110.893 175.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 4.5 tt0 -36.89 -52.73 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.922 1.689 . . . . 10.0 111.015 176.511 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 p -58.07 -49.43 76.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.101 0.56 . . . . 10.0 111.399 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.3 m -62.93 -48.23 79.83 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.326 0.65 . . . . 10.0 110.402 -177.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 30' ' ' VAL . 54.0 t -59.45 -42.72 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.863 0.865 . . . . 10.0 109.69 176.375 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.21 -43.35 56.82 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 123.579 0.609 . . . . 10.0 112.09 170.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.96 -30.32 70.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.585 0.692 . . . . 10.0 111.984 177.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 110.38 2.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.608 1.094 . . . . 10.0 110.431 177.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -35.31 -43.7 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.184 2.194 . . . . 10.0 113.081 173.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 20.22 1.92 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.223 0.849 . . . . 10.0 115.223 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 24' ' ' VAL . 1.4 t -125.13 113.46 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 169.258 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.8 t -72.72 -33.79 66.66 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.457 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.24 159.75 9.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 -177.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 44' ' ' VAL . 39.8 t -134.01 137.04 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.506 1.522 . . . . 10.0 107.695 179.138 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -136.31 82.47 1.94 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 125.599 1.56 . . . . 10.0 107.185 168.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.19 130.05 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.96 -1.018 . . . . 10.0 108.892 174.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.86 44.75 0.16 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.06 0.457 . . . . 10.0 111.11 -173.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 17' ' ' VAL . 1.6 pt? -57.68 -47.03 83.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.385 0.674 . . . . 10.0 112.114 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.766 1.226 . . . . 10.0 110.106 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.99 38.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.516 -178.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.43 -60.56 0.15 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.303 0.954 . . . . 10.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -170.65 166.33 8.09 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.09 1.356 . . . . 10.0 110.592 -171.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.467 HG13 ' CB ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.72 118.15 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 172.488 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.08 120.05 40.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 56.1 t -131.48 138.9 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -170.805 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -92.51 67.28 4.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.738 -2.319 . . . . 10.0 104.738 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 45.6 m-85 -69.32 139.7 54.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.911 -1.515 . . . . 10.0 106.911 -177.787 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.59 88.6 5.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 -176.116 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.65 -24.01 45.46 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.443 0.534 . . . . 10.0 112.443 -178.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.76 -17.97 56.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.749 1.62 . . . . 10.0 110.253 -177.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -107.62 -55.09 2.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.222 1.009 . . . . 10.0 108.401 -173.103 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.33 178.49 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.656 1.182 . . . . 10.0 108.931 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 p -112.75 152.22 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -32.17 -44.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 129.74 3.216 . . . . 10.0 110.656 168.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -30.05 -53.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.42 1.088 . . . . 10.0 111.578 171.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.96 -59.1 5.08 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.592 0.757 . . . . 10.0 111.366 178.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -68.31 -53.68 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 125.096 1.358 . . . . 10.0 111.727 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.59 -55.7 2.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 126.235 1.814 . . . . 10.0 110.226 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.79 -45.93 88.72 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.728 -0.607 . . . . 10.0 110.695 174.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.13 65.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.675 0.39 . . . . 10.0 111.183 178.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.531 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -71.25 -35.98 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.245 -0.909 . . . . 10.0 110.306 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.13 -37.99 72.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.702 1.137 . . . . 10.0 111.624 173.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -55.72 -66.9 0.34 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.455 0.57 . . . . 10.0 111.533 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.9 39.32 2.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -174.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.75 -58.28 0.09 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.92 -0.933 . . . . 10.0 112.348 -178.392 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 66.76 109.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.038 2.135 . . . . 10.0 110.938 178.081 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 166.92 -29.89 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 10.0 110.664 -168.198 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' CG2' ' A' ' 60' ' ' ILE . 40.6 t -68.14 85.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 121.077 -1.014 . . . . 10.0 112.229 -171.132 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.75 -57.23 4.13 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 121.808 0.813 . . . . 10.0 108.811 170.714 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -175.93 146.26 0.7 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 -171.526 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.76 133.26 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 124.524 1.129 . . . . 10.0 109.18 168.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -113.87 134.8 54.58 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.816 -1.92 . . . . 10.0 105.816 168.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.7 -121.57 1.68 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.984 -1.246 . . . . 10.0 109.984 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.415 -1.278 . . . . 10.0 111.301 -176.228 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 106.496 -1.668 . . . . 10.0 106.496 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.0 155.37 13.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.848 -0.741 . . . . 10.0 112.586 -165.169 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -71.26 63.47 0.36 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 10.0 110.569 172.662 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' NZ ' ' OXT' ' A' ' 73' ' ' ARG . 24.9 mttm -69.8 172.48 7.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.315 1.055 . . . . 10.0 108.206 168.316 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.13 104.89 15.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 177.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -62.55 150.09 41.35 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.705 0.802 . . . . 10.0 108.912 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.22 123.8 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 125.51 1.524 . . . . 10.0 111.063 -172.676 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.44 -45.48 75.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.594 1.558 . . . . 10.0 109.505 174.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.34 -8.41 0.39 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.855 -0.97 . . . . 10.0 114.094 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.93 179.45 1.47 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 119.425 1.612 . . . . 10.0 110.843 175.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -160.04 41.09 0.19 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -122.9 93.79 4.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.378 0.671 . . . . 10.0 109.672 176.372 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -55.92 -10.13 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.042 1.497 . . . . 10.0 115.042 172.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.94 -50.3 6.52 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 120.097 1.317 . . . . 10.0 109.609 -176.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -46.53 -62.62 1.29 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.196 0.998 . . . . 10.0 109.959 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -45.73 -52.58 2.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 122.41 0.284 . . . . 10.0 111.553 176.414 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 4.2 tmtp? -56.88 -37.49 71.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.811 0.844 . . . . 10.0 112.68 -178.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.31 -41.75 51.51 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.341 -0.615 . . . . 10.0 109.341 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.93 -36.69 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-O 117.229 -1.367 . . . . 10.0 111.592 173.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.5 tp10 -43.54 -51.15 6.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.888 1.677 . . . . 10.0 110.001 -177.229 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.46 -47.98 83.4 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.278 0.561 . . . . 10.0 111.387 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -60.31 -40.73 91.6 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.471 1.108 . . . . 10.0 110.752 -177.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.5 -39.11 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.933 0.893 . . . . 10.0 109.846 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.76 -23.93 46.53 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.416 1.008 . . . . 10.0 112.281 178.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.33 -32.33 68.45 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.318 1.047 . . . . 10.0 110.655 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.43 111.97 2.9 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.179 -0.951 . . . . 10.0 110.688 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -37.54 -37.88 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.683 2.793 . . . . 10.0 112.973 174.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.47 4.55 81.27 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.448 0.939 . . . . 10.0 115.448 -177.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.13 107.65 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 104.289 -2.485 . . . . 10.0 104.289 167.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 -28.72 55.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.26 157.29 15.22 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 178.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.69 140.61 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.609 1.564 . . . . 10.0 109.013 -177.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -155.72 80.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.544 1.537 . . . . 10.0 109.078 173.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.33 115.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 121.688 -0.633 . . . . 10.0 109.885 169.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.6 m120 -143.86 48.52 1.41 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.901 0.881 . . . . 10.0 110.71 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -55.74 25.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.392 0.677 . . . . 10.0 111.261 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.64 -22.47 64.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.815 -0.553 . . . . 10.0 110.324 -172.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -85.4 -35.45 21.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.948 0.899 . . . . 10.0 111.287 177.57 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.09 -72.1 0.06 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.125 0.869 . . . . 10.0 112.49 -171.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 176.77 5.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.283 2.233 . . . . 10.0 110.933 -175.088 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.3 t -96.35 102.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.186 0.994 . . . . 10.0 108.486 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -84.14 132.13 34.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.05 0.94 . . . . 10.0 108.583 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.88 129.52 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 O-C-N 121.528 -0.732 . . . . 10.0 110.001 -172.027 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.5 m -96.49 80.99 3.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.147 -1.427 . . . . 10.0 107.147 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CE2' HG12 ' A' ' 53' ' ' VAL . 42.2 m-85 -81.63 130.64 35.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.429 -0.805 . . . . 10.0 110.234 -178.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -91.69 87.23 6.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.422 1.889 . . . . 10.0 108.653 174.022 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -20.51 2.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.593 1.157 . . . . 10.0 113.293 171.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.657 1.583 . . . . 10.0 109.237 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -59.0 1.96 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 125.959 1.704 . . . . 10.0 109.155 -170.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 m -140.05 154.21 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 123.826 0.851 . . . . 10.0 110.742 178.678 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 t -100.01 160.09 14.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.13 0.966 . . . . 10.0 111.016 177.227 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' CE2' ' A' ' 46' ' ' PHE . 31.1 m -48.22 -35.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 C-N-CA 128.187 2.595 . . . . 10.0 109.418 166.641 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -52.53 -28.2 19.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.193 0.906 . . . . 10.0 112.392 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.09 -62.98 1.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.346 0.976 . . . . 10.0 109.358 169.003 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -65.66 -51.39 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 O-C-N 121.512 -0.743 . . . . 10.0 112.491 -169.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.05 -53.51 6.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.013 1.725 . . . . 10.0 109.872 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.84 -49.11 78.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.818 0.847 . . . . 10.0 110.05 175.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.13 -42.46 66.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.569 1.147 . . . . 10.0 111.595 -179.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.38 -56.39 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 118.215 -0.897 . . . . 10.0 108.832 174.488 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -34.5 59.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.883 1.219 . . . . 10.0 112.105 -171.264 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -38.19 -54.82 1.36 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.935 1.694 . . . . 10.0 113.527 172.172 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -144.86 -38.39 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.89 85.56 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.32 171.38 0.24 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.025 1.33 . . . . 10.0 109.958 -176.012 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.269 0.1 OUTLIER 102.13 3.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 127.425 2.29 . . . . 10.0 113.203 174.752 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 60' ' ' ILE . 38.6 t -88.65 88.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 124.806 1.242 . . . . 10.0 110.173 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.56 -58.44 4.29 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -175.36 152.88 1.44 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -175.688 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.25 147.1 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 123.81 0.844 . . . . 10.0 111.811 173.682 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -111.06 -123.07 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 167.294 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.27 -67.8 0.15 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.491 1.52 . . . . 10.0 112.541 -170.334 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 N-CA-C 107.856 -1.165 . . . . 10.0 107.856 -174.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 29.6 ttp . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.14 137.51 49.07 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 123.795 0.684 . . . . 10.0 111.808 -168.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -84.6 99.19 10.61 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.662 1.185 . . . . 10.0 110.276 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.65 164.84 12.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 167.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.82 113.78 21.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.072 -1.825 . . . . 10.0 106.072 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 42' ' ' VAL . 5.7 mt -80.88 83.19 6.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 174.262 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.82 147.02 20.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 -176.3 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.28 130.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.938 0.718 . . . . 10.0 112.938 -169.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -66.39 -48.6 69.59 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.847 1.659 . . . . 10.0 107.468 172.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.33 11.76 0.12 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.4 -1.222 . . . . 10.0 114.624 175.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -175.27 2.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 120.382 2.091 . . . . 10.0 108.52 173.182 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -170.17 58.45 0.04 OUTLIER 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.649 -1.241 . . . . 10.0 107.649 173.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.8 t -132.16 108.94 9.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 174.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -66.04 -10.56 41.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.11 0.964 . . . . 10.0 111.41 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -93.05 -48.27 6.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.538 0.735 . . . . 10.0 110.156 -171.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 m -43.64 -70.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.008 1.723 . . . . 10.0 110.197 171.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.591 HG21 HG11 ' A' ' 35' ' ' VAL . 4.1 m -39.56 -48.66 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 C-N-CA 123.962 0.905 . . . . 10.0 111.789 173.459 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.07 -34.86 61.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -31.34 45.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.36 0.527 . . . . 10.0 110.542 174.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.01 -32.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.498 1.519 . . . . 10.0 111.232 177.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 27.8 tt0 -43.37 -47.58 6.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.154 1.382 . . . . 10.0 110.087 -179.323 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -44.62 -70.04 0.12 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.802 1.641 . . . . 10.0 111.836 169.711 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.5 t -58.59 -47.21 85.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.116 1.367 . . . . 10.0 110.57 -172.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.37 -42.99 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.023 0.529 . . . . 10.0 109.8 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.31 -45.35 74.97 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.419 0.533 . . . . 10.0 111.769 170.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -61.52 -36.42 80.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 10.0 111.632 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 95.65 0.21 Allowed 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.276 -0.89 . . . . 10.0 109.972 177.131 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -28.03 -41.94 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.942 2.497 . . . . 10.0 114.902 173.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.83 5.15 0.56 Allowed Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.885 1.231 . . . . 10.0 115.74 174.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.74 111.31 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 104.474 -2.417 . . . . 10.0 104.474 169.083 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -74.08 -30.59 62.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.32 156.78 10.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.874 -1.528 . . . . 10.0 106.874 178.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.58 145.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 O-C-N 123.927 0.767 . . . . 10.0 109.677 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.29 96.67 1.2 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 173.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 17' ' ' VAL . 25.7 t -87.3 120.34 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.08 49.8 2.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.424 0.556 . . . . 10.0 110.023 -174.118 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -42.46 -53.96 4.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.655 1.582 . . . . 10.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -35.68 74.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.508 0.723 . . . . 10.0 111.706 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -32.65 41.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.978 -171.138 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.95 -73.59 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.413 -1.475 . . . . 10.0 109.413 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -171.87 1.93 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 127.129 2.171 . . . . 10.0 108.582 177.195 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -85.76 128.44 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 172.255 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -120.98 100.78 7.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.564 -1.273 . . . . 10.0 107.564 176.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.48 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.7 t -110.83 148.58 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.649 1.58 . . . . 10.0 106.97 -175.422 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 t -101.25 72.19 1.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.034 -1.839 . . . . 10.0 106.034 -175.393 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 27.6 m-85 -75.82 134.68 40.32 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.112 -172.07 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -83.03 81.17 8.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.492 -0.755 . . . . 10.0 109.81 177.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.42 -25.97 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.865 1.266 . . . . 10.0 113.252 169.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 1' ' ' MET . 21.9 m-20 -83.0 -22.54 33.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 126.325 1.85 . . . . 10.0 110.294 -173.255 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -117.67 -48.74 2.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.378 0.671 . . . . 10.0 109.448 -169.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.15 -170.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 125.445 1.498 . . . . 10.0 108.836 177.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.9 m -143.64 144.48 31.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 169.072 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 m -32.35 -42.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 130.524 3.529 . . . . 10.0 111.596 174.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -29.67 -55.88 0.16 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.192 0.997 . . . . 10.0 111.522 170.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -51.75 -67.45 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.721 1.208 . . . . 10.0 110.75 175.695 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -60.32 -55.49 23.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 124.296 1.038 . . . . 10.0 111.869 -175.048 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.83 -59.94 1.53 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.886 2.074 . . . . 10.0 110.572 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.88 -46.86 78.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.763 0.792 . . . . 10.0 110.39 176.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.78 -42.84 80.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.102 0.961 . . . . 10.0 111.45 -178.537 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.465 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -70.13 -43.85 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.045 -1.034 . . . . 10.0 108.765 175.105 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.18 -36.99 32.79 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.119 1.327 . . . . 10.0 112.27 176.027 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.54 -67.72 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.697 0.68 . . . . 10.0 112.584 176.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -129.48 14.87 6.05 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.97 -53.59 0.18 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.212 0.911 . . . . 10.0 112.904 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 63.4 169.97 0.15 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.241 2.216 . . . . 10.0 110.97 -172.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.288 1.3 p30 108.43 -8.24 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 129.395 3.078 . . . . 10.0 113.166 -176.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 60' ' ' ILE . 53.4 t -74.2 81.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 124.302 1.041 . . . . 10.0 111.664 -178.023 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.33 -56.64 5.15 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 168.254 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -179.07 145.07 0.25 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.486 1.114 . . . . 10.0 108.433 -171.045 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.34 137.22 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.327 1.051 . . . . 10.0 110.061 169.549 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.76 -58.24 7.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.5 0.591 . . . . 10.0 111.326 174.742 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.32 104.22 2.93 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.672 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.479 0 N-CA-C 101.263 -3.606 . . . . 10.0 101.263 163.197 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -147.2 75.35 1.37 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.579 1.151 . . . . 10.0 108.204 170.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -92.2 175.52 6.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.308 1.051 . . . . 10.0 109.341 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -150.86 137.85 19.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -92.87 101.7 14.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.774 -2.306 . . . . 10.0 104.774 177.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.05 147.27 51.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.28 131.53 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.203 1.401 . . . . 10.0 112.587 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -78.6 -59.66 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.332 2.653 . . . . 10.0 110.862 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.05 -36.15 0.05 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.757 -0.469 . . . . 10.0 112.778 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 166.48 2.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.129 0.966 . . . . 10.0 111.957 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 m -156.17 42.94 0.4 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t -112.61 96.15 5.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.552 -1.648 . . . . 10.0 106.552 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -55.96 -25.12 42.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.353 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -74.95 -41.34 59.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.76 0.824 . . . . 10.0 109.322 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.66 -71.41 0.08 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.832 0.853 . . . . 10.0 109.43 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -48.57 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 O-C-N 121.677 -0.639 . . . . 10.0 112.663 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -28.15 64.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.24 78.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -84.39 -41.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 118.61 -0.71 . . . . 10.0 110.519 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -39.4 -52.94 2.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.293 1.037 . . . . 10.0 110.503 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -48.84 75.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.612 -0.722 . . . . 10.0 110.907 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 m -59.34 -49.79 76.48 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.166 0.586 . . . . 10.0 111.227 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -55.27 -33.67 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.529 -0.732 . . . . 10.0 110.985 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.42 -18.37 14.77 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.922 0.772 . . . . 10.0 113.105 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.08 -34.38 75.04 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 118.626 1.213 . . . . 10.0 110.369 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 95.37 0.56 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.372 -0.83 . . . . 10.0 110.593 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -21.03 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.615 2.766 . . . . 10.0 114.347 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -44.66 -53.93 6.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.28 0.943 . . . . 10.0 113.865 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -52.63 111.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.452 1.101 . . . . 10.0 109.721 -173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -37.92 58.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.118 -0.947 . . . . 10.0 108.727 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.86 156.97 9.63 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.42 113.27 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.211 1.405 . . . . 10.0 107.231 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -116.66 78.18 1.18 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.089 0.956 . . . . 10.0 108.684 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.02 115.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.185 0.994 . . . . 10.0 109.847 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 41.0 m-80 -144.92 48.78 1.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.139 0.975 . . . . 10.0 110.09 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -49.84 -45.81 50.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 10.0 112.205 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.42 -42.71 82.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.515 1.126 . . . . 10.0 111.11 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -76.47 -32.06 58.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.036 -175.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.29 -70.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.474 1.035 . . . . 10.0 111.064 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.36 177.88 5.82 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.681 1.593 . . . . 10.0 109.418 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.422 HG23 HD12 ' A' ' 6' ' ' LEU . 17.2 m -93.71 109.85 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 108.094 -1.076 . . . . 10.0 108.094 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -93.51 118.8 31.8 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.1 t -132.35 137.49 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 122.227 1.013 . . . . 10.0 109.958 -168.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.1 m -105.12 66.36 0.75 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 -172.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.41 138.77 56.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.158 -1.383 . . . . 10.0 108.643 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -83.44 89.74 7.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.503 -0.479 . . . . 10.0 111.473 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.86 -19.59 1.81 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.77 -14.3 45.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.447 1.021 . . . . 10.0 110.62 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -117.34 -52.95 2.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.272 1.029 . . . . 10.0 109.252 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.84 139.37 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.175 0.99 . . . . 10.0 110.31 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -93.04 145.18 24.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.541 -0.724 . . . . 10.0 109.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -34.83 -46.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 128.956 2.902 . . . . 10.0 110.405 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -32.3 -51.26 0.25 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.523 1.129 . . . . 10.0 112.221 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -52.37 -72.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.954 1.302 . . . . 10.0 110.59 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -57.96 -49.17 82.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 125.366 1.466 . . . . 10.0 112.161 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.81 -59.13 2.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.495 1.918 . . . . 10.0 109.916 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.11 -43.72 82.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.395 0.617 . . . . 10.0 109.827 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.83 61.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.607 0.763 . . . . 10.0 111.045 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.495 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.16 -32.74 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 120.799 -1.188 . . . . 10.0 109.813 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -53.26 40.97 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.535 -0.728 . . . . 10.0 109.572 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -39.3 -64.66 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.888 1.275 . . . . 10.0 114.067 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -139.9 30.77 2.03 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.99 -54.09 0.32 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.0 -0.889 . . . . 10.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 64.66 110.65 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.795 2.038 . . . . 10.0 110.77 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 163.47 -32.25 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.78 1.232 . . . . 10.0 109.644 -168.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' CG2' ' A' ' 60' ' ' ILE . 69.3 t -72.4 87.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.394 -0.816 . . . . 10.0 111.073 -173.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.47 -55.75 12.35 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.296 -1.002 . . . . 10.0 108.296 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -174.59 156.9 2.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.099 -1.445 . . . . 10.0 107.099 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.444 -0.765 0 C-N-CA 124.506 1.122 . . . . 10.0 110.4 168.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.5 102.82 4.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.089 1.756 . . . . 10.0 107.847 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -117.83 168.74 10.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.503 1.145 . . . . 10.0 109.694 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.55 126.13 49.57 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.608 -2.367 . . . . 10.0 104.608 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -93.92 105.79 17.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 103.582 -2.747 . . . . 10.0 103.582 167.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -68.29 151.71 46.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.381 -0.97 . . . . 10.0 108.381 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.29 131.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.188 1.395 . . . . 10.0 113.604 -169.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -73.81 -62.3 1.54 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 128.547 2.739 . . . . 10.0 109.319 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.53 -26.79 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.834 -1.174 . . . . 10.0 114.163 -169.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -179.35 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.125 1.463 . . . . 10.0 110.656 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 t -163.7 65.23 0.17 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -144.82 91.86 2.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -55.86 -3.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.206 1.187 . . . . 10.0 114.206 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -94.84 -42.52 8.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 10.0 109.771 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.46 -66.29 0.41 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.648 0.779 . . . . 10.0 109.184 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -40.56 -47.83 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.49 0.716 . . . . 10.0 111.769 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.2 tttm -58.62 -31.48 68.14 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.8 -31.32 58.86 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.548 0.613 . . . . 10.0 110.133 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -95.03 -35.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.879 1.272 . . . . 10.0 111.073 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 19.2 tt0 -36.45 -57.3 0.76 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.018 1.727 . . . . 10.0 110.724 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 p -51.98 -59.89 3.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.677 1.191 . . . . 10.0 111.204 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -56.28 -49.4 74.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.042 0.937 . . . . 10.0 110.929 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 30' ' ' VAL . 24.2 t -59.33 -43.9 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 122.02 -0.425 . . . . 10.0 110.269 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.71 -30.87 14.9 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 123.474 0.559 . . . . 10.0 112.968 171.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.73 -36.36 80.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.169 0.985 . . . . 10.0 110.569 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 95.14 0.54 Allowed 'General case' 0 C--O 1.22 -0.473 0 O-C-N 121.352 -0.842 . . . . 10.0 109.409 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -19.02 -50.53 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.979 2.911 . . . . 10.0 114.756 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.01 -18.98 20.93 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.676 1.132 . . . . 10.0 115.138 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 24' ' ' VAL . 2.1 t -81.63 108.25 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 119.392 -2.24 . . . . 10.0 105.699 170.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -36.14 78.16 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.023 -0.99 . . . . 10.0 109.912 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.13 154.76 9.15 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.974 -0.751 . . . . 10.0 108.974 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.34 142.21 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.496 1.518 . . . . 10.0 109.334 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 88.83 1.51 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 122.33 1.062 . . . . 10.0 108.94 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.56 124.46 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 124.834 1.253 . . . . 10.0 108.903 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 59.8 m-80 -145.48 48.97 1.25 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.015 0.526 . . . . 10.0 110.83 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -49.2 24.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.511 0.724 . . . . 10.0 110.333 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.79 -23.52 61.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.261 1.024 . . . . 10.0 111.869 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.22 -29.79 21.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.588 0.232 . . . . 10.0 110.423 174.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.24 -57.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.935 0.778 . . . . 10.0 111.777 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 174.32 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.061 1.344 . . . . 10.0 111.586 -170.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -91.1 132.84 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 169.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.36 112.05 18.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 42' ' ' VAL . 42.9 t -127.7 146.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.753 1.221 . . . . 10.0 109.001 -168.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -99.04 81.67 2.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 104.469 -2.419 . . . . 10.0 104.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 15.1 m-85 -85.88 127.91 34.7 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.079 -1.082 . . . . 10.0 108.079 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -86.08 82.17 8.19 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.38 -1.341 . . . . 10.0 107.38 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 -14.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.961 1.704 . . . . 10.0 113.528 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.15 -26.74 60.48 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.017 2.127 . . . . 10.0 108.775 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -121.19 -56.18 1.92 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.388 1.075 . . . . 10.0 108.496 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.12 138.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 124.131 0.972 . . . . 10.0 108.935 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 t -89.12 158.5 17.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.488 1.137 . . . . 10.0 110.202 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 70' ' ' ILE . 18.1 m -47.45 -37.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 128.062 2.545 . . . . 10.0 107.744 165.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -56.06 -25.76 46.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 119.793 1.179 . . . . 10.0 112.853 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.45 -60.99 2.37 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.71 1.595 . . . . 10.0 109.104 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -65.28 -53.16 43.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 124.785 1.234 . . . . 10.0 112.599 -171.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.91 -56.37 4.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.681 1.992 . . . . 10.0 110.163 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -59.76 -44.82 93.68 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.419 1.488 . . . . 10.0 108.87 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.27 -46.74 72.76 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.57 -0.706 . . . . 10.0 112.004 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.553 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.51 -34.82 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 O-C-N 120.824 -1.172 . . . . 10.0 110.335 178.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -53.52 -42.34 67.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.776 -1.203 . . . . 10.0 110.394 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -53.6 -65.73 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.261 1.025 . . . . 10.0 112.72 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -136.42 34.48 2.74 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.188 -0.945 . . . . 10.0 113.543 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.05 -57.26 0.26 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.686 0.676 . . . . 10.0 112.484 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 62.64 102.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.445 1.898 . . . . 10.0 111.775 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t0 172.57 -40.07 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.752 2.021 . . . . 10.0 107.655 -168.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.553 HG23 HG21 ' A' ' 60' ' ' ILE . 51.4 t -69.06 98.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 120.526 -1.359 . . . . 10.0 112.657 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.99 -55.08 5.21 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.89 -0.782 . . . . 10.0 108.89 167.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -170.47 146.28 2.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.346 1.459 . . . . 10.0 107.125 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.73 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 123.886 0.875 . . . . 10.0 109.594 171.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 122.458 1.123 . . . . 10.0 109.337 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 pm0 -72.99 72.26 1.12 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.081 1.352 . . . . 10.0 110.337 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 160.65 30.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.745 1.259 . . . . 10.0 108.289 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -120.75 115.5 23.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 67' ' ' VAL . 74.0 mt -86.3 92.24 8.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.912 -2.255 . . . . 10.0 104.912 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -67.09 142.73 57.02 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.72 130.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.599 1.56 . . . . 10.0 112.784 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -81.72 -53.73 5.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.47 2.708 . . . . 10.0 110.479 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.79 -40.13 0.09 OUTLIER Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.237 -0.506 . . . . 10.0 112.428 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 156.92 21.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.55 0.675 . . . . 10.0 110.994 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.17 11.57 3.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.901 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.6 t -85.25 94.25 8.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.817 0.817 . . . . 10.0 109.101 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -57.63 -4.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.325 1.05 . . . . 10.0 113.651 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -92.9 -32.06 14.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.778 1.172 . . . . 10.0 111.15 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.4 m -63.35 -74.45 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -46.62 -49.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 112.944 0.72 . . . . 10.0 112.944 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.27 -33.45 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.209 0.818 . . . . 10.0 113.209 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.95 67.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.938 0.495 . . . . 10.0 109.911 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.39 -49.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 118.287 -0.863 . . . . 10.0 109.88 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -38.71 -49.29 1.57 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.977 1.711 . . . . 10.0 110.883 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.69 -51.33 50.57 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 10.0 111.152 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.94 -42.24 63.64 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.871 0.868 . . . . 10.0 111.568 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.59 -41.19 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.097 -1.002 . . . . 10.0 109.898 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.03 -26.33 19.31 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.702 1.144 . . . . 10.0 113.866 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.63 -29.83 67.4 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.845 1.323 . . . . 10.0 110.685 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 111.98 5.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.109 0.868 . . . . 10.0 109.407 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -42.62 -41.1 2.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.566 1.947 . . . . 10.0 112.693 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.54 -26.99 57.95 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.262 0.934 . . . . 10.0 113.904 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.96 112.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 120.203 -1.763 . . . . 10.0 106.616 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -79.39 -37.77 36.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 10.0 109.758 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.82 161.29 17.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.659 -1.237 . . . . 10.0 107.659 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.73 134.16 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.012 1.325 . . . . 10.0 108.25 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -143.36 89.57 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.49 1.116 . . . . 10.0 110.072 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 t -66.8 134.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.218 1.007 . . . . 10.0 110.286 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.8 m-20 -156.79 49.45 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.871 0.468 . . . . 10.0 110.933 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -54.39 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 10.0 111.943 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.65 -38.11 86.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.566 0.746 . . . . 10.0 111.208 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -73.51 -34.77 65.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.919 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.33 -73.35 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.61 -1.396 . . . . 10.0 109.61 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 -172.35 1.6 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.094 1.758 . . . . 10.0 107.666 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 35' ' ' VAL . 41.9 t -99.06 117.8 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -100.88 130.1 46.84 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 44.5 t -136.55 149.54 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.87 -1.53 . . . . 10.0 106.87 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -111.04 85.77 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 104.915 -2.254 . . . . 10.0 104.915 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 39.9 m-85 -92.11 141.61 28.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.673 1.589 . . . . 10.0 108.276 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -89.89 93.3 9.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.617 0.767 . . . . 10.0 109.969 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.6 -14.67 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.714 -0.66 . . . . 10.0 112.296 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.3 -0.25 57.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.801 0.728 . . . . 10.0 109.685 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -130.52 -53.25 1.09 Allowed 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.675 -0.641 . . . . 10.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.89 164.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 118.701 0.682 . . . . 10.0 110.72 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.5 m -111.17 147.96 33.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 46' ' ' PHE . 15.4 m -42.26 -34.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 C-N-CA 127.068 2.147 . . . . 10.0 110.148 167.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -48.29 -28.41 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.014 0.825 . . . . 10.0 112.324 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -68.9 -70.79 0.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.78 0.832 . . . . 10.0 109.008 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.489 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.0 mp -59.33 -53.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.239 1.416 . . . . 10.0 113.787 -172.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.11 -56.92 3.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.124 1.77 . . . . 10.0 109.953 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -58.91 -46.25 88.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.906 0.882 . . . . 10.0 109.459 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.5 67.62 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.767 -0.583 . . . . 10.0 111.207 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -71.07 -38.6 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.09 -1.006 . . . . 10.0 110.037 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -54.5 -41.18 69.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.523 -1.361 . . . . 10.0 110.293 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -53.95 -65.53 0.55 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.424 1.09 . . . . 10.0 112.925 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.28 50.39 1.8 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.655 -0.653 . . . . 10.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.79 -55.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 64.0 112.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.255 2.222 . . . . 10.0 110.432 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 168.34 -41.85 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.461 0 O-C-N 121.543 -0.723 . . . . 10.0 109.337 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 60' ' ' ILE . 88.1 t -75.09 84.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.028 0.442 . . . . 10.0 110.885 -168.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.28 -50.38 60.58 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -163.79 153.0 14.22 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 172.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.439 -1.01 0 C-N-CA 124.904 1.282 . . . . 10.0 108.28 168.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -141.04 113.42 8.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -120.54 -178.63 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.973 0.909 . . . . 10.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -137.87 116.6 12.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.128 -1.805 . . . . 10.0 106.128 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 HG22 ' A' ' 70' ' ' ILE . 1.2 mt -86.28 94.19 9.27 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 104.58 -2.378 . . . . 10.0 104.58 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -59.32 148.02 33.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.1 128.16 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.205 1.402 . . . . 10.0 110.797 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.9 -56.52 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.808 2.043 . . . . 10.0 108.016 170.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.82 -37.03 0.05 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.513 -1.327 . . . . 10.0 113.909 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 161.26 30.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.062 0.931 . . . . 10.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -143.31 21.28 1.89 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.246 0.618 . . . . 10.0 109.955 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.5 t -97.39 101.37 12.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -66.8 2.36 1.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -45.52 6.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.969 1.308 . . . . 10.0 110.641 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.0 m -49.43 -68.88 0.14 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.377 1.471 . . . . 10.0 109.526 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.784 HG21 HG11 ' A' ' 35' ' ' VAL . 2.0 m -39.85 -45.65 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 C-N-CA 123.972 0.909 . . . . 10.0 112.297 172.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 6.0 tttp -56.17 -31.17 63.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.158 1.17 . . . . 10.0 114.158 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -31.8 52.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.199 0.454 . . . . 10.0 110.524 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' C ' ' A' ' 59' ' ' ALA . 2.5 t -97.75 -33.58 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.855 1.662 . . . . 10.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 25.4 tt0 -43.3 -47.82 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.994 1.318 . . . . 10.0 110.592 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -46.39 -61.37 1.83 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.987 0.915 . . . . 10.0 110.996 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -57.56 -50.35 73.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.385 1.074 . . . . 10.0 110.877 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 20' ' ' VAL . 97.2 t -55.53 -47.29 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.757 0.823 . . . . 10.0 109.57 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.16 -38.92 88.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.716 0.674 . . . . 10.0 112.204 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -42.57 99.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.359 1.063 . . . . 10.0 110.724 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 112.58 1.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.796 -0.565 . . . . 10.0 111.216 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -35.85 -56.09 0.71 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.852 2.461 . . . . 10.0 112.303 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.94 -19.84 51.62 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.251 0.46 . . . . 10.0 114.251 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.45 109.17 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 119.17 -2.371 . . . . 10.0 107.498 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -74.84 -31.12 61.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.806 -1.088 . . . . 10.0 109.415 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 158.07 8.91 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.2 m -133.22 138.61 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.358 1.063 . . . . 10.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -158.48 101.14 1.68 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.784 HG11 HG21 ' A' ' 17' ' ' VAL . 36.9 t -89.9 123.03 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 C-N-CA 125.339 1.456 . . . . 10.0 107.732 176.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -137.19 53.1 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.46 0.573 . . . . 10.0 110.871 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 37' ' ' LEU . 1.2 mp -44.99 -47.67 11.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.465 1.106 . . . . 10.0 112.136 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.32 -33.39 73.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.491 0.716 . . . . 10.0 111.902 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.0 58.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.34 -64.04 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.82 -170.23 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.941 1.296 . . . . 10.0 110.822 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.98 128.29 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.778 1.231 . . . . 10.0 108.824 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.96 71.39 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.744 1.618 . . . . 10.0 109.04 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.634 HG23 ' CG2' ' A' ' 42' ' ' VAL . 12.4 t -84.78 152.31 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.836 1.254 . . . . 10.0 109.393 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 t -110.15 71.32 0.75 Allowed 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.257 -1.757 . . . . 10.0 106.257 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 12.4 m-85 -72.03 130.11 40.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.355 -1.293 . . . . 10.0 109.107 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -80.93 85.4 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.281 -0.887 . . . . 10.0 109.838 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.35 -21.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.902 1.281 . . . . 10.0 113.845 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.78 -19.91 51.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.296 0.953 . . . . 10.0 109.706 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -116.65 -53.96 2.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.889 1.275 . . . . 10.0 110.466 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -138.2 159.71 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.077 0.551 . . . . 10.0 109.938 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.5 p -108.37 161.51 14.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 m -31.86 -42.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.238 2.215 . . . . 10.0 111.656 168.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -29.6 -54.47 0.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.65 1.58 . . . . 10.0 111.303 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.11 -59.42 5.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.376 1.084 . . . . 10.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.41 HG23 ' CG1' ' A' ' 24' ' ' VAL . 3.6 mm -62.61 -58.67 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.623 1.569 . . . . 10.0 111.955 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' A' ' 67' ' ' VAL . . . -41.46 -55.31 2.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 128.003 2.521 . . . . 10.0 110.007 172.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -56.86 -48.69 77.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.891 0.853 . . . . 10.0 110.557 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -56.23 -45.6 79.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.454 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.66 -35.84 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 120.558 -1.339 . . . . 10.0 109.967 178.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.26 -39.77 73.14 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.169 1.349 . . . . 10.0 111.755 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -49.43 -63.23 1.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.168 0.587 . . . . 10.0 112.341 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -134.81 13.34 3.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.532 0.938 . . . . 10.0 113.532 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -55.21 0.55 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.062 -0.854 . . . . 10.0 113.241 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 64.33 108.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.973 2.109 . . . . 10.0 111.256 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.75 -36.58 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.187 0.995 . . . . 10.0 109.951 -167.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 57' ' ' ALA . 66.2 t -73.03 87.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.409 -0.807 . . . . 10.0 111.773 -169.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.79 10.36 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.288 -0.882 . . . . 10.0 110.136 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -174.13 152.85 1.93 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.579 -1.638 . . . . 10.0 106.579 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.676 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.438 -1.041 0 C-N-CA 123.815 0.846 . . . . 10.0 110.038 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 . . . . . 0 N--CA 1.439 -1.011 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 114.39 19.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.688 2.395 . . . . 10.0 105.379 170.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -123.01 168.05 12.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.946 -1.501 . . . . 10.0 106.946 168.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.64 122.24 32.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -91.45 97.43 11.07 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 172.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.86 153.28 42.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.604 0.761 . . . . 10.0 109.379 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.27 131.63 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -70.0 -56.91 5.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 130.491 3.516 . . . . 10.0 109.824 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.32 -30.21 0.18 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.451 -0.638 . . . . 10.0 112.423 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 169.58 10.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.133 0.967 . . . . 10.0 111.557 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.3 m -156.07 40.73 0.37 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.42 89.56 3.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -52.93 -16.28 1.0 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.132 0.973 . . . . 10.0 113.43 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -82.6 -39.64 21.92 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.196 -0.94 . . . . 10.0 109.835 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -57.53 -71.24 0.11 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.772 1.295 . . . . 10.0 108.31 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -46.46 -51.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.219 0.452 . . . . 10.0 112.219 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -28.93 68.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.366 0.984 . . . . 10.0 113.01 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.77 61.75 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 121.719 -0.613 . . . . 10.0 110.923 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.0 -44.59 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 118.156 -0.926 . . . . 10.0 110.633 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -44.95 -46.91 11.3 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.927 1.291 . . . . 10.0 110.302 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -50.14 -60.26 3.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.016 0.526 . . . . 10.0 111.553 174.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -58.7 -43.85 90.18 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.476 0.71 . . . . 10.0 111.767 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 56' ' ' ILE . 6.3 t -53.45 -39.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.221 1.008 . . . . 10.0 110.21 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -45.92 -27.28 2.32 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.317 0.96 . . . . 10.0 114.423 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.23 -26.3 61.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.15 1.475 . . . . 10.0 112.149 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.77 113.56 2.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.179 0.9 . . . . 10.0 110.542 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -39.78 -45.9 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.194 2.198 . . . . 10.0 111.735 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -17.9 75.32 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.785 0.674 . . . . 10.0 114.785 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.91 107.54 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 118.683 -2.657 . . . . 10.0 107.245 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 t -79.35 -29.3 42.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.3 157.64 13.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 44' ' ' VAL . 5.9 m -134.43 135.53 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.158 0.983 . . . . 10.0 109.103 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -149.21 87.22 1.52 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 t -73.19 117.4 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 123.726 0.81 . . . . 10.0 110.275 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.42 49.07 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.555 0.742 . . . . 10.0 111.437 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -52.42 -39.86 61.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.472 0.653 . . . . 10.0 112.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.91 -39.55 90.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.463 1.505 . . . . 10.0 110.69 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.2 -33.65 24.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.189 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.18 -67.65 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 179.01 5.16 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.355 1.862 . . . . 10.0 110.842 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.539 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -92.56 127.81 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 124.944 1.298 . . . . 10.0 107.941 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.83 94.02 4.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.33 1.052 . . . . 10.0 109.494 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' CG2' ' A' ' 42' ' ' VAL . 31.4 t -104.86 146.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.957 1.703 . . . . 10.0 107.738 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -103.8 68.89 0.94 Allowed 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.156 -2.165 . . . . 10.0 105.156 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 m-85 -66.78 128.43 36.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.915 -1.493 . . . . 10.0 108.662 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -79.95 85.4 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.83 -23.36 0.42 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.189 1.396 . . . . 10.0 113.385 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.04 -15.15 52.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.361 1.064 . . . . 10.0 110.603 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -121.48 -56.13 1.9 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.769 1.228 . . . . 10.0 109.42 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.41 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.227 1.411 . . . . 10.0 108.409 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -156.51 167.23 31.08 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.537 -1.283 . . . . 10.0 107.537 168.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -34.24 -42.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 128.116 2.566 . . . . 10.0 112.237 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -35.05 -41.48 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.017 1.327 . . . . 10.0 113.224 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.92 -67.38 0.51 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.869 0.843 . . . . 10.0 110.627 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 24' ' ' VAL . 3.6 mm -55.92 -55.81 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.846 1.259 . . . . 10.0 112.97 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.61 -56.9 4.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.813 2.045 . . . . 10.0 109.731 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.92 -49.62 65.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.55 0.691 . . . . 10.0 110.131 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.96 78.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.793 -0.639 . . . . 10.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -69.52 -36.86 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 120.656 -1.278 . . . . 10.0 110.096 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.32 -40.87 71.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.499 -1.376 . . . . 10.0 111.645 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -51.5 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.154 0.888 . . . . 10.0 112.54 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.0 46.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.24 0.459 . . . . 10.0 112.24 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.57 -59.65 0.11 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.02 110.64 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.41 2.284 . . . . 10.0 110.919 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 t0 169.78 -38.55 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.93 1.692 . . . . 10.0 109.224 -167.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 60' ' ' ILE . 73.4 t -74.93 90.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 120.484 -1.385 . . . . 10.0 112.382 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.9 -56.84 4.62 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.467 -0.77 . . . . 10.0 110.708 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -163.63 143.74 8.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.848 -1.538 . . . . 10.0 106.848 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.666 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.437 -1.078 0 C-N-CA 124.7 1.2 . . . . 10.0 108.311 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 121.346 0.593 . . . . 10.0 109.978 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.92 107.81 5.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.252 2.221 . . . . 10.0 106.369 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.411 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -110.29 161.34 15.71 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.24 -1.393 . . . . 10.0 107.24 168.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.38 115.55 26.77 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 6' ' ' LEU . 20.9 mt -81.99 96.98 7.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.948 -1.871 . . . . 10.0 105.948 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -65.0 155.71 33.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 10.0 109.662 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' A' ' 66' ' ' ASP . 2.1 t -63.12 129.61 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.302 1.441 . . . . 10.0 110.447 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ASP . 28.1 tt0 -75.14 -43.63 51.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.962 1.705 . . . . 10.0 107.408 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.37 12.19 0.96 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.533 -1.148 . . . . 10.0 113.371 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -177.04 1.96 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.714 1.757 . . . . 10.0 109.722 169.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 p -155.53 15.16 0.37 Allowed 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.034 -0.416 . . . . 10.0 111.362 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -99.35 95.29 6.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -64.2 2.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.468 0.914 . . . . 10.0 113.468 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -94.0 -48.36 6.28 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.781 1.173 . . . . 10.0 110.046 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.3 m -48.21 -70.16 0.1 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.536 1.134 . . . . 10.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 m -38.45 -48.46 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.35 1.06 . . . . 10.0 111.89 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.85 -38.14 89.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.359 1.064 . . . . 10.0 112.535 -174.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.4 69.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.5 t -73.46 -38.14 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.68 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 28.8 tt0 -46.2 -49.81 16.57 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.922 1.289 . . . . 10.0 110.358 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -50.57 72.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.901 0.381 . . . . 10.0 111.264 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -70.79 -10.49 59.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.947 0.721 . . . . 10.0 112.947 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 -43.0 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.624 1.17 . . . . 10.0 108.312 169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.54 -30.35 19.64 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.886 1.231 . . . . 10.0 114.2 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.21 -31.24 72.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.145 0.973 . . . . 10.0 111.462 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.3 105.19 1.37 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -31.8 -42.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.054 2.142 . . . . 10.0 113.836 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.83 -20.43 47.97 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.426 1.012 . . . . 10.0 114.808 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.32 107.93 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 119.542 -2.152 . . . . 10.0 106.833 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -77.05 -29.4 55.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.185 -0.916 . . . . 10.0 109.378 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.08 13.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.182 -1.784 . . . . 10.0 106.182 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.84 119.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -136.31 97.87 3.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.282 1.033 . . . . 10.0 108.951 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.47 114.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.513 -0.921 . . . . 10.0 108.513 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -127.05 47.61 2.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.322 0.51 . . . . 10.0 111.963 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -49.53 -48.57 48.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 10.0 112.291 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -35.41 74.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.588 0.755 . . . . 10.0 110.99 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.08 -30.64 31.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.894 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.21 -69.72 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 123.98 0.8 . . . . 10.0 111.218 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -170.44 174.31 5.23 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.941 1.696 . . . . 10.0 112.627 -169.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.2 t -88.77 103.57 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 124.787 1.235 . . . . 10.0 107.971 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.2 116.36 30.26 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 57.0 t -136.3 135.13 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 -171.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.4 t -94.71 73.58 3.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.307 -1.368 . . . . 10.0 107.307 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.487 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 43.1 m-85 -68.67 136.41 52.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.519 -1.218 . . . . 10.0 109.281 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.71 87.03 7.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.545 0.688 . . . . 10.0 110.15 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.13 -20.1 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.08 -1.418 . . . . 10.0 113.623 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.67 -18.84 32.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 119.12 0.873 . . . . 10.0 110.215 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -117.45 -44.93 2.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.364 0.666 . . . . 10.0 109.745 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.53 -172.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.044 0.938 . . . . 10.0 109.425 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -142.62 159.18 42.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.737 0.779 . . . . 10.0 109.403 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 70' ' ' ILE . 34.6 m -44.83 -36.44 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 128.274 2.63 . . . . 10.0 110.294 170.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -41.92 -50.3 4.51 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.434 1.016 . . . . 10.0 110.736 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.24 -49.84 74.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.587 1.185 . . . . 10.0 111.46 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -71.52 -58.46 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.256 1.822 . . . . 10.0 111.674 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.99 -59.21 1.51 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.348 2.259 . . . . 10.0 109.57 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -49.25 -51.99 30.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.442 1.497 . . . . 10.0 109.888 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.56 80.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.5 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -68.77 -58.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -37.42 -47.51 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.224 1.01 . . . . 10.0 113.007 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -42.92 -60.08 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.019 0.927 . . . . 10.0 113.407 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -136.63 -30.45 0.9 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.086 1.143 . . . . 10.0 114.086 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.8 94.43 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.51 172.18 0.19 Allowed 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.826 1.65 . . . . 10.0 110.112 -174.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' A' ' 8' ' ' VAL 0.336 7.5 t70 81.55 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.904 1.281 . . . . 10.0 112.431 177.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG23 HG21 ' A' ' 60' ' ' ILE . 3.4 t -120.38 93.95 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.223 1.409 . . . . 10.0 109.623 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.0 4.1 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.03 159.62 1.35 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.84 1.256 . . . . 10.0 107.791 -175.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 108.28 -1.008 . . . . 10.0 108.28 166.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -122.99 121.16 35.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.629 -2.73 . . . . 10.0 103.629 167.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -117.82 178.25 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.52 121.71 12.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 -177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.02 90.34 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 103.631 -2.729 . . . . 10.0 103.631 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.46 141.77 58.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -67.71 126.54 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.849 1.659 . . . . 10.0 112.45 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -75.03 -55.26 5.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.992 2.117 . . . . 10.0 109.319 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.02 -35.75 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.13 -1.034 . . . . 10.0 113.313 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.86 158.87 26.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.929 0.865 . . . . 10.0 109.24 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.71 20.93 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.918 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.2 113.14 25.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.64 -1.615 . . . . 10.0 106.64 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.02 -16.8 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.744 -0.383 . . . . 10.0 111.511 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -83.92 -44.17 14.52 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.709 0.686 . . . . 10.0 110.332 -169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -43.91 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.978 1.711 . . . . 10.0 109.195 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 35' ' ' VAL . 6.2 m -43.55 -47.85 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 112.689 0.626 . . . . 10.0 112.689 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 9.7 tptt -44.25 -41.97 6.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.123 1.157 . . . . 10.0 114.123 174.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.86 -34.91 42.87 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.716 0.406 . . . . 10.0 110.379 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.4 -31.84 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.319 1.447 . . . . 10.0 111.123 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 35.2 tt0 -43.6 -47.49 7.49 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.259 1.423 . . . . 10.0 109.323 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -55.04 -58.69 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.651 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -56.73 -49.66 74.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.947 1.299 . . . . 10.0 110.271 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 56' ' ' ILE . 35.7 t -60.23 -49.96 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.568 0.747 . . . . 10.0 109.981 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.6 -32.14 38.57 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.007 0.813 . . . . 10.0 112.598 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.7 -32.35 73.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.385 1.074 . . . . 10.0 110.498 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 109.37 3.81 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 121.214 -0.929 . . . . 10.0 109.325 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -42.29 -40.42 2.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.755 1.622 . . . . 10.0 112.899 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.07 -18.39 54.6 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.094 1.33 . . . . 10.0 114.898 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.46 113.34 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 169.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -77.28 -32.96 55.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.331 -0.849 . . . . 10.0 110.69 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -171.5 158.97 5.38 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.894 -1.521 . . . . 10.0 106.894 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.58 136.88 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 105.995 -1.854 . . . . 10.0 105.995 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.89 84.15 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.575 1.178 . . . . 10.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 17' ' ' VAL . 48.1 t -64.18 118.77 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.313 1.445 . . . . 10.0 110.302 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 42.6 m-80 -144.69 50.12 1.28 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.942 0.497 . . . . 10.0 111.43 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mp -48.2 -58.03 5.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.37 1.068 . . . . 10.0 112.359 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.77 -43.21 94.0 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.94 0.876 . . . . 10.0 110.553 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.34 -29.34 68.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.733 -1.122 . . . . 10.0 111.019 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.27 -72.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.462 1.03 . . . . 10.0 111.098 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.37 -178.05 3.87 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.324 1.45 . . . . 10.0 110.25 -173.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -87.6 106.8 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -82.33 140.6 33.46 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.329 -1.359 . . . . 10.0 107.329 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -160.27 140.78 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 118.669 0.668 . . . . 10.0 109.45 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -116.91 82.91 1.88 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 -169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.676 ' CD2' HG12 ' A' ' 53' ' ' VAL . 44.0 m-85 -70.06 172.89 7.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.467 -0.788 . . . . 10.0 108.967 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -127.95 101.51 6.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 10.0 108.942 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -18.45 24.88 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.174 0.59 . . . . 10.0 111.881 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.03 -11.89 59.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.697 0.68 . . . . 10.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -121.29 -56.25 1.91 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.487 1.115 . . . . 10.0 109.246 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.1 159.49 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.454 1.102 . . . . 10.0 111.237 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 p -107.49 148.48 29.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.287 0.565 . . . . 10.0 109.991 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 46' ' ' PHE . 21.4 m -37.62 -45.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 C-N-CA 129.063 2.945 . . . . 10.0 110.677 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -35.67 -49.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.773 0.829 . . . . 10.0 112.016 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -54.25 -63.93 0.99 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.885 0.874 . . . . 10.0 110.429 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.491 HG21 ' HE1' ' A' ' 46' ' ' PHE . 4.5 mp -65.89 -50.73 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.184 0.994 . . . . 10.0 112.776 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.95 -62.84 0.58 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.924 2.09 . . . . 10.0 109.192 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.07 -45.06 79.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.605 0.717 . . . . 10.0 110.268 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.73 69.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.487 0.715 . . . . 10.0 110.872 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.639 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.69 -34.87 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 120.969 -1.082 . . . . 10.0 110.117 178.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -57.62 -33.56 68.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.871 1.214 . . . . 10.0 111.738 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -56.9 -68.4 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.19 0.904 . . . . 10.0 111.862 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -135.49 33.6 3.01 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.84 -57.81 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.22 -0.767 . . . . 10.0 112.216 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.49 107.17 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.733 2.013 . . . . 10.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t70 171.49 -35.52 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 124.813 1.245 . . . . 10.0 110.171 -168.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.639 HG23 ' CG2' ' A' ' 60' ' ' ILE . 65.1 t -69.9 85.81 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.546 -0.721 . . . . 10.0 111.063 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.84 -49.78 55.51 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -167.14 148.51 5.8 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.585 -1.635 . . . . 10.0 106.585 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.8 pp . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 169.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -144.71 108.73 4.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -115.22 164.49 14.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.752 1.263 . . . . 10.0 108.809 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -122.23 114.59 21.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 127.004 2.122 . . . . 10.0 106.709 -167.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' ILE . 88.5 mt -89.79 85.79 6.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -59.96 149.75 30.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.04 0.936 . . . . 10.0 109.836 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.84 129.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.636 1.574 . . . . 10.0 111.86 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.59 -64.33 0.9 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 130.024 3.33 . . . . 10.0 108.799 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.08 -31.39 0.19 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.248 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 169.03 5.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.621 1.211 . . . . 10.0 110.048 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.7 t -158.86 39.32 0.22 Allowed 'General case' 0 C--N 1.334 -0.074 0 O-C-N 121.568 -0.708 . . . . 10.0 109.228 -169.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.09 97.55 6.14 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.87 -14.37 2.38 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.526 0.936 . . . . 10.0 113.526 174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -86.54 -47.97 8.77 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.509 1.05 . . . . 10.0 109.38 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.4 m -45.96 -65.45 0.55 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.676 1.19 . . . . 10.0 110.198 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 m -48.71 -48.18 15.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.23 0.468 . . . . 10.0 110.894 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.3 tttm -54.71 -34.62 62.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.23 57.62 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.78 -33.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.509 1.124 . . . . 10.0 111.085 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.1 tt0 -41.15 -55.9 2.5 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 10.0 109.727 176.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.93 96.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.627 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m -56.88 -58.54 7.7 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.202 0.601 . . . . 10.0 109.989 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -49.99 -32.92 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.107 1.363 . . . . 10.0 112.446 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -22.8 4.05 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 114.637 0.615 . . . . 10.0 114.637 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.66 -32.28 73.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.422 1.489 . . . . 10.0 111.429 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.7 104.04 0.62 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.06 -37.07 14.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.965 1.306 . . . . 10.0 111.832 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.42 70.46 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.443 1.02 . . . . 10.0 113.977 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.75 106.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 120.192 -1.769 . . . . 10.0 107.501 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 m -73.37 -40.12 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.8 -1.091 . . . . 10.0 110.196 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.79 156.79 23.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.376 -1.342 . . . . 10.0 107.376 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.89 127.7 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.36 98.98 5.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 107.216 -1.402 . . . . 10.0 107.216 170.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.73 112.59 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.96 1.304 . . . . 10.0 108.441 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.99 48.3 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.632 0.604 . . . . 10.0 112.632 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.4 -46.54 62.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.618 -0.676 . . . . 10.0 112.304 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.1 -31.71 71.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.137 0.975 . . . . 10.0 111.017 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.01 18.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.861 0.362 . . . . 10.0 111.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.3 -78.49 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -1.379 . . . . 10.0 109.652 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 178.56 5.4 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.365 1.866 . . . . 10.0 109.256 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.19 105.44 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -102.0 125.88 48.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 10.0 108.119 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 74.4 t -136.54 142.35 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.979 0.895 . . . . 10.0 108.746 -168.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -101.69 77.5 1.74 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 105.849 -1.908 . . . . 10.0 105.849 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG12 ' A' ' 53' ' ' VAL . 28.1 m-85 -72.44 138.04 46.84 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.048 -1.887 . . . . 10.0 107.509 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -90.49 95.78 10.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.035 -0.357 . . . . 10.0 110.035 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -19.94 14.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.881 0.872 . . . . 10.0 112.818 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.75 -15.86 59.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 119.23 0.923 . . . . 10.0 109.878 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -119.99 -54.39 2.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.752 0.821 . . . . 10.0 110.346 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.0 161.72 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.417 0.687 . . . . 10.0 110.782 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.9 t -110.3 156.38 20.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.485 1.136 . . . . 10.0 110.444 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 70' ' ' ILE . 36.0 m -45.14 -39.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.098 2.559 . . . . 10.0 109.304 166.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -43.39 -39.27 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.445 1.02 . . . . 10.0 111.844 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.4 -58.9 3.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.425 0.557 . . . . 10.0 111.034 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.18 -50.09 71.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 120.84 -1.163 . . . . 10.0 112.163 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.97 -54.85 4.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.161 1.785 . . . . 10.0 109.352 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.37 -49.15 77.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.815 0.817 . . . . 10.0 109.879 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.69 67.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.63 0.772 . . . . 10.0 111.356 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -72.11 -42.94 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 O-C-N 120.962 -1.087 . . . . 10.0 110.878 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.287 0.1 OUTLIER -66.5 -26.7 67.29 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.723 1.601 . . . . 10.0 112.13 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -45.63 -66.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.059 0.944 . . . . 10.0 112.859 171.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.76 15.09 2.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.099 0.777 . . . . 10.0 113.099 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.2 -56.16 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.528 1.061 . . . . 10.0 111.461 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.31 113.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 10.0 112.292 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 163.13 -39.25 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 126.647 1.979 . . . . 10.0 108.487 -169.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 HG21 ' A' ' 60' ' ' ILE . 40.3 t -65.22 93.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 121.649 -0.657 . . . . 10.0 111.312 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.25 -56.97 5.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -170.61 162.86 8.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.728 -1.582 . . . . 10.0 106.728 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.894 0 C-N-CA 125.628 1.571 . . . . 10.0 110.474 170.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 121.949 0.881 . . . . 10.0 112.453 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.76 82.27 7.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.038 0.935 . . . . 10.0 110.473 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -75.96 150.31 37.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.4 132.11 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 103.809 -2.663 . . . . 10.0 103.809 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -108.4 92.89 4.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.007 -2.22 . . . . 10.0 105.007 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -61.71 146.65 48.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.708 -1.587 . . . . 10.0 108.534 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.72 134.4 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.961 1.304 . . . . 10.0 113.42 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -78.09 -68.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.686 1.995 . . . . 10.0 109.063 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.0 -38.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.018 -0.61 . . . . 10.0 113.252 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.04 160.43 6.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 117.961 0.88 . . . . 10.0 111.858 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 m -149.22 48.65 0.97 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -126.4 91.43 3.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.332 1.053 . . . . 10.0 108.402 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.5 -5.33 0.52 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.03 -37.69 14.96 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 120.87 -1.144 . . . . 10.0 110.291 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -58.72 -71.94 0.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 171.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -43.6 -52.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -56.84 -31.18 64.5 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.967 0.728 . . . . 10.0 112.967 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.36 68.19 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 HG11 ' C ' ' A' ' 59' ' ' ALA . 59.1 t -88.05 -40.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 123.939 0.895 . . . . 10.0 109.749 176.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -41.62 -48.5 4.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.889 0.876 . . . . 10.0 110.533 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -53.16 61.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.959 0.409 . . . . 10.0 111.123 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -62.52 -16.86 58.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.106 1.762 . . . . 10.0 113.043 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -89.22 -42.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.477 1.111 . . . . 10.0 109.91 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.96 -26.18 47.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.748 1.166 . . . . 10.0 112.878 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -69.31 -28.26 66.11 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.948 0.874 . . . . 10.0 111.719 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.9 110.46 2.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.948 -0.701 . . . . 10.0 110.036 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -35.64 -44.16 0.31 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.404 2.282 . . . . 10.0 111.403 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 8.64 5.89 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.185 1.234 . . . . 10.0 116.185 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.21 111.49 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -74.45 -31.18 62.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.59 161.31 9.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.24 145.51 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.298 1.039 . . . . 10.0 109.757 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.35 82.89 0.84 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.988 0.899 . . . . 10.0 109.304 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.31 140.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.784 0.834 . . . . 10.0 109.597 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -161.17 44.44 0.17 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-O 121.172 0.51 . . . . 10.0 111.787 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.83 -46.64 64.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.507 0.723 . . . . 10.0 112.819 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -70.39 -24.78 63.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.965 1.306 . . . . 10.0 110.783 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.37 -27.27 19.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.136 0.574 . . . . 10.0 111.182 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.64 -69.7 0.09 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.524 1.059 . . . . 10.0 111.036 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.76 173.9 8.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.292 1.837 . . . . 10.0 108.701 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.598 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -83.9 138.6 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 169.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -122.52 110.46 15.61 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.103 1.761 . . . . 10.0 107.435 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.598 HG23 ' CG2' ' A' ' 42' ' ' VAL . 34.7 t -124.09 146.55 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.004 1.322 . . . . 10.0 107.576 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 t -103.28 78.59 1.63 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.308 -1.738 . . . . 10.0 106.308 -170.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 6' ' ' LEU . 69.1 m-85 -83.78 138.1 33.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.936 -1.029 . . . . 10.0 109.905 -172.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -88.08 84.36 6.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.167 -0.924 . . . . 10.0 108.707 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.44 -21.19 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.138 1.375 . . . . 10.0 113.056 168.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -25.8 59.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.914 2.086 . . . . 10.0 109.976 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -117.7 -49.64 2.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.253 1.021 . . . . 10.0 109.261 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.98 -175.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.303 1.041 . . . . 10.0 109.612 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.9 p -133.81 158.82 42.41 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.72 -0.844 . . . . 10.0 108.72 170.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -44.02 -34.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.35 1.86 . . . . 10.0 111.133 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -47.39 -30.34 3.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.592 0.633 . . . . 10.0 112.129 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.4 -65.5 0.69 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 118.574 0.625 . . . . 10.0 109.623 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.479 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.2 mp -65.58 -53.93 33.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.909 1.283 . . . . 10.0 112.909 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -44.0 -56.3 4.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.187 1.395 . . . . 10.0 109.764 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.6 -45.2 85.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.815 0.446 . . . . 10.0 110.271 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -51.37 -48.6 62.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.882 0.473 . . . . 10.0 110.601 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.544 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.56 -38.7 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.086 -1.009 . . . . 10.0 110.49 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.26 -34.84 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.32 -1.488 . . . . 10.0 111.564 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.02 -66.86 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.448 0.567 . . . . 10.0 112.262 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -134.69 40.86 2.93 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.212 0.605 . . . . 10.0 112.593 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.67 -59.04 0.08 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.825 -0.986 . . . . 10.0 111.305 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 64.92 108.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.215 2.206 . . . . 10.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.0 -37.6 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.888 0.875 . . . . 10.0 109.869 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.544 HG23 HG21 ' A' ' 60' ' ' ILE . 54.4 t -74.19 89.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.248 -0.908 . . . . 10.0 110.914 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.82 -52.3 31.46 Favored 'General case' 0 C--O 1.227 -0.103 0 O-C-N 121.508 -0.745 . . . . 10.0 109.016 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -170.13 153.12 4.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.028 0 C-N-CA 124.175 0.99 . . . . 10.0 110.686 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.03 126.09 24.45 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.229 1.411 . . . . 10.0 107.319 168.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.72 159.84 19.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.142 0.977 . . . . 10.0 109.879 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.16 122.25 46.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.588 HD23 HG22 ' A' ' 70' ' ' ILE . 45.2 mt -91.89 80.7 5.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.682 -1.97 . . . . 10.0 105.682 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -57.15 149.04 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 110.212 -0.292 . . . . 10.0 110.212 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.68 131.1 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.389 1.075 . . . . 10.0 113.212 -169.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.0 -58.65 3.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.245 2.618 . . . . 10.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.43 -34.33 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.134 -0.485 . . . . 10.0 112.551 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.93 165.79 10.26 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.781 0.791 . . . . 10.0 111.27 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 p -135.54 -34.81 0.83 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.368 1.067 . . . . 10.0 112.405 -168.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 t -48.37 88.49 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.14 1.776 . . . . 10.0 112.813 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.85 -7.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.498 -0.751 . . . . 10.0 112.904 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -86.61 -36.02 19.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.077 0.951 . . . . 10.0 110.031 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.7 m -59.6 -66.67 0.48 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -47.24 -50.88 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 112.213 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.261 0.7 OUTLIER -58.8 -32.25 69.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.403 -0.519 . . . . 10.0 112.297 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.37 -49.01 68.08 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.421 -0.799 . . . . 10.0 109.464 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.43 -44.25 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.814 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -39.8 -48.48 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.202 1.401 . . . . 10.0 110.844 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.3 p -50.51 -50.03 54.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.17 0.441 . . . . 10.0 111.574 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 m -71.26 -51.34 25.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.964 0.906 . . . . 10.0 110.552 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -53.78 -41.8 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.946 0.403 . . . . 10.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.96 -5.35 5.42 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.017 -1.435 . . . . 10.0 114.812 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -98.9 -18.58 17.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.672 1.736 . . . . 10.0 112.909 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 123.41 18.08 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 120.717 1.599 . . . . 10.0 109.941 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -41.26 -43.34 2.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.325 1.85 . . . . 10.0 112.58 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.85 -8.97 86.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.896 0.76 . . . . 10.0 114.897 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 102.56 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.728 -2.323 . . . . 10.0 104.728 169.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -70.54 -33.47 71.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.961 -1.018 . . . . 10.0 109.273 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.92 157.85 14.29 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.91 135.98 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.793 1.237 . . . . 10.0 108.794 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 91.75 2.5 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.276 1.03 . . . . 10.0 108.379 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -82.86 115.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.345 1.058 . . . . 10.0 109.48 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -143.96 49.55 1.37 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.35 -45.27 62.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.039 0.755 . . . . 10.0 113.039 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.11 -30.01 67.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.221 1.008 . . . . 10.0 111.646 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.77 -34.89 18.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.759 0.314 . . . . 10.0 110.782 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.97 -69.89 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.34 -177.41 3.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.818 1.247 . . . . 10.0 110.975 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -92.46 110.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.523 -1.658 . . . . 10.0 106.523 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.57 126.3 51.53 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 76.8 t -138.54 143.43 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 t -100.12 78.01 2.04 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 53.5 m-85 -82.94 137.27 34.26 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.498 -1.228 . . . . 10.0 110.79 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.61 89.2 7.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.137 1.375 . . . . 10.0 109.728 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.93 -15.92 1.6 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.77 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -30.76 71.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.219 2.207 . . . . 10.0 108.96 178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -120.7 -54.07 2.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.138 0.975 . . . . 10.0 109.615 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.77 160.52 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 123.75 0.82 . . . . 10.0 110.356 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 m -110.38 152.92 25.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.137 -1.06 . . . . 10.0 108.137 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 70' ' ' ILE . 21.9 m -37.76 -39.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 127.902 2.481 . . . . 10.0 110.796 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -43.07 -31.32 0.53 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 10.0 113.599 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.01 -64.18 0.91 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.694 0.759 . . . . 10.0 110.605 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.8 mp -62.75 -54.66 30.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 C-N-CA 125.792 1.637 . . . . 10.0 112.628 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.46 -65.1 0.33 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.798 2.039 . . . . 10.0 109.026 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -51.65 -47.64 63.68 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 10.0 110.868 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -46.57 70.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.203 0.601 . . . . 10.0 111.813 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.13 -39.53 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.792 -1.192 . . . . 10.0 110.015 177.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.55 -30.88 65.57 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.868 -1.145 . . . . 10.0 111.154 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -59.45 -69.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.674 0.67 . . . . 10.0 112.17 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -133.03 33.11 3.69 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.845 0.858 . . . . 10.0 112.362 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.12 -61.07 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.798 0.713 . . . . 10.0 111.884 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 67.63 113.06 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.065 2.146 . . . . 10.0 112.297 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 166.64 -39.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 126.053 1.741 . . . . 10.0 109.267 -169.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 HG21 ' A' ' 60' ' ' ILE . 88.0 t -72.2 91.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.577 -0.702 . . . . 10.0 110.844 -171.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.28 -53.78 18.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 121.692 -0.63 . . . . 10.0 109.586 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 147.96 5.81 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.641 -1.615 . . . . 10.0 106.641 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.588 HG22 HD23 ' A' ' 6' ' ' LEU . 1.3 pp . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 107.903 -1.147 . . . . 10.0 107.903 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -146.83 69.7 1.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.769 2.028 . . . . 10.0 109.02 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -77.64 158.05 29.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.681 0.753 . . . . 10.0 109.66 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.44 125.61 51.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 -175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' CD2' HG22 ' A' ' 70' ' ' ILE . 74.3 mt -95.13 88.41 5.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 169.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -61.41 148.33 42.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.41 0.684 . . . . 10.0 109.48 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.23 132.38 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.765 1.024 . . . . 10.0 113.765 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -71.73 -54.73 9.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.679 2.792 . . . . 10.0 108.596 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.36 -23.68 0.13 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.308 -0.86 . . . . 10.0 113.738 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 169.74 4.23 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.589 1.195 . . . . 10.0 111.987 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 28.83 0.73 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.37 93.39 4.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.087 -1.079 . . . . 10.0 108.087 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -58.75 -13.06 5.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -80.02 -45.59 18.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.6 m -52.07 -63.4 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.814 0.846 . . . . 10.0 109.609 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.69 -50.25 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.903 -0.57 . . . . 10.0 111.109 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -61.86 -32.97 73.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.44 1.018 . . . . 10.0 112.936 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.56 -40.83 69.13 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.585 -0.697 . . . . 10.0 109.484 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.13 -42.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 118.166 -0.921 . . . . 10.0 111.385 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -35.92 -57.9 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.145 1.778 . . . . 10.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -42.78 76.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 10.0 111.281 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -64.93 -50.64 65.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.234 1.014 . . . . 10.0 109.676 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 56' ' ' ILE . 12.9 t -54.18 -39.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.461 0.704 . . . . 10.0 110.41 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.5 -27.87 9.13 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.755 1.169 . . . . 10.0 113.766 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -71.54 -25.96 62.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.984 1.392 . . . . 10.0 111.533 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 104.48 1.28 Allowed 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.356 -0.84 . . . . 10.0 109.315 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -46.08 -37.24 6.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.271 1.828 . . . . 10.0 112.729 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -8.99 55.54 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.844 -0.535 . . . . 10.0 114.166 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.84 109.85 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.97 1.885 . . . . 10.0 106.303 168.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -73.71 -30.07 62.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.731 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -172.25 168.35 5.66 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.89 135.26 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.863 1.265 . . . . 10.0 108.756 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 90.02 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.198 0.999 . . . . 10.0 109.602 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.56 106.77 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.527 1.131 . . . . 10.0 109.455 -176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.2 m120 -134.76 49.55 2.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.202 0.601 . . . . 10.0 112.241 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.6 -47.18 70.42 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.383 0.512 . . . . 10.0 112.383 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -63.91 -36.41 83.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.845 0.858 . . . . 10.0 111.074 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -84.74 -34.22 22.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.859 -172.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.62 -69.41 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 10.0 110.572 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.29 178.67 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.167 2.187 . . . . 10.0 110.822 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.55 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.45 121.19 39.07 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 53.7 t -132.27 144.4 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 t -101.73 69.49 1.21 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 33.3 m-85 -69.01 137.87 54.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.973 -1.467 . . . . 10.0 108.733 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -94.24 87.12 5.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.047 168.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 -16.58 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.349 1.06 . . . . 10.0 113.376 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.82 -12.72 59.39 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.293 0.951 . . . . 10.0 110.033 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -131.12 -54.42 1.04 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.473 1.109 . . . . 10.0 110.391 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.62 135.74 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.817 1.247 . . . . 10.0 109.435 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 150.72 20.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -36.38 -41.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 128.72 2.808 . . . . 10.0 111.242 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -34.39 -49.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.302 0.955 . . . . 10.0 111.768 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.63 -67.22 0.3 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.42 1.105 . . . . 10.0 110.716 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 24' ' ' VAL . 4.0 mm -60.68 -57.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.374 . . . . 10.0 112.496 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.15 -59.34 0.87 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.656 2.382 . . . . 10.0 109.971 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.48 -51.11 68.07 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.87 0.468 . . . . 10.0 110.56 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.08 73.31 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.653 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.561 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.76 -41.09 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.182 -0.949 . . . . 10.0 110.094 175.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.51 -36.75 69.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.974 1.261 . . . . 10.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.37 -59.57 4.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.085 0.554 . . . . 10.0 112.457 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -139.08 -18.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.382 1.252 . . . . 10.0 114.382 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.97 -47.13 40.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.847 0.749 . . . . 10.0 111.29 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 56.61 110.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.109 2.164 . . . . 10.0 112.525 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 167.24 -39.84 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.239 1.415 . . . . 10.0 109.285 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 60' ' ' ILE . 62.9 t -69.84 92.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 O-C-N 121.496 -0.753 . . . . 10.0 111.209 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.86 4.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.711 0.767 . . . . 10.0 109.084 169.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.88 146.54 7.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.18 -1.415 . . . . 10.0 107.18 -171.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 pp . . . . . 0 N--CA 1.438 -1.03 0 C-N-CA 124.782 1.233 . . . . 10.0 107.778 175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.443 -0.807 0 CA-C-O 121.963 0.887 . . . . 10.0 108.826 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -140.98 112.91 7.74 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.788 2.435 . . . . 10.0 105.389 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 172.92 7.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.951 -1.87 . . . . 10.0 105.951 169.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.49 126.35 38.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.313 -2.476 . . . . 10.0 104.313 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -95.95 95.62 8.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -68.91 148.1 50.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.832 -0.803 . . . . 10.0 108.832 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.04 130.45 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 125.268 1.427 . . . . 10.0 112.958 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -71.64 -61.23 1.85 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.033 2.933 . . . . 10.0 108.196 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.0 -39.21 0.13 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.172 -0.771 . . . . 10.0 111.172 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.64 157.98 13.46 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.588 0.694 . . . . 10.0 110.518 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.9 51.84 0.39 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 -172.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.97 94.01 4.1 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.824 1.25 . . . . 10.0 107.785 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -59.99 0.57 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.19 1.182 . . . . 10.0 114.19 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -43.15 10.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.504 1.047 . . . . 10.0 109.464 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 m -57.96 -67.69 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.609 0.764 . . . . 10.0 109.13 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -43.11 -46.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 C-N-CA 123.331 0.652 . . . . 10.0 112.086 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 14.5 tttt -54.87 -33.07 61.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.776 1.028 . . . . 10.0 113.776 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.31 -29.15 57.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.473 0.309 . . . . 10.0 110.737 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.66 -33.57 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.564 1.546 . . . . 10.0 110.989 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 12.6 tt0 -41.19 -49.47 3.56 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.706 1.203 . . . . 10.0 110.289 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.5 p -46.15 -68.65 0.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.517 1.527 . . . . 10.0 111.231 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -57.19 -39.37 75.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.873 1.269 . . . . 10.0 111.85 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.02 -42.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.875 -0.417 . . . . 10.0 109.875 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.83 48.38 1.97 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.274 1.416 . . . . 10.0 112.136 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.27 -42.86 0.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 127.86 2.464 . . . . 10.0 109.1 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -50.64 127.28 17.65 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.411 1.459 . . . . 10.0 110.794 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -46.46 -42.86 16.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.357 1.463 . . . . 10.0 111.966 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 -13.27 83.11 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.404 0.522 . . . . 10.0 114.404 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.55 109.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 119.708 -2.054 . . . . 10.0 106.094 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.04 -32.54 50.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.448 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.58 151.05 9.11 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.551 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.5 m -123.1 146.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.5 100.92 1.05 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 -173.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -107.88 109.92 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -135.33 46.61 2.38 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 111.762 0.282 . . . . 10.0 111.762 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -52.5 -48.68 65.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.835 0.854 . . . . 10.0 111.746 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -67.47 -26.83 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.991 0.916 . . . . 10.0 110.488 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 -30.89 16.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.572 0.349 . . . . 10.0 111.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -67.38 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.06 0.838 . . . . 10.0 112.074 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -171.11 176.11 4.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.862 1.665 . . . . 10.0 111.674 -169.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -93.52 129.51 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.296 0.638 . . . . 10.0 109.732 171.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -120.27 74.12 1.03 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.31 2.244 . . . . 10.0 108.852 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 42' ' ' VAL . 24.1 t -94.05 149.97 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.205 1.402 . . . . 10.0 109.195 -176.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -107.04 76.23 1.08 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -73.26 139.26 46.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.283 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.49 95.7 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.597 0.759 . . . . 10.0 109.78 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.87 -21.9 12.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.499 0.719 . . . . 10.0 112.784 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -87.62 -8.24 56.46 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.907 0.776 . . . . 10.0 110.68 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -119.72 -54.82 2.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.14 -170.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.433 1.493 . . . . 10.0 108.878 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.2 t -147.35 158.19 43.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.765 -0.828 . . . . 10.0 108.765 168.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -38.71 -46.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 C-N-CA 128.37 2.668 . . . . 10.0 109.598 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -44.15 2.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.54 1.064 . . . . 10.0 112.284 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.32 -61.54 2.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.566 0.698 . . . . 10.0 110.844 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.486 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.0 mp -61.43 -53.6 46.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 124.542 1.137 . . . . 10.0 111.514 -176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.69 -62.52 0.53 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.923 2.089 . . . . 10.0 109.41 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.47 -43.87 75.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.366 0.603 . . . . 10.0 110.741 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.43 75.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.694 0.798 . . . . 10.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.431 HG22 HG23 ' A' ' 67' ' ' VAL . 1.6 mp -70.51 -36.21 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 120.76 -1.212 . . . . 10.0 109.23 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.82 -42.19 75.32 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.609 -1.307 . . . . 10.0 111.273 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -52.25 -62.92 1.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.885 0.874 . . . . 10.0 112.546 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -144.22 66.89 1.27 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.088 0.555 . . . . 10.0 110.666 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.97 -59.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.012 -0.882 . . . . 10.0 111.467 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 68.84 113.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.253 2.221 . . . . 10.0 111.35 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 166.43 -32.45 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.284 1.434 . . . . 10.0 109.737 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' ILE . 6.7 t -71.94 85.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 121.0 -1.063 . . . . 10.0 112.257 -168.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.1 -52.68 25.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.315 -0.866 . . . . 10.0 109.596 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -166.5 142.39 4.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.905 -1.517 . . . . 10.0 106.905 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.125 0 C-N-CA 125.483 1.513 . . . . 10.0 107.671 174.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.68 86.14 1.38 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.304 -0.999 . . . . 10.0 108.304 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -103.32 163.8 12.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.956 0.884 . . . . 10.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.68 109.62 16.86 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.613 -2.366 . . . . 10.0 104.613 -170.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' CD1' HG22 ' A' ' 70' ' ' ILE . 3.6 mp -83.07 87.72 6.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 171.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -54.73 152.17 7.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.115 0.966 . . . . 10.0 110.01 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.56 131.78 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 124.265 1.026 . . . . 10.0 110.65 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -69.61 -54.23 15.0 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 124.015 0.822 . . . . 10.0 109.312 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.37 -9.34 2.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.749 -0.473 . . . . 10.0 113.357 -170.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.562 ' SD ' HD13 ' A' ' 37' ' ' LEU . 3.5 ppp? -58.29 176.31 0.18 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.969 0.884 . . . . 10.0 111.478 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t -152.44 31.76 0.52 Allowed 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.601 -0.687 . . . . 10.0 110.36 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.5 t -118.86 89.56 3.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.14 0.495 . . . . 10.0 110.8 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.71 -11.98 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.353 1.242 . . . . 10.0 114.353 170.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -91.69 -25.86 18.91 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.07 0.85 . . . . 10.0 111.395 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.28 -67.16 0.44 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -42.56 -55.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.519 0.728 . . . . 10.0 111.906 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -21.44 65.04 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.948 0.722 . . . . 10.0 112.948 -175.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.91 99.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.404 1.002 . . . . 10.0 109.232 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -82.51 -37.55 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.02 0.528 . . . . 10.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -41.34 -47.04 3.44 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.545 1.138 . . . . 10.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -51.3 64.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.078 0.466 . . . . 10.0 110.871 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -63.16 -47.63 81.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.447 1.099 . . . . 10.0 110.72 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 t -56.0 -40.93 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 10.0 110.013 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.11 -27.95 16.5 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.776 1.179 . . . . 10.0 113.767 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.15 -29.8 69.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.134 1.467 . . . . 10.0 110.744 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.61 80.67 1.09 Allowed 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.616 -0.678 . . . . 10.0 110.927 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -5.74 -57.52 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.948 3.299 . . . . 10.0 115.651 168.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.32 -56.65 1.48 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.868 1.223 . . . . 10.0 113.913 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.54 111.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.48 1.512 . . . . 10.0 109.853 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.31 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.88 -1.055 . . . . 10.0 109.982 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.95 12.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 33' ' ' VAL . 10.6 m -136.27 94.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.912 1.285 . . . . 10.0 109.463 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -107.54 91.07 3.5 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.31 109.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 172.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -128.32 47.86 2.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.457 0.539 . . . . 10.0 112.457 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD13 ' SD ' ' A' ' 11' ' ' MET . 1.6 pt? -51.33 -46.76 62.72 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.525 0.602 . . . . 10.0 112.113 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -70.12 -34.83 73.57 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.579 0.752 . . . . 10.0 110.955 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.09 -32.53 30.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.593 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.35 -73.02 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.26 -172.12 1.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.965 1.306 . . . . 10.0 112.598 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.06 100.73 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 108.466 -0.939 . . . . 10.0 108.466 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -98.0 108.99 21.83 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 42.7 t -128.14 131.5 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 -169.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 m -83.56 69.74 10.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' A' ' 6' ' ' LEU . 57.6 m-85 -64.73 141.41 58.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.321 0.648 . . . . 10.0 109.771 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -86.68 86.95 7.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.08 -18.26 0.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.844 1.054 . . . . 10.0 113.844 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.49 -18.65 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.599 1.091 . . . . 10.0 110.401 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.17 -55.78 2.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.07 129.88 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 124.402 1.081 . . . . 10.0 110.531 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.2 m -88.82 152.7 21.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.629 -0.669 . . . . 10.0 110.198 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.4 m -41.1 -38.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 128.269 2.628 . . . . 10.0 110.659 167.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -49.84 -37.42 30.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.429 -0.794 . . . . 10.0 112.342 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.44 -58.36 4.08 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.263 1.03 . . . . 10.0 109.399 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -56.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -168.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.21 -52.32 4.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.377 1.471 . . . . 10.0 109.861 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.97 -49.09 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.437 0.695 . . . . 10.0 110.54 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.7 68.15 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.765 0.826 . . . . 10.0 111.172 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -58.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 108.76 -0.83 . . . . 10.0 108.76 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -40.01 -40.63 1.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.512 1.051 . . . . 10.0 113.79 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -40.83 -50.88 3.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.605 0.965 . . . . 10.0 113.605 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -151.32 -41.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.533 1.133 . . . . 10.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-O 118.793 -1.004 . . . . 10.0 111.295 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 58.29 175.29 0.06 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.203 1.801 . . . . 10.0 112.545 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 93.9 28.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.437 2.295 . . . . 10.0 112.771 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.66 91.36 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.866 1.267 . . . . 10.0 109.484 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.61 -55.52 7.6 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 168.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -172.34 162.13 5.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.014 1.325 . . . . 10.0 107.429 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.485 HG22 ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.915 0 C-N-CA 125.09 1.356 . . . . 10.0 110.241 170.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -141.84 87.63 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.037 -1.098 . . . . 10.0 108.037 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -98.03 162.65 13.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.956 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 122.77 46.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 104.65 -2.352 . . . . 10.0 104.65 -177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.702 ' HB2' HG13 ' A' ' 42' ' ' VAL . 6.0 mp -93.53 95.99 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 103.512 -2.773 . . . . 10.0 103.512 170.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.04 150.65 46.39 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 10.0 108.189 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.95 134.54 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -168.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -69.22 -64.96 0.77 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.04 -34.37 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.348 -0.93 . . . . 10.0 114.881 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.0 172.37 2.37 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.305 1.053 . . . . 10.0 112.022 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -157.41 52.69 0.48 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.6 t -130.98 94.88 3.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.414 1.086 . . . . 10.0 108.143 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.61 -21.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.87 1.668 . . . . 10.0 111.418 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -82.74 -41.7 18.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.044 -0.725 . . . . 10.0 109.044 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.9 m -52.47 -66.27 0.41 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -51.41 -50.93 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 122.006 -0.434 . . . . 10.0 111.563 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU 0.26 0.0 OUTLIER -60.35 -26.42 66.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.995 0.739 . . . . 10.0 112.995 -178.174 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.22 84.08 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.06 -1.025 . . . . 10.0 109.035 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -75.64 -40.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.343 0.657 . . . . 10.0 111.364 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 3.4 tm-20 -34.78 -49.28 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.114 1.766 . . . . 10.0 111.019 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -54.72 -60.11 3.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.631 0.253 . . . . 10.0 111.522 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -55.09 -48.54 73.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.01 0.924 . . . . 10.0 110.502 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 t -56.85 -44.26 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.141 0.576 . . . . 10.0 110.367 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.7 -31.2 57.61 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.185 0.898 . . . . 10.0 113.146 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.28 -29.16 66.99 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.167 0.984 . . . . 10.0 110.773 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 108.31 4.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.077 -1.015 . . . . 10.0 109.624 176.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -37.35 -37.1 0.17 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 10.0 112.61 169.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.69 -2.07 1.59 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.225 1.393 . . . . 10.0 116.036 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.29 120.29 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.539 1.936 . . . . 10.0 106.32 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -29.2 25.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.269 0.628 . . . . 10.0 109.894 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.09 160.51 9.9 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.34 133.82 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.351 1.061 . . . . 10.0 110.58 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -143.21 81.4 1.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.909 1.284 . . . . 10.0 108.855 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.64 135.74 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.319 1.048 . . . . 10.0 108.85 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -163.55 48.07 0.13 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.517 0.675 . . . . 10.0 110.796 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -61.05 -41.97 97.6 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.86 -0.525 . . . . 10.0 111.373 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.98 -39.91 93.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.499 0.72 . . . . 10.0 110.25 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.0 -31.8 27.29 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.507 0.723 . . . . 10.0 110.932 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.61 -59.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.397 -0.668 . . . . 10.0 113.154 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 173.33 4.96 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.859 2.064 . . . . 10.0 109.78 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -91.05 119.88 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 172.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.26 120.21 40.32 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 48.1 t -133.01 143.83 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.881 -1.526 . . . . 10.0 106.881 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.0 m -96.59 71.54 2.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 49.3 m-85 -73.39 134.56 44.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.871 0.843 . . . . 10.0 109.108 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.57 77.8 9.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.699 0.762 . . . . 10.0 109.069 172.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.96 -17.68 0.42 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.886 1.675 . . . . 10.0 113.917 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.11 -6.28 59.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.424 1.89 . . . . 10.0 111.072 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -57.52 1.13 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.736 1.614 . . . . 10.0 108.726 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.7 143.96 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 126.222 1.809 . . . . 10.0 107.572 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 m -98.22 147.65 24.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -31.82 -44.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 128.346 2.658 . . . . 10.0 110.96 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -28.36 -53.23 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.967 1.307 . . . . 10.0 111.892 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.04 -69.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.358 1.063 . . . . 10.0 111.473 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.548 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.5 mp -60.38 -53.53 47.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 125.207 1.403 . . . . 10.0 111.683 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.35 -58.61 1.49 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.924 2.089 . . . . 10.0 110.398 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.4 -45.26 91.99 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.891 0.377 . . . . 10.0 110.219 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.77 -45.18 67.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 10.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.08 -53.02 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 O-C-N 121.272 -0.892 . . . . 10.0 108.713 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.23 -21.4 47.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.956 1.707 . . . . 10.0 114.288 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.29 -58.67 5.94 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.897 0.771 . . . . 10.0 111.474 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -143.56 -19.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.534 1.679 . . . . 10.0 115.534 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.68 -51.68 24.11 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.686 1.136 . . . . 10.0 112.045 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 66.42 97.61 0.05 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.412 1.885 . . . . 10.0 111.759 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 174.28 31.09 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.362 1.865 . . . . 10.0 112.987 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.486 HG13 ' HG ' ' A' ' 6' ' ' LEU . 5.8 t -141.7 80.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 O-C-N 119.617 -1.927 . . . . 10.0 110.331 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.7 76.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 171.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -167.55 143.8 4.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 6' ' ' LEU . 2.2 pp . . . . . 0 N--CA 1.436 -1.126 0 C-N-CA 125.091 1.357 . . . . 10.0 107.415 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 23.8 mt-10 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.473 -0.565 . . . . 10.0 109.473 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -140.2 78.87 1.68 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.804 1.242 . . . . 10.0 107.695 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' NZ ' ' OE1' ' A' ' 2' ' ' GLU . 1.8 mttt -89.73 165.54 14.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.279 -0.873 . . . . 10.0 108.91 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.83 133.3 44.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 102.796 -3.038 . . . . 10.0 102.796 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.751 HD11 ' HZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -104.02 96.6 6.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 104.371 -2.455 . . . . 10.0 104.371 176.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -62.23 148.74 43.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.069 -0.968 . . . . 10.0 108.624 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.61 132.34 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 125.07 1.348 . . . . 10.0 112.807 -172.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.89 -64.22 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.046 2.538 . . . . 10.0 109.453 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.0 -40.53 0.04 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.656 -0.578 . . . . 10.0 111.656 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 170.05 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.437 0.903 . . . . 10.0 113.437 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 p -145.99 12.77 1.27 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.742 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.84 86.47 6.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -55.58 -12.18 1.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -83.43 -35.89 24.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.408 -0.807 . . . . 10.0 109.375 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -62.12 -68.21 0.35 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.85 -52.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.689 0.795 . . . . 10.0 113.117 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -29.79 64.53 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.671 -0.643 . . . . 10.0 112.595 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.16 -43.86 64.32 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.61 -41.97 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.218 -0.896 . . . . 10.0 110.838 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.04 -38.51 11.11 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.311 0.96 . . . . 10.0 110.509 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.4 p -51.1 -65.03 0.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.933 0.788 . . . . 10.0 111.533 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -55.8 -51.0 68.97 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.994 1.318 . . . . 10.0 110.079 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.06 -42.76 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.693 0.797 . . . . 10.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.22 -27.71 11.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.561 1.077 . . . . 10.0 113.816 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.25 -19.81 35.69 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.768 1.284 . . . . 10.0 112.279 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.73 118.89 7.73 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.851 1.205 . . . . 10.0 109.985 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -39.9 -44.26 1.64 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.156 1.783 . . . . 10.0 112.515 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.49 -16.23 80.1 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.113 0.387 . . . . 10.0 113.884 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.84 111.59 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 O-C-N 119.454 -2.204 . . . . 10.0 106.628 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -30.74 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.804 . . . . 10.0 109.618 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.74 157.54 24.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.88 145.01 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.976 1.311 . . . . 10.0 108.192 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -161.86 82.86 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -64.77 138.72 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.191 0.596 . . . . 10.0 110.543 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.04 46.41 0.24 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.065 0.46 . . . . 10.0 111.061 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.51 -49.65 67.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.268 0.47 . . . . 10.0 112.268 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.08 -31.13 70.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.036 0.934 . . . . 10.0 110.707 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.76 -29.52 32.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.94 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.23 -62.17 0.12 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.169 0.89 . . . . 10.0 112.119 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.24 171.59 7.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.498 1.919 . . . . 10.0 109.833 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -87.53 132.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 169.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.18 111.04 16.91 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 42' ' ' VAL . 47.5 t -130.0 142.25 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.384 1.074 . . . . 10.0 108.218 -168.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.7 m -102.07 73.57 1.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.751 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 39.9 m-85 -66.85 131.81 46.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.701 -1.591 . . . . 10.0 109.089 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.89 86.1 7.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.526 -0.916 . . . . 10.0 108.526 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.01 -10.96 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.994 1.109 . . . . 10.0 113.994 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -85.89 -13.21 48.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.411 1.005 . . . . 10.0 110.141 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -131.31 -54.36 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 52' ' ' SER . 9.7 p -103.09 -174.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 125.184 1.394 . . . . 10.0 109.239 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.498 ' H ' HG22 ' A' ' 51' ' ' VAL . 63.4 p -148.81 151.91 35.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.182 -0.949 . . . . 10.0 108.523 167.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.75 -40.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.85 2.06 . . . . 10.0 110.132 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.47 -25.89 27.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.879 0.763 . . . . 10.0 112.813 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -70.67 -64.03 0.98 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.15 0.886 . . . . 10.0 109.637 168.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.2 mp -63.65 -51.41 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.097 0.959 . . . . 10.0 112.563 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.24 -56.8 3.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.293 1.837 . . . . 10.0 109.622 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.01 -44.58 91.72 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.578 0.751 . . . . 10.0 110.329 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.48 70.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.212 0.605 . . . . 10.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.72 -35.92 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 121.095 -1.003 . . . . 10.0 109.447 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.32 -41.84 85.46 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.628 -1.295 . . . . 10.0 110.533 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -54.5 -67.7 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.016 0.926 . . . . 10.0 112.14 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -133.41 57.25 1.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.161 0.584 . . . . 10.0 111.704 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.01 -58.85 0.01 OUTLIER Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.213 -0.771 . . . . 10.0 111.369 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 67.46 106.9 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.153 2.181 . . . . 10.0 110.623 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 168.16 -35.17 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.241 1.416 . . . . 10.0 109.595 -168.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.73 93.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.181 -0.949 . . . . 10.0 111.285 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.21 -56.49 4.6 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.456 0.646 . . . . 10.0 109.907 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -164.4 143.13 7.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 10.0 109.057 175.042 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 121.965 0.888 . . . . 10.0 110.418 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.14 68.25 1.13 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.613 2.365 . . . . 10.0 106.998 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -75.68 160.27 30.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -131.15 132.85 45.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.978 -1.489 . . . . 10.0 106.978 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD12 HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -88.79 108.32 19.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 173.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -75.96 148.28 38.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.683 -0.636 . . . . 10.0 109.306 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.05 130.33 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.584 1.554 . . . . 10.0 113.617 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -74.84 -58.74 3.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.143 2.577 . . . . 10.0 109.475 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.84 -32.24 0.06 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-O 119.185 -0.786 . . . . 10.0 113.464 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.03 169.5 5.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.594 1.197 . . . . 10.0 111.44 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 m -160.66 54.38 0.31 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 t -128.75 93.04 3.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -51.74 2.52 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.05 1.87 . . . . 10.0 116.05 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -50.81 4.3 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.841 1.655 . . . . 10.0 109.784 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.17 -62.14 1.8 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.083 0.953 . . . . 10.0 110.176 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.01 -47.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.764 0.316 . . . . 10.0 110.783 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 15.9 tttt -56.61 -35.54 68.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.307 1.225 . . . . 10.0 114.307 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -38.27 56.74 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 t -84.49 -37.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.142 0.977 . . . . 10.0 110.984 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 21.1 tt0 -38.6 -56.09 1.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.697 1.599 . . . . 10.0 110.62 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -58.0 -48.7 79.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -56.98 -54.5 45.96 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.639 1.175 . . . . 10.0 109.57 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.441 ' CG1' HG21 ' A' ' 30' ' ' VAL . 42.0 t -57.64 -40.85 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 121.926 -0.484 . . . . 10.0 110.288 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.1 -31.86 6.17 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.059 0.837 . . . . 10.0 113.494 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -74.01 -26.38 60.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.865 1.332 . . . . 10.0 111.589 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.71 96.76 1.27 Allowed 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.138 -0.976 . . . . 10.0 110.157 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -20.56 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.58 2.752 . . . . 10.0 113.286 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.39 1.16 5.53 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.273 1.269 . . . . 10.0 116.273 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.441 HG21 ' CG1' ' A' ' 24' ' ' VAL . 1.3 t -94.87 110.93 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 104.602 -2.369 . . . . 10.0 104.602 168.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -30.05 48.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.658 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.96 158.15 10.35 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.95 125.01 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.983 1.313 . . . . 10.0 108.383 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -128.4 80.54 1.97 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.763 1.225 . . . . 10.0 108.498 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.683 ' HA ' HG12 ' A' ' 42' ' ' VAL . 7.2 t -74.42 108.5 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 126.273 1.829 . . . . 10.0 109.884 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 53.0 m-80 -142.07 52.28 1.48 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.176 1.39 . . . . 10.0 110.173 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.55 -46.72 88.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.711 0.291 . . . . 10.0 111.458 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -68.11 -40.86 82.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.111 1.364 . . . . 10.0 109.922 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -72.56 -35.27 67.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.397 -0.819 . . . . 10.0 111.518 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.56 -64.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.434 0.54 . . . . 10.0 112.764 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 165.14 12.02 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 125.594 1.557 . . . . 10.0 109.259 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 35' ' ' VAL . 17.2 m -88.14 115.12 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -102.6 121.25 42.01 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.12 131.96 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -94.54 78.55 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.239 -1.393 . . . . 10.0 107.239 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -75.59 135.82 40.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.54 -1.209 . . . . 10.0 109.489 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -90.08 89.08 7.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.011 1.324 . . . . 10.0 107.805 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.45 -16.18 8.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.249 0.833 . . . . 10.0 113.249 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.24 -18.33 62.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.828 1.651 . . . . 10.0 109.722 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -124.73 -55.86 1.6 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.757 1.223 . . . . 10.0 110.152 -169.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -137.33 148.44 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.092 0.957 . . . . 10.0 109.989 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -101.08 152.37 20.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -39.87 -40.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 C-N-CA 127.608 2.363 . . . . 10.0 110.961 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.87 -34.12 0.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.69 -65.38 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.855 0.752 . . . . 10.0 110.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.462 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.4 mp -64.79 -48.98 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.53 1.132 . . . . 10.0 112.543 -172.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.77 -57.01 2.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.549 1.94 . . . . 10.0 110.423 170.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.5 -46.8 85.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.77 0.795 . . . . 10.0 109.662 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.54 -48.91 68.64 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.573 0.749 . . . . 10.0 111.332 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.437 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -73.03 -39.33 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.15 -0.969 . . . . 10.0 111.022 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.5 -34.55 78.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.588 1.54 . . . . 10.0 110.767 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -47.8 -66.25 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.594 1.157 . . . . 10.0 112.731 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -126.59 3.73 6.83 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.239 1.2 . . . . 10.0 114.239 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.07 -53.5 0.89 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.643 1.116 . . . . 10.0 112.489 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 68.0 111.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.5 2.32 . . . . 10.0 111.258 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 164.41 -34.88 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 110.574 -168.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG23 ' CG2' ' A' ' 60' ' ' ILE . 74.0 t -72.99 89.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 121.096 -1.003 . . . . 10.0 112.066 -168.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.39 -54.4 7.68 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 121.145 0.497 . . . . 10.0 110.042 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -169.04 143.58 3.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 -169.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.705 0 C-N-CA 125.414 1.486 . . . . 10.0 110.015 177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 110.718 -0.104 . . . . 10.0 110.718 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -128.72 90.7 3.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.755 2.422 . . . . 10.0 107.44 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -94.53 179.48 5.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.294 1.045 . . . . 10.0 109.957 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 t -146.14 134.96 22.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.931 -1.507 . . . . 10.0 106.931 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 70' ' ' ILE . 21.0 mt -88.61 95.73 10.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.522 -2.399 . . . . 10.0 104.522 170.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.59 144.1 57.28 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 128.12 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 124.644 1.178 . . . . 10.0 113.794 -169.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -69.55 -58.49 3.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 129.526 3.131 . . . . 10.0 110.254 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.73 -28.01 0.19 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.42 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.35 164.05 12.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.871 0.836 . . . . 10.0 110.35 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -147.52 12.05 1.02 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.784 0.434 . . . . 10.0 111.075 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -95.4 94.35 7.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -50.91 -18.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -35.83 36.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.87 0.759 . . . . 10.0 109.829 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -63.04 -67.27 0.44 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -49.97 -49.24 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.032 -0.417 . . . . 10.0 112.075 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -27.94 65.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.08 0.77 . . . . 10.0 113.08 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -36.4 74.43 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.42 -43.83 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 123.792 0.837 . . . . 10.0 110.163 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -39.25 -45.98 1.46 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.891 1.676 . . . . 10.0 111.339 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -48.99 68.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.544 0.688 . . . . 10.0 111.654 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.8 t -68.37 -54.18 19.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.654 1.182 . . . . 10.0 109.118 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 t -53.78 -38.96 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.197 0.599 . . . . 10.0 111.321 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.24 71.34 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.98 1.276 . . . . 10.0 113.385 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.25 -37.55 37.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.679 1.239 . . . . 10.0 110.39 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.92 122.67 10.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.798 0.726 . . . . 10.0 110.551 -175.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -48.24 -41.7 28.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.047 1.739 . . . . 10.0 112.532 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.55 -6.15 88.14 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.275 0.464 . . . . 10.0 113.928 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.96 115.32 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.363 -2.088 . . . . 10.0 105.363 168.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -77.85 -32.61 52.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.377 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.11 160.39 11.81 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.23 147.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.64 1.576 . . . . 10.0 107.975 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.51 89.98 1.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.713 0.768 . . . . 10.0 109.256 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.6 t -75.27 118.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 123.449 0.699 . . . . 10.0 109.392 -177.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.95 44.65 1.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.568 0.747 . . . . 10.0 109.123 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -59.65 -51.33 70.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.502 -0.749 . . . . 10.0 112.19 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.89 -36.83 80.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.966 0.906 . . . . 10.0 110.034 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.33 62.53 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.479 -0.782 . . . . 10.0 111.286 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.97 -77.77 0.07 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.223 0.916 . . . . 10.0 111.498 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 171.26 11.66 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 126.586 1.954 . . . . 10.0 107.977 -173.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 35' ' ' VAL . 44.6 t -90.83 105.55 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -82.45 136.99 34.8 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.62 139.55 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-O 122.161 0.981 . . . . 10.0 109.875 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 m -111.64 77.03 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.639 -0.71 . . . . 10.0 109.454 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.663 ' HE1' HG21 ' A' ' 56' ' ' ILE . 21.5 m-85 -73.34 140.64 46.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -96.51 94.09 7.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.428 0.691 . . . . 10.0 109.439 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.66 -22.03 1.22 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.965 1.306 . . . . 10.0 113.738 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.34 -6.99 58.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.275 0.943 . . . . 10.0 110.048 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -126.54 -55.83 1.41 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.15 0.98 . . . . 10.0 109.891 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.28 164.05 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 119.535 1.062 . . . . 10.0 111.018 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.2 m -118.14 168.4 10.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.56 0.744 . . . . 10.0 109.344 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -44.43 -29.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.69 2.796 . . . . 10.0 112.462 170.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -36.29 6.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.667 0.667 . . . . 10.0 111.397 172.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.89 -60.14 2.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.637 1.208 . . . . 10.0 110.385 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.663 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.2 mm -70.01 -57.0 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 114.535 1.309 . . . . 10.0 114.535 -168.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.67 8.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.897 0.879 . . . . 10.0 108.871 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.74 -51.38 56.59 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.789 0.435 . . . . 10.0 110.72 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.641 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.664 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.6 -48.61 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.137 -0.977 . . . . 10.0 110.272 177.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.66 -25.6 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.308 -0.87 . . . . 10.0 112.178 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.96 -44.56 40.92 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.626 0.77 . . . . 10.0 112.378 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -166.1 -28.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.21 -55.14 16.8 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.798 -1.001 . . . . 10.0 112.103 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 60.32 120.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.768 2.027 . . . . 10.0 111.963 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 163.66 -34.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 126.03 1.732 . . . . 10.0 109.805 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.664 HG23 HG21 ' A' ' 60' ' ' ILE . 92.3 t -71.5 88.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 121.006 -1.059 . . . . 10.0 111.424 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.39 -52.93 27.56 Favored 'General case' 0 CA--C 1.523 -0.066 0 O-C-N 121.587 -0.696 . . . . 10.0 109.135 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -169.6 159.39 8.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.604 HG22 HD23 ' A' ' 6' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 126.033 1.733 . . . . 10.0 108.367 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.483 0.659 . . . . 10.0 111.715 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.46 112.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.516 1.527 . . . . 10.0 107.892 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.66 172.48 6.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.359 1.464 . . . . 10.0 108.071 172.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 124.77 42.28 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.775 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -93.29 97.67 10.76 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -62.32 153.89 29.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.249 -0.648 . . . . 10.0 109.249 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -65.65 128.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.672 1.589 . . . . 10.0 111.968 -173.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -73.28 -61.56 1.78 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.868 2.867 . . . . 10.0 109.135 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.38 -34.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.437 -0.887 . . . . 10.0 112.347 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.29 170.59 5.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.041 0.921 . . . . 10.0 110.928 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -159.15 30.89 0.21 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.848 -0.614 . . . . 10.0 109.412 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.43 102.68 12.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -56.11 -20.1 15.93 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -76.91 -42.23 40.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.984 0.811 . . . . 10.0 109.127 -172.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -55.49 -68.13 0.22 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.459 1.104 . . . . 10.0 109.874 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.5 -50.07 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -54.35 -33.69 59.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.943 0.792 . . . . 10.0 113.128 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.23 -34.23 66.13 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.361 0.6 . . . . 10.0 110.224 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 37.8 t -85.56 -45.07 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.783 0.833 . . . . 10.0 109.919 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -46.39 -42.1 14.57 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.571 1.148 . . . . 10.0 110.591 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -54.92 -45.69 74.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.43 0.559 . . . . 10.0 112.309 174.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -72.37 -42.37 65.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.607 0.763 . . . . 10.0 111.893 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 56' ' ' ILE . 15.0 t -66.22 -43.22 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.516 0.726 . . . . 10.0 109.744 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.37 2.7 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.882 1.229 . . . . 10.0 111.877 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.39 -47.03 0.19 Allowed 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 127.382 2.273 . . . . 10.0 108.212 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 126.28 15.36 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.394 0.997 . . . . 10.0 110.488 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.73 -39.39 58.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.744 1.218 . . . . 10.0 112.156 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.33 -8.4 59.16 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.79 0.71 . . . . 10.0 114.14 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.76 106.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 O-C-N 119.271 -2.311 . . . . 10.0 105.441 168.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 t -74.37 -28.28 61.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.51 156.65 11.93 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.0 m -130.6 148.13 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.218 1.007 . . . . 10.0 108.604 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -165.73 87.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.48 118.96 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.243 1.817 . . . . 10.0 109.915 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.11 48.74 1.87 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.745 0.418 . . . . 10.0 111.385 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -52.61 -44.55 66.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 10.0 111.963 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.63 -26.75 66.39 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.942 0.897 . . . . 10.0 111.286 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.12 13.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.678 0.391 . . . . 10.0 111.155 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.0 -65.63 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.8 179.29 3.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.026 2.13 . . . . 10.0 110.741 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.597 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -93.67 130.46 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 125.512 1.525 . . . . 10.0 107.609 172.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.63 70.7 0.95 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.863 0.839 . . . . 10.0 110.374 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 42' ' ' VAL . 11.3 t -83.79 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.828 1.251 . . . . 10.0 108.783 -171.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.87 77.17 1.31 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 8.8 m-85 -79.82 134.05 36.32 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.472 1.509 . . . . 10.0 108.84 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.41 88.22 6.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.334 -0.853 . . . . 10.0 109.221 170.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.31 -16.09 0.16 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.15 0.98 . . . . 10.0 113.292 168.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.95 -20.67 28.61 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.362 2.265 . . . . 10.0 110.461 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -129.26 -58.14 1.13 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 10.0 109.786 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.0 t -129.87 120.26 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 125.02 1.328 . . . . 10.0 108.002 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 p -87.76 158.19 18.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -38.03 -40.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 126.885 2.074 . . . . 10.0 110.618 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.95 -47.06 0.51 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.275 0.943 . . . . 10.0 111.551 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -64.06 -57.74 8.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.562 1.172 . . . . 10.0 111.096 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' CG1' ' A' ' 24' ' ' VAL . 5.9 mm -65.72 -57.11 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.836 1.654 . . . . 10.0 112.001 -173.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.19 -61.58 0.87 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.166 2.186 . . . . 10.0 109.52 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.56 -49.97 54.74 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.157 0.583 . . . . 10.0 110.666 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.41 77.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.745 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -71.44 -39.53 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 120.98 -1.075 . . . . 10.0 110.415 177.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.33 -29.14 69.71 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.261 -0.899 . . . . 10.0 111.628 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.45 -64.27 0.87 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.976 0.807 . . . . 10.0 111.614 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.98 -7.33 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.265 1.58 . . . . 10.0 115.265 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.74 -51.8 10.77 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.714 -0.954 . . . . 10.0 110.714 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 58.25 109.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.75 2.42 . . . . 10.0 111.539 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t0 175.59 -41.31 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 125.363 1.465 . . . . 10.0 107.991 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 60' ' ' ILE . 72.0 t -69.95 95.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 120.806 -1.184 . . . . 10.0 112.298 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.86 -57.46 3.86 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.773 0.829 . . . . 10.0 109.731 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.4 ptmm? -164.94 142.94 6.33 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.888 -1.523 . . . . 10.0 106.888 -171.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.775 HG22 HD23 ' A' ' 6' ' ' LEU . 2.2 pp . . . . . 0 N--CA 1.439 -0.99 0 C-N-CA 124.163 0.985 . . . . 10.0 108.552 172.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.91 -1.144 . . . . 10.0 107.91 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.25 98.22 10.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -175.79 4.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.569 -1.641 . . . . 10.0 106.569 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -139.17 137.13 35.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.754 -1.943 . . . . 10.0 105.754 169.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -94.15 99.89 12.08 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 105.141 -2.17 . . . . 10.0 105.141 171.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.03 146.57 42.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.152 -0.684 . . . . 10.0 109.152 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.19 130.3 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 125.13 1.372 . . . . 10.0 113.128 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -78.86 -57.56 3.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.375 2.27 . . . . 10.0 110.618 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.65 -46.46 0.1 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 117.637 -2.22 . . . . 10.0 112.792 -169.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.91 158.99 4.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 117.3 0.55 . . . . 10.0 110.928 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.1 m -144.83 37.57 1.18 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.084 -0.962 . . . . 10.0 108.875 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.3 t -110.12 94.96 5.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.66 -9.85 0.6 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -90.35 -29.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.182 0.901 . . . . 10.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -65.33 -73.79 0.12 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.931 -1.137 . . . . 10.0 107.931 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 35' ' ' VAL . 4.5 m -33.83 -54.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 125.542 1.537 . . . . 10.0 113.858 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -56.01 -33.16 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.969 0.729 . . . . 10.0 112.969 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.94 -32.8 61.69 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.599 0.76 . . . . 10.0 110.582 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.28 -47.68 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 117.829 -1.081 . . . . 10.0 110.39 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -41.85 -49.48 4.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.077 1.351 . . . . 10.0 110.752 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.5 p -46.17 -62.32 1.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.349 1.06 . . . . 10.0 111.247 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -57.76 -48.06 80.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.598 1.159 . . . . 10.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -55.08 -40.64 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.76 0.824 . . . . 10.0 110.155 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.63 6.4 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.54 1.066 . . . . 10.0 113.744 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.87 -26.62 60.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.92 1.36 . . . . 10.0 111.621 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.15 107.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 119.128 0.877 . . . . 10.0 109.373 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -36.7 -43.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.165 2.186 . . . . 10.0 113.17 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.05 -28.5 63.9 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.688 0.661 . . . . 10.0 114.119 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.51 109.56 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 119.566 -2.137 . . . . 10.0 107.399 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -81.82 -31.73 31.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.903 -1.044 . . . . 10.0 109.712 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.19 158.22 18.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' HG22 ' A' ' 44' ' ' VAL . 10.4 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.509 1.123 . . . . 10.0 108.303 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -162.55 106.4 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 17' ' ' VAL . 43.7 t -95.69 117.55 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 C-N-CA 124.124 0.97 . . . . 10.0 109.237 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -132.22 48.58 2.4 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.505 0.322 . . . . 10.0 111.349 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -47.52 -42.96 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.087 0.955 . . . . 10.0 112.89 177.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.49 -37.92 88.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.82 0.848 . . . . 10.0 111.032 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -35.9 20.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.564 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.38 -67.8 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.926 -0.87 . . . . 10.0 110.926 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -174.74 2.51 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.055 1.342 . . . . 10.0 110.673 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.565 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -97.28 125.79 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 175.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -110.77 92.69 4.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.524 2.33 . . . . 10.0 108.343 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.4 t -110.89 151.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.647 1.579 . . . . 10.0 107.88 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -109.73 77.2 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.556 -1.646 . . . . 10.0 106.556 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 5.6 m-85 -78.01 127.67 32.69 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.317 -1.31 . . . . 10.0 107.721 -176.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.93 85.0 6.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.642 -0.662 . . . . 10.0 110.292 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.75 -23.17 0.96 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.985 0.914 . . . . 10.0 113.389 174.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.27 -5.38 56.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.436 0.562 . . . . 10.0 109.943 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -133.35 -54.15 0.9 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.492 1.117 . . . . 10.0 110.511 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.18 141.04 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 125.051 1.341 . . . . 10.0 109.435 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -97.26 143.57 27.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.0 m -31.76 -49.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 129.369 3.068 . . . . 10.0 110.003 168.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -31.93 -51.61 0.23 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.807 1.243 . . . . 10.0 112.089 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -55.69 -60.54 3.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.396 1.079 . . . . 10.0 110.949 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -66.05 -54.53 26.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 125.17 1.388 . . . . 10.0 110.948 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.15 -62.28 0.66 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.917 2.087 . . . . 10.0 110.389 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -53.85 -50.25 66.65 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.731 0.813 . . . . 10.0 110.097 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.27 -47.69 55.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.035 0.534 . . . . 10.0 111.453 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 HG21 HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -71.55 -35.9 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.974 -1.079 . . . . 10.0 111.067 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.65 -30.59 65.53 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.871 -1.143 . . . . 10.0 111.579 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.87 -62.08 2.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.234 0.925 . . . . 10.0 111.964 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -142.86 56.07 1.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.89 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.22 -0.766 . . . . 10.0 111.288 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 65.08 107.15 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.124 1.77 . . . . 10.0 112.248 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' HD23 ' A' ' 37' ' ' LEU . 12.0 p-10 161.28 -24.87 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 128.413 2.685 . . . . 10.0 110.987 -170.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 HG21 ' A' ' 60' ' ' ILE . 63.5 t -67.88 90.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 120.985 -1.072 . . . . 10.0 111.486 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.67 -52.07 11.35 Favored 'General case' 0 C--N 1.338 0.094 0 O-C-N 121.774 -0.579 . . . . 10.0 109.463 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -170.24 144.12 2.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.52 1.128 . . . . 10.0 108.409 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.732 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp . . . . . 0 N--CA 1.445 -0.708 0 C-N-CA 124.433 1.093 . . . . 10.0 108.489 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 122.372 1.082 . . . . 10.0 109.147 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.62 126.56 35.01 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.566 -2.753 . . . . 10.0 103.566 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -124.86 176.07 6.86 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.87 126.81 38.88 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -92.7 97.86 11.05 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 104.69 -2.337 . . . . 10.0 104.69 172.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.88 150.7 44.35 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.01 127.68 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.658 1.183 . . . . 10.0 113.019 -169.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -62.35 1.42 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.602 1.961 . . . . 10.0 108.57 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.34 -31.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.508 -169.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 178.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.461 1.124 . . . . 10.0 112.582 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p -150.31 -43.57 0.13 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.533 -1.212 . . . . 10.0 110.913 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -37.44 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.855 1.262 . . . . 10.0 111.678 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -3.27 23.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.337 -0.363 . . . . 10.0 111.687 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -46.64 8.71 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.603 0.638 . . . . 10.0 109.448 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 m -46.93 -68.68 0.17 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.703 0.801 . . . . 10.0 110.157 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -46.63 -51.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 O-C-N 122.304 -0.247 . . . . 10.0 111.483 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 10.4 tttt -60.61 -33.75 73.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.17 50.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.981 0.512 . . . . 10.0 110.144 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.94 -41.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.232 -0.889 . . . . 10.0 110.726 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 tt0 -39.89 -51.49 2.45 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.345 1.458 . . . . 10.0 111.297 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -51.0 -55.69 16.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.03 0.932 . . . . 10.0 110.552 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.82 -49.73 74.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.705 1.202 . . . . 10.0 110.534 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 HD12 ' A' ' 56' ' ' ILE . 49.7 t -53.85 -41.5 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.248 1.019 . . . . 10.0 110.111 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.0 -32.55 6.3 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.72 1.152 . . . . 10.0 114.052 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.09 -26.21 60.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.924 1.362 . . . . 10.0 111.944 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.4 109.67 2.81 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.435 -0.79 . . . . 10.0 110.251 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.3 -38.44 2.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.097 2.159 . . . . 10.0 113.175 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.33 -20.89 71.85 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.503 -0.748 . . . . 10.0 114.215 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.02 105.31 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 120.036 -1.861 . . . . 10.0 107.211 171.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -29.86 62.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.351 -1.295 . . . . 10.0 110.097 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.49 157.05 14.48 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.532 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.8 m -136.25 130.51 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.074 0.95 . . . . 10.0 109.913 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -148.07 94.3 2.31 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.931 0.892 . . . . 10.0 108.714 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 t -86.66 114.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 10.0 108.371 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.95 48.62 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.835 0.454 . . . . 10.0 111.497 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.95 -44.17 60.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.673 0.789 . . . . 10.0 112.414 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.1 -29.84 70.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.727 1.211 . . . . 10.0 111.096 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 -36.86 14.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.63 0.372 . . . . 10.0 110.755 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.07 -65.07 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.218 0.913 . . . . 10.0 111.045 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.12 178.78 4.87 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.399 1.48 . . . . 10.0 111.025 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.2 127.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 125.145 1.378 . . . . 10.0 108.228 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -117.59 89.13 3.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.622 1.169 . . . . 10.0 108.629 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 42' ' ' VAL . 17.1 t -98.2 149.76 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.668 1.587 . . . . 10.0 107.637 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 t -104.29 79.89 1.64 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 9.7 m-85 -73.93 130.35 39.71 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.912 -1.494 . . . . 10.0 108.204 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -84.33 87.1 7.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -11.82 1.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.162 0.801 . . . . 10.0 113.162 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.46 -15.37 52.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.608 1.094 . . . . 10.0 109.759 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -127.08 -61.44 1.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.451 1.1 . . . . 10.0 109.152 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.9 126.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.825 1.25 . . . . 10.0 109.223 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 m -96.4 163.84 12.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.308 -0.86 . . . . 10.0 108.828 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -38.43 -39.57 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 127.478 2.311 . . . . 10.0 111.353 168.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -37.33 1.47 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.594 0.633 . . . . 10.0 112.543 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.61 -63.87 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.071 0.938 . . . . 10.0 111.061 172.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 24' ' ' VAL . 3.8 mm -60.29 -54.03 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.713 1.205 . . . . 10.0 112.483 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.47 -53.05 15.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.904 2.082 . . . . 10.0 109.593 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.57 -47.78 78.77 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.133 0.573 . . . . 10.0 110.204 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -51.0 68.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.14 -34.74 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.118 -0.989 . . . . 10.0 109.948 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -57.04 -43.36 81.89 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.603 -1.311 . . . . 10.0 111.503 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.69 -62.24 1.75 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.469 0.577 . . . . 10.0 111.969 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -141.18 44.67 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.04 -57.78 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.944 0.783 . . . . 10.0 112.102 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 66.3 107.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.129 2.172 . . . . 10.0 111.087 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 t0 170.39 -38.47 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.668 1.587 . . . . 10.0 108.253 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 ' CG2' ' A' ' 60' ' ' ILE . 54.7 t -69.24 89.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 120.746 -1.221 . . . . 10.0 112.031 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.72 2.62 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.284 -0.885 . . . . 10.0 109.689 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -165.3 155.91 13.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.166 -1.791 . . . . 10.0 106.166 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.522 ' CG2' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.119 0 C-N-CA 124.607 1.163 . . . . 10.0 110.143 174.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 106.937 -1.505 . . . . 10.0 106.937 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -139.72 110.16 6.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.868 -1.901 . . . . 10.0 105.868 168.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.83 176.39 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.514 1.926 . . . . 10.0 106.717 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -148.81 128.8 13.5 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.064 -1.828 . . . . 10.0 106.064 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.68 104.26 15.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 172.518 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -68.43 149.71 49.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.51 132.78 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -170.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -74.41 -60.51 2.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.916 2.486 . . . . 10.0 108.174 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.31 -31.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.862 -0.966 . . . . 10.0 115.137 -171.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.8 178.45 4.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.606 1.703 . . . . 10.0 110.241 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -158.81 26.96 0.22 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.693 0.797 . . . . 10.0 109.249 170.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.8 t -90.09 100.04 12.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.098 -1.815 . . . . 10.0 106.098 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -52.57 -26.73 14.14 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 174.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -72.55 -46.08 56.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.939 -0.763 . . . . 10.0 108.939 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.9 m -50.31 -65.88 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.848 1.659 . . . . 10.0 110.415 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.77 -45.09 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 120.484 -0.487 . . . . 10.0 111.08 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 17.7 tttm -52.44 -33.76 45.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.624 1.342 . . . . 10.0 114.624 176.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.06 65.39 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.065 0.848 . . . . 10.0 110.038 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -87.05 -37.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 117.339 -1.315 . . . . 10.0 110.575 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 1.4 tt0 -36.63 -56.03 0.84 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.556 1.542 . . . . 10.0 110.549 174.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -58.94 -45.38 90.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.686 0.395 . . . . 10.0 111.381 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m -65.55 -57.03 9.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.43 0.692 . . . . 10.0 109.8 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.71 -37.48 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.992 0.917 . . . . 10.0 110.796 177.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.63 -27.32 54.69 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.024 0.821 . . . . 10.0 112.193 177.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.37 -27.35 59.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 118.319 1.059 . . . . 10.0 110.416 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.51 103.65 2.54 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 120.94 -1.1 . . . . 10.0 108.859 178.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -41.01 -32.37 0.23 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.668 1.987 . . . . 10.0 113.043 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.72 3.76 4.76 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.15 0.881 . . . . 10.0 115.288 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.17 119.61 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 169.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -36.99 29.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.61 157.24 14.41 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 176.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.986 2.114 . . . . 10.0 107.281 171.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -133.46 96.33 3.69 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 126.327 1.851 . . . . 10.0 107.742 172.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 42' ' ' VAL . 2.2 t -87.8 119.12 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.044 0.937 . . . . 10.0 108.933 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 15.3 m120 -146.38 51.59 1.13 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.073 0.549 . . . . 10.0 111.213 -172.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.52 -48.99 56.93 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.279 0.632 . . . . 10.0 112.078 178.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.83 -37.01 83.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.176 0.591 . . . . 10.0 110.718 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -83.4 -31.92 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.133 -173.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.43 -79.33 0.05 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.598 -1.001 . . . . 10.0 110.598 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -168.8 179.8 4.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.549 2.739 . . . . 10.0 106.873 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 6' ' ' LEU . 31.0 m -94.31 118.58 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 107.68 -1.229 . . . . 10.0 107.68 -174.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.15 127.68 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 176.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.1 t -139.58 137.19 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.408 1.099 . . . . 10.0 108.757 -171.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -110.08 76.0 0.97 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 -169.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 28.1 m-85 -82.12 137.19 35.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.7 1.6 . . . . 10.0 109.797 -173.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -84.64 84.25 7.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.95 0.881 . . . . 10.0 108.83 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.31 -20.25 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.648 1.579 . . . . 10.0 112.409 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.04 -12.87 58.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.815 1.646 . . . . 10.0 110.12 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -120.59 -53.67 2.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.131 0.972 . . . . 10.0 109.248 -174.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 m -125.92 -168.65 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.879 1.672 . . . . 10.0 108.971 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 m -144.28 147.68 33.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.022 -1.049 . . . . 10.0 108.744 169.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -31.46 -48.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 130.037 3.335 . . . . 10.0 110.731 175.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -28.93 -52.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.312 1.445 . . . . 10.0 112.352 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.53 -59.77 4.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.18 0.592 . . . . 10.0 111.739 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.2 mp -67.64 -51.03 55.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 125.325 1.45 . . . . 10.0 110.737 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.26 -63.89 0.46 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.87 2.068 . . . . 10.0 109.399 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -56.46 -47.87 78.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.403 0.681 . . . . 10.0 110.126 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.29 -46.79 62.62 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.978 0.911 . . . . 10.0 111.546 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -72.53 -42.19 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.616 -0.677 . . . . 10.0 110.586 176.361 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.19 -34.89 66.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.984 1.266 . . . . 10.0 112.159 178.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -48.49 -63.02 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.697 0.681 . . . . 10.0 112.533 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -134.59 -17.89 1.96 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.37 1.068 . . . . 10.0 113.387 -171.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.23 -49.26 12.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.879 -0.888 . . . . 10.0 110.879 -177.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 58.67 108.48 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.689 2.395 . . . . 10.0 111.586 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.29 -42.0 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 121.807 0.813 . . . . 10.0 109.189 -167.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' A' ' 60' ' ' ILE . 55.1 t -71.32 94.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.601 -0.687 . . . . 10.0 111.245 -172.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.64 -51.65 11.14 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.399 0.618 . . . . 10.0 109.396 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -171.4 143.13 1.77 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 -170.133 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 6' ' ' LEU . 2.4 pp . . . . . 0 N--CA 1.442 -0.866 0 C-N-CA 124.864 1.266 . . . . 10.0 109.779 176.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 106.04 -1.837 . . . . 10.0 106.04 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -147.55 75.48 1.36 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HD2' HG11 ' A' ' 53' ' ' VAL . 6.5 mtmt -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.022 1.392 . . . . 10.0 110.806 169.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.0 m -130.36 124.5 32.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.788 -2.301 . . . . 10.0 104.788 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 HG22 ' A' ' 70' ' ' ILE . 1.1 mt -83.31 110.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.372 -2.455 . . . . 10.0 104.372 169.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -65.99 155.71 35.79 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.9 126.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.895 0.878 . . . . 10.0 110.028 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.32 -47.54 60.66 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.975 1.31 . . . . 10.0 109.203 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -19.75 0.67 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.442 -176.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 167.14 3.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.831 0.815 . . . . 10.0 111.5 174.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 19.83 1.35 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.34 -177.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -101.74 96.73 7.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.25 -14.47 7.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.802 0.667 . . . . 10.0 112.802 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -85.76 -35.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.997 0.817 . . . . 10.0 109.976 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.5 m -58.09 -67.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.883 1.273 . . . . 10.0 109.262 172.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -45.55 -51.43 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -177.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -20.79 63.03 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.623 0.972 . . . . 10.0 113.623 -177.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.78 90.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 175.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.44 -42.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.88 -0.581 . . . . 10.0 110.301 177.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -38.65 -48.91 1.51 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.429 1.492 . . . . 10.0 111.393 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -47.93 76.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.233 0.539 . . . . 10.0 111.328 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -65.14 -50.04 67.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.015 0.926 . . . . 10.0 110.203 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -52.73 -44.05 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.812 0.845 . . . . 10.0 109.914 176.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.48 -30.26 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.953 1.263 . . . . 10.0 113.765 173.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.77 -27.69 64.11 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.914 1.357 . . . . 10.0 110.91 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.43 105.58 2.65 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 174.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -36.04 -39.05 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.631 1.972 . . . . 10.0 113.543 170.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -13.39 21.42 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.849 1.214 . . . . 10.0 115.524 176.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 108.56 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 O-C-N 120.164 -1.786 . . . . 10.0 106.336 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -80.15 -29.89 38.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.91 158.97 15.37 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 177.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -139.35 122.12 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.328 1.451 . . . . 10.0 108.417 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -132.79 77.27 1.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.794 2.038 . . . . 10.0 107.546 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.13 123.81 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 125.026 1.33 . . . . 10.0 109.173 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 36.5 m-80 -147.94 53.19 1.03 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.044 0.937 . . . . 10.0 110.09 -177.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.63 -46.27 87.43 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.631 -0.668 . . . . 10.0 112.123 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.06 -35.14 77.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.09 0.956 . . . . 10.0 110.811 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.67 -32.5 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.34 -175.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.05 -88.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.906 1.241 . . . . 10.0 110.945 -173.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -166.49 164.09 17.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.393 2.677 . . . . 10.0 106.411 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -86.85 118.63 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 118.824 0.738 . . . . 10.0 110.575 -168.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.88 124.72 37.07 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.717 1.207 . . . . 10.0 108.402 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.414 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.2 t -134.5 136.73 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -99.96 70.98 1.62 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.26 -1.385 . . . . 10.0 107.26 -174.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 20.4 m-85 -72.46 135.46 45.74 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.023 -176.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.65 86.84 7.27 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.287 1.435 . . . . 10.0 108.264 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -18.61 1.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.905 1.282 . . . . 10.0 112.537 168.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.68 -16.05 56.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.561 1.544 . . . . 10.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.99 -56.1 2.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.324 1.05 . . . . 10.0 109.289 -177.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.12 155.92 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 123.91 0.884 . . . . 10.0 109.305 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -99.37 147.03 25.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.493 -0.928 . . . . 10.0 108.493 176.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 53' ' ' VAL . 18.7 m -30.71 -43.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 129.228 3.011 . . . . 10.0 111.202 168.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -28.87 -55.41 0.13 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.747 1.219 . . . . 10.0 111.549 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -48.21 -71.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.275 1.43 . . . . 10.0 111.05 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -60.41 -55.34 25.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.511 1.525 . . . . 10.0 112.238 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.6 -58.41 1.3 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.263 2.225 . . . . 10.0 110.908 172.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.47 -45.93 92.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.558 0.743 . . . . 10.0 109.752 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.67 -44.11 65.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.443 0.697 . . . . 10.0 111.535 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.41 HG21 HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.42 -58.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 117.824 -1.084 . . . . 10.0 108.805 176.555 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER -46.74 -37.81 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.772 1.169 . . . . 10.0 112.849 -174.655 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -41.17 -61.14 1.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.041 1.336 . . . . 10.0 112.882 172.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -132.82 -40.52 0.95 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.62 98.69 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.29 -1.124 . . . . 10.0 110.29 -176.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 173.67 0.17 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.131 1.372 . . . . 10.0 110.5 -176.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 86.67 37.98 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.451 1.5 . . . . 10.0 111.621 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 60' ' ' ILE . 40.0 t -117.96 89.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.91 1.284 . . . . 10.0 110.09 172.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.64 -58.86 3.42 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.419 -0.585 . . . . 10.0 109.419 169.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -176.13 158.44 1.96 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.691 -1.596 . . . . 10.0 106.691 -174.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.407 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.932 0 C-N-CA 123.715 0.806 . . . . 10.0 111.474 171.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.472 0.653 . . . . 10.0 111.692 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.98 94.94 8.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.264 1.425 . . . . 10.0 108.235 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HB3' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -95.97 161.13 14.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 173.412 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.85 107.53 14.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.613 1.565 . . . . 10.0 107.381 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.67 HD22 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -78.8 92.41 4.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 169.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -69.17 144.87 53.68 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.86 126.93 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.045 2.138 . . . . 10.0 113.281 -174.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -70.15 -66.19 0.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.653 2.381 . . . . 10.0 109.782 176.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.01 -25.86 0.05 OUTLIER Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.688 -1.062 . . . . 10.0 115.465 -168.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 177.17 2.36 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.837 1.819 . . . . 10.0 109.765 174.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.738 ' HA ' HD21 ' A' ' 37' ' ' LEU . 31.6 m -165.17 56.77 0.12 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 -178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.73 108.05 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.046 -1.835 . . . . 10.0 106.046 173.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.17 -24.49 64.8 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.489 0.185 . . . . 10.0 110.576 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -45.21 38.28 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.1 m -47.1 -71.11 0.08 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.039 1.335 . . . . 10.0 110.437 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.17 -49.1 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.249 0.219 . . . . 10.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 28.7 tttt -55.62 -34.7 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.84 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.531 -0.731 . . . . 10.0 109.352 174.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -82.38 -40.08 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 117.684 -1.15 . . . . 10.0 111.209 176.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -35.09 -60.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.994 1.718 . . . . 10.0 110.669 178.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -40.59 88.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.851 -1.068 . . . . 10.0 111.227 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -63.6 -56.13 18.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.077 0.951 . . . . 10.0 110.285 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.35 -33.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 124.185 0.994 . . . . 10.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -41.45 -27.93 0.31 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.951 -0.916 . . . . 10.0 114.981 170.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.16 70.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.568 1.684 . . . . 10.0 112.262 177.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.16 93.15 0.28 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 174.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.21 -39.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.887 1.675 . . . . 10.0 112.97 172.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.56 -9.02 42.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.121 0.867 . . . . 10.0 115.022 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.74 105.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.875 -2.268 . . . . 10.0 104.875 168.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -73.51 -33.21 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.564 179.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.92 159.05 13.07 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.747 -1.205 . . . . 10.0 107.747 177.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.49 128.2 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.637 1.175 . . . . 10.0 108.486 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 91.54 2.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.338 -0.986 . . . . 10.0 108.338 175.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 t -86.46 108.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.772 1.229 . . . . 10.0 109.073 -171.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.2 m120 -142.99 52.45 1.38 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.563 0.745 . . . . 10.0 111.665 -173.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.94 -48.62 51.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.249 0.62 . . . . 10.0 111.136 -178.915 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD22 ' A' ' 37' ' ' LEU . 38.0 mt-10 -66.27 -46.72 76.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.573 1.149 . . . . 10.0 110.172 -175.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.67 -30.49 69.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.339 -0.846 . . . . 10.0 110.089 -176.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.9 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 122.92 0.295 . . . . 10.0 112.432 170.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 171.67 7.91 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.93 0.892 . . . . 10.0 112.049 -169.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG12 HG23 ' A' ' 44' ' ' VAL . 40.2 t -93.71 102.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 173.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -93.19 113.67 25.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 45.5 t -125.78 143.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.355 -1.35 . . . . 10.0 107.355 -171.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -105.97 82.7 1.81 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.329 -2.1 . . . . 10.0 105.329 -174.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 53' ' ' VAL . 13.7 m-85 -88.24 132.31 34.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.259 1.424 . . . . 10.0 108.948 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -90.77 88.28 7.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.209 1.003 . . . . 10.0 108.356 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.85 -18.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.677 1.591 . . . . 10.0 112.819 167.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -19.15 58.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.614 1.966 . . . . 10.0 110.465 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -127.68 -48.61 1.39 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.199 1.0 . . . . 10.0 110.756 -169.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 m -134.09 165.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 123.986 0.914 . . . . 10.0 109.565 176.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 p -109.81 143.36 39.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.282 0.492 . . . . 10.0 109.921 175.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 46' ' ' PHE . 23.6 m -40.34 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 128.23 2.612 . . . . 10.0 108.841 169.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -35.16 -49.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.448 1.022 . . . . 10.0 112.194 175.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.45 -53.81 54.16 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.519 0.676 . . . . 10.0 111.077 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.89 -51.75 41.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.475 1.51 . . . . 10.0 111.289 -177.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -40.03 -59.96 1.13 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.971 2.108 . . . . 10.0 109.923 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.75 -48.34 75.42 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.082 0.953 . . . . 10.0 109.989 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.71 71.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.93 0.892 . . . . 10.0 111.511 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 HG23 ' A' ' 67' ' ' VAL . 1.3 mp -71.08 -34.09 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 O-C-N 120.729 -1.232 . . . . 10.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.21 -40.98 92.02 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.7 -1.25 . . . . 10.0 110.837 175.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -45.85 -66.62 0.38 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.356 1.063 . . . . 10.0 112.41 178.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -139.93 23.79 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.45 -49.4 0.6 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.46 1.029 . . . . 10.0 112.219 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 64.31 101.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.407 1.883 . . . . 10.0 111.558 173.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 173.36 -32.88 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 125.473 1.509 . . . . 10.0 109.799 -168.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.691 HG23 HG22 ' A' ' 60' ' ' ILE . 64.3 t -67.5 86.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 121.359 -0.838 . . . . 10.0 112.104 -171.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.41 -58.79 3.35 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 169.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -164.29 150.41 10.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 4' ' ' LYS . 5.2 tp . . . . . 0 N--CA 1.452 -0.349 0 C-N-CA 124.973 1.309 . . . . 10.0 110.429 179.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 104.919 -2.252 . . . . 10.0 104.919 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.21 124.76 23.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.646 -1.983 . . . . 10.0 105.646 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -127.76 158.95 36.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.868 1.318 . . . . 10.0 108.617 167.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 41' ' ' LYS . 1.8 m -119.5 98.14 5.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.982 2.913 . . . . 10.0 104.933 -168.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.65 86.63 4.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.793 -2.299 . . . . 10.0 104.793 170.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 53.9 tt0 -55.96 152.79 9.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.111 0.964 . . . . 10.0 109.267 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 2.2 t -63.63 127.12 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.698 1.199 . . . . 10.0 109.234 -178.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -75.23 -68.61 0.54 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 172.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.59 -32.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.518 -1.325 . . . . 10.0 115.806 -168.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -175.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.233 1.016 . . . . 10.0 108.721 173.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -168.47 39.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.133 1.373 . . . . 10.0 108.03 172.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -99.29 98.23 9.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.07 -17.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.39 1.876 . . . . 10.0 114.6 176.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -96.84 -37.28 10.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.797 1.239 . . . . 10.0 110.251 -176.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 m -56.62 -62.64 1.59 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 177.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 37' ' ' LEU . 9.2 m -49.65 -47.13 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.947 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 7.2 tttp -56.26 -34.82 66.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.269 1.211 . . . . 10.0 114.269 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -39.34 61.16 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.55 -0.537 . . . . 10.0 109.55 172.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.65 -37.26 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 117.903 -1.046 . . . . 10.0 111.199 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 26.8 tt0 -40.47 -57.0 1.92 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.733 1.613 . . . . 10.0 110.255 -178.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -46.61 89.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.369 -0.832 . . . . 10.0 111.012 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 t -56.46 -53.77 53.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.207 1.003 . . . . 10.0 109.687 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.86 -39.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 O-C-N 121.655 -0.653 . . . . 10.0 110.055 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.13 -26.94 3.39 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.05 -0.861 . . . . 10.0 113.92 172.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.47 -27.94 64.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.125 1.462 . . . . 10.0 111.579 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.44 108.49 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.945 0.793 . . . . 10.0 110.8 178.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -39.65 -45.52 1.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.551 1.54 . . . . 10.0 111.922 170.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.37 17.43 1.92 Allowed Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.378 0.911 . . . . 10.0 115.378 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.48 109.39 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 104.213 -2.514 . . . . 10.0 104.213 167.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -74.38 -32.6 62.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.1 151.83 6.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.932 -1.506 . . . . 10.0 106.932 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.05 136.31 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 177.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.07 92.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 t -93.47 108.58 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 126.601 1.96 . . . . 10.0 107.38 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 72.11 1.35 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 10.0 109.721 -171.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -70.72 -49.79 43.18 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -172.264 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.155 1.782 . . . . 10.0 110.029 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -35.25 44.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.628 -176.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.49 -75.25 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 177.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -166.16 -177.92 4.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.671 1.988 . . . . 10.0 111.631 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 HG23 ' A' ' 44' ' ' VAL . 61.9 t -89.61 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 -176.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -95.14 99.27 11.28 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 42' ' ' VAL . 52.5 t -116.74 148.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -170.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -112.32 90.25 3.29 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 -174.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.71 144.17 26.2 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 126.972 2.109 . . . . 10.0 108.803 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -97.57 94.52 7.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 167.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.8 7.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 10.0 111.973 170.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.6 t70 -71.59 -25.25 62.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.002 2.121 . . . . 10.0 110.346 173.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -121.8 -56.51 1.85 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.239 1.016 . . . . 10.0 109.668 -168.092 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.85 144.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 125.691 1.596 . . . . 10.0 109.63 -175.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 p -97.67 142.82 28.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.432 0.634 . . . . 10.0 110.146 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -43.31 -43.28 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 127.978 2.511 . . . . 10.0 108.615 168.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -44.73 -44.3 9.11 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.652 -1.165 . . . . 10.0 111.269 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.47 -63.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.614 0.643 . . . . 10.0 110.25 177.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.3 mp -62.27 -51.58 70.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.366 1.066 . . . . 10.0 111.817 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.72 -56.56 2.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.594 1.958 . . . . 10.0 109.763 171.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.96 -46.57 88.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.052 0.453 . . . . 10.0 110.314 175.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.99 77.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 10.0 111.154 -175.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.7 -49.8 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -49.56 -36.13 22.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.714 1.143 . . . . 10.0 112.939 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.91 -61.34 2.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.554 1.142 . . . . 10.0 112.545 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -138.86 -17.41 1.08 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.55 -46.29 48.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 119.147 0.885 . . . . 10.0 110.915 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 58.17 93.45 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.932 2.093 . . . . 10.0 111.102 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.28 46.17 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.1 2.56 . . . . 10.0 112.869 173.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.08 86.17 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.107 -0.996 . . . . 10.0 109.071 173.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 8' ' ' VAL . . . -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 174.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.32 155.92 0.52 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.239 1.816 . . . . 10.0 106.38 176.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.437 -1.123 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 169.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 122.201 1.0 . . . . 10.0 112.134 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -71.93 71.67 0.8 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.461 1.505 . . . . 10.0 111.479 175.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -72.39 151.43 42.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 123.445 1.593 . . . . 10.0 108.883 168.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.87 111.12 21.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.144 -2.539 . . . . 10.0 104.144 -176.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' A' ' 70' ' ' ILE . 9.0 mp -90.49 87.91 6.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.55 -2.019 . . . . 10.0 105.55 173.048 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -60.9 146.3 47.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.296 -1.32 . . . . 10.0 109.355 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASP . 5.0 p -67.64 129.74 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.259 1.824 . . . . 10.0 113.547 -169.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -77.0 -51.42 11.12 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 127.623 2.369 . . . . 10.0 109.465 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.66 -0.67 1.7 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.467 -0.873 . . . . 10.0 114.181 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.26 171.06 4.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.873 1.337 . . . . 10.0 107.542 168.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -153.15 56.26 0.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.374 -1.343 . . . . 10.0 107.374 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.56 96.7 3.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.359 -1.349 . . . . 10.0 107.359 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -52.25 -21.73 3.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.304 0.483 . . . . 10.0 112.304 170.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.35 -35.72 35.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.845 -0.535 . . . . 10.0 110.166 -170.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.0 m -55.66 -74.13 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.366 1.067 . . . . 10.0 108.167 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -44.58 -52.02 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 113.523 0.934 . . . . 10.0 113.523 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -55.38 -31.18 61.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.205 0.911 . . . . 10.0 113.284 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.82 65.43 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 122.724 0.41 . . . . 10.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.45 -44.11 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 118.061 -0.971 . . . . 10.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -45.3 -45.1 11.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.525 1.057 . . . . 10.0 110.529 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -52.8 -48.92 66.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.497 0.665 . . . . 10.0 111.792 175.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 t -71.14 -38.47 72.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.931 1.292 . . . . 10.0 111.218 -178.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.25 -37.38 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.698 -0.626 . . . . 10.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.29 0.83 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.605 1.097 . . . . 10.0 113.025 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.7 -43.53 2.37 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.825 2.85 . . . . 10.0 109.364 175.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.72 123.56 13.68 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.22 0.918 . . . . 10.0 109.727 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -50.23 -41.57 50.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.246 1.018 . . . . 10.0 112.068 -174.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.78 69.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 116.233 -0.44 . . . . 10.0 113.588 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -74.62 108.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 119.643 -2.092 . . . . 10.0 106.197 172.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -37.97 73.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.166 173.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.88 155.2 11.93 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.128 -1.434 . . . . 10.0 107.128 -176.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.13 137.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -149.8 91.72 1.83 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.266 -1.012 . . . . 10.0 108.266 176.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.08 110.44 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 124.327 1.051 . . . . 10.0 110.218 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.43 49.81 2.15 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.699 0.8 . . . . 10.0 112.114 -178.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -50.2 30.85 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.025 0.93 . . . . 10.0 111.429 -175.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.47 -36.2 73.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.565 0.746 . . . . 10.0 110.858 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.96 62.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.458 -177.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.73 -65.33 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.7 178.92 5.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.342 1.057 . . . . 10.0 112.631 -169.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.57 105.97 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.075 -1.454 . . . . 10.0 107.075 176.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.14 117.86 35.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 72.3 t -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -168.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.2 t -110.91 87.76 2.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.879 -1.896 . . . . 10.0 105.879 -169.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 58.6 m-85 -95.36 129.12 42.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.435 1.494 . . . . 10.0 109.959 -173.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -81.46 88.98 6.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 172.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.36 -11.16 1.11 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -89.89 -2.9 58.28 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.571 1.078 . . . . 10.0 110.615 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -134.69 -54.52 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.889 0.876 . . . . 10.0 110.335 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.22 141.86 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 124.662 1.185 . . . . 10.0 109.911 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.7 p -107.77 153.6 22.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.679 0.752 . . . . 10.0 109.664 178.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -43.56 -37.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 127.483 2.313 . . . . 10.0 111.056 169.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -47.97 -32.59 6.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.475 0.58 . . . . 10.0 111.77 176.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -59.64 2.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.097 0.862 . . . . 10.0 111.108 171.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.8 -52.53 34.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 124.18 0.992 . . . . 10.0 112.775 -170.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.98 -54.35 13.19 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.54 1.536 . . . . 10.0 109.486 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -51.14 -50.73 58.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 10.0 109.71 172.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.96 76.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.04 0.536 . . . . 10.0 112.107 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.46 -37.03 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 O-C-N 120.61 -1.306 . . . . 10.0 111.258 178.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -51.3 -45.84 62.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.841 -1.162 . . . . 10.0 110.932 168.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -47.82 -62.2 1.57 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -147.15 55.65 1.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.838 0.455 . . . . 10.0 112.04 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.78 -54.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.84 -0.978 . . . . 10.0 111.039 176.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 64.69 107.0 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.323 1.849 . . . . 10.0 111.563 173.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 m-20 164.19 -25.73 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 125.368 1.467 . . . . 10.0 110.453 -169.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 60' ' ' ILE . 61.7 t -86.13 88.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 121.027 -1.046 . . . . 10.0 109.087 -174.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.98 69.5 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -169.41 153.45 5.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.116 -1.809 . . . . 10.0 106.116 177.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.885 0 C-N-CA 123.572 0.749 . . . . 10.0 109.312 173.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.399 -0.593 . . . . 10.0 109.399 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -147.35 82.55 1.54 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.015 0.926 . . . . 10.0 109.292 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.48 165.39 14.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.557 1.143 . . . . 10.0 108.966 173.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -120.46 111.28 17.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.314 1.846 . . . . 10.0 108.141 -168.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.586 HD21 HG22 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -87.99 83.32 7.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 178.646 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.08 147.41 50.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.127 -0.942 . . . . 10.0 110.288 -176.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' OD1' ' A' ' 66' ' ' ASP . 10.4 p -65.51 119.37 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.983 2.113 . . . . 10.0 113.138 -169.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -66.04 -50.11 65.33 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.887 1.275 . . . . 10.0 110.094 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.3 -22.48 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.048 -0.524 . . . . 10.0 112.242 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.97 170.36 0.86 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.539 1.162 . . . . 10.0 111.852 174.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -151.94 23.91 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.594 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.7 t -103.88 92.69 4.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -52.77 -20.14 2.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.046 0.758 . . . . 10.0 113.046 171.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.08 -39.42 29.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.336 -0.852 . . . . 10.0 109.21 -175.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 m -56.68 -67.03 0.34 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 175.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -46.99 -50.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 119.281 -0.39 . . . . 10.0 111.887 -177.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -58.78 -31.09 68.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.761 0.71 . . . . 10.0 112.808 -175.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.24 68.33 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 110.29 -0.263 . . . . 10.0 110.29 176.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.0 t -87.28 -39.24 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 118.437 -0.792 . . . . 10.0 110.951 176.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -41.64 -43.28 2.74 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.183 1.393 . . . . 10.0 110.964 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.8 -57.35 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.977 0.353 . . . . 10.0 110.88 174.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -58.64 -54.57 45.57 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.841 1.256 . . . . 10.0 109.968 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 HG12 ' A' ' 56' ' ' ILE . 14.0 t -52.76 -42.89 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.201 1.001 . . . . 10.0 110.1 176.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.92 -38.19 83.06 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.748 1.166 . . . . 10.0 112.733 173.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.0 -27.55 65.79 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.36 1.08 . . . . 10.0 111.502 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.91 104.24 0.53 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 119.572 -0.851 . . . . 10.0 109.196 171.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -26.3 -49.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.116 2.566 . . . . 10.0 114.11 169.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.99 -13.43 59.58 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.597 0.599 . . . . 10.0 114.597 -176.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.64 110.12 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 119.871 1.836 . . . . 10.0 106.469 171.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -82.21 -28.8 31.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.22 -176.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.04 159.17 17.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 176.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.62 128.95 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 78.5 1.83 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.66 116.91 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 124.744 1.218 . . . . 10.0 108.504 176.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -149.36 46.96 0.97 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.328 0.651 . . . . 10.0 110.622 -175.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -54.09 -43.4 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.079 0.551 . . . . 10.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.03 -40.45 75.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.862 1.265 . . . . 10.0 110.533 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.92 -30.26 50.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.653 -0.703 . . . . 10.0 111.51 -178.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 -61.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.539 0.59 . . . . 10.0 112.457 -179.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -170.06 176.05 4.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.484 1.514 . . . . 10.0 112.087 -171.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 96.1 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 106.109 -1.811 . . . . 10.0 106.109 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.71 118.85 31.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 40.6 t -129.22 146.21 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -169.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 t -106.93 71.03 0.82 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.38 -1.711 . . . . 10.0 106.38 -173.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 22.0 m-85 -67.34 142.34 56.83 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.64 -1.618 . . . . 10.0 107.435 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -100.83 94.71 6.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.018 0.527 . . . . 10.0 109.954 169.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.54 -15.42 2.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.105 0.962 . . . . 10.0 113.443 174.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.71 -9.52 58.78 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.079 0.854 . . . . 10.0 110.009 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -126.25 -54.61 1.47 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.367 1.067 . . . . 10.0 108.49 -175.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.97 144.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.817 1.247 . . . . 10.0 110.482 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 m -101.58 139.24 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.407 HG13 ' H ' ' A' ' 53' ' ' VAL . 9.4 m -34.24 -50.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 129.9 3.28 . . . . 10.0 110.877 176.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -29.71 -53.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.06 1.344 . . . . 10.0 112.491 172.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.05 -63.14 1.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.089 0.956 . . . . 10.0 110.679 177.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.415 HG12 HG13 ' A' ' 24' ' ' VAL . 2.7 mp -64.51 -54.49 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 C-N-CA 125.97 1.708 . . . . 10.0 111.779 -176.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 70' ' ' ILE . . . -38.49 -60.56 0.79 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.016 2.126 . . . . 10.0 110.403 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.54 -46.21 89.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.006 0.522 . . . . 10.0 110.569 176.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.19 71.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.023 0.929 . . . . 10.0 111.489 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -67.71 -59.27 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 174.858 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.8 -45.13 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.647 0.779 . . . . 10.0 112.249 -176.371 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -32.8 -50.91 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.493 1.517 . . . . 10.0 114.675 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -152.22 -37.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.096 0.959 . . . . 10.0 113.003 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -53.51 -44.24 67.4 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.424 -0.671 . . . . 10.0 111.424 178.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.44 169.6 0.23 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.266 1.426 . . . . 10.0 110.5 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 8' ' ' VAL . 12.1 t70 104.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.588 1.955 . . . . 10.0 112.4 171.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG22 HD21 ' A' ' 6' ' ' LEU . 21.3 t -102.53 77.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.943 1.697 . . . . 10.0 108.697 -177.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.31 -52.16 43.81 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.663 1.221 . . . . 10.0 108.446 176.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.51 127.92 2.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 104.829 -2.285 . . . . 10.0 104.829 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.405 HG21 ' HB2' ' A' ' 57' ' ' ALA . 3.6 tp . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 106.029 -1.841 . . . . 10.0 106.029 168.103 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 . . . . . 0 CA--C 1.537 0.477 0 N-CA-C 106.11 -1.811 . . . . 10.0 106.11 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -135.51 133.2 38.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.93 2.092 . . . . 10.0 106.616 169.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.01 -178.07 4.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.64 -2.726 . . . . 10.0 103.64 168.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 124.1 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.185 -2.524 . . . . 10.0 104.185 -177.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.654 HD12 HG11 ' A' ' 42' ' ' VAL . 4.0 mt -88.26 89.25 7.91 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 105.102 -2.184 . . . . 10.0 105.102 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -53.44 143.33 19.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.423 0.556 . . . . 10.0 110.314 -174.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.31 132.63 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.179 0.992 . . . . 10.0 112.745 -168.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -86.13 -47.26 9.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.811 2.444 . . . . 10.0 111.249 -176.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -37.27 0.16 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.653 -0.526 . . . . 10.0 113.149 -174.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 155.97 38.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.054 0.927 . . . . 10.0 109.567 175.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -140.47 16.45 2.38 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.593 0.757 . . . . 10.0 110.535 175.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -88.99 103.76 16.35 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.58 -1.64 0.87 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.171 -0.919 . . . . 10.0 113.398 174.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.7 -45.37 7.04 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.158 1.345 . . . . 10.0 110.572 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -47.13 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.574 1.95 . . . . 10.0 109.844 175.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.585 HG21 HG11 ' A' ' 35' ' ' VAL . 5.8 m -36.47 -46.43 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.238 1.415 . . . . 10.0 112.767 173.011 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 2.5 tttm -55.27 -31.7 61.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.176 1.176 . . . . 10.0 114.176 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.31 -34.95 62.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.751 0.25 . . . . 10.0 110.548 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.07 -34.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.031 1.333 . . . . 10.0 110.942 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 30.9 tt0 -42.62 -47.37 5.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.553 1.141 . . . . 10.0 109.947 178.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -56.49 18.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.952 0.406 . . . . 10.0 111.112 177.144 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 m -62.92 -53.51 53.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.924 1.289 . . . . 10.0 110.963 -175.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.74 -43.87 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.923 0.889 . . . . 10.0 109.738 178.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.92 -42.01 69.05 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.595 0.617 . . . . 10.0 111.969 171.15 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -34.82 78.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.398 1.079 . . . . 10.0 111.038 178.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 105.21 1.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.222 -0.924 . . . . 10.0 110.025 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -32.96 -35.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.093 2.557 . . . . 10.0 114.173 170.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.19 5.4 2.83 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 116.115 1.206 . . . . 10.0 116.115 175.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.33 124.95 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.074 1.75 . . . . 10.0 107.24 169.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -92.32 -27.66 17.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.787 0.835 . . . . 10.0 111.028 175.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 151.47 10.14 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 44' ' ' VAL . 14.2 m -136.64 128.76 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.779 1.232 . . . . 10.0 109.825 -177.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -151.49 100.17 2.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.295 1.038 . . . . 10.0 109.289 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 17' ' ' VAL . 37.1 t -93.35 108.66 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 126.024 1.73 . . . . 10.0 109.329 -175.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 32.1 m-80 -128.1 53.44 1.8 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.097 0.559 . . . . 10.0 111.604 -176.049 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -41.93 -52.34 4.14 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.281 1.432 . . . . 10.0 112.259 -178.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.13 -36.47 83.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.668 0.787 . . . . 10.0 111.619 -177.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -81.16 -37.6 28.51 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.872 0.367 . . . . 10.0 110.448 -171.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.89 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.649 -1.381 . . . . 10.0 109.649 177.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -171.88 1.91 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.513 1.525 . . . . 10.0 109.342 178.191 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG11 HD12 ' A' ' 6' ' ' LEU . 2.8 p -84.81 133.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.016 0.927 . . . . 10.0 108.873 168.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.4 96.21 5.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.858 1.263 . . . . 10.0 108.265 175.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 33' ' ' VAL . 17.7 t -105.44 149.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.835 1.654 . . . . 10.0 107.684 -178.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -106.71 77.21 1.17 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.912 -1.884 . . . . 10.0 105.912 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CZ ' HD21 ' A' ' 6' ' ' LEU . 6.9 m-85 -74.45 131.84 41.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.29 -1.323 . . . . 10.0 108.469 -176.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.62 83.58 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.471 0.708 . . . . 10.0 109.091 171.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.59 -18.42 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 170.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.64 -12.11 60.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.687 1.995 . . . . 10.0 110.033 178.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -131.42 -58.48 0.99 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.76 1.624 . . . . 10.0 109.219 -172.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -131.39 141.09 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.966 1.706 . . . . 10.0 109.553 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -90.18 149.0 22.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.511 -0.743 . . . . 10.0 109.837 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 4' ' ' LYS . 11.4 m -37.3 -46.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 C-N-CA 128.047 2.539 . . . . 10.0 109.431 167.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -42.22 -41.27 2.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.619 -0.705 . . . . 10.0 112.145 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.76 -66.48 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.479 0.581 . . . . 10.0 110.52 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.7 mp -58.52 -56.99 12.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.306 1.442 . . . . 10.0 112.145 -175.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -37.93 -64.04 0.43 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.666 2.386 . . . . 10.0 110.137 172.551 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.46 -38.75 91.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.33 0.586 . . . . 10.0 110.185 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.27 76.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.542 -0.723 . . . . 10.0 111.41 175.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.46 -37.69 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 120.677 -1.265 . . . . 10.0 109.302 174.666 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.22 -42.34 73.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.035 1.288 . . . . 10.0 111.112 173.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -46.96 -66.98 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.681 0.792 . . . . 10.0 112.755 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.6 52.22 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.956 0.502 . . . . 10.0 111.453 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.94 -69.3 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 t80 69.25 130.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.08 1.752 . . . . 10.0 107.943 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 158.88 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.325 1.45 . . . . 10.0 109.965 -167.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.452 HG23 ' CG2' ' A' ' 60' ' ' ILE . 94.3 t -82.79 87.85 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.6 0.76 . . . . 10.0 111.602 -169.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.44 -53.72 17.89 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.685 -0.634 . . . . 10.0 109.671 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -168.1 167.77 12.25 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 178.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.65 HG22 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.44 -0.951 0 C-N-CA 126.685 1.994 . . . . 10.0 110.536 173.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 121.155 0.502 . . . . 10.0 111.256 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -66.55 81.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.479 0.711 . . . . 10.0 110.498 169.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -85.86 157.94 20.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.147 0.975 . . . . 10.0 109.028 168.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.25 101.25 8.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.458 -2.053 . . . . 10.0 105.458 -171.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.467 ' CB ' HG13 ' A' ' 42' ' ' VAL . 8.1 mt -72.18 101.39 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.058 -2.201 . . . . 10.0 105.058 167.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -77.34 147.77 35.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.71 128.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 125.941 1.697 . . . . 10.0 112.901 -170.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -69.41 -61.55 1.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.308 2.243 . . . . 10.0 108.964 177.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.51 -35.2 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.358 -0.69 . . . . 10.0 113.3 -169.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.91 178.24 2.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.593 1.197 . . . . 10.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 p -141.42 -50.98 0.43 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.453 -169.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -32.46 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.987 1.715 . . . . 10.0 113.202 -175.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -54.73 -9.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -88.46 -43.14 11.67 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.407 1.003 . . . . 10.0 110.166 -177.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.4 m -50.58 -68.18 0.19 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.746 0.818 . . . . 10.0 109.375 175.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 37' ' ' LEU . 2.6 m -46.61 -46.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.672 -0.24 . . . . 10.0 111.338 178.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.84 -36.4 64.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.138 1.162 . . . . 10.0 114.138 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.68 54.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.517 0.675 . . . . 10.0 110.02 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.14 -38.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 117.832 -1.08 . . . . 10.0 110.893 175.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 4.5 tt0 -36.89 -52.73 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.922 1.689 . . . . 10.0 111.015 176.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 p -58.07 -49.43 76.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.101 0.56 . . . . 10.0 111.399 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.3 m -62.93 -48.23 79.83 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.326 0.65 . . . . 10.0 110.402 -177.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 30' ' ' VAL . 54.0 t -59.45 -42.72 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.863 0.865 . . . . 10.0 109.69 176.375 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.21 -43.35 56.82 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 123.579 0.609 . . . . 10.0 112.09 170.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.96 -30.32 70.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.585 0.692 . . . . 10.0 111.984 177.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 110.38 2.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.608 1.094 . . . . 10.0 110.431 177.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -35.31 -43.7 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.184 2.194 . . . . 10.0 113.081 173.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 20.22 1.92 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.223 0.849 . . . . 10.0 115.223 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 24' ' ' VAL . 1.4 t -125.13 113.46 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 169.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.8 t -72.72 -33.79 66.66 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.457 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.24 159.75 9.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 -177.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 44' ' ' VAL . 39.8 t -134.01 137.04 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.506 1.522 . . . . 10.0 107.695 179.138 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -136.31 82.47 1.94 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 125.599 1.56 . . . . 10.0 107.185 168.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.19 130.05 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.96 -1.018 . . . . 10.0 108.892 174.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.86 44.75 0.16 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.06 0.457 . . . . 10.0 111.11 -173.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 17' ' ' VAL . 1.6 pt? -57.68 -47.03 83.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.385 0.674 . . . . 10.0 112.114 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.766 1.226 . . . . 10.0 110.106 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.99 38.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.516 -178.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.43 -60.56 0.15 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.303 0.954 . . . . 10.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -170.65 166.33 8.09 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.09 1.356 . . . . 10.0 110.592 -171.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.467 HG13 ' CB ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.72 118.15 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 172.488 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.08 120.05 40.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 56.1 t -131.48 138.9 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -170.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -92.51 67.28 4.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.738 -2.319 . . . . 10.0 104.738 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 45.6 m-85 -69.32 139.7 54.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.911 -1.515 . . . . 10.0 106.911 -177.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.59 88.6 5.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 -176.116 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.65 -24.01 45.46 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.443 0.534 . . . . 10.0 112.443 -178.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.76 -17.97 56.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.749 1.62 . . . . 10.0 110.253 -177.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -107.62 -55.09 2.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.222 1.009 . . . . 10.0 108.401 -173.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.33 178.49 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.656 1.182 . . . . 10.0 108.931 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 p -112.75 152.22 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -32.17 -44.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 129.74 3.216 . . . . 10.0 110.656 168.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -30.05 -53.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.42 1.088 . . . . 10.0 111.578 171.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.96 -59.1 5.08 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.592 0.757 . . . . 10.0 111.366 178.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -68.31 -53.68 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 125.096 1.358 . . . . 10.0 111.727 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.59 -55.7 2.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 126.235 1.814 . . . . 10.0 110.226 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.79 -45.93 88.72 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.728 -0.607 . . . . 10.0 110.695 174.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.13 65.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.675 0.39 . . . . 10.0 111.183 178.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.531 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -71.25 -35.98 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.245 -0.909 . . . . 10.0 110.306 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.13 -37.99 72.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.702 1.137 . . . . 10.0 111.624 173.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -55.72 -66.9 0.34 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.455 0.57 . . . . 10.0 111.533 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.9 39.32 2.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -174.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.75 -58.28 0.09 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.92 -0.933 . . . . 10.0 112.348 -178.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 66.76 109.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.038 2.135 . . . . 10.0 110.938 178.081 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 166.92 -29.89 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 10.0 110.664 -168.198 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' CG2' ' A' ' 60' ' ' ILE . 40.6 t -68.14 85.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 121.077 -1.014 . . . . 10.0 112.229 -171.132 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.75 -57.23 4.13 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 121.808 0.813 . . . . 10.0 108.811 170.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -175.93 146.26 0.7 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 -171.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.441 -0.913 0 C-N-CA 124.524 1.129 . . . . 10.0 109.18 168.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 112.586 0.587 . . . . 10.0 112.586 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -71.26 63.47 0.36 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 10.0 110.569 172.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -69.8 172.48 7.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.315 1.055 . . . . 10.0 108.206 168.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.13 104.89 15.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 177.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -62.55 150.09 41.35 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.705 0.802 . . . . 10.0 108.912 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.22 123.8 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 125.51 1.524 . . . . 10.0 111.063 -172.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.44 -45.48 75.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.594 1.558 . . . . 10.0 109.505 174.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.34 -8.41 0.39 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.855 -0.97 . . . . 10.0 114.094 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.93 179.45 1.47 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 119.425 1.612 . . . . 10.0 110.843 175.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -160.04 41.09 0.19 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -122.9 93.79 4.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.378 0.671 . . . . 10.0 109.672 176.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -55.92 -10.13 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.042 1.497 . . . . 10.0 115.042 172.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.94 -50.3 6.52 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 120.097 1.317 . . . . 10.0 109.609 -176.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -46.53 -62.62 1.29 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.196 0.998 . . . . 10.0 109.959 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -45.73 -52.58 2.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 122.41 0.284 . . . . 10.0 111.553 176.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 4.2 tmtp? -56.88 -37.49 71.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.811 0.844 . . . . 10.0 112.68 -178.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.31 -41.75 51.51 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.341 -0.615 . . . . 10.0 109.341 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.93 -36.69 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-O 117.229 -1.367 . . . . 10.0 111.592 173.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.5 tp10 -43.54 -51.15 6.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.888 1.677 . . . . 10.0 110.001 -177.229 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.46 -47.98 83.4 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.278 0.561 . . . . 10.0 111.387 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -60.31 -40.73 91.6 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.471 1.108 . . . . 10.0 110.752 -177.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.5 -39.11 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.933 0.893 . . . . 10.0 109.846 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.76 -23.93 46.53 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.416 1.008 . . . . 10.0 112.281 178.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.33 -32.33 68.45 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.318 1.047 . . . . 10.0 110.655 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.43 111.97 2.9 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.179 -0.951 . . . . 10.0 110.688 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -37.54 -37.88 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.683 2.793 . . . . 10.0 112.973 174.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.47 4.55 81.27 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.448 0.939 . . . . 10.0 115.448 -177.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.13 107.65 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 104.289 -2.485 . . . . 10.0 104.289 167.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 -28.72 55.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.26 157.29 15.22 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.69 140.61 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.609 1.564 . . . . 10.0 109.013 -177.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -155.72 80.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.544 1.537 . . . . 10.0 109.078 173.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.33 115.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 121.688 -0.633 . . . . 10.0 109.885 169.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.6 m120 -143.86 48.52 1.41 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.901 0.881 . . . . 10.0 110.71 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -55.74 25.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.392 0.677 . . . . 10.0 111.261 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.64 -22.47 64.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.815 -0.553 . . . . 10.0 110.324 -172.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -85.4 -35.45 21.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.948 0.899 . . . . 10.0 111.287 177.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.09 -72.1 0.06 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.125 0.869 . . . . 10.0 112.49 -171.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 176.77 5.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.283 2.233 . . . . 10.0 110.933 -175.088 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.3 t -96.35 102.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.186 0.994 . . . . 10.0 108.486 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -84.14 132.13 34.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.05 0.94 . . . . 10.0 108.583 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.88 129.52 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 O-C-N 121.528 -0.732 . . . . 10.0 110.001 -172.027 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.5 m -96.49 80.99 3.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.147 -1.427 . . . . 10.0 107.147 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CE2' HG12 ' A' ' 53' ' ' VAL . 42.2 m-85 -81.63 130.64 35.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.429 -0.805 . . . . 10.0 110.234 -178.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -91.69 87.23 6.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.422 1.889 . . . . 10.0 108.653 174.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -20.51 2.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.593 1.157 . . . . 10.0 113.293 171.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.657 1.583 . . . . 10.0 109.237 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -59.0 1.96 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 125.959 1.704 . . . . 10.0 109.155 -170.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 m -140.05 154.21 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 123.826 0.851 . . . . 10.0 110.742 178.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 t -100.01 160.09 14.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.13 0.966 . . . . 10.0 111.016 177.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' CE2' ' A' ' 46' ' ' PHE . 31.1 m -48.22 -35.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 C-N-CA 128.187 2.595 . . . . 10.0 109.418 166.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -52.53 -28.2 19.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.193 0.906 . . . . 10.0 112.392 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.09 -62.98 1.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.346 0.976 . . . . 10.0 109.358 169.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -65.66 -51.39 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 O-C-N 121.512 -0.743 . . . . 10.0 112.491 -169.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.05 -53.51 6.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.013 1.725 . . . . 10.0 109.872 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.84 -49.11 78.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.818 0.847 . . . . 10.0 110.05 175.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.13 -42.46 66.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.569 1.147 . . . . 10.0 111.595 -179.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.38 -56.39 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 118.215 -0.897 . . . . 10.0 108.832 174.488 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -34.5 59.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.883 1.219 . . . . 10.0 112.105 -171.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -38.19 -54.82 1.36 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.935 1.694 . . . . 10.0 113.527 172.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -144.86 -38.39 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.89 85.56 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.32 171.38 0.24 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.025 1.33 . . . . 10.0 109.958 -176.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.269 0.1 OUTLIER 102.13 3.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 127.425 2.29 . . . . 10.0 113.203 174.752 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 60' ' ' ILE . 38.6 t -88.65 88.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 124.806 1.242 . . . . 10.0 110.173 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.56 -58.44 4.29 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -175.36 152.88 1.44 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -175.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.865 0 C-N-CA 123.81 0.844 . . . . 10.0 111.811 173.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.235 0.54 . . . . 10.0 111.808 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -84.6 99.19 10.61 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.662 1.185 . . . . 10.0 110.276 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.65 164.84 12.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 167.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.82 113.78 21.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.072 -1.825 . . . . 10.0 106.072 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 42' ' ' VAL . 5.7 mt -80.88 83.19 6.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 174.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.82 147.02 20.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 -176.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.28 130.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.938 0.718 . . . . 10.0 112.938 -169.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -66.39 -48.6 69.59 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.847 1.659 . . . . 10.0 107.468 172.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.33 11.76 0.12 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.4 -1.222 . . . . 10.0 114.624 175.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -175.27 2.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 120.382 2.091 . . . . 10.0 108.52 173.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -170.17 58.45 0.04 OUTLIER 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.649 -1.241 . . . . 10.0 107.649 173.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.8 t -132.16 108.94 9.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 174.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -66.04 -10.56 41.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.11 0.964 . . . . 10.0 111.41 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -93.05 -48.27 6.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.538 0.735 . . . . 10.0 110.156 -171.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 m -43.64 -70.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.008 1.723 . . . . 10.0 110.197 171.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.591 HG21 HG11 ' A' ' 35' ' ' VAL . 4.1 m -39.56 -48.66 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 C-N-CA 123.962 0.905 . . . . 10.0 111.789 173.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.07 -34.86 61.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -31.34 45.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.36 0.527 . . . . 10.0 110.542 174.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.01 -32.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.498 1.519 . . . . 10.0 111.232 177.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 27.8 tt0 -43.37 -47.58 6.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.154 1.382 . . . . 10.0 110.087 -179.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -44.62 -70.04 0.12 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.802 1.641 . . . . 10.0 111.836 169.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.5 t -58.59 -47.21 85.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.116 1.367 . . . . 10.0 110.57 -172.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.37 -42.99 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.023 0.529 . . . . 10.0 109.8 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.31 -45.35 74.97 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.419 0.533 . . . . 10.0 111.769 170.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -61.52 -36.42 80.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 10.0 111.632 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 95.65 0.21 Allowed 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.276 -0.89 . . . . 10.0 109.972 177.131 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -28.03 -41.94 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.942 2.497 . . . . 10.0 114.902 173.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.83 5.15 0.56 Allowed Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.885 1.231 . . . . 10.0 115.74 174.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.74 111.31 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 104.474 -2.417 . . . . 10.0 104.474 169.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -74.08 -30.59 62.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.32 156.78 10.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.874 -1.528 . . . . 10.0 106.874 178.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.58 145.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 O-C-N 123.927 0.767 . . . . 10.0 109.677 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.29 96.67 1.2 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 173.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 17' ' ' VAL . 25.7 t -87.3 120.34 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.08 49.8 2.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.424 0.556 . . . . 10.0 110.023 -174.118 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -42.46 -53.96 4.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.655 1.582 . . . . 10.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -35.68 74.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.508 0.723 . . . . 10.0 111.706 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -32.65 41.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.978 -171.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.95 -73.59 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.413 -1.475 . . . . 10.0 109.413 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -171.87 1.93 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 127.129 2.171 . . . . 10.0 108.582 177.195 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -85.76 128.44 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 172.255 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -120.98 100.78 7.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.564 -1.273 . . . . 10.0 107.564 176.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.48 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.7 t -110.83 148.58 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.649 1.58 . . . . 10.0 106.97 -175.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 t -101.25 72.19 1.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.034 -1.839 . . . . 10.0 106.034 -175.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 27.6 m-85 -75.82 134.68 40.32 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.112 -172.07 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -83.03 81.17 8.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.492 -0.755 . . . . 10.0 109.81 177.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.42 -25.97 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.865 1.266 . . . . 10.0 113.252 169.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -83.0 -22.54 33.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 126.325 1.85 . . . . 10.0 110.294 -173.255 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -117.67 -48.74 2.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.378 0.671 . . . . 10.0 109.448 -169.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.15 -170.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 125.445 1.498 . . . . 10.0 108.836 177.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.9 m -143.64 144.48 31.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 169.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 m -32.35 -42.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 130.524 3.529 . . . . 10.0 111.596 174.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -29.67 -55.88 0.16 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.192 0.997 . . . . 10.0 111.522 170.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -51.75 -67.45 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.721 1.208 . . . . 10.0 110.75 175.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.0 mp -60.32 -55.49 23.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 124.296 1.038 . . . . 10.0 111.869 -175.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.83 -59.94 1.53 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.886 2.074 . . . . 10.0 110.572 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.88 -46.86 78.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.763 0.792 . . . . 10.0 110.39 176.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.78 -42.84 80.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.102 0.961 . . . . 10.0 111.45 -178.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.465 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -70.13 -43.85 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.045 -1.034 . . . . 10.0 108.765 175.105 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.18 -36.99 32.79 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.119 1.327 . . . . 10.0 112.27 176.027 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.54 -67.72 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.697 0.68 . . . . 10.0 112.584 176.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -129.48 14.87 6.05 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.97 -53.59 0.18 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.212 0.911 . . . . 10.0 112.904 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 63.4 169.97 0.15 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.241 2.216 . . . . 10.0 110.97 -172.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.288 1.3 p30 108.43 -8.24 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 129.395 3.078 . . . . 10.0 113.166 -176.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 60' ' ' ILE . 53.4 t -74.2 81.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 124.302 1.041 . . . . 10.0 111.664 -178.023 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.33 -56.64 5.15 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 168.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -179.07 145.07 0.25 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.486 1.114 . . . . 10.0 108.433 -171.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 124.327 1.051 . . . . 10.0 110.061 169.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 118.697 -0.668 . . . . 10.0 109.416 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.54 -175.59 4.49 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.076 1.35 . . . . 10.0 109.161 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -147.2 75.35 1.37 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.579 1.151 . . . . 10.0 108.204 170.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -92.2 175.52 6.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.308 1.051 . . . . 10.0 109.341 172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -150.86 137.85 19.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.124 -1.806 . . . . 10.0 106.124 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -92.87 101.7 14.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.774 -2.306 . . . . 10.0 104.774 177.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -63.05 147.27 51.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 p -67.28 131.53 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.203 1.401 . . . . 10.0 112.587 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -78.6 -59.66 2.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.332 2.653 . . . . 10.0 110.862 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.05 -36.15 0.05 OUTLIER Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.757 -0.469 . . . . 10.0 112.778 -173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.17 166.48 2.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 122.129 0.966 . . . . 10.0 111.957 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.7 m -156.17 42.94 0.4 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 173.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.2 t -112.61 96.15 5.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.552 -1.648 . . . . 10.0 106.552 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -55.96 -25.12 42.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.353 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -74.95 -41.34 59.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.76 0.824 . . . . 10.0 109.322 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.2 m -54.66 -71.41 0.08 Allowed 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.832 0.853 . . . . 10.0 109.43 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -48.57 -50.04 13.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 O-C-N 121.677 -0.639 . . . . 10.0 112.663 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -28.15 64.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.24 78.8 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.241 -0.651 . . . . 10.0 109.241 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.8 t -84.39 -41.26 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-O 118.61 -0.71 . . . . 10.0 110.519 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -39.4 -52.94 2.06 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.293 1.037 . . . . 10.0 110.503 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -48.84 75.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.612 -0.722 . . . . 10.0 110.907 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 m -59.34 -49.79 76.48 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 123.166 0.586 . . . . 10.0 111.227 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -55.27 -33.67 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.529 -0.732 . . . . 10.0 110.985 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.42 -18.37 14.77 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 123.922 0.772 . . . . 10.0 113.105 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.08 -34.38 75.04 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 118.626 1.213 . . . . 10.0 110.369 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.09 95.37 0.56 Allowed 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.372 -0.83 . . . . 10.0 110.593 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -21.03 -51.73 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 128.615 2.766 . . . . 10.0 114.347 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -44.66 -53.93 6.88 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.28 0.943 . . . . 10.0 113.865 175.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -52.63 111.89 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 124.452 1.101 . . . . 10.0 109.721 -173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -37.92 58.3 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.118 -0.947 . . . . 10.0 108.727 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.86 156.97 9.63 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.416 -1.327 . . . . 10.0 107.416 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 m -140.42 113.27 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.211 1.405 . . . . 10.0 107.231 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.8 m170 -116.66 78.18 1.18 Allowed 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.089 0.956 . . . . 10.0 108.684 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.02 115.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 124.185 0.994 . . . . 10.0 109.847 176.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 41.0 m-80 -144.92 48.78 1.3 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.139 0.975 . . . . 10.0 110.09 178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -49.84 -45.81 50.68 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 10.0 112.205 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.42 -42.71 82.77 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.515 1.126 . . . . 10.0 111.11 -178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -76.47 -32.06 58.15 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.52 -0.764 . . . . 10.0 111.036 -175.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.29 -70.66 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.474 1.035 . . . . 10.0 111.064 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.36 177.88 5.82 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.681 1.593 . . . . 10.0 109.418 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.422 HG23 HD12 ' A' ' 6' ' ' LEU . 17.2 m -93.71 109.85 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 108.094 -1.076 . . . . 10.0 108.094 175.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -93.51 118.8 31.8 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.1 t -132.35 137.49 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 122.227 1.013 . . . . 10.0 109.958 -168.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 72.1 m -105.12 66.36 0.75 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 -172.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -67.41 138.77 56.94 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.158 -1.383 . . . . 10.0 108.643 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -83.44 89.74 7.1 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.503 -0.479 . . . . 10.0 111.473 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.86 -19.59 1.81 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.653 0.983 . . . . 10.0 113.653 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.77 -14.3 45.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.447 1.021 . . . . 10.0 110.62 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -117.34 -52.95 2.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.272 1.029 . . . . 10.0 109.252 -175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.84 139.37 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.175 0.99 . . . . 10.0 110.31 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -93.04 145.18 24.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.541 -0.724 . . . . 10.0 109.445 -176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -34.83 -46.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 128.956 2.902 . . . . 10.0 110.405 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -32.3 -51.26 0.25 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.523 1.129 . . . . 10.0 112.221 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -52.37 -72.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.954 1.302 . . . . 10.0 110.59 175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -57.96 -49.17 82.14 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 125.366 1.466 . . . . 10.0 112.161 -176.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.81 -59.13 2.97 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.495 1.918 . . . . 10.0 109.916 174.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.11 -43.72 82.58 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.395 0.617 . . . . 10.0 109.827 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.83 61.93 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.607 0.763 . . . . 10.0 111.045 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.495 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.16 -32.74 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 120.799 -1.188 . . . . 10.0 109.813 -179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -53.26 40.97 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.535 -0.728 . . . . 10.0 109.572 172.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -39.3 -64.66 0.44 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.888 1.275 . . . . 10.0 114.067 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -139.9 30.77 2.03 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.108 0.781 . . . . 10.0 113.108 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.99 -54.09 0.32 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.0 -0.889 . . . . 10.0 111.073 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 64.66 110.65 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.795 2.038 . . . . 10.0 110.77 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 163.47 -32.25 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 124.78 1.232 . . . . 10.0 109.644 -168.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG23 ' CG2' ' A' ' 60' ' ' ILE . 69.3 t -72.4 87.52 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.394 -0.816 . . . . 10.0 111.073 -173.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.47 -55.75 12.35 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.296 -1.002 . . . . 10.0 108.296 170.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -174.59 156.9 2.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.099 -1.445 . . . . 10.0 107.099 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -74.1 137.08 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 124.506 1.122 . . . . 10.0 110.4 168.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -110.14 -112.0 0.32 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.85 -0.796 . . . . 10.0 108.85 168.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 58.34 -95.67 0.06 OUTLIER Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.117 1.341 . . . . 10.0 113.765 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.234 0 CA-C-O 116.922 -1.513 . . . . 10.0 107.8 -173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttp . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 106.313 -1.736 . . . . 10.0 106.313 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.86 170.4 12.84 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 174.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.5 102.82 4.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.089 1.756 . . . . 10.0 107.847 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -117.83 168.74 10.2 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 122.503 1.145 . . . . 10.0 109.694 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.55 126.13 49.57 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.608 -2.367 . . . . 10.0 104.608 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 70' ' ' ILE . 0.2 OUTLIER -93.92 105.79 17.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 103.582 -2.747 . . . . 10.0 103.582 167.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -68.29 151.71 46.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.381 -0.97 . . . . 10.0 108.381 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.29 131.6 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 C-N-CA 125.188 1.395 . . . . 10.0 113.604 -169.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -73.81 -62.3 1.54 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 128.547 2.739 . . . . 10.0 109.319 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.53 -26.79 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 119.834 -1.174 . . . . 10.0 114.163 -169.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -179.35 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.125 1.463 . . . . 10.0 110.656 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 t -163.7 65.23 0.17 Allowed 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 107.818 -1.179 . . . . 10.0 107.818 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -144.82 91.86 2.21 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -55.86 -3.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.206 1.187 . . . . 10.0 114.206 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -94.84 -42.52 8.66 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 10.0 109.771 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 m -52.46 -66.29 0.41 Allowed 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.648 0.779 . . . . 10.0 109.184 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -40.56 -47.83 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.49 0.716 . . . . 10.0 111.769 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.412 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.2 tttm -58.62 -31.48 68.14 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.8 -31.32 58.86 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.548 0.613 . . . . 10.0 110.133 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.3 t -95.03 -35.76 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.879 1.272 . . . . 10.0 111.073 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 19.2 tt0 -36.45 -57.3 0.76 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.018 1.727 . . . . 10.0 110.724 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 p -51.98 -59.89 3.83 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.677 1.191 . . . . 10.0 111.204 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -56.28 -49.4 74.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.042 0.937 . . . . 10.0 110.929 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 30' ' ' VAL . 24.2 t -59.33 -43.9 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 122.02 -0.425 . . . . 10.0 110.269 178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.71 -30.87 14.9 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 123.474 0.559 . . . . 10.0 112.968 171.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.73 -36.36 80.42 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.169 0.985 . . . . 10.0 110.569 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.08 95.14 0.54 Allowed 'General case' 0 C--O 1.22 -0.473 0 O-C-N 121.352 -0.842 . . . . 10.0 109.409 176.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -19.02 -50.53 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.979 2.911 . . . . 10.0 114.756 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.01 -18.98 20.93 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.676 1.132 . . . . 10.0 115.138 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' CG1' ' A' ' 24' ' ' VAL . 2.1 t -81.63 108.25 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 119.392 -2.24 . . . . 10.0 105.699 170.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.66 -36.14 78.16 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.023 -0.99 . . . . 10.0 109.912 173.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.13 154.76 9.15 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 108.974 -0.751 . . . . 10.0 108.974 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.34 142.21 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.496 1.518 . . . . 10.0 109.334 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 88.83 1.51 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 122.33 1.062 . . . . 10.0 108.94 169.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.9 t -77.56 124.46 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 C-N-CA 124.834 1.253 . . . . 10.0 108.903 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 59.8 m-80 -145.48 48.97 1.25 Allowed 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.015 0.526 . . . . 10.0 110.83 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.32 -49.2 24.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.511 0.724 . . . . 10.0 110.333 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -71.79 -23.52 61.59 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.261 1.024 . . . . 10.0 111.869 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.22 -29.79 21.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.588 0.232 . . . . 10.0 110.423 174.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.24 -57.48 0.1 OUTLIER Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.935 0.778 . . . . 10.0 111.777 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.86 174.32 6.55 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.061 1.344 . . . . 10.0 111.586 -170.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG22 HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -91.1 132.84 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 169.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -121.36 112.05 18.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 42' ' ' VAL . 42.9 t -127.7 146.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.753 1.221 . . . . 10.0 109.001 -168.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -99.04 81.67 2.62 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 104.469 -2.419 . . . . 10.0 104.469 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 15.1 m-85 -85.88 127.91 34.7 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.079 -1.082 . . . . 10.0 108.079 178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -86.08 82.17 8.19 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.38 -1.341 . . . . 10.0 107.38 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.28 -14.15 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.961 1.704 . . . . 10.0 113.528 172.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -74.15 -26.74 60.48 Favored 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 127.017 2.127 . . . . 10.0 108.775 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.1 tttt -121.19 -56.18 1.92 Allowed 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.388 1.075 . . . . 10.0 108.496 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.12 138.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 C-N-CA 124.131 0.972 . . . . 10.0 108.935 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 t -89.12 158.5 17.92 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.488 1.137 . . . . 10.0 110.202 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.407 HG21 HG21 ' A' ' 70' ' ' ILE . 18.1 m -47.45 -37.72 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 C-N-CA 128.062 2.545 . . . . 10.0 107.744 165.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -56.06 -25.76 46.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 119.793 1.179 . . . . 10.0 112.853 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.45 -60.99 2.37 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.71 1.595 . . . . 10.0 109.104 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.466 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -65.28 -53.16 43.58 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 124.785 1.234 . . . . 10.0 112.599 -171.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.91 -56.37 4.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.681 1.992 . . . . 10.0 110.163 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -59.76 -44.82 93.68 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.419 1.488 . . . . 10.0 108.87 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.27 -46.74 72.76 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.57 -0.706 . . . . 10.0 112.004 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.51 -34.82 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 O-C-N 120.824 -1.172 . . . . 10.0 110.335 178.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -53.52 -42.34 67.28 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.776 -1.203 . . . . 10.0 110.394 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -53.6 -65.73 0.51 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.261 1.025 . . . . 10.0 112.72 -177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -136.42 34.48 2.74 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.188 -0.945 . . . . 10.0 113.543 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.05 -57.26 0.26 Allowed Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.686 0.676 . . . . 10.0 112.484 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 62.64 102.25 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.445 1.898 . . . . 10.0 111.775 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.6 t0 172.57 -40.07 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.752 2.021 . . . . 10.0 107.655 -168.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.553 HG23 HG21 ' A' ' 60' ' ' ILE . 51.4 t -69.06 98.96 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 120.526 -1.359 . . . . 10.0 112.657 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.99 -55.08 5.21 Favored 'General case' 0 C--N 1.338 0.069 0 N-CA-C 108.89 -0.782 . . . . 10.0 108.89 167.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -170.47 146.28 2.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.346 1.459 . . . . 10.0 107.125 -171.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.73 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -73.55 151.03 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 123.886 0.875 . . . . 10.0 109.594 171.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -150.83 142.71 23.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 168.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.25 -120.57 1.06 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 -169.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.29 0 CA-C-N 117.857 0.828 . . . . 10.0 111.161 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 117.662 -1.161 . . . . 10.0 107.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.85 126.37 44.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.086 1.354 . . . . 10.0 109.337 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.9 pm0 -72.99 72.26 1.12 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.081 1.352 . . . . 10.0 110.337 173.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 160.65 30.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.745 1.259 . . . . 10.0 108.289 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.0 m -120.75 115.5 23.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.858 -2.275 . . . . 10.0 104.858 -171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 67' ' ' VAL . 74.0 mt -86.3 92.24 8.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.912 -2.255 . . . . 10.0 104.912 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -67.09 142.73 57.02 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 109.738 -0.468 . . . . 10.0 109.738 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.72 130.67 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.599 1.56 . . . . 10.0 112.784 -168.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -81.72 -53.73 5.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.47 2.708 . . . . 10.0 110.479 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.79 -40.13 0.09 OUTLIER Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.237 -0.506 . . . . 10.0 112.428 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 156.92 21.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.55 0.675 . . . . 10.0 110.994 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.17 11.57 3.56 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.286 -0.87 . . . . 10.0 110.901 173.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.6 t -85.25 94.25 8.87 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 121.817 0.817 . . . . 10.0 109.101 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -57.63 -4.2 0.25 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.325 1.05 . . . . 10.0 113.651 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -92.9 -32.06 14.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.778 1.172 . . . . 10.0 111.15 173.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.4 m -63.35 -74.45 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.217 -1.031 . . . . 10.0 108.217 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -46.62 -49.19 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 N-CA-C 112.944 0.72 . . . . 10.0 112.944 -172.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -54.27 -33.45 58.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.209 0.818 . . . . 10.0 113.209 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.06 -35.95 67.52 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 122.938 0.495 . . . . 10.0 109.911 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -85.39 -49.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 118.287 -0.863 . . . . 10.0 109.88 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -38.71 -49.29 1.57 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.977 1.711 . . . . 10.0 110.883 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -50.69 -51.33 50.57 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 10.0 111.152 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.1 t -72.94 -42.24 63.64 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.871 0.868 . . . . 10.0 111.568 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.2 t -53.59 -41.19 45.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.097 -1.002 . . . . 10.0 109.898 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.03 -26.33 19.31 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.702 1.144 . . . . 10.0 113.866 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.63 -29.83 67.4 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.845 1.323 . . . . 10.0 110.685 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.02 111.98 5.36 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 119.109 0.868 . . . . 10.0 109.407 178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -42.62 -41.1 2.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.566 1.947 . . . . 10.0 112.693 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.54 -26.99 57.95 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.262 0.934 . . . . 10.0 113.904 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 t -81.96 112.64 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 120.203 -1.763 . . . . 10.0 106.616 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -79.39 -37.77 36.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.246 1.018 . . . . 10.0 109.758 178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.82 161.29 17.76 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.659 -1.237 . . . . 10.0 107.659 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -141.73 134.16 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 125.012 1.325 . . . . 10.0 108.25 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -143.36 89.57 2.1 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.49 1.116 . . . . 10.0 110.072 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.2 t -66.8 134.07 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 124.218 1.007 . . . . 10.0 110.286 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.8 m-20 -156.79 49.45 0.47 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.871 0.468 . . . . 10.0 110.933 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.25 -54.39 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.692 . . . . 10.0 111.943 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -66.65 -38.11 86.18 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.566 0.746 . . . . 10.0 111.208 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -73.51 -34.77 65.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.641 -0.709 . . . . 10.0 110.919 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -174.33 -73.35 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.61 -1.396 . . . . 10.0 109.61 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 -172.35 1.6 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 126.094 1.758 . . . . 10.0 107.666 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 35' ' ' VAL . 41.9 t -99.06 117.8 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -100.88 130.1 46.84 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 44.5 t -136.55 149.54 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.87 -1.53 . . . . 10.0 106.87 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.4 t -111.04 85.77 2.18 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 104.915 -2.254 . . . . 10.0 104.915 -171.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 39.9 m-85 -92.11 141.61 28.41 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 125.673 1.589 . . . . 10.0 108.276 -173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -89.89 93.3 9.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.617 0.767 . . . . 10.0 109.969 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.6 -14.67 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.714 -0.66 . . . . 10.0 112.296 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -89.3 -0.25 57.33 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.801 0.728 . . . . 10.0 109.685 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -130.52 -53.25 1.09 Allowed 'General case' 0 N--CA 1.45 -0.441 0 O-C-N 121.675 -0.641 . . . . 10.0 111.362 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.0 m -132.89 164.81 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 118.701 0.682 . . . . 10.0 110.72 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.5 m -111.17 147.96 33.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 46' ' ' PHE . 15.4 m -42.26 -34.45 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 C-N-CA 127.068 2.147 . . . . 10.0 110.148 167.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -48.29 -28.41 3.09 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.014 0.825 . . . . 10.0 112.324 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -68.9 -70.79 0.25 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.78 0.832 . . . . 10.0 109.008 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.489 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.0 mp -59.33 -53.22 51.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.239 1.416 . . . . 10.0 113.787 -172.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.11 -56.92 3.16 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.124 1.77 . . . . 10.0 109.953 174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -58.91 -46.25 88.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.906 0.882 . . . . 10.0 109.459 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.82 -47.5 67.62 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.767 -0.583 . . . . 10.0 111.207 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.489 HG21 HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -71.07 -38.6 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 O-C-N 121.09 -1.006 . . . . 10.0 110.037 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -54.5 -41.18 69.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.523 -1.361 . . . . 10.0 110.293 176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -53.95 -65.53 0.55 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.424 1.09 . . . . 10.0 112.925 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -139.28 50.39 1.8 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.655 -0.653 . . . . 10.0 112.287 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.79 -55.17 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.71 -0.956 . . . . 10.0 110.71 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 64.0 112.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.255 2.222 . . . . 10.0 110.432 175.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 168.34 -41.85 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.461 0 O-C-N 121.543 -0.723 . . . . 10.0 109.337 -168.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.489 HG23 HG21 ' A' ' 60' ' ' ILE . 88.1 t -75.09 84.57 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.028 0.442 . . . . 10.0 110.885 -168.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.28 -50.38 60.58 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.095 -0.705 . . . . 10.0 109.095 174.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -163.79 153.0 14.22 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 172.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.14 147.21 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 124.904 1.282 . . . . 10.0 108.28 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -81.62 -82.49 0.13 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 110.157 -0.312 . . . . 10.0 110.157 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -49.73 -71.54 0.6 Allowed Glycine 0 CA--C 1.531 1.066 0 N-CA-C 116.02 1.168 . . . . 10.0 116.02 -169.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 . . . . . 0 C--O 1.251 1.145 0 N-CA-C 105.658 -1.978 . . . . 10.0 105.658 -179.012 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -130.24 170.0 14.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.738 1.215 . . . . 10.0 108.564 -175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -141.04 113.42 8.05 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -120.54 -178.63 3.75 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.973 0.909 . . . . 10.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -137.87 116.6 12.24 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.128 -1.805 . . . . 10.0 106.128 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.676 HD23 HG22 ' A' ' 70' ' ' ILE . 1.2 mt -86.28 94.19 9.27 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 104.58 -2.378 . . . . 10.0 104.58 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -59.32 148.02 33.78 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.1 128.16 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.205 1.402 . . . . 10.0 110.797 -172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -70.9 -56.52 6.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.808 2.043 . . . . 10.0 108.016 170.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.82 -37.03 0.05 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 119.513 -1.327 . . . . 10.0 113.909 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.27 161.26 30.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.062 0.931 . . . . 10.0 109.54 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.1 p -143.31 21.28 1.89 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.246 0.618 . . . . 10.0 109.955 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 50.5 t -97.39 101.37 12.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -66.8 2.36 1.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.804 0.668 . . . . 10.0 112.804 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.84 -45.52 6.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.969 1.308 . . . . 10.0 110.641 175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.0 m -49.43 -68.88 0.14 Allowed 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.377 1.471 . . . . 10.0 109.526 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.784 HG21 HG11 ' A' ' 35' ' ' VAL . 2.0 m -39.85 -45.65 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 C-N-CA 123.972 0.909 . . . . 10.0 112.297 172.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 6.0 tttp -56.17 -31.17 63.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.158 1.17 . . . . 10.0 114.158 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -31.8 52.64 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.199 0.454 . . . . 10.0 110.524 173.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 ' C ' ' A' ' 59' ' ' ALA . 2.5 t -97.75 -33.58 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 C-N-CA 125.855 1.662 . . . . 10.0 110.602 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 25.4 tt0 -43.3 -47.82 6.7 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.994 1.318 . . . . 10.0 110.592 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -46.39 -61.37 1.83 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.987 0.915 . . . . 10.0 110.996 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -57.56 -50.35 73.38 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.385 1.074 . . . . 10.0 110.877 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 20' ' ' VAL . 97.2 t -55.53 -47.29 78.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.757 0.823 . . . . 10.0 109.57 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.16 -38.92 88.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.716 0.674 . . . . 10.0 112.204 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.82 -42.57 99.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.359 1.063 . . . . 10.0 110.724 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.98 112.58 1.55 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.796 -0.565 . . . . 10.0 111.216 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -35.85 -56.09 0.71 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.852 2.461 . . . . 10.0 112.303 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.94 -19.84 51.62 Favored Glycine 0 CA--C 1.535 1.282 0 N-CA-C 114.251 0.46 . . . . 10.0 114.251 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.45 109.17 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 119.17 -2.371 . . . . 10.0 107.498 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 t -74.84 -31.12 61.58 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.806 -1.088 . . . . 10.0 109.415 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.7 158.07 8.91 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.2 m -133.22 138.61 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.358 1.063 . . . . 10.0 109.403 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -158.48 101.14 1.68 Allowed 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.784 HG11 HG21 ' A' ' 17' ' ' VAL . 36.9 t -89.9 123.03 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 C-N-CA 125.339 1.456 . . . . 10.0 107.732 176.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -137.19 53.1 1.89 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.46 0.573 . . . . 10.0 110.871 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 37' ' ' LEU . 1.2 mp -44.99 -47.67 11.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.465 1.106 . . . . 10.0 112.136 -175.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.32 -33.39 73.08 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.491 0.716 . . . . 10.0 111.902 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.87 -38.0 58.33 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.34 -64.04 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 109.48 -1.448 . . . . 10.0 109.48 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.82 -170.23 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.941 1.296 . . . . 10.0 110.822 -174.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.634 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.98 128.29 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 124.778 1.231 . . . . 10.0 108.824 178.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -114.96 71.39 0.76 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.744 1.618 . . . . 10.0 109.04 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.634 HG23 ' CG2' ' A' ' 42' ' ' VAL . 12.4 t -84.78 152.31 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.836 1.254 . . . . 10.0 109.393 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.3 t -110.15 71.32 0.75 Allowed 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.257 -1.757 . . . . 10.0 106.257 -172.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 12.4 m-85 -72.03 130.11 40.15 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.355 -1.293 . . . . 10.0 109.107 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -80.93 85.4 6.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.281 -0.887 . . . . 10.0 109.838 170.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.35 -21.52 0.31 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.902 1.281 . . . . 10.0 113.845 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.78 -19.91 51.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.296 0.953 . . . . 10.0 109.706 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -116.65 -53.96 2.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.889 1.275 . . . . 10.0 110.466 -173.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.7 m -138.2 159.71 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 123.077 0.551 . . . . 10.0 109.938 173.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.5 p -108.37 161.51 14.96 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 m -31.86 -42.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 127.238 2.215 . . . . 10.0 111.656 168.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -29.6 -54.47 0.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.65 1.58 . . . . 10.0 111.303 174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.11 -59.42 5.45 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.376 1.084 . . . . 10.0 110.633 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.41 HG23 ' CG1' ' A' ' 24' ' ' VAL . 3.6 mm -62.61 -58.67 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.623 1.569 . . . . 10.0 111.955 -175.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' HA ' HG21 ' A' ' 67' ' ' VAL . . . -41.46 -55.31 2.86 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 128.003 2.521 . . . . 10.0 110.007 172.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -56.86 -48.69 77.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.891 0.853 . . . . 10.0 110.557 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -56.23 -45.6 79.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.115 -0.493 . . . . 10.0 111.454 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.66 -35.84 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 O-C-N 120.558 -1.339 . . . . 10.0 109.967 178.05 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.26 -39.77 73.14 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 120.169 1.349 . . . . 10.0 111.755 171.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -49.43 -63.23 1.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.168 0.587 . . . . 10.0 112.341 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -134.81 13.34 3.67 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.532 0.938 . . . . 10.0 113.532 -174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -55.21 0.55 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 119.062 -0.854 . . . . 10.0 113.241 -169.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 64.33 108.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.973 2.109 . . . . 10.0 111.256 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 171.75 -36.58 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.187 0.995 . . . . 10.0 109.951 -167.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 57' ' ' ALA . 66.2 t -73.03 87.31 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.409 -0.807 . . . . 10.0 111.773 -169.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.78 -54.79 10.36 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 121.288 -0.882 . . . . 10.0 110.136 170.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -174.13 152.85 1.93 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.579 -1.638 . . . . 10.0 106.579 -174.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.676 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -93.38 140.41 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 C-N-CA 123.815 0.846 . . . . 10.0 110.038 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -106.39 -103.47 0.34 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 169.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 59.04 -116.48 8.84 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.975 1.261 . . . . 10.0 113.168 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.134 0 C-N-CA 125.792 1.637 . . . . 10.0 107.296 -174.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 114.865 1.431 . . . . 10.0 114.865 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -128.53 173.49 10.2 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 126.106 2.128 . . . . 10.0 108.341 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.98 114.39 19.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.688 2.395 . . . . 10.0 105.379 170.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.4 mttp -123.01 168.05 12.83 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.946 -1.501 . . . . 10.0 106.946 168.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.64 122.24 32.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.666 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -91.45 97.43 11.07 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 105.911 -1.885 . . . . 10.0 105.911 172.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -65.86 153.28 42.4 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.604 0.761 . . . . 10.0 109.379 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.4 m -65.27 131.63 31.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -70.0 -56.91 5.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 130.491 3.516 . . . . 10.0 109.824 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.32 -30.21 0.18 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.451 -0.638 . . . . 10.0 112.423 -172.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.53 169.58 10.7 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.133 0.967 . . . . 10.0 111.557 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.3 m -156.07 40.73 0.37 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.5 t -116.42 89.56 3.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -52.93 -16.28 1.0 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.132 0.973 . . . . 10.0 113.43 173.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -82.6 -39.64 21.92 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 121.196 -0.94 . . . . 10.0 109.835 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -57.53 -71.24 0.11 Allowed 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 124.772 1.295 . . . . 10.0 108.31 171.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -46.46 -51.4 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 112.219 0.452 . . . . 10.0 112.219 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -28.93 68.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.366 0.984 . . . . 10.0 113.01 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.77 61.75 Favored 'General case' 0 C--N 1.343 0.314 0 O-C-N 121.719 -0.613 . . . . 10.0 110.923 172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.2 t -93.0 -44.59 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-O 118.156 -0.926 . . . . 10.0 110.633 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -44.95 -46.91 11.3 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.927 1.291 . . . . 10.0 110.302 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -50.14 -60.26 3.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.016 0.526 . . . . 10.0 111.553 174.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -58.7 -43.85 90.18 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.476 0.71 . . . . 10.0 111.767 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.697 HG13 HD12 ' A' ' 56' ' ' ILE . 6.3 t -53.45 -39.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.221 1.008 . . . . 10.0 110.21 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -45.92 -27.28 2.32 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 124.317 0.96 . . . . 10.0 114.423 172.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.23 -26.3 61.08 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.15 1.475 . . . . 10.0 112.149 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.77 113.56 2.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.179 0.9 . . . . 10.0 110.542 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -39.78 -45.9 1.83 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.194 2.198 . . . . 10.0 111.735 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.67 -17.9 75.32 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.785 0.674 . . . . 10.0 114.785 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.91 107.54 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 118.683 -2.657 . . . . 10.0 107.245 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 t -79.35 -29.3 42.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.3 157.64 13.27 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.462 ' HA ' HG22 ' A' ' 44' ' ' VAL . 5.9 m -134.43 135.53 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 124.158 0.983 . . . . 10.0 109.103 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -149.21 87.22 1.52 Allowed 'General case' 0 CA--C 1.523 -0.08 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 t -73.19 117.4 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 123.726 0.81 . . . . 10.0 110.275 170.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.42 49.07 2.2 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.555 0.742 . . . . 10.0 111.437 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -52.42 -39.86 61.47 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.472 0.653 . . . . 10.0 112.177 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -65.91 -39.55 90.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.463 1.505 . . . . 10.0 110.69 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.2 -33.65 24.12 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.93 -0.577 . . . . 10.0 111.189 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.18 -67.65 0.06 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.261 -0.736 . . . . 10.0 111.261 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 179.01 5.16 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.355 1.862 . . . . 10.0 110.842 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.539 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -92.56 127.81 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 124.944 1.298 . . . . 10.0 107.941 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -118.83 94.02 4.31 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.33 1.052 . . . . 10.0 109.494 176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG23 ' CG2' ' A' ' 42' ' ' VAL . 31.4 t -104.86 146.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 125.957 1.703 . . . . 10.0 107.738 -175.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -103.8 68.89 0.94 Allowed 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.156 -2.165 . . . . 10.0 105.156 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.438 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 25.6 m-85 -66.78 128.43 36.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 113.915 -1.493 . . . . 10.0 108.662 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 29.5 t0 -79.95 85.4 5.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.745 -0.465 . . . . 10.0 109.745 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.83 -23.36 0.42 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.189 1.396 . . . . 10.0 113.385 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.04 -15.15 52.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.361 1.064 . . . . 10.0 110.603 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -121.48 -56.13 1.9 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.769 1.228 . . . . 10.0 109.42 -172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.41 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.227 1.411 . . . . 10.0 108.409 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.3 m -156.51 167.23 31.08 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.537 -1.283 . . . . 10.0 107.537 168.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.2 m -34.24 -42.71 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 128.116 2.566 . . . . 10.0 112.237 174.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -35.05 -41.48 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.017 1.327 . . . . 10.0 113.224 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -70.92 -67.38 0.51 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.869 0.843 . . . . 10.0 110.627 171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.697 HD12 HG13 ' A' ' 24' ' ' VAL . 3.6 mm -55.92 -55.81 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.846 1.259 . . . . 10.0 112.97 -173.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -45.61 -56.9 4.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.813 2.045 . . . . 10.0 109.731 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -52.92 -49.62 65.61 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.55 0.691 . . . . 10.0 110.131 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.54 -47.96 78.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.793 -0.639 . . . . 10.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -69.52 -36.86 73.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 120.656 -1.278 . . . . 10.0 110.096 -179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -55.32 -40.87 71.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.499 -1.376 . . . . 10.0 111.645 170.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -51.5 -63.68 1.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.154 0.888 . . . . 10.0 112.54 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -145.0 46.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.24 0.459 . . . . 10.0 112.24 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.57 -59.65 0.11 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.041 -0.824 . . . . 10.0 111.041 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.02 110.64 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.41 2.284 . . . . 10.0 110.919 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.9 t0 169.78 -38.55 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 125.93 1.692 . . . . 10.0 109.224 -167.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.517 HG23 HG21 ' A' ' 60' ' ' ILE . 73.4 t -74.93 90.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 O-C-N 120.484 -1.385 . . . . 10.0 112.382 -172.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.9 -56.84 4.62 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.467 -0.77 . . . . 10.0 110.708 169.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -163.63 143.74 8.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.848 -1.538 . . . . 10.0 106.848 -169.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.666 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp -83.52 135.97 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 C-N-CA 124.7 1.2 . . . . 10.0 108.311 172.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.86 135.91 47.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.144 -1.799 . . . . 10.0 106.144 170.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 153.47 -120.44 1.04 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 107.393 -2.283 . . . . 10.0 107.393 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.365 -1.302 . . . . 10.0 109.045 169.519 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ttp . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.93 -174.55 4.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.905 0.775 . . . . 10.0 109.978 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.92 107.81 5.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.252 2.221 . . . . 10.0 106.369 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -110.29 161.34 15.71 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.24 -1.393 . . . . 10.0 107.24 168.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.38 115.55 26.77 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.563 -2.014 . . . . 10.0 105.563 175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 6' ' ' LEU . 20.9 mt -81.99 96.98 7.88 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.948 -1.871 . . . . 10.0 105.948 168.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -65.0 155.71 33.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.792 -0.64 . . . . 10.0 109.662 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' OD2' ' A' ' 66' ' ' ASP . 2.1 t -63.12 129.61 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.302 1.441 . . . . 10.0 110.447 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ASP . 28.1 tt0 -75.14 -43.63 51.44 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 125.962 1.705 . . . . 10.0 107.408 169.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.37 12.19 0.96 Allowed Glycine 0 CA--C 1.527 0.832 0 CA-C-O 118.533 -1.148 . . . . 10.0 113.371 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.16 -177.04 1.96 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 119.714 1.757 . . . . 10.0 109.722 169.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 p -155.53 15.16 0.37 Allowed 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.034 -0.416 . . . . 10.0 111.362 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -99.35 95.29 6.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.564 -0.902 . . . . 10.0 108.564 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -64.2 2.56 0.55 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.468 0.914 . . . . 10.0 113.468 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -94.0 -48.36 6.28 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.781 1.173 . . . . 10.0 110.046 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.3 m -48.21 -70.16 0.1 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.536 1.134 . . . . 10.0 110.759 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.1 m -38.45 -48.46 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 124.35 1.06 . . . . 10.0 111.89 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 0.5 OUTLIER -64.85 -38.14 89.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.359 1.064 . . . . 10.0 112.535 -174.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.15 -42.4 69.52 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 81.5 t -73.46 -38.14 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.68 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 28.8 tt0 -46.2 -49.81 16.57 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.922 1.289 . . . . 10.0 110.358 -177.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -50.57 72.8 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.901 0.381 . . . . 10.0 111.264 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.8 t -70.79 -10.49 59.63 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.947 0.721 . . . . 10.0 112.947 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.8 t -91.19 -43.0 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 124.624 1.17 . . . . 10.0 108.312 169.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.54 -30.35 19.64 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.886 1.231 . . . . 10.0 114.2 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.21 -31.24 72.36 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.145 0.973 . . . . 10.0 111.462 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.3 105.19 1.37 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -31.8 -42.91 0.06 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.054 2.142 . . . . 10.0 113.836 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.83 -20.43 47.97 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.426 1.012 . . . . 10.0 114.808 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -74.32 107.93 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 119.542 -2.152 . . . . 10.0 106.833 169.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.0 t -77.05 -29.4 55.13 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.185 -0.916 . . . . 10.0 109.378 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.42 158.08 13.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.182 -1.784 . . . . 10.0 106.182 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.84 119.42 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 -175.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -136.31 97.87 3.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.282 1.033 . . . . 10.0 108.951 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.47 114.17 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.513 -0.921 . . . . 10.0 108.513 168.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -127.05 47.61 2.32 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.322 0.51 . . . . 10.0 111.963 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -49.53 -48.57 48.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.49 0.716 . . . . 10.0 112.291 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -35.41 74.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.588 0.755 . . . . 10.0 110.99 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.08 -30.64 31.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.894 -175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.21 -69.72 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 123.98 0.8 . . . . 10.0 111.218 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.5 pttt -170.44 174.31 5.23 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 125.941 1.696 . . . . 10.0 112.627 -169.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.2 t -88.77 103.57 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 C-N-CA 124.787 1.235 . . . . 10.0 107.971 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -98.2 116.36 30.26 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -176.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 57.0 t -136.3 135.13 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 -171.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.4 t -94.71 73.58 3.65 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.307 -1.368 . . . . 10.0 107.307 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.487 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 43.1 m-85 -68.67 136.41 52.88 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.519 -1.218 . . . . 10.0 109.281 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -86.71 87.03 7.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.545 0.688 . . . . 10.0 110.15 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.13 -20.1 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.08 -1.418 . . . . 10.0 113.623 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.67 -18.84 32.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 119.12 0.873 . . . . 10.0 110.215 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -117.45 -44.93 2.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.364 0.666 . . . . 10.0 109.745 -173.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.53 -172.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 124.044 0.938 . . . . 10.0 109.425 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.8 t -142.62 159.18 42.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.737 0.779 . . . . 10.0 109.403 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.713 HG11 HG21 ' A' ' 70' ' ' ILE . 34.6 m -44.83 -36.44 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 128.274 2.63 . . . . 10.0 110.294 170.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -41.92 -50.3 4.51 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.434 1.016 . . . . 10.0 110.736 174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -62.24 -49.84 74.13 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.587 1.185 . . . . 10.0 111.46 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -71.52 -58.46 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.256 1.822 . . . . 10.0 111.674 -169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.99 -59.21 1.51 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.348 2.259 . . . . 10.0 109.57 169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -49.25 -51.99 30.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.442 1.497 . . . . 10.0 109.888 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.05 -42.56 80.78 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.481 0.549 . . . . 10.0 112.481 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.5 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -68.77 -58.95 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -37.42 -47.51 0.88 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.224 1.01 . . . . 10.0 113.007 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -42.92 -60.08 1.75 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.019 0.927 . . . . 10.0 113.407 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -136.63 -30.45 0.9 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.086 1.143 . . . . 10.0 114.086 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.8 94.43 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.51 172.18 0.19 Allowed 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.826 1.65 . . . . 10.0 110.112 -174.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.43 ' OD2' HG22 ' A' ' 8' ' ' VAL 0.336 7.5 t70 81.55 42.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.904 1.281 . . . . 10.0 112.431 177.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG23 HG21 ' A' ' 60' ' ' ILE . 3.4 t -120.38 93.95 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.223 1.409 . . . . 10.0 109.623 169.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.7 -58.0 4.1 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 169.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.03 159.62 1.35 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 124.84 1.256 . . . . 10.0 107.791 -175.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.713 HG21 HG11 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -71.34 139.96 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 108.28 -1.008 . . . . 10.0 108.28 166.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -89.9 -44.75 9.7 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.7 2.0 . . . . 10.0 109.796 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.84 -88.49 0.06 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.674 1.131 . . . . 10.0 113.851 -171.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.909 0 CA-C-O 115.671 -2.109 . . . . 10.0 107.463 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 119.297 -0.382 . . . . 10.0 110.104 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -140.89 178.68 7.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.89 2.076 . . . . 10.0 106.726 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -122.99 121.16 35.41 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.629 -2.73 . . . . 10.0 103.629 167.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -117.82 178.25 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.52 121.71 12.23 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 -177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.3 mp -91.02 90.34 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 103.631 -2.729 . . . . 10.0 103.631 168.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -63.46 141.77 58.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.125 -1.065 . . . . 10.0 108.125 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.3 p -67.71 126.54 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.849 1.659 . . . . 10.0 112.45 -170.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -75.03 -55.26 5.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.992 2.117 . . . . 10.0 109.319 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.02 -35.75 0.06 OUTLIER Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.13 -1.034 . . . . 10.0 113.313 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.86 158.87 26.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 117.929 0.865 . . . . 10.0 109.24 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.71 20.93 1.3 Allowed 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.918 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.6 t -92.2 113.14 25.33 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 106.64 -1.615 . . . . 10.0 106.64 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -65.02 -16.8 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.744 -0.383 . . . . 10.0 111.511 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -83.92 -44.17 14.52 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.709 0.686 . . . . 10.0 110.332 -169.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -43.91 -74.66 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.978 1.711 . . . . 10.0 109.195 169.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 35' ' ' VAL . 6.2 m -43.55 -47.85 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.289 0 N-CA-C 112.689 0.626 . . . . 10.0 112.689 176.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 9.7 tptt -44.25 -41.97 6.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 114.123 1.157 . . . . 10.0 114.123 174.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.86 -34.91 42.87 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 122.716 0.406 . . . . 10.0 110.379 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.4 -31.84 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.319 1.447 . . . . 10.0 111.123 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 35.2 tt0 -43.6 -47.49 7.49 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.259 1.423 . . . . 10.0 109.323 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t -55.04 -58.69 6.62 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.651 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 m -56.73 -49.66 74.53 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.947 1.299 . . . . 10.0 110.271 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG13 HG12 ' A' ' 56' ' ' ILE . 35.7 t -60.23 -49.96 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 123.568 0.747 . . . . 10.0 109.981 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.6 -32.14 38.57 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.007 0.813 . . . . 10.0 112.598 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.7 -32.35 73.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.385 1.074 . . . . 10.0 110.498 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.75 109.37 3.81 Favored 'General case' 0 C--O 1.221 -0.441 0 O-C-N 121.214 -0.929 . . . . 10.0 109.325 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -42.29 -40.42 2.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.755 1.622 . . . . 10.0 112.899 177.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.07 -18.39 54.6 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.094 1.33 . . . . 10.0 114.898 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -73.46 113.34 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 169.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.3 t -77.28 -32.96 55.86 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.331 -0.849 . . . . 10.0 110.69 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -171.5 158.97 5.38 Favored 'General case' 0 C--N 1.343 0.321 0 N-CA-C 106.894 -1.521 . . . . 10.0 106.894 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.58 136.88 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 105.995 -1.854 . . . . 10.0 105.995 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -149.89 84.15 1.4 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.575 1.178 . . . . 10.0 110.17 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 17' ' ' VAL . 48.1 t -64.18 118.77 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 125.313 1.445 . . . . 10.0 110.302 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 42.6 m-80 -144.69 50.12 1.28 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.942 0.497 . . . . 10.0 111.43 -177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mp -48.2 -58.03 5.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.37 1.068 . . . . 10.0 112.359 -176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.77 -43.21 94.0 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.94 0.876 . . . . 10.0 110.553 -176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.34 -29.34 68.05 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.733 -1.122 . . . . 10.0 111.019 -176.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.27 -72.6 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 124.462 1.03 . . . . 10.0 111.098 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.37 -178.05 3.87 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 125.324 1.45 . . . . 10.0 110.25 -173.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.0 t -87.6 106.8 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -82.33 140.6 33.46 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.329 -1.359 . . . . 10.0 107.329 171.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 p -160.27 140.78 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-N 118.669 0.668 . . . . 10.0 109.45 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.0 m -116.91 82.91 1.88 Allowed 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 -169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.676 ' CD2' HG12 ' A' ' 53' ' ' VAL . 44.0 m-85 -70.06 172.89 7.21 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.467 -0.788 . . . . 10.0 108.967 173.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -127.95 101.51 6.35 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.31 -0.859 . . . . 10.0 108.942 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.08 -18.45 24.88 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.174 0.59 . . . . 10.0 111.881 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.03 -11.89 59.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.697 0.68 . . . . 10.0 109.577 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.6 tmtt? -121.29 -56.25 1.91 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.487 1.115 . . . . 10.0 109.246 -175.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.1 159.49 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.454 1.102 . . . . 10.0 111.237 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 p -107.49 148.48 29.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.287 0.565 . . . . 10.0 109.991 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.676 HG12 ' CD2' ' A' ' 46' ' ' PHE . 21.4 m -37.62 -45.34 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 C-N-CA 129.063 2.945 . . . . 10.0 110.677 172.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -35.67 -49.8 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.773 0.829 . . . . 10.0 112.016 174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -54.25 -63.93 0.99 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.885 0.874 . . . . 10.0 110.429 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.491 HG21 ' HE1' ' A' ' 46' ' ' PHE . 4.5 mp -65.89 -50.73 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 124.184 0.994 . . . . 10.0 112.776 -174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.95 -62.84 0.58 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.924 2.09 . . . . 10.0 109.192 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.07 -45.06 79.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.605 0.717 . . . . 10.0 110.268 177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.92 -48.73 69.9 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.487 0.715 . . . . 10.0 110.872 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.639 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.69 -34.87 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 O-C-N 120.969 -1.082 . . . . 10.0 110.117 178.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -57.62 -33.56 68.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.871 1.214 . . . . 10.0 111.738 172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -56.9 -68.4 0.22 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.19 0.904 . . . . 10.0 111.862 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -135.49 33.6 3.01 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.84 -57.81 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 CA-C-O 119.22 -0.767 . . . . 10.0 112.216 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 64.49 107.17 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.733 2.013 . . . . 10.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t70 171.49 -35.52 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 124.813 1.245 . . . . 10.0 110.171 -168.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.639 HG23 ' CG2' ' A' ' 60' ' ' ILE . 65.1 t -69.9 85.81 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 O-C-N 121.546 -0.721 . . . . 10.0 111.063 -172.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.84 -49.78 55.51 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -167.14 148.51 5.8 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.585 -1.635 . . . . 10.0 106.585 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.8 pp -85.17 136.34 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 169.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.92 140.37 32.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 173.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.48 -91.8 0.1 OUTLIER Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.583 0.611 . . . . 10.0 111.885 167.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 116.427 -1.749 . . . . 10.0 107.621 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 118.9 -0.572 . . . . 10.0 110.146 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.98 -176.25 2.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.597 1.559 . . . . 10.0 108.399 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -144.71 108.73 4.75 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 168.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -115.22 164.49 14.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.752 1.263 . . . . 10.0 108.809 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 90.0 m -122.23 114.59 21.04 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 127.004 2.122 . . . . 10.0 106.709 -167.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' CD2' HG22 ' A' ' 70' ' ' ILE . 88.5 mt -89.79 85.79 6.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 174.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.7 tp60 -59.96 149.75 30.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.04 0.936 . . . . 10.0 109.836 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.84 129.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.636 1.574 . . . . 10.0 111.86 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -69.59 -64.33 0.9 Allowed 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 130.024 3.33 . . . . 10.0 108.799 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.08 -31.39 0.19 Allowed Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.291 -0.727 . . . . 10.0 112.248 -169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 169.03 5.65 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.621 1.211 . . . . 10.0 110.048 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.7 t -158.86 39.32 0.22 Allowed 'General case' 0 C--N 1.334 -0.074 0 O-C-N 121.568 -0.708 . . . . 10.0 109.228 -169.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.09 97.55 6.14 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -55.87 -14.37 2.38 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.526 0.936 . . . . 10.0 113.526 174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -86.54 -47.97 8.77 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 119.509 1.05 . . . . 10.0 109.38 -174.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.4 m -45.96 -65.45 0.55 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.676 1.19 . . . . 10.0 110.198 172.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.7 m -48.71 -48.18 15.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.23 0.468 . . . . 10.0 110.894 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 3.3 tttm -54.71 -34.62 62.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.85 -41.23 57.62 Favored 'General case' 0 C--O 1.226 -0.155 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.78 -33.51 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 C-N-CA 124.509 1.124 . . . . 10.0 111.085 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.1 tt0 -41.15 -55.9 2.5 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 10.0 109.727 176.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -44.93 96.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.991 -1.004 . . . . 10.0 110.627 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m -56.88 -58.54 7.7 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 123.202 0.601 . . . . 10.0 109.989 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.6 t -49.99 -32.92 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.107 1.363 . . . . 10.0 112.446 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -22.8 4.05 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 114.637 0.615 . . . . 10.0 114.637 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.66 -32.28 73.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.422 1.489 . . . . 10.0 111.429 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.7 104.04 0.62 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 172.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.06 -37.07 14.24 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.965 1.306 . . . . 10.0 111.832 176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.09 -27.42 70.46 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.443 1.02 . . . . 10.0 113.977 177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.75 106.75 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 120.192 -1.769 . . . . 10.0 107.501 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 m -73.37 -40.12 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.8 -1.091 . . . . 10.0 110.196 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.79 156.79 23.24 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.376 -1.342 . . . . 10.0 107.376 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.89 127.7 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.36 98.98 5.04 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 107.216 -1.402 . . . . 10.0 107.216 170.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.73 112.59 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.96 1.304 . . . . 10.0 108.441 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.99 48.3 1.8 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.632 0.604 . . . . 10.0 112.632 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.4 -46.54 62.91 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.618 -0.676 . . . . 10.0 112.304 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -68.1 -31.71 71.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.137 0.975 . . . . 10.0 111.017 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.74 -34.01 18.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.861 0.362 . . . . 10.0 111.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.3 -78.49 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 109.652 -1.379 . . . . 10.0 109.652 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.45 178.56 5.4 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 126.365 1.866 . . . . 10.0 109.256 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.19 105.44 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -102.0 125.88 48.79 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.119 -1.067 . . . . 10.0 108.119 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 74.4 t -136.54 142.35 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.979 0.895 . . . . 10.0 108.746 -168.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -101.69 77.5 1.74 Allowed 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 105.849 -1.908 . . . . 10.0 105.849 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG12 ' A' ' 53' ' ' VAL . 28.1 m-85 -72.44 138.04 46.84 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 113.048 -1.887 . . . . 10.0 107.509 173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -90.49 95.78 10.33 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.035 -0.357 . . . . 10.0 110.035 169.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -19.94 14.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.881 0.872 . . . . 10.0 112.818 175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.75 -15.86 59.64 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 119.23 0.923 . . . . 10.0 109.878 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.1 ttpt -119.99 -54.39 2.13 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.752 0.821 . . . . 10.0 110.346 -171.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.0 161.72 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 C-N-CA 123.417 0.687 . . . . 10.0 110.782 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.9 t -110.3 156.38 20.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.485 1.136 . . . . 10.0 110.444 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 70' ' ' ILE . 36.0 m -45.14 -39.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.098 2.559 . . . . 10.0 109.304 166.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -43.39 -39.27 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.445 1.02 . . . . 10.0 111.844 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.4 -58.9 3.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.425 0.557 . . . . 10.0 111.034 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mp -66.18 -50.09 71.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 120.84 -1.163 . . . . 10.0 112.163 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.97 -54.85 4.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.161 1.785 . . . . 10.0 109.352 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.37 -49.15 77.1 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.815 0.817 . . . . 10.0 109.879 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.69 67.67 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.63 0.772 . . . . 10.0 111.356 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.536 HG21 HG23 ' A' ' 67' ' ' VAL . 1.1 mp -72.11 -42.94 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 O-C-N 120.962 -1.087 . . . . 10.0 110.878 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.287 0.1 OUTLIER -66.5 -26.7 67.29 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 120.723 1.601 . . . . 10.0 112.13 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -45.63 -66.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.059 0.944 . . . . 10.0 112.859 171.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.76 15.09 2.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.099 0.777 . . . . 10.0 113.099 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.2 -56.16 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 C-N-CA 124.528 1.061 . . . . 10.0 111.461 -173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 66.31 113.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.773 2.029 . . . . 10.0 112.292 174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 163.13 -39.25 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 126.647 1.979 . . . . 10.0 108.487 -169.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.536 HG23 HG21 ' A' ' 60' ' ' ILE . 40.3 t -65.22 93.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 O-C-N 121.649 -0.657 . . . . 10.0 111.312 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.25 -56.97 5.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.182 -1.414 . . . . 10.0 107.182 167.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -170.61 162.86 8.11 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.728 -1.582 . . . . 10.0 106.728 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -83.25 144.42 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.628 1.571 . . . . 10.0 110.474 170.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -138.73 149.71 45.35 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 106.43 -1.693 . . . . 10.0 106.43 165.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.74 -129.99 3.49 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 107.191 -2.364 . . . . 10.0 107.191 -174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? . . . . . 0 C--O 1.251 1.142 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 167.283 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 ttp . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -158.47 142.14 15.29 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.949 0.881 . . . . 10.0 112.453 -167.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -86.76 82.27 7.9 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.038 0.935 . . . . 10.0 110.473 -178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -75.96 150.31 37.49 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.4 132.11 56.35 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 103.809 -2.663 . . . . 10.0 103.809 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -108.4 92.89 4.25 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 105.007 -2.22 . . . . 10.0 105.007 178.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -61.71 146.65 48.58 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.708 -1.587 . . . . 10.0 108.534 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.2 p -68.72 134.4 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.961 1.304 . . . . 10.0 113.42 -168.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -78.09 -68.99 0.58 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.686 1.995 . . . . 10.0 109.063 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.0 -38.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.018 -0.61 . . . . 10.0 113.252 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.04 160.43 6.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 117.961 0.88 . . . . 10.0 111.858 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.6 m -149.22 48.65 0.97 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 46.1 t -126.4 91.43 3.36 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.332 1.053 . . . . 10.0 108.402 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -58.5 -5.33 0.52 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.444 0.905 . . . . 10.0 113.444 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.03 -37.69 14.96 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 120.87 -1.144 . . . . 10.0 110.291 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 m -58.72 -71.94 0.11 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 171.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -43.6 -52.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -56.84 -31.18 64.5 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.967 0.728 . . . . 10.0 112.967 -176.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.07 -34.36 68.19 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 110.041 -0.355 . . . . 10.0 110.041 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 HG11 ' C ' ' A' ' 59' ' ' ALA . 59.1 t -88.05 -40.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 C-N-CA 123.939 0.895 . . . . 10.0 109.749 176.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -41.62 -48.5 4.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.889 0.876 . . . . 10.0 110.533 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.42 -53.16 61.24 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.959 0.409 . . . . 10.0 111.123 177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -62.52 -16.86 58.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.106 1.762 . . . . 10.0 113.043 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -89.22 -42.69 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.477 1.111 . . . . 10.0 109.91 174.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.96 -26.18 47.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.748 1.166 . . . . 10.0 112.878 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -69.31 -28.26 66.11 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.948 0.874 . . . . 10.0 111.719 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.9 110.46 2.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.948 -0.701 . . . . 10.0 110.036 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -35.64 -44.16 0.31 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.404 2.282 . . . . 10.0 111.403 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.87 8.64 5.89 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 116.185 1.234 . . . . 10.0 116.185 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.21 111.49 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 169.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -74.45 -31.18 62.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.504 -0.771 . . . . 10.0 110.09 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.59 161.31 9.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -135.24 145.51 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.298 1.039 . . . . 10.0 109.757 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.35 82.89 0.84 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.988 0.899 . . . . 10.0 109.304 175.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -67.31 140.17 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 123.784 0.834 . . . . 10.0 109.597 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -161.17 44.44 0.17 Allowed 'General case' 0 C--O 1.226 -0.179 0 CA-C-O 121.172 0.51 . . . . 10.0 111.787 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -51.83 -46.64 64.41 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.507 0.723 . . . . 10.0 112.819 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -70.39 -24.78 63.0 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.965 1.306 . . . . 10.0 110.783 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.37 -27.27 19.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.136 0.574 . . . . 10.0 111.182 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.64 -69.7 0.09 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.524 1.059 . . . . 10.0 111.036 -176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.76 173.9 8.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.292 1.837 . . . . 10.0 108.701 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.598 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -83.9 138.6 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 169.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -122.52 110.46 15.61 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.103 1.761 . . . . 10.0 107.435 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.598 HG23 ' CG2' ' A' ' 42' ' ' VAL . 34.7 t -124.09 146.55 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.004 1.322 . . . . 10.0 107.576 -175.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 t -103.28 78.59 1.63 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 106.308 -1.738 . . . . 10.0 106.308 -170.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 6' ' ' LEU . 69.1 m-85 -83.78 138.1 33.41 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.936 -1.029 . . . . 10.0 109.905 -172.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -88.08 84.36 6.94 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.167 -0.924 . . . . 10.0 108.707 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.44 -21.19 0.85 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.138 1.375 . . . . 10.0 113.056 168.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -25.8 59.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.914 2.086 . . . . 10.0 109.976 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -117.7 -49.64 2.54 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.253 1.021 . . . . 10.0 109.261 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.3 m -131.98 -175.39 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 124.303 1.041 . . . . 10.0 109.612 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.9 p -133.81 158.82 42.41 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.72 -0.844 . . . . 10.0 108.72 170.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -44.02 -34.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 C-N-CA 126.35 1.86 . . . . 10.0 111.133 170.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -47.39 -30.34 3.21 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.592 0.633 . . . . 10.0 112.129 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -68.4 -65.5 0.69 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 118.574 0.625 . . . . 10.0 109.623 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.479 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.2 mp -65.58 -53.93 33.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 C-N-CA 124.909 1.283 . . . . 10.0 112.909 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -44.0 -56.3 4.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.187 1.395 . . . . 10.0 109.764 174.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -57.6 -45.2 85.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 122.815 0.446 . . . . 10.0 110.271 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' C ' HG11 ' A' ' 20' ' ' VAL . . . -51.37 -48.6 62.48 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.882 0.473 . . . . 10.0 110.601 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.544 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.56 -38.7 68.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.086 -1.009 . . . . 10.0 110.49 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -59.26 -34.84 72.73 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.32 -1.488 . . . . 10.0 111.564 175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.02 -66.86 0.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.448 0.567 . . . . 10.0 112.262 176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -134.69 40.86 2.93 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.212 0.605 . . . . 10.0 112.593 -176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.67 -59.04 0.08 OUTLIER Glycine 0 CA--C 1.526 0.752 0 CA-C-O 118.825 -0.986 . . . . 10.0 111.305 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 64.92 108.08 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.215 2.206 . . . . 10.0 110.887 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.0 -37.6 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 123.888 0.875 . . . . 10.0 109.869 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.544 HG23 HG21 ' A' ' 60' ' ' ILE . 54.4 t -74.19 89.25 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 O-C-N 121.248 -0.908 . . . . 10.0 110.914 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.82 -52.3 31.46 Favored 'General case' 0 C--O 1.227 -0.103 0 O-C-N 121.508 -0.745 . . . . 10.0 109.016 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -170.13 153.12 4.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.87 159.14 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 124.175 0.99 . . . . 10.0 110.686 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -75.62 -69.34 0.49 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.679 -0.692 . . . . 10.0 109.234 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.95 -80.29 0.48 Allowed Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.363 0.505 . . . . 10.0 114.363 -168.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.245 0.826 0 CA-C-O 118.229 -0.891 . . . . 10.0 110.842 -169.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 40.4 ttm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 117.679 -1.153 . . . . 10.0 107.921 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -144.08 -173.11 3.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.522 1.129 . . . . 10.0 108.053 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -137.03 126.09 24.45 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.229 1.411 . . . . 10.0 107.319 168.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.72 159.84 19.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.142 0.977 . . . . 10.0 109.879 169.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.16 122.25 46.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.588 HD23 HG22 ' A' ' 70' ' ' ILE . 45.2 mt -91.89 80.7 5.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.682 -1.97 . . . . 10.0 105.682 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -57.15 149.04 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 110.212 -0.292 . . . . 10.0 110.212 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.68 131.1 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.389 1.075 . . . . 10.0 113.212 -169.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -77.0 -58.65 3.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.245 2.618 . . . . 10.0 109.404 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.43 -34.33 0.15 Allowed Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.134 -0.485 . . . . 10.0 112.551 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.93 165.79 10.26 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.781 0.791 . . . . 10.0 111.27 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 p -135.54 -34.81 0.83 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.368 1.067 . . . . 10.0 112.405 -168.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 t -48.37 88.49 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.14 1.776 . . . . 10.0 112.813 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.85 -7.89 1.9 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.498 -0.751 . . . . 10.0 112.904 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -86.61 -36.02 19.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.077 0.951 . . . . 10.0 110.031 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.7 m -59.6 -66.67 0.48 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -47.24 -50.88 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 O-C-N 121.77 -0.581 . . . . 10.0 112.213 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.261 0.7 OUTLIER -58.8 -32.25 69.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.403 -0.519 . . . . 10.0 112.297 -178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.37 -49.01 68.08 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.421 -0.799 . . . . 10.0 109.464 176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.6 t -71.43 -44.25 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.814 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -39.8 -48.48 2.25 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.202 1.401 . . . . 10.0 110.844 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.3 p -50.51 -50.03 54.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.17 0.441 . . . . 10.0 111.574 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 m -71.26 -51.34 25.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.964 0.906 . . . . 10.0 110.552 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -53.78 -41.8 49.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.946 0.403 . . . . 10.0 110.44 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.96 -5.35 5.42 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 118.017 -1.435 . . . . 10.0 114.812 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -98.9 -18.58 17.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.672 1.736 . . . . 10.0 112.909 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.12 123.41 18.08 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 120.717 1.599 . . . . 10.0 109.941 177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -41.26 -43.34 2.38 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.325 1.85 . . . . 10.0 112.58 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.85 -8.97 86.73 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 123.896 0.76 . . . . 10.0 114.897 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -85.61 102.56 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.728 -2.323 . . . . 10.0 104.728 169.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.4 t -70.54 -33.47 71.18 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.961 -1.018 . . . . 10.0 109.273 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.92 157.85 14.29 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.574 -1.269 . . . . 10.0 107.574 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 m -133.91 135.98 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.793 1.237 . . . . 10.0 108.794 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 91.75 2.5 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.276 1.03 . . . . 10.0 108.379 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 t -82.86 115.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.345 1.058 . . . . 10.0 109.48 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.516 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -143.96 49.55 1.37 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -51.35 -45.27 62.28 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.039 0.755 . . . . 10.0 113.039 -175.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -70.11 -30.01 67.11 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.221 1.008 . . . . 10.0 111.646 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -87.77 -34.89 18.16 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.759 0.314 . . . . 10.0 110.782 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.97 -69.89 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.825 -1.31 . . . . 10.0 109.825 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.34 -177.41 3.63 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.818 1.247 . . . . 10.0 110.975 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.3 t -92.46 110.46 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 106.523 -1.658 . . . . 10.0 106.523 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -104.57 126.3 51.53 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.053 -1.092 . . . . 10.0 108.053 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 76.8 t -138.54 143.43 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -168.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 24.3 t -100.12 78.01 2.04 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.419 -1.326 . . . . 10.0 107.419 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 53.5 m-85 -82.94 137.27 34.26 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.498 -1.228 . . . . 10.0 110.79 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.61 89.2 7.89 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.137 1.375 . . . . 10.0 109.728 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.93 -15.92 1.6 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.77 167.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -66.67 -30.76 71.1 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.219 2.207 . . . . 10.0 108.96 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -120.7 -54.07 2.06 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 124.138 0.975 . . . . 10.0 109.615 -169.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.77 160.52 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 123.75 0.82 . . . . 10.0 110.356 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.2 m -110.38 152.92 25.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.137 -1.06 . . . . 10.0 108.137 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 70' ' ' ILE . 21.9 m -37.76 -39.32 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 127.902 2.481 . . . . 10.0 110.796 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -43.07 -31.32 0.53 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.599 0.962 . . . . 10.0 113.599 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -68.01 -64.18 0.91 Allowed 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.694 0.759 . . . . 10.0 110.605 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.8 mp -62.75 -54.66 30.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 C-N-CA 125.792 1.637 . . . . 10.0 112.628 -174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.46 -65.1 0.33 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.798 2.039 . . . . 10.0 109.026 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -51.65 -47.64 63.68 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.983 0.913 . . . . 10.0 110.868 176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.58 -46.57 70.37 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.203 0.601 . . . . 10.0 111.813 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.13 -39.53 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 120.792 -1.192 . . . . 10.0 110.015 177.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.55 -30.88 65.57 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.868 -1.145 . . . . 10.0 111.154 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -59.45 -69.66 0.19 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.674 0.67 . . . . 10.0 112.17 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -133.03 33.11 3.69 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.845 0.858 . . . . 10.0 112.362 -171.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.12 -61.07 0.12 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 123.798 0.713 . . . . 10.0 111.884 -175.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 67.63 113.06 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.065 2.146 . . . . 10.0 112.297 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 166.64 -39.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 126.053 1.741 . . . . 10.0 109.267 -169.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 HG21 ' A' ' 60' ' ' ILE . 88.0 t -72.2 91.4 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 121.577 -0.702 . . . . 10.0 110.844 -171.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.28 -53.78 18.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 O-C-N 121.692 -0.63 . . . . 10.0 109.586 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 147.96 5.81 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.641 -1.615 . . . . 10.0 106.641 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.588 HG22 HD23 ' A' ' 6' ' ' LEU . 1.3 pp -84.87 132.42 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.903 -1.147 . . . . 10.0 107.903 176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.19 124.54 51.76 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.86 -1.533 . . . . 10.0 106.86 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 145.08 -131.81 4.41 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 116.801 -1.571 . . . . 10.0 110.158 -177.806 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttp . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 118.187 -0.911 . . . . 10.0 108.907 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.97 -173.09 4.42 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -146.83 69.7 1.18 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.769 2.028 . . . . 10.0 109.02 -176.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.3 mttt -77.64 158.05 29.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.681 0.753 . . . . 10.0 109.66 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.44 125.61 51.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 -175.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' CD2' HG22 ' A' ' 70' ' ' ILE . 74.3 mt -95.13 88.41 5.19 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 169.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -61.41 148.33 42.02 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.41 0.684 . . . . 10.0 109.48 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.0 m -67.23 132.38 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 113.765 1.024 . . . . 10.0 113.765 -173.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -71.73 -54.73 9.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.679 2.792 . . . . 10.0 108.596 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.36 -23.68 0.13 Allowed Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.308 -0.86 . . . . 10.0 113.738 -173.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 169.74 4.23 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.589 1.195 . . . . 10.0 111.987 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.27 28.83 0.73 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.602 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.37 93.39 4.45 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.087 -1.079 . . . . 10.0 108.087 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -58.75 -13.06 5.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -80.02 -45.59 18.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.6 m -52.07 -63.4 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.814 0.846 . . . . 10.0 109.609 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -51.69 -50.25 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 118.903 -0.57 . . . . 10.0 111.109 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -61.86 -32.97 73.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.44 1.018 . . . . 10.0 112.936 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.56 -40.83 69.13 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.585 -0.697 . . . . 10.0 109.484 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.9 t -78.13 -42.51 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-O 118.166 -0.921 . . . . 10.0 111.385 175.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -35.92 -57.9 0.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.145 1.778 . . . . 10.0 110.964 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.0 -42.78 76.92 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 10.0 111.281 -177.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.4 t -64.93 -50.64 65.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.234 1.014 . . . . 10.0 109.676 178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 56' ' ' ILE . 12.9 t -54.18 -39.6 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.461 0.704 . . . . 10.0 110.41 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.5 -27.87 9.13 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.755 1.169 . . . . 10.0 113.766 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -71.54 -25.96 62.44 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.984 1.392 . . . . 10.0 111.533 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.58 104.48 1.28 Allowed 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.356 -0.84 . . . . 10.0 109.315 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -46.08 -37.24 6.56 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.271 1.828 . . . . 10.0 112.729 175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -8.99 55.54 Favored Glycine 0 CA--C 1.536 1.38 0 O-C-N 121.844 -0.535 . . . . 10.0 114.166 177.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.84 109.85 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 119.97 1.885 . . . . 10.0 106.303 168.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 t -73.71 -30.07 62.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.731 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -172.25 168.35 5.66 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 106.805 -1.554 . . . . 10.0 106.805 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.7 m -140.89 135.26 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.863 1.265 . . . . 10.0 108.756 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -139.28 90.02 2.39 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.198 0.999 . . . . 10.0 109.602 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.56 106.77 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.527 1.131 . . . . 10.0 109.455 -176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 9.2 m120 -134.76 49.55 2.22 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.202 0.601 . . . . 10.0 112.241 -177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.6 -47.18 70.42 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.383 0.512 . . . . 10.0 112.383 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -63.91 -36.41 83.85 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.845 0.858 . . . . 10.0 111.074 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -84.74 -34.22 22.91 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.859 -172.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.62 -69.41 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.572 -1.011 . . . . 10.0 110.572 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.29 178.67 3.7 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 127.167 2.187 . . . . 10.0 110.822 -172.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.6 t -95.55 103.47 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -97.45 121.19 39.07 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 53.7 t -132.27 144.4 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 -169.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.5 t -101.73 69.49 1.21 Allowed 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.047 -1.464 . . . . 10.0 107.047 -169.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 33.3 m-85 -69.01 137.87 54.04 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.973 -1.467 . . . . 10.0 108.733 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -94.24 87.12 5.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.047 168.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.37 -16.58 0.58 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.349 1.06 . . . . 10.0 113.376 171.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -80.82 -12.72 59.39 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.293 0.951 . . . . 10.0 110.033 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -131.12 -54.42 1.04 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.473 1.109 . . . . 10.0 110.391 -173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.8 t -128.62 135.74 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 C-N-CA 124.817 1.247 . . . . 10.0 109.435 177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -97.64 150.72 20.85 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.5 m -36.38 -41.34 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 C-N-CA 128.72 2.808 . . . . 10.0 111.242 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -34.39 -49.44 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.302 0.955 . . . . 10.0 111.768 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -55.63 -67.22 0.3 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 122.42 1.105 . . . . 10.0 110.716 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.7 HD12 HG13 ' A' ' 24' ' ' VAL . 4.0 mm -60.68 -57.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 125.136 1.374 . . . . 10.0 112.496 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.15 -59.34 0.87 Allowed 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.656 2.382 . . . . 10.0 109.971 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.48 -51.11 68.07 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.87 0.468 . . . . 10.0 110.56 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.53 -45.08 73.31 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.653 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.561 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.76 -41.09 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 121.182 -0.949 . . . . 10.0 110.094 175.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -56.51 -36.75 69.55 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 119.974 1.261 . . . . 10.0 111.078 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.37 -59.57 4.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.085 0.554 . . . . 10.0 112.457 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -139.08 -18.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.382 1.252 . . . . 10.0 114.382 -171.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.97 -47.13 40.19 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 118.847 0.749 . . . . 10.0 111.29 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 56.61 110.23 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.109 2.164 . . . . 10.0 112.525 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 t70 167.24 -39.84 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.239 1.415 . . . . 10.0 109.285 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.561 HG23 HG21 ' A' ' 60' ' ' ILE . 62.9 t -69.84 92.43 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 O-C-N 121.496 -0.753 . . . . 10.0 111.209 -173.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.86 4.32 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.711 0.767 . . . . 10.0 109.084 169.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.88 146.54 7.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.18 -1.415 . . . . 10.0 107.18 -171.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 6' ' ' LEU . 1.3 pp -84.21 131.73 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.782 1.233 . . . . 10.0 107.778 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.14 121.21 36.37 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 156.48 -154.98 25.97 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 107.228 -2.349 . . . . 10.0 107.228 -171.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 124.754 1.222 . . . . 10.0 109.03 169.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 CA--C 1.514 -0.43 0 N-CA-C 106.912 -1.514 . . . . 10.0 106.912 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -175.95 2.88 Favored 'General case' 0 N--CA 1.443 -0.807 0 O-C-N 124.998 1.436 . . . . 10.0 108.826 -169.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -140.98 112.91 7.74 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 127.788 2.435 . . . . 10.0 105.389 178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.97 172.92 7.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 105.951 -1.87 . . . . 10.0 105.951 169.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -129.49 126.35 38.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 104.313 -2.476 . . . . 10.0 104.313 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mp -95.95 95.62 8.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -68.91 148.1 50.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.832 -0.803 . . . . 10.0 108.832 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.04 130.45 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 125.268 1.427 . . . . 10.0 112.958 -171.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -71.64 -61.23 1.85 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.033 2.933 . . . . 10.0 108.196 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.0 -39.21 0.13 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 111.172 -0.771 . . . . 10.0 111.172 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.64 157.98 13.46 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.588 0.694 . . . . 10.0 110.518 174.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.9 51.84 0.39 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 -172.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 t -123.97 94.01 4.1 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.824 1.25 . . . . 10.0 107.785 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -59.99 0.57 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.19 1.182 . . . . 10.0 114.19 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.18 -43.15 10.03 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.504 1.047 . . . . 10.0 109.464 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.3 m -57.96 -67.69 0.32 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.609 0.764 . . . . 10.0 109.13 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -43.11 -46.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.041 0 C-N-CA 123.331 0.652 . . . . 10.0 112.086 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 14.5 tttt -54.87 -33.07 61.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.776 1.028 . . . . 10.0 113.776 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.31 -29.15 57.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.473 0.309 . . . . 10.0 110.737 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.7 t -97.66 -33.57 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.564 1.546 . . . . 10.0 110.989 176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 12.6 tt0 -41.19 -49.47 3.56 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.706 1.203 . . . . 10.0 110.289 177.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.5 p -46.15 -68.65 0.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.517 1.527 . . . . 10.0 111.231 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -57.19 -39.37 75.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.873 1.269 . . . . 10.0 111.85 -176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.0 t -70.02 -42.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.875 -0.417 . . . . 10.0 109.875 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.83 48.38 1.97 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.274 1.416 . . . . 10.0 112.136 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -149.27 -42.86 0.14 Allowed 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 127.86 2.464 . . . . 10.0 109.1 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -50.64 127.28 17.65 Favored 'General case' 0 C--N 1.348 0.5 0 CA-C-N 120.411 1.459 . . . . 10.0 110.794 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -46.46 -42.86 16.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.357 1.463 . . . . 10.0 111.966 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.59 -13.27 83.11 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 114.404 0.522 . . . . 10.0 114.404 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -75.55 109.64 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 O-C-N 119.708 -2.054 . . . . 10.0 106.094 169.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.04 -32.54 50.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.448 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.58 151.05 9.11 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.551 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.5 m -123.1 146.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.5 100.92 1.05 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.429 -2.063 . . . . 10.0 105.429 -173.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 2.9 t -107.88 109.92 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 -171.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -135.33 46.61 2.38 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 111.762 0.282 . . . . 10.0 111.762 -174.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -52.5 -48.68 65.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.835 0.854 . . . . 10.0 111.746 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -67.47 -26.83 66.57 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.991 0.916 . . . . 10.0 110.488 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.22 -30.89 16.39 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.572 0.349 . . . . 10.0 111.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -67.38 0.06 OUTLIER Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.06 0.838 . . . . 10.0 112.074 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -171.11 176.11 4.09 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.862 1.665 . . . . 10.0 111.674 -169.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -93.52 129.51 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 123.296 0.638 . . . . 10.0 109.732 171.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -120.27 74.12 1.03 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.31 2.244 . . . . 10.0 108.852 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG23 HG23 ' A' ' 42' ' ' VAL . 24.1 t -94.05 149.97 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 125.205 1.402 . . . . 10.0 109.195 -176.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -107.04 76.23 1.08 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.708 -1.59 . . . . 10.0 106.708 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -73.26 139.26 46.04 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.283 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -89.49 95.7 10.39 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 123.597 0.759 . . . . 10.0 109.78 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.87 -21.9 12.95 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.499 0.719 . . . . 10.0 112.784 174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -87.62 -8.24 56.46 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 118.907 0.776 . . . . 10.0 110.68 -176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -119.72 -54.82 2.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.14 -170.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 125.433 1.493 . . . . 10.0 108.878 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 28.2 t -147.35 158.19 43.87 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.765 -0.828 . . . . 10.0 108.765 168.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 m -38.71 -46.43 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 C-N-CA 128.37 2.668 . . . . 10.0 109.598 171.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -41.28 -44.15 2.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.54 1.064 . . . . 10.0 112.284 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.32 -61.54 2.48 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.566 0.698 . . . . 10.0 110.844 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.486 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.0 mp -61.43 -53.6 46.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 124.542 1.137 . . . . 10.0 111.514 -176.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -37.69 -62.52 0.53 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.923 2.089 . . . . 10.0 109.41 169.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -55.47 -43.87 75.91 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.366 0.603 . . . . 10.0 110.741 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.78 -48.43 75.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.694 0.798 . . . . 10.0 111.156 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.431 HG22 HG23 ' A' ' 67' ' ' VAL . 1.6 mp -70.51 -36.21 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 120.76 -1.212 . . . . 10.0 109.23 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -55.82 -42.19 75.32 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.609 -1.307 . . . . 10.0 111.273 172.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -52.25 -62.92 1.33 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.885 0.874 . . . . 10.0 112.546 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -144.22 66.89 1.27 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.088 0.555 . . . . 10.0 110.666 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.97 -59.09 0.01 OUTLIER Glycine 0 CA--C 1.525 0.664 0 CA-C-O 119.012 -0.882 . . . . 10.0 111.467 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 68.84 113.54 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.253 2.221 . . . . 10.0 111.35 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 166.43 -32.45 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.284 1.434 . . . . 10.0 109.737 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 HG22 ' A' ' 60' ' ' ILE . 6.7 t -71.94 85.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 121.0 -1.063 . . . . 10.0 112.257 -168.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.1 -52.68 25.83 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 121.315 -0.866 . . . . 10.0 109.596 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -166.5 142.39 4.64 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 106.905 -1.517 . . . . 10.0 106.905 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.433 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -86.98 138.45 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 125.483 1.513 . . . . 10.0 107.671 174.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -50.7 -44.21 57.94 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.67 0.788 . . . . 10.0 109.645 171.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 57.26 43.28 93.68 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.687 -0.965 . . . . 10.0 110.687 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.203 0 N-CA-C 107.852 -1.166 . . . . 10.0 107.852 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 118.705 -0.664 . . . . 10.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -102.67 -174.19 2.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.451 1.9 . . . . 10.0 108.766 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.68 86.14 1.38 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.304 -0.999 . . . . 10.0 108.304 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.8 mttt -103.32 163.8 12.03 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.956 0.884 . . . . 10.0 110.608 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.562 HG22 ' HB3' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -117.68 109.62 16.86 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.613 -2.366 . . . . 10.0 104.613 -170.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' CD1' HG22 ' A' ' 70' ' ' ILE . 3.6 mp -83.07 87.72 6.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 171.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -54.73 152.17 7.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.115 0.966 . . . . 10.0 110.01 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -62.56 131.78 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 C-N-CA 124.265 1.026 . . . . 10.0 110.65 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -69.61 -54.23 15.0 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 124.015 0.822 . . . . 10.0 109.312 171.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.37 -9.34 2.67 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.749 -0.473 . . . . 10.0 113.357 -170.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.562 ' SD ' HD13 ' A' ' 37' ' ' LEU . 3.5 ppp? -58.29 176.31 0.18 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 117.969 0.884 . . . . 10.0 111.478 170.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 t -152.44 31.76 0.52 Allowed 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.601 -0.687 . . . . 10.0 110.36 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.5 t -118.86 89.56 3.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.14 0.495 . . . . 10.0 110.8 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.71 -11.98 0.45 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.353 1.242 . . . . 10.0 114.353 170.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -91.69 -25.86 18.91 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.07 0.85 . . . . 10.0 111.395 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -62.28 -67.16 0.44 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -42.56 -55.85 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.519 0.728 . . . . 10.0 111.906 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.14 -21.44 65.04 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.948 0.722 . . . . 10.0 112.948 -175.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.91 99.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.404 1.002 . . . . 10.0 109.232 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -82.51 -37.55 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 123.02 0.528 . . . . 10.0 111.17 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -41.34 -47.04 3.44 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.545 1.138 . . . . 10.0 111.318 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.21 -51.3 64.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.078 0.466 . . . . 10.0 110.871 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -63.16 -47.63 81.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.447 1.099 . . . . 10.0 110.72 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.4 t -56.0 -40.93 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 O-C-N 121.686 -0.634 . . . . 10.0 110.013 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.11 -27.95 16.5 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.776 1.179 . . . . 10.0 113.767 172.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.15 -29.8 69.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.134 1.467 . . . . 10.0 110.744 178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.61 80.67 1.09 Allowed 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.616 -0.678 . . . . 10.0 110.927 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -5.74 -57.52 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 129.948 3.299 . . . . 10.0 115.651 168.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -37.32 -56.65 1.48 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.868 1.223 . . . . 10.0 113.913 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -46.54 111.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 125.48 1.512 . . . . 10.0 109.853 -175.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.31 25.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.88 -1.055 . . . . 10.0 109.982 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -163.27 149.95 12.37 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 33' ' ' VAL . 10.6 m -136.27 94.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.912 1.285 . . . . 10.0 109.463 -177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -107.54 91.07 3.5 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.6 t -73.31 109.02 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 107.738 -1.208 . . . . 10.0 107.738 172.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 2.8 m-80 -128.32 47.86 2.37 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.457 0.539 . . . . 10.0 112.457 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD13 ' SD ' ' A' ' 11' ' ' MET . 1.6 pt? -51.33 -46.76 62.72 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.525 0.602 . . . . 10.0 112.113 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -70.12 -34.83 73.57 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.579 0.752 . . . . 10.0 110.955 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.09 -32.53 30.2 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.606 -0.27 . . . . 10.0 110.593 -174.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.35 -73.02 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 109.677 -1.369 . . . . 10.0 109.677 -174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.26 -172.12 1.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.965 1.306 . . . . 10.0 112.598 -175.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.1 t -90.06 100.73 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 108.466 -0.939 . . . . 10.0 108.466 177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -98.0 108.99 21.83 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 42.7 t -128.14 131.5 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 108.402 -0.962 . . . . 10.0 108.402 -169.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.2 m -83.56 69.74 10.15 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.682 -0.859 . . . . 10.0 108.682 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.466 ' CZ ' HD13 ' A' ' 6' ' ' LEU . 57.6 m-85 -64.73 141.41 58.78 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 123.321 0.648 . . . . 10.0 109.771 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -86.68 86.95 7.35 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.08 -18.26 0.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.844 1.054 . . . . 10.0 113.844 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.49 -18.65 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.599 1.091 . . . . 10.0 110.401 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.17 -55.78 2.3 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.284 -1.006 . . . . 10.0 108.284 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 p -135.07 129.88 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 124.402 1.081 . . . . 10.0 110.531 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 52.2 m -88.82 152.7 21.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.629 -0.669 . . . . 10.0 110.198 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.4 m -41.1 -38.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 C-N-CA 128.269 2.628 . . . . 10.0 110.659 167.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -49.84 -37.42 30.56 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 121.429 -0.794 . . . . 10.0 112.342 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.44 -58.36 4.08 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.263 1.03 . . . . 10.0 109.399 171.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -69.3 -56.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -168.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -42.21 -52.32 4.44 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.377 1.471 . . . . 10.0 109.861 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -58.97 -49.09 79.18 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.437 0.695 . . . . 10.0 110.54 177.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.41 -43.7 68.15 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 123.765 0.826 . . . . 10.0 111.172 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.68 -58.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 108.76 -0.83 . . . . 10.0 108.76 172.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -40.01 -40.63 1.07 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.512 1.051 . . . . 10.0 113.79 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -40.83 -50.88 3.19 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.605 0.965 . . . . 10.0 113.605 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -151.32 -41.75 0.12 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 124.533 1.133 . . . . 10.0 111.966 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.58 -40.18 86.89 Favored Glycine 0 N--CA 1.44 -1.04 0 CA-C-O 118.793 -1.004 . . . . 10.0 111.295 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 58.29 175.29 0.06 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.203 1.801 . . . . 10.0 112.545 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.7 t70 93.9 28.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 127.437 2.295 . . . . 10.0 112.771 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.9 t -116.66 91.36 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.866 1.267 . . . . 10.0 109.484 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.61 -55.52 7.6 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.042 -0.725 . . . . 10.0 109.042 168.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -172.34 162.13 5.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.014 1.325 . . . . 10.0 107.429 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.485 HG22 ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -80.69 142.57 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 125.09 1.356 . . . . 10.0 110.241 170.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.562 ' HB3' HG22 ' A' ' 5' ' ' THR . 7.7 tt0 -129.24 147.78 51.11 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 104.637 -2.357 . . . . 10.0 104.637 165.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 139.47 -131.34 5.15 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 107.774 -2.13 . . . . 10.0 107.774 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.224 0 N-CA-C 108.377 -0.972 . . . . 10.0 108.377 168.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.715 -0.476 . . . . 10.0 109.715 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -153.19 175.69 12.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 171.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -141.84 87.63 2.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.037 -1.098 . . . . 10.0 108.037 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -98.03 162.65 13.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.233 -0.894 . . . . 10.0 108.956 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 122.77 46.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 104.65 -2.352 . . . . 10.0 104.65 -177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.702 ' HB2' HG13 ' A' ' 42' ' ' VAL . 6.0 mp -93.53 95.99 9.59 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 103.512 -2.773 . . . . 10.0 103.512 170.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.04 150.65 46.39 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.818 -1.176 . . . . 10.0 108.189 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -64.95 134.54 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 111.952 0.353 . . . . 10.0 111.952 -168.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -69.22 -64.96 0.77 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 171.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.04 -34.37 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.348 -0.93 . . . . 10.0 114.881 -168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.0 172.37 2.37 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.305 1.053 . . . . 10.0 112.022 -178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t -157.41 52.69 0.48 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.6 t -130.98 94.88 3.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.414 1.086 . . . . 10.0 108.143 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.61 -21.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.87 1.668 . . . . 10.0 111.418 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -82.74 -41.7 18.92 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.044 -0.725 . . . . 10.0 109.044 -174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.9 m -52.47 -66.27 0.41 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 171.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.6 m -51.41 -50.93 26.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 O-C-N 122.006 -0.434 . . . . 10.0 111.563 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU 0.26 0.0 OUTLIER -60.35 -26.42 66.59 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.995 0.739 . . . . 10.0 112.995 -178.174 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.52 -46.22 84.08 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.06 -1.025 . . . . 10.0 109.035 173.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.4 t -75.64 -40.92 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 123.343 0.657 . . . . 10.0 111.364 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 3.4 tm-20 -34.78 -49.28 0.42 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.114 1.766 . . . . 10.0 111.019 173.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -54.72 -60.11 3.8 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.631 0.253 . . . . 10.0 111.522 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 m -55.09 -48.54 73.42 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.01 0.924 . . . . 10.0 110.502 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 t -56.85 -44.26 81.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.141 0.576 . . . . 10.0 110.367 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.7 -31.2 57.61 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.185 0.898 . . . . 10.0 113.146 174.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.28 -29.16 66.99 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.167 0.984 . . . . 10.0 110.773 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.41 108.31 4.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.077 -1.015 . . . . 10.0 109.624 176.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -37.35 -37.1 0.17 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 10.0 112.61 169.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.69 -2.07 1.59 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.225 1.393 . . . . 10.0 116.036 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -106.29 120.29 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 126.539 1.936 . . . . 10.0 106.32 169.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -29.2 25.18 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.269 0.628 . . . . 10.0 109.894 176.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.09 160.51 9.9 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 107.217 -1.401 . . . . 10.0 107.217 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.34 133.82 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.351 1.061 . . . . 10.0 110.58 -176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -143.21 81.4 1.71 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.909 1.284 . . . . 10.0 108.855 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.64 135.74 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.319 1.048 . . . . 10.0 108.85 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -163.55 48.07 0.13 Allowed 'General case' 0 C--O 1.225 -0.192 0 CA-C-O 121.517 0.675 . . . . 10.0 110.796 -173.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -61.05 -41.97 97.6 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.86 -0.525 . . . . 10.0 111.373 -177.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -61.98 -39.91 93.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.499 0.72 . . . . 10.0 110.25 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.0 -31.8 27.29 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.507 0.723 . . . . 10.0 110.932 -172.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.61 -59.7 0.09 OUTLIER Glycine 0 CA--C 1.526 0.75 0 CA-C-O 119.397 -0.668 . . . . 10.0 113.154 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.25 173.33 4.96 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 126.859 2.064 . . . . 10.0 109.78 -177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.702 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -91.05 119.88 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 107.824 -1.176 . . . . 10.0 107.824 172.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.26 120.21 40.32 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 46' ' ' PHE . 48.1 t -133.01 143.83 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 106.881 -1.526 . . . . 10.0 106.881 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.0 m -96.59 71.54 2.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.414 -1.698 . . . . 10.0 106.414 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 49.3 m-85 -73.39 134.56 44.08 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.871 0.843 . . . . 10.0 109.108 -172.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.57 77.8 9.78 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 121.699 0.762 . . . . 10.0 109.069 172.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.96 -17.68 0.42 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.886 1.675 . . . . 10.0 113.917 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -84.11 -6.28 59.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.424 1.89 . . . . 10.0 111.072 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.45 -57.52 1.13 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.736 1.614 . . . . 10.0 108.726 -174.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 39.8 t -136.7 143.96 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 126.222 1.809 . . . . 10.0 107.572 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 m -98.22 147.65 24.4 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.02 -1.104 . . . . 10.0 108.02 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.2 m -31.82 -44.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 C-N-CA 128.346 2.658 . . . . 10.0 110.96 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.5 tttp -28.36 -53.23 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.967 1.307 . . . . 10.0 111.892 171.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -52.04 -69.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.358 1.063 . . . . 10.0 111.473 174.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.548 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.5 mp -60.38 -53.53 47.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.392 0 C-N-CA 125.207 1.403 . . . . 10.0 111.683 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.35 -58.61 1.49 Allowed 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 126.924 2.089 . . . . 10.0 110.398 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -59.4 -45.26 91.99 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.891 0.377 . . . . 10.0 110.219 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.77 -45.18 67.0 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.921 0.888 . . . . 10.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.08 -53.02 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 O-C-N 121.272 -0.892 . . . . 10.0 108.713 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -58.23 -21.4 47.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.956 1.707 . . . . 10.0 114.288 -177.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.29 -58.67 5.94 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.897 0.771 . . . . 10.0 111.474 169.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -143.56 -19.69 0.61 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.534 1.679 . . . . 10.0 115.534 -176.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.68 -51.68 24.11 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.686 1.136 . . . . 10.0 112.045 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 66.42 97.61 0.05 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.412 1.885 . . . . 10.0 111.759 174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 43.1 t0 174.28 31.09 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.362 1.865 . . . . 10.0 112.987 -169.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.486 HG13 ' HG ' ' A' ' 6' ' ' LEU . 5.8 t -141.7 80.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 O-C-N 119.617 -1.927 . . . . 10.0 110.331 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.93 -44.7 76.23 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 171.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -167.55 143.8 4.18 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.542 HG22 ' CD1' ' A' ' 6' ' ' LEU . 2.2 pp -83.71 131.33 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 C-N-CA 125.091 1.357 . . . . 10.0 107.415 169.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.75 125.58 46.89 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 105.15 -2.167 . . . . 10.0 105.15 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.31 -153.48 24.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 108.728 -1.749 . . . . 10.0 108.728 -170.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? . . . . . 0 C--O 1.258 1.523 0 CA-C-O 117.503 -1.237 . . . . 10.0 113.469 -170.78 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 4' ' ' LYS . 23.8 mt-10 -111.39 175.24 5.5 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.999 0.92 . . . . 10.0 109.473 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -140.2 78.87 1.68 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.804 1.242 . . . . 10.0 107.695 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' NZ ' ' OE1' ' A' ' 2' ' ' GLU . 1.8 mttt -89.73 165.54 14.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.279 -0.873 . . . . 10.0 108.91 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.83 133.3 44.52 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 102.796 -3.038 . . . . 10.0 102.796 -176.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.751 HD11 ' HZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -104.02 96.6 6.77 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 104.371 -2.455 . . . . 10.0 104.371 176.482 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -62.23 148.74 43.84 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.069 -0.968 . . . . 10.0 108.624 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.61 132.34 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 C-N-CA 125.07 1.348 . . . . 10.0 112.807 -172.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -75.89 -64.22 1.13 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 128.046 2.538 . . . . 10.0 109.453 -178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -174.0 -40.53 0.04 OUTLIER Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.656 -0.578 . . . . 10.0 111.656 -170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.24 170.05 1.42 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 113.437 0.903 . . . . 10.0 113.437 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 p -145.99 12.77 1.27 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.352 -0.84 . . . . 10.0 110.742 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.84 86.47 6.65 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.45 -0.944 . . . . 10.0 108.45 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -55.58 -12.18 1.11 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.366 0.876 . . . . 10.0 113.366 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -83.43 -35.89 24.66 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.408 -0.807 . . . . 10.0 109.375 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.1 m -62.12 -68.21 0.35 Allowed 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 177.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -41.85 -52.5 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.689 0.795 . . . . 10.0 113.117 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -29.79 64.53 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 121.671 -0.643 . . . . 10.0 112.595 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.16 -43.86 64.32 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.2 t -80.61 -41.97 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 118.218 -0.896 . . . . 10.0 110.838 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -47.04 -38.51 11.11 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.311 0.96 . . . . 10.0 110.509 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.4 p -51.1 -65.03 0.63 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.933 0.788 . . . . 10.0 111.533 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -55.8 -51.0 68.97 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.994 1.318 . . . . 10.0 110.079 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.6 t -55.06 -42.76 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.693 0.797 . . . . 10.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.22 -27.71 11.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.561 1.077 . . . . 10.0 113.816 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -83.25 -19.81 35.69 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.768 1.284 . . . . 10.0 112.279 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.73 118.89 7.73 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.851 1.205 . . . . 10.0 109.985 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -39.9 -44.26 1.64 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.156 1.783 . . . . 10.0 112.515 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.49 -16.23 80.1 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 123.113 0.387 . . . . 10.0 113.884 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.84 111.59 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 O-C-N 119.454 -2.204 . . . . 10.0 106.628 170.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -84.56 -30.74 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.43 -0.804 . . . . 10.0 109.618 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.74 157.54 24.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.88 145.01 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 124.976 1.311 . . . . 10.0 108.192 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -161.86 82.86 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 t -64.77 138.72 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.191 0.596 . . . . 10.0 110.543 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.04 46.41 0.24 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-O 121.065 0.46 . . . . 10.0 111.061 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -53.51 -49.65 67.11 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.268 0.47 . . . . 10.0 112.268 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.08 -31.13 70.55 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.036 0.934 . . . . 10.0 110.707 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.76 -29.52 32.77 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.94 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.23 -62.17 0.12 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.169 0.89 . . . . 10.0 112.119 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.24 171.59 7.87 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 126.498 1.919 . . . . 10.0 109.833 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG2' HG23 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -87.53 132.82 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 169.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.18 111.04 16.91 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 176.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG23 ' CG2' ' A' ' 42' ' ' VAL . 47.5 t -130.0 142.25 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 124.384 1.074 . . . . 10.0 108.218 -168.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.7 m -102.07 73.57 1.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.751 ' HZ ' HD11 ' A' ' 6' ' ' LEU . 39.9 m-85 -66.85 131.81 46.69 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.701 -1.591 . . . . 10.0 109.089 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.89 86.1 7.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.526 -0.916 . . . . 10.0 108.526 169.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.01 -10.96 0.38 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.994 1.109 . . . . 10.0 113.994 171.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -85.89 -13.21 48.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.411 1.005 . . . . 10.0 110.141 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -131.31 -54.36 1.03 Allowed 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.122 -0.696 . . . . 10.0 109.122 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.498 HG22 ' H ' ' A' ' 52' ' ' SER . 9.7 p -103.09 -174.86 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 C-N-CA 125.184 1.394 . . . . 10.0 109.239 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.498 ' H ' HG22 ' A' ' 51' ' ' VAL . 63.4 p -148.81 151.91 35.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 121.182 -0.949 . . . . 10.0 108.523 167.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.75 -40.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 126.85 2.06 . . . . 10.0 110.132 169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -54.47 -25.89 27.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.879 0.763 . . . . 10.0 112.813 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -70.67 -64.03 0.98 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.15 0.886 . . . . 10.0 109.637 168.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.471 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.2 mp -63.65 -51.41 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 124.097 0.959 . . . . 10.0 112.563 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -43.24 -56.8 3.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.293 1.837 . . . . 10.0 109.622 174.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -59.01 -44.58 91.72 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.578 0.751 . . . . 10.0 110.329 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.48 70.62 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.212 0.605 . . . . 10.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -70.72 -35.92 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 121.095 -1.003 . . . . 10.0 109.447 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -58.32 -41.84 85.46 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.628 -1.295 . . . . 10.0 110.533 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -54.5 -67.7 0.24 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.016 0.926 . . . . 10.0 112.14 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -133.41 57.25 1.81 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.161 0.584 . . . . 10.0 111.704 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.01 -58.85 0.01 OUTLIER Glycine 0 CA--C 1.525 0.677 0 CA-C-O 119.213 -0.771 . . . . 10.0 111.369 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 67.46 106.9 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.153 2.181 . . . . 10.0 110.623 174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 168.16 -35.17 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.241 1.416 . . . . 10.0 109.595 -168.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.73 93.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.181 -0.949 . . . . 10.0 111.285 -172.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.21 -56.49 4.6 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.456 0.646 . . . . 10.0 109.907 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -164.4 143.13 7.18 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 -173.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.12 147.35 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 124.947 1.299 . . . . 10.0 109.057 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -67.01 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.191 0.52 . . . . 10.0 109.678 176.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 87.15 55.62 2.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.013 -1.235 . . . . 10.0 110.013 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 . . . . . 0 C--O 1.255 1.369 0 CA-C-O 115.777 -2.059 . . . . 10.0 107.422 -169.737 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -138.86 -175.31 4.1 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.965 0.888 . . . . 10.0 110.418 -168.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.14 68.25 1.13 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.613 2.365 . . . . 10.0 106.998 170.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -75.68 160.27 30.24 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -131.15 132.85 45.05 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.978 -1.489 . . . . 10.0 106.978 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD12 HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -88.79 108.32 19.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 173.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -75.96 148.28 38.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.683 -0.636 . . . . 10.0 109.306 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.05 130.33 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 125.584 1.554 . . . . 10.0 113.617 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -74.84 -58.74 3.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.143 2.577 . . . . 10.0 109.475 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.84 -32.24 0.06 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-O 119.185 -0.786 . . . . 10.0 113.464 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.03 169.5 5.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.594 1.197 . . . . 10.0 111.44 -178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 m -160.66 54.38 0.31 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 t -128.75 93.04 3.52 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -51.74 2.52 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.05 1.87 . . . . 10.0 116.05 169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.82 -50.81 4.3 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.841 1.655 . . . . 10.0 109.784 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.17 -62.14 1.8 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.083 0.953 . . . . 10.0 110.176 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -47.01 -47.74 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.764 0.316 . . . . 10.0 110.783 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 15.9 tttt -56.61 -35.54 68.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 114.307 1.225 . . . . 10.0 114.307 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.09 -38.27 56.74 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.5 t -84.49 -37.99 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 C-N-CA 124.142 0.977 . . . . 10.0 110.984 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 21.1 tt0 -38.6 -56.09 1.35 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.697 1.599 . . . . 10.0 110.62 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -58.0 -48.7 79.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.165 -0.47 . . . . 10.0 111.33 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -56.98 -54.5 45.96 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.639 1.175 . . . . 10.0 109.57 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.441 ' CG1' HG21 ' A' ' 30' ' ' VAL . 42.0 t -57.64 -40.85 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 O-C-N 121.926 -0.484 . . . . 10.0 110.288 177.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.1 -31.86 6.17 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.059 0.837 . . . . 10.0 113.494 171.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -74.01 -26.38 60.41 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.865 1.332 . . . . 10.0 111.589 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.71 96.76 1.27 Allowed 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 121.138 -0.976 . . . . 10.0 110.157 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -20.56 -53.55 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.58 2.752 . . . . 10.0 113.286 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.39 1.16 5.53 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.273 1.269 . . . . 10.0 116.273 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.441 HG21 ' CG1' ' A' ' 24' ' ' VAL . 1.3 t -94.87 110.93 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 104.602 -2.369 . . . . 10.0 104.602 168.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -30.05 48.75 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.658 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.96 158.15 10.35 Favored 'General case' 0 C--N 1.346 0.455 0 N-CA-C 108.022 -1.103 . . . . 10.0 108.022 177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -135.95 125.01 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.983 1.313 . . . . 10.0 108.383 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 48.8 m170 -128.4 80.54 1.97 Allowed 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.763 1.225 . . . . 10.0 108.498 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.683 ' HA ' HG12 ' A' ' 42' ' ' VAL . 7.2 t -74.42 108.5 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 126.273 1.829 . . . . 10.0 109.884 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.611 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 53.0 m-80 -142.07 52.28 1.48 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.176 1.39 . . . . 10.0 110.173 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.55 -46.72 88.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.711 0.291 . . . . 10.0 111.458 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -68.11 -40.86 82.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.111 1.364 . . . . 10.0 109.922 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -72.56 -35.27 67.94 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.397 -0.819 . . . . 10.0 111.518 -177.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.56 -64.53 0.06 OUTLIER Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.434 0.54 . . . . 10.0 112.764 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 165.14 12.02 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 125.594 1.557 . . . . 10.0 109.259 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 35' ' ' VAL . 17.2 m -88.14 115.12 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -102.6 121.25 42.01 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.12 131.96 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -94.54 78.55 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 107.239 -1.393 . . . . 10.0 107.239 -175.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -75.59 135.82 40.52 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.54 -1.209 . . . . 10.0 109.489 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -90.08 89.08 7.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.011 1.324 . . . . 10.0 107.805 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.45 -16.18 8.8 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.249 0.833 . . . . 10.0 113.249 174.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -71.24 -18.33 62.45 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.828 1.651 . . . . 10.0 109.722 175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -124.73 -55.86 1.6 Allowed 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 124.757 1.223 . . . . 10.0 110.152 -169.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -137.33 148.44 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 C-N-CA 124.092 0.957 . . . . 10.0 109.989 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.8 m -101.08 152.37 20.69 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.1 m -39.87 -40.51 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 C-N-CA 127.608 2.363 . . . . 10.0 110.961 169.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -42.87 -34.12 0.9 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.951 0.723 . . . . 10.0 112.951 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -66.69 -65.38 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 118.855 0.752 . . . . 10.0 110.853 169.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.462 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.4 mp -64.79 -48.98 82.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.53 1.132 . . . . 10.0 112.543 -172.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.77 -57.01 2.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.549 1.94 . . . . 10.0 110.423 170.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -58.5 -46.8 85.97 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.77 0.795 . . . . 10.0 109.662 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.54 -48.91 68.64 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.573 0.749 . . . . 10.0 111.332 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.437 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -73.03 -39.33 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.15 -0.969 . . . . 10.0 111.022 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.5 -34.55 78.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.588 1.54 . . . . 10.0 110.767 -178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -47.8 -66.25 0.43 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.594 1.157 . . . . 10.0 112.731 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -126.59 3.73 6.83 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.239 1.2 . . . . 10.0 114.239 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.07 -53.5 0.89 Allowed Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.643 1.116 . . . . 10.0 112.489 -172.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 68.0 111.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.5 2.32 . . . . 10.0 111.258 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 164.41 -34.88 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 125.012 1.325 . . . . 10.0 110.574 -168.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG23 ' CG2' ' A' ' 60' ' ' ILE . 74.0 t -72.99 89.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 121.096 -1.003 . . . . 10.0 112.066 -168.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.39 -54.4 7.68 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 121.145 0.497 . . . . 10.0 110.042 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -169.04 143.58 3.08 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 -169.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.52 129.4 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.414 1.486 . . . . 10.0 110.015 177.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -127.09 135.8 51.26 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.95 -83.91 0.09 OUTLIER Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 C--O 1.256 1.399 0 N-CA-C 104.482 -2.414 . . . . 10.0 104.482 175.46 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ttt . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -129.79 -179.84 5.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.964 0.505 . . . . 10.0 110.718 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -128.72 90.7 3.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.755 2.422 . . . . 10.0 107.44 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -94.53 179.48 5.26 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 122.294 1.045 . . . . 10.0 109.957 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 t -146.14 134.96 22.4 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.931 -1.507 . . . . 10.0 106.931 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.604 HD23 HG22 ' A' ' 70' ' ' ILE . 21.0 mt -88.61 95.73 10.36 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.522 -2.399 . . . . 10.0 104.522 170.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -63.59 144.1 57.28 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.0 128.12 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 124.644 1.178 . . . . 10.0 113.794 -169.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -69.55 -58.49 3.89 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 129.526 3.131 . . . . 10.0 110.254 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.73 -28.01 0.19 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.42 -172.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.35 164.05 12.0 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 117.871 0.836 . . . . 10.0 110.35 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -147.52 12.05 1.02 Allowed 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 122.784 0.434 . . . . 10.0 111.075 -171.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.7 t -95.4 94.35 7.77 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.998 -1.112 . . . . 10.0 107.998 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -50.91 -18.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.321 0.86 . . . . 10.0 113.321 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -35.83 36.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.87 0.759 . . . . 10.0 109.829 -177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.2 m -63.04 -67.27 0.44 Allowed 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 174.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -49.97 -49.24 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.032 -0.417 . . . . 10.0 112.075 -176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -27.94 65.36 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.08 0.77 . . . . 10.0 113.08 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.81 -36.4 74.43 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t -85.42 -43.83 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 123.792 0.837 . . . . 10.0 110.163 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -39.25 -45.98 1.46 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.891 1.676 . . . . 10.0 111.339 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.34 -48.99 68.02 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.544 0.688 . . . . 10.0 111.654 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.8 t -68.37 -54.18 19.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.654 1.182 . . . . 10.0 109.118 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.2 t -53.78 -38.96 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 123.197 0.599 . . . . 10.0 111.321 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.24 71.34 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.98 1.276 . . . . 10.0 113.385 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -79.25 -37.55 37.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 118.679 1.239 . . . . 10.0 110.39 -177.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.92 122.67 10.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.798 0.726 . . . . 10.0 110.551 -175.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -48.24 -41.7 28.37 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.047 1.739 . . . . 10.0 112.532 -175.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.55 -6.15 88.14 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.275 0.464 . . . . 10.0 113.928 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.96 115.32 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.363 -2.088 . . . . 10.0 105.363 168.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -77.85 -32.61 52.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.564 -0.744 . . . . 10.0 109.377 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.11 160.39 11.81 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.23 147.58 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 125.64 1.576 . . . . 10.0 107.975 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -154.51 89.98 1.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.713 0.768 . . . . 10.0 109.256 177.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' HA ' HG22 ' A' ' 42' ' ' VAL . 2.6 t -75.27 118.94 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 C-N-CA 123.449 0.699 . . . . 10.0 109.392 -177.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -145.95 44.65 1.26 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.568 0.747 . . . . 10.0 109.123 -169.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -59.65 -51.33 70.25 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.502 -0.749 . . . . 10.0 112.19 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.89 -36.83 80.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.966 0.906 . . . . 10.0 110.034 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.33 62.53 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.479 -0.782 . . . . 10.0 111.286 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.97 -77.77 0.07 OUTLIER Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.223 0.916 . . . . 10.0 111.498 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.74 171.26 11.66 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 126.586 1.954 . . . . 10.0 107.977 -173.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 35' ' ' VAL . 44.6 t -90.83 105.55 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -82.45 136.99 34.8 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.517 -1.29 . . . . 10.0 107.517 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 p -160.62 139.55 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-O 122.161 0.981 . . . . 10.0 109.875 -169.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 m -111.64 77.03 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.639 -0.71 . . . . 10.0 109.454 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.663 ' HE1' HG21 ' A' ' 56' ' ' ILE . 21.5 m-85 -73.34 140.64 46.84 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 -179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -96.51 94.09 7.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.428 0.691 . . . . 10.0 109.439 167.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.66 -22.03 1.22 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.965 1.306 . . . . 10.0 113.738 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.34 -6.99 58.86 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 119.275 0.943 . . . . 10.0 110.048 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -126.54 -55.83 1.41 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.15 0.98 . . . . 10.0 109.891 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.2 m -139.28 164.05 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 119.535 1.062 . . . . 10.0 111.018 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.2 m -118.14 168.4 10.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.56 0.744 . . . . 10.0 109.344 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.2 m -44.43 -29.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.69 2.796 . . . . 10.0 112.462 170.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.28 -36.29 6.08 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.667 0.667 . . . . 10.0 111.397 172.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.89 -60.14 2.39 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.637 1.208 . . . . 10.0 110.385 169.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.663 HG21 ' HE1' ' A' ' 46' ' ' PHE . 11.2 mm -70.01 -57.0 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 114.535 1.309 . . . . 10.0 114.535 -168.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.67 8.99 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.897 0.879 . . . . 10.0 108.871 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.74 -51.38 56.59 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.789 0.435 . . . . 10.0 110.72 176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.35 -43.97 75.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.504 -0.317 . . . . 10.0 111.641 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.664 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.6 -48.61 51.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 121.137 -0.977 . . . . 10.0 110.272 177.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -58.66 -25.6 62.94 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.308 -0.87 . . . . 10.0 112.178 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -48.96 -44.56 40.92 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.626 0.77 . . . . 10.0 112.378 172.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -166.1 -28.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 114.54 1.311 . . . . 10.0 114.54 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -50.21 -55.14 16.8 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.798 -1.001 . . . . 10.0 112.103 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 60.32 120.61 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.768 2.027 . . . . 10.0 111.963 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 163.66 -34.91 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 126.03 1.732 . . . . 10.0 109.805 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.664 HG23 HG21 ' A' ' 60' ' ' ILE . 92.3 t -71.5 88.44 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 121.006 -1.059 . . . . 10.0 111.424 -174.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.39 -52.93 27.56 Favored 'General case' 0 CA--C 1.523 -0.066 0 O-C-N 121.587 -0.696 . . . . 10.0 109.135 169.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -169.6 159.39 8.29 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.604 HG22 HD23 ' A' ' 6' ' ' LEU . 1.7 pp -102.62 121.98 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 126.033 1.733 . . . . 10.0 108.367 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -109.59 117.57 34.31 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 159.42 -91.21 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.742 1.163 . . . . 10.0 110.497 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 117.668 -1.158 . . . . 10.0 112.078 -173.216 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 38.3 ttp . . . . . 0 N--CA 1.466 0.34 0 CA-C-O 119.04 -0.505 . . . . 10.0 111.34 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -156.27 129.85 8.3 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.8 0.727 . . . . 10.0 111.715 168.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -83.46 112.46 19.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.516 1.527 . . . . 10.0 107.892 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.66 172.48 6.8 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.359 1.464 . . . . 10.0 108.071 172.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 124.77 42.28 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.775 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -93.29 97.67 10.76 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 104.516 -2.402 . . . . 10.0 104.516 168.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -62.32 153.89 29.56 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.249 -0.648 . . . . 10.0 109.249 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 19.6 t -65.65 128.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 125.672 1.589 . . . . 10.0 111.968 -173.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -73.28 -61.56 1.78 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 128.868 2.867 . . . . 10.0 109.135 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.38 -34.44 0.09 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.437 -0.887 . . . . 10.0 112.347 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.29 170.59 5.72 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.041 0.921 . . . . 10.0 110.928 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -159.15 30.89 0.21 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.848 -0.614 . . . . 10.0 109.412 -176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.5 t -104.43 102.68 12.33 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.962 -1.125 . . . . 10.0 107.962 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -56.11 -20.1 15.93 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.053 0.76 . . . . 10.0 113.053 174.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -76.91 -42.23 40.34 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.984 0.811 . . . . 10.0 109.127 -172.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -55.49 -68.13 0.22 Allowed 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 124.459 1.104 . . . . 10.0 109.874 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.5 -50.07 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.575 0.583 . . . . 10.0 112.575 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -54.35 -33.69 59.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.943 0.792 . . . . 10.0 113.128 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.23 -34.23 66.13 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.361 0.6 . . . . 10.0 110.224 177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 37.8 t -85.56 -45.07 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 C-N-CA 123.783 0.833 . . . . 10.0 109.919 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -46.39 -42.1 14.57 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.571 1.148 . . . . 10.0 110.591 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.0 p -54.92 -45.69 74.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.43 0.559 . . . . 10.0 112.309 174.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -72.37 -42.37 65.34 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.607 0.763 . . . . 10.0 111.893 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 56' ' ' ILE . 15.0 t -66.22 -43.22 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.516 0.726 . . . . 10.0 109.744 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.97 48.37 2.7 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.882 1.229 . . . . 10.0 111.877 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.39 -47.03 0.19 Allowed 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 127.382 2.273 . . . . 10.0 108.212 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.74 126.28 15.36 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.394 0.997 . . . . 10.0 110.488 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.73 -39.39 58.36 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.744 1.218 . . . . 10.0 112.156 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.33 -8.4 59.16 Favored Glycine 0 CA--C 1.537 1.406 0 C-N-CA 123.79 0.71 . . . . 10.0 114.14 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.76 106.28 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 O-C-N 119.271 -2.311 . . . . 10.0 105.441 168.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 t -74.37 -28.28 61.05 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.152 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.51 156.65 11.93 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.0 m -130.6 148.13 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.218 1.007 . . . . 10.0 108.604 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -165.73 87.23 0.38 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.427 -0.953 . . . . 10.0 108.427 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.8 t -87.48 118.96 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 126.243 1.817 . . . . 10.0 109.915 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.11 48.74 1.87 Allowed 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 122.745 0.418 . . . . 10.0 111.385 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -52.61 -44.55 66.09 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.83 0.452 . . . . 10.0 111.963 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.63 -26.75 66.39 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.942 0.897 . . . . 10.0 111.286 -178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.12 13.22 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 122.678 0.391 . . . . 10.0 111.155 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -175.0 -65.63 0.05 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.973 -0.851 . . . . 10.0 110.973 -175.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -170.8 179.29 3.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 127.026 2.13 . . . . 10.0 110.741 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.597 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.3 p -93.67 130.46 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 125.512 1.525 . . . . 10.0 107.609 172.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -121.63 70.7 0.95 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.863 0.839 . . . . 10.0 110.374 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 42' ' ' VAL . 11.3 t -83.79 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 124.828 1.251 . . . . 10.0 108.783 -171.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.87 77.17 1.31 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.706 -1.59 . . . . 10.0 106.706 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 8.8 m-85 -79.82 134.05 36.32 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.472 1.509 . . . . 10.0 108.84 -175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.41 88.22 6.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 121.334 -0.853 . . . . 10.0 109.221 170.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.31 -16.09 0.16 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.15 0.98 . . . . 10.0 113.292 168.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 1' ' ' MET . 5.6 m-20 -85.95 -20.67 28.61 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.362 2.265 . . . . 10.0 110.461 -177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -129.26 -58.14 1.13 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.922 1.289 . . . . 10.0 109.786 -172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 75.0 t -129.87 120.26 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 C-N-CA 125.02 1.328 . . . . 10.0 108.002 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.1 p -87.76 158.19 18.85 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.263 -1.014 . . . . 10.0 108.263 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 m -38.03 -40.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 C-N-CA 126.885 2.074 . . . . 10.0 110.618 169.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.95 -47.06 0.51 Allowed 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 119.275 0.943 . . . . 10.0 111.551 174.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -64.06 -57.74 8.74 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.562 1.172 . . . . 10.0 111.096 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.451 HG23 ' CG1' ' A' ' 24' ' ' VAL . 5.9 mm -65.72 -57.11 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.836 1.654 . . . . 10.0 112.001 -173.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -40.19 -61.58 0.87 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.166 2.186 . . . . 10.0 109.52 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -50.56 -49.97 54.74 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.157 0.583 . . . . 10.0 110.666 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.55 -45.41 77.27 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.328 -0.396 . . . . 10.0 111.745 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -71.44 -39.53 71.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 120.98 -1.075 . . . . 10.0 110.415 177.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -61.33 -29.14 69.71 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.261 -0.899 . . . . 10.0 111.628 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.45 -64.27 0.87 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.976 0.807 . . . . 10.0 111.614 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -139.98 -7.33 1.23 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.265 1.58 . . . . 10.0 115.265 -177.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.74 -51.8 10.77 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.714 -0.954 . . . . 10.0 110.714 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 58.25 109.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.75 2.42 . . . . 10.0 111.539 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t0 175.59 -41.31 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.684 0 C-N-CA 125.363 1.465 . . . . 10.0 107.991 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.601 HG23 HG21 ' A' ' 60' ' ' ILE . 72.0 t -69.95 95.84 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 O-C-N 120.806 -1.184 . . . . 10.0 112.298 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.86 -57.46 3.86 Favored 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.773 0.829 . . . . 10.0 109.731 169.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 71' ' ' GLU . 6.4 ptmm? -164.94 142.94 6.33 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.888 -1.523 . . . . 10.0 106.888 -171.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.775 HG22 HD23 ' A' ' 6' ' ' LEU . 2.2 pp -80.97 141.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 124.163 0.985 . . . . 10.0 108.552 172.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' OE1' ' NZ ' ' A' ' 69' ' ' LYS . 3.5 tt0 -131.06 130.96 43.91 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.085 -1.08 . . . . 10.0 108.085 174.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 138.18 -103.91 0.43 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.759 1.647 . . . . 10.0 109.803 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 . . . . . 0 C--O 1.251 1.174 0 C-N-CA 124.154 0.982 . . . . 10.0 109.264 -173.497 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 112.875 0.694 . . . . 10.0 112.875 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -129.33 127.18 40.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.975 1.422 . . . . 10.0 107.91 -174.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -86.25 98.22 10.82 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 170.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.39 -175.79 4.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 106.569 -1.641 . . . . 10.0 106.569 169.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 t -139.17 137.13 35.79 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 105.754 -1.943 . . . . 10.0 105.754 169.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.732 HD23 HG22 ' A' ' 70' ' ' ILE . 0.3 OUTLIER -94.15 99.89 12.08 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 105.141 -2.17 . . . . 10.0 105.141 171.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -60.03 146.57 42.3 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.152 -0.684 . . . . 10.0 109.152 -178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.19 130.3 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 125.13 1.372 . . . . 10.0 113.128 -170.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -78.86 -57.56 3.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 127.375 2.27 . . . . 10.0 110.618 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.65 -46.46 0.1 OUTLIER Glycine 0 C--N 1.338 0.668 0 C-N-CA 117.637 -2.22 . . . . 10.0 112.792 -169.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.91 158.99 4.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 117.3 0.55 . . . . 10.0 110.928 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.1 m -144.83 37.57 1.18 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.084 -0.962 . . . . 10.0 108.875 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.3 t -110.12 94.96 5.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 -174.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -55.66 -9.85 0.6 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.573 0.953 . . . . 10.0 113.573 173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -90.35 -29.33 18.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.182 0.901 . . . . 10.0 110.45 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.9 m -65.33 -73.79 0.12 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.931 -1.137 . . . . 10.0 107.931 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 35' ' ' VAL . 4.5 m -33.83 -54.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 125.542 1.537 . . . . 10.0 113.858 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -56.01 -33.16 64.63 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.969 0.729 . . . . 10.0 112.969 -175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.94 -32.8 61.69 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.599 0.76 . . . . 10.0 110.582 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.6 t -92.28 -47.68 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 117.829 -1.081 . . . . 10.0 110.39 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -41.85 -49.48 4.46 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.077 1.351 . . . . 10.0 110.752 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.5 p -46.17 -62.32 1.39 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.349 1.06 . . . . 10.0 111.247 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.4 t -57.76 -48.06 80.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.598 1.159 . . . . 10.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.7 t -55.08 -40.64 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 123.76 0.824 . . . . 10.0 110.155 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.63 6.4 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.54 1.066 . . . . 10.0 113.744 173.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -73.87 -26.62 60.66 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.92 1.36 . . . . 10.0 111.621 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.15 107.94 2.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 119.128 0.877 . . . . 10.0 109.373 175.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -36.7 -43.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.165 2.186 . . . . 10.0 113.17 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.05 -28.5 63.9 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 123.688 0.661 . . . . 10.0 114.119 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.51 109.56 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 119.566 -2.137 . . . . 10.0 107.399 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 t -81.82 -31.73 31.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.903 -1.044 . . . . 10.0 109.712 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.19 158.22 18.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.478 ' HA ' HG22 ' A' ' 44' ' ' VAL . 10.4 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.509 1.123 . . . . 10.0 108.303 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -162.55 106.4 1.13 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 17' ' ' VAL . 43.7 t -95.69 117.55 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 C-N-CA 124.124 0.97 . . . . 10.0 109.237 -178.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -132.22 48.58 2.4 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.505 0.322 . . . . 10.0 111.349 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.558 HD23 ' HB3' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -47.52 -42.96 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.087 0.955 . . . . 10.0 112.89 177.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -65.49 -37.92 88.23 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.82 0.848 . . . . 10.0 111.032 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -35.9 20.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.564 -172.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.38 -67.8 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 110.926 -0.87 . . . . 10.0 110.926 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.82 -174.74 2.51 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 125.055 1.342 . . . . 10.0 110.673 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.565 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -97.28 125.79 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 175.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -110.77 92.69 4.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.524 2.33 . . . . 10.0 108.343 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.565 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.4 t -110.89 151.22 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.647 1.579 . . . . 10.0 107.88 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.0 t -109.73 77.2 1.04 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.556 -1.646 . . . . 10.0 106.556 -176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 5.6 m-85 -78.01 127.67 32.69 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.317 -1.31 . . . . 10.0 107.721 -176.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 50.8 t0 -81.93 85.0 6.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.642 -0.662 . . . . 10.0 110.292 176.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.75 -23.17 0.96 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.985 0.914 . . . . 10.0 113.389 174.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -80.27 -5.38 56.15 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.436 0.562 . . . . 10.0 109.943 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -133.35 -54.15 0.9 Allowed 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.492 1.117 . . . . 10.0 110.511 -176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.1 t -129.18 141.04 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 C-N-CA 125.051 1.341 . . . . 10.0 109.435 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.6 p -97.26 143.57 27.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.0 m -31.76 -49.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 129.369 3.068 . . . . 10.0 110.003 168.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -31.93 -51.61 0.23 Allowed 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.807 1.243 . . . . 10.0 112.089 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -55.69 -60.54 3.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.396 1.079 . . . . 10.0 110.949 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mp -66.05 -54.53 26.02 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 125.17 1.388 . . . . 10.0 110.948 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.15 -62.28 0.66 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.917 2.087 . . . . 10.0 110.389 171.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -53.85 -50.25 66.65 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.731 0.813 . . . . 10.0 110.097 175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -50.27 -47.69 55.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.035 0.534 . . . . 10.0 111.453 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 HG21 HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -71.55 -35.9 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.974 -1.079 . . . . 10.0 111.067 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.65 -30.59 65.53 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.871 -1.143 . . . . 10.0 111.579 170.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -61.87 -62.08 2.05 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.234 0.925 . . . . 10.0 111.964 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -142.86 56.07 1.4 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.89 -54.77 0.04 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-O 119.22 -0.766 . . . . 10.0 111.288 173.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 65.08 107.15 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.124 1.77 . . . . 10.0 112.248 173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.558 ' HB3' HD23 ' A' ' 37' ' ' LEU . 12.0 p-10 161.28 -24.87 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 128.413 2.685 . . . . 10.0 110.987 -170.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.43 HG23 HG21 ' A' ' 60' ' ' ILE . 63.5 t -67.88 90.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 120.985 -1.072 . . . . 10.0 111.486 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.67 -52.07 11.35 Favored 'General case' 0 C--N 1.338 0.094 0 O-C-N 121.774 -0.579 . . . . 10.0 109.463 169.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -170.24 144.12 2.52 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.52 1.128 . . . . 10.0 108.409 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.732 HG22 HD23 ' A' ' 6' ' ' LEU . 2.3 pp -73.21 140.86 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 124.433 1.093 . . . . 10.0 108.489 169.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.68 132.19 48.03 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.452 -1.314 . . . . 10.0 107.452 168.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.33 -148.25 19.29 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.485 -1.846 . . . . 10.0 108.485 -175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 168.089 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -132.76 177.15 7.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 122.372 1.082 . . . . 10.0 109.147 -169.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -131.62 126.56 35.01 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 103.566 -2.753 . . . . 10.0 103.566 167.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -124.86 176.07 6.86 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.42 -2.437 . . . . 10.0 104.42 168.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -129.87 126.81 38.88 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 ' CG2' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -92.7 97.86 11.05 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 104.69 -2.337 . . . . 10.0 104.69 172.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.88 150.7 44.35 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.01 127.68 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 C-N-CA 124.658 1.183 . . . . 10.0 113.019 -169.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -62.35 1.42 Allowed 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.602 1.961 . . . . 10.0 108.57 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.34 -31.86 0.08 OUTLIER Glycine 0 CA--C 1.524 0.596 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.508 -169.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 178.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.461 1.124 . . . . 10.0 112.582 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 p -150.31 -43.57 0.13 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 114.533 -1.212 . . . . 10.0 110.913 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.3 t -37.44 101.3 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.855 1.262 . . . . 10.0 111.678 175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.39 -3.27 23.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 119.337 -0.363 . . . . 10.0 111.687 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.02 -46.64 8.71 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.603 0.638 . . . . 10.0 109.448 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.5 m -46.93 -68.68 0.17 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.703 0.801 . . . . 10.0 110.157 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -46.63 -51.54 4.53 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 O-C-N 122.304 -0.247 . . . . 10.0 111.483 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 10.4 tttt -60.61 -33.75 73.21 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 112.828 0.677 . . . . 10.0 112.828 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -32.17 50.95 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.981 0.512 . . . . 10.0 110.144 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.94 -41.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-O 118.232 -0.889 . . . . 10.0 110.726 172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 9.1 tt0 -39.89 -51.49 2.45 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.345 1.458 . . . . 10.0 111.297 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -51.0 -55.69 16.14 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.03 0.932 . . . . 10.0 110.552 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.0 t -56.82 -49.73 74.5 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.705 1.202 . . . . 10.0 110.534 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.514 HG13 HD12 ' A' ' 56' ' ' ILE . 49.7 t -53.85 -41.5 48.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 124.248 1.019 . . . . 10.0 110.111 178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.0 -32.55 6.3 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.72 1.152 . . . . 10.0 114.052 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.09 -26.21 60.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.924 1.362 . . . . 10.0 111.944 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.4 109.67 2.81 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 121.435 -0.79 . . . . 10.0 110.251 178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -43.3 -38.44 2.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.097 2.159 . . . . 10.0 113.175 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.33 -20.89 71.85 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.503 -0.748 . . . . 10.0 114.215 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.02 105.31 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 O-C-N 120.036 -1.861 . . . . 10.0 107.211 171.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.69 -29.86 62.54 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.351 -1.295 . . . . 10.0 110.097 174.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.49 157.05 14.48 Favored 'General case' 0 C--N 1.344 0.353 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.532 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.8 m -136.25 130.51 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 124.074 0.95 . . . . 10.0 109.913 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -148.07 94.3 2.31 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 123.931 0.892 . . . . 10.0 108.714 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 t -86.66 114.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 125.256 1.422 . . . . 10.0 108.371 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.95 48.62 2.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.835 0.454 . . . . 10.0 111.497 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -50.95 -44.17 60.37 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.673 0.789 . . . . 10.0 112.414 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.1 -29.84 70.23 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.727 1.211 . . . . 10.0 111.096 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 -36.86 14.74 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.63 0.372 . . . . 10.0 110.755 -175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.07 -65.07 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 124.218 0.913 . . . . 10.0 111.045 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.12 178.78 4.87 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.399 1.48 . . . . 10.0 111.025 -177.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 44' ' ' VAL . 1.5 p -94.2 127.82 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 125.145 1.378 . . . . 10.0 108.228 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -117.59 89.13 3.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.622 1.169 . . . . 10.0 108.629 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.542 HG23 ' CG2' ' A' ' 42' ' ' VAL . 17.1 t -98.2 149.76 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.668 1.587 . . . . 10.0 107.637 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.3 t -104.29 79.89 1.64 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 9.7 m-85 -73.93 130.35 39.71 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.912 -1.494 . . . . 10.0 108.204 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -84.33 87.1 7.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.61 -11.82 1.51 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.162 0.801 . . . . 10.0 113.162 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.46 -15.37 52.8 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.608 1.094 . . . . 10.0 109.759 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -127.08 -61.44 1.16 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.451 1.1 . . . . 10.0 109.152 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.5 t -129.9 126.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 124.825 1.25 . . . . 10.0 109.223 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.1 m -96.4 163.84 12.89 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.308 -0.86 . . . . 10.0 108.828 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.7 m -38.43 -39.57 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 C-N-CA 127.478 2.311 . . . . 10.0 111.353 168.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.27 -37.33 1.47 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.594 0.633 . . . . 10.0 112.543 175.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.61 -63.87 1.04 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.071 0.938 . . . . 10.0 111.061 172.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.514 HD12 HG13 ' A' ' 24' ' ' VAL . 3.8 mm -60.29 -54.03 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.713 1.205 . . . . 10.0 112.483 -172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.47 -53.05 15.24 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.904 2.082 . . . . 10.0 109.593 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.57 -47.78 78.77 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.133 0.573 . . . . 10.0 110.204 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -51.0 68.9 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.233 -0.439 . . . . 10.0 111.004 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -68.14 -34.74 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 O-C-N 121.118 -0.989 . . . . 10.0 109.948 -179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -57.04 -43.36 81.89 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.603 -1.311 . . . . 10.0 111.503 171.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -51.69 -62.24 1.75 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.469 0.577 . . . . 10.0 111.969 -176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -141.18 44.67 1.77 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -131.04 -57.78 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 123.944 0.783 . . . . 10.0 112.102 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 66.3 107.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.129 2.172 . . . . 10.0 111.087 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 t0 170.39 -38.47 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.668 1.587 . . . . 10.0 108.253 -168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG23 ' CG2' ' A' ' 60' ' ' ILE . 54.7 t -69.24 89.21 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 120.746 -1.221 . . . . 10.0 112.031 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.05 -59.72 2.62 Favored 'General case' 0 N--CA 1.461 0.124 0 O-C-N 121.284 -0.885 . . . . 10.0 109.689 169.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -165.3 155.91 13.78 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.166 -1.791 . . . . 10.0 106.166 -175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.522 ' CG2' HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -86.72 145.07 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 124.607 1.163 . . . . 10.0 110.143 174.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.03 147.27 41.88 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 106.218 -1.771 . . . . 10.0 106.218 169.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 144.56 -128.72 3.32 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.028 1.299 . . . . 10.0 111.264 -172.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.989 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 168.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.08 -173.54 3.14 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.134 1.522 . . . . 10.0 106.937 167.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -139.72 110.16 6.63 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.868 -1.901 . . . . 10.0 105.868 168.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -122.83 176.39 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.514 1.926 . . . . 10.0 106.717 175.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -148.81 128.8 13.5 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 106.064 -1.828 . . . . 10.0 106.064 -177.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -85.68 104.26 15.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 172.518 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -68.43 149.71 49.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 m -66.51 132.78 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -170.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -74.41 -60.51 2.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.916 2.486 . . . . 10.0 108.174 173.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.31 -31.96 0.04 OUTLIER Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.862 -0.966 . . . . 10.0 115.137 -171.28 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.8 178.45 4.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.606 1.703 . . . . 10.0 110.241 -177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 m -158.81 26.96 0.22 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.693 0.797 . . . . 10.0 109.249 170.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 47.8 t -90.09 100.04 12.94 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.098 -1.815 . . . . 10.0 106.098 178.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -52.57 -26.73 14.14 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.069 0.396 . . . . 10.0 112.069 174.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -72.55 -46.08 56.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.939 -0.763 . . . . 10.0 108.939 -172.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.9 m -50.31 -65.88 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.848 1.659 . . . . 10.0 110.415 174.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -51.77 -45.09 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 120.484 -0.487 . . . . 10.0 111.08 178.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 17.7 tttm -52.44 -33.76 45.61 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.624 1.342 . . . . 10.0 114.624 176.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.06 65.39 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.065 0.848 . . . . 10.0 110.038 175.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.4 t -87.05 -37.91 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 117.339 -1.315 . . . . 10.0 110.575 176.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 1.4 tt0 -36.63 -56.03 0.84 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.556 1.542 . . . . 10.0 110.549 174.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.9 p -58.94 -45.38 90.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.686 0.395 . . . . 10.0 111.381 -178.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.3 m -65.55 -57.03 9.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.43 0.692 . . . . 10.0 109.8 -177.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 50.5 t -55.71 -37.48 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.992 0.917 . . . . 10.0 110.796 177.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.63 -27.32 54.69 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.024 0.821 . . . . 10.0 112.193 177.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.37 -27.35 59.11 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 118.319 1.059 . . . . 10.0 110.416 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.51 103.65 2.54 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 120.94 -1.1 . . . . 10.0 108.859 178.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -41.01 -32.37 0.23 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.668 1.987 . . . . 10.0 113.043 171.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.72 3.76 4.76 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.15 0.881 . . . . 10.0 115.288 174.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -109.17 119.61 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 105.688 -1.967 . . . . 10.0 105.688 169.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.99 -36.99 29.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 177.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.61 157.24 14.41 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 176.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.7 t -130.39 135.76 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.986 2.114 . . . . 10.0 107.281 171.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -133.46 96.33 3.69 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 126.327 1.851 . . . . 10.0 107.742 172.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 42' ' ' VAL . 2.2 t -87.8 119.12 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 124.044 0.937 . . . . 10.0 108.933 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 15.3 m120 -146.38 51.59 1.13 Allowed 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.073 0.549 . . . . 10.0 111.213 -172.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.52 -48.99 56.93 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.279 0.632 . . . . 10.0 112.078 178.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.83 -37.01 83.67 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.176 0.591 . . . . 10.0 110.718 -175.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -83.4 -31.92 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.133 -173.229 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.43 -79.33 0.05 OUTLIER Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.598 -1.001 . . . . 10.0 110.598 -178.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.4 pttm -168.8 179.8 4.04 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 128.549 2.739 . . . . 10.0 106.873 -175.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG23 HD12 ' A' ' 6' ' ' LEU . 31.0 m -94.31 118.58 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 107.68 -1.229 . . . . 10.0 107.68 -174.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.15 127.68 37.71 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 107.39 -1.337 . . . . 10.0 107.39 176.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.1 t -139.58 137.19 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.283 0 CA-C-O 122.408 1.099 . . . . 10.0 108.757 -171.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 73.5 m -110.08 76.0 0.97 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 -169.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 28.1 m-85 -82.12 137.19 35.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 125.7 1.6 . . . . 10.0 109.797 -173.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -84.64 84.25 7.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.95 0.881 . . . . 10.0 108.83 169.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.31 -20.25 2.61 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.648 1.579 . . . . 10.0 112.409 168.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.04 -12.87 58.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.815 1.646 . . . . 10.0 110.12 -177.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -120.59 -53.67 2.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.131 0.972 . . . . 10.0 109.248 -174.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.7 m -125.92 -168.65 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 125.879 1.672 . . . . 10.0 108.971 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.3 m -144.28 147.68 33.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.022 -1.049 . . . . 10.0 108.744 169.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -31.46 -48.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 C-N-CA 130.037 3.335 . . . . 10.0 110.731 175.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -28.93 -52.12 0.1 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.312 1.445 . . . . 10.0 112.352 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.53 -59.77 4.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.18 0.592 . . . . 10.0 111.739 177.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.2 mp -67.64 -51.03 55.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 C-N-CA 125.325 1.45 . . . . 10.0 110.737 -175.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -38.26 -63.89 0.46 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.87 2.068 . . . . 10.0 109.399 169.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -56.46 -47.87 78.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.403 0.681 . . . . 10.0 110.126 177.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -51.29 -46.79 62.62 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.978 0.911 . . . . 10.0 111.546 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.8 OUTLIER -72.53 -42.19 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.616 -0.677 . . . . 10.0 110.586 176.361 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.19 -34.89 66.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.984 1.266 . . . . 10.0 112.159 178.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -48.49 -63.02 1.2 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.697 0.681 . . . . 10.0 112.533 178.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -134.59 -17.89 1.96 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.37 1.068 . . . . 10.0 113.387 -171.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.23 -49.26 12.71 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.879 -0.888 . . . . 10.0 110.879 -177.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 58.67 108.48 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.689 2.395 . . . . 10.0 111.586 -177.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.29 -42.0 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.496 0 CA-C-O 121.807 0.813 . . . . 10.0 109.189 -167.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG23 ' CG2' ' A' ' 60' ' ' ILE . 55.1 t -71.32 94.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 O-C-N 121.601 -0.687 . . . . 10.0 111.245 -172.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.64 -51.65 11.14 Favored 'General case' 0 C--O 1.227 -0.119 0 CA-C-O 121.399 0.618 . . . . 10.0 109.396 169.169 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -171.4 143.13 1.77 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 -170.133 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG22 HD23 ' A' ' 6' ' ' LEU . 2.4 pp -89.1 127.94 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.864 1.266 . . . . 10.0 109.779 176.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -75.2 80.79 2.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.852 -1.166 . . . . 10.0 107.852 174.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.26 87.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.667 1.604 . . . . 10.0 113.927 -169.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 116.01 -1.948 . . . . 10.0 111.899 173.819 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 111.804 0.298 . . . . 10.0 111.804 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.22 -172.46 2.22 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.04 -1.837 . . . . 10.0 106.04 168.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -147.55 75.48 1.36 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HD2' HG11 ' A' ' 53' ' ' VAL . 6.5 mtmt -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 123.022 1.392 . . . . 10.0 110.806 169.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.0 m -130.36 124.5 32.35 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 104.788 -2.301 . . . . 10.0 104.788 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.407 HD23 HG22 ' A' ' 70' ' ' ILE . 1.1 mt -83.31 110.92 18.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 104.372 -2.455 . . . . 10.0 104.372 169.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -65.99 155.71 35.79 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.213 -0.662 . . . . 10.0 109.213 178.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.9 126.51 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.895 0.878 . . . . 10.0 110.028 -174.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -70.32 -47.54 60.66 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.975 1.31 . . . . 10.0 109.203 174.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.89 -19.75 0.67 Allowed Glycine 0 CA--C 1.525 0.697 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.442 -176.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 167.14 3.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.831 0.815 . . . . 10.0 111.5 174.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.46 19.83 1.35 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.34 -177.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -101.74 96.73 7.27 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.25 -14.47 7.26 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.802 0.667 . . . . 10.0 112.802 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -85.76 -35.47 20.73 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.997 0.817 . . . . 10.0 109.976 -172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.5 m -58.09 -67.14 0.37 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.883 1.273 . . . . 10.0 109.262 172.053 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -45.55 -51.43 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.181 0.438 . . . . 10.0 112.181 -177.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -20.79 63.03 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.623 0.972 . . . . 10.0 113.623 -177.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.12 -40.78 90.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 175.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.44 -42.18 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.88 -0.581 . . . . 10.0 110.301 177.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -38.65 -48.91 1.51 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.429 1.492 . . . . 10.0 111.393 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.0 -47.93 76.82 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.233 0.539 . . . . 10.0 111.328 178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -65.14 -50.04 67.56 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.015 0.926 . . . . 10.0 110.203 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.3 t -52.73 -44.05 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.812 0.845 . . . . 10.0 109.914 176.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -51.48 -30.26 26.02 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.953 1.263 . . . . 10.0 113.765 173.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.77 -27.69 64.11 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.914 1.357 . . . . 10.0 110.91 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.43 105.58 2.65 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 174.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -36.04 -39.05 0.15 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.631 1.972 . . . . 10.0 113.543 170.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -13.39 21.42 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 124.849 1.214 . . . . 10.0 115.524 176.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.5 t -89.52 108.56 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 O-C-N 120.164 -1.786 . . . . 10.0 106.336 172.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -80.15 -29.89 38.88 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.91 158.97 15.37 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 107.877 -1.157 . . . . 10.0 107.877 177.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -139.35 122.12 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.328 1.451 . . . . 10.0 108.417 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -132.79 77.27 1.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.794 2.038 . . . . 10.0 107.546 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.13 123.81 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 125.026 1.33 . . . . 10.0 109.173 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 36.5 m-80 -147.94 53.19 1.03 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.044 0.937 . . . . 10.0 110.09 -177.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.63 -46.27 87.43 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.631 -0.668 . . . . 10.0 112.123 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.06 -35.14 77.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.09 0.956 . . . . 10.0 110.811 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -82.67 -32.5 28.1 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.49 -0.323 . . . . 10.0 111.34 -175.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.05 -88.02 0.07 OUTLIER Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.906 1.241 . . . . 10.0 110.945 -173.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -166.49 164.09 17.18 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 128.393 2.677 . . . . 10.0 106.411 -177.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 m -86.85 118.63 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-N 118.824 0.738 . . . . 10.0 110.575 -168.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -92.88 124.72 37.07 Favored 'General case' 0 C--O 1.227 -0.099 0 C-N-CA 124.717 1.207 . . . . 10.0 108.402 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.414 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 70.2 t -134.5 136.73 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 -177.352 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -99.96 70.98 1.62 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.26 -1.385 . . . . 10.0 107.26 -174.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 20.4 m-85 -72.46 135.46 45.74 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.023 -176.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -84.65 86.84 7.27 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.287 1.435 . . . . 10.0 108.264 169.166 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.64 -18.61 1.86 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.905 1.282 . . . . 10.0 112.537 168.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -79.68 -16.05 56.43 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.561 1.544 . . . . 10.0 109.912 -178.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.2 tttp -116.99 -56.1 2.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.324 1.05 . . . . 10.0 109.289 -177.021 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.12 155.92 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 123.91 0.884 . . . . 10.0 109.305 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.0 p -99.37 147.03 25.66 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.493 -0.928 . . . . 10.0 108.493 176.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 53' ' ' VAL . 18.7 m -30.71 -43.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 129.228 3.011 . . . . 10.0 111.202 168.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -28.87 -55.41 0.13 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.747 1.219 . . . . 10.0 111.549 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -48.21 -71.11 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.275 1.43 . . . . 10.0 111.05 173.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.1 mp -60.41 -55.34 25.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.511 1.525 . . . . 10.0 112.238 -176.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -39.6 -58.41 1.3 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 127.263 2.225 . . . . 10.0 110.908 172.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -61.47 -45.93 92.2 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.558 0.743 . . . . 10.0 109.752 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.67 -44.11 65.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.443 0.697 . . . . 10.0 111.535 177.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.41 HG21 HG23 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -70.42 -58.88 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 117.824 -1.084 . . . . 10.0 108.805 176.555 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . 0.251 0.0 OUTLIER -46.74 -37.81 9.03 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.772 1.169 . . . . 10.0 112.849 -174.655 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -41.17 -61.14 1.06 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.041 1.336 . . . . 10.0 112.882 172.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -132.82 -40.52 0.95 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -63.88 -41.62 98.69 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.29 -1.124 . . . . 10.0 110.29 -176.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 173.67 0.17 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.131 1.372 . . . . 10.0 110.5 -176.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 86.67 37.98 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 125.451 1.5 . . . . 10.0 111.621 175.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG23 HG21 ' A' ' 60' ' ' ILE . 40.0 t -117.96 89.14 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.91 1.284 . . . . 10.0 110.09 172.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.64 -58.86 3.42 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.419 -0.585 . . . . 10.0 109.419 169.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -176.13 158.44 1.96 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.691 -1.596 . . . . 10.0 106.691 -174.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.407 HG22 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.09 143.74 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 123.715 0.806 . . . . 10.0 111.474 171.865 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -106.65 115.05 29.53 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 168.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 150.61 -111.46 0.51 Allowed Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 176.305 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.856 -1.069 . . . . 10.0 110.069 -177.975 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.32 152.27 38.86 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 121.472 0.653 . . . . 10.0 111.692 -169.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -83.98 94.94 8.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.264 1.425 . . . . 10.0 108.235 169.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HB3' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -95.97 161.13 14.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.974 -0.75 . . . . 10.0 108.974 173.412 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.85 107.53 14.23 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 125.613 1.565 . . . . 10.0 107.381 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.67 HD22 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -78.8 92.41 4.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 169.266 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -69.17 144.87 53.68 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.854 -0.795 . . . . 10.0 108.854 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 p -67.86 126.93 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 127.045 2.138 . . . . 10.0 113.281 -174.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -70.15 -66.19 0.63 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.653 2.381 . . . . 10.0 109.782 176.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.01 -25.86 0.05 OUTLIER Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.688 -1.062 . . . . 10.0 115.465 -168.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 177.17 2.36 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 119.837 1.819 . . . . 10.0 109.765 174.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.738 ' HA ' HD21 ' A' ' 37' ' ' LEU . 31.6 m -165.17 56.77 0.12 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 -178.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.4 t -127.73 108.05 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.046 -1.835 . . . . 10.0 106.046 173.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.17 -24.49 64.8 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.489 0.185 . . . . 10.0 110.576 174.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 -45.21 38.28 Favored 'General case' 0 CA--C 1.522 -0.105 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 -169.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 33.1 m -47.1 -71.11 0.08 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.039 1.335 . . . . 10.0 110.437 172.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.9 m -45.17 -49.1 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 122.249 0.219 . . . . 10.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 28.7 tttt -55.62 -34.7 65.13 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 115.119 1.525 . . . . 10.0 115.119 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.84 63.84 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.531 -0.731 . . . . 10.0 109.352 174.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -82.38 -40.08 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 CA-C-O 117.684 -1.15 . . . . 10.0 111.209 176.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -35.09 -60.89 0.45 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.994 1.718 . . . . 10.0 110.669 178.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -40.59 88.81 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.851 -1.068 . . . . 10.0 111.227 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -63.6 -56.13 18.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.077 0.951 . . . . 10.0 110.285 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.7 t -52.35 -33.71 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 C-N-CA 124.185 0.994 . . . . 10.0 111.073 178.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -41.45 -27.93 0.31 Allowed Glycine 0 CA--C 1.54 1.65 0 CA-C-O 118.951 -0.916 . . . . 10.0 114.981 170.082 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -31.16 70.03 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.568 1.684 . . . . 10.0 112.262 177.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.16 93.15 0.28 Allowed 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 174.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -39.21 -39.55 0.63 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.887 1.675 . . . . 10.0 112.97 172.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.56 -9.02 42.3 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 124.121 0.867 . . . . 10.0 115.022 178.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.74 105.48 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 104.875 -2.268 . . . . 10.0 104.875 168.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -73.51 -33.21 64.66 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.564 179.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -166.92 159.05 13.07 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 107.747 -1.205 . . . . 10.0 107.747 177.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.1 m -135.49 128.2 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 124.637 1.175 . . . . 10.0 108.486 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 91.54 2.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.338 -0.986 . . . . 10.0 108.338 175.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.9 t -86.46 108.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 124.772 1.229 . . . . 10.0 109.073 -171.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.2 m120 -142.99 52.45 1.38 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.563 0.745 . . . . 10.0 111.665 -173.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.738 HD21 ' HA ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -49.94 -48.62 51.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.249 0.62 . . . . 10.0 111.136 -178.915 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD22 ' A' ' 37' ' ' LEU . 38.0 mt-10 -66.27 -46.72 76.09 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.573 1.149 . . . . 10.0 110.172 -175.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -68.67 -30.49 69.19 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.339 -0.846 . . . . 10.0 110.089 -176.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.9 -51.15 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 122.92 0.295 . . . . 10.0 112.432 170.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.16 171.67 7.91 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.93 0.892 . . . . 10.0 112.049 -169.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG12 HG23 ' A' ' 44' ' ' VAL . 40.2 t -93.71 102.55 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 173.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -93.19 113.67 25.96 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 45.5 t -125.78 143.99 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 107.355 -1.35 . . . . 10.0 107.355 -171.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 t -105.97 82.7 1.81 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.329 -2.1 . . . . 10.0 105.329 -174.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 53' ' ' VAL . 13.7 m-85 -88.24 132.31 34.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.259 1.424 . . . . 10.0 108.948 -176.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -90.77 88.28 7.01 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.209 1.003 . . . . 10.0 108.356 171.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.85 -18.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.677 1.591 . . . . 10.0 112.819 167.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -19.15 58.61 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.614 1.966 . . . . 10.0 110.465 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -127.68 -48.61 1.39 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.199 1.0 . . . . 10.0 110.756 -169.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.3 m -134.09 165.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 123.986 0.914 . . . . 10.0 109.565 176.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.4 p -109.81 143.36 39.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.282 0.492 . . . . 10.0 109.921 175.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 46' ' ' PHE . 23.6 m -40.34 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 128.23 2.612 . . . . 10.0 108.841 169.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -35.16 -49.14 0.47 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.448 1.022 . . . . 10.0 112.194 175.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.45 -53.81 54.16 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.519 0.676 . . . . 10.0 111.077 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.89 -51.75 41.57 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.475 1.51 . . . . 10.0 111.289 -177.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -40.03 -59.96 1.13 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.971 2.108 . . . . 10.0 109.923 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -55.75 -48.34 75.42 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.082 0.953 . . . . 10.0 109.989 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.71 71.8 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.93 0.892 . . . . 10.0 111.511 -178.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.691 HG22 HG23 ' A' ' 67' ' ' VAL . 1.3 mp -71.08 -34.09 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 O-C-N 120.729 -1.232 . . . . 10.0 109.271 177.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.21 -40.98 92.02 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 120.7 -1.25 . . . . 10.0 110.837 175.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -45.85 -66.62 0.38 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.356 1.063 . . . . 10.0 112.41 178.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -139.93 23.79 2.41 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.685 0.624 . . . . 10.0 112.685 -174.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.45 -49.4 0.6 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.46 1.029 . . . . 10.0 112.219 -176.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 64.31 101.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.407 1.883 . . . . 10.0 111.558 173.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 t70 173.36 -32.88 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 125.473 1.509 . . . . 10.0 109.799 -168.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.691 HG23 HG22 ' A' ' 60' ' ' ILE . 64.3 t -67.5 86.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 121.359 -0.838 . . . . 10.0 112.104 -171.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.41 -58.79 3.35 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.502 -0.925 . . . . 10.0 108.502 169.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 pttp -164.29 150.41 10.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.475 -1.676 . . . . 10.0 106.475 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 4' ' ' LYS . 5.2 tp -120.2 98.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.973 1.309 . . . . 10.0 110.429 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -118.8 -100.49 0.44 Allowed 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 174.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 71.43 -66.87 0.98 Allowed Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.488 -1.045 . . . . 10.0 110.488 -171.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.89 -1.893 . . . . 10.0 105.89 170.48 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -106.22 -172.42 2.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.919 -2.252 . . . . 10.0 104.919 -176.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.21 124.76 23.61 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.646 -1.983 . . . . 10.0 105.646 174.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HZ3' ' C ' ' A' ' 73' ' ' ARG . 1.9 mttt -127.76 158.95 36.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 122.868 1.318 . . . . 10.0 108.617 167.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.486 HG23 ' HG3' ' A' ' 41' ' ' LYS . 1.8 m -119.5 98.14 5.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.982 2.913 . . . . 10.0 104.933 -168.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.65 86.63 4.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 104.793 -2.299 . . . . 10.0 104.793 170.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 41' ' ' LYS . 53.9 tt0 -55.96 152.79 9.64 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.111 0.964 . . . . 10.0 109.267 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 2.2 t -63.63 127.12 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.698 1.199 . . . . 10.0 109.234 -178.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -75.23 -68.61 0.54 Allowed 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 172.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.59 -32.62 0.02 OUTLIER Glycine 0 CA--C 1.525 0.711 0 C-N-CA 119.518 -1.325 . . . . 10.0 115.806 -168.562 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -175.28 1.04 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.233 1.016 . . . . 10.0 108.721 173.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 m -168.47 39.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.133 1.373 . . . . 10.0 108.03 172.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -99.29 98.23 9.21 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -47.07 -17.6 0.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.39 1.876 . . . . 10.0 114.6 176.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -96.84 -37.28 10.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.797 1.239 . . . . 10.0 110.251 -176.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 m -56.62 -62.64 1.59 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.265 -1.013 . . . . 10.0 108.265 177.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.757 HG21 HD21 ' A' ' 37' ' ' LEU . 9.2 m -49.65 -47.13 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.947 179.314 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 7.2 tttp -56.26 -34.82 66.77 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.269 1.211 . . . . 10.0 114.269 -178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -39.34 61.16 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.55 -0.537 . . . . 10.0 109.55 172.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.65 -37.26 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 117.903 -1.046 . . . . 10.0 111.199 177.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' LYS . 26.8 tt0 -40.47 -57.0 1.92 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.733 1.613 . . . . 10.0 110.255 -178.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -46.61 89.84 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.369 -0.832 . . . . 10.0 111.012 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.9 t -56.46 -53.77 53.58 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.207 1.003 . . . . 10.0 109.687 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.2 t -59.86 -39.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 O-C-N 121.655 -0.653 . . . . 10.0 110.055 178.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -47.13 -26.94 3.39 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-O 119.05 -0.861 . . . . 10.0 113.92 172.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -70.47 -27.94 64.61 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.125 1.462 . . . . 10.0 111.579 178.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.44 108.49 2.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 118.945 0.793 . . . . 10.0 110.8 178.452 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -39.65 -45.52 1.67 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.551 1.54 . . . . 10.0 111.922 170.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.37 17.43 1.92 Allowed Glycine 0 CA--C 1.536 1.38 0 N-CA-C 115.378 0.911 . . . . 10.0 115.378 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.48 109.39 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 104.213 -2.514 . . . . 10.0 104.213 167.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 t -74.38 -32.6 62.79 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.035 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -168.1 151.83 6.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.932 -1.506 . . . . 10.0 106.932 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.05 136.31 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 N-CA-C 107.779 -1.193 . . . . 10.0 107.779 177.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -142.07 92.61 2.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 t -93.47 108.58 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 C-N-CA 126.601 1.96 . . . . 10.0 107.38 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 72.11 1.35 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 10.0 109.721 -171.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -70.72 -49.79 43.18 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -172.264 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 126.155 1.782 . . . . 10.0 110.029 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -35.25 44.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.549 -0.75 . . . . 10.0 111.628 -176.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.49 -75.25 0.05 OUTLIER Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 177.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HG3' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -166.16 -177.92 4.37 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 126.671 1.988 . . . . 10.0 111.631 -178.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 HG23 ' A' ' 44' ' ' VAL . 61.9 t -89.61 96.54 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 -176.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -95.14 99.27 11.28 Favored 'General case' 0 C--N 1.334 -0.093 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.421 HG23 HG12 ' A' ' 42' ' ' VAL . 52.5 t -116.74 148.34 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -170.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.3 t -112.32 90.25 3.29 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 105.085 -2.191 . . . . 10.0 105.085 -174.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -89.71 144.17 26.2 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 126.972 2.109 . . . . 10.0 108.803 -178.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -97.57 94.52 7.04 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 167.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.88 -13.8 7.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.712 1.205 . . . . 10.0 111.973 170.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.6 t70 -71.59 -25.25 62.11 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.002 2.121 . . . . 10.0 110.346 173.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -121.8 -56.51 1.85 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 124.239 1.016 . . . . 10.0 109.668 -168.092 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.85 144.15 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 C-N-CA 125.691 1.596 . . . . 10.0 109.63 -175.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.4 p -97.67 142.82 28.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.432 0.634 . . . . 10.0 110.146 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.4 m -43.31 -43.28 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 127.978 2.511 . . . . 10.0 108.615 168.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -44.73 -44.3 9.11 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 117.652 -1.165 . . . . 10.0 111.269 178.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.47 -63.12 1.3 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.614 0.643 . . . . 10.0 110.25 177.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.499 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.3 mp -62.27 -51.58 70.61 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.366 1.066 . . . . 10.0 111.817 -176.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.72 -56.56 2.61 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.594 1.958 . . . . 10.0 109.763 171.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.96 -46.57 88.98 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.052 0.453 . . . . 10.0 110.314 175.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.56 -44.99 77.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.693 1.197 . . . . 10.0 111.154 -175.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.7 -49.8 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -49.56 -36.13 22.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.714 1.143 . . . . 10.0 112.939 177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -49.91 -61.34 2.19 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.554 1.142 . . . . 10.0 112.545 176.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -138.86 -17.41 1.08 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -174.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.55 -46.29 48.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 119.147 0.885 . . . . 10.0 110.915 175.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 58.17 93.45 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.932 2.093 . . . . 10.0 111.102 178.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 170.28 46.17 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.1 2.56 . . . . 10.0 112.869 173.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.08 86.17 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.107 -0.996 . . . . 10.0 109.071 173.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 8' ' ' VAL . . . -67.51 -41.36 84.56 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 174.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.32 155.92 0.52 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.239 1.816 . . . . 10.0 106.38 176.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.19 130.54 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 169.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -121.78 133.51 54.91 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.721 -1.585 . . . . 10.0 106.721 172.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.59 -134.68 2.86 Favored Glycine 0 N--CA 1.458 0.162 0 N-CA-C 108.471 -1.851 . . . . 10.0 108.471 177.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.41 ' C ' ' HZ3' ' A' ' 4' ' ' LYS . 25.9 ttt-85 . . . . . 0 C--O 1.252 1.185 0 N-CA-C 103.559 -2.756 . . . . 10.0 103.559 168.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -110.2 116.45 31.54 Favored 'General case' 0 N--CA 1.438 -1.034 0 O-C-N 124.756 1.285 . . . . 10.0 112.134 -165.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.8 pm0 -71.93 71.67 0.8 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.461 1.505 . . . . 10.0 111.479 175.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -72.39 151.43 42.65 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 123.445 1.593 . . . . 10.0 108.883 168.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.87 111.12 21.66 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.144 -2.539 . . . . 10.0 104.144 -176.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.411 ' HG ' HG22 ' A' ' 70' ' ' ILE . 9.0 mp -90.49 87.91 6.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.55 -2.019 . . . . 10.0 105.55 173.048 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -60.9 146.3 47.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.296 -1.32 . . . . 10.0 109.355 -177.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 66' ' ' ASP . 5.0 p -67.64 129.74 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 126.259 1.824 . . . . 10.0 113.547 -169.294 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -77.0 -51.42 11.12 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 127.623 2.369 . . . . 10.0 109.465 179.642 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.66 -0.67 1.7 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 120.467 -0.873 . . . . 10.0 114.181 175.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.26 171.06 4.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.873 1.337 . . . . 10.0 107.542 168.045 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.1 t -153.15 56.26 0.77 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.374 -1.343 . . . . 10.0 107.374 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.56 96.7 3.39 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.359 -1.349 . . . . 10.0 107.359 178.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -52.25 -21.73 3.72 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.304 0.483 . . . . 10.0 112.304 170.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -80.35 -35.72 35.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.845 -0.535 . . . . 10.0 110.166 -170.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.0 m -55.66 -74.13 0.05 OUTLIER 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.366 1.067 . . . . 10.0 108.167 169.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -44.58 -52.02 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 113.523 0.934 . . . . 10.0 113.523 -175.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.4 ptmm? -55.38 -31.18 61.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.205 0.911 . . . . 10.0 113.284 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.82 65.43 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 122.724 0.41 . . . . 10.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.45 -44.11 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-O 118.061 -0.971 . . . . 10.0 110.177 174.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -45.3 -45.1 11.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.525 1.057 . . . . 10.0 110.529 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.1 t -52.8 -48.92 66.57 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.497 0.665 . . . . 10.0 111.792 175.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 t -71.14 -38.47 72.25 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.931 1.292 . . . . 10.0 111.218 -178.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.25 -37.38 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.698 -0.626 . . . . 10.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -73.54 35.29 0.83 Allowed Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.605 1.097 . . . . 10.0 113.025 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -121.7 -43.53 2.37 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 128.825 2.85 . . . . 10.0 109.364 175.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.72 123.56 13.68 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-N 119.22 0.918 . . . . 10.0 109.727 -173.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -50.23 -41.57 50.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.246 1.018 . . . . 10.0 112.068 -174.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -25.78 69.94 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 116.233 -0.44 . . . . 10.0 113.588 178.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -74.62 108.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 O-C-N 119.643 -2.092 . . . . 10.0 106.197 172.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.8 -37.97 73.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.499 -0.773 . . . . 10.0 110.166 173.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.88 155.2 11.93 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.128 -1.434 . . . . 10.0 107.128 -176.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.13 137.76 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -149.8 91.72 1.83 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.266 -1.012 . . . . 10.0 108.266 176.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.08 110.44 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 124.327 1.051 . . . . 10.0 110.218 175.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.43 49.81 2.15 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 123.699 0.8 . . . . 10.0 112.114 -178.469 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -50.2 30.85 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.025 0.93 . . . . 10.0 111.429 -175.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -70.47 -36.2 73.74 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.565 0.746 . . . . 10.0 110.858 -175.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.79 -32.96 62.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.458 -177.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.73 -65.33 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.7 178.92 5.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 124.342 1.057 . . . . 10.0 112.631 -169.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.57 105.97 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 N-CA-C 107.075 -1.454 . . . . 10.0 107.075 176.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.14 117.86 35.26 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.183 -1.414 . . . . 10.0 107.183 -178.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 72.3 t -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -168.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.2 t -110.91 87.76 2.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.879 -1.896 . . . . 10.0 105.879 -169.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 58.6 m-85 -95.36 129.12 42.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.435 1.494 . . . . 10.0 109.959 -173.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -81.46 88.98 6.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.941 -0.763 . . . . 10.0 108.941 172.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.36 -11.16 1.11 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.611 0.967 . . . . 10.0 113.611 174.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -89.89 -2.9 58.28 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.571 1.078 . . . . 10.0 110.615 177.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -134.69 -54.52 0.83 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.889 0.876 . . . . 10.0 110.335 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -131.22 141.86 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 124.662 1.185 . . . . 10.0 109.911 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 30.7 p -107.77 153.6 22.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.679 0.752 . . . . 10.0 109.664 178.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.9 m -43.56 -37.07 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 C-N-CA 127.483 2.313 . . . . 10.0 111.056 169.046 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 7.1 tmtt? -47.97 -32.59 6.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.475 0.58 . . . . 10.0 111.77 176.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -71.57 -59.64 2.65 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.097 0.862 . . . . 10.0 111.108 171.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.8 -52.53 34.15 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 C-N-CA 124.18 0.992 . . . . 10.0 112.775 -170.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -47.98 -54.35 13.19 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.54 1.536 . . . . 10.0 109.486 178.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -51.14 -50.73 58.31 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.835 1.654 . . . . 10.0 109.71 172.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.96 76.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.04 0.536 . . . . 10.0 112.107 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -72.46 -37.03 56.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 O-C-N 120.61 -1.306 . . . . 10.0 111.258 178.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -51.3 -45.84 62.33 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.841 -1.162 . . . . 10.0 110.932 168.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -47.82 -62.2 1.57 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -147.15 55.65 1.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.838 0.455 . . . . 10.0 112.04 178.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -137.78 -54.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.84 -0.978 . . . . 10.0 111.039 176.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 64.69 107.0 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.323 1.849 . . . . 10.0 111.563 173.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.9 m-20 164.19 -25.73 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 125.368 1.467 . . . . 10.0 110.453 -169.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 60' ' ' ILE . 61.7 t -86.13 88.11 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 121.027 -1.046 . . . . 10.0 109.087 -174.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.98 69.5 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 108.618 -0.882 . . . . 10.0 108.618 177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 pttt -169.41 153.45 5.25 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 106.116 -1.809 . . . . 10.0 106.116 177.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.411 HG22 ' HG ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.83 142.44 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 123.572 0.749 . . . . 10.0 109.312 173.501 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -93.88 84.82 4.62 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.821 -0.807 . . . . 10.0 108.821 169.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.86 -107.13 0.32 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.736 -0.48 . . . . 10.0 112.23 169.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 114.996 -2.43 . . . . 10.0 105.522 -169.511 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mpp? . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 106.503 -1.666 . . . . 10.0 106.503 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -125.2 177.3 6.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.992 1.317 . . . . 10.0 109.399 -174.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -147.35 82.55 1.54 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.015 0.926 . . . . 10.0 109.292 179.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' NZ ' ' OXT' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -89.48 165.39 14.34 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.557 1.143 . . . . 10.0 108.966 173.736 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.1 m -120.46 111.28 17.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.314 1.846 . . . . 10.0 108.141 -168.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.586 HD21 HG22 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -87.99 83.32 7.06 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 178.646 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -63.08 147.41 50.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.127 -0.942 . . . . 10.0 110.288 -176.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG23 ' OD1' ' A' ' 66' ' ' ASP . 10.4 p -65.51 119.37 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 C-N-CA 126.983 2.113 . . . . 10.0 113.138 -169.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -66.04 -50.11 65.33 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.887 1.275 . . . . 10.0 110.094 179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.3 -22.48 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 116.048 -0.524 . . . . 10.0 112.242 -176.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.97 170.36 0.86 Allowed 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.539 1.162 . . . . 10.0 111.852 174.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -151.94 23.91 0.66 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.594 -179.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.7 t -103.88 92.69 4.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.963 -0.754 . . . . 10.0 108.963 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -52.77 -20.14 2.98 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.046 0.758 . . . . 10.0 113.046 171.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.08 -39.42 29.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.336 -0.852 . . . . 10.0 109.21 -175.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.4 m -56.68 -67.03 0.34 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 175.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -46.99 -50.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 119.281 -0.39 . . . . 10.0 111.887 -177.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -58.78 -31.09 68.08 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.761 0.71 . . . . 10.0 112.808 -175.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.26 -36.24 68.33 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 110.29 -0.263 . . . . 10.0 110.29 176.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.0 t -87.28 -39.24 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-O 118.437 -0.792 . . . . 10.0 110.951 176.185 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -41.64 -43.28 2.74 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.183 1.393 . . . . 10.0 110.964 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.8 -57.35 11.9 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 117.977 0.353 . . . . 10.0 110.88 174.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 t -58.64 -54.57 45.57 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.841 1.256 . . . . 10.0 109.968 -177.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.415 HG13 HG12 ' A' ' 56' ' ' ILE . 14.0 t -52.76 -42.89 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 124.201 1.001 . . . . 10.0 110.1 176.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.92 -38.19 83.06 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.748 1.166 . . . . 10.0 112.733 173.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.0 -27.55 65.79 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.36 1.08 . . . . 10.0 111.502 -178.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.91 104.24 0.53 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 119.572 -0.851 . . . . 10.0 109.196 171.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -26.3 -49.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.116 2.566 . . . . 10.0 114.11 169.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.99 -13.43 59.58 Favored Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.597 0.599 . . . . 10.0 114.597 -176.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.64 110.12 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 119.871 1.836 . . . . 10.0 106.469 171.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 t -82.21 -28.8 31.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.22 -176.415 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.04 159.17 17.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.599 -1.63 . . . . 10.0 106.599 176.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -135.62 128.95 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 177.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 78.5 1.83 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 174.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.66 116.91 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 C-N-CA 124.744 1.218 . . . . 10.0 108.504 176.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -149.36 46.96 0.97 Allowed 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.328 0.651 . . . . 10.0 110.622 -175.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -54.09 -43.4 70.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.079 0.551 . . . . 10.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.03 -40.45 75.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.862 1.265 . . . . 10.0 110.533 -176.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.92 -30.26 50.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.653 -0.703 . . . . 10.0 111.51 -178.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 -61.0 0.08 OUTLIER Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.539 0.59 . . . . 10.0 112.457 -179.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -170.06 176.05 4.81 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.484 1.514 . . . . 10.0 112.087 -171.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.54 96.1 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 106.109 -1.811 . . . . 10.0 106.109 177.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.71 118.85 31.03 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.512 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 40.6 t -129.22 146.21 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -169.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.6 t -106.93 71.03 0.82 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.38 -1.711 . . . . 10.0 106.38 -173.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 22.0 m-85 -67.34 142.34 56.83 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 113.64 -1.618 . . . . 10.0 107.435 179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -100.83 94.71 6.19 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 123.018 0.527 . . . . 10.0 109.954 169.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.54 -15.42 2.82 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.105 0.962 . . . . 10.0 113.443 174.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.71 -9.52 58.78 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.079 0.854 . . . . 10.0 110.009 -179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -126.25 -54.61 1.47 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.367 1.067 . . . . 10.0 108.49 -175.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.0 t -133.97 144.38 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 C-N-CA 124.817 1.247 . . . . 10.0 110.482 -178.755 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 m -101.58 139.24 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 -179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.407 HG13 ' H ' ' A' ' 53' ' ' VAL . 9.4 m -34.24 -50.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 C-N-CA 129.9 3.28 . . . . 10.0 110.877 176.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -29.71 -53.23 0.14 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.06 1.344 . . . . 10.0 112.491 172.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.05 -63.14 1.24 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.089 0.956 . . . . 10.0 110.679 177.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.415 HG12 HG13 ' A' ' 24' ' ' VAL . 2.7 mp -64.51 -54.49 29.92 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 C-N-CA 125.97 1.708 . . . . 10.0 111.779 -176.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 70' ' ' ILE . . . -38.49 -60.56 0.79 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.016 2.126 . . . . 10.0 110.403 171.165 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -59.54 -46.21 89.54 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.006 0.522 . . . . 10.0 110.569 176.819 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.19 71.36 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.023 0.929 . . . . 10.0 111.489 -178.049 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.46 HG22 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -67.71 -59.27 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 174.858 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -41.8 -45.13 3.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.647 0.779 . . . . 10.0 112.249 -176.371 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -32.8 -50.91 0.28 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.493 1.517 . . . . 10.0 114.675 174.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -152.22 -37.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.096 0.959 . . . . 10.0 113.003 178.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -53.51 -44.24 67.4 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.424 -0.671 . . . . 10.0 111.424 178.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 66.44 169.6 0.23 Allowed 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.266 1.426 . . . . 10.0 110.5 -178.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 8' ' ' VAL . 12.1 t70 104.06 21.73 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 126.588 1.955 . . . . 10.0 112.4 171.579 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG22 HD21 ' A' ' 6' ' ' LEU . 21.3 t -102.53 77.95 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.943 1.697 . . . . 10.0 108.697 -177.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.31 -52.16 43.81 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 122.663 1.221 . . . . 10.0 108.446 176.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.51 127.92 2.88 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 104.829 -2.285 . . . . 10.0 104.829 176.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.405 HG21 ' HB2' ' A' ' 57' ' ' ALA . 3.6 tp -89.71 124.93 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 106.029 -1.841 . . . . 10.0 106.029 168.103 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -60.45 176.32 0.37 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.496 0.665 . . . . 10.0 109.802 174.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.96 75.18 0.18 Allowed Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -173.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.463 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 19.7 ttm180 . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 167.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttp . . . . . 0 N--CA 1.471 0.604 0 CA-C-O 119.107 -0.473 . . . . 10.0 109.933 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -149.12 179.46 7.87 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 106.11 -1.811 . . . . 10.0 106.11 169.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -135.51 133.2 38.2 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 126.93 2.092 . . . . 10.0 106.616 169.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.01 -178.07 4.8 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 103.64 -2.726 . . . . 10.0 103.64 168.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.46 124.1 13.29 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.185 -2.524 . . . . 10.0 104.185 -177.007 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.654 HD12 HG11 ' A' ' 42' ' ' VAL . 4.0 mt -88.26 89.25 7.91 Favored 'General case' 0 C--O 1.223 -0.303 0 N-CA-C 105.102 -2.184 . . . . 10.0 105.102 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -53.44 143.33 19.58 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.423 0.556 . . . . 10.0 110.314 -174.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.31 132.63 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 124.179 0.992 . . . . 10.0 112.745 -168.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -86.13 -47.26 9.67 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.811 2.444 . . . . 10.0 111.249 -176.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 171.87 -37.27 0.16 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-O 119.653 -0.526 . . . . 10.0 113.149 -174.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.92 155.97 38.24 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 118.054 0.927 . . . . 10.0 109.567 175.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.3 m -140.47 16.45 2.38 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.593 0.757 . . . . 10.0 110.535 175.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 t -88.99 103.76 16.35 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.921 -1.14 . . . . 10.0 107.921 -175.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -62.58 -1.64 0.87 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.171 -0.919 . . . . 10.0 113.398 174.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.7 -45.37 7.04 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 120.158 1.345 . . . . 10.0 110.572 179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.4 m -47.13 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.574 1.95 . . . . 10.0 109.844 175.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.585 HG21 HG11 ' A' ' 35' ' ' VAL . 5.8 m -36.47 -46.43 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.238 1.415 . . . . 10.0 112.767 173.011 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 2.5 tttm -55.27 -31.7 61.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 114.176 1.176 . . . . 10.0 114.176 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.31 -34.95 62.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.751 0.25 . . . . 10.0 110.548 171.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.6 t -89.07 -34.95 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 125.031 1.333 . . . . 10.0 110.942 175.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 30.9 tt0 -42.62 -47.37 5.25 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.553 1.141 . . . . 10.0 109.947 178.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -56.49 18.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.952 0.406 . . . . 10.0 111.112 177.144 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.9 m -62.92 -53.51 53.0 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.924 1.289 . . . . 10.0 110.963 -175.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.5 t -58.74 -43.87 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.923 0.889 . . . . 10.0 109.738 178.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.92 -42.01 69.05 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 123.595 0.617 . . . . 10.0 111.969 171.15 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -34.82 78.44 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.398 1.079 . . . . 10.0 111.038 178.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 105.21 1.92 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.222 -0.924 . . . . 10.0 110.025 179.132 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -32.96 -35.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.093 2.557 . . . . 10.0 114.173 170.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.19 5.4 2.83 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 116.115 1.206 . . . . 10.0 116.115 175.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.33 124.95 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 126.074 1.75 . . . . 10.0 107.24 169.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.4 t -92.32 -27.66 17.43 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.787 0.835 . . . . 10.0 111.028 175.378 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.14 151.47 10.14 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -179.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.56 ' HA ' HG22 ' A' ' 44' ' ' VAL . 14.2 m -136.64 128.76 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.779 1.232 . . . . 10.0 109.825 -177.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -151.49 100.17 2.69 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 124.295 1.038 . . . . 10.0 109.289 176.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.585 HG11 HG21 ' A' ' 17' ' ' VAL . 37.1 t -93.35 108.66 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 126.024 1.73 . . . . 10.0 109.329 -175.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 32.1 m-80 -128.1 53.44 1.8 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.097 0.559 . . . . 10.0 111.604 -176.049 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mp -41.93 -52.34 4.14 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.281 1.432 . . . . 10.0 112.259 -178.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.13 -36.47 83.23 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.668 0.787 . . . . 10.0 111.619 -177.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -81.16 -37.6 28.51 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.872 0.367 . . . . 10.0 110.448 -171.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.89 -69.91 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.649 -1.381 . . . . 10.0 109.649 177.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.97 -171.88 1.91 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.513 1.525 . . . . 10.0 109.342 178.191 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG11 HD12 ' A' ' 6' ' ' LEU . 2.8 p -84.81 133.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.016 0.927 . . . . 10.0 108.873 168.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.4 96.21 5.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.858 1.263 . . . . 10.0 108.265 175.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 33' ' ' VAL . 17.7 t -105.44 149.71 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.835 1.654 . . . . 10.0 107.684 -178.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.4 t -106.71 77.21 1.17 Allowed 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.912 -1.884 . . . . 10.0 105.912 -178.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CZ ' HD21 ' A' ' 6' ' ' LEU . 6.9 m-85 -74.45 131.84 41.4 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.29 -1.323 . . . . 10.0 108.469 -176.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.62 83.58 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.471 0.708 . . . . 10.0 109.091 171.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.59 -18.42 2.89 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.202 1.186 . . . . 10.0 114.202 170.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.64 -12.11 60.14 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.687 1.995 . . . . 10.0 110.033 178.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -131.42 -58.48 0.99 Allowed 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.76 1.624 . . . . 10.0 109.219 -172.704 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.1 t -131.39 141.09 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.966 1.706 . . . . 10.0 109.553 179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.3 p -90.18 149.0 22.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.511 -0.743 . . . . 10.0 109.837 178.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 4' ' ' LYS . 11.4 m -37.3 -46.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 C-N-CA 128.047 2.539 . . . . 10.0 109.431 167.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -42.22 -41.27 2.67 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 118.619 -0.705 . . . . 10.0 112.145 179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -57.76 -66.48 0.46 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.479 0.581 . . . . 10.0 110.52 171.611 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 56' ' ' ILE . 3.7 mp -58.52 -56.99 12.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 C-N-CA 125.306 1.442 . . . . 10.0 112.145 -175.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.426 ' HB1' HG11 ' A' ' 67' ' ' VAL . . . -37.93 -64.04 0.43 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.666 2.386 . . . . 10.0 110.137 172.551 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -62.46 -38.75 91.03 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.33 0.586 . . . . 10.0 110.185 -179.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.27 76.67 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.542 -0.723 . . . . 10.0 111.41 175.181 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.452 ' CG2' HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -70.46 -37.69 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 O-C-N 120.677 -1.265 . . . . 10.0 109.302 174.666 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -55.22 -42.34 73.24 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.035 1.288 . . . . 10.0 111.112 173.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -46.96 -66.98 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.681 0.792 . . . . 10.0 112.755 179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.6 52.22 2.06 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.956 0.502 . . . . 10.0 111.453 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.94 -69.3 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 173.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.5 t80 69.25 130.71 0.03 OUTLIER 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.08 1.752 . . . . 10.0 107.943 -169.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 158.88 -32.44 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.325 1.45 . . . . 10.0 109.965 -167.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.452 HG23 ' CG2' ' A' ' 60' ' ' ILE . 94.3 t -82.79 87.85 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 123.6 0.76 . . . . 10.0 111.602 -169.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.44 -53.72 17.89 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.685 -0.634 . . . . 10.0 109.671 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -168.1 167.77 12.25 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 178.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.65 HG22 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -98.73 148.44 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 126.685 1.994 . . . . 10.0 110.536 173.013 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -95.79 -63.53 1.15 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.685 0.794 . . . . 10.0 112.453 179.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.81 -61.05 7.81 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 -169.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.262 0 N-CA-C 105.408 -2.071 . . . . 10.0 105.408 164.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mmt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 106.821 -1.548 . . . . 10.0 106.821 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -96.16 118.59 33.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 123.981 0.801 . . . . 10.0 111.256 -167.013 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -66.55 81.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.479 0.711 . . . . 10.0 110.498 169.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -85.86 157.94 20.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.147 0.975 . . . . 10.0 109.028 168.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.25 101.25 8.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.458 -2.053 . . . . 10.0 105.458 -171.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.467 ' CB ' HG13 ' A' ' 42' ' ' VAL . 8.1 mt -72.18 101.39 2.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 105.058 -2.201 . . . . 10.0 105.058 167.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -77.34 147.77 35.97 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.71 128.84 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 125.941 1.697 . . . . 10.0 112.901 -170.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -69.41 -61.55 1.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.308 2.243 . . . . 10.0 108.964 177.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.51 -35.2 0.04 OUTLIER Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.358 -0.69 . . . . 10.0 113.3 -169.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.91 178.24 2.76 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.593 1.197 . . . . 10.0 110.421 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.9 p -141.42 -50.98 0.43 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.453 -169.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 24.8 t -32.46 93.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.987 1.715 . . . . 10.0 113.202 -175.87 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -54.73 -9.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 174.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -88.46 -43.14 11.67 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.407 1.003 . . . . 10.0 110.166 -177.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.4 m -50.58 -68.18 0.19 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.746 0.818 . . . . 10.0 109.375 175.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 37' ' ' LEU . 2.6 m -46.61 -46.79 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 116.672 -0.24 . . . . 10.0 111.338 178.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.84 -36.4 64.99 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.138 1.162 . . . . 10.0 114.138 179.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.68 54.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.517 0.675 . . . . 10.0 110.02 176.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.14 -38.78 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 117.832 -1.08 . . . . 10.0 110.893 175.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 4.5 tt0 -36.89 -52.73 0.94 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.922 1.689 . . . . 10.0 111.015 176.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 p -58.07 -49.43 76.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.101 0.56 . . . . 10.0 111.399 178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.3 m -62.93 -48.23 79.83 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.326 0.65 . . . . 10.0 110.402 -177.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 30' ' ' VAL . 54.0 t -59.45 -42.72 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 123.863 0.865 . . . . 10.0 109.69 176.375 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.21 -43.35 56.82 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 123.579 0.609 . . . . 10.0 112.09 170.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.96 -30.32 70.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.585 0.692 . . . . 10.0 111.984 177.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 110.38 2.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.608 1.094 . . . . 10.0 110.431 177.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -35.31 -43.7 0.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.184 2.194 . . . . 10.0 113.081 173.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.94 20.22 1.92 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.223 0.849 . . . . 10.0 115.223 -179.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 24' ' ' VAL . 1.4 t -125.13 113.46 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 169.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.8 t -72.72 -33.79 66.66 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.457 177.846 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -169.24 159.75 9.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 -177.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 44' ' ' VAL . 39.8 t -134.01 137.04 52.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.506 1.522 . . . . 10.0 107.695 179.138 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -136.31 82.47 1.94 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 125.599 1.56 . . . . 10.0 107.185 168.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -64.19 130.05 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 114.96 -1.018 . . . . 10.0 108.892 174.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -161.86 44.75 0.16 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.06 0.457 . . . . 10.0 111.11 -173.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 17' ' ' VAL . 1.6 pt? -57.68 -47.03 83.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.385 0.674 . . . . 10.0 112.114 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 -64.38 -36.19 83.35 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.766 1.226 . . . . 10.0 110.106 179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -28.99 38.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.516 -178.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 172.43 -60.56 0.15 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.303 0.954 . . . . 10.0 112.346 -177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -170.65 166.33 8.09 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.09 1.356 . . . . 10.0 110.592 -171.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.467 HG13 ' CB ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -90.72 118.15 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 172.488 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.08 120.05 40.26 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 175.655 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 46' ' ' PHE . 56.1 t -131.48 138.9 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -170.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 56.7 m -92.51 67.28 4.69 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 104.738 -2.319 . . . . 10.0 104.738 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' CE1' ' HB ' ' A' ' 44' ' ' VAL . 45.6 m-85 -69.32 139.7 54.28 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.911 -1.515 . . . . 10.0 106.911 -177.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.59 88.6 5.93 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.975 -1.121 . . . . 10.0 107.975 -176.116 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.65 -24.01 45.46 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.443 0.534 . . . . 10.0 112.443 -178.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -77.76 -17.97 56.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.749 1.62 . . . . 10.0 110.253 -177.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -107.62 -55.09 2.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.222 1.009 . . . . 10.0 108.401 -173.103 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.33 178.49 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 124.656 1.182 . . . . 10.0 108.931 178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 p -112.75 152.22 29.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.353 -0.61 . . . . 10.0 109.353 174.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -32.17 -44.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 129.74 3.216 . . . . 10.0 110.656 168.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -30.05 -53.6 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.42 1.088 . . . . 10.0 111.578 171.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.96 -59.1 5.08 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.592 0.757 . . . . 10.0 111.366 178.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -68.31 -53.68 26.99 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 C-N-CA 125.096 1.358 . . . . 10.0 111.727 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.59 -55.7 2.82 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 126.235 1.814 . . . . 10.0 110.226 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.79 -45.93 88.72 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.728 -0.607 . . . . 10.0 110.695 174.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -52.16 -48.13 65.11 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.675 0.39 . . . . 10.0 111.183 178.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.531 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.1 mp -71.25 -35.98 60.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.245 -0.909 . . . . 10.0 110.306 178.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.13 -37.99 72.83 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.702 1.137 . . . . 10.0 111.624 173.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -55.72 -66.9 0.34 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.455 0.57 . . . . 10.0 111.533 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.9 39.32 2.98 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 113.049 0.759 . . . . 10.0 113.049 -174.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.75 -58.28 0.09 OUTLIER Glycine 0 CA--C 1.527 0.836 0 CA-C-O 118.92 -0.933 . . . . 10.0 112.348 -178.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 66.76 109.3 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.038 2.135 . . . . 10.0 110.938 178.081 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 166.92 -29.89 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 10.0 110.664 -168.198 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' CG2' ' A' ' 60' ' ' ILE . 40.6 t -68.14 85.16 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 O-C-N 121.077 -1.014 . . . . 10.0 112.229 -171.132 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.75 -57.23 4.13 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-O 121.808 0.813 . . . . 10.0 108.811 170.714 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.8 tttp -175.93 146.26 0.7 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 -171.526 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.76 133.26 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 C-N-CA 124.524 1.129 . . . . 10.0 109.18 168.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -113.87 134.8 54.58 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.816 -1.92 . . . . 10.0 105.816 168.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.7 -121.57 1.68 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 109.984 -1.246 . . . . 10.0 109.984 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.415 -1.278 . . . . 10.0 111.301 -176.228 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 106.496 -1.668 . . . . 10.0 106.496 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.0 155.37 13.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.848 -0.741 . . . . 10.0 112.586 -165.169 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -71.26 63.47 0.36 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 10.0 110.569 172.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' NZ ' ' OXT' ' A' ' 73' ' ' ARG . 24.9 mttm -69.8 172.48 7.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.315 1.055 . . . . 10.0 108.206 168.316 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.2 t -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 -175.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.13 104.89 15.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 106.033 -1.84 . . . . 10.0 106.033 177.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -62.55 150.09 41.35 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.705 0.802 . . . . 10.0 108.912 176.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.3 t -64.22 123.8 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 125.51 1.524 . . . . 10.0 111.063 -172.676 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -67.44 -45.48 75.9 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.594 1.558 . . . . 10.0 109.505 174.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.34 -8.41 0.39 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-O 118.855 -0.97 . . . . 10.0 114.094 -176.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.93 179.45 1.47 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 119.425 1.612 . . . . 10.0 110.843 175.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 t -160.04 41.09 0.19 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.6 t -122.9 93.79 4.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.378 0.671 . . . . 10.0 109.672 176.372 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -55.92 -10.13 0.72 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.042 1.497 . . . . 10.0 115.042 172.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -87.94 -50.3 6.52 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 120.097 1.317 . . . . 10.0 109.609 -176.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.1 m -46.53 -62.62 1.29 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.196 0.998 . . . . 10.0 109.959 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -45.73 -52.58 2.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 122.41 0.284 . . . . 10.0 111.553 176.414 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.406 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 4.2 tmtp? -56.88 -37.49 71.44 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.811 0.844 . . . . 10.0 112.68 -178.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.31 -41.75 51.51 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 109.341 -0.615 . . . . 10.0 109.341 173.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.6 t -79.93 -36.69 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 CA-C-O 117.229 -1.367 . . . . 10.0 111.592 173.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 3.5 tp10 -43.54 -51.15 6.95 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.888 1.677 . . . . 10.0 110.001 -177.229 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.46 -47.98 83.4 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.278 0.561 . . . . 10.0 111.387 177.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 t -60.31 -40.73 91.6 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.471 1.108 . . . . 10.0 110.752 -177.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.5 -39.11 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.933 0.893 . . . . 10.0 109.846 178.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.76 -23.93 46.53 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.416 1.008 . . . . 10.0 112.281 178.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.33 -32.33 68.45 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 124.318 1.047 . . . . 10.0 110.655 177.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.43 111.97 2.9 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 121.179 -0.951 . . . . 10.0 110.688 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -37.54 -37.88 0.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.683 2.793 . . . . 10.0 112.973 174.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.47 4.55 81.27 Favored Glycine 0 CA--C 1.531 1.072 0 N-CA-C 115.448 0.939 . . . . 10.0 115.448 -177.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.13 107.65 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 104.289 -2.485 . . . . 10.0 104.289 167.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.79 -28.72 55.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -165.26 157.29 15.22 Favored 'General case' 0 C--N 1.344 0.343 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 178.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.2 m -137.69 140.61 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.609 1.564 . . . . 10.0 109.013 -177.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -155.72 80.65 1.02 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.544 1.537 . . . . 10.0 109.078 173.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.33 115.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 O-C-N 121.688 -0.633 . . . . 10.0 109.885 169.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 14.6 m120 -143.86 48.52 1.41 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.901 0.881 . . . . 10.0 110.71 -179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -55.74 25.11 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.392 0.677 . . . . 10.0 111.261 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.64 -22.47 64.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.815 -0.553 . . . . 10.0 110.324 -172.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -85.4 -35.45 21.32 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.948 0.899 . . . . 10.0 111.287 177.57 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.09 -72.1 0.06 OUTLIER Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.125 0.869 . . . . 10.0 112.49 -171.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.72 176.77 5.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.283 2.233 . . . . 10.0 110.933 -175.088 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 75.3 t -96.35 102.71 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 124.186 0.994 . . . . 10.0 108.486 -177.318 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -84.14 132.13 34.71 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.05 0.94 . . . . 10.0 108.583 -179.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.88 129.52 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 O-C-N 121.528 -0.732 . . . . 10.0 110.001 -172.027 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.5 m -96.49 80.99 3.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 107.147 -1.427 . . . . 10.0 107.147 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.439 ' CE2' HG12 ' A' ' 53' ' ' VAL . 42.2 m-85 -81.63 130.64 35.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.429 -0.805 . . . . 10.0 110.234 -178.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -91.69 87.23 6.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.422 1.889 . . . . 10.0 108.653 174.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.41 -20.51 2.87 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.593 1.157 . . . . 10.0 113.293 171.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -65.42 -25.27 67.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.657 1.583 . . . . 10.0 109.237 177.236 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 -59.0 1.96 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 125.959 1.704 . . . . 10.0 109.155 -170.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.0 m -140.05 154.21 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 123.826 0.851 . . . . 10.0 110.742 178.678 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 t -100.01 160.09 14.58 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 122.13 0.966 . . . . 10.0 111.016 177.227 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' CE2' ' A' ' 46' ' ' PHE . 31.1 m -48.22 -35.74 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 C-N-CA 128.187 2.595 . . . . 10.0 109.418 166.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -52.53 -28.2 19.71 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.193 0.906 . . . . 10.0 112.392 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -70.09 -62.98 1.18 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.346 0.976 . . . . 10.0 109.358 169.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 56' ' ' ILE . 4.0 mp -65.66 -51.39 63.1 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.318 0 O-C-N 121.512 -0.743 . . . . 10.0 112.491 -169.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -44.05 -53.51 6.27 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.013 1.725 . . . . 10.0 109.872 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -60.84 -49.11 78.82 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.818 0.847 . . . . 10.0 110.05 175.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.13 -42.46 66.06 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.569 1.147 . . . . 10.0 111.595 -179.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -71.38 -56.39 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 118.215 -0.897 . . . . 10.0 108.832 174.488 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -34.5 59.06 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.883 1.219 . . . . 10.0 112.105 -171.264 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -38.19 -54.82 1.36 Allowed 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.935 1.694 . . . . 10.0 113.527 172.172 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -144.86 -38.39 0.27 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.572 0.953 . . . . 10.0 113.572 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 -47.89 85.56 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 66.32 171.38 0.24 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.025 1.33 . . . . 10.0 109.958 -176.012 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.269 0.1 OUTLIER 102.13 3.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 127.425 2.29 . . . . 10.0 113.203 174.752 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 60' ' ' ILE . 38.6 t -88.65 88.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 124.806 1.242 . . . . 10.0 110.173 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.56 -58.44 4.29 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 169.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -175.36 152.88 1.44 Allowed 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.942 -1.503 . . . . 10.0 106.942 -175.688 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.25 147.1 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 123.81 0.844 . . . . 10.0 111.811 173.682 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -111.06 -123.07 0.27 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 167.294 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 66.27 -67.8 0.15 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 125.491 1.52 . . . . 10.0 112.541 -170.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 N-CA-C 107.856 -1.165 . . . . 10.0 107.856 -174.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' N ' ' OD2' ' A' ' 49' ' ' ASP . 29.6 ttp . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.3 -0.63 . . . . 10.0 109.3 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -131.14 137.51 49.07 Favored 'General case' 0 C--N 1.343 0.32 0 O-C-N 123.795 0.684 . . . . 10.0 111.808 -168.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -84.6 99.19 10.61 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.662 1.185 . . . . 10.0 110.276 174.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -98.65 164.84 12.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 167.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.82 113.78 21.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.072 -1.825 . . . . 10.0 106.072 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.581 ' HB2' HG13 ' A' ' 42' ' ' VAL . 5.7 mt -80.88 83.19 6.67 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 104.668 -2.345 . . . . 10.0 104.668 174.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -55.82 147.02 20.04 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.277 -0.638 . . . . 10.0 109.277 -176.3 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.28 130.57 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 112.938 0.718 . . . . 10.0 112.938 -169.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -66.39 -48.6 69.59 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.847 1.659 . . . . 10.0 107.468 172.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.33 11.76 0.12 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.4 -1.222 . . . . 10.0 114.624 175.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -175.27 2.55 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 120.382 2.091 . . . . 10.0 108.52 173.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 t -170.17 58.45 0.04 OUTLIER 'General case' 0 N--CA 1.458 -0.059 0 N-CA-C 107.649 -1.241 . . . . 10.0 107.649 173.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.8 t -132.16 108.94 9.6 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 174.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -66.04 -10.56 41.16 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.11 0.964 . . . . 10.0 111.41 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -93.05 -48.27 6.58 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.538 0.735 . . . . 10.0 110.156 -171.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 23.3 m -43.64 -70.69 0.1 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.008 1.723 . . . . 10.0 110.197 171.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.591 HG21 HG11 ' A' ' 35' ' ' VAL . 4.1 m -39.56 -48.66 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.122 0 C-N-CA 123.962 0.905 . . . . 10.0 111.789 173.459 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HA ' ' CB ' ' A' ' 21' ' ' GLU . 5.5 tttp -54.07 -34.86 61.23 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -31.34 45.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.36 0.527 . . . . 10.0 110.542 174.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.3 t -96.01 -32.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 C-N-CA 125.498 1.519 . . . . 10.0 111.232 177.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 18' ' ' LYS . 27.8 tt0 -43.37 -47.58 6.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.154 1.382 . . . . 10.0 110.087 -179.323 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -44.62 -70.04 0.12 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.802 1.641 . . . . 10.0 111.836 169.711 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.5 t -58.59 -47.21 85.07 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.116 1.367 . . . . 10.0 110.57 -172.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.37 -42.99 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.023 0.529 . . . . 10.0 109.8 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.31 -45.35 74.97 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.419 0.533 . . . . 10.0 111.769 170.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -61.52 -36.42 80.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 10.0 111.632 178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 95.65 0.21 Allowed 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.276 -0.89 . . . . 10.0 109.972 177.131 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -28.03 -41.94 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.942 2.497 . . . . 10.0 114.902 173.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.83 5.15 0.56 Allowed Glycine 0 CA--C 1.542 1.756 0 C-N-CA 124.885 1.231 . . . . 10.0 115.74 174.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.74 111.31 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 104.474 -2.417 . . . . 10.0 104.474 169.083 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 t -74.08 -30.59 62.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 178.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -167.32 156.78 10.45 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.874 -1.528 . . . . 10.0 106.874 178.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 m -128.58 145.86 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 O-C-N 123.927 0.767 . . . . 10.0 109.677 177.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -160.29 96.67 1.2 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 173.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 17' ' ' VAL . 25.7 t -87.3 120.34 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.08 49.8 2.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.424 0.556 . . . . 10.0 110.023 -174.118 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -42.46 -53.96 4.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.655 1.582 . . . . 10.0 111.557 -177.244 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.86 -35.68 74.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.508 0.723 . . . . 10.0 111.706 -177.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.72 -32.65 41.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.424 -0.353 . . . . 10.0 110.978 -171.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.95 -73.59 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.413 -1.475 . . . . 10.0 109.413 179.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -171.87 1.93 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 127.129 2.171 . . . . 10.0 108.582 177.195 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -85.76 128.44 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 172.255 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -120.98 100.78 7.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.564 -1.273 . . . . 10.0 107.564 176.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.48 HG23 ' CG2' ' A' ' 42' ' ' VAL . 25.7 t -110.83 148.58 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.649 1.58 . . . . 10.0 106.97 -175.422 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 t -101.25 72.19 1.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.034 -1.839 . . . . 10.0 106.034 -175.393 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 44' ' ' VAL . 27.6 m-85 -75.82 134.68 40.32 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 114.74 -1.118 . . . . 10.0 109.112 -172.07 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -83.03 81.17 8.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 121.492 -0.755 . . . . 10.0 109.81 177.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.42 -25.97 0.49 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.865 1.266 . . . . 10.0 113.252 169.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.475 ' OD2' ' N ' ' A' ' 1' ' ' MET . 21.9 m-20 -83.0 -22.54 33.6 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 126.325 1.85 . . . . 10.0 110.294 -173.255 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -117.67 -48.74 2.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.378 0.671 . . . . 10.0 109.448 -169.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.0 m -124.15 -170.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 125.445 1.498 . . . . 10.0 108.836 177.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.9 m -143.64 144.48 31.91 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 169.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 m -32.35 -42.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 C-N-CA 130.524 3.529 . . . . 10.0 111.596 174.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -29.67 -55.88 0.16 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.192 0.997 . . . . 10.0 111.522 170.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -51.75 -67.45 0.25 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.721 1.208 . . . . 10.0 110.75 175.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 56' ' ' ILE . 4.0 mp -60.32 -55.49 23.95 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.334 0 C-N-CA 124.296 1.038 . . . . 10.0 111.869 -175.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.83 -59.94 1.53 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.886 2.074 . . . . 10.0 110.572 172.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.88 -46.86 78.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.763 0.792 . . . . 10.0 110.39 176.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.78 -42.84 80.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.102 0.961 . . . . 10.0 111.45 -178.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.465 ' CG2' HG23 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -70.13 -43.85 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 O-C-N 121.045 -1.034 . . . . 10.0 108.765 175.105 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.18 -36.99 32.79 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 120.119 1.327 . . . . 10.0 112.27 176.027 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -53.54 -67.72 0.23 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.697 0.68 . . . . 10.0 112.584 176.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -129.48 14.87 6.05 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.97 -53.59 0.18 Allowed Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.212 0.911 . . . . 10.0 112.904 -169.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 63.4 169.97 0.15 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.241 2.216 . . . . 10.0 110.97 -172.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.288 1.3 p30 108.43 -8.24 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 129.395 3.078 . . . . 10.0 113.166 -176.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG23 ' CG2' ' A' ' 60' ' ' ILE . 53.4 t -74.2 81.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 124.302 1.041 . . . . 10.0 111.664 -178.023 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -72.33 -56.64 5.15 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 108.163 -1.051 . . . . 10.0 108.163 168.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -179.07 145.07 0.25 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.486 1.114 . . . . 10.0 108.433 -171.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -76.34 137.22 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.327 1.051 . . . . 10.0 110.061 169.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.76 -58.24 7.52 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.5 0.591 . . . . 10.0 111.326 174.742 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 106.32 104.22 2.93 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 115.905 -0.589 . . . . 10.0 111.672 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.479 0 N-CA-C 101.263 -3.606 . . . . 10.0 101.263 163.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_